|
5436 genotypes with 8915 annotations displayed
of selected term and subterms
|
|
Searched Term: abnormal nervous system physiology
|
5031439G07Rikem1(IMPC)Mbp/5031439G07Rikem1(IMPC)Mbp
(C57BL/6NCrl-5031439G07Rikem1(IMPC)Mbp/MbpMmucd)
|
increased prepulse inhibition
|
J:211773
|
7630403G23RikTg(Th-cre)1Tmd/7630403G23Rik+
Trpc5tm1.1Mfre/Trpc5tm1.1Mfre
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6N * SJL)
|
abnormal action potential
|
J:277600
|
9630013A20Rikem1Qrlu/9630013A20Rikem1Qrlu
(Not Specified)
|
dysmyelination
|
J:256017
|
A930011O12Rik/Mir124a-1tm1Tfur/A930011O12Rik/Mir124a-1tm1Tfur
(involves: 129S6/SvEvTac)
|
increased neuron apoptosis
|
J:179784
|
Aak1tm1b(EUCOMM)Hmgu/Aak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Aak1tm1b(EUCOMM)Hmgu/Orl)
|
increased prepulse inhibition
|
J:211773
|
Aanatrs216509331-A/Aanatrs216509331-A
(C57BL/6J)
|
abnormal pineal gland melatonin secretion
|
J:27126
|
| abnormal pineal gland physiology
|
J:27126
|
Aatktm1Shhi/Aatktm1Shhi
(involves: C57BL/6J)
|
abnormal axonal transport
|
J:184851
|
Abca1tm1Jdm/Abca1tm1Jdm
Tg(Thy1-APP)3Somm/0
(involves: C57BL/6J * DBA/1LacJ * DBA/2)
|
intracerebral hemorrhage
|
J:105902
|
Abca13em1Kueda/Abca13em1Kueda
(C57BL/6N-Abca13em1Kueda/Kueda)
|
abnormal neuron physiology
|
J:304162
|
| abnormal synaptic vesicle endocytosis
|
J:304162
|
| decreased prepulse inhibition
|
J:304162
|
Abca13tm1b(EUCOMM)Wtsi/Abca13tm1b(EUCOMM)Wtsi
(C57BL/6N-Abca13tm1b(EUCOMM)Wtsi/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Abcb1atm1Bor/Abcb1atm1Bor
(involves: 129P2/OlaHsd * FVB)
|
impaired blood-brain barrier function
|
J:18554
|
Abcb9tm1b(KOMP)Wtsi/Abcb9tm1b(KOMP)Wtsi
(C57BL/6N-Abcb9tm1b(KOMP)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Abcc4tm1Jsch/Abcc4tm1Jsch
(involves: 129X1/SvJ)
|
abnormal blood-brain barrier function
|
J:92788
|
| abnormal blood-cerebrospinal fluid barrier function
|
J:92788
|
Abcc4tm1Kruh/Abcc4tm1Kruh
(B6.129-Abcc4tm1Kruh)
|
abnormal blood-brain barrier function
|
J:117326
|
Abcc9em1Nich/Abcc9+
(involves: C57BL/6J * CBA/J)
|
abnormal channel response
|
J:281903
|
Abcc9em1Nich/Abcc9em1Nich
(involves: C57BL/6J * CBA/J)
|
abnormal channel response
|
J:281903
|
Abcc9em2Nich/Abcc9em2Nich
(involves: C57BL/6J * CBA/J)
|
abnormal channel response
|
J:281630
|
Abcd1tm1Kds/Y
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal myelination
|
J:94583
|
| abnormal nerve conduction
|
J:94583
|
| abnormal nervous system physiology
|
J:94583
|
Abcd1tm1Kds/Y
Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
abnormal nerve conduction
|
J:94583
|
| abnormal nervous system electrophysiology
|
J:104122
|
| abnormal nervous system physiology
|
J:94583
|
Abcd1tm1Kds/Abcd1tm1Kds
(involves: 129/Sv * 129S4/SvJae * C57BL/6J)
|
abnormal myelination
|
J:75388
|
| abnormal nerve conduction
|
J:75388
|
Abcd2tm1Apuj/Abcd2tm1Apuj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:104122
|
| abnormal nervous system physiology
|
J:104122
|
Abce1tm1.1(KOMP)Vlcg/Abce1+
(C57BL/6N-Abce1tm1.1(KOMP)Vlcg/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Abhd17aem1Eko/Abhd17aem1Eko
(involves: C57BL/6)
|
abnormal neuron physiology
|
J:329241
|
Abi2tm1b(EUCOMM)Wtsi/Abi2tm1b(EUCOMM)Wtsi
(C57BL/6N-Abi2tm1b(EUCOMM)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Abl1tm2.1Goff/Abl1tm2.1Goff
Abl2tm1Ajk/Abl2tm1Ajk
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
decreased cerebellar granule cell precursor proliferation
|
J:166211
|
Abrtm1Jhg/Abrtm1Jhg
Bcrtm1Hkp/Bcrtm1Hkp
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * Black Swiss * C57BL/6)
|
abnormal astrocyte physiology
|
J:72425
|
Abtb3tm1c(EUCOMM)Wtsi/Abtb3tm1c(EUCOMM)Wtsi
Slc32a1tm2(cre)Lowl/Slc32a1+
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal nervous system electrophysiology
|
J:337062
|
| decreased miniature excitatory postsynaptic current frequency
|
J:337062
|
| impaired synaptic physiology
|
J:337062
|
Acbd5tm1a(EUCOMM)Wtsi/Acbd5tm1a(EUCOMM)Wtsi
(C57BL/6N-Atm1Brd Acbd5tm1a(EUCOMM)Wtsi/WtsiCnbc)
|
brain inflammation
|
J:299448
|
| demyelination
|
J:299448
|
Achetm1.1Hssh/Achetm1.1Hssh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal sympathetic nervous system physiology
|
J:140622
|
Achetm4Pata/Achetm4Pata
(involves: 129X1/SvJ * Black Swiss * C57BL/6 * FVB)
|
seizures
|
J:147855
|
Acot7tm1.1Mwol/Acot7tm1.1Mwol
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
decreased prepulse inhibition
|
J:203753
|
Acp2tm1Psa/Acp2tm1Psa
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6J)
|
tonic-clonic seizures
|
J:41986
|
Acsl6tm1.1Jeme/Acsl6tm1.1Jeme
(involves: BALB/cJ * C57BL/6)
|
abnormal microglial cell activation
|
J:267563
|
Actbtm1.1(tetO-COP4*/EYFP)Kftnk/Actb+
Tg(Mlc1-tTA)2Rhn/0
(involves: 129 * 129S4/SvJaeSor * C57BL/6 * CBA)
|
abnormal astrocyte physiology
|
J:193127
|
| abnormal neuron physiology
|
J:193127
|
Actl6btm1Grc/Actl6btm1Grc
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal myelination
|
J:132101
|
Acvr1tm1Mak/Acvr1+
Olig2tm1.1(cre)Wdr/Olig2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal glial cell physiology
|
J:285841
|
Acvrl1tm1Enl/Acvrl1+
(B6.Cg-Acvrl1tm1Enl)
|
abnormal sympathetic nervous system physiology
|
J:226550
|
Adam10tm2Psa/Adam10tm2Psa
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
intracranial hemorrhage
|
J:159624
|
Adam22tm1.1Mejr/Adam22tm1.1Mejr
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S4/SvJaeSor * C57BL/6J * CBA/J)
|
abnormal myelination
|
J:158973
|
Adam22tm1Sag/Adam22tm1Sag
(either: B6.Cg-Adam22tm1Sag or (involves: C57BL/6 * C57BL/6N * CBA))
|
abnormal myelination
|
J:99692
|
| convulsive seizures
|
J:99692
|
Adam22tm1Sag/Adam22tm1Sag
(involves: C57BL/6 * CBA)
|
demyelination
|
J:158973,
J:166449
|
Adam22tm1Sag/Adam22tm1Sag
Lgi4tm1Sjm/Lgi4tm1Sjm
(involves: C57BL/6 * CBA * SJL)
|
demyelination
|
J:166449
|
Adam23tm1.1Mejr/Adam23tm1.1Mejr
Pvalbtm1(cre)Arbr/Pvalb+
(involves: 129P2/OlaHsd)
|
abnormal neuron physiology
|
J:333962
|
Adamts4tm1Dgen/Adamts4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Adap1tm1.1Ryya/Adap1tm1.1Ryya
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
enhanced long-term potentiation
|
J:308995
|
Adarb1tm1Phs/Adarb1tm1Phs
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal AMPA-mediated synaptic currents
|
J:63273
|
| seizures
|
J:63273
|
Adcy1brl/Adcy1brl
(involves: C57BL/6)
|
abnormal somatosensory cortex physiology
|
J:32194
|
Adcy1brl/Adcy1brl
(B6.Cg-Adcy1brl)
|
abnormal excitatory postsynaptic currents
|
J:106269
|
| impaired synaptic plasticity
|
J:106269
|
Adcy1tm1.1Ito/Adcy1tm1.1Ito
(B6.129P2-Adcy1tm1.1Ito)
|
abnormal CNS synaptic transmission
|
J:137123
|
Adcy1tm1Drs/Adcy1tm1Drs
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:22287
|
Adcy1tm1Drs/Adcy1tm1Drs
Adcy8tm1Ljm/Adcy8tm1Ljm
(involves: 129/Sv * C57BL/6)
|
reduced long-term potentiation
|
J:57343
|
Adcy1tm1Ito/Adcy1tm1.1Ito
Emx1tm1(cre)Ito/Emx1+
(B6.129P2-Emx1tm1(cre)Ito Adcy1tm1Ito Adcy1tm1.1Ito)
|
decreased miniature excitatory postsynaptic current amplitude
|
J:137123
|
| reduced long-term potentiation
|
J:137123
|
Adcy1tm1Ito/Adcy1tm1.1Ito
Tg(Emx1-cre)3Ito/0
(B6.Cg-Adcy1tm1Ito Adcy1tm1.1Ito Tg(Emx1-cre)3Ito)
|
decreased miniature excitatory postsynaptic current amplitude
|
J:137123
|
| reduced long-term potentiation
|
J:137123
|
Adcy3tm1Drs/Adcy3tm1Drs
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:281839
|
| abnormal excitatory postsynaptic potential
|
J:281839
|
| abnormal neuron physiology
|
J:281839
|
| reduced long-term potentiation
|
J:281839
|
Adcy8tm1Ljm/Adcy8tm1Ljm
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
absent long-term depression
|
J:63173
|
Adcy8tm1Ljm/Adcy8tm1Ljm
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal single cell response
|
J:164682
|
Adcyap1tm1Clw/Adcyap1tm1Clw
(B6.129S4-Adcyap1tm1Clw)
|
increased microglial cell activation
|
J:194151
|
| increased susceptibility to dopaminergic neuron neurotoxicity
|
J:194151
|
Adcyap1r1tm1.1Gsc/Adcyap1r1tm1.1Gsc
(involves: 129P2/OlaHsd)
|
reduced long-term potentiation
|
J:76715
|
Add2tm1Llp/Add2tm1Llp
(B6.129S4-Add2tm1Llp/LlpJ)
|
abnormal CNS synaptic transmission
|
J:98208
|
| enhanced paired-pulse facilitation
|
J:98208
|
| impaired synaptic plasticity
|
J:98208
|
| increased post-tetanic potentiation
|
J:98208
|
| reduced long-term potentiation
|
J:98208
|
Adgra2tm1.1Bstc/Adgra2tm1.2Bstc
Tg(Tek-cre)12Flv/0
(B6.Cg-Adgra2tm1.1Bstc/Adgra2tm1.2Bstc Tg(Tek-cre)12Flv)
|
intracranial hemorrhage
|
J:171226
|
| spinal hemorrhage
|
J:171226
|
Adgra2tm1.2Bstc/Adgra2tm1.2Bstc
(B6.Cg-Adgra2tm1.2Bstc)
|
abnormal blood-cerebrospinal fluid barrier function
|
J:171226
|
| impaired blood-brain barrier function
|
J:171226
|
| intracranial hemorrhage
|
J:171226
|
| intraventricular hemorrhage
|
J:171226
|
| spinal hemorrhage
|
J:171226
|
Adgra2tm1Cjku/Adgra2tm1Cjku
(involves: 129)
|
abnormal nervous system physiology
|
J:166127
|
Adgrb1tm1Egvm/Adgrb1tm1Egvm
(involves: 129S6/SvEvTac * C57BL/6)
|
enhanced long-term potentiation
|
J:222100
|
| impaired synaptic plasticity
|
J:222100
|
| reduced long-term depression
|
J:222100
|
Adgrb3tm1Ksak/Adgrb3tm1Ksak
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal afterhyperpolarization
|
J:219706
|
| abnormal single cell response
|
J:219706
|
| absent long-term depression
|
J:219706
|
Adgrg1tm1Lex/Adgrg1tm1Lex
(involves: 129 * BALB/c * C57BL/6 * FVB/N)
|
abnormal cerebellar granule cell migration
|
J:149816
|
| abnormal neuronal migration
|
J:136385
|
Adgrg6em1Jlp/Adgrg6em1Jlp
(C57BL/6-Adgrg6em1Jlp)
|
abnormal myelination
|
J:315981
|
Adgrg6tm1Lex/Adgrg6tm1Lex
(involves: 129S/SvEvBrd * C57BL/6)
|
abnormal myelination
|
J:173574
|
Adgrl1tm1Sud/Adgrl1tm1Sud
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal nervous system physiology
|
J:115214
|
| decreased synaptic glutamate release
|
J:115214
|
Adgrl1tm1Sud/Adgrl1tm1Sud
Nrxn1tm1Sud/Nrxn1tm1Sud
(involves: 129 * 129S6/SvEvTac * C57BL/6)
|
abnormal nervous system physiology
|
J:115214
|
| abnormal synaptic glutamate release
|
J:115214
|
| decreased synaptic glutamate release
|
J:115214
|
Adgrv1frings/Adgrv1frings
(RB/1)
|
audiogenic seizures
|
J:25341
|
Adgrv1frings/Adgrv1frings
(BUB/BnJ)
|
audiogenic seizures
|
J:97534
|
Adgrv1tm1.1(KOMP)Vlcg/Adgrv1tm1.1(KOMP)Vlcg
(C57BL/6N-Adgrv1tm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Adgrv1tm1Msat/Adgrv1tm1Msat
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal cochlear outer hair cell physiology
|
J:122415
|
| abnormal hair cell mechanoelectric transduction
|
J:122415
|
| audiogenic seizures
|
J:95518
|
Adgrv1tm1Msat/Adgrv1tm1Msat
(B6.129P2-Adgrv1tm1Msat)
|
audiogenic seizures
|
J:95518
|
Adgrv1tm1Pwh/Adgrv1tm1Pwh
(involves: 129S1/Sv * C57BL/6J)
|
abnormal cochlear outer hair cell physiology
|
J:109595
|
| abnormal hair cell mechanoelectric transduction
|
J:109595
|
| audiogenic seizures
|
J:90899
|
Adktm2Bois/Adktm2Bois
Adora1tm1Bbf/Adora1tm1Bbf
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
environmentally induced seizures
|
J:237189
|
Adktm2Bois/Adktm2Bois
Adora2atm1Jfc/Adora2atm1Jfc
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
decreased susceptibility to induction of seizure by inducing agent
|
J:237189
|
Adktm2Bois/Adktm2Bois
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal CNS synaptic transmission
|
J:237189
|
| abnormal excitatory postsynaptic potential
|
J:237189
|
| abnormal synaptic plasticity
|
J:237189
|
| convulsive seizures
|
J:237189
|
| enhanced long-term potentiation
|
J:237189
|
| environmentally induced seizures
|
J:237189
|
| increased susceptibility to pharmacologically induced seizures
|
J:237189
|
Adnp2em3(IMPC)Tcp/Adnp2em3(IMPC)Tcp
(C57BL/6NCrl-Adnp2em3(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Adora1tm1Bbf/Adora1tm1Bbf
(involves: 129P2/OlaHsd * C57BL)
|
abnormal CNS synaptic transmission
|
J:70664
|
| abnormal excitatory postsynaptic currents
|
J:70664
|
| abnormal excitatory postsynaptic potential
|
J:70664
|
| decreased synaptic depression
|
J:70664
|
Adora1tm1Rgrn/Adora1tm1Rgrn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:120655
|
| abnormal nervous system electrophysiology
|
J:120655
|
Adora2atm1Jfc/Adora2atm1Jfc
(involves: 129S4/SvJae * C57BL/6)
|
decreased cerebral infarct size
|
J:73594
|
| decreased susceptibility to ischemic brain injury
|
J:73594
|
Adora2atm1Jfc/Adora2atm1Jfc
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
decreased cerebral infarct size
|
J:73594
|
| decreased susceptibility to ischemic brain injury
|
J:73594
|
Adora2btm1.1(KOMP)Vlcg/Adora2b+
(B6N(Cg)-Adora2btm1.1(KOMP)Vlcg/J)
|
convulsive seizures
|
J:211773
|
Adprstm1.2Jlms/Adprstm1.2Jlms
(involves: 129 * C57BL/6J * FVB/N * SJL)
|
increased susceptibility to ischemic brain injury
|
J:291285
|
Adra1btm1Cta/Adra1btm1Cta
(involves: 129P2/OlaHsd)
|
abnormal baroreceptor physiology
|
J:103581
|
Adra1dtm1Gzt/Adra1dtm1Gzt
(involves: 129X1/SvJ * C57BL/6)
|
abnormal prepulse inhibition
|
J:91151
|
Adra2atm1.1(KOMP)Vlcg/Adra2atm1.1(KOMP)Vlcg
(C57BL/6N-Adra2atm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Adra2atm1Bkk/Adra2atm1Bkk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal synaptic norepinephrine release
|
J:58591
|
Adra2atm1Bkk/Adra2atm1Bkk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal spike wave discharge
|
J:197965
|
Adra2atm1Bkk/Adra2atm1Bkk
Adra2ctm1Gsb/Adra2ctm1Gsb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2J)
|
abnormal synaptic norepinephrine release
|
J:58591
|
Afdnem1(IMPC)Mbp/Afdn+
(C57BL/6N-Afdnem1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Afdntm1.1Lfr/Afdntm1.1Lfr
Neurod6tm1(cre)Kan/Neurod6+
(involves: 129 * C57BL/6 * SJL)
|
abnormal excitatory postsynaptic potential
|
J:179366
|
Aff2tm1Dln/Y
(involves: 129/Sv * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:76005
|
| abnormal excitatory postsynaptic potential
|
J:76005
|
| enhanced long-term potentiation
|
J:76005
|
Aff3em1Andg/Aff3em1Andg
(chimera involves: 129S6/SvEvTac * C57BL/6NCrl * CD-1)
|
abnormal nervous system physiology
|
J:317476
|
Afg3l1tm1.1Arte/Afg3l1tm1.1Arte
Afg3l2tm1Arte/Afg3l2tm1Arte
Gt(ROSA)26Sortm1Lrsn/Gt(ROSA)26Sor+
Tg(Plp1-cre/ERT)3Pop/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * C57BL/6N)
|
abnormal oligodendrocyte physiology
|
J:237410
|
| demyelination
|
J:237410
|
Afg3l1tm1.1Arte/Afg3l1tm1.1Arte
Afg3l2tm1Arte/Afg3l2tm1Arte
Tg(Plp1-cre/ERT)3Pop/0
(involves: C57BL/6J * C57BL/6N)
|
demyelination
|
J:237410
|
Afg3l2Emv66/Afg3l2Emv66
(FVB.MEV2-Afg3l2Emv66/TyJ)
|
abnormal myelination
|
J:132285
|
Afg3l2par/Afg3l2par
(Not Specified)
|
abnormal miniature endplate potential
|
J:13950
|
| abnormal myelination
|
J:132285
|
Afg3l2tm1Arte/Afg3l2tm1Arte
Gt(ROSA)26Sortm1Lrsn/Gt(ROSA)26Sor+
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:193564
|
Afg3l2tm1Arte/Afg3l2tm1Arte
Tg(Plp1-cre/ERT)3Pop/0
(involves: C57BL/6J)
|
dysmyelination
|
J:237410
|
Aggf1Gt(PT036)Byg/Aggf1+
(involves: 129P2/OlaHsd * C57BL/6)
|
intracranial hemorrhage
|
J:239252
|
Agpat1tm1Garg/Agpat1tm1Garg
(involves: 129S6/SvEvTac * C57BL/6)
|
audiogenic seizures
|
J:250301
|
Agrntm1Jrs/Agrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal paired-pulse inhibition
|
J:79028
|
| increased post-tetanic potentiation
|
J:79028
|
Agrptm1(cre)Lowl/Agrp+
Slc32a1tm1Lowl/Slc32a1tm1Lowl
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:140858
|
Agrptm2(HBEGF)Rpa/Agrp+
Tg(Pomc-EGFP)1Low/0
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal inhibitory postsynaptic currents
|
J:132184
|
Agttm1Afu/Agttm1Afu
(involves: C57BL/6 * CBA)
|
impaired blood-brain barrier function
|
J:59299
|
Agtr2tm1Tin/Y
(involves: 129P2/OlaHsd)
|
abnormal baroreceptor physiology
|
J:103144
|
Ahrtm3.1Bra/Ahrtm3.1Bra
Tg(Nes-cre)1Kln/0
(involves: 129/Sv * C57BL/6 * SJL)
|
decreased susceptibility to ischemic brain injury
|
J:292713
|
Aifm1Hq/Y
(B6CBACa Aw-J/A-Aifm1Hq/J)
|
abnormal seizure response to pharmacological agent
|
J:98103
|
| decreased susceptibility to neuronal excitotoxicity
|
J:98103
|
Aifm1Hq/Aifm1Hq
(B6CBACa Aw-J/A-Aifm1Hq/J)
|
abnormal seizure response to pharmacological agent
|
J:98103
|
| decreased susceptibility to neuronal excitotoxicity
|
J:98103
|
Aifm1Hq/Aifm1Hq
Apaf1Gt(IRESBetageo)XIX18Pgr/Apaf1Gt(IRESBetageo)XIX18Pgr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased neuron apoptosis
|
J:98103
|
Aifm1tm2Pngr/Y
Foxg1tm1(cre)Skm/Foxg1+
(involves: 129P2/OlaHsd)
|
decreased neuron apoptosis
|
J:112874
|
| increased neuron apoptosis
|
J:112874
|
Airetm1.1(NCOM)Mfgc/Airetm1.1(NCOM)Mfgc
(C57BL/6N-Airetm1.1(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Airetm1Mand/Aire+
(NOD.129P2-Airetm1Mand)
|
CNS inflammation
|
J:135154
|
| demyelination
|
J:188686
|
Ak9em1Mdj/Ak9+
(C57BL/6-Ak9em1Mdj)
|
abnormal brain ependyma motile cilium physiology
|
J:344356
|
Ak9em1Mdj/Ak9em1Mdj
(C57BL/6-Ak9em1Mdj)
|
abnormal brain ependyma motile cilium physiology
|
J:344356
|
Akap5tm1.1Jsco/Akap5tm1.1Jsco
(involves: 129S * C57BL/6 * FVB/N)
|
abnormal AMPA-mediated synaptic currents
|
J:138972
|
| decreased susceptibility to pharmacologically induced seizures
|
J:138972
|
| reduced long-term depression
|
J:138972
|
Akap5tm1Gsm/Akap5tm1Gsm
(B6.129-Akap5tm1Gsm)
|
reduced long-term potentiation
|
J:127739
|
Akap5tm1Mdaq/Akap5tm1Mdaq
(involves: 129 * C57BL/6)
|
abnormal AMPA-mediated synaptic currents
|
J:191219
|
| abnormal excitatory postsynaptic potential
|
J:191219
|
| abnormal synaptic plasticity
|
J:191219
|
| absent long-term depression
|
J:191219
|
| enhanced long-term potentiation
|
J:191219
|
| reduced long-term depression
|
J:191219
|
Akap5tm2Mdaq/Akap5tm2Mdaq
(involves: 129 * C57BL/6)
|
abnormal synaptic plasticity
|
J:211790
|
Akap10Gt(RRC139)Byg/Akap10Gt(RRC139)Byg
(involves: 129P2/OlaHsd)
|
abnormal baroreceptor physiology
|
J:121838
|
Akr1c14tm1.1Penn/Akr1c14tm1.1Penn
(involves: FVB)
|
dysmyelination
|
J:323376
|
| hypermyelination
|
J:323376
|
Akt1tm1Mbb/Akt1tm1Mbb
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prepulse inhibition
|
J:185487
|
Akt1s1tm1.1Rrth/Akt1s1tm1.1Rrth
(B6(Cg)-Akt1s1tm1.1Rrth)
|
increased cerebral infarct size
|
J:231219
|
| increased susceptibility to ischemic brain injury
|
J:231219
|
Akt3Nmf350/Akt3+
(C57BL/6J-Akt3Nmf350)
|
abnormal seizure response to electrical stimulation
|
J:169028
|
| increased susceptibility to pharmacologically induced seizures
|
J:169028
|
| maximal tonic hindlimb extension seizures
|
J:169028
|
| sporadic seizures
|
J:169028
|
| tonic-clonic seizures
|
J:169028
|
Akt3Nmf350/Akt3Nmf350
(C57BL/6J-Akt3Nmf350)
|
abnormal seizure response to electrical stimulation
|
J:169028
|
| increased susceptibility to pharmacologically induced seizures
|
J:169028
|
| maximal tonic hindlimb extension seizures
|
J:169028
|
| tonic-clonic seizures
|
J:169028
|
Akt3tm1Hem/Akt3tm1Hem
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:98804
|
Akt3tm1Mbb/Akt3tm1Mbb
(involves: C57BL/6J)
|
abnormal seizure response to electrical stimulation
|
J:169028
|
| maximal tonic hindlimb extension seizures
|
J:169028
|
| tonic-clonic seizures
|
J:169028
|
Alcw2C57BL/6J/Alcw2C57BL/6J
(D2.B6-Alcw2C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:143371
|
Aldh3a2tm1a(EUCOMM)Wtsi/Aldh3a2tm1a(EUCOMM)Wtsi
(C57BL/6N-Aldh3a2tm1a(EUCOMM)Wtsi/Ics)
|
decreased prepulse inhibition
|
J:165965
|
Aldh5a1tm1Kmg/Aldh5a1tm1Kmg
(involves: 129/Sv * C57BL/6)
|
abnormal brain wave pattern
|
J:91856
|
| absence seizures
|
J:91856
|
| myoclonus
|
J:71949
|
| tonic seizures
|
J:71949
|
Aldh7a1tm1d(EUCOMM)Hmgu/Aldh7a1tm1d(EUCOMM)Hmgu
(B6(FVB)-Aldh7a1tm1d(EUCOMM)Hmgu)
|
seizures
|
J:298561
|
Aldh7a1tm1d(EUCOMM)Hmgu/Aldh7a1tm1d(EUCOMM)Hmgu
(129S1.B6N(FVB)-Aldh7a1tm1d(EUCOMM)Hmgu)
|
seizures
|
J:298561
|
Alg10bnse5/Alg10bnse5
(129S6.B6-Alg10bnse5)
|
absent cochlear microphonics
|
J:209766
|
Alg13em1Bayu/Y
(involves: C57BL/6J)
|
abnormal synaptic plasticity
|
J:275180
|
| environmentally induced seizures
|
J:275180
|
| increased susceptibility to pharmacologically induced seizures
|
J:275180
|
Alktm1.1Rhp/Alktm1.1Rhp
(involves: 129 * C57BL/6N)
|
abnormal hypothalamus secretion
|
J:226955
|
Alkbh1tm1Klng/Alkbh1tm1Klng
(involves: 129X1/SvJ * C57BL/6)
|
intracranial hemorrhage
|
J:166841
|
Alpk2em1(IMPC)J/Alpk2em1(IMPC)J
(C57BL/6NJ-Alpk2em1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Alpltm1(cre)Nagy/Alpl+
Phldb2tm1Msat/Phldb2tm1Msat
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JSlc * C57BL/6NCrlj * CBA/JNCrlj)
|
reduced long-term potentiation
|
J:275597
|
Alpltm1Jlm/Alpltm1Jlm
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))
|
intracranial hemorrhage
|
J:39015
|
| seizures
|
J:39015
|
Alpltm1Sor/Alpltm1Sor
(either: (involves: 129S7/SvEvBrd-Alpltm1Sor) or (involves: 129S7/SvEvBrd * C57BL/6))
|
seizures
|
J:28394
|
Als2tm1Garo/Als2tm1Garo
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal axonal transport
|
J:138147
|
Als2tm1Jei/Als2tm1Jei
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal action potential
|
J:104446
|
| CNS inflammation
|
J:104446
|
Ambra1em1(IMPC)Bay/Ambra1+
(C57BL/6N-Ambra1em1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Ambra1Gt(pGT1.8geo)1Fcec/Ambra1Gt(pGT1.8geo)1Fcec
(involves: C57BL/6)
|
increased embryonic neuroepithelial cell proliferation
|
J:122795
|
| increased embryonic neuroepithelium apoptosis
|
J:122795
|
Amphtm1Pdc/Amphtm1Pdc
(involves: 129/Sv * C57BL/6)
|
abnormal synaptic vesicle recycling
|
J:75306
|
| increased susceptibility to pharmacologically induced seizures
|
J:75306
|
| tonic seizures
|
J:75306
|
Ank2em1Bnt/Ank2em1Bnt
(C57BL/6J-Ank2em1Bnt)
|
abnormal miniature excitatory postsynaptic currents
|
J:277752
|
| decreased paired-pulse facilitation
|
J:277752
|
| increased miniature excitatory postsynaptic current amplitude
|
J:277752
|
| increased miniature excitatory postsynaptic current frequency
|
J:277752
|
Ank3tm1Bnt/Ank3tm1Bnt
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
convulsive seizures
|
J:51377
|
| impaired ability to fire action potentials
|
J:51377
|
Ank3tm3Bnt/Ank3tm3Bnt
Tg(Nes-cre)1Kln/?
(involves: 129S6/SvEvTac * C57BL/6 * SJL/J)
|
abnormal action potential
|
J:218905
|
| abnormal brain wave pattern
|
J:218905
|
| abnormal nervous system electrophysiology
|
J:218905
|
Ankfy1Gt(RRE069)Byg/Ankfy1+
(B6.129P2-Ankfy1Gt(RRE069)Byg)
|
increased brain apoptosis
|
J:250135
|
Ankrd11tm1b(EUCOMM)Wtsi/Ankrd11+
(C57BL/6N-Ankrd11tm1b(EUCOMM)Wtsi/Ics)
|
decreased prepulse inhibition
|
J:211773
|
Ankrd17tm1.1Yty/Ankrd17tm1.1Yty
(B6.129P2-Ankrd17tm1.1Yty)
|
intracranial hemorrhage
|
J:152840
|
Anks1btm1b(KOMP)Wtsi/Anks1btm1b(KOMP)Wtsi
(B6(FVB)-Anks1btm1b(KOMP)Wtsi)
|
decreased prepulse inhibition
|
J:240601
|
Anks1btm1Bnaj/Anks1btm1Bnaj
Tg(Camk2a-cre)T29-1Stl/0
(involves: 129S6/SvEvTac * BALB/c * C57BL * C57BL/6NTac)
|
impaired synaptic plasticity
|
J:222552
|
| reduced long-term depression
|
J:222552
|
| short excitatory postsynaptic current decay time
|
J:222552
|
Anlntm1c(EUCOMM)Wtsi/Anlntm1c(EUCOMM)Wtsi
Cnptm1(cre)Kan/Cnp+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6N)
|
abnormal myelination
|
J:272250
|
| decreased nerve conduction velocity
|
J:272250
|
Ano3tm1.1Lyj/Ano3tm1.1Lyj
Ptgdstm1.1(cre)Gvn/Ptgds+
(involves: 129X1/SvJ * C57BL/6 * FVB/N)
|
environmentally induced seizures
|
J:310618
|
Ano3tm1.1Lyj/Ano3tm1.1Lyj
Tg(Nes-cre)1Kln/0
(involves: 129X1/SvJ * C57BL/6)
|
environmentally induced seizures
|
J:310618
|
Ano9em1Uoh/Ano9em1.1Uoh
Tg(CMV-cre)1Cgn/0
(involves: BALB/cJ * C57BL/6)
|
abnormal olfactory sensory neuron physiology
|
J:344977
|
Anxa7tm1Ngl/Anxa7tm1Ngl
(involves: 129S2/SvPas)
|
abnormal astrocyte physiology
|
J:86832
|
Anxa7tm1Pll/Anxa7tm1Pll
(Not Specified)
|
intraventricular hemorrhage
|
J:58572
|
Aoc1l1tm1.1(KOMP)Vlcg/Aoc1l1tm1.1(KOMP)Vlcg
(C57BL/6N-Aoc1l1tm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Ap1s2tm1Pschu/Ap1s2tm1Pschu
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal synaptic vesicle clustering
|
J:218588
|
| abnormal synaptic vesicle recycling
|
J:218588
|
Ap3b1tm1Sms/Ap3b1tm1Sms
(B6.129-Ap3b1tm1Sms)
|
abnormal nervous system physiology
|
J:94942
|
Ap3b2m1J/Ap3b2m1J
(C57BL/6J-Ap3b2m1J/FrkJ)
|
tonic-clonic seizures
|
J:205908
|
Ap3b2m2J/Ap3b2m2J
(B6;129S-Ap3b2m2J/GrsrJ)
|
tonic-clonic seizures
|
J:222308,
J:205908
|
Ap3b2tm1Bur/Ap3b2tm1Bur
(C57BL/6-Ap3b2tm1Bur)
|
abnormal nervous system physiology
|
J:94942
|
| tonic-clonic seizures
|
J:94942
|
Ap3d1mh-2J/Ap3d1mh-2J
(involves: C3H/HeJ * C57BL/6J * CAST/Ei)
|
abnormal spike wave discharge
|
J:59842
|
Ap3d1mh Mfsd12+/Ap3d1+ Mfsd12gr
(STOCK Mfsd12gr +/+ Ap3d1mh/J)
|
abnormal brain wave pattern
|
J:96307
|
Ap3d1mh/Ap3d1mh
(STOCK Mfsd12gr +/+ Ap3d1mh/J)
|
abnormal brain wave pattern
|
J:96307
|
| abnormal nervous system physiology
|
J:94942
|
| abnormal spike wave discharge
|
J:59842
|
| abnormal synaptic dopamine release
|
J:163596
|
| enhanced sensorimotor gating
|
J:59842
|
Ap3m2tm1Ohno/Ap3m2tm1Ohno
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal kindling response
|
J:93312
|
| abnormal nervous system electrophysiology
|
J:93312
|
| decreased neurotransmitter release
|
J:93312
|
| enhanced long-term potentiation
|
J:93312
|
| increased susceptibility to pharmacologically induced seizures
|
J:93312
|
| nonconvulsive seizures
|
J:93312
|
| seizures
|
J:93312
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Wtsi)
|
increased prepulse inhibition
|
J:211773
|
Ap4e1tm1b(KOMP)Wtsi/Ap4e1tm1b(KOMP)Wtsi
(C57BL/6N-Ap4e1tm1b(KOMP)Wtsi/Orl)
|
increased prepulse inhibition
|
J:211773
|
Apaf1fog/Apaf1fog
(involves: C3H/HeJ)
|
intracerebral hemorrhage
|
J:41353
|
Apaf1fog/Apaf1Gt(IRESBetageo)XIX18Pgr
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C3H/HeJ * NMRI)
|
decreased neuron apoptosis
|
J:131954
|
Apaf1fog/Apaf1tm1Mak
(involves: 129S6/SvEvTac * C3H/HeJ * CD-1)
|
decreased neuron apoptosis
|
J:131954
|
Apaf1Gt(IRESBetageo)XIX18Pgr/Apaf1Gt(IRESBetageo)XIX18Pgr
(involves: 129S1/Sv * 129X1/SvJ * NMRI)
|
abnormal neuron physiology
|
J:131954
|
Apaf1Gt(IRESBetageo)XIX18Pgr/Apaf1Gt(IRESBetageo)XIX18Pgr
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased neuron apoptosis
|
J:112874
|
| increased neuron apoptosis
|
J:112874
|
Apaf1Gt(IRESBetageo)XIX18Pgr/Apaf1Gt(IRESBetageo)XIX18Pgr
Aifm1tm2Pngr/Y
Foxg1tm1(cre)Skm/Foxg1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
decreased neuron apoptosis
|
J:112874
|
| increased neuron apoptosis
|
J:112874
|
Apaf1tm1Her/Apaf1tm1Her
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal neuronal migration
|
J:60409
|
| decreased neuron apoptosis
|
J:60409
|
Apaf1tm1Mak/Apaf1tm1Mak
(involves: 129P2/OlaHsd * CD-1)
|
abnormal neuron physiology
|
J:131954
|
Apba1tm1.1Sud/Apba1tm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal inhibitory postsynaptic currents
|
J:81845
|
Apba1tm1.1Sud/Apba1tm1.1Sud
Apba2tm1.1Sud/Apba2tm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal CNS synaptic transmission
|
J:115573
|
| abnormal excitatory postsynaptic currents
|
J:115573
|
| enhanced paired-pulse facilitation
|
J:115573
|
Apba1tm1.1Sud/Apba1tm1.1Sud
Apba2tm1.1Sud/Apba2tm1.1Sud
Apba3tm1.1Sud/Apba3tm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal CNS synaptic transmission
|
J:115573
|
| abnormal inhibitory postsynaptic currents
|
J:115573
|
Apc2tm1Mno/Apc2tm1Mno
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal cerebellar granule cell migration
|
J:184856
|
| abnormal neuronal migration
|
J:184856
|
| increased neuron apoptosis
|
J:184856
|
| seizures
|
J:184856
|
Apcdd1em1(IMPC)Mbp/Apcdd1em1(IMPC)Mbp
(C57BL/6NCrl-Apcdd1em1(IMPC)Mbp/MbpMmucd)
|
increased prepulse inhibition
|
J:211773
|
Apehtm2b(EUCOMM)Hmgu/Apehtm2b(EUCOMM)Hmgu
(C57BL/6N-Apehtm2b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Aph1atm1.1Bdes/Aph1atm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased embryonic neuroepithelium apoptosis
|
J:96106
|
Aph1ctm1b(KOMP)Wtsi/Aph1ctm1b(KOMP)Wtsi
(C57BL/6N-Aph1ctm1b(KOMP)Wtsi/H)
|
increased prepulse inhibition
|
J:211773
|
Aplnrtm1.1(KOMP)Vlcg/Aplnr+
(C57BL/6N-Aplnrtm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Aplp2tm1Dbo/Aplp2tm1Dbo
Apptm1.1Zhe/Apptm1.1Zhe
Tg(Ckmm-cre)5Khn/0
(involves: 129S7/SvEvBrd * C57BL/6J * FVB)
|
abnormal miniature endplate potential
|
J:152457
|
Aplp2tm1Dbo/Aplp2tm1Dbo
Apptm1.1Zhe/Apptm1.1Zhe
Tg(Nes-cre)1Kln/0
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/6J * SJL)
|
abnormal miniature endplate potential
|
J:152457
|
Apodtm1Dsan/Apodtm1Dsan
(either: B6.129X1-Apodtm1Dsan or C.129X1-Apodtm1Dsan)
|
abnormal nervous system physiology
|
J:143809
|
Apoetm1(APOE_i4)Sfu/Apoetm1(APOE_i4)Sfu
(involves: 129P2/OlaHsd)
|
abnormal response to CNS ischemic injury
|
J:104859
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc/J)
|
impaired blood-brain barrier function
|
J:69455
|
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal astrocyte physiology
|
J:58019
|
Apoetm1Unc/Apoetm1Unc
(involves: 129P2/OlaHsd)
|
decreased cerebral infarct size
|
J:133156
|
Apoetm1Unc/Apoetm1Unc
(B6.129P2-Apoetm1Unc)
|
abnormal kindling response
|
J:118390
|
| hypopituitarism
|
J:60585
|
Apoetm1Unc/Apoetm1Unc
Cdh18Tg(GFAP-APOE_i4)1Hol/0
(B6.Cg-Apoetm1Unc Cdh18Tg(GFAP-APOE_i4)1Hol/J)
|
abnormal astrocyte physiology
|
J:58019
|
Apoetm1Unc/Apoetm1Unc
Clutm1Jakh/Clutm1Jakh
Tg(APPV717F)109Ili/Tg(APPV717F)109Ili
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
increased cerebrospinal fluid amyloid beta 40 isoform level
|
J:107702
|
| increased cerebrospinal fluid amyloid beta 42 isoform level
|
J:107702
|
Apoetm1Unc/Apoetm1Unc
Tg(APPV717F)109Ili/Tg(APPV717F)109Ili
(involves: 129P2/OlaHsd)
|
increased cerebrospinal fluid amyloid beta 40 isoform level
|
J:107702
|
| increased cerebrospinal fluid amyloid beta 42 isoform level
|
J:107702
|
Apoetm1Unc/Apoetm1Unc
Tg(Eno2-APOE_i3)1Rabr/0
(involves: 129P2/OlaHsd * C57BL/6J * ICR)
|
abnormal nervous system physiology
|
J:55835,
J:100975
|
Apoetm1Unc/Apoetm1Unc
Tg(Eno2-APP*751)10Cord/0
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cerebral infarct size
|
J:133156
|
Apoetm1Unc/Apoetm1Unc
Tg(Eno2-APP*751)10Cord/0
Cdh18Tg(GFAP-APOE_i4)1Hol/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased cerebral infarct size
|
J:133156
|
Apoetm1Unc/Apoetm1Unc
Tg(Eno2-APP*751)10Cord/0
Tg(GFAP-APOE_i3)37Hol/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased cerebral infarct size
|
J:133156
|
Apoetm1Unc/Apoetm1Unc
Tg(GFAP-APOE_i3)37Hol/0
(B6.Cg-Tg(GFAP-APOE_i3)37Hol Apoetm1Unc/J)
|
abnormal astrocyte physiology
|
J:58019
|
Apoetm2(APOE*3)Mae/Apoetm2(APOE*3)Mae
Tg(APPSWE)2576Kha/?
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal cerebrospinal fluid amyloid beta 40 isoform level
|
J:98636
|
| abnormal cerebrospinal fluid amyloid beta 42 isoform level
|
J:98636
|
Apoetm2(APOE_i2)Sfu/Apoetm2(APOE_i2)Sfu
(involves: 129P2/OlaHsd)
|
abnormal response to CNS ischemic injury
|
J:104859
|
Apoetm3(APOE*4)Mae/Apoetm3(APOE*4)Mae
Tg(APPSWE)2576Kha/?
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal cerebrospinal fluid amyloid beta 40 isoform level
|
J:98636
|
| abnormal cerebrospinal fluid amyloid beta 42 isoform level
|
J:98636
|
Apoetm3(APOE_i3)Sfu/Apoetm3(APOE_i3)Sfu
(involves: 129P2/OlaHsd)
|
abnormal response to CNS ischemic injury
|
J:104859
|
Apold1tm1Pfw/Apold1tm1Pfw
(involves: C57BL/6)
|
decreased susceptibility to ischemic brain injury
|
J:302897
|
Apptm1.1Wevn/Apptm1.1Wevn
(B6.129S6(FVB)-Apptm1.1Wevn)
|
intracerebral hemorrhage
|
J:241632
|
Apptm1Cwe/Apptm1Cwe
(involves: 129S2/SvPas)
|
reduced long-term potentiation
|
J:123316
|
Apptm1Dbo/Apptm1Dbo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal long-term potentiation
|
J:53824
|
| intracerebral hemorrhage
|
J:241632
|
Apptm1Dbo/Apptm1Dbo
Npc1m1N/Npc1m1N
(C.Cg-Apptm1Dbo Npc1m1N)
|
demyelination
|
J:172769
|
Apptm1Somm/Apptm1Somm
(C57BL/6-Apptm1Somm)
|
abnormal excitatory postsynaptic currents
|
J:276486
|
Apptm3.1Tcs/Apptm3.1Tcs
Mapttm1.1(MAPT)Tcs/Mapttm1.1(MAPT)Tcs
(involves: 129S/SvEv * C57BL/6)
|
CNS inflammation
|
J:278451
|
| increased neuron apoptosis
|
J:278451
|
Aptxtm1Pmc/Aptxtm1Pmc
Atmtm2.1Mfgc/Atmtm2.1Mfgc
(involves: 129 * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:316365
|
| abnormal synaptic physiology
|
J:316365
|
| impaired neuron physiology
|
J:316365
|
| increased excitatory postsynaptic current frequency
|
J:316365
|
Aqp4tm1.1Geno/Aqp4tm1.1Geno
Tg(GFAP-cre)25Mes/0
(involves: C57BL/6J * FVB/N)
|
abnormal blood-brain barrier function
|
J:177412
|
Aqp4tm1.1Lmno/Aqp4tm1.1Lmno
(B6.Cg-Aqp4tm1.1Lmno)
|
abnormal astrocyte physiology
|
J:168686
|
| abnormal blood-brain barrier function
|
J:177412
|
Aqp4tm1.1Mysi/Aqp4tm1.1Mysi
(involves: C57BL/6JJcl * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal microglial cell physiology
|
J:214906
|
Aqp4tm1.1Tsna/Aqp4tm1.1Tsna
(involves: C57BL/6 * CBA)
|
abnormal glial cell physiology
|
J:149545
|
Aqp4tm1Ask/Aqp4tm1Ask
(involves: C57BL/6J * CD-1)
|
decreased susceptibility to ischemic brain injury
|
J:111923
|
Aqp4tm1Gghu/Aqp4tm1Gghu
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal nervous system physiology
|
J:111202
|
Arctm1.1Kuhl/Arctm1.1Kuhl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
enhanced long-term potentiation
|
J:122980
|
| reduced long-term potentiation
|
J:122980
|
Arctm1.1Kuhl/Arctm1.1Kuhl
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal AMPA-mediated synaptic currents
|
J:122964
|
| abnormal miniature excitatory postsynaptic currents
|
J:122964
|
Arctm1Stl/Arctm1Stl
(involves: C57BL/6)
|
abnormal nervous system electrophysiology
|
J:115255
|
| abnormal nervous system physiology
|
J:115255
|
Arf4Gt(CSH658)Byg/Arf4+
(B6.129P2-Arf4Gt(CSH658)Byg)
|
decreased miniature excitatory postsynaptic current amplitude
|
J:192108
|
Arf4tm1.1Tsdk/Arf4+
Arf5tm1.1Tsdk/Arf5tm1.1Tsdk
(B6J.B6N-Arf4tm1.1Tsdk Arf5tm1.1Tsdk)
|
abnormal action potential
|
J:279779
|
| abnormal brain wave pattern
|
J:279779
|
| abnormal nervous system electrophysiology
|
J:279779
|
| abnormal spike wave discharge
|
J:279779
|
Arfgef1Gt(CSH465)Byg/Arfgef1Gt(CSH465)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased neuron apoptosis
|
J:248338
|
Arfgef2tm1Itl/Arfgef2tm1Itl
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal neuronal migration
|
J:187673
|
Arglu1tm1a(EUCOMM)Hmgu/Arglu1tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
increased brain apoptosis
|
J:273438
|
Arhgap1tm1Yizh/Arhgap1tm1Yizh
(involves: 129S6/SvEvTac)
|
increased neuron apoptosis
|
J:101418
|
Arhgap31em1(IMPC)Bay/Arhgap31+
(C57BL/6N-Arhgap31em1(IMPC)Bay/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Arhgap32tm1Taki/Arhgap32tm1Taki
(B6N.Cg-Arhgap32tm1Taki)
|
decreased miniature inhibitory postsynaptic current amplitude
|
J:236753
|
| increased susceptibility to pharmacologically induced seizures
|
J:236753
|
Arhgef2Gt(IST13976A8)Tigm/Arhgef2Gt(IST13976A8)Tigm
(involves: C57BL/6N)
|
abnormal neuronal migration
|
J:242973
|
Arhgef6tm1Kkut/Y
(B6.129-Arhgef6tm1Kkut)
|
abnormal long-term depression
|
J:179026
|
| reduced long-term potentiation
|
J:179026
|
Arhgef9tm1.1Betz/Y
(B6.129P2-Arhgef9tm1.1Betz)
|
abnormal excitatory postsynaptic potential
|
J:124926
|
| abnormal inhibitory postsynaptic currents
|
J:124926
|
| abnormal synaptic plasticity
|
J:124926
|
| enhanced long-term potentiation
|
J:124926
|
| reduced long-term depression
|
J:124926
|
Arhgef12tm1b(KOMP)Wtsi/Arhgef12+
(C57BL/6N-Arhgef12tm1b(KOMP)Wtsi/Tcp)
|
increased prepulse inhibition
|
J:211773
|
Arid1bem1(IMPC)Tcp/Arid1b+
(C57BL/6NCrl-Arid1bem1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Arid1bem1Hzhu/Arid1b+
(C57BL/6J-Arid1bem1Hzhu)
|
abnormal hypothalamus physiology
|
J:256668
|
Arid1bem1Iha/Arid1b+
(C57BL/6J-Arid1bem1Iha)
|
decreased prepulse inhibition
|
J:271850
|
Arih1em1(IMPC)Tcp/Arih1+
(C57BL/6N-Arih1em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Arl6tm2Vcs/Arl6tm2Vcs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal brain ependyma motile cilium physiology
|
J:180524
|
| abnormal sympathetic nervous system physiology
|
J:180524
|
Arl8btm1.1(NCOM)Mfgc/Arl8b+
(C57BL/6N-Arl8btm1.1(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Arnt2tm1Yfk/Arnt2tm1Yfk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pituitary secretion
|
J:74118
|
Arpc3tm1Ssod/Arpc3tm1Ssod
Tg(Camk2a-cre)T29-1Stl/0
(involves: 129S6/SvEvTac * BALB/c * C57BL)
|
decreased prepulse inhibition
|
J:196577
|
Arpp21tm1Lex/Arpp21tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal channel response
|
J:94124
|
Arrb1tm1b(KOMP)Wtsi/Arrb1tm1b(KOMP)Wtsi
(B6N(Cg)-Arrb1tm1b(KOMP)Wtsi/J)
|
decreased prepulse inhibition
|
J:211773
|
Arsatm1Gie/Arsatm1Gie
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal myelination
|
J:37978
|
| demyelination
|
J:52310
|
Arv1tm1.2Geno/Arv1tm1.2Geno
(involves: C57BL/6 * C57BL/6J)
|
seizures
|
J:263695
|
Arxtm1.1Ics/Y
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N)
|
abnormal nervous system electrophysiology
|
J:262482
|
| abnormal neuronal migration
|
J:262482
|
Arxtm1.1Jno/Y
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal brain wave pattern
|
J:151082
|
| clonic seizures
|
J:151082
|
| myoclonus
|
J:151082
|
| seizures
|
J:151082
|
| tonic-clonic seizures
|
J:151082
|
Arxtm1.1Jno/Arxtm1.1Jno
(involves: 129S7/SvEvBrd * C57BL/6J)
|
myoclonus
|
J:151082
|
Arxtm1Gldn/Y
Tg(mI56i-cre,EGFP)1Kc/0
(involves: 129/Sv * C57BL/6 * CD-1 * FVB/N)
|
abnormal brain wave pattern
|
J:148311
|
| clonic seizures
|
J:148311
|
| sporadic seizures
|
J:148311
|
| tonic-clonic seizures
|
J:148311
|
Arxtm1Gldn/Arx+
Tg(mI56i-cre,EGFP)1Kc/0
(involves: 129/Sv * C57BL/6 * CD-1 * FVB/N)
|
abnormal brain wave pattern
|
J:148311
|
| clonic seizures
|
J:148311
|
| convulsive seizures
|
J:148311
|
| sporadic seizures
|
J:148311
|
| tonic-clonic seizures
|
J:148311
|
Arxtm1Kki/Y
(involves: 129P2/OlaHsd * C57BL)
|
abnormal neuronal migration
|
J:79871
|
Arxtm2Kki/Y
(involves: 129S/SvEv * C57BL/6J)
|
abnormal neuronal migration
|
J:152416
|
Arxtm3Kki/Y
(involves: 129S/SvEv * C57BL/6J)
|
abnormal neuronal migration
|
J:152416
|
| increased susceptibility to pharmacologically induced seizures
|
J:152416
|
Arxtm4Kki/Y
(involves: 129S/SvEv * C57BL/6J)
|
abnormal neuronal migration
|
J:152416
|
| abnormal spike wave discharge
|
J:152416
|
| seizures
|
J:152416
|
| tonic seizures
|
J:152416
|
Arxtm4Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd)
|
myoclonus
|
J:260340
|
Arxtm5Kki/Y
(involves: 129S/SvEv * C57BL/6NHsd)
|
myoclonus
|
J:260340
|
| seizures
|
J:260340
|
Asap2em1(IMPC)Wtsi/Asap2em1(IMPC)Wtsi
(C57BL/6NCrl-Asap2em1(IMPC)Wtsi/Wtsi)
|
decreased prepulse inhibition
|
J:211773
|
Ascl1tm1(Neurog2)Fgu/Ascl1tm1(Neurog2)Fgu
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuron apoptosis
|
J:109482
|
Ascl1tm1And/Ascl1tm1And
(involves: 129)
|
abnormal neuron apoptosis
|
J:109482
|
| decreased neuronal precursor proliferation
|
J:203419
|
Ascl1tm2Fgu/Ascl1tm2Fgu
(Not Specified)
|
abnormal neuronal migration
|
J:174732
|
Asic1tm1.1Ccli/Asic1tm1.1Ccli
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
abnormal CNS synaptic transmission
|
J:193892
|
Asic1tm1Wsh/Asic1tm1Wsh
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal acid-activated cation-mediated receptor currents
|
J:76361
|
| abnormal excitatory postsynaptic potential
|
J:76361
|
| abnormal long-term potentiation
|
J:76361
|
Asic2tm1Wsh/Asic2tm1Wsh
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal nervous system electrophysiology
|
J:76712
|
Asic3em1(IMPC)Mbp/Asic3em1(IMPC)Mbp
(C57BL/6NCrl-Asic3em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Asic3tm1Wsh/Asic3tm1Wsh
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal nervous system electrophysiology
|
J:119060
|
AsmtC57BL/6JJcl/AsmtC57BL/6JJcl
(C57BL/6JJcl)
|
abnormal pineal gland melatonin secretion
|
J:159317
|
Asnsd1Gt(OST460318)Lex/Asnsd1Gt(OST460318)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
environmentally induced seizures
|
J:320329
|
Asp1/Asp1
(DBA/2J)
|
audiogenic seizures
|
J:6355
|
Asp2/Asp2
(DBA/2J)
|
audiogenic seizures
|
J:11261,
J:5094
|
Asp3DBA/2J/Asp3DBA/2J
(DBA/2J)
|
audiogenic seizures
|
J:11261
|
Aspanur7/Aspanur7
(involves: C57BL/6J)
|
abnormal myelination
|
J:143201
|
| demyelination
|
J:226682
|
| seizures
|
J:143201,
J:226682
|
Aspanur7/Aspanur7
Ugt8atm1Pop/Ugt8a+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal myelination
|
J:143201
|
Aspatm1b(EUCOMM)Wtsi/Aspatm1b(EUCOMM)Wtsi
(C57BL/6N-Aspatm1b(EUCOMM)Wtsi/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Aspatm1Mata/Aspatm1Mata
(involves: 129S5/SvEvBrd)
|
abnormal synaptic neurotransmitter level
|
J:89099
|
Ass1bar/Ass1bar
(FVB.BAR-Ass1bar)
|
abnormal cerebellar granule cell migration
|
J:165341
|
Ass1bar/Ass1bar
(B6.BAR-Ass1bar)
|
abnormal cerebellar granule cell migration
|
J:165341
|
Ass1bar/Ass1fold
(involves: C57BL/6Ei * C57BL/6J * OF1 * P/J)
|
abnormal cerebellar granule cell migration
|
J:165341
|
Ass1fold/Ass1fold
(B6Ei.P-Ass1fold/GrsrJ)
|
abnormal cerebellar granule cell migration
|
J:165341
|
Astn1tm1Hatn/Astn1tm1Hatn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal cerebellar granule cell migration
|
J:74969
|
| increased neuron apoptosis
|
J:74969
|
Atad1tm1.1Vdaw/Atad1tm1.1Vdaw
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
absent long-term depression
|
J:173768
|
| enhanced AMPA-mediated synaptic currents
|
J:173768
|
| enhanced long-term potentiation
|
J:173768
|
| increased miniature excitatory postsynaptic current amplitude
|
J:173768
|
| seizures
|
J:173768
|
Atad1tm1Vdaw/Atad1tm1Vdaw
Tg(Camk2a-cre)2Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
seizures
|
J:173768
|
Atcayji/Atcayji
(Not Specified)
|
seizures
|
J:14903
|
Ate1tm1Avar/Ate1tm2.1Avar
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
seizures
|
J:155421
|
| tonic-clonic seizures
|
J:155421
|
Atf1tm1Gsc/Atf1tm1Gsc
Creb1tm3Gsc/Creb1tm3Gsc
Tg(Dbh-icre)1Gsc/0
(involves: 129 * 129P2/OlaHsd * C57BL/6)
|
decreased neuron apoptosis
|
J:121244
|
Atf3tm1.2Kitab/Atf3tm1.2Kitab
Tg(Pdx1-cre)89.1Dam/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA)
|
abnormal hypothalamus physiology
|
J:231262
|
| abnormal sympathetic nervous system physiology
|
J:231262
|
Atf7tm1Sis/Atf7tm1Sis
(either: B6.Cg-Atf7tm1Sis or (involves: C57BL/6 * CBA))
|
decreased prepulse inhibition
|
J:156409
|
Atf7tm2b(EUCOMM)Hmgu/Atf7tm2b(EUCOMM)Hmgu
(C57BL/6N-Atf7tm2b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Atg4btm1b(EUCOMM)Hmgu/Atg4btm1b(EUCOMM)Hmgu
(C57BL/6N-Atg4btm1b(EUCOMM)Hmgu/H)
|
decreased prepulse inhibition
|
J:211773
|
Atg7tm1Tchi/Atg7tm1Tchi
Aviltm2(cre)Fawa/Avil+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased neuron apoptosis
|
J:160568
|
Atg7tm1Tchi/Atg7tm1Tchi
Sqstm1tm1Keta/Sqstm1tm1Keta
Tg(Nes-cre)1Wme/0
(involves: 129 * C57BL/6 * C57BL/6NCrlj * CBA * CBA/JNCrlj)
|
abnormal nervous system physiology
|
J:130839
|
| increased neuron apoptosis
|
J:130839
|
Atg7tm1Tchi/Atg7tm1Tchi
Tg(Nes-cre)1Wme/0
(involves: C57BL/6 * CBA)
|
abnormal nervous system physiology
|
J:130839
|
| increased neuron apoptosis
|
J:130839
|
Atmtm1Bal/Atmtm1Bal
(involves: 129S4/SvJae)
|
abnormal microglial cell physiology
|
J:44190
|
Atmtm1Pmc/Atm+
Lig4tm1Icrf/Lig4tm1Icrf
(either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv * 129X1/SvJ))
|
increased neuron apoptosis
|
J:65540
|
Atmtm1Pmc/Atmtm1Pmc
Lig4tm1Icrf/Lig4+
(either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv * 129X1/SvJ))
|
increased neuron apoptosis
|
J:65540
|
Atmtm1Pmc/Atmtm1Pmc
Lig4tm1Icrf/Lig4tm1Icrf
(either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv * 129X1/SvJ))
|
decreased neuron apoptosis
|
J:111068,
J:65540
|
Atmtm2Pmc/Atmtm2Pmc
Atrtm2Bal/Atrtm2Bal
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal neuron apoptosis
|
J:181920
|
Atmtm2Pmc/Atmtm2Pmc
Pnkptm1.1Pmc/Pnkptm1.1Pmc
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * C57BL/6 * SJL)
|
increased brain apoptosis
|
J:226703
|
| intracranial hemorrhage
|
J:226703
|
Atoh1tm2Hzo/Atoh1+
Tcf4tm1Zhu/Tcf4+
(involves: 129P2/OlaHsd)
|
abnormal neuronal migration
|
J:125313
|
Atoh1tm3Hzo/Atoh1+
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sortm1(Smo/EYFP)Amc
(involves: 129 * 129S7/SvEvBrd * 129X1/SvJ)
|
abnormal neuronal precursor proliferation
|
J:155047
|
Atoh1tm3Hzo/Atoh1tm1Hzo
Gt(ROSA)26Sortm1(cre/ERT)Nat/Gt(ROSA)26Sortm1(Smo/EYFP)Amc
(involves: 129 * 129S7/SvEvBrd * 129X1/SvJ)
|
abnormal neuronal precursor proliferation
|
J:155047
|
Atoh1tm3Hzo/Atoh1tm3Hzo
(involves: 129S7/SvEvBrd)
|
decreased neuronal precursor proliferation
|
J:155047
|
Atoh1tm4.1Hzo/Atoh1+
Piezo2tm2.2Apat/Piezo2tm2.2Apat
Tg(KRT14-cre)1Amc/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
abnormal nervous system electrophysiology
|
J:211312
|
Atox1Gt(IRESBetageo)3Pgr/Atox1Gt(IRESBetageo)3Pgr
(B6.129(Cg)-Atox1Gt(IRESBetageo)3Pgr/Mmucd)
|
seizures
|
J:74249
|
Atp1a2tm1.1Gica/Atp1a2+
(B6.Cg-Atp1a2tm1.1Gica)
|
abnormal nervous system electrophysiology
|
J:307518
|
Atp1a2tm1.1Tmklh/Atp1a2+
(B6.129S1(Cg)-Atp1a2tm1.1Tmklh)
|
abnormal nervous system electrophysiology
|
J:259556
|
Atp1a2tm1.1Tmklh/Atp1a2tm1.1Tmklh
(involves: 129S1/Sv * C57BL/6J)
|
abnormal hippocampus physiology
|
J:259556
|
Atp1a2tm2Kwk/Atp1a2tm2Kwk
(B6.129X1-Atp1a2tm2Kwk)
|
abnormal action potential
|
J:94810
|
| abnormal nervous system electrophysiology
|
J:94810
|
| abnormal somatic nervous system physiology
|
J:94810
|
| abnormal synaptic neurotransmitter level
|
J:94810
|
Atp1a3Myk/Atp1a3+
(B6NCr.129S1-Atp1a3Myk)
|
abnormal neuron physiology
|
J:180250
|
| abnormal seizure response to inducing agent
|
J:180250
|
| abnormal sensorimotor gating
|
J:180250
|
| abnormal spike wave discharge
|
J:151948
|
| convulsive seizures
|
J:151948
|
| decreased prepulse inhibition
|
J:180250
|
| environmentally induced seizures
|
J:151948
|
Atp1a3Myk/Atp1a3+
(involves: 129S1/SvImJ * C57BL/6J * C57BL/6NCr)
|
abnormal spike wave discharge
|
J:151948
|
| convulsive seizures
|
J:151948
|
| environmentally induced seizures
|
J:151948
|
Atp1a3tm1.1Kwk/Atp1a3+
(B6JJcl.Cg-Atp1a3tm1.1Kwk/Kwk)
|
abnormal CNS synaptic transmission
|
J:210870
|
| increased miniature inhibitory postsynaptic current frequency
|
J:210870
|
Atp1a3tm1.1Tmklh/Atp1a3+
(B6JRj.129S1-Atp1a3tm1.1Tmklh)
|
abnormal action potential
|
J:254463
|
| increased susceptibility to pharmacologically induced seizures
|
J:254463
|
Atp1a3tm1Mika/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal seizure response to inducing agent
|
J:264408
|
| increased kindling response
|
J:264408
|
| seizures
|
J:264408
|
Atp1a3tm1Ute/Atp1a3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:262419
|
| increased kindling response
|
J:262419
|
| increased susceptibility to pharmacologically induced seizures
|
J:262419
|
| seizures
|
J:262419
|
Atp2b2dfw/Atp2b2+
(C3H/HeJ-Atp2b2dfw/J)
|
abnormal cochlear microphonics
|
J:108888
|
| abnormal cochlear nerve compound action potential
|
J:108888
|
Atp2b2dfw/Atp2b2dfw
(C3H/HeJ-Atp2b2dfw/J)
|
abnormal cochlear hair cell physiology
|
J:119503
|
| abnormal hair cell mechanoelectric transduction
|
J:119503
|
| abnormal vestibular hair cell physiology
|
J:119503
|
Atp2b2m1Mae/Atp2b2+
Ppargtm2Mae/Pparg+
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal prepulse inhibition
|
J:110607
|
Atp2b2m1Mae/Atp2b2m1Mae
Ppargtm2Mae/Ppargtm2Mae
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal prepulse inhibition
|
J:110607
|
Atp2b2Obv/Atp2b2+
(C3HeB/FeJ-Atp2b2Obv)
|
abnormal vestibular hair cell physiology
|
J:151733
|
Atp2b2Obv/Atp2b2Obv
(C3HeB/FeJ-Atp2b2Obv)
|
abnormal vestibular hair cell physiology
|
J:151733
|
Atp2b2tm1Ges/Atp2b2tm1Ges
(involves: 129/Sv * 129X1/SvJ * Black Swiss)
|
abnormal cochlear hair cell physiology
|
J:119503
|
| abnormal hair cell mechanoelectric transduction
|
J:119503
|
| abnormal vestibular hair cell physiology
|
J:119503
|
Atp2c1tm1Ges/Atp2c1tm1Ges
(involves: 129X1/SvJ * Black Swiss)
|
increased neural tube apoptosis
|
J:124662
|
Atp5f1btm1b(EUCOMM)Hmgu/Atp5f1b+
(C57BL/6N-Atp5f1btm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Atp6v0a1em2Hisa/Atp6v0a1em2Hisa
(involves: ICR)
|
abnormal miniature excitatory postsynaptic currents
|
J:305201
|
| abnormal miniature inhibitory postsynaptic currents
|
J:305201
|
| increased neuron apoptosis
|
J:305201
|
Atp6v1b2em1Pcamp/Atp6v1b2+
(C57BL/6N-Atp6v1b2em1Pcamp)
|
increased susceptibility to pharmacologically induced seizures
|
J:342781
|
Atp6v1b2em1Pcamp/Atp6v1b2em1Pcamp
(C57BL/6N-Atp6v1b2em1Pcamp)
|
environmentally induced seizures
|
J:342781
|
| increased susceptibility to pharmacologically induced seizures
|
J:342781
|
Atp6v1b2tm1Yoyu/Atp6v1b2tm1Yoyu
(involves: C57BL/6)
|
environmentally induced seizures
|
J:278514
|
Atp6v1c1tm1b(NCOM)Mfgc/Atp6v1c1+
(C57BL/6N-Atp6v1c1tm1b(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Atp7aMo-ml/Y
(C3Hf/He)
|
tonic seizures
|
J:40664
|
Atp7aMo-ms/Y
(Not Specified)
|
increased neuron apoptosis
|
J:157286
|
Atp7aMo-Tohm/Atp7a+
(B6.Cg-Atp7aMo-Tohm)
|
increased brain apoptosis
|
J:105797
|
Atp8a2agil/Atp8a2agil
(C3H/HeJ-Atp8a2agil/GrsrJ)
|
abnormal myelination
|
J:84746
|
Atp8a2wl-3J/Atp8a2wl-3J
(CBA/J-Atp8a2wl-3J/J)
|
demyelination
|
J:29158
|
Atp8a2wl/Atp8a2+
(Not Specified)
|
demyelination
|
J:13068,
J:15162
|
Atp8a2wl/Atp8a2wl
(Not Specified)
|
demyelination
|
J:13068,
J:15162
|
Atp8b1em1(IMPC)Tcp/Atp8b1em1(IMPC)Tcp
(C57BL/6NCrl-Atp8b1em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Atp9aem1Bcgen/Atp9aem1Bcgen
(involves: C57BL/6)
|
abnormal CNS synaptic transmission
|
J:335674
|
| abnormal miniature excitatory postsynaptic currents
|
J:335674
|
Atp13a5tm1Lex/Atp13a5tm1Lex
(B6;129S5-Atp13a5tm1Lex/Mmucd)
|
reduced sensorimotor gating
|
J:171883
|
Atpsckmtem1(IMPC)J/Atpsckmt+
(C57BL/6NJ-Atpsckmtem1(IMPC)J)
|
abnormal nervous system electrophysiology
|
J:343227
|
Atrtm2Bal/Atrtm2Bal
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
abnormal neuron proliferation
|
J:181920
|
Atrtm2Bal/Atrtm2Bal
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal neuron proliferation
|
J:181920
|
| decreased cerebellar granule cell precursor proliferation
|
J:181920
|
| increased neuron apoptosis
|
J:181920
|
Atrtm2Bal/Atrtm2Bal
Trp53tm1Tyj/Trp53tm1Tyj
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal neuron apoptosis
|
J:181920
|
| abnormal neuron proliferation
|
J:181920
|
AtrnGt(PST112)Byg/AtrnGt(PST112)Byg
(C3.129P2-AtrnGt(PST112)Byg)
|
abnormal myelination
|
J:130463
|
AtrnGt(PST112)Byg/AtrnGt(PST112)Byg
Tg(ACTB-Atrnl1)B4Tmg/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal myelination
|
J:130463
|
Atrnmg-3J/Atrnmg-3J
(C3HeB/FeJ-Atrnmg-3J/J)
|
seizures
|
J:96070
|
Atrxtm1Enl/Atrxtm1Enl
(B6.129S4-Atrxtm1Enl)
|
reduced long-term potentiation
|
J:168608
|
Atxn1tm1Hzo/Atxn1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:77225
|
| reduced long-term potentiation
|
J:77225
|
Atxn1tm2Hzo/Atxn1tm2Hzo
(involves: 129S/SvEv * 129S7/SvEvBrd * C57BL/6J)
|
decreased paired-pulse facilitation
|
J:48508
|
Atxn1tm2Hzo/Atxn1tm2Hzo
(129S/SvEv-Atxn1tm2Hzo)
|
decreased paired-pulse facilitation
|
J:48508
|
Atxn2lem1Aub/Atxn2lem1Aub
(Not Specified)
|
increased neuron apoptosis
|
J:294770
|
Atxn7tm1Hzo/Atxn7+
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased post-tetanic potentiation
|
J:82072
|
| myoclonus
|
J:82072
|
Auts2tm1.1Mhos/Auts2tm1.1Mhos
(involves: C57BL/6 * C57BL/6N)
|
abnormal neuronal migration
|
J:243531
|
Auts2tm1.2Mhos/Auts2+
(involves: C57BL/6 * C57BL/6N)
|
abnormal collateral sprouting
|
J:243531
|
| abnormal neuronal migration
|
J:243531
|
Auts2tm1.2Mhos/Auts2tm1.2Mhos
(involves: C57BL/6 * C57BL/6N)
|
abnormal collateral sprouting
|
J:243531
|
| abnormal neuronal migration
|
J:243531
|
Auts2tm1Mhos/Auts2+
(C57BL/6N-Auts2tm1Mhos)
|
abnormal neuronal migration
|
J:243531
|
Auts2tm1Mhos/Auts2tm1Mhos
(C57BL/6N-Auts2tm1Mhos)
|
abnormal neuronal migration
|
J:243531
|
Avenem1(IMPC)Hmgu/Avenem1(IMPC)Hmgu
(C57BL/6NCrl-Avenem1(IMPC)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Aviltm1(ALPP)Fawa/Aviltm1(ALPP)Fawa
(involves: 129P2/OlaHsd)
|
impaired central nervous system regeneration
|
J:130971
|
Aviltm2(cre)Fawa/Avil+
Pik3c3tm1Fawa/Pik3c3tm1Fawa
(involves: 129P2/OlaHsd)
|
increased neuron apoptosis
|
J:160568
|
Aviltm2(cre)Fawa/Avil+
Prdm12tm1.1Ejbd/Prdm12tm1.1Ejbd
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6N)
|
increased neuron apoptosis
|
J:283226
|
Avptm1Lja/Avp+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal hypothalamus physiology
|
J:148012
|
Avpr1atm1Dgen/Avpr1atm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prepulse inhibition
|
J:101679
|
Avpr1atm1Gzt/Avpr1atm1Gzt
(involves: 129 * C57BL/6J)
|
abnormal baroreceptor physiology
|
J:110099
|
Avpr1btm1Dgen/Avpr1btm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Axltm1Grl/Axltm1Grl
Mertktm1Grl/Mertktm1Grl
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased brain apoptosis
|
J:54681
|
Axltm1Grl/Axltm1Grl
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal neuronal migration
|
J:141251
|
| increased neuron apoptosis
|
J:141251
|
B2mtm1Jae/B2mtm1Jae
Tap1tm1Hpl/Tap1tm1Hpl
(B6.129-B2mtm1Jae Tap1tm1Hpl)
|
abnormal long-term depression
|
J:66246
|
| abnormal miniature excitatory postsynaptic currents
|
J:120941
|
| enhanced long-term potentiation
|
J:66246
|
| reduced long-term depression
|
J:66246
|
B2mtm1Unc/B2mtm1Unc
H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal neuron proliferation
|
J:170591
|
B3gat1tm1Tkaw/B3gat1tm1Tkaw
(B6.129P2-B3gat1tm1Tkaw)
|
reduced long-term potentiation
|
J:125254
|
B3gnt2Gt(KST308)Byg/B3gnt2Gt(KST308)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased neuron apoptosis
|
J:97372
|
B4galnt1tm1Rlp/B4galnt1tm1Rlp
St3gal5tm1Rlp/St3gal5tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
increased brain apoptosis
|
J:96830
|
B4galnt1tm1Rlp/B4galnt1tm1Rlp
St8sia1tm1Rlp/St8sia1tm1Rlp
(involves: 129S6/SvEvTac)
|
audiogenic seizures
|
J:67955
|
| seizures
|
J:67955
|
| tonic-clonic seizures
|
J:67955
|
B4galnt1tm1Sia/B4galnt1tm1Sia
(Not Specified)
|
abnormal nervous system physiology
|
J:35787
|
B4gat1m1Ddg/B4gat1tm1(KOMP)Vlcg
(involves: C3H/He * C57BL/6 * C57BL/6NTac)
|
abnormal neuronal migration
|
J:194150
|
Bace1tm1Pcw/Bace1tm1Pcw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal long-term depression
|
J:123534
|
| decreased prepulse inhibition
|
J:133643
|
| enhanced paired-pulse facilitation
|
J:123534
|
Bace1tm1Pcw/Bace1tm1Pcw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myelination
|
J:116162
|
Bace1tm1Psa/Bace1tm1Psa
(either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * CD-1))
|
abnormal channel response
|
J:100925
|
| abnormal nervous system physiology
|
J:100925
|
Bace1tm1Psa/Bace1tm1Psa
(involves: 129S2/SvPas * C57BL/6)
|
demyelination
|
J:199150
|
Bace1tm1Psa/Bace1tm1Psa
Bace2tm1Bdes/Bace2tm1Bdes
(either: (involves: 129/Sv * 129P2/OlaHsd * C57BL/6J) or (involves: 129/Sv * 129P2/OlaHsd * C57BL/6J * CD-1))
|
abnormal nervous system physiology
|
J:100925
|
Bach2tm1b(EUCOMM)Wtsi/Bach2tm1b(EUCOMM)Wtsi
(C57BL/6N-Bach2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Bag6tm1Pmc/Bag6tm1Pmc
(involves: 129S1/Sv * C57BL/6)
|
decreased susceptibility to neuronal excitotoxicity
|
J:119857
|
Baiap2Gt(XG757)Byg/Baiap2Gt(XG757)Byg
(B6.129P2-Baiap2Gt(XG757)Byg)
|
abnormal CNS synaptic transmission
|
J:144939
|
| enhanced long-term potentiation
|
J:144939
|
Baiap2l2em1Pgg/Baiap2l2em1Pgg
(involves: C57BL/6)
|
abnormal hair cell mechanoelectric transduction
|
J:305454
|
Baiap2l2tm1a(EUCOMM)Hmgu/Baiap2l2tm1a(EUCOMM)Hmgu
(C57BL/6N-Baiap2l2tm1a(EUCOMM)Hmgu/Ics)
|
decreased prepulse inhibition
|
J:211773
|
Baiap2l2tm1b(EUCOMM)Hmgu/Baiap2l2tm1b(EUCOMM)Hmgu
(C57BL/6N-Baiap2l2tm1b(EUCOMM)Hmgu/Ics)
|
decreased prepulse inhibition
|
J:211773
|
Baiap2l2tm1b(EUCOMM)Hmgu/Baiap2l2tm1b(EUCOMM)Hmgu
(C57BL/6N-Baiap2l2tm1b(EUCOMM)Hmgu)
|
abnormal hair cell mechanoelectric transduction
|
J:305454
|
Baiap3tm1Smwk/Baiap3tm1Smwk
(B6N.129P2-Baiap3tm1Smwk)
|
abnormal action potential
|
J:221234
|
| abnormal inhibitory postsynaptic currents
|
J:221234
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:221234
|
| increased susceptibility to pharmacologically induced seizures
|
J:221234
|
Bak1tm1Thsn/Bak1tm1Thsn
Baxtm1Sjk/Baxtm1Sjk
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6)
|
seizures
|
J:66872
|
Basp1tm1Crni/Basp1tm1Crni
(Not Specified)
|
abnormal motor nerve collateral sprouting
|
J:63023
|
Basp1tm2(Gap43)Crni/Basp1tm2(Gap43)Crni
(Not Specified)
|
abnormal motor nerve collateral sprouting
|
J:63023
|
Baxtm1Dlo/Baxtm1Dlo
(involves: 129P2/OlaHsd)
|
decreased neuron apoptosis
|
J:39573,
J:66953
|
Baxtm1Dlo/Baxtm1Dlo
Bcl2l1tm1Dlo/Bcl2l1tm1Dlo
(involves: 129P2/OlaHsd)
|
decreased neuron apoptosis
|
J:39573
|
Baxtm1Ofxa/Baxtm1Ofxa
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased neuron apoptosis
|
J:61471
|
Baxtm1Sjk/Baxtm1Sjk
(involves: 129X1/SvJ)
|
decreased neuron apoptosis
|
J:35372
|
Bbc3tm1Ast/Bbc3tm1Ast
(involves: C57BL/6 * NZB)
|
abnormal neuron physiology
|
J:130581,
J:127640
|
Bbc3tm1Gpz/Bbc3tm1Gpz
(involves: 129P2/OlaHsd)
|
abnormal nervous system physiology
|
J:115660
|
Bbs1tm1Vcs/Bbs1tm1Vcs
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuronal precursor proliferation
|
J:194096
|
| increased neuron apoptosis
|
J:194096
|
Bbs1tm2Vcs/Bbs1tm2Vcs
Tg(Pdgfra-cre)1Clc/0
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased neuronal precursor proliferation
|
J:194096
|
| increased neuron apoptosis
|
J:194096
|
Bbs4Gt1Nk/Bbs4Gt1Nk
(B6.129S7-Bbs4Gt1Nk)
|
abnormal miniature excitatory postsynaptic currents
|
J:279506
|
Bcantm1Ref/Bcantm1Ref
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6))
|
abnormal long-term potentiation
|
J:79605
|
Bcap31tm1.1Bwang/Bcap31tm1.1Bwang
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased microglial cell activation
|
J:292505
|
Bcas1tm1Himo/Bcas1tm1Himo
(C57BL/6-Bcas1tm1Himo)
|
brain inflammation
|
J:242041
|
| decreased prepulse inhibition
|
J:242041
|
| dysmyelination
|
J:242041
|
BckdkGt(OST79912)Lex/BckdkGt(OST79912)Lex
(involves: 129S5/SvEvBrd)
|
decreased miniature inhibitory postsynaptic current frequency
|
J:238065
|
BckdkGt(VICT48)710Lex/BckdkGt(VICT48)710Lex
(B6.129S5/SvEvBrd-BckdkGt(VICT48)710Lex)
|
seizures
|
J:117564
|
| tonic-clonic seizures
|
J:117564
|
Bcl2l1tm1Dlo/Bcl2l1tm1Dlo
(Not Specified)
|
increased neuron apoptosis
|
J:39573
|
Bcl2l1tm1Dlo/Bcl2l1tm1Dlo
Casp9tm1Flv/?
(involves: 129S1/Sv * C57BL/6)
|
increased neuron apoptosis
|
J:66953
|
Bcl10tm1Mak/Bcl10tm1Mak
(involves: 129P2/OlaHsd)
|
increased hindbrain apoptosis
|
J:67297
|
Bcl11atm1Sbri/Bcl11atm1Sbri
Tg(Pou3f4-cre)32Cren/0
(involves: CD-1)
|
abnormal excitatory postsynaptic currents
|
J:184011
|
Bcorl1em1(IMPC)Tcp/Bcorl1em1(IMPC)Tcp
(C57BL/6N-Bcorl1em1(IMPC)Tcp/Cmmr)
|
decreased prepulse inhibition
|
J:211773
|
Bdnftm1Bail/Bdnftm1Bail
(B6.129-Bdnftm1Bail)
|
abnormal inhibitory postsynaptic currents
|
J:147571
|
| abnormal nervous system physiology
|
J:147571
|
| abnormal synaptic plasticity
|
J:147571
|
Bdnftm1Flee/Bdnf+
(B6.129-Bdnftm1Flee)
|
abnormal neuron physiology
|
J:113019
|
Bdnftm1Flee/Bdnftm1Flee
(B6.129-Bdnftm1Flee)
|
abnormal neuron physiology
|
J:113019
|
Bdnftm1Jae/Bdnftm1Jae
(involves: 129S4/SvJae)
|
increased neuron apoptosis
|
J:123022
|
Bdnftm1Jae/Bdnftm1Jae
(involves: 129S4/SvJae * BALB/c)
|
abnormal neuron apoptosis
|
J:46125
|
Bdnftm1Krj/Bdnftm1Krj
(involves: 129S2/SvPas * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:184139
|
| abnormal nervous system physiology
|
J:184139
|
Bdnftm1Msd/Bdnftm1Msd
Mapttm1(cre)Nagy/Mapt+
(involves: 129S1/Sv * 129X1/SvJ)
|
reduced long-term potentiation
|
J:131394
|
Bdnftm1Par/Bdnf+
(B6.129S1-Bdnftm1Par)
|
abnormal CNS synaptic transmission
|
J:59077
|
Bdnftm1Par/Bdnftm1Par
(involves: 129S1/Sv)
|
increased neuron apoptosis
|
J:60927
|
Bdnftm1Sieg/Bdnftm1Sieg
Tg(Camk2a-cre)1Szi/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
reduced long-term potentiation
|
J:85602
|
Bdnftm1Tbn/Bdnf+
(involves: 129S4/SvJae * NMRI)
|
abnormal excitatory postsynaptic potential
|
J:64962
|
| impaired synaptic plasticity
|
J:64962
|
| reduced long-term potentiation
|
J:64962
|
Bdnftm1Tbn/Bdnftm1Tbn
(involves: 129S4/SvJae * NMRI)
|
abnormal excitatory postsynaptic potential
|
J:64962
|
| impaired synaptic plasticity
|
J:64962
|
| reduced long-term potentiation
|
J:64962
|
Bdnftm3Jae/Bdnftm3Jae
Mecp2tm1.1Jae/Y
Tg(Camk2a-cre)93Kln/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
abnormal action potential
|
J:106973
|
Bdnftm3Jae/Bdnftm3Jae
Tg(Eno2tTA)5030Nes/0
Tg(tetO-cre)1Jaw/0
(involves: 129/Sv * C57BL/6 * ICR * SJL)
|
reduced long-term potentiation
|
J:91563
|
Bdnftm3Jae/Bdnftm3Jae
Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR)
|
abnormal kindling response
|
J:91467
|
Begaintm1.1Tayk/Begaintm1.1Tayk
(involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal excitatory postsynaptic currents
|
J:237768
|
| prolonged excitatory postsynaptic current rise time
|
J:237768
|
bella/bella
(involves: BALB/c * C3H/HeH)
|
increased neuron apoptosis
|
J:230923,
J:177995
|
Bex2tm1b(EUCOMM)Hmgu/Bex2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bex2tm1b(EUCOMM)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Bex3em1Jjcar/Bex3em1Jjcar
(involves: C57BL/6 * CBA)
|
abnormal inhibitory postsynaptic currents
|
J:332746
|
| decreased excitatory postsynaptic current frequency
|
J:332746
|
| increased prepulse inhibition
|
J:332746
|
Bex3em2Jjcar/Bex3em2Jjcar
(involves: C57BL/6 * CBA)
|
increased prepulse inhibition
|
J:332746
|
Bhlhe22tm1Meg/Bhlhe22tm1Meg
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6) or (involves: 129/Sv * CD-1))
|
abnormal nervous system physiology
|
J:158273
|
Bhlhe40tm1.1Rhli/Bhlhe40tm1.1Rhli
(involves: 129S1/Sv * C57BL/6 * CD-1 * SJL)
|
increased susceptibility to pharmacologically induced seizures
|
J:131834
|
Bicd1tm1.1(KOMP)Wtsi/Bicd1tm1.1(KOMP)Wtsi
(C57BL/6N-Bicd1tm1.1(KOMP)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Bicd2tm1.1Hgrd/Bicd2tm1.1Hgrd
(involves: C57BL/6)
|
abnormal cerebellar granule cell migration
|
J:210236
|
Bicd2tm1Hgrd/Bicd2tm1Hgrd
Emx1tm1(cre)Krj/Emx1+
(involves: C57BL/6)
|
abnormal neuronal migration
|
J:210236
|
Bicd2tm1Hgrd/Bicd2tm1Hgrd
Tg(GFAP-cre)25Mes/0
(involves: C57BL/6 * FVB/N)
|
abnormal cerebellar granule cell migration
|
J:210236
|
| abnormal neuronal migration
|
J:210236
|
Bicralem1(IMPC)J/Bicralem1(IMPC)J
(C57BL/6NJ-Bicralem1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Bidtm1Sjk/Bidtm1Sjk
Cstbtm1Rm/Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal brain wave pattern
|
J:115694
|
| myoclonus
|
J:115694
|
| seizures
|
J:115694
|
Bin2tm1.1Beni/Bin2tm1.1Beni
Tg(Pf4-icre)Q3Rsko/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
decreased cerebral infarct size
|
J:302510
|
| decreased susceptibility to ischemic brain injury
|
J:302510
|
Birc6tm1Sjen/Birc6tm1Sjen
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intraventricular hemorrhage
|
J:94169
|
Bis1C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal seizure response to pharmacological agent
|
J:54925
|
Bis4A/J/?
(involves: A/J * C57BL/6J)
|
abnormal seizure response to pharmacological agent
|
J:54925
|
Bloc1s2tm1Wli/Bloc1s2tm1Wli
(involves: 129 * C57BL/6J)
|
increased neuronal precursor proliferation
|
J:238623
|
Bloc1s6pa/Bloc1s6pa
(B6.Cg-Bloc1s6pa/J)
|
tonic seizures
|
J:5215
|
Bmi1tm1Brn/Bmi1tm1Brn
(either: (involves: 129P2/OlaHsd) or (involves: 129P2/OlaHsd * FVB))
|
sporadic seizures
|
J:17712
|
Borcs7Q87X/Borcs7Q87X
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2)
|
abnormal axonal transport
|
J:271219
|
Borcs7tm1Bhk/Borcs7tm1Bhk
(129S6/SvEvTac-Borcs7tm1Bhk)
|
abnormal axonal transport
|
J:271219
|
Bptfem1(IMPC)Bay/Bptf+
(C57BL/6N-Bptfem1(IMPC)Bay/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Bptftm1.1Cwu/Bptftm1.1Cwu
Emx1tm1(cre)Krj/Emx1+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:334252
|
| increased neuron apoptosis
|
J:334252
|
Braftm1.1Sva/Braftm1.1Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased neuron apoptosis
|
J:121660
|
Braftm1.1Wds/Braftm1.1Wds
(involves: 129P2/OlaHsd * C57BL/6)
|
increased neuron apoptosis
|
J:121660
|
Braftm1Bbd/Braf+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CD-1)
|
convulsive seizures
|
J:170095
|
Braftm1Cpri/Braf+
Scn10atm2(cre)Jwo/Scn10a+
(involves: 129 * 129P2/OlaHsd)
|
abnormal nervous system electrophysiology
|
J:205122
|
| abnormal neuron physiology
|
J:205122
|
Braftm1Sva/Braftm1Sva
Tg(Camk2a-cre)1557Sva/0
(involves: 129S1/Sv * 129T2/SvEms * 129X1/SvJ * FVB)
|
reduced long-term potentiation
|
J:107042
|
Braftm1Zim/Braftm1Zim
(involves: 129)
|
intraventricular hemorrhage
|
J:41257
|
Braftm2.1Urr/Braftm2.1Urr
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
increased neuronal precursor proliferation
|
J:199842
|
Braftm2Cpri/Braf+
Tg(CMV-cre)1Cgn/0
(B6.Cg-Braftm2Cpri Tg(CMV-cre)1Cgn)
|
increased susceptibility to ischemic brain injury
|
J:187371
|
Braftm2Urr/Braftm2Urr
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:199842
|
Brd4tm1b(EUCOMM)Wtsi/Brd4+
(C57BL/6N-Brd4tm1b(EUCOMM)Wtsi/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Brpf1tm1c(EUCOMM)Wtsi/Brpf1tm1c(EUCOMM)Wtsi
Emx1tm1(cre)Krj/Emx1+
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N)
|
abnormal neuronal precursor cell migration
|
J:224155
|
| decreased neuronal precursor proliferation
|
J:224155,
J:241490
|
Bscl2tm1b(EUCOMM)Hmgu/Bscl2tm1b(EUCOMM)Hmgu
(C57BL/6N-Bscl2tm1b(EUCOMM)Hmgu/Ics)
|
decreased prepulse inhibition
|
J:211773
|
Bsntm1Gund/Bsntm1Gund
(Not Specified)
|
abnormal brain wave pattern
|
J:82241
|
| abnormal CNS synaptic transmission
|
J:82241
|
| abnormal cochlear inner hair cell physiology
|
J:167745,
J:114223
|
| abnormal somatic nervous system physiology
|
J:114223
|
| abnormal synaptic transmission
|
J:114223
|
| clonic seizures
|
J:82241
|
| convulsive seizures
|
J:82241
|
| decreased cochlear nerve compound action potential
|
J:114223
|
| decreased synaptic depression
|
J:82241
|
| increased susceptibility to pharmacologically induced seizures
|
J:82241
|
| myoclonus
|
J:82241
|
Btbd9Gt(RRE078)Byg/Btbd9Gt(RRE078)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:187734
|
| abnormal synaptic plasticity
|
J:187734
|
| enhanced long-term potentiation
|
J:187734
|
| increased paired-pulse ratio
|
J:187734
|
Btbd9Gt(RRE078)Byg/Btbd9Gt(RRE078)Byg
(involves: 129P2/OlaHsd)
|
abnormal nervous system physiology
|
J:298663,
J:282582
|
Btbd9tm1d(EUCOMM)Wtsi/Btbd9tm1d(EUCOMM)Wtsi
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6N)
|
abnormal nervous system electrophysiology
|
J:298663
|
| abnormal synaptic plasticity
|
J:282582
|
| enhanced paired-pulse facilitation
|
J:282582
|
Btg1tm1Ftir/Btg1tm1Ftir
(Not Specified)
|
decreased neuronal precursor proliferation
|
J:217516
|
| increased neuron apoptosis
|
J:217516
|
C1galt1tm1Rpmc/C1galt1tm1Rpmc
(involves: 129S1/Sv * C57BL/6J)
|
intracranial hemorrhage
|
J:96775
|
| spinal hemorrhage
|
J:96775
|
C1galt1c1tm1.2Rdcu/Y
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
spinal hemorrhage
|
J:160290
|
C1qatm1Mjw/C1qatm1Mjw
(involves: 129S/SvEv)
|
abnormal excitatory postsynaptic currents
|
J:159281
|
| abnormal inhibitory postsynaptic currents
|
J:159281
|
| absence seizures
|
J:159281
|
| increased excitatory postsynaptic current frequency
|
J:159281
|
| increased miniature excitatory postsynaptic current frequency
|
J:159281
|
| seizures
|
J:159281
|
C1ql1tm1.1Yuza/C1ql1tm1.1Yuza
(involves: C57BL/6N)
|
abnormal afterhyperpolarization
|
J:219706
|
| abnormal single cell response
|
J:219706
|
| absent long-term depression
|
J:219706
|
C1qtnf9tm1(KOMP)Vlcg/C1qtnf9tm1(KOMP)Vlcg
(C57BL/6-C1qtnf9tm1(KOMP)Vlcg)
|
abnormal hypothalamus physiology
|
J:212299
|
C2cd5em1(IMPC)Tcp/C2cd5em1(IMPC)Tcp
(C57BL/6NCrl-C2cd5em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
C3tm1Crr/C3tm1Crr
(involves: 129S4/SvJae * C57BL/6)
|
enhanced central nervous system regeneration
|
J:112353
|
C3tm1Crr/C3tm1Crr
(B6.129S4-C3tm1Crr)
|
abnormal synaptic plasticity
|
J:224676
|
| brain inflammation
|
J:123658
|
| decreased cerebral infarct size
|
J:123658
|
| enhanced long-term potentiation
|
J:224676
|
| enhanced paired-pulse facilitation
|
J:224676
|
C3tm1Crr/C3tm1Crr
Zbtb20Tg(PDGFB-APPSwInd)20Lms/?
(involves: 129S4/SvJae * C57BL/6)
|
increased microglial cell activation
|
J:135902
|
C3ar1tm1Raw/C3ar1tm1Raw
(B6.129X1(B6)-C3ar1tm1Raw)
|
demyelination
|
J:93791
|
C9orf72em5Lutzy/C9orf72em5Lutzy
(C57BL/6-C9orf72em5Lutzy)
|
abnormal microglial cell physiology
|
J:101977
|
C9orf72tm1.1Eggn/C9orf72tm1.1Eggn
(involves: C57BL/6 * C57BL/6N)
|
brain inflammation
|
J:240357
|
Cabp2tm1b(KOMP)Mbp/Cabp2tm1b(KOMP)Mbp
(involves: C57BL/6N * FVB/N)
|
abnormal cochlear inner hair cell physiology
|
J:255028
|
Cacna1arkr/Cacna1arkr
(B6.Cg-Cacna1arkr)
|
absence seizures
|
J:71860
|
Cacna1atg-4J/Cacna1atg-4J
(B6.C3Bir-Cacna1atg-4J)
|
abnormal nervous system electrophysiology
|
J:137816
|
| absence seizures
|
J:137816
|
Cacna1aTg-5J/Cacna1a+
(B10.Cg-Cacna1aTg-5J)
|
abnormal nervous system electrophysiology
|
J:137816
|
Cacna1atg-la/Cacna1atg-la
(B6.Cg-Os +/+ Cacna1atg-la/J)
|
abnormal action potential
|
J:72853
|
| abnormal channel response
|
J:72853
|
| abnormal nerve fiber response
|
J:72853
|
| decreased nerve fiber response intensity
|
J:72853
|
Cacna1atg-rol/Cacna1a+
(involves: C3Hf/Nga * C57BL/6 * SIII)
|
abnormal nervous system physiology
|
J:3611
|
Cacna1atg-rol/Cacna1atg-rol
(involves: C57BL/6 * SIII)
|
abnormal CNS synaptic transmission
|
J:109231
|
| abnormal excitatory postsynaptic currents
|
J:109231
|
| abnormal miniature excitatory postsynaptic currents
|
J:109231
|
| enhanced paired-pulse facilitation
|
J:109231
|
| prolonged excitatory postsynaptic current decay time
|
J:164115
|
Cacna1atg-rol/Cacna1atg-rol
(involves: C3Hf/Nga * C57BL/6 * SIII)
|
abnormal nervous system physiology
|
J:3611
|
Cacna1atg/Cacna1atg
(involves: C57BL/6J * DBA/2J)
|
abnormal CNS synaptic transmission
|
J:106959
|
| abnormal nervous system physiology
|
J:221681
|
| abnormal somatosensory cortex physiology
|
J:221681
|
| abnormal synaptic transmission
|
J:221681
|
Cacna1atg/Cacna1atg
(B6.D2-Cacna1atg/J)
|
abnormal nervous system electrophysiology
|
J:6154
|
| abnormal paired-pulse inhibition
|
J:109231
|
| decreased excitatory postsynaptic current amplitude
|
J:109231
|
| increased susceptibility to pharmacologically induced seizures
|
J:6154
|
| seizures
|
J:6154
|
Cacna1atg/Cacna1atg
(involves: 101 * C3H * C57BL/10 * DBA/2J)
|
seizures
|
J:262
|
| sporadic seizures
|
J:262
|
Cacna1atm1.1Ehess/Cacna1atm1.1Ehess
(C57BL/6-Cacna1atm1.1Ehess)
|
abnormal channel response
|
J:217557
|
Cacna1atm1.1Sher/Cacna1atm1.1Sher
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal action potential
|
J:170451
|
| abnormal channel response
|
J:170451
|
| abnormal inhibitory postsynaptic currents
|
J:170451
|
| abnormal seizure response to inducing agent
|
J:170451
|
| abnormal spike wave discharge
|
J:170451
|
| absence seizures
|
J:170451
|
| environmentally induced seizures
|
J:170451
|
Cacna1atm1.2Sher/Cacna1atm1.2Sher
(involves: 129S4/SvJae)
|
abnormal inhibitory postsynaptic currents
|
J:170451
|
| seizures
|
J:170451
|
Cacna1atm1Fcr/Cacna1atm1Fcr
(involves: 129S1/Sv * C57BL/6J)
|
abnormal nervous system physiology
|
J:76459
|
Cacna1atm1Hssh/Cacna1atm1Hssh
(involves: 129 * C57BL/6J)
|
abnormal channel response
|
J:59076
|
| abnormal excitatory postsynaptic potential
|
J:59076
|
Cacna1atm1Hssh/Cacna1atm1Hssh
(involves: C57BL/6J)
|
abnormal brain wave pattern
|
J:59076
|
| abnormal channel response
|
J:59076
|
| abnormal CNS synaptic transmission
|
J:59076
|
| abnormal spike wave discharge
|
J:59076
|
Cacna1atm1Hssh/Cacna1atm1Hssh
(Not Specified)
|
abnormal excitatory postsynaptic currents
|
J:173318
|
Cacna1atm1Hzo/Cacna1atm1Hzo
(involves: 129S/SvEv)
|
abnormal channel response
|
J:139488
|
Cacna1atm1Kano/Cacna1atm1Kano
Grid2tm1(cre)Mwa/Grid2+
(involves: C57BL/6 * C57BL/6N)
|
abnormal CNS synaptic transmission
|
J:173318
|
| abnormal excitatory postsynaptic currents
|
J:173318
|
| prolonged excitatory postsynaptic current decay time
|
J:173318
|
| prolonged excitatory postsynaptic current rise time
|
J:173318
|
Cacna1atm1Kano/Cacna1atm1Kano
Grid2tm1(cre)Mwa/Grid2+
(involves: C57BL/6N)
|
abnormal excitatory postsynaptic current amplitude
|
J:180582
|
| increased neurotransmitter release
|
J:180582
|
Cacna1atm1Lory/Cacna1a+
(involves: C57BL/6 * C57BL/6J)
|
abnormal action potential
|
J:258570
|
| abnormal excitatory postsynaptic currents
|
J:258570
|
| absence seizures
|
J:258570
|
| decreased excitatory postsynaptic current amplitude
|
J:258570
|
| increased excitatory postsynaptic current amplitude
|
J:258570
|
Cacna1atm1Maag/Cacna1a+
(B6.129P2-Cacna1atm1Maag)
|
abnormal nervous system electrophysiology
|
J:144701
|
Cacna1atm1Maag/Cacna1atm1Maag
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal channel response
|
J:88693
|
| abnormal CNS synaptic transmission
|
J:88693
|
| abnormal miniature endplate potential
|
J:88693
|
| abnormal PNS synaptic transmission
|
J:88693
|
| abnormal synaptic acetylcholine release
|
J:88693
|
Cacna1atm1Maag/Cacna1atm1Maag
(B6.129P2-Cacna1atm1Maag)
|
abnormal nervous system electrophysiology
|
J:144701
|
| increased cerebral infarct size
|
J:193793
|
| increased susceptibility to ischemic brain injury
|
J:193793
|
Cacna1atm1Nobs/Cacna1atm2Nobs
(involves: 129 * C57BL/6J)
|
absence seizures
|
J:155607
|
Cacna1atm2.1Kewa/Cacna1atm2.1Kewa
(B6.Cg-Cacna1atm2.1Kewa)
|
abnormal nervous system electrophysiology
|
J:190729
|
Cacna1atm2.1Maag/Cacna1atm2.2Maag
Tg(EIIa-cre)C5379Lmgd/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal synaptic acetylcholine release
|
J:117062
|
| decreased neurotransmitter release
|
J:117062
|
Cacna1atm2Hzo/Cacna1atm2Hzo
(involves: 129S/SvEv)
|
abnormal channel response
|
J:139488
|
Cacna1atm2Nobs/Cacna1atm2Nobs
(involves: 129 * C57BL/6J)
|
abnormal spike wave discharge
|
J:155607
|
| absence seizures
|
J:155607
|
| clonic seizures
|
J:155607
|
Cacna1atm3Hzo/Cacna1atm3Hzo
(involves: 129S/SvEv)
|
abnormal channel response
|
J:139488
|
Cacna1atm3Maag/Cacna1a+
(B6.129P2-Cacna1atm3Maag)
|
abnormal nervous system electrophysiology
|
J:144701
|
Cacna1atm3Maag/Cacna1a+
(involves: 129P2/OlaHsd)
|
increased cerebral infarct size
|
J:193793
|
| increased susceptibility to ischemic brain injury
|
J:193793
|
Cacna1atm3Maag/Cacna1atm3Maag
(B6.129P2-Cacna1atm3Maag)
|
abnormal nervous system electrophysiology
|
J:144701
|
| seizures
|
J:144701
|
Cacna1atm3Maag/Cacna1atm3Maag
(involves: 129P2/OlaHsd)
|
increased cerebral infarct size
|
J:193793
|
| increased susceptibility to ischemic brain injury
|
J:193793
|
Cacna1btm1.1Dili/Cacna1btm1.1Dili
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal single cell response
|
J:165258
|
Cacna1btm1Hssh/Cacna1btm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal channel response
|
J:71480
|
| abnormal excitatory postsynaptic potential
|
J:137285
|
| abnormal hypothalamus secretion
|
J:147238
|
| abnormal inhibitory postsynaptic currents
|
J:147238
|
| abnormal miniature excitatory postsynaptic currents
|
J:137285
|
| abnormal miniature inhibitory postsynaptic currents
|
J:147238
|
| abnormal nervous system electrophysiology
|
J:147238
|
| abnormal single cell response
|
J:147238
|
| abnormal summary potential
|
J:147238
|
| abnormal synaptic transmission
|
J:147238
|
| reduced long-term potentiation
|
J:137285
|
Cacna1btm1Ksw/Cacna1btm1Ksw
(involves: C57BL/6 * CBA)
|
abnormal baroreceptor physiology
|
J:76458
|
| abnormal channel response
|
J:103705
|
| abnormal sympathetic nervous system physiology
|
J:76458
|
Cacna1btm1Ttan/Cacna1btm1Ttan
(involves: 129S4/SvJae * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:107971
|
Cacna1btm2.1Dili/Cacna1btm2.1Dili
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal single cell response
|
J:165258
|
Cacna1ctm1Itl/Cacna1ctm1Itl
(B6.129S6-Cacna1ctm1Itl)
|
abnormal neuron physiology
|
J:171157
|
Cacna1ctm1Jst/Cacna1ctm1Jst
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:91092
|
| abnormal nervous system physiology
|
J:91092
|
Cacna1dtm1Hssh/Cacna1dtm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal cochlear outer hair cell physiology
|
J:118306
|
Cacna1dtm1Jst/Cacna1dtm1Jst
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal action potential
|
J:230439
|
| abnormal cochlear inner hair cell physiology
|
J:117764,
J:63515
|
| abnormal cochlear outer hair cell physiology
|
J:117764
|
Cacna1dtm1Jst/Cacna1dtm1Jst
(B6.129S7-Cacna1dtm1Jst)
|
abnormal cochlear inner hair cell physiology
|
J:113161,
J:88205
|
Cacna1etm1.1Beck/Cacna1etm1.1Beck
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased channel response intensity
|
J:105917
|
| increased channel response threshold
|
J:105917
|
Cacna1etm1Hssh/Cacna1etm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal channel response
|
J:81788
|
Cacna1ftm1.1Sdie/Y
(B6.Cg-Cacna1ftm1.1Sdie/J)
|
abnormal neuron physiology
|
J:212726
|
Cacna1ftm1.1Sdie/Cacna1ftm1.1Sdie
(B6.Cg-Cacna1ftm1.1Sdie/J)
|
abnormal neuron physiology
|
J:212726
|
Cacna1ftm1.2Sdie/Y
(B6.Cg-Cacna1ftm1.2Sdie/J)
|
abnormal neuron physiology
|
J:212726
|
Cacna1ftm1.2Sdie/Cacna1ftm1.2Sdie
(B6.Cg-Cacna1ftm1.2Sdie/J)
|
abnormal neuron physiology
|
J:212726
|
Cacna1gem1Ftan/Cacna1g+
(C57BL/6NCrSlc-Cacna1gem1Ftan)
|
abnormal afterhyperpolarization
|
J:278129
|
Cacna1gem1Ftan/Cacna1gem1Ftan
(C57BL/6NCrSlc-Cacna1gem1Ftan)
|
abnormal afterhyperpolarization
|
J:278129
|
| abnormal channel response
|
J:278129
|
| abnormal neuron physiology
|
J:278129
|
Cacna1gtm1.1Stl/Cacna1gtm1.1Stl
(involves: C57BL/6)
|
abnormal action potential
|
J:96099
|
| impaired ability to fire action potentials
|
J:96099
|
Cacna1gtm1.3Ksak/Cacna1gtm1.3Ksak
(involves: C57BL/6)
|
abnormal single cell response
|
J:151465
|
Cacna1gtm1Hssh/Cacna1gtm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal action potential
|
J:70557
|
| abnormal nervous system physiology
|
J:70557
|
| abnormal spike wave discharge
|
J:70557
|
| decreased susceptibility to pharmacologically induced seizures
|
J:70557
|
Cacna1htm1Kcam/Cacna1htm1Kcam
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal channel response
|
J:86616
|
Cacna1iem1Jqp/Cacna1i+
(Not Specified)
|
abnormal nervous system electrophysiology
|
J:302192
|
Cacna1iem1Jqp/Cacna1iem1Jqp
(Not Specified)
|
abnormal action potential
|
J:302192
|
| abnormal afterhyperpolarization
|
J:302192
|
| abnormal brain wave pattern
|
J:302192
|
| abnormal nervous system electrophysiology
|
J:302192
|
| abnormal single cell response
|
J:302192
|
Cacna1iem2Jqp/Cacna1iem2Jqp
(Not Specified)
|
abnormal action potential
|
J:302192
|
| abnormal afterhyperpolarization
|
J:302192
|
| abnormal nervous system electrophysiology
|
J:302192
|
| abnormal single cell response
|
J:302192
|
Cacna2d1em1(IMPC)Mbp/Cacna2d1em1(IMPC)Mbp
(C57BL/6N-Cacna2d1em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Cacna2d1tm1Aschw/Cacna2d1tm1Aschw
(involves: Black Swiss)
|
decreased channel response intensity
|
J:151101
|
| increased channel response threshold
|
J:151101
|
Cacna2d1tm1Cptl/Cacna2d1tm1Cptl
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:117098
|
Cacna2d2du-2J/Cacna2d2+
(involves: C57BL/6 * C57BLKS/J)
|
abnormal CNS synaptic transmission
|
J:213548
|
Cacna2d2du-2J/Cacna2d2du-2J
(involves: C57BLKS/J-Cacna2d2du-2J/LetJ)
|
abnormal brain wave pattern
|
J:70845
|
| abnormal nervous system electrophysiology
|
J:116185
|
| abnormal spike wave discharge
|
J:70845
|
| absence seizures
|
J:70845
|
Cacna2d2du-2J/Cacna2d2du-2J
(involves: C57BL/6 * C57BLKS/J)
|
abnormal CNS synaptic transmission
|
J:213548
|
| abnormal miniature inhibitory postsynaptic currents
|
J:213548
|
| absence seizures
|
J:213548
|
Cacna2d2du-3J/Cacna2d2du-3J
(involves: BALB/cByJ * C57BL/6J)
|
myoclonus
|
J:82238
|
Cacna2d2du/Cacna2d2du
(involves: C3H * DBA/2J)
|
abnormal miniature endplate potential
|
J:121463
|
| decreased neurotransmitter release
|
J:121463
|
Cacna2d2du/Cacna2d2du
(TKDU/DnJ)
|
abnormal myelination
|
J:5263
|
| seizures
|
J:5263
|
Cacna2d2du/Cacna2d2du
(TKDU)
|
abnormal glial cell physiology
|
J:152373
|
| abnormal myelination
|
J:152373
|
| seizures
|
J:152373
|
Cacna2d2ent/Cacna2d2ent
(either: B6.D2-Cacna2d2ent or (involves: C57BL/6J * CD-1 * DBA/2J))
|
abnormal brain wave pattern
|
J:88967
|
| abnormal neuron physiology
|
J:88967
|
| seizures
|
J:88967
|
Cacna2d2tm1Svi/Cacna2d2tm1Svi
(involves: 129S1/Sv * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:92396
|
| myoclonus
|
J:92396
|
| seizures
|
J:92396
|
| tonic seizures
|
J:92396
|
Cacna2d3tm1Pngr/Cacna2d3tm1Pngr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal nervous system physiology
|
J:167904
|
Cacnb3tm1Hssh/Cacnb3tm1Hssh
(involves: 129/Sv * 129S4/SvJae)
|
abnormal channel response
|
J:50152
|
Cacnb3tm1Hssh/Cacnb3tm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
enhanced long-term potentiation
|
J:136837
|
| enhanced NMDA-mediated synaptic currents
|
J:136837
|
Cacnb4lh-2J/Cacnb4lh-2J
(involves: C3H * C57BL/6 * DBA/2J)
|
seizures
|
J:137891
|
Cacnb4lh/Cacnb4lh
(involves: BALB/cGn * C3H/HeSnJ * C57BL/6JEi)
|
abnormal brain wave pattern
|
J:1484,
J:79139
|
| abnormal CNS synaptic transmission
|
J:106959
|
| clonic seizures
|
J:79139
|
| seizures
|
J:1484
|
| tonic seizures
|
J:79139
|
Cacnb4lh/Cacnb4lh
(involves: BALB/cGn)
|
abnormal nerve conduction
|
J:6556
|
| convulsive seizures
|
J:28466
|
| decreased nerve conduction velocity
|
J:6556
|
Cacng2em1Tern/Cacng2em1Tern
(C57BL/6J-Cacng2em1Tern)
|
abnormal miniature excitatory postsynaptic currents
|
J:301313
|
| decreased miniature excitatory postsynaptic current amplitude
|
J:301313
|
| decreased miniature excitatory postsynaptic current frequency
|
J:301313
|
Cacng2em1Tern/Cacng2em1Tern
Gsg1ltm1.2Tern/Gsg1ltm1.2Tern
(C57BL/6J-Cacng2em1Tern Gsg1ltm1.2Tern)
|
abnormal miniature excitatory postsynaptic currents
|
J:301313
|
| increased excitatory postsynaptic current amplitude
|
J:301313
|
| short excitatory postsynaptic current decay time
|
J:301313
|
| short excitatory postsynaptic current rise time
|
J:301313
|
Cacng2stg-3J/Cacng2+
Cacng4tm1Frk/Cacng4+
(involves: B6C3-Cacng2stg-3J/J * B6.129-Cacng4tm1Frk/J)
|
absence seizures
|
J:96506
|
Cacng2stg-3J/Cacng2stg-3J
Cacng4tm1Frk/Cacng4+
(involves: B6C3-Cacng2stg-3J/J * B6.129-Cacng4tm1Frk/J)
|
absence seizures
|
J:96506
|
Cacng2stg-3J/Cacng2stg-3J
Cacng4tm1Frk/Cacng4tm1Frk
(involves: B6C3-Cacng2stg-3J/J * B6.129-Cacng4tm1Frk/J)
|
absence seizures
|
J:96506
|
Cacng2stg-wag/Cacng2stg-wag
(B6.MRL-Cacng2stg-wag/J)
|
absence seizures
|
J:96506
|
Cacng2stg-wag/Cacng2stg-wag
Cacng4tm1Frk/Cacng4tm1Frk
(involves: B6.MRL-Cacng2stg-wag/J * B6.129-Cacng4tm1Frk/J)
|
absence seizures
|
J:96506
|
Cacng2stg/Cacng2stg
(B6C3Fe a/a-Cacng2stg/J)
|
abnormal brain wave pattern
|
J:91987
|
Cacng2stg/Cacng2stg
(B6C3Fe a/a-Cacng2stg)
|
abnormal brain wave pattern
|
J:11008,
J:15527
|
| absence seizures
|
J:15527
|
Cacng2stg/Cacng2stg
(involves: A/J * C3HeB/FeJ * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:106959
|
Cacng2stg/Cacng2stg
(involves: A/J)
|
abnormal miniature excitatory postsynaptic currents
|
J:163184
|
| absence of AMPA-mediated synaptic currents
|
J:163184
|
Cacng2stg/Cacng2stg
(Not Specified)
|
reduced AMPA-mediated synaptic currents
|
J:140010
|
Cacng2stg/Cacng2stg
Cacng3tm1Ran/Cacng3tm1Ran
(involves: A/J)
|
abnormal CNS synaptic transmission
|
J:138791
|
| abnormal excitatory postsynaptic currents
|
J:138791
|
| abnormal miniature excitatory postsynaptic currents
|
J:138791
|
Cacng2tm1.1Mwa/Cacng2tm1.1Mwa
(involves: C57BL/6 * C57BL/6N * CBA)
|
decreased excitatory postsynaptic current amplitude
|
J:163029
|
| reduced AMPA-mediated synaptic currents
|
J:163029
|
Cacng2tm1.1Mwa/Cacng2tm1.1Mwa
Cacng7tm1.1Mwa/Cacng7tm1.1Mwa
(involves: C57BL/6 * C57BL/6N * CBA)
|
decreased excitatory postsynaptic current amplitude
|
J:163029
|
| reduced AMPA-mediated synaptic currents
|
J:163029
|
Cacng2tm1.1Suto/Cacng2tm1.1Suto
(Not Specified)
|
abnormal AMPA-mediated synaptic currents
|
J:163184
|
| increased miniature excitatory postsynaptic current amplitude
|
J:163184
|
Cacng2tm2.1Suto/Cacng2tm2.1Suto
(Not Specified)
|
abnormal AMPA-mediated synaptic currents
|
J:163184
|
| decreased miniature excitatory postsynaptic current amplitude
|
J:163184
|
Cacng4tm1Ran/Cacng4tm1Ran
(involves: C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:175164
|
| decreased miniature excitatory postsynaptic current amplitude
|
J:175164
|
Cacng8tm1.1Suto/Cacng8tm1.1Suto
(Not Specified)
|
abnormal AMPA-mediated synaptic currents
|
J:179775
|
| abnormal excitatory postsynaptic currents
|
J:179775
|
| abnormal glutamate-mediated receptor currents
|
J:179775
|
Cacng8tm1Ran/Cacng8+
(C57BL/6-Cacng8tm1Ran)
|
decreased miniature excitatory postsynaptic current amplitude
|
J:322011
|
Cacng8tm1Ran/Cacng8tm1Ran
(involves: C57BL/6)
|
abnormal synaptic transmission
|
J:102515
|
| decreased miniature excitatory postsynaptic current amplitude
|
J:197912
|
| reduced long-term potentiation
|
J:179775,
J:102515
|
Cacng8tm1Ran/Cacng8tm1Ran
(C57BL/6-Cacng8tm1Ran)
|
decreased miniature excitatory postsynaptic current amplitude
|
J:322011
|
Cadem1(IMPC)Mbp/Cad+
(C57BL/6N-Cadem1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Cadm3tm1Qiu/Cadm3tm1Qiu
(Not Specified)
|
abnormal myelination
|
J:142504
|
Cadm4tm1.1Pele/Cadm4tm1.1Pele
Tg(Pgk1-cre)1Lni/0
(involves: 129S/SvEv * 129S4/SvJaeSor * BALB/c * C57BL/6)
|
abnormal myelination
|
J:199632
|
| decreased nerve conduction velocity
|
J:199632
|
Cadps2tm1Tfr/Cadps2tm1Tfr
(C57BL/6-Cadps2tm1Tfr)
|
abnormal cerebellar granule cell migration
|
J:120106
|
| abnormal paired-pulse facilitation
|
J:120106
|
Cadpstm1.1Tfr/Cadpstm1.2Tfr
Ptf1atm1.1(cre)Cvw/Ptf1a+
(B6.Cg-Ptf1atm1.1(cre)Cvw Cadpstm1.1Tfr Cadpstm1.2Tfr)
|
abnormal paired-pulse inhibition
|
J:204664
|
| decreased excitatory postsynaptic current amplitude
|
J:204664
|
Cadpstm1Bros/Cadpstm1Bros
(Not Specified)
|
abnormal neuron physiology
|
J:131212
|
| decreased excitatory postsynaptic current amplitude
|
J:131212
|
| decreased miniature excitatory postsynaptic current amplitude
|
J:131212
|
| decreased miniature excitatory postsynaptic current frequency
|
J:131212
|
Cadpstm1Bros/Cadpstm1Bros
Cadps2tm1Bros/Cadps2tm1Bros
(Not Specified)
|
abnormal CNS synaptic transmission
|
J:131212
|
| abnormal excitatory postsynaptic current amplitude
|
J:131212
|
| abnormal miniature excitatory postsynaptic currents
|
J:131212
|
| abnormal neuron physiology
|
J:167753,
J:131212
|
| abnormal neurotransmitter secretion
|
J:263391
|
Calb1tm1Mpin/Calb1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:38599
|
Calb1tm1Mpin/Calb1tm1Mpin
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:38599
|
Calb1tm2.1Mpin/Calb1tm2.1Mpin
Tg(Pcp2-cre)2Mpin/?
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuron physiology
|
J:83378
|
Calb2tm1Map/Calb2tm1Map
(involves: 129P2/OlaHsd * C57BL/6JIco)
|
abnormal long-term potentiation
|
J:42924
|
| abnormal nervous system electrophysiology
|
J:54517
|
Calb2tm2.1(cre/ERT2)Zjh/Calb2tm2.1(cre/ERT2)Zjh
(involves: C57BL/6 * SJL)
|
abnormal nervous system electrophysiology
|
J:151755
|
| reduced long-term potentiation
|
J:151755
|
Calcatm1.1(cre/EGFP)Rpa/Calca+
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal excitatory postsynaptic currents
|
J:206070
|
Calcatm1Hku/Calcatm1Hku
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal sympathetic nervous system physiology
|
J:80225
|
Calhm1tm1Geno/Calhm1tm1Geno
(involves: 129 * C57BL/6)
|
abnormal neuron physiology
|
J:186424
|
Calhm4em1(IMPC)Tcp/Calhm4em1(IMPC)Tcp
(C57BL/6NCrl-Calhm4em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Caln1em1Mrkr/Caln1em1Mrkr
(C57BL/6J-Caln1em1Mrkr)
|
abnormal excitatory postsynaptic potential
|
J:338143
|
| impaired synaptic plasticity
|
J:338143
|
| reduced long-term potentiation
|
J:338143
|
Calytm1.1Cber/Calytm1.1Cber
(C57BL/6-Calytm1.1Cber)
|
abnormal synaptic vesicle recycling
|
J:145984,
J:146583
|
| absent long-term depression
|
J:145984
|
Camk1tm2b(EUCOMM)Hmgu/Camk1tm2b(EUCOMM)Hmgu
(C57BL/6N-Camk1tm2b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Camk2atm1.1Oyam/Camk2a+
(either: B6.Cg-Camk2atm1.1Oyam or (involves: C57BL/6 * CBA * ICR))
|
sporadic seizures
|
J:150046
|
Camk2atm1.1Oyam/Camk2atm1.1Oyam
(either: B6.Cg-Camk2atm1.1Oyam or (involves: C57BL/6 * CBA * ICR))
|
reduced long-term potentiation
|
J:150046
|
| sporadic seizures
|
J:150046
|
Camk2atm1.1Yelg/Camk2atm1.1Yelg
Tg(CAG-cre/Esr1*)5Amc/0
(B6J.Cg-Camk2atm1.1Yelg Tg(CAG-cre/Esr1*)5Amc)
|
impaired synaptic plasticity
|
J:216169
|
| reduced long-term potentiation
|
J:216169
|
Camk2atm1Kub/Camk2atm1Kub
(involves: 129 * C57BL/6)
|
absent long-term depression
|
J:208776
|
Camk2atm1Mllr/Camk2atm1Mllr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal long-term potentiation
|
J:79713
|
Camk2atm1Sva/Camk2a+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased cerebral infarct size
|
J:113259
|
Camk2atm1Sva/Camk2a+
(B6.129P2-Camk2atm1Sva/J)
|
abnormal CNS synaptic transmission
|
J:263327
|
| abnormal neuron physiology
|
J:263327
|
Camk2atm1Sva/Camk2atm1Sva
(involves: 129P2/OlaHsd * BALB/c)
|
decreased paired-pulse facilitation
|
J:1421
|
| reduced long-term potentiation
|
J:1421
|
Camk2atm1Sva/Camk2atm1Sva
(involves: 129P2/OlaHsd)
|
abnormal CNS synaptic transmission
|
J:113007
|
| reduced long-term depression
|
J:113007
|
| reduced long-term potentiation
|
J:113007
|
Camk2atm1Sva/Camk2atm1Sva
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased cerebral infarct size
|
J:113259
|
Camk2atm1Vyb/Camk2atm1Vyb
Tg(Grik4-cre)G32-4Stl/0
(involves: C57BL/6)
|
abnormal CNS synaptic transmission
|
J:82744
|
| abnormal synaptic transmission
|
J:82744
|
Camk2atm2Sva/Camk2atm2Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absent long-term depression
|
J:208776
|
| reduced long-term potentiation
|
J:127397
|
Camk2atm2Sva/Camk2atm2Sva
(B6.129P2-Camk2atm2Sva)
|
abnormal excitatory postsynaptic currents
|
J:116531
|
Camk2atm3Sva/Camk2atm3Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:127397
|
| abnormal synaptic plasticity
|
J:127397
|
| reduced long-term potentiation
|
J:127397
|
Camk2atm3Sva/Camk2atm3Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
reduced long-term potentiation
|
J:79714
|
Camk2atm4Sva/Camk2atm4Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
enhanced long-term potentiation
|
J:127397
|
Camk2atm4Sva/Camk2atm4Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
abnormal long-term potentiation
|
J:79714
|
| seizures
|
J:79714
|
Camk2atm5Sva/Camk2a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
reduced long-term potentiation
|
J:79714
|
Camk2atm5Sva/Camk2atm5Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
reduced long-term potentiation
|
J:127397
|
Camk2atm5Sva/Camk2atm5Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
abnormal long-term depression
|
J:79714
|
| reduced long-term potentiation
|
J:79714
|
| seizures
|
J:79714
|
Camk2btm1b(EUCOMM)Hmgu/Camk2b+
(C57BL/6N-Camk2btm1b(EUCOMM)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Camk2btm1Yelg/Camk2btm1Yelg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal long-term depression
|
J:152575
|
| abnormal long-term potentiation
|
J:152575
|
| abnormal synaptic plasticity
|
J:152575
|
Camk2btm1Yelg/Camk2btm1Yelg
(involves: 129P2/OlaHsd)
|
reduced long-term potentiation
|
J:174521
|
Camk4tm1Arm/Camk4tm1Arm
(involves: 129 * C57BL/6J)
|
abnormal synaptic depression
|
J:70431
|
| decreased excitatory postsynaptic current amplitude
|
J:70431
|
| increased excitatory postsynaptic current amplitude
|
J:70431
|
Camk4tm1Tch/Camk4tm1Tch
(involves: 129X1/SvJ * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:64210
|
| decreased excitatory postsynaptic current frequency
|
J:64210
|
| reduced long-term depression
|
J:64210
|
Camk4tm1Tch/Camk4tm1Tch
(B6.129X1-Camk4tm1Tch)
|
abnormal inhibitory postsynaptic currents
|
J:108062
|
Camkk2tm1Kpg/Camkk2tm1Kpg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal long-term potentiation
|
J:86370
|
Camsap1tm1Wem/Camsap1tm1Wem
(involves: C57BL/6J)
|
abnormal neuronal migration
|
J:296029
|
| seizures
|
J:296029
|
CanxGt(KST286)Byg/CanxGt(KST286)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased nerve conduction velocity
|
J:164553
|
| demyelination
|
J:164553
|
Caprin1tm1Mtok/Caprin1tm1Mtok
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:164650
|
| abnormal neuron physiology
|
J:164650
|
| increased neuron apoptosis
|
J:164650
|
Car1tm1.1Nju/Car1tm1.1Nju
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal synaptic physiology
|
J:336771
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:336771
|
| enhanced long-term potentiation
|
J:336771
|
Car2n/Car2n
Car7tm1.1Kkai/Car7tm1.1Kkai
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2J)
|
abnormal GABA-mediated receptor currents
|
J:200079
|
Car7tm1.1Kkai/Car7tm1.1Kkai
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal GABA-mediated receptor currents
|
J:200079
|
| environmentally induced seizures
|
J:200079
|
Car8wdl/Car8wdl
(C57BLKS/J-Car8wdl/GrsrJ)
|
abnormal neuron physiology
|
J:230904
|
Casktm1Sud/Casktm1.1Sud
Tg(Prm-cre)58Og/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal neurotransmitter secretion
|
J:117978
|
| increased neuron apoptosis
|
J:117978
|
Caskin1em1(IMPC)Mbp/Caskin1em1(IMPC)Mbp
(C57BL/6NCrl-Caskin1em1(IMPC)Mbp/Mmucd)
|
decreased prepulse inhibition
|
J:211773
|
Caskin1tm1.1Lasb/Caskin1tm1.1Lasb
Caskin2tm1.1Lasb/Caskin2tm1.1Lasb
(involves: C57BL/6J * C57BL/6N)
|
reduced long-term potentiation
|
J:297862
|
Caskin2tm1.1(KOMP)Vlcg/Caskin2tm1.1(KOMP)Vlcg
(C57BL/6N-Caskin2tm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Casp1tm1Sesh/Casp1tm1Sesh
Casp4del/Casp4del
(involves: 129S2/SvPas * C57BL/6)
|
decreased neuron apoptosis
|
J:88212
|
| decreased susceptibility to ischemic brain injury
|
J:69589,
J:98866
|
Casp2tm1Yuan/Casp2tm1Yuan
(involves: 129S4/SvJae * C57BL/6J * DBA/2)
|
abnormal neuron apoptosis
|
J:47601
|
Casp3tm1Dsp/Casp3tm1Dsp
(involves: 129X1/SvJ)
|
decreased neuron apoptosis
|
J:90572
|
Casp6tm1.2Xen/Casp6+
(FVB.B6NTac-Casp6tm1.2Xen)
|
decreased susceptibility to neuronal excitotoxicity
|
J:181879
|
Casp6tm1.2Xen/Casp6tm1.2Xen
(FVB.B6NTac-Casp6tm1.2Xen)
|
abnormal nervous system physiology
|
J:181879
|
| decreased susceptibility to neuronal excitotoxicity
|
J:181879
|
Casp9tm1Flv/Casp9tm1Flv
(involves: 129S1/Sv * C57BL/6)
|
decreased neuron apoptosis
|
J:49088,
J:90572
|
Casp9tm1Mak/Casp9tm1Mak
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))
|
decreased neuron apoptosis
|
J:49087
|
| intracerebral hemorrhage
|
J:49087
|
Casp12tm1Yuan/Casp12tm1Yuan
(involves: 129S4/SvJae * C57BL/6J)
|
decreased susceptibility to neuronal excitotoxicity
|
J:59337
|
Casrtm1b(KOMP)Mbp/Casr+
(C57BL/6N-Casrtm1b(KOMP)Mbp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Casttm1Tcs/Casttm1Tcs
(B6.129-Casttm1Tcs)
|
increased susceptibility to neuronal excitotoxicity
|
J:109976
|
Cav1tm1Mls/Cav1tm1Mls
(involves: 129/Sv * C57BL/6 * SJL)
|
increased cerebral infarct size
|
J:133702
|
Cav1tm1Mls/Cav1tm1Mls
(Not Specified)
|
brain ischemia
|
J:168335
|
Cav3em1(IMPC)Kmpc/Cav3em1(IMPC)Kmpc
(C57BL/6NTac-Cav3em1(IMPC)Kmpc/Kmpc)
|
increased prepulse inhibition
|
J:211773
|
Cbarpem1Dsb/Cbarpem1Dsb
(involves: C57BL/6)
|
abnormal synaptic dopamine release
|
J:288382
|
Cbarptm1.1Yamo/Cbarptm1.1Yamo
(B6.129S4(Cg)-Cbarptm1.1Yamo)
|
increased prepulse inhibition
|
J:288588
|
Cbfbtm1Ppl/Cbfb+
(either: (involves: 129/Sv * 129S6/SvEvTac) or (involves: 129S6/SvEvTac * Black Swiss) or (involves: 129S6/SvEvTac * C57BL/6))
|
brainstem hemorrhage
|
J:36594
|
| intracranial hemorrhage
|
J:36594
|
| intraventricular hemorrhage
|
J:36594
|
| spinal hemorrhage
|
J:36594
|
Cbfbtm1Spe/Cbfbtm1Spe
(either: (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6))
|
intracranial hemorrhage
|
J:36593
|
| intraventricular hemorrhage
|
J:36593
|
| spinal hemorrhage
|
J:36593
|
Cbfbtm1Tno/Cbfbtm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
intraventricular hemorrhage
|
J:40963
|
| spinal hemorrhage
|
J:40963
|
Cbfbtm1Tok/Cbfbtm1Tok
(involves: 129P2/OlaHsd * C57BL/6J)
|
intracranial hemorrhage
|
J:36250
|
| spinal hemorrhage
|
J:36250
|
Cbfbtm5Ppl/Cbfbtm5Ppl
(Not Specified)
|
intracranial hemorrhage
|
J:193140
|
Cbln1tm1Jim/Cbln1tm1Jim
(involves: 129S7/SvEvBrd)
|
abnormal long-term depression
|
J:102516
|
| decreased excitatory postsynaptic current amplitude
|
J:102516
|
Cbln1osem1Xis/Cbln1osem1Xis
(Not Specified)
|
abnormal inhibitory postsynaptic currents
|
J:310647
|
| decreased excitatory postsynaptic current amplitude
|
J:310647
|
| decreased excitatory postsynaptic current frequency
|
J:310647
|
Cbr1tm1.1Tmnb/Cbr1+
Ts(16C-tel)1Cje/0
(involves: C57BL/6J * FVB/N)
|
abnormal nervous system electrophysiology
|
J:294908
|
Cbstm1Unc/Cbs+
(B6.129P2-Cbstm1Unc/J)
|
abnormal blood-retina barrier function
|
J:213631
|
Cc2d1atm1Bisu/Cc2d1atm1Bisu
(Not Specified)
|
abnormal neuron physiology
|
J:184920
|
Cc2d1atm1Zjc/Cc2d1atm1Zjc
(involves: 129S/SvEv * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:177407
|
| abnormal inhibitory postsynaptic currents
|
J:177407
|
| abnormal miniature inhibitory postsynaptic current frequency
|
J:177407
|
| abnormal miniature inhibitory postsynaptic currents
|
J:177407
|
| abnormal synaptic vesicle recycling
|
J:177407
|
| increased miniature inhibitory postsynaptic current amplitude
|
J:177407
|
Ccdc7aTg(Prnp-Sirt1)10Imai/?
(B6.Cg-Ccdc7aTg(Prnp-Sirt1)10Imai)
|
abnormal neuron physiology
|
J:203814
|
Ccdc9bem1(IMPC)Tcp/Ccdc9bem1(IMPC)Tcp
(C57BL/6NCrl-Ccdc9bem1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Ccdc30em1(IMPC)J/Ccdc30em1(IMPC)J
(C57BL/6NJ-Ccdc30em1(IMPC)J/J)
|
decreased prepulse inhibition
|
J:211773
|
Ccdc39prh/Ccdc39prh
(involves: A/J * FVB/N)
|
abnormal brain ependyma motile cilium physiology
|
J:253968
|
| abnormal cerebrospinal fluid flow
|
J:253968
|
| dysmyelination
|
J:253968
|
Ccdc65em11Gpt/Ccdc65em11Gpt
(C57BL/6J-Ccdc65em11Gpt)
|
abnormal cerebrospinal fluid flow
|
J:327251
|
Ccdc85chhy/Ccdc85chhy
(involves: BALB/cHeA * STS/A)
|
abnormal nervous system physiology
|
J:93608
|
| intracranial hemorrhage
|
J:93608
|
Ccdc88atm1Mat/Ccdc88a+
(Not Specified)
|
abnormal excitatory postsynaptic currents
|
J:217412
|
| reduced long-term potentiation
|
J:217412
|
Ccdc88atm1Mat/Ccdc88atm1Mat
(Not Specified)
|
abnormal neuronal precursor cell migration
|
J:173379
|
Ccdc88atm2.1Mat/Ccdc88atm2.1Mat
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:217412
|
| decreased prepulse inhibition
|
J:217412
|
| reduced long-term potentiation
|
J:217412
|
| reduced sensorimotor gating
|
J:217412
|
Ccdc88atm3.1Mat/Ccdc88atm3.1Mat
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal neuronal precursor cell migration
|
J:173379
|
Ccdc134tm1.2Jhua/Ccdc134tm1.2Jhua
(involves: C57BL/6NTac)
|
intracranial hemorrhage
|
J:256995
|
Ccdc141tm1.1Ygi/Ccdc141tm1.1Ygi
(B6N(Cg)-Ccdc141tm1.1Ygi)
|
abnormal neuronal migration
|
J:238090
|
Ccktm1Dgen/Ccktm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prepulse inhibition
|
J:101679
|
Cckartm1Kpn/Cckartm1Kpn
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neuronal migration
|
J:96891
|
Cckbrtm1Tom/Cckbrtm1Tom
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal excitatory postsynaptic currents
|
J:159855
|
Ccl2tm1Rol/Ccl2+
Mpztm1Msch/Mpz+
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
demyelination
|
J:133028
|
Ccl2tm1Rol/Ccl2+
Tg(PMP22)C61Clh/0
(involves: 129S4/SvJae * C57BL/6J * CBA/Ca)
|
demyelination
|
J:158350
|
Ccl2tm1Rol/Ccl2tm1Rol
(B6.129S4-Ccl2tm1Rol/J)
|
abnormal action potential
|
J:326871
|
| abnormal microglial cell physiology
|
J:141739
|
| abnormal neuron physiology
|
J:326871
|
| decreased susceptibility to neuronal excitotoxicity
|
J:141739
|
Ccl2tm1Rol/Ccl2tm1Rol
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6J)
|
increased microglial cell activation
|
J:200877
|
Ccl2tm1Rol/Ccl2tm1Rol
Mpztm1Msch/Mpz+
(involves: 129S4/SvJae * 129S7/SvEvBrd)
|
demyelination
|
J:133028
|
Ccl2tm1Rol/Ccl2tm1Rol
Tg(PMP22)C61Clh/0
(involves: 129S4/SvJae * C57BL/6J * CBA/Ca)
|
abnormal action potential
|
J:158350
|
| decreased nerve conduction velocity
|
J:158350
|
| demyelination
|
J:158350
|
Ccl3tm1Unc/Ccl3tm1Unc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal astrocyte physiology
|
J:153059
|
| decreased microglial cell activation
|
J:153059
|
Ccl3tm1Unc/Ccl3tm1Unc
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
CNS inflammation
|
J:90687
|
Ccm2Gt(RRG051)Byg/Ccm2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
intracranial hemorrhage
|
J:105314
|
Ccm2tm1.1Etl/Ccm2tm1Etl
Tg(Cdh5-cre/ERT2)1Rha/0
(involves: 129 * C57BL/6)
|
cerebellum hemorrhage
|
J:177584
|
Ccm2tm1Kwhi/Ccm2tm1.1Kwhi
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/?
(involves: C57BL/6 * CBA)
|
CNS inflammation
|
J:173947
|
Ccm2tm2.1Sbn/Ccm2tm2.1Sbn
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * CBA)
|
cerebellum hemorrhage
|
J:174085
|
| impaired blood-brain barrier function
|
J:174085
|
| intracerebral hemorrhage
|
J:174085
|
| intracranial hemorrhage
|
J:174085
|
| seizures
|
J:174085
|
Ccne1tm3.1Pisc/Ccne1tm3.1Pisc
Ccne2tm1Pisc/Ccne2tm1Pisc
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal excitatory postsynaptic potential
|
J:178882
|
| decreased excitatory postsynaptic current frequency
|
J:178882
|
| reduced long-term potentiation
|
J:178882
|
| reduced NMDA-mediated synaptic currents
|
J:178882
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(B6.129S4-Ccr2tm1Ifc/J)
|
abnormal microglial cell physiology
|
J:106738
|
Ccr2tm1Ifc/Ccr2tm1Ifc
(involves: 129S4/SvJae * C57BL/6)
|
abnormal microglial cell physiology
|
J:121703
|
Ccr2tm1Ifc/Ccr2tm1Ifc
Tg(APPSWE)2576Kha/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
abnormal microglial cell physiology
|
J:121703
|
| intracranial hemorrhage
|
J:121703
|
Ccr5tm1Kuz/Ccr5tm1Kuz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal astrocyte physiology
|
J:153059
|
| abnormal glial cell physiology
|
J:153059
|
| abnormal nervous system physiology
|
J:132342
|
| decreased microglial cell activation
|
J:153059
|
Ccr5tm1Kuz/Ccr5tm1Kuz
Cxcr4tm1Qma/Cxcr4tm1Qma
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
abnormal nervous system physiology
|
J:132342
|
Ccr7Gt(hpk)Byg/Ccr7Gt(hpk)Byg
(involves: 129 * C57BL/6)
|
enhanced long-term potentiation
|
J:161269
|
Ccr10/Cntnap1tm1Bhat/Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
abnormal action potential
|
J:69621
|
| abnormal nerve conduction
|
J:342323
|
| decreased nerve conduction velocity
|
J:342323,
J:69621
|
| dysmyelination
|
J:342323
|
| hypermyelination
|
J:69621
|
Ccr10/Cntnap1tm1Bhat/Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
abnormal action potential
|
J:69621
|
| abnormal nerve conduction
|
J:342323
|
| decreased nerve conduction velocity
|
J:342323,
J:69621
|
| dysmyelination
|
J:342323
|
| hypermyelination
|
J:69621
|
Ccsapem1(IMPC)J/Ccsapem1(IMPC)J
(C57BL/6NJ-Ccsapem1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Ccser2em1Skpk/Ccser2em1Skpk
(C57BL/6N-Ccser2em1Skpk)
|
abnormal neuronal migration
|
J:333716
|
Cd1d1tm1.2Aben/Cd1d1tm1.2Aben
(B6(C)-Cd1d1tm1.2Aben/J)
|
increased susceptibility to ischemic brain injury
|
J:177038
|
Cd3em1Btlr/Cd3em1Btlr
(C57BL/6J-Cd3em1Btlr)
|
seizures
|
J:132486
|
Cd4tm1Mak/Cd4tm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
demyelination
|
J:92227
|
Cd4tm1Mak/Cd4tm1Mak
(PL.129S2(B6)-Cd4tm1Mak/Rdgz)
|
brain inflammation
|
J:92227
|
| demyelination
|
J:92227
|
Cd4tm1Mak/Cd4tm1Mak
(SJL.129S2(B6)-Cd4tm1Mak/Rdgz)
|
brain inflammation
|
J:92227
|
| demyelination
|
J:92227
|
Cd8atm1Mak/Cd8atm1Mak
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
demyelination
|
J:92227
|
Cd8atm1Mak/Cd8atm1Mak
(PL.129S2(B6)-Cd8atm1Mak/Rdgz)
|
demyelination
|
J:92227
|
Cd8atm1Mak/Cd8atm1Mak
(SJL.129S2(B6)-Cd8atm1Mak/Rdgz)
|
demyelination
|
J:92227
|
Cd19tm1Tft/Cd19tm1Tft
(B6.Cg-Cd19tm1Tft)
|
demyelination
|
J:106487
|
Cd27em1(IMPC)Ccpcz/Cd27em1(IMPC)Ccpcz
(C57BL/6NCrl-Cd27em1(IMPC)Ccpcz/Ccpcz)
|
increased prepulse inhibition
|
J:211773
|
Cd28tm1Mak/Cd28tm1Mak
(B6.129S2-Cd28tm1Mak/J)
|
brain inflammation
|
J:57613
|
Cd36tm1Frm/Cd36tm1Frm
(involves: 129S4/SvJae)
|
abnormal microglial cell physiology
|
J:140907
|
Cd36tm1Mfe/Cd36tm1Mfe
(involves: 129S1/Sv)
|
abnormal myelination
|
J:89664
|
| abnormal peripheral nervous system regeneration
|
J:89664
|
Cd40tm1Kik/Cd40tm1Kik
(B6.129P2-Cd40tm1Kik/J)
|
decreased cerebral infarct size
|
J:108988
|
Cd40lgtm1Imx/Y
(B6.129S2-Cd40lgtm1Imx/J)
|
decreased cerebral infarct size
|
J:108988
|
Cd40lgtm1Imx/Cd40lgtm1Imx
(involves: 129S2/SvPas * C57BL/6)
|
abnormal nervous system physiology
|
J:115487
|
Cd44tm1Mak/Cd44tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:128984
|
| decreased miniature excitatory postsynaptic current frequency
|
J:128984
|
| increased miniature excitatory postsynaptic current amplitude
|
J:128984
|
Cd44tm1Mak/Cd44tm1Mak
Mettm1Cbm/Met+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:128984
|
| abnormal miniature inhibitory postsynaptic currents
|
J:128984
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:128984
|
Cd47tm1Fpl/Cd47tm1Fpl
(involves: 129S7/SvEvBrd)
|
brain ischemia
|
J:148196
|
Cd47tm1Fpl/Cd47tm1Fpl
(C.129S7-Cd47tm1Fpl)
|
abnormal excitatory postsynaptic potential
|
J:59818
|
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129 * C57BL/6)
|
demyelination
|
J:89014
|
Cd59atm1Bpm/Cd59atm1Bpm
(involves: 129)
|
abnormal Wallerian degeneration
|
J:148367
|
Cd80tm1Shr/Cd80tm1Shr
Cd86tm1Shr/Cd86tm1Shr
(B6.129S4-Cd80tm1Shr Cd86tm1Shr)
|
brain inflammation
|
J:57613
|
Cd86tm1Shr/Cd86tm1Shr
(NOD.129S4-Cd86tm1Shr)
|
abnormal action potential
|
J:71352
|
| abnormal nerve conduction
|
J:142046,
J:71352
|
| decreased nerve conduction velocity
|
J:142046
|
| demyelination
|
J:71352
|
Cd200tm1Jods/Cd200tm1Jods
(C57BL/6-Cd200tm1Jods)
|
abnormal microglial cell physiology
|
J:65982
|
Cd247tm1Lov/Cd247tm1Lov
(involves: 129S4/SvJae)
|
abnormal CNS synaptic transmission
|
J:66246
|
| abnormal excitatory postsynaptic potential
|
J:66246
|
| absent long-term depression
|
J:66246
|
| enhanced long-term potentiation
|
J:66246
|
Cd247tm1Lov/Cd247tm1Lov
(B6.129S4-Cd247tm1Lov/J)
|
abnormal long-term depression
|
J:66246
|
| enhanced long-term potentiation
|
J:66246
|
| reduced long-term depression
|
J:66246
|
Cd300lftm1Gne/Cd300lftm1Gne
(involves: C57BL/6N)
|
demyelination
|
J:156819
|
Cdc42tm1.1Ayam/Cdc42tm1.1Ayam
Tg(Mpz-cre)94Imeg/0
(Not Specified)
|
intracranial hemorrhage
|
J:250065
|
Cdc42tm1.1Rac/Cdc42tm1.1Rac
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
abnormal neuronal precursor proliferation
|
J:197886
|
| intraventricular hemorrhage
|
J:197886
|
Cdc42ep4tm1.1Ksh/Cdc42ep4tm1.1Ksh
(involves: C57BL/6 * C57BL/6N)
|
abnormal excitatory postsynaptic currents
|
J:228294
|
| abnormal synaptic transmission
|
J:228294
|
| enhanced AMPA-mediated synaptic currents
|
J:228294
|
| prolonged excitatory postsynaptic current decay time
|
J:228294
|
Cdca7lem1(IMPC)Mbp/Cdca7lem1(IMPC)Mbp
(C57BL/6NCrl-Cdca7lem1(IMPC)Mbp/Mmucd)
|
decreased prepulse inhibition
|
J:211773
|
Cdh2em1Obir/Cdh2em1Obir
(C57BL/6JRcc-Cdh2em1Obir)
|
abnormal prepulse inhibition
|
J:331911
|
| abnormal sensorimotor gating
|
J:331911
|
| abnormal synaptic vesicle clustering
|
J:331911
|
| abnormal synaptic vesicle recycling
|
J:331911
|
| decreased miniature excitatory postsynaptic current frequency
|
J:331911
|
| decreased neurotransmitter release
|
J:331911
|
| impaired synaptic plasticity
|
J:331911
|
Cdh2tm1.1Ayki/Cdh2tm1.1Ayki
(involves: C57BL/6 * DBA/2)
|
abnormal CNS synaptic transmission
|
J:302799
|
| abnormal excitatory postsynaptic potential
|
J:302799
|
| enhanced long-term potentiation
|
J:302799
|
Cdh2tm1Glr/Cdh2tm1Glr
Olig2tm1(cre)Tmj/Olig2+
(involves: 129S6/SvEvTac)
|
abnormal neuronal migration
|
J:178688
|
Cdh8tm1Mta/Cdh8tm1Mta
(B6.129P2-Cdh8tm1Mta)
|
abnormal CNS synaptic transmission
|
J:120130
|
| abnormal miniature excitatory postsynaptic currents
|
J:120130
|
Cdh2312J/Cdh2312J
(involves: C57BL/6J)
|
abnormal cochlear outer hair cell physiology
|
J:174758
|
Cdh23sals/Cdh23sals
(involves: C57BL/6J)
|
abnormal cochlear hair cell physiology
|
J:147149
|
Cdh23tm1.1Ugds/Cdh23tm1.1Ugds
Myo15atm1.1(cre)Ugds/Myo15a+
(involves: 129S1/SvImJ * C57BL/6J)
|
absent cochlear microphonics
|
J:171218
|
Cdh23tm1.2Ugds/Cdh23tm1.2Ugds
(involves: 129S1/SvImJ)
|
abnormal hair cell mechanoelectric transduction
|
J:171218
|
Cdh23v-2J/Cdh23v-2J
(involves: C57BL/6J)
|
abnormal cochlear hair cell physiology
|
J:186316
|
Cdh23v/Cdh23+
(involves: BALB/cRl * 47BS/Rl * CBA/Ca)
|
abnormal cochlear nerve compound action potential
|
J:134369
|
Cdh23v/Cdh23+
Myo7a4626SB/Myo7a+
(involves: BALB/cRl * 47BS/Rl * CBA/Ca)
|
abnormal cochlear nerve compound action potential
|
J:134369
|
Cdk5tm1Bibb/Cdk5tm1Bibb
Tg(Prnp-cre/ERT)28.4Ics/0
(involves: C57BL/6 * SJL)
|
abnormal excitatory postsynaptic currents
|
J:124046
|
| abnormal excitatory postsynaptic potential
|
J:124046
|
| abnormal long-term potentiation
|
J:124046
|
| abnormal synaptic plasticity
|
J:124046
|
| increased post-tetanic potentiation
|
J:124046
|
Cdk5r1tm1Lht/Cdk5r1tm1Lht
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:38857
|
| seizures
|
J:38857
|
Cdk5r1tm1Lht/Cdk5r1tm1Lht
(involves: 129S4/SvJae)
|
reduced long-term potentiation
|
J:193542
|
| seizures
|
J:38857
|
Cdk5r1tm1Ohsh/Cdk5r1tm1Ohsh
(involves: 129 * C57BL/6J)
|
reduced long-term depression
|
J:100692
|
Cdk5r1tm2.1Lht/Cdk5r1tm2.1Lht
(B6.129-Cdk5r1tm2.1Lht)
|
abnormal excitatory postsynaptic potential
|
J:208030
|
| abnormal long-term depression
|
J:208030
|
Cdk5r1tm2Ohsh/Cdk5r1tm2Ohsh
Tg(Pcp2-cre)1Amc/0
(involves: C57BL/6 * C57BL/6N)
|
absent long-term depression
|
J:215344
|
| impaired synaptic plasticity
|
J:215344
|
| reduced long-term potentiation
|
J:215344
|
Cdk5rap2an/Cdk5rap2an
(B6.Cg-Cdk5rap2an)
|
abnormal neuron proliferation
|
J:160533
|
| increased neuron apoptosis
|
J:160533
|
Cdkl5tm1.1Joez/Y
(B6.129(FVB)-Cdkl5tm1.1Joez)
|
abnormal nervous system electrophysiology
|
J:193172
|
Cdkl5tm1.2Cogr/Y
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J)
|
abnormal seizure response to inducing agent
|
J:209635
|
| seizures
|
J:209635
|
Cdkl5tm1.2Cogr/Cdkl5tm1.2Cogr
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * C57BL/6J)
|
abnormal seizure response to inducing agent
|
J:209635
|
| seizures
|
J:209635
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
(involves: 129S2/SvPas)
|
abnormal neuronal precursor proliferation
|
J:90479
|
| abnormal response to CNS ischemic injury
|
J:90479
|
Cdkn1atm1Tyj/Cdkn1atm1Tyj
Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129P2/OlaHsd * 129S2/SvPas * 129X1/SvJ * C57BL/6 * CD-1)
|
abnormal cochlear hair cell physiology
|
J:118337
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor)
|
abnormal neuronal migration
|
J:109091
|
Cdkn1btm1Mlf/Cdkn1btm1Mlf
Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129X1/SvJ * C57BL/6)
|
increased neuron apoptosis
|
J:58522
|
| seizures
|
J:58522
|
Cdkn1ctm1Bbd/Cdkn1ctm1Bbd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased midbrain apoptosis
|
J:88146
|
Cdkn2atm1Nesh/Cdkn2atm1Nesh
(involves: 129S6/SvEvTac * FVB/N)
|
seizures
|
J:88365
|
Cdkn2atm1Rdp/Cdkn2a+
Lig4tm1Fwa/Lig4tm1Fwa
(involves: 129/Sv * 129S6/SvEvTac * C57BL/6J * SJL)
|
increased neuron apoptosis
|
J:63078
|
Cdkn2ctm1Bbd/Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6)
|
abnormal neuronal migration
|
J:102702
|
Cdkn2dtm1Maro/Cdkn2dtm1Maro
(involves: 129X1/SvJ * C57BL/6 * CD-1)
|
abnormal cochlear hair cell physiology
|
J:83482
|
Cdnftm1.1Uhb/Cdnftm1.1Uhb
(either: B6JRcc.129P2(Cg)-Cdnftm1.1Uhb or (involves: 129P2/OlaHsd * C57BL/6JRcc * ICR))
|
abnormal neuron physiology
|
J:285339
|
Cdontm1Rsk/Cdontm1Rsk
(B6.129-Cdontm1Rsk)
|
abnormal neuronal precursor proliferation
|
J:109070
|
Cdontm2Rsk/Cdontm2Rsk
(B6.129-Cdontm2Rsk)
|
abnormal neuronal precursor proliferation
|
J:109070
|
Cdr1osem1Nikr/Y
(C57BL/6N-Cdr1osem1Nikr)
|
abnormal action potential
|
J:249957
|
| decreased prepulse inhibition
|
J:249957
|
| increased miniature excitatory postsynaptic current frequency
|
J:249957
|
Cds2Gt(OST184358)Lex/Cds2+
(involves: 129S5/SvEvBrd * C57BL/6J)
|
enhanced sensorimotor gating
|
J:103485
|
Cdyltm1.1Yuw/Cdyltm1.1Yuw
Emx1tm1(cre)Yql/Emx1+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal neuronal migration
|
J:251551
|
| increased susceptibility to pharmacologically induced seizures
|
J:251551
|
Cela2atm1Bdr/Cela2atm1Bdr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal parasympathetic nervous system physiology
|
J:275582
|
| abnormal sympathetic nervous system physiology
|
J:275582
|
Celf2tm1Yjin/Celf2tm1Yjin
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Pvalbtm1(cre)Arbr/Pvalb+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * BALB/c * C57BL/6NCrl)
|
abnormal neuron physiology
|
J:269731
|
Celf2tm1Yjin/Celf2tm1Yjin
Tg(Nes-cre)1Kln/0
(involves: BALB/c * C57BL/6 * SJL)
|
abnormal neuron physiology
|
J:269731
|
Celf4Ff/Celf4+
(involves: C57BL/6J)
|
abnormal seizure response to electrical stimulation
|
J:123744
|
| seizures
|
J:123744
|
Celf4Ff/Celf4Ff
(involves: C57BL/6J)
|
tonic-clonic seizures
|
J:123744
|
Celf4Ff/Celf4Ff
(involves: C57BL/6J * FVB/NJ)
|
absence seizures
|
J:123744
|
Celf4tm1.1Frk/Celf4tm1.1Frk
Emx1tm1(cre)Krj/?
(involves: 129 * C57BL/6J)
|
increased susceptibility to induction of seizure by inducing agent
|
J:19671
|
Celf4tm1.1Frk/Celf4tm1.1Frk
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6J)
|
abnormal spike wave discharge
|
J:181678
|
| convulsive seizures
|
J:181678
|
Celf4tm1.1Frk/Celf4tm1.1Frk
Tg(Camk2a-cre)1Lfr/0
(involves: 129 * C57BL/6J)
|
increased susceptibility to induction of seizure by inducing agent
|
J:194671
|
Celf4tm1.1Frk/Celf4tm1.1Frk
Tg(Slc32a1-cre)2.1Hzo/0
(involves: 129 * C57BL/6J * FVB)
|
decreased susceptibility to induction of seizure by inducing agent
|
J:194671
|
Celf4tm1.2Frk/Celf4+
(129S1.129(Cg)-Celf4tm1.2Frk/Frk)
|
tonic-clonic seizures
|
J:181678
|
Celf4tm1.2Frk/Celf4tm1.2Frk
(129S1.129(Cg)-Celf4tm1.2Frk/Frk)
|
abnormal miniature excitatory postsynaptic currents
|
J:181678
|
| abnormal spike wave discharge
|
J:181678
|
| absence seizures
|
J:181678
|
| seizures
|
J:181678
|
| tonic-clonic seizures
|
J:181678
|
Celf4tm1.2Frk/Celf4tm1.2Frk
((B6.129(Cg)-Celf4tm1.2Frk/Frk x 129S1.129(Cg)-Celf4tm1.2Frk/Frk)F1)
|
abnormal spike wave discharge
|
J:181678
|
| absence seizures
|
J:181678
|
Celf4tm1.2Frk/Celf4tm1.2Frk
(B6.129(Cg)-Celf4tm1.2Frk/Frk)
|
seizures
|
J:181678
|
| tonic-clonic seizures
|
J:181678
|
Celsr3tm1Mrc/Celsr3tm1Mrc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S6/SvEvTac * C57BL/6NCr))
|
abnormal neuronal migration
|
J:149145
|
Cemiptm1.1Tac/Cemiptm1.1Tac
Tg(Dhh-cre)1Mejr/0
(involves: C57BL/6NTac * FVB/N)
|
abnormal myelination
|
J:244311
|
Cemiptm1.1Tac/Cemiptm1.1Tac
Tg(Plp1-cre/ERT)3Pop/0
(involves: C57BL/6 * C57BL/6NTac * DBA/2)
|
abnormal Schwann cell physiology
|
J:244311
|
Cend1tm1.1Rmat/Cend1tm1.1Rmat
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6)
|
abnormal cerebellar granule cell migration
|
J:164148
|
| abnormal neuron proliferation
|
J:164148
|
Cep19tm1b(EUCOMM)Hmgu/Cep19tm1b(EUCOMM)Hmgu
(C57BL/6N-Cep19tm1b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Cep41Gt(AW0157)Wtsi/Cep41Gt(AW0157)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
intracranial hemorrhage
|
J:181179
|
Cep55tm1a(EUCOMM)Hmgu/Cep55tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
increased neuron apoptosis
|
J:287102
|
Cep63Gt(EUCE0251h11)Hmgu/Cep63Gt(EUCE0251h11)Hmgu
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6)
|
increased forebrain apoptosis
|
J:224364
|
Cep85lem1(IMPC)Mbp/Cep85lem1(IMPC)Mbp
(C57BL/6N-Cep85lem1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Cep120tm1.1Blnw/Cep120tm1.2Blnw
Tg(Nes-cre)1Atp/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
decreased cerebellar granule cell precursor proliferation
|
J:220629
|
Cep135em2Mama/Cep135em2Mama
(involves: C57BL/6 * C57BL/6J * CBA)
|
abnormal nervous system physiology
|
J:310617
|
Cers1tm1.1Kwi/Cers1tm1.1Kwi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased neuron apoptosis
|
J:193419
|
Cers1to/Cers1to
(either: FVB/N or (involves: C3H * C57BL/6J * FVB/N))
|
seizures
|
J:91243
|
Cetn2tm1.1Wbae/Y
(involves: 129 * FVB/N)
|
abnormal cerebrospinal fluid flow
|
J:211061
|
Cfap54Gt(IST10309B2)Tigm/Cfap54Gt(IST10309B2)Tigm
(B6J.B6N-Cfap54Gt(IST10309B2)Tigm)
|
abnormal brain ependyma motile cilium physiology
|
J:228444
|
| intraventricular hemorrhage
|
J:228444
|
Cfap54Gt(IST10309B2)Tigm/Cfap54Gt(IST10309B2)Tigm
((B6J.B6N-Cfap54Gt(IST10309B2)Tigm x 129S6.B6N-Cfap54Gt(IST10309B2)Tigm)F1)
|
abnormal brain ependyma motile cilium physiology
|
J:228444
|
Cfap69tm1c(KOMP)Wtsi/Cfap69tm1c(KOMP)Wtsi
Omptm4(cre)Mom/Omp+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6N)
|
abnormal olfactory sensory neuron physiology
|
J:242686
|
Cfap97d1tm1b(KOMP)Wtsi/Cfap97d1tm1b(KOMP)Wtsi
(C57BL/6N-Cfap97d1tm1b(KOMP)Wtsi/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Cfap276em1Fuxi/Cfap276+
(C57BL/6J-Cfap276em1Fuxi)
|
abnormal action potential
|
J:283448
|
| demyelination
|
J:283448
|
Cfap276em1Fuxi/Cfap276em1Fuxi
(C57BL/6J-Cfap276em1Fuxi)
|
demyelination
|
J:283448
|
Cfap276em2.1Fuxi/Cfap276+
(involves: C57BL/6J)
|
abnormal action potential
|
J:295996
|
| decreased nerve conduction velocity
|
J:295996
|
| demyelination
|
J:295996
|
Cfap276em2.1Fuxi/Cfap276em2.1Fuxi
(involves: C57BL/6J)
|
abnormal action potential
|
J:295996
|
| decreased nerve conduction velocity
|
J:295996
|
| demyelination
|
J:295996
|
Cfhtm1.1Song/Cfhtm1.1Song
(involves: C57BL/6)
|
brain ischemia
|
J:240426
|
| intracerebral hemorrhage
|
J:240426
|
Cfl1tm1.1Wit/Cfl1tm1.1Wit
(involves: 129 * C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:125317
|
| seizures
|
J:125317
|
Cfl1tm1.2Wit/Cfl1tm1.2Wit
(involves: 129)
|
decreased embryonic neuroepithelial cell proliferation
|
J:96452
|
cg/cg
(involves: C57BL/6Ga)
|
tonic-clonic seizures
|
J:11941
|
Chat/Slc18a3tm1.1Vpra/Chat/Slc18a3tm1.1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal miniature endplate potential
|
J:153908
|
| abnormal synaptic acetylcholine release
|
J:153908
|
Chat/Slc18a3tm1.1Vpra/Chat+
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal miniature endplate potential
|
J:171696
|
Chat/Slc18a3tm1.1Vpra/Chat/Slc18a3tm1.1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal miniature endplate potential
|
J:153908
|
| abnormal synaptic acetylcholine release
|
J:153908
|
Chat/Slc18a3tm1.1Vpra/Slc18a3+
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal miniature endplate potential
|
J:171696
|
Chat/Slc18a3tm1Vpra/Chat/Slc18a3tm1.1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal miniature endplate potential
|
J:171696
|
Chat/Slc18a3tm1Vpra/Chat/Slc18a3tm1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal miniature endplate potential
|
J:171696
|
Chat/Slc18a3tm1Vpra/Chat/Slc18a3tm1.1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal miniature endplate potential
|
J:171696
|
Chat/Slc18a3tm1Vpra/Chat/Slc18a3tm1Vpra
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal miniature endplate potential
|
J:171696
|
Chattm1Fhg/Chattm1Fhg
(involves: 129S2/SvPas * C57BL/6)
|
abnormal PNS synaptic transmission
|
J:81738
|
Chattm2(cre)Lowl/Chat+
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Sema6aGt(KST069)Byg/Sema6aGt(KST069)Byg
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6NCr)
|
abnormal inhibitory postsynaptic currents
|
J:202884
|
Chd2tm1b(EUCOMM)Hmgu/Chd2tm1b(EUCOMM)Hmgu
(C57BL/6N-Chd2tm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Chd7Edy/Chd7+
(involves: BALB/c * C3H/HeN)
|
decreased cochlear nerve compound action potential
|
J:75619
|
Chd7Gt(S20-7E1)Sor/Chd7+
(involves: 129S4/SvJaeSor)
|
abnormal neuronal precursor proliferation
|
J:164582
|
Chd7Gt(S20-7E1)Sor/Chd7+
(129S1.129S4(B6)-Chd7Gt(S20-7E1)Sor)
|
abnormal hypothalamus physiology
|
J:174086
|
| abnormal neuron physiology
|
J:148116
|
| abnormal olfactory sensory neuron physiology
|
J:148116
|
| abnormal pituitary gland physiology
|
J:174086
|
Chd7Gt(S20-7E1)Sor/Chd7+
(involves: 129S1/SvImJ * 129S4/SvJae)
|
hypermyelination
|
J:332873
|
Chd7Gt(S20-7E1)Sor/Chd7Gt(S20-7E1)Sor
(involves: 129S4/SvJaeSor)
|
abnormal neuronal precursor proliferation
|
J:164582
|
Chd7Gt(S20-7E1)Sor/Chd7tm1.1Dmm
Foxg1tm1(cre)Skm/Foxg1+
(involves: 129 * C57BL/6 * Swiss Webster)
|
abnormal neuronal precursor proliferation
|
J:164582
|
Chd7Ome/Chd7+
(involves: BALB/cByJ * C57BL/6J)
|
absent cochlear microphonics
|
J:187200
|
Chd7tm1.1Dmm/Chd7tm1.1Dmm
Olig1tm1(cre)Rth/Olig1+
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
dysmyelination
|
J:234565
|
Chd7tm1.1Dmm/Chd7tm1.1Dmm
Tg(Pdgfra-cre/ERT)467Dbe/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal oligodendrocyte apoptosis
|
J:264451
|
| abnormal oligodendrocyte physiology
|
J:264451,
J:234565
|
Chd7tm2c(EUCOMM)Wtsi/Chd7tm2c(EUCOMM)Wtsi
Slc1a3tm1(cre/ERT2)Mgoe/Slc1a3+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6N * SJL)
|
increased neuron apoptosis
|
J:222062
|
| increased neuronal stem cell self-renewal
|
J:222062
|
Chd7tm2c(EUCOMM)Wtsi/Chd7tm2c(EUCOMM)Wtsi
Tg(Atoh1-cre)1Bfri/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
|
decreased cerebellar granule cell precursor proliferation
|
J:242933
|
| increased neuron apoptosis
|
J:242933
|
Chd7tm2c(EUCOMM)Wtsi/Chd7tm2c(EUCOMM)Wtsi
Tg(Atoh1-cre)1Bfri/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
increased neuron apoptosis
|
J:243947
|
Chd8tm1.1Csbd/Chd8+
(involves: C57BL/6J)
|
abnormal miniature inhibitory postsynaptic currents
|
J:267025
|
| abnormal nervous system electrophysiology
|
J:267025
|
| abnormal neuron physiology
|
J:267025
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:267025
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:267025
|
| increased miniature inhibitory postsynaptic current frequency
|
J:267025
|
Chd8tm1Kei/Chd8+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased prepulse inhibition
|
J:235128
|
Chd8tm2.1Kei/Chd8+
(B6J.129P2-Chd8tm2.1Kei)
|
increased prepulse inhibition
|
J:235128
|
Chmp1aGt(XC472)Byg/Chmp1aGt(XC472)Byg
(B6.129P2-Chmp1aGt(XC472)Byg)
|
decreased cerebellar granule cell precursor proliferation
|
J:271138
|
| decreased neuronal precursor proliferation
|
J:271138
|
Chmp3tm1b(EUCOMM)Hmgu/Chmp3+
(C57BL/6N-Chmp3tm1b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Chn1mfy/Chn1mfy
(involves: C57BL/6)
|
abnormal nervous system electrophysiology
|
J:125703
|
Chn1tm1.1Abet/Chn1tm1.1Abet
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal central pattern generator function
|
J:128724
|
| tonic seizures
|
J:128724
|
Chn1tm1.1Ito/Chn1tm1.1Ito
(involves: C57BL/6NSlc)
|
abnormal nervous system electrophysiology
|
J:125703
|
Chn1tm1Ito/Chn1tm1.1Ito
Tg(Slc17a6-icre)1Oki/0
(involves: C57BL/6 * C57BL/6NSlc)
|
abnormal nerve fiber response
|
J:209606
|
Chn1tm2Abet/Chn1tm2Abet
(involves: 129P2/OlaHsd * FVB/N)
|
tonic seizures
|
J:128724
|
Chrdtm1Emdr/Chrdtm1Emdr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal miniature excitatory postsynaptic currents
|
J:123318
|
| enhanced long-term potentiation
|
J:123318
|
| enhanced paired-pulse facilitation
|
J:123318
|
| increased neurotransmitter release
|
J:123318
|
Chrdl1em1Nja/Y
(involves: C57BL/6J * DBA/2J)
|
abnormal miniature excitatory postsynaptic currents
|
J:269376
|
| abnormal synaptic plasticity
|
J:269376
|
Chrm1tm1Jwe/Chrm1tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
abnormal nervous system electrophysiology
|
J:74588
|
Chrm1tm1Jwe/Chrm1tm1Jwe
Chrm4tm1Jwe/Chrm4tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
abnormal CNS synaptic transmission
|
J:112505
|
| decreased synaptic depression
|
J:112505
|
Chrm1tm1Kano/Chrm1tm1Kano
(involves: 129X1/SvJ * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:98902
|
Chrm1tm1Kano/Chrm1tm1Kano
Chrm3tm1Mmt/Chrm3tm1Mmt
(involves: 129X1/SvJ * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:98902
|
Chrm1tm1Stl/Chrm1tm1Stl
(involves: C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:112782
|
| decreased paired-pulse facilitation
|
J:112782
|
| reduced long-term depression
|
J:112782
|
Chrm1tm2.1Stl/Chrm1tm2.1Stl
Emx1tm1.1(cre)Ito/0
(involves: 129P2/OlaHsd)
|
abnormal excitatory postsynaptic currents
|
J:156540
|
| abnormal long-term depression
|
J:156540
|
| abnormal miniature excitatory postsynaptic currents
|
J:156540
|
| decreased paired-pulse facilitation
|
J:156540
|
Chrm1tm2.1Stl/Chrm1tm2.1Stl
Tg(Grik4-cre)G32-4Stl/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:156540
|
| abnormal long-term depression
|
J:156540
|
| decreased paired-pulse facilitation
|
J:156540
|
Chrm2tm1Jwe/Chrm2tm1Jwe
(involves: 129S4/SvJae * CF-1)
|
abnormal CNS synaptic transmission
|
J:112505
|
Chrm2tm1Jwe/Chrm2tm1Jwe
Chrm4tm1Jwe/Chrm4tm1Jwe
(involves: 129S4/SvJae * 129S6/SvEvTac * CF-1)
|
abnormal brain wave pattern
|
J:103891
|
| abnormal CNS synaptic transmission
|
J:112505
|
Chrm3tm1Jwe/Chrm3tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
abnormal brain wave pattern
|
J:103891
|
Chrm3tm1Mmt/Chrm3tm1Mmt
(involves: 129X1/SvJ)
|
abnormal inhibitory postsynaptic currents
|
J:98902
|
Chrm4tm1Jwe/Chrm4tm1Jwe
(involves: 129S6/SvEvTac * CF-1)
|
abnormal CNS synaptic transmission
|
J:112505
|
Chrm4tm2.1Jwe/Chrm4tm2.1Jwe
Tg(Drd1a-cre)AGsc/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal neuron physiology
|
J:157841
|
Chrm5tm1Jabe/Chrm5tm1Jabe
(involves: C57BL/6)
|
abnormal synaptic dopamine release
|
J:163596
|
Chrm5tm1Jwe/Chrm5tm1Jwe
(B6.129S6-Chrm5tm1Jwe)
|
abnormal synaptic dopamine release
|
J:163596
|
Chrna1tm1Klee/Chrna1tm1Klee
(involves: 129S4/SvJae * C57BL/6)
|
abnormal endplate potential
|
J:161300
|
| abnormal miniature endplate potential
|
J:161300
|
Chrna2tm1.1Slot/Chrna2tm1.1Slot
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J)
|
enhanced long-term potentiation
|
J:272596
|
Chrna2tm1Jbou/Chrna2tm1Jbou
(B6.129X1-Chrna2tm1Jbou)
|
abnormal excitatory postsynaptic currents
|
J:126075
|
| abnormal inhibitory postsynaptic currents
|
J:126075
|
| abnormal long-term potentiation
|
J:126075
|
Chrna3tm1.1Hwrt/Chrna3tm1.1Hwrt
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6 * CD-1)
|
abnormal action potential
|
J:157611
|
| abnormal excitatory postsynaptic potential
|
J:157611
|
Chrna3tm1.1Hwrt/Chrna3tm1.1Hwrt
Chrna7tm1Bay/Chrna7tm1Bay
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:157611
|
Chrna3tm1Bay/Chrna3tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal autonomic nervous system physiology
|
J:54994
|
| abnormal channel response
|
J:54994
|
Chrna4tm1.1Tmcg/Chrna4tm1.1Tmcg
Slc6a3tm1(cre)Xz/Slc6a3+
(involves: 129S/SvEv * 129S1/Sv * C57BL/6)
|
abnormal synaptic dopamine release
|
J:174505
|
Chrna4tm1.2Tmcg/Chrna4tm1.2Tmcg
(involves: 129S/SvEv * 129S1/Sv * C57BL/6)
|
abnormal synaptic dopamine release
|
J:174505
|
| decreased neurotransmitter release
|
J:174505
|
Chrna4tm1Dra/Chrna4tm1Dra
(involves: 129S4/SvJae * C57BL/6)
|
abnormal brain wave pattern
|
J:97020
|
| increased susceptibility to pharmacologically induced seizures
|
J:97020
|
Chrna4tm1Jbou/Chrna4+
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J))
|
abnormal brain wave pattern
|
J:118273
|
| abnormal inhibitory postsynaptic currents
|
J:118273
|
| abnormal nervous system physiology
|
J:118273
|
| clonic seizures
|
J:118273
|
| seizures
|
J:118273
|
Chrna4tm1Jbou/Chrna4tm1Jbou
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J))
|
abnormal brain wave pattern
|
J:118273
|
| abnormal nervous system physiology
|
J:118273
|
| clonic seizures
|
J:118273
|
| seizures
|
J:118273
|
Chrna4tm1Jpc/Chrna4tm1Jpc
(involves: C57BL/6)
|
abnormal nicotine-mediated receptor currents
|
J:54505
|
Chrna4tm2Jbou/Chrna4+
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J))
|
abnormal brain wave pattern
|
J:118273
|
| abnormal nervous system physiology
|
J:118273
|
| clonic seizures
|
J:118273
|
| seizures
|
J:118273
|
Chrna4tm2Jbou/Chrna4tm2Jbou
(either: (involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J) or (involves: 129X1/SvJ * C57BL/6J))
|
abnormal brain wave pattern
|
J:118273
|
| abnormal nervous system physiology
|
J:118273
|
| clonic seizures
|
J:118273
|
| seizures
|
J:118273
|
Chrna5tm1Mdb/Chrna5tm1Mdb
(B6.129-Chrna5tm1Mdb)
|
decreased susceptibility to pharmacologically induced seizures
|
J:89266
|
Chrna5tm1Mdb/Chrna5tm1Mdb
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb Chrna5tm1Mdb)
|
decreased susceptibility to pharmacologically induced seizures
|
J:89266
|
Chrna7tm1Bay/Chrna7tm1Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal nicotine-mediated receptor currents
|
J:44288
|
Chrna7tm1Bay/Chrna7tm1Bay
(B6.Cg-Chrna7tm1Bay)
|
abnormal seizure response to pharmacological agent
|
J:74703
|
Chrna7tm1Bay/Chrna7tm1Bay
(B6.129S7-Chrna7tm1Bay/J)
|
abnormal GABA-mediated receptor currents
|
J:214099
|
| abnormal GABAergic neuron physiology
|
J:214099
|
Chrna7tm2Bay/Chrna7tm2Bay
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal nicotine-mediated receptor currents
|
J:61536
|
| increased neuron apoptosis
|
J:61536
|
Chrna9tm1Bedv/Chrna9tm1Bedv
(either: CB.129S1-Chrna9tm1Bedv or (involves: 129S1/Sv) or (involves: 129S1/Sv * CBA/CaJ))
|
abnormal cochlear nerve compound action potential
|
J:55406,
J:100073
|
Chrna9tm1Bedv/Chrna9tm1Bedv
(Not Specified)
|
abnormal cochlear outer hair cell physiology
|
J:130585
|
Chrna9tm1Elgo/Chrna9+
(involves: 129S4/SvJae * FVB/N)
|
abnormal cochlear inner hair cell physiology
|
J:144698
|
Chrna9tm1Elgo/Chrna9tm1Elgo
(involves: 129S4/SvJae * FVB/N)
|
abnormal cochlear inner hair cell physiology
|
J:144698
|
| abnormal cochlear outer hair cell physiology
|
J:144698
|
| abnormal inhibitory postsynaptic currents
|
J:144698
|
Chrna10tm1Jbou/Chrna10tm1Jbou
(Not Specified)
|
abnormal cochlear hair cell physiology
|
J:130585
|
| abnormal cochlear inner hair cell physiology
|
J:130585
|
| abnormal cochlear outer hair cell physiology
|
J:130585
|
Chrnb1tm1Sjb/Chrnb1tm1Sjb
(Not Specified)
|
abnormal miniature endplate potential
|
J:128926
|
Chrnb2tm1.1Cont/Chrnb2+
(B6.129-Chrnb2tm1.1Cont)
|
increased susceptibility to induction of seizure by inducing agent
|
J:228269
|
Chrnb2tm1.1Cont/Chrnb2tm1.1Cont
(B6.129-Chrnb2tm1.1Cont)
|
increased susceptibility to induction of seizure by inducing agent
|
J:228269
|
Chrnb2tm1Jpc/Chrnb2tm1Jpc
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal nicotine-mediated receptor currents
|
J:23256
|
Chrnb2tm1Jpc/Chrnb2tm1Jpc
(B6.129P2-Chrnb2tm1Jpc)
|
abnormal nervous system electrophysiology
|
J:109772
|
| abnormal nicotine-mediated receptor currents
|
J:54505
|
Chrnb2tm1Mdb/Chrnb2tm1Mdb
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal autonomic nervous system physiology
|
J:73590
|
| abnormal single cell response
|
J:73590
|
Chrnb4tm1Mdb/Chrnb4tm1Mdb
(B6.129-Chrnb4tm1Mdb)
|
decreased susceptibility to pharmacologically induced seizures
|
J:89266
|
Chrnetm1Jrs/Chrnetm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal motor nerve collateral sprouting
|
J:74958
|
Chrnetm1Vwi/Chrnetm1Vwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal miniature endplate potential
|
J:36557
|
| abnormal PNS synaptic transmission
|
J:36557
|
Chrnetm2Vwi/Chrnetm2Vwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal miniature endplate potential
|
J:182046
|
| abnormal PNS synaptic transmission
|
J:182046
|
Chrngtm1(Chrne)Mknn/Chrngtm1(Chrne)Mknn
(involves: 129/Sv * C57BL/6)
|
abnormal endplate potential
|
J:105142
|
Chrngtm1Mtak/Chrngtm1Mtak
(involves: 129X1/SvJ * C57BL/6)
|
abnormal miniature endplate potential
|
J:99894
|
Chrngtm2(Chrne)Vwi/Chrngtm2(Chrne)Vwi
(involves: C57BL/6)
|
abnormal miniature endplate potential
|
J:169541
|
Chst3tm1Dgen/Chst3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prepulse inhibition
|
J:101679
|
Chst3tm1Tmu/Chst3tm1Tmu
(involves: 129S2/SvPas)
|
decreased prepulse inhibition
|
J:217719
|
Chst10tm1Msch/Chst10tm1Msch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:79015
|
| abnormal excitatory postsynaptic potential
|
J:79015
|
| reduced long-term potentiation
|
J:79015
|
Chst14tm1.1Msch/Chst14tm1.1Msch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased Schwann cell proliferation
|
J:203583
|
Chst14tm1Lex/Chst14tm1Lex
(B6;129S5-Chst14tm1Lex/Mmucd)
|
enhanced sensorimotor gating
|
J:171883
|
Chuktm1Ver/Chuktm1Ver
Ikbkbtm1Ver/Ikbkbtm1Ver
(involves: 129S4/SvJae * C57BL/6J)
|
increased embryonic neuroepithelium apoptosis
|
J:63443
|
| increased hindbrain apoptosis
|
J:63443
|
| increased spinal cord apoptosis
|
J:63443
|
Cib2em1Xuzg/Cib2em1Xuzg
(C57BL/6-Cib2em1Xuzg)
|
abnormal cochlear outer hair cell physiology
|
J:280151
|
| abnormal hair cell mechanoelectric transduction
|
J:280151
|
Cib2em1Xuzg/Cib2em1Xuzg
Cib3em1Xuzg/Cib3em1Xuzg
(involves: C57BL/6 * C57BL/6N)
|
abnormal hair cell mechanoelectric transduction
|
J:345936
|
Cib2tm1.1Aela/Cib2tm1.1Aela
(involves: BALB/c * C57BL/6 * C57BL/6N)
|
abnormal hair cell mechanoelectric transduction
|
J:262464
|
| absent cochlear microphonics
|
J:262464
|
Cib2tm1b(EUCOMM)Wtsi/Cib2tm1b(EUCOMM)Wtsi
(C57BL/6N-Cib2tm1b(EUCOMM)Wtsi/H)
|
decreased prepulse inhibition
|
J:211773
|
Cictm1c(KOMP)Wtsi/Cictm1c(KOMP)Wtsi
Emx1tm1(cre)Krj/Emx1+
(involves: 129S2/SvPas * C57BL/6 * C57BL/6N)
|
decreased neurotransmitter release
|
J:240674
|
Cisd2tm1Tfts/Cisd2tm1Tfts
(B6.129S7-Cisd2tm1Tfts)
|
demyelination
|
J:148467
|
Cittm1Fdc/Cittm1Fdc
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
increased neuron apoptosis
|
J:80899
|
| increased susceptibility to pharmacologically induced seizures
|
J:77297
|
| myoclonus
|
J:77297
|
Cited2tm1Jpmb/Cited2tm1Jpmb
(involves: 129P2/OlaHsd * C57BL/6)
|
increased embryonic neuroepithelium apoptosis
|
J:74736
|
Ckap5tm1.1Eba/Ckap5tm1.1Eba
Tg(Camk2a-cre)T29-1Stl/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * BALB/c * C57BL * C57BL/6J)
|
abnormal excitatory postsynaptic potential
|
J:205779
|
| abnormal neuron physiology
|
J:205779
|
| reduced long-term potentiation
|
J:205779
|
Ckbtm1.1(KOMP)Wtsi/Ckbtm1.1(KOMP)Wtsi
(C57BL/6N-Ckbtm1.1(KOMP)Wtsi/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Ckbtm1Bew/Ckbtm1Bew
(involves: 129P/Ola * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:89399
|
Ckmt1tm2Bew/Ckmt1tm2Bew
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal prepulse inhibition
|
J:116302
|
Clcf1tm1Zou/Clcf1tm1Zou
(involves: 129X1/SvJ * NIHS)
|
abnormal nervous system physiology
|
J:164637
|
Clcn1em1(IMPC)Mbp/Clcn1em1(IMPC)Mbp
(C57BL/6NCrl-Clcn1em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Clcn2tm1Tjj/Clcn2tm1Tjj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal glial cell physiology
|
J:210308
|
| abnormal microglial cell physiology
|
J:122365
|
| abnormal nerve conduction
|
J:122365
|
| abnormal oligodendrocyte physiology
|
J:210308
|
| impaired blood-brain barrier function
|
J:122365
|
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal excitatory postsynaptic currents
|
J:122982
|
| abnormal excitatory postsynaptic potential
|
J:122982
|
Clcn3tm1Lamb/Clcn3tm1Lamb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal nervous system physiology
|
J:80901
|
| decreased susceptibility to pharmacologically induced seizures
|
J:80901
|
| seizures
|
J:80901
|
| tonic-clonic seizures
|
J:80901
|
Clcn3tm1Tjj/Clcn3tm1Tjj
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal microglial cell physiology
|
J:77635
|
| abnormal nervous system physiology
|
J:77635
|
| impaired synaptic plasticity
|
J:77635
|
Clcn7tm1.1Lex/Clcn7tm1.1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
tonic seizures
|
J:186049
|
Cldn5tm1Sts/Cldn5tm1Sts
(involves: 129S4/SvJae * C57BL/6)
|
impaired blood-brain barrier function
|
J:83341
|
Clec1btm1.1Arte/Clec1btm1.1Arte
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6)
|
intracranial hemorrhage
|
J:181715
|
Clec1btm1.2Arte/Clec1btm1.2Arte
(Not Specified)
|
intracranial hemorrhage
|
J:181715
|
| spinal hemorrhage
|
J:181715
|
Clic5tm1b(EUCOMM)Hmgu/Clic5tm1b(EUCOMM)Hmgu
(C57BL/6N-Clic5tm1b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Clip2tm1.1Gal/Clip2+
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired synaptic plasticity
|
J:78711
|
Clip2tm1.1Gal/Clip2tm1.1Gal
(involves: 129P2/OlaHsd * C57BL/6)
|
impaired synaptic plasticity
|
J:78711
|
Clk2em1(IMPC)Bay/Clk2em1(IMPC)Bay
(C57BL/6N-Clk2em1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Clmntm1b(EUCOMM)Wtsi/Clmntm1b(EUCOMM)Wtsi
(C57BL/6N-Clmntm1b(EUCOMM)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Cln3em1Dprc/Cln3em1Dprc
(C57BL/6-Cln3em1Dprc)
|
increased microglial cell activation
|
J:294634
|
Cln3tm1Blda/Cln3tm1Blda
(B6.129-Cln3tm1Blda)
|
increased susceptibility to pharmacologically induced seizures
|
J:125194
|
Cln6nclf/Cln6nclf
(involves: C57BL/6J * C57BL/10J * C3HeB/FeJLe)
|
abnormal myelination
|
J:47292
|
| abnormal neuron physiology
|
J:47292
|
| seizures
|
J:47292
|
Cln6tm1b(EUCOMM)Hmgu/Cln6tm1b(EUCOMM)Hmgu
(C57BL/6N-Cln6tm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Cln8mnd/Cln8mnd
(involves: B6.KB2)
|
abnormal myelination
|
J:47292
|
| seizures
|
J:47292
|
Clockm1Jt/Clockm1Jt
(involves: C57BL/6)
|
abnormal single cell response
|
J:99868
|
Clockm1Jt/Clockm1Jt
(involves: BALB/cJ * C57BL/6 * C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:166742
|
Clp1tm1.1Pngr/Clp1tm1.1Pngr
(B6.Cg-Clp1tm1.1Pngr)
|
increased neuron apoptosis
|
J:209564
|
Clptm1lem1(IMPC)J/Clptm1lem1(IMPC)J
(C57BL/6NJ-Clptm1lem1(IMPC)J/Mmjax)
|
increased prepulse inhibition
|
J:211773
|
Clrn1tm1.1Kuna/Clrn1tm1.1Kuna
(involves: C57BL/6J)
|
abnormal cochlear hair cell physiology
|
J:186316
|
| abnormal vestibular hair cell physiology
|
J:186316
|
| decreased cochlear microphonics
|
J:186316
|
Clrn1tm1.1Ugpa/Clrn1tm1.1Ugpa
Myo15atm1.1(cre)Ugds/Myo15a+
(involves: 129S1/SvImJ * C57BL/6N)
|
abnormal cochlear inner hair cell physiology
|
J:265318
|
| abnormal cochlear nerve compound action potential
|
J:265318
|
| abnormal cochlear nerve fiber response
|
J:265318
|
| abnormal synaptic vesicle exocytosis
|
J:265318
|
Clrn1tm1.2Ugpa/Clrn1tm1.2Ugpa
(involves: BALB/c * C57BL/6 * C57BL/6N)
|
abnormal cochlear inner hair cell physiology
|
J:265318
|
| abnormal cochlear nerve fiber response
|
J:265318
|
| abnormal synaptic vesicle exocytosis
|
J:265318
|
Clrn2em1(IMPC)J/Clrn2em1(IMPC)J
(C57BL/6NJ-Clrn2em1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Clrn2mpc169H/Clrn2mpc169H
(C57BL/6J-Clrn2mpc169H)
|
abnormal cochlear inner hair cell physiology
|
J:283627
|
| abnormal hair cell mechanoelectric transduction
|
J:283627
|
Clstn1tm1.1Uge/Clstn1tm1.1Uge
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal CNS synaptic transmission
|
J:212386
|
| abnormal excitatory postsynaptic potential
|
J:212386
|
| abnormal glutamate-mediated receptor currents
|
J:212386
|
| abnormal NMDA-mediated synaptic currents
|
J:212386
|
| decreased excitatory postsynaptic current frequency
|
J:212386
|
| enhanced long-term potentiation
|
J:212386
|
| prolonged excitatory postsynaptic current decay time
|
J:212386
|
Clstn3tm1.1Amcr/Clstn3tm1.1Amcr
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
abnormal excitatory postsynaptic potential
|
J:201987
|
| decreased miniature excitatory postsynaptic current frequency
|
J:201987
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:201987
|
Cltatm1.2Fmb/Cltatm1.2Fmb
(involves: C57BL/6)
|
abnormal CNS synaptic transmission
|
J:296366
|
| abnormal synaptic vesicle recycling
|
J:296366
|
| decreased excitatory postsynaptic current amplitude
|
J:296366
|
| decreased neurotransmitter release
|
J:296366
|
Cltbtm1(KOMP)Vlcg/Cltbtm1(KOMP)Vlcg
(C57BL/6-Cltbtm1(KOMP)Vlcg)
|
abnormal synaptic vesicle recycling
|
J:296366
|
| increased excitatory postsynaptic current amplitude
|
J:296366
|
Cluap1tm1.2Hmd/Cluap1tm1.2Hmd
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
abnormal ependyma motile cilium physiology
|
J:200709
|
Clvs1tm1.1(KOMP)Vlcg/Clvs1tm1.1(KOMP)Vlcg
(B6N(Cg)-Clvs1tm1.1(KOMP)Vlcg/J)
|
decreased prepulse inhibition
|
J:211773
|
Clxntm1.1Osb/Clxntm1.1Osb
(involves: C57BL * C57BL/6NSlc * DBA)
|
abnormal brain ependyma motile cilium physiology
|
J:278278
|
Cm/+
(C3Sn.Cg-Cm/J)
|
abnormal synaptic norepinephrine release
|
J:150776
|
Cm/+
(Not Specified)
|
abnormal brain wave pattern
|
J:40705
|
| abnormal paired-pulse inhibition
|
J:40705
|
| decreased post-tetanic potentiation
|
J:40705
|
| reduced long-term potentiation
|
J:40705
|
Cmahtm1Avrk/Cmahtm1Avrk
Dock2m1Hsd/Dock2m1Hsd
(B6NHsd.Cg-Dock2m1Hsd Cmahtm1Avrk)
|
abnormal sensorimotor gating
|
J:122351
|
Cmahtm1Ykoz/Cmahtm1Ykoz
(B6.129P2-Cmahtm1Ykoz)
|
abnormal sensorimotor gating
|
J:122351
|
Cmtm6tm1c(EUCOMM)Wtsi/Cmtm6tm1c(EUCOMM)Wtsi
Tg(Dhh-cre)1Mejr/0
(involves: 129S4/SvJaeSor * C57BL/6N * FVB/N)
|
abnormal action potential
|
J:296495
|
| increased nerve conduction velocity
|
J:296495
|
Cmya5tm1Cap/Cmya5tm1Cap
(129-Cmya5tm1Cap)
|
increased prepulse inhibition
|
J:322761
|
Cnbpm1Hrb/Cnbpm1Hrb
(B6.129S4-Cnbpm1Hrb)
|
decreased embryonic neuroepithelial cell proliferation
|
J:81582
|
Cnga2tm1Gvr/Y
(involves: 129 * C57BL/6)
|
decreased post-tetanic potentiation
|
J:74854
|
| reduced long-term potentiation
|
J:74854
|
Cnga2tm1Gvr/Cnga2tm1Gvr
(involves: 129 * C57BL/6)
|
decreased post-tetanic potentiation
|
J:74854
|
| reduced long-term potentiation
|
J:74854
|
Cnga2tm1Mom/Y
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal neuron physiology
|
J:67661
|
Cnga2tm1Mom/Y
Or8a1btm5(Cnga2)Mom/Or8a1b+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal neuron physiology
|
J:67661
|
Cnga2tm1Mom/Y
Trpc2tm2Mom/Trpc2tm2Mom
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal olfactory sensory neuron physiology
|
J:235858
|
Cnga2tm1Mom/Cnga2tm1Mom
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal neuron physiology
|
J:67661
|
Cnga2tm1Mom/Cnga2tm1Mom
Or8a1btm5(Cnga2)Mom/Or8a1b+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal neuron physiology
|
J:67661
|
Cnga2tm1Mom/Cnga2tm1Mom
S100a5tm1.1Mom/?
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
abnormal olfactory sensory neuron physiology
|
J:215302
|
Cnga2tm1Mom/Cnga2tm1Mom
Trpc2tm2Mom/Trpc2tm2Mom
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal olfactory sensory neuron physiology
|
J:235858
|
Cnga2tm1Reed/Y
(involves: 129/Sv * BALB/cJ)
|
abnormal sensory neuron physiology
|
J:77304
|
Cnga2tm2Reed/Y
(involves: 129/Sv * BALB/cJ)
|
abnormal sensory neuron physiology
|
J:77304
|
Cngb1tm1Hazh/Cngb1tm1Hazh
(involves: 129S6/SvEvTac * BALB/cJ * C57BL/6)
|
abnormal action potential
|
J:145296
|
| abnormal neuron physiology
|
J:145296
|
| abnormal single cell response
|
J:145296
|
Cnih2tm1.1Ran/Cnih2tm1.1Ran
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal AMPA-mediated synaptic currents
|
J:197912
|
| abnormal miniature excitatory postsynaptic currents
|
J:197912
|
| reduced AMPA-mediated synaptic currents
|
J:197912
|
Cnih2tm1.1Ran/Cnih2tm1.1Ran
Cnih3tm1.1Ran/Cnih3tm1.1Ran
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal miniature excitatory postsynaptic currents
|
J:197912
|
| reduced AMPA-mediated synaptic currents
|
J:197912
|
| reduced long-term potentiation
|
J:197912
|
Cnih2tm1.1Ran/Cnih2tm1.1Ran
Neurod6tm1(cre)Kan/Neurod6+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NTac)
|
reduced AMPA-mediated synaptic currents
|
J:197912
|
Cnptm1(cre)Kan/Cnp+
Septin8tm1c(EUCOMM)Wtsi/Septin8tm1c(EUCOMM)Wtsi
(B6N.Cg-Septin8tm1c(EUCOMM)Wtsi Cnptm1(cre)Kan)
|
decreased nerve conduction velocity
|
J:236408
|
Cnptm1(cre)Kan/Cnptm1(cre)Kan
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
convulsive seizures
|
J:91814
|
Cnptm1(cre)Kan/Cnptm1(cre)Kan
(B6N.129-Cnptm1(cre)Kan)
|
dysmyelination
|
J:236408
|
Cnr1tm1.1Kpm/Cnr1tm1.1Kpm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal neuron physiology
|
J:208116
|
| abnormal synaptic plasticity
|
J:208116
|
Cnr1tm1.1Ltz/Cnr1+
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to pharmacologically induced seizures
|
J:89842
|
Cnr1tm1.1Ltz/Cnr1tm1.1Ltz
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to pharmacologically induced seizures
|
J:89842
|
Cnr1tm1.1Ltz/Cnr1tm1.1Ltz
(B6.129P2-Cnr1tm1.1Ltz)
|
abnormal paired-pulse facilitation
|
J:77936
|
| absent long-term depression
|
J:77936
|
| enhanced long-term potentiation
|
J:77936
|
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
(involves: 129P2/OlaHsd * C57BL/6NCrl)
|
increased susceptibility to pharmacologically induced seizures
|
J:122066
|
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Neurod6tm1(cre)Kan/Neurod6+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6NCrl)
|
increased susceptibility to pharmacologically induced seizures
|
J:122066
|
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to neuronal excitotoxicity
|
J:89842
|
| increased susceptibility to pharmacologically induced seizures
|
J:89842
|
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Tg(Camk2a-cre)2Gsc/?
(involves: 129P2/OlaHsd * C57BL/6NCrl * FVB/N)
|
increased susceptibility to pharmacologically induced seizures
|
J:122066
|
Cnr1tm1.2Ltz/Cnr1tm1.2Ltz
Tg(dlx5a-cre)1Mekk/?
(involves: 129P2/OlaHsd * C57BL/6NCrl * CD-1)
|
abnormal inhibitory postsynaptic currents
|
J:122066
|
Cnr1tm1Dgen/Cnr1tm1Dgen
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
reduced long-term depression
|
J:144773
|
Cnr1tm1Map/Cnr1+
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased cerebral infarct size
|
J:109213
|
Cnr1tm1Map/Cnr1tm1Map
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal neuronal precursor proliferation
|
J:102006
|
| increased cerebral infarct size
|
J:109213
|
| increased susceptibility to ischemic brain injury
|
J:109213
|
| increased susceptibility to neuronal excitotoxicity
|
J:109213
|
Cnr1tm1Map/Cnr1tm1Map
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal inhibitory postsynaptic currents
|
J:109305
|
| enhanced long-term potentiation
|
J:60079
|
Cnr1tm1Map/Cnr1tm1Map
(B6.129-Cnr1tm1Map)
|
abnormal nervous system physiology
|
J:156514
|
Cnr1tm1Ojm/Cnr1tm1Ojm
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:93698
|
| absent long-term depression
|
J:93698
|
Cnr1tm2Ltz/Cnr1tm2.1Ltz
Neurod6tm1(cre)Kan/Neurod6+
(B6.Cg-Cnr1tm2Ltz/Cnr1tm2.1Ltz Neurod6tm1(cre)Kan)
|
decreased synaptic depression
|
J:199647
|
Cnr1tm2Ltz/Cnr1tm2Ltz
(B6.Cg-Cnr1tm2Ltz)
|
decreased synaptic depression
|
J:199647
|
| increased susceptibility to pharmacologically induced seizures
|
J:199647
|
Cntftm1Mpin/Cntftm1Mpin
(B6.129S2-Cntftm1Mpin)
|
abnormal oligodendrocyte apoptosis
|
J:126852
|
Cntftm1Mpin/Cntftm1Mpin
(involves: 129S2/SvPas * C57BL/6)
|
abnormal astrocyte physiology
|
J:84375
|
Cntftm1Vlcg/Cntftm1Vlcg
(B6.Cg-Cntftm1Vlcg)
|
increased cerebral infarct size
|
J:185957
|
Cntftm1Vlcg/Cntftm1Vlcg
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal neuron proliferation
|
J:186611
|
Cntn2tm1Fuka/Cntn2tm1Fuka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:67556
|
| sporadic seizures
|
J:67556
|
Cntn2tm1Furl/Cntn2tm1Furl
(involves: 129S1/Sv)
|
abnormal somatic nervous system physiology
|
J:137627
|
Cntn2tm1Furl/Cntn2tm1Furl
(involves: 129S1/Sv * C57BL/6)
|
abnormal somatic nervous system physiology
|
J:137627
|
Cntn2tm2Furl/Cntn2tm2Furl
(C57BL/6-Cntn2tm2Furl)
|
abnormal somatic nervous system physiology
|
J:137627
|
Cntn5tm1Kwat/Cntn5tm1Kwat
(involves: 129X1/SvJ * C57BL/6J)
|
audiogenic seizures
|
J:89425
|
Cntnap1em1Bhat/Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
abnormal nerve conduction
|
J:342323
|
| decreased nerve conduction velocity
|
J:342323
|
| dysmyelination
|
J:342323
|
Cntnap1em2Bhat/Ccr10/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
abnormal nerve conduction
|
J:342323
|
| decreased nerve conduction velocity
|
J:342323
|
| dysmyelination
|
J:342323
|
Cntnap1shm/Cntnap1shm
(SHM/Nem)
|
abnormal nerve conduction
|
J:165697
|
| decreased nerve conduction velocity
|
J:165697
|
Cntnap1tm1Bhat/Cntnap1tm1Bhat
(involves: 129S7/SvEvBrd)
|
abnormal action potential
|
J:107653
|
| decreased nerve conduction velocity
|
J:107653
|
| hypermyelination
|
J:107653
|
Cntnap1tm1Pele/Cntnap1tm1Pele
(involves: ICR)
|
decreased nerve conduction velocity
|
J:166099
|
Cntnap1tm1Pele/Cntnap1tm1Pele
Gldntm1Pele/Gldntm1Pele
(involves: ICR)
|
decreased nerve conduction velocity
|
J:166099
|
Cntnap1tm1Pele/Cntnap1tm1Pele
Nrcamtm1Gmt/Nrcamtm1Gmt
(involves: 129P2/OlaHsd * ICR)
|
decreased nerve conduction velocity
|
J:166099
|
Cntnap2tm1Pele/Cntnap2tm1Pele
(B6.129-Cntnap2tm1Pele)
|
abnormal brain wave pattern
|
J:177110
|
| abnormal neuron physiology
|
J:177110
|
| abnormal neuronal migration
|
J:177110
|
| environmentally induced seizures
|
J:177110
|
| seizures
|
J:177110
|
Cntnap4tm1Pele/Cntnap4+
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
abnormal prepulse inhibition
|
J:211338
|
Cntnap4tm1Pele/Cntnap4tm1Pele
(involves: 129S1/Sv * 129X1/SvJ * ICR)
|
abnormal inhibitory postsynaptic currents
|
J:211338
|
| abnormal miniature inhibitory postsynaptic currents
|
J:211338
|
| abnormal prepulse inhibition
|
J:211338
|
| seizures
|
J:211338
|
Cntnap5aem1(IMPC)J/Cntnap5aem1(IMPC)J
(C57BL/6NJ-Cntnap5aem1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Cog6tm1a(EUCOMM)Wtsi/Cog6tm1a(EUCOMM)Wtsi
(C57BL/6N-Cog6tm1a(EUCOMM)Wtsi/Wtsi)
|
intracerebral hemorrhage
|
J:239583
|
Col1a1Aga2/Col1a1+
(involves: C3HeB/FeJ * C57BL/6J)
|
intracranial hemorrhage
|
J:129569
|
Col1a1m1Btlr/Col1a1m1Btlr
(C57BL/6J-Col1a1m1Btlr)
|
spinal hemorrhage
|
J:132554
|
Col1a1tm1(CAG-Sirt2)Jmi/Col1a1+
Tg(Mpz-cre)26Mes/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
abnormal myelination
|
J:177468
|
Col1a1tm3(CAG-IDH2*R140Q)Kkw/Col1a1+
Tmem163Tg(ACTB-cre)2Mrt/0
(involves: 129S4/SvJae * BALB/c * C57BL/6 * FVB/N)
|
seizures
|
J:209629
|
Col1a1tm3(tetO-Mirlet7g/Mir21)Gqda/Col1a1+
(involves: 129S4/SvJae * C57BL/6)
|
decreased neuronal stem cell self-renewal
|
J:207231
|
Col1a1tm8(CAG-BDNF)Jae/Col1a1+
Mecp2tm1.1Jae/Y
Tg(Camk2a-cre)93Kln/0
(involves: 129S4/SvJae * C57BL/6 * CBA/J)
|
abnormal action potential
|
J:106973
|
Col1a1tm8(CAG-BDNF)Jae/Col1a1tm8(CAG-BDNF)Jae
Tg(Sim1-cre)1Lowl/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
abnormal hypothalamus physiology
|
J:179918
|
Col2a1sedc/Col2a1sedc
(involves: C57BL/6J)
|
seizures
|
J:85735
|
Col4a1deltaex40/Col4a1+
(B6.129S-Col4a1deltaex40)
|
intracerebral hemorrhage
|
J:98572,
J:215446
|
| seizures
|
J:215446
|
| subarachnoid hemorrhage
|
J:215446
|
Col4a1tm1.1Ics/Col4a1+
(involves: 129S2/SvPas * C57BL/6)
|
intracranial hemorrhage
|
J:240798
|
Col4a1tm1.1Ics/Col4a1tm1.1Ics
(involves: 129S2/SvPas * C57BL/6)
|
intracranial hemorrhage
|
J:240798
|
Col9a2tm1b(EUCOMM)Wtsi/Col9a2tm1b(EUCOMM)Wtsi
(C57BL/6N-Col9a2tm1b(EUCOMM)Wtsi/H)
|
decreased prepulse inhibition
|
J:211773
|
Col13a1tm1Pih/Col13a1tm1Pih
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal endplate potential
|
J:164671
|
Col13a1tm2Pih/Col13a1tm2Pih
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal endplate potential
|
J:164671
|
Col13a1tm3.1Pih/Col13a1tm3.1Pih
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal endplate potential
|
J:164671
|
| abnormal miniature endplate potential
|
J:164671
|
| abnormal synaptic acetylcholine release
|
J:164671
|
Col13a1tm4.1Pih/Col13a1tm4.1Pih
(involves: C57BL/6)
|
abnormal endplate potential
|
J:242846
|
| abnormal miniature endplate potential
|
J:242846
|
| abnormal synaptic vesicle exocytosis
|
J:242846
|
Col18a1tm1Hms/Col18a1tm1Hms
(involves: 129S4/SvJae * C57BL/6J * C57BL/6JOlaHsd)
|
subarachnoid hemorrhage
|
J:92842
|
Col25a1tm1.1Tiwa/Col25a1tm1.1Tiwa
Tg(Hlxb9-GFP)1Tmj/0
(B6.Cg-Col25a1tm1.1Tiwa Tg(Hlxb9-GFP)1Tmj)
|
increased neuron apoptosis
|
J:206855
|
Colec12em1(IMPC)Mbp/Colec12em1(IMPC)Mbp
(C57BL/6N-Colec12em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Commd9Gt(AQ0362)Wtsi/Commd9Gt(AQ0362)Wtsi
(involves: 129P2/OlaHsd)
|
intracerebral hemorrhage
|
J:230747
|
| intracranial hemorrhage
|
J:230747
|
Comttm1(COMT)Xzho/Comttm1(COMT)Xzho
(involves: 129 * C57BL/6J)
|
decreased prepulse inhibition
|
J:224284
|
| increased prepulse inhibition
|
J:224284
|
Comttm2(COMT)Xzho/Comttm2(COMT)Xzho
(involves: 129 * C57BL/6J)
|
decreased prepulse inhibition
|
J:224284
|
| increased prepulse inhibition
|
J:224284
|
Copb2em1Rstot/Copb2em2Rstot
(involves: C57BL/6 * C57BL/6J * CD-1 * DBA/2)
|
abnormal neuron proliferation
|
J:252710
|
| increased neuron apoptosis
|
J:252710
|
| increased neuronal precursor proliferation
|
J:252710
|
Cops7atm1b(KOMP)Mbp/Cops7atm1b(KOMP)Mbp
(C57BL/6N-Cops7atm1b(KOMP)Mbp/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Coq8atm1.1Ics/Coq8atm1.1Ics
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N)
|
abnormal nervous system electrophysiology
|
J:249129
|
| environmentally induced seizures
|
J:249129
|
| increased susceptibility to pharmacologically induced seizures
|
J:249129
|
Coq9tm1.1Lcl/Coq9tm1.1Lcl
(involves: C57BL/6 * C57BL/6NTac * SJL)
|
demyelination
|
J:193288
|
| increased neuron apoptosis
|
J:193288
|
Cosz1DBA/2J/Cosz1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:66464
|
Cosz2DBA/2J/Cosz2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:66464
|
Cosz3C57BL/6J/Cosz3C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:66464
|
Cosz3C57BL/6J/Cosz3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:66464
|
Cox6a1tm1(KOMP)Wtsi/Cox6a1tm1(KOMP)Wtsi
(involves: C57BL/6JJcl * C57BL/6N)
|
abnormal nerve conduction
|
J:230212
|
Cox10tm1Ctm/Cox10tm1Ctm
Slc6a3tm1.1(cre)Bkmn/?
(B6.Cg-Cox10tm1Ctm Slc6a3tm1.1(cre)Bkmn)
|
increased microglial cell activation
|
J:231810
|
Cox10tm1Ctm/Cox10tm1Ctm
Tg(Camk2a-cre)#Szi/0
(involves: 129X1/SvJ * C57BL/6 * C57BL/6J * CBA)
|
abnormal glial cell physiology
|
J:188773
|
| abnormal nervous system physiology
|
J:188773
|
Cox18em1(IMPC)J/Cox18+
(C57BL/6NJ-Cox18em1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Cptm1Samd/Cptm1Samd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal astrocyte physiology
|
J:120651
|
| demyelination
|
J:142344
|
Cpefat/Cpefat
(BKSChpLt.HRS-Cpefat/J)
|
abnormal hypothalamus secretion
|
J:80698
|
Cpetm1Yplo/Cpetm1Yplo
(involves: 129S1/Sv * C57BL/6)
|
abnormal hypothalamus secretion
|
J:95741
|
Cpeb1tm1Rcht/Cpeb1tm1Rcht
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal long-term potentiation
|
J:101987
|
Cpeb2tm1.2Yshu/Cpeb2tm1.2Yshu
(involves: 129S/Sv * C57BL/6 * C57BL/6J * SJL/J)
|
abnormal parasympathetic nervous system physiology
|
J:237513
|
Cpeb3tm1.2Yshu/Cpeb3tm1.2Yshu
(involves: 129S4/SvJae * C57BL/6)
|
abnormal long-term depression
|
J:202741
|
| abnormal neuron physiology
|
J:202741
|
Cplx1tm2Bros/Cplx1tm2Bros
(Not Specified)
|
abnormal neuron physiology
|
J:150417
|
| abnormal paired-pulse inhibition
|
J:150417
|
| decreased excitatory postsynaptic current amplitude
|
J:150417
|
| decreased miniature excitatory postsynaptic current frequency
|
J:150417
|
| sporadic seizures
|
J:86365
|
Cplx1tm2Bros/Cplx1tm2Bros
Cplx2tm1Bros/Cplx2tm1Bros
(Not Specified)
|
abnormal CNS synaptic transmission
|
J:86365
|
| abnormal inhibitory postsynaptic currents
|
J:136393
|
| abnormal neuron physiology
|
J:136393
|
| abnormal neurotransmitter secretion
|
J:136393
|
| abnormal pre-Botzinger complex physiology
|
J:136393
|
| decreased excitatory postsynaptic current amplitude
|
J:136393
|
| decreased miniature excitatory postsynaptic current amplitude
|
J:136393
|
| decreased miniature excitatory postsynaptic current frequency
|
J:136393
|
| impaired synaptic plasticity
|
J:136393
|
Cplx1tm2Bros/Cplx1tm2Bros
Cplx2tm1Bros/Cplx2tm1Bros
Cplx3tm1Bros/Cplx3tm1Bros
(Not Specified)
|
abnormal inhibitory postsynaptic currents
|
J:136393
|
| abnormal miniature excitatory postsynaptic currents
|
J:136393
|
| abnormal neuron physiology
|
J:136393
|
| abnormal neurotransmitter secretion
|
J:136393
|
| abnormal pre-Botzinger complex physiology
|
J:136393
|
| decreased excitatory postsynaptic current amplitude
|
J:136393
|
| decreased excitatory postsynaptic current frequency
|
J:136393
|
| impaired synaptic plasticity
|
J:136393
|
Cplx2tm1Tyag/Cplx2tm1Tyag
(involves: C57BL/6 * CBA)
|
reduced long-term potentiation
|
J:57368
|
Cplx2tm1Tyag/Cplx2tm1Tyag
(B6.Cg-Cplx2tm1Tyag)
|
reduced long-term potentiation
|
J:106335
|
Cpne6tm1.1Rueg/Cpne6tm1.1Rueg
(involves: 129 * 129S1/Sv * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:239922
|
| impaired synaptic plasticity
|
J:239922
|
| reduced long-term potentiation
|
J:239922
|
Cramp1em1(IMPC)Bay/Cramp1+
(C57BL/6N-Cramp1em1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Crbntm1.2Jjh/Crbntm1.2Jjh
(involves: C57BL/6)
|
reduced long-term potentiation
|
J:259276
|
Crbntm1b(KOMP)Wtsi/Crbntm1b(KOMP)Wtsi
(C57BL/6N-Crbntm1b(KOMP)Wtsi/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Creb1tm1Gsc/Creb1tm1Gsc
(involves: 129S2/SvPas)
|
abnormal CNS synaptic transmission
|
J:20672
|
| reduced long-term potentiation
|
J:20672
|
Creb1tm1Nes/Creb1tm1Nes
(involves: C57BL/6J)
|
abnormal single cell response
|
J:164682
|
Creb1tm3Gsc/Creb1tm3Gsc
Cremtm1Gsc/Cremtm1Gsc
Tg(Dbh-icre)1Gsc/0
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased neuron apoptosis
|
J:121244
|
CrebbpGt(U-San)112Imeg/Crebbp+
(involves: C57BL/6 * CBA)
|
seizures
|
J:53370
|
Crebbptm1Sis/Crebbptm1Sis
(involves: BALB/cCrSlc * C57BL/6NCrlj * CBA/JNCrlj)
|
intracranial hemorrhage
|
J:63763
|
Crebbptm2Pkb/Crebbptm2Pkb
((B6.129P2-Crebbptm2Pkb/Pkb x 129S2.129P2(B6)-Crebbptm2Pkb/Pkb)F1)
|
increased post-tetanic potentiation
|
J:230850
|
Cremtm1.1Endo/Cremtm1.1Endo
(C57BL/6-Cremtm1.1Endo)
|
abnormal kindling response
|
J:137666
|
Crhr1tm2Wrst/Crhr1tm2Wrst
Neurod6tm1(cre)Kan/Neurod6+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:176339
|
Crhr1tm2Wrst/Crhr1tm2Wrst
Tg(Fev-cre)1Esd/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal synaptic dopamine release
|
J:176339
|
cri/cri
(involves: DBA/2J)
|
clonic seizures
|
J:6110
|
Crmp1tm1.1Swl/Crmp1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal long-term potentiation
|
J:120105
|
Crmp1tm1.1Swl/Crmp1tm1.1Swl
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal long-term potentiation
|
J:120105
|
Crmp1tm1Pako/Crmp1tm1Pako
(involves: 129/Sv * ICR)
|
abnormal neuronal migration
|
J:119127,
J:116689
|
| abnormal neuronal precursor proliferation
|
J:119127
|
Cry1tm1Asn/Cry1tm1Asn
Cry2tm1Hnos/Cry2tm1Hnos
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal baroreceptor physiology
|
J:134129
|
Crybg1tm1b(KOMP)Wtsi/Crybg1+
(C57BL/6N-Crybg1tm1b(KOMP)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Cstm1.1(KOMP)Wtsi/Cs+
(C57BL/6N-Cstm1.1(KOMP)Wtsi/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Csf1op/Csf1op
Galctwi/Galctwi
(involves: C3HeB/Fe * C57BL/6J * CE/J)
|
abnormal oligodendrocyte physiology
|
J:170081
|
| demyelination
|
J:170081
|
Csf1op/Csf1op
Mpztm1Msch/Mpz+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myelination
|
J:67581
|
Csf1rtm1Ers/Csf1r+
(B6.129X1-Csf1rtm1Ers)
|
demyelination
|
J:219294
|
| hypermyelination
|
J:219294
|
Csnk1etm1Asil/Csnk1e+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neuron physiology
|
J:135186
|
Csnk1etm1Asil/Csnk1etm1Asil
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neuron physiology
|
J:135186
|
Csnk2btm1.1Bb/Csnk2btm1.1Bb
Tg(ACTA1-cre)79Jme/?
(involves: 129S2/SvPasCrl * C57BL/6J * SJL)
|
abnormal miniature endplate potential
|
J:110237
|
Cspg5tm1Fgr/Cspg5tm1Fgr
(B6.129P2-Cspg5tm1Fgr)
|
abnormal CNS synaptic transmission
|
J:99761
|
| abnormal inhibitory postsynaptic currents
|
J:99761
|
| decreased excitatory postsynaptic current frequency
|
J:99761
|
| enhanced paired-pulse facilitation
|
J:99761
|
| reduced long-term depression
|
J:99761
|
Cst3tm1Karl/Cst3tm1Karl
(involves: 129S/SvEv * C57BL/6J * CBA)
|
decreased susceptibility to ischemic brain injury
|
J:93568
|
| increased cerebral infarct size
|
J:93568
|
Cstbtm1Rm/Cstbtm1Rm
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal nervous system physiology
|
J:71823
|
| myoclonus
|
J:50587
|
Cstbtm1Rm/Cstbtm1Rm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal brain wave pattern
|
J:115694
|
| myoclonus
|
J:115694
|
| seizures
|
J:115694
|
Ctc1tm1b(KOMP)Wtsi/Ctc1+
(C57BL/6N-Ctc1tm1b(KOMP)Wtsi/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Ctcfem1Hyao/Ctcfem1Hyao
(C57BL/6N-Ctcfem1Hyao)
|
abnormal nervous system electrophysiology
|
J:350502
|
Ctnna1tm1Efu/Ctnna1tm1Efu
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/0
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * C57BL/6NCrl * CBA)
|
impaired blood-brain barrier function
|
J:328283
|
Ctnna2cdf/Ctnna2cdf
(C3Sn.C3-Ctnna2cdf/J)
|
decreased prepulse inhibition
|
J:77488
|
Ctnnb1Bfc/Ctnnb1+
(involves: BALB/cCrl * C3H/HeNCrl)
|
abnormal synaptic vesicle clustering
|
J:209611
|
| decreased prepulse inhibition
|
J:209611
|
| reduced long-term potentiation
|
J:209611
|
Ctnnb1tm2Kem/Ctnnb1tm2.1Kem
Kdrtm1(cre)Sato/Kdr+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal blood-brain barrier function
|
J:142352
|
| intracranial hemorrhage
|
J:142352
|
| spinal hemorrhage
|
J:142352
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Emx1tm1(cre)Yql/Emx1+
(B6.129-Emx1tm1(cre)Yql Ctnnb1tm2Kem)
|
increased susceptibility to pharmacologically induced seizures
|
J:92923
|
| seizures
|
J:92923
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Juptm1Ruiz/Juptm1Ruiz
Olig2tm1(cre)Tmj/Olig2+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal neuronal migration
|
J:178688
|
Ctnnb1tm2Kem/Ctnnb1tm2Kem
Pvalbtm1(cre)Arbr/Pvalb+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neuron physiology
|
J:236989
|
Ctnnd2tm1Lxin/Ctnnd2tm1Lxin
(involves: 129S4/SvJae * C57BL/6NTac)
|
abnormal long-term potentiation
|
J:93226
|
Ctsatm2b(EUCOMM)Hmgu/Ctsatm2b(EUCOMM)Hmgu
(C57BL/6N-Ctsatm2b(EUCOMM)Hmgu/H)
|
decreased prepulse inhibition
|
J:211773
|
Ctsbtm1Jde/Ctsbtm1Jde
Ctsltm1Cptr/Ctsltm1Cptr
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal neuron apoptosis
|
J:77103
|
Ctsctm1Dgen/Ctsctm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prepulse inhibition
|
J:101679
|
Ctsdtm1Cptr/Ctsdtm1Cptr
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd))
|
increased forebrain apoptosis
|
J:71688
|
| seizures
|
J:64892,
J:71688
|
| tonic seizures
|
J:64892
|
Ctsktm1b(EUCOMM)Hmgu/Ctsktm1b(EUCOMM)Hmgu
(C57BL/6N-Ctsktm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Cul3em1Limi/Cul3+
(C57BL/6N-Cul3em1Limi)
|
abnormal nervous system electrophysiology
|
J:332937
|
Cul3tm1Jdsr/Cul3+
Neurod6tm1(cre)Kan/Neurod6+
Tg(Thy1-EGFP)MJrs/0
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J * CBA)
|
increased miniature excitatory postsynaptic current frequency
|
J:292173
|
| increased miniature inhibitory postsynaptic current frequency
|
J:292173
|
Cul3tm1Jdsr/Cul3+
Tg(GFAP-cre)25Mes/0
(involves: 129S4/SvJaeSor * FVB/N)
|
abnormal action potential
|
J:292173
|
| abnormal CNS synaptic transmission
|
J:292173
|
| decreased paired-pulse facilitation
|
J:292173
|
| increased miniature excitatory postsynaptic current frequency
|
J:292173
|
| increased miniature inhibitory postsynaptic current frequency
|
J:292173
|
Cul4btm1Swl/Y
Edil3Tg(Sox2-cre)1Amc/Edil3+
(B6.Cg-Edil3Tg(Sox2-cre)1Amc Cul4btm1Swl)
|
increased susceptibility to pharmacologically induced seizures
|
J:187403
|
Cux2tm1.1Nieto/Cux2tm1.1Nieto
(involves: 129S4/SvJae * C57BL/6 * FVB/N * Swiss Webster)
|
abnormal neuronal precursor proliferation
|
J:156578
|
Cx3cl1tm1Lira/Cx3cl1tm1Lira
(Not Specified)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:110266
|
Cx3cl1tm1Sgs/Cx3cl1tm1Sgs
(involves: 129S4/SvJae)
|
decreased cerebral infarct size
|
J:95634
|
Cx3cr1tm1Litt/Cx3cr1+
Psen1tm1Mpm/Psen1tm1Mpm
Tg(APPSwe,tauP301L)1Lfa/0
Tg(Thy1-YFP)HJrs/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal microglial cell physiology
|
J:159680
|
Cx3cr1tm1Litt/Cx3cr1tm1Litt
(B6.129P2-Cx3cr1tm1Litt)
|
abnormal microglial cell physiology
|
J:110266,
J:265696
|
| brain inflammation
|
J:129712
|
| brainstem hemorrhage
|
J:129712
|
| demyelination
|
J:129712
|
| increased neuron apoptosis
|
J:110266
|
| increased susceptibility to dopaminergic neuron neurotoxicity
|
J:110266
|
Cx3cr1tm2.1(cre/ERT2)Litt/Cx3cr1+
Vps35Gt(RRK261)Byg/Vps35Gt(RRK261)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cerebral infarct size
|
J:292365
|
| decreased neuron apoptosis
|
J:292365
|
Cxcl10tm1Adl/Cxcl10tm1Adl
(involves: 129S4/SvJae * C57BL/6)
|
demyelination
|
J:75584
|
Cxcl10tm1Adl/Cxcl10tm1Adl
(B6.129S4-Cxcl10tm1Adl)
|
CNS inflammation
|
J:87076
|
Cxcr2tm1Mwm/Cxcr2tm1Mwm
(C.129S2(B6)-Cxcr2tm1Mwm/J)
|
abnormal myelination
|
J:78470
|
Cxcr4tm1Qma/Cxcr4tm1Qma
(involves: 129X1/SvJ * C57BL/6)
|
abnormal nervous system physiology
|
J:132342
|
Cyb5d1tm1.1(KOMP)Vlcg/Cyb5d1tm1.1(KOMP)Vlcg
(B6N(Cg)-Cyb5d1tm1.1(KOMP)Vlcg/J)
|
convulsive seizures
|
J:211773
|
Cybatm1Dgh/Cybatm1Dgh
(B6.Cg-Cybatm1Dgh)
|
abnormal nervous system physiology
|
J:231269
|
| abnormal sympathetic nervous system physiology
|
J:231269
|
Cybbtm1Din/Y
(B6.129S-Cybbtm1Din)
|
abnormal long-term potentiation
|
J:147954
|
Cybbtm1Din/Cybbtm1Din
(B6.129S-Cybbtm1Din)
|
decreased post-tetanic potentiation
|
J:111410
|
| reduced long-term potentiation
|
J:111410
|
Cycstm1Mak/Cycstm1Mak
(involves: C57BL/6)
|
intracerebral hemorrhage
|
J:98949
|
Cyfip1tm1Yhj/Cyfip1+
(B6J.129S7-Cyfip1tm1Yhj)
|
abnormal CNS synaptic transmission
|
J:229098
|
| abnormal long-term depression
|
J:229098
|
| enhanced paired-pulse facilitation
|
J:229098
|
Cyfip2M1N/Cyfip2M1N
(C57BL/6N)
|
decreased miniature excitatory postsynaptic current frequency
|
J:203183
|
Cyfip2tm1(KOMP)Vlcg/Cyfip2+
(involves: C57BL/6J * C57BL/6NTac)
|
increased prepulse inhibition
|
J:219363
|
Cyfip2tm1(KOMP)Vlcg/Cyfip2+
Fmr1tm1Cgr/Y
(involves: 129P2/OlaHsd * C57BL/6J * C57BL/6NTac)
|
increased prepulse inhibition
|
J:219363
|
Cyp4v3em1Xsu/Cyp4v3em1Xsu
(C57BL/6J-Cyp4v3em1Xsu)
|
abnormal glial cell physiology
|
J:321817
|
| increased microglial cell activation
|
J:321817
|
Cyp19a1tm1Esi/Cyp19a1tm1Esi
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal baroreceptor physiology
|
J:105620
|
Cyrenem1Vokh/Cyrenem1Vokh
(C57BL/6-Cyrenem1Vokh)
|
decreased neuronal precursor proliferation
|
J:306598
|
Cyrentm1.1(KOMP)Vlcg/Cyrentm1.1(KOMP)Vlcg
Nhej1tm1Fwa/Nhej1tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
increased neuron apoptosis
|
J:265834
|
Cyth1tm1Jya/Cyth1tm1Jya
(B6JJms.129-Cyth1tm1Jya)
|
dysmyelination
|
J:259473
|
Cyth2tm1c(EUCOMM)Wtsi/Cyth2tm1c(EUCOMM)Wtsi
Tg(Mpz-cre)26Mes/0
(involves: C57BL/6N * FVB/NTac)
|
dysmyelination
|
J:260347
|
D130043K22Riktm1b(KOMP)Wtsi/D130043K22Riktm1b(KOMP)Wtsi
(involves: C57BL/6 * CBA)
|
increased prepulse inhibition
|
J:241324
|
Dab1tm1.1Mull/Dab1tm1.1Mull
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal neuronal migration
|
J:174747
|
Dab1tm1.1Mull/Dab1tm1.1Mull
Cux2tm2.1(cre)Mull/Cux2+
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
abnormal neuronal migration
|
J:174747
|
Dab1tm1.1Mull/Dab1tm1.1Mull
Neurod6tm1(cre)Kan/Neurod6+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal neuronal migration
|
J:174747
|
Dab1tm1.1Mull/Dab1tm1.1Mull
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
abnormal neuronal migration
|
J:174747
|
Dab1tm1Cpr/Dab1tm1Cpr
(either: (involves: 129S4/SvJaeSor * BALB/c) or (involves: 129S4/SvJaeSor * C57BL/6))
|
abnormal neuronal precursor cell migration
|
J:121846
|
Dab1tm1Cpr/Dab1tm3.1Cpr
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal neuronal migration
|
J:74239
|
Dact1tm1.1Bnrc/Dact1tm1.1Bnrc
(involves: 129)
|
decreased miniature excitatory postsynaptic current frequency
|
J:159217
|
Dag1tm1Kcam/Dag1tm2Kcam
Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal neuronal migration
|
J:86901
|
Dag1tm2Kcam/Dag1tm2Kcam
Itgb4tm1Mfel/Itgb4tm1Mfel
Tg(Mpz-cre)26Mes/0
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal action potential
|
J:137852
|
| abnormal nerve conduction
|
J:137852
|
| decreased nerve conduction velocity
|
J:137852
|
| demyelination
|
J:137852
|
Dag1tm2Kcam/Dag1tm2Kcam
Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal neuronal migration
|
J:86901
|
| reduced long-term potentiation
|
J:86901
|
Dag1tm2Kcam/Dag1tm2Kcam
Tg(Mpz-cre)26Mes/0
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal action potential
|
J:137852
|
| abnormal nerve conduction
|
J:137852
|
| decreased nerve conduction velocity
|
J:137852
|
| demyelination
|
J:137852
|
DaglaGt(OST288027)Lex/DaglaGt(OST288027)Lex
(involves: 129S5/SvEvBrd)
|
abnormal CNS synaptic transmission
|
J:189393
|
| increased single cell response threshold
|
J:189393
|
Daglatm1.1Kano/Daglatm1.1Kano
(involves: C57BL/6 * C57BL/6N * CBA)
|
abnormal inhibitory postsynaptic currents
|
J:167891
|
| absent long-term depression
|
J:167891
|
Daglatm1.1Kano/Daglatm1.1Kano
(involves: C57BL/6N)
|
abnormal excitatory postsynaptic currents
|
J:173327
|
Daglatm1Pado/Dagla+
(C57BL/6-Daglatm1Pado)
|
abnormal neuron proliferation
|
J:157850
|
Daglatm1Pado/Daglatm1Pado
(C57BL/6-Daglatm1Pado)
|
abnormal inhibitory postsynaptic currents
|
J:157850
|
| abnormal neuron proliferation
|
J:157850
|
DaglbGt(OST195261)Lex/Daglb+
(B6.129S5-DaglbGt(OST195261)Lex)
|
abnormal neuron proliferation
|
J:157850
|
DaglbGt(OST195261)Lex/DaglbGt(OST195261)Lex
(B6.129S5-DaglbGt(OST195261)Lex)
|
abnormal neuron proliferation
|
J:157850
|
DaoG181R/DaoG181R
(DDY-Dao1G181R)
|
abnormal synaptic neurotransmitter level
|
J:21994
|
Dapk1Gt(IST12766D5)Tigm/Dapk1Gt(IST12766D5)Tigm
(C57BL/6-Dapk1Gt(IST12766D5)Tigm)
|
decreased cerebral infarct size
|
J:161179
|
| decreased neuron apoptosis
|
J:161179
|
| decreased susceptibility to ischemic brain injury
|
J:161179
|
| reduced NMDA-mediated synaptic currents
|
J:161179
|
Dars1Gt(Ayu17-9366)Tgjp/Dars1+
(involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased prepulse inhibition
|
J:242754
|
Daxxtm1Led/Daxxtm1Led
(involves: 129S6/SvEvTac * Black Swiss)
|
increased embryonic neuroepithelium apoptosis
|
J:56796
|
Dbhtm2(Th)Rpa/Dbh+
Thtm1Rpa/Thtm1Rpa
(involves: 129S7/SvEvBrd)
|
abnormal nervous system physiology
|
J:30404
|
Dbn1tm1.1Lbc/Dbn1tm1.1Lbc
(B6.Cg-Dbn1tm1.1Lbc)
|
impaired synaptic plasticity
|
J:224553
|
Dbn1tm1b(KOMP)Wtsi/Dbn1+
(C57BL/6N-Dbn1tm1b(KOMP)Wtsi/MbpMmucd)
|
increased prepulse inhibition
|
J:211773
|
Dbndd2tm1b(EUCOMM)Wtsi/Dbndd2tm1b(EUCOMM)Wtsi
(C57BL/6N-Dbndd2tm1b(EUCOMM)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Dbnltm1Jwnd/Dbnl+
(involves: BALB/c)
|
convulsive seizures
|
J:109363
|
Dbnltm1Jwnd/Dbnltm1Jwnd
(involves: BALB/c)
|
abnormal synaptic vesicle recycling
|
J:109363
|
Dbptm1Schb/Dbptm1Schb
Hlftm1Schb/Hlftm1Schb
Teftm1Schb/Tef+
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal brain wave pattern
|
J:90854
|
| absence seizures
|
J:90854
|
| seizures
|
J:90854
|
Dbptm1Schb/Dbptm1Schb
Hlftm1Schb/Hlftm1Schb
Teftm1Schb/Teftm1Schb
(involves: 129P2/OlaHsd * 129S2/SvPas)
|
abnormal brain wave pattern
|
J:90854
|
| absence seizures
|
J:90854
|
| audiogenic seizures
|
J:90854
|
| seizures
|
J:90854
|
| tonic-clonic seizures
|
J:90854
|
Dbx1tm1Tmj/Dbx1tm1Tmj
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal somatic nervous system physiology
|
J:89813
|
Dbx1tm1Tmj/Dbx1tm1Tmj
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pre-Botzinger complex physiology
|
J:165285
|
Dbx1tm2(cre)Apie/Dbx1+
Robo3tm1.1Ache/Robo3tm1.1Ache
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal pre-Botzinger complex physiology
|
J:165285
|
Dbx1tm2Jcor/Dbx1tm1Tmj
Tg(Nkx2-1-cre)2Sand/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal action potential
|
J:221571
|
| abnormal hypothalamus secretion
|
J:221571
|
Dcaf11tm1d(KOMP)Wtsi/Dcaf11tm1d(KOMP)Wtsi
(B6(Cg)-Dcaf11tm1d(KOMP)Wtsi)
|
abnormal hippocampus physiology
|
J:345927
|
Dclk2tm1.2Jgg/Dclk2tm1.2Jgg
Dcxtm1Caw/Y
(involves: 129/Sv * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:148345
|
| convulsive seizures
|
J:148345
|
| tonic-clonic seizures
|
J:148345
|
Dclk2tm1.2Jgg/Dclk2tm1.2Jgg
Dcxtm1Caw/Dcxtm1Caw
(involves: 129/Sv * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:148345
|
| convulsive seizures
|
J:148345
|
| tonic-clonic seizures
|
J:148345
|
Dctn1tm2.1Cai/Dctn1tm2.1Cai
Tg(Thy1-cre)1Vln/?
(involves: 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased susceptibility to neuronal excitotoxicity
|
J:264431
|
Dctn6em1(IMPC)J/Dctn6+
(C57BL/6NJ-Dctn6em1(IMPC)J/J)
|
decreased prepulse inhibition
|
J:211773
|
Dcxtm1Caw/Y
(involves: 129/Sv * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:148345
|
Ddb1tm1Spg/Ddb1tm1Spg
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal nervous system physiology
|
J:117820
|
| abnormal neuron apoptosis
|
J:117820
|
| cerebellum hemorrhage
|
J:117820
|
| intracerebral hemorrhage
|
J:117820
|
| intracranial hemorrhage
|
J:117820
|
Ddctm1.1Nwlh/Ddctm1.1Nwlh
(involves: C57BL/6)
|
abnormal synaptic neurotransmitter level
|
J:197646
|
Ddit3tm1Aki/Ddit3tm1Aki
(involves: 129P2/OlaHsd)
|
decreased neuron apoptosis
|
J:109623
|
Ddit3tm1Dron/Ddit3tm1Dron
Mpztm3.1Wra/Mpztm3.1Wra
(involves: 129S2/SvPas * C3H * C57BL/6 * FVB/N)
|
decreased nerve conduction velocity
|
J:241742
|
| dysmyelination
|
J:241742
|
Ddit4tm1Fein/Ddit4tm1Fein
(involves: 129S5/SvEvBrd * C57BL/6)
|
hypermyelination
|
J:202688
|
Ddotm1Snyd/Ddotm1Snyd
(involves: 129S4/SvJae)
|
abnormal pituitary gland physiology
|
J:106267
|
Ddx39atm1b(KOMP)Wtsi/Ddx39a+
(C57BL/6N-Ddx39atm1b(KOMP)Wtsi/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Del(2Dlx1-Dlx2)1Jlr/Del(2Dlx1-Dlx2)1Jlr
(involves: 129X1/SvJ)
|
abnormal neuronal migration
|
J:41860
|
Del(5D5Mit73-D5Mit351)5Jcs/+
(involves: 129S4/SvJae * C57BL/6J)
|
maximal tonic hindlimb extension seizures
|
J:67077
|
| seizures
|
J:67077
|
Del(5D5Mit388-D5Mit351)4Jcs/+
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal seizure response to electrical stimulation
|
J:67077
|
Del(5Gtf2i-Limk1)1Uta/+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased prepulse inhibition
|
J:182796
|
Del(5Letm1-D5Mit81)3Jcs/+
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal seizure response to electrical stimulation
|
J:67077
|
Del(5Letm1-Htt)1Jcs/+
(involves: 129S4/SvJae * C57BL/6J)
|
convulsive seizures
|
J:67077
|
Del(6)1Mom/Del(6)1Mom
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
avnosmia
|
J:78894
|
Del(6Snca)1Slab/Del(6Snca)1Slab
Tg(Th-SNCA*)1Mgsp/0
(involves: C57BL/6J * C57BL/6JOlaHsd * CBA/Ca)
|
brain inflammation
|
J:108310
|
Del(7Chrna7-Fan1)1Mima/+
(C57BL/6N-Del(7Chrna7-Fan1)1Mima)
|
abnormal brain wave pattern
|
J:227984
|
Del(7Chrna7-Fan1)3Arte/+
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal seizure response to electrical stimulation
|
J:260165
|
| abnormal seizure response to pharmacological agent
|
J:260165
|
| decreased susceptibility to pharmacologically induced seizures
|
J:260165
|
Del(7Coro1a-Spn)1Dolm/+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6N * CD-1)
|
abnormal excitatory postsynaptic currents
|
J:210018
|
| decreased paired-pulse facilitation
|
J:210018
|
| increased miniature excitatory postsynaptic current frequency
|
J:210018
|
Del(7Coro1a-Spn)1Dolm/+
Tg(Drd2-EGFP)S118Gsat/0
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6N * CD-1 * FVB/N)
|
increased excitatory postsynaptic current frequency
|
J:210018
|
Del(7Cyp2s1-Cyp2a5)1Ding/Del(7Cyp2s1-Cyp2a5)1Ding
(involves: BALB/cJ * C57BL/6)
|
abnormal nervous system physiology
|
J:190445
|
Del(7Gabrb3-Ube3a)1Yhj/+
(B6.129S7-Del(7Gabrb3-Ube3a)1Yhj)
|
abnormal brain wave pattern
|
J:164010
|
| tonic-clonic seizures
|
J:164010
|
Del(7Mrgpra1-Mrgprb4)1And/Del(7Mrgpra1-Mrgprb4)1And
(involves: 129S1/Sv * C57BL/6)
|
abnormal sensory neuron physiology
|
J:157470
|
Del(7Slx1b-Sept1)4Aam/0
(B6129S-Del(7Slx1b-Sept1)4Aam/J)
|
increased neuronal precursor proliferation
|
J:219859
|
Del(8Col4a1-Col4a2)1Epo/Del(8Col4a1-Col4a2)1Epo
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neuronal migration
|
J:89190
|
Del(11Cops3-Rnf112)1Jrl/+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal brain wave pattern
|
J:83302
|
| seizures
|
J:88027
|
| tonic-clonic seizures
|
J:83302
|
Del(16Dgcr2-Hira)3Aam/+
(involves: 129S1/Sv * 129S7/SvEvBrd * C57BL/6J)
|
decreased prepulse inhibition
|
J:136969
|
Del(16Dgcr2-Hira)3Aam/+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal nervous system physiology
|
J:158957
|
Del(16Dgcr2-Hira)3Aam/+
(involves: 129S7/SvEvBrd)
|
decreased miniature excitatory postsynaptic current frequency
|
J:141432
|
Del(16Dyrk1a-Kcnj6)14Yey/Dp(16Lipi-Zbtb21)1Yey
(B6.129S7-Del(16Dyrk1a-Kcnj6)14Yey/Dp(16Lipi-Zbtb21)1Yey)
|
reduced long-term potentiation
|
J:224899
|
Del(16Es2el-Sept5)3Bld/+
(B6.Cg-Tyrc-Brd Del(16Es2el-Sept5)3Bld)
|
decreased prepulse inhibition
|
J:110101
|
Del(16Es2el-T10)2Bld/+
(B6.129S7-Del(16Es2el-T10)2Bld)
|
enhanced long-term potentiation
|
J:190908
|
Del(16Es2el-Ufd1l)217Bld/+
(B6.Cg-Tyrc-Brd Del(16Es2el-Ufd1l)217Bld)
|
decreased prepulse inhibition
|
J:110101
|
Del(16Es2el-Ufd1l)217Bld/+
(B6.129S7-Del(16Es2el-Ufd1l)217Bld)
|
abnormal neuron proliferation
|
J:201966
|
| abnormal neuronal migration
|
J:201966
|
| enhanced long-term potentiation
|
J:190908
|
Del(16Kcnj15-Mx2)13Yey/Dp(16Lipi-Zbtb21)1Yey
(B6.129S7-Del(16Kcnj15-Mx2)13Yey/Dp(16Lipi-Zbtb21)1Yey)
|
reduced long-term potentiation
|
J:224899
|
Del(16Lipi-Usp25)1Dja/Del(16Lipi-Usp25)1Dja
(involves: 129P2/OlaHsd * C57BL/6)
|
increased neural tube apoptosis
|
J:184302
|
Del(16Pi4ka-Hira)1Atai/+
(C57BL/6N-Del(16Pi4ka-Hira)1Atai)
|
decreased prepulse inhibition
|
J:285407
|
| reduced sensorimotor gating
|
J:285407
|
Del(16Setd4-Kcnj6)12Yey/Dp(16Lipi-Zbtb21)1Yey
(B6.129S7-Del(16Setd4-Kcnj6)12Yey/Dp(16Lipi-Zbtb21)1Yey)
|
reduced long-term potentiation
|
J:224899
|
Del(16T10-Hira)4Bld/+
(B6.Cg-Tyrc-Brd Del(16T10-Hira)4Bld)
|
decreased prepulse inhibition
|
J:110101
|
Del(16Zfp520-Slc25a1)1Awb/+
(involves: 129S6/SvEvTac * NIH Black Swiss)
|
abnormal prepulse inhibition
|
J:58432
|
Del(16Zfp520-Slc25a1)1Awb/+
(involves: 129S6/SvEvTac)
|
abnormal prepulse inhibition
|
J:58432
|
Del(17)5Mom/Del(17)5Mom
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
abnormal vomeronasal sensory neuron physiology
|
J:207447
|
Del(17)5Mom/Del(17)5Mom
Vmn2r81tm2Mom/Vmn2r81tm2Mom
(involves: 129P2/OlaHsd * 129S6/SvEvTac * 129S7/SvEvBrd)
|
abnormal vomeronasal sensory neuron physiology
|
J:207447
|
Del(17Abcg1-Cbs)2Yah/+
(B6.129P2-Del(17Abcg1-Cbs)2Yah)
|
enhanced long-term potentiation
|
J:214512
|
Del(18Pcdhg)1Xzw/Del(18Pcdhg)1Xzw
(Not Specified)
|
increased neuron apoptosis
|
J:188341
|
| increased spinal cord apoptosis
|
J:107735
|
Del(XArmcx5-Nxf3)3Jw/+
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
environmentally induced seizures
|
J:210663
|
Del(XNxf2-Nxf3)1Jw/+
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
audiogenic seizures
|
J:210663
|
| environmentally induced seizures
|
J:210663
|
| sporadic seizures
|
J:210663
|
Dennd2dtm2b(KOMP)Mbp/Dennd2dtm2b(KOMP)Mbp
(C57BL/6N-Dennd2dtm2b(KOMP)Mbp/J)
|
decreased prepulse inhibition
|
J:211773
|
Depdc5tm1c(EUCOMM)Hmgu/Depdc5tm1c(EUCOMM)Hmgu
Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6N * CBA)
|
increased susceptibility to pharmacologically induced seizures
|
J:260943
|
| seizures
|
J:260943
|
| tonic seizures
|
J:260943
|
| tonic-clonic seizures
|
J:260943
|
Dffatm1Mxu/Dffatm1Mxu
(involves: 129S4/SvJae * C57BL/6)
|
decreased susceptibility to neuronal excitotoxicity
|
J:114416
|
Dgcr8Gt(XG058)Byg/Dgcr8+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:198659
|
Dgcr8Gt(XG058)Byg/Dgcr8+
(B6.129P2-Dgcr8Gt(XG058)Byg)
|
abnormal neuronal migration
|
J:201966
|
Dgcr8Gt(XH157)Byg/Dgcr8+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased prepulse inhibition
|
J:136969
|
Dgcr8Gt(XH157)Byg/Dgcr8+
(B6.129P2-Dgcr8Gt(XH157)Byg)
|
enhanced long-term potentiation
|
J:190908
|
DgkbTn(sb-lacZ,GFP)IR3.PV122Jtak/DgkbTn(sb-lacZ,GFP)IR3.PV122Jtak
(involves: C3H * C57BL/6 * DBA/2 * ICR)
|
reduced long-term potentiation
|
J:163104
|
DgkdGt(RRT600)Byg/DgkdGt(RRT600)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
seizures
|
J:126380
|
Dgketm1Ngb/Dgketm1Ngb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
reduced long-term potentiation
|
J:68824
|
| tonic seizures
|
J:68824
|
Dgkgtm1Yash/Dgkgtm1Yash
(involves: C57BL/6NSlc)
|
abnormal nervous system electrophysiology
|
J:288365
|
| absent long-term depression
|
J:288365
|
| increased excitatory postsynaptic current amplitude
|
J:288365
|
Dhcr7tm1Fdp/Dhcr7tm1Fdp
(involves: 129S4/SvJae)
|
abnormal glutamate-mediated receptor currents
|
J:68084
|
Dhfrtm1b(EUCOMM)Wtsi/Dhfr+
(C57BL/6N-Dhfrtm1b(EUCOMM)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Dhrs3tm1Lex/Dhrs3+
(involves: 129S5/SvEvBrd * C57BL/6J)
|
enhanced sensorimotor gating
|
J:171883
|
Dhtkd1tm1Mmgu/Dhtkd1tm1Mmgu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myelination
|
J:288186
|
Dhtkd1tm1Zgwg/Dhtkd1tm1Zgwg
(involves: C57BL/6)
|
abnormal Schwann cell physiology
|
J:267178
|
| decreased nerve conduction velocity
|
J:267178
|
| demyelination
|
J:267178
|
Dhx8em1(IMPC)Mbp/Dhx8+
(C57BL/6NCrl-Dhx8em1(IMPC)Mbp/Mmucd)
|
decreased prepulse inhibition
|
J:211773
|
Dhx15em1(IMPC)Tcp/Dhx15+
(C57BL/6NCrl-Dhx15em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Dhx58em1(IMPC)J/Dhx58em1(IMPC)J
(C57BL/6NJ-Dhx58em1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Diaph1tm1.1Sna/Diaph1tm1.1Sna
Diaph2tm1.2Sna/Y
(B6N.Cg-Diaph1tm1.1Sna Diahp2tm1.2Sna)
|
abnormal neuronal migration
|
J:215740
|
Diaph1tm1.1Sna/Diaph1tm1.1Sna
Diaph2tm1.2Sna/Diaph2tm1.2Sna
(B6N.Cg-Diaph1tm1.1Sna Diahp2tm1.2Sna)
|
abnormal neuronal migration
|
J:215740
|
Dicer1tm1Bdh/Dicer1tm1Bdh
Tg(Pax2-cre)1Akg/0
(involves: 129)
|
intracerebral hemorrhage
|
J:200017
|
Dido1tm3Cmar/Dido1tm3.1Cmar
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6)
|
seizures
|
J:328215
|
Dipk1cem1Yxy/Dipk1cem1Yxy
(C57BL/6-Dipk1cem1Yxy)
|
abnormal excitatory postsynaptic potential
|
J:328853
|
Disc1em1(IMPC)Mbp/Disc1em1(IMPC)Mbp
(C57BL/6N-Disc1em1(IMPC)Mbp/MbpMmucd)
|
increased prepulse inhibition
|
J:211773
|
Disc1Rgsc1390/Disc1+
(B6.Cg-Disc1Rgsc1390)
|
abnormal prepulse inhibition
|
J:120634
|
Disc1Rgsc1390/Disc1Rgsc1390
(B6.Cg-Disc1Rgsc1390)
|
abnormal prepulse inhibition
|
J:120634
|
Disc1Rgsc1390/Disc1Rgsc1393
(B6.Cg-Disc1Rgsc1390/Disc1Rgsc1393)
|
abnormal prepulse inhibition
|
J:120634
|
Disc1Rgsc1393/Disc1Rgsc1393
(B6.Cg-Disc1Rgsc1393)
|
abnormal prepulse inhibition
|
J:120634
|
Disc1tm1(DISC1/DISC1FP1,DISC1FP1/DISC1,DISC1)Xzho/Disc1del
(129S2/SvPasCrl-Disc1del Disc1tm1(DISC1/DISC1FP1,DISC1FP1/DISC1,DISC1)Xzho)
|
increased prepulse inhibition
|
J:214737
|
Disc1tm1Kozo/Disc1tm1Kozo
(B6JJmsSlc.Cg-Disc1tm1Kozo)
|
abnormal long-term potentiation
|
J:177560
|
| abnormal synaptic depression
|
J:177560
|
| decreased prepulse inhibition
|
J:177560
|
| reduced long-term potentiation
|
J:177560
|
Dlatem1(IMPC)J/Dlat+
(C57BL/6NJ-Dlatem1(IMPC)J/J)
|
decreased prepulse inhibition
|
J:211773
|
Dlg1tm1Rlh/Dlg1tm1Rlh
Tg(Mpz-cre)26Mes/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/NTac)
|
hypermyelination
|
J:202688
|
Dlg2tm1Dsb/Dlg2tm1Dsb
(involves: 129/Sv * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:84686
|
| abnormal excitatory postsynaptic currents
|
J:84686
|
| abnormal excitatory postsynaptic potential
|
J:84686
|
Dlg3tm1Grnt/Y
(involves: 129P2/OlaHsd * MF1)
|
abnormal long-term potentiation
|
J:120078
|
Dlg3tm1Grnt/Y
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased excitatory postsynaptic current amplitude
|
J:238576
|
| prolonged excitatory postsynaptic current decay time
|
J:238576
|
Dlg4tm1.1Tdoi/Dlg4tm1.1Tdoi
(B6.Cg-Dlg4tm1.1Tdoi)
|
abnormal synaptic plasticity
|
J:197875
|
| abnormal synaptic transmission
|
J:197875
|
| decreased neurotransmitter release
|
J:197875
|
| enhanced long-term potentiation
|
J:197875
|
| enhanced paired-pulse facilitation
|
J:197875
|
| reduced AMPA-mediated synaptic currents
|
J:197875
|
Dlg4tm1Grnt/Dlg4tm1Grnt
(involves: 129P2/OlaHsd * MF1)
|
abnormal CNS synaptic transmission
|
J:77693
|
| enhanced long-term potentiation
|
J:77693,
J:98903
|
| enhanced paired-pulse facilitation
|
J:77693
|
Dlg4tm1Grnt/Dlg4tm1Grnt
Syngap1tm1Grnt/Syngap1+
(involves: 129P2/OlaHsd * MF1)
|
enhanced long-term potentiation
|
J:98903
|
Dlg4tm1Rlh/Dlg4tm1Rlh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal AMPA-mediated synaptic currents
|
J:118286
|
| abnormal glutamate-mediated receptor currents
|
J:118286
|
| abnormal NMDA-mediated synaptic currents
|
J:118286
|
| enhanced long-term potentiation
|
J:118286
|
Dlg4tm2.1Grnt/Dlg4tm2.1Grnt
(involves: 129P2/OlaHsd)
|
enhanced long-term potentiation
|
J:89778
|
Dlgap2tm1.1Ssfg/Dlgap2tm1.1Ssfg
(B6.129S1-Dlgap2tm1.1Ssfg)
|
abnormal miniature excitatory postsynaptic currents
|
J:263415
|
| abnormal neuron physiology
|
J:263415
|
Dlgap3tm1Gfng/Dlgap3tm1Gfng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:125181
|
| enhanced NMDA-mediated synaptic currents
|
J:125181
|
Dlgap4Gt(XH723)Byg/Dlgap4Gt(XH723)Byg
(B6.129P2-Dlgap4Gt(XH723)Byg)
|
abnormal excitatory postsynaptic currents
|
J:277713
|
| abnormal miniature excitatory postsynaptic currents
|
J:277713
|
| abnormal nervous system electrophysiology
|
J:277713
|
| reduced long-term depression
|
J:277713
|
Dlk2tm1.1Geno/Dlk2tm1.1Geno
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal nervous system physiology
|
J:272796
|
Dlx6os1tm1.1Jhdk/Dlx6os1tm1.1Jhdk
(involves: 129 * C57BL/6 * FVB/N)
|
abnormal inhibitory postsynaptic currents
|
J:152532
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:152532
|
Dmrt3tm1Hgc/Dmrt3tm1Hgc
(Not Specified)
|
abnormal central pattern generator function
|
J:187218
|
Dmrta2tm1.2Fuma/Dmrta2tm1.2Fuma
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj * FVB/N * SJL)
|
abnormal neuronal precursor proliferation
|
J:203109
|
Dmrta2tm1Ejbd/Dmrta2tm1Ejbd
(involves: C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:215514
|
Dmtf1tm1Cjs/Dmtf1tm1Cjs
(involves: 129/Sv * C57BL/6)
|
seizures
|
J:63444
|
Dmxl2tm1c(EUCOMM)Wtsi/Dmxl2+
Tg(Nes-cre)1Atp/0
(involves: C57BL/6N * FVB/N)
|
abnormal hypothalamus secretion
|
J:217623
|
Dnaaf2tm1.1(KOMP)Vlcg/Dnaaf2tm1.1(KOMP)Vlcg
(B6N(Cg)-Dnaaf2tm1.1(KOMP)Vlcg/J)
|
increased neural tube apoptosis
|
J:278736
|
Dnaaf2tm1.1Mkis/Dnaaf2tm1.1Mkis
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal brain ependyma motile cilium physiology
|
J:201474
|
Dnaaf4b2b811.1Clo/Dnaaf4b2b811.1Clo
(C57BL/6J-Dnaaf4b2b811.1Clo)
|
abnormal brain ependyma motile cilium physiology
|
J:205312
|
Dnaaf4tm1.2Jjlo/Dnaaf4tm1.2Jjlo
(involves: 129S1/Sv * 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J)
|
abnormal brain ependyma motile cilium physiology
|
J:205312
|
Dnaaf5em1Slb/Dnaaf5em1Slb
(C57BL/6-Dnaaf5em1Slb)
|
abnormal brain ependyma motile cilium physiology
|
J:342770
|
Dnaaf9tm1b(EUCOMM)Hmgu/Dnaaf9tm1b(EUCOMM)Hmgu
(C57BL/6N-Dnaaf9tm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Dnaaf11tm1.2Hmd/Dnaaf11tm1.2Hmd
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal brain ependyma motile cilium physiology
|
J:258369
|
Dnajc5tm1Sud/Dnajc5tm1Sud
(involves: 129S6/SvEvTac)
|
abnormal endplate potential
|
J:91702
|
| abnormal PNS synaptic transmission
|
J:91702
|
Dnajc6tm1Legr/Dnajc6tm1Legr
(B6.129-Dnajc6tm1Legr)
|
abnormal synaptic vesicle recycling
|
J:158574
|
Dnajc30tm1(KOMP)Vlcg/Dnajc30tm1(KOMP)Vlcg
Tg(Thy1-YFP)HJrs/0
(involves: C57BL/6J * C57BL/6N)
|
abnormal neuron physiology
|
J:266469
|
Dnertm1Hta/Dnertm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal excitatory postsynaptic currents
|
J:106886
|
| decreased excitatory postsynaptic current amplitude
|
J:106886
|
Dnm1Ftfl/Dnm1+
(C57BL/6J-Dnm1Ftfl)
|
abnormal kindling response
|
J:163311
|
| abnormal seizure response to electrical stimulation
|
J:163311
|
| tonic seizures
|
J:163311
|
Dnm1Ftfl/Dnm1+
(FVB.B6-Dnm1Ftfl/Frk)
|
seizures
|
J:235711
|
Dnm1Ftfl/Dnm1Ftfl
(C57BL/6J-Dnm1Ftfl)
|
convulsive seizures
|
J:163311
|
| tonic-clonic seizures
|
J:163311
|
Dnm1Ftfl/Dnm1tm1.2Frk
(involves: 129 * C57BL/6J * FVB)
|
abnormal brain wave pattern
|
J:235711
|
| seizures
|
J:235711
|
Dnm1Ftfl/Dnm1tm2.2Frk
(involves: 129 * C57BL/6J * FVB)
|
seizures
|
J:235711
|
Dnm1tm1Pdc/Dnm1tm1Pdc
(involves: 129X1/SvJ * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:121111
|
| abnormal inhibitory postsynaptic currents
|
J:121111
|
| abnormal miniature excitatory postsynaptic currents
|
J:121111
|
| abnormal synaptic vesicle recycling
|
J:121111
|
Dnm1tm1Pdc/Dnm1tm1Pdc
Dnm3tm1.2Pdc/Dnm3tm1.2Pdc
(involves: 129S1/Sv * C57BL/6 * FVB/N)
|
abnormal miniature excitatory postsynaptic currents
|
J:175247
|
| abnormal synaptic vesicle recycling
|
J:175247
|
| decreased excitatory postsynaptic current amplitude
|
J:175247
|
Dnm1lem1Hise/Dnm1lem1Hise
(involves: C57BL/6J * SJL/J)
|
enhanced sensorimotor gating
|
J:291773
|
| increased prepulse inhibition
|
J:291773
|
Dnm1ltm1.1Miha/Dnm1ltm1.1Miha
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased neuron apoptosis
|
J:158142
|
Dnm1ltm1.2Miha/Dnm1ltm1.2Miha
(involves: C57BL/6J)
|
increased brain apoptosis
|
J:158142
|
Dnm2tm1Ueli/Dnm2tm2.1Ics
Tg(Mpz-cre)26Mes/0
(involves: C57BL/6J * C57BL/6N * FVB/NTac)
|
abnormal action potential
|
J:288372
|
| decreased nerve conduction velocity
|
J:288372
|
| demyelination
|
J:288372
|
Dnm2tm2.1Ics/Dnm2+
(involves: C57BL/6J)
|
abnormal action potential
|
J:288372
|
Dnmbpem1(IMPC)Mbp/Dnmbpem1(IMPC)Mbp
(C57BL/6N-Dnmbpem1(IMPC)Mbp/Ucd)
|
increased prepulse inhibition
|
J:211773
|
Dnmt1em2Jiemw/Dnmt1+
(C57BL/6-Dnmt1em2Jiemw)
|
decreased neuronal stem cell self-renewal
|
J:310870
|
| increased neuron apoptosis
|
J:310870
|
Dnmt3atm1b(KOMP)Wtsi/Dnmt3a+
(C57BL/6N-Dnmt3atm1b(KOMP)Wtsi/J)
|
convulsive seizures
|
J:211773
|
Doc2atm1Ytk/Doc2atm1Ytk
(involves: 129P2/OlaHsd * C57BL/6J)
|
reduced long-term potentiation
|
J:89423
|
Doc2atm1Ytk/Doc2atm1Ytk
Doc2btm1Aljg/Doc2btm1Aljg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:158605
|
| decreased neurotransmitter release
|
J:158605
|
Doc2btm1Aljg/Doc2btm1Aljg
(B6.129P2-Doc2btm1Aljg)
|
abnormal CNS synaptic transmission
|
J:158605
|
| abnormal inhibitory postsynaptic currents
|
J:158605
|
Dock3tm1Dasc/Dock3tm1Dasc
(B6.Cg-Dock3tm1Dasc)
|
abnormal axonal transport
|
J:144341
|
| abnormal microglial cell physiology
|
J:144341
|
Dock8pri/Dock8pri
(involves: C57BL/6JAnu)
|
abnormal myelination
|
J:238772
|
Dock10tm1Thar/Dock10tm1Thar
(involves: C57BL/6)
|
abnormal astrocyte physiology
|
J:300632
|
| abnormal microglial cell chemotaxis
|
J:300632
|
Dp(4D4Mit190-D4Mit51)1Aam/0
(involves: 129S7/SvEvBrd)
|
increased neural tube apoptosis
|
J:121726
|
Dp(7Herc2-Mkrn3)1Taku/0
(B6J.129S7-Dp(7Herc2-Mkrn3)1Taku)
|
abnormal long-term depression
|
J:225285
|
Dp(10Prmt2-Pdxk)2Yey/0
Dp(16Lipi-Zbtb21)1Yey/0
Dp(17Abcg1-Rrp1b)3Yey/0
(B6.129S7-Dp(10Prmt2-Pdxk)2Yey Dp(16Lipi-Zbtb21)1Yey Dp(17Abcg1-Rrp1b)3Yey)
|
reduced long-term potentiation
|
J:161325
|
Dp(16Cbr1-Fam3b)1Rhr/0
(B6.129S6-Dp(16Cbr1-Fam3b)1Rhr)
|
abnormal brain ependyma motile cilium physiology
|
J:241597
|
Dp(16Cbr1-Fam3b)1Rhr/0
(involves: 129S6/SvEvTac * C3H/HeSnJ * C57BL/6Ei)
|
reduced long-term potentiation
|
J:148478
|
Dp(16Cbr1-Fam3b)1Rhr/0
Pcp4tm1.1Kzy/Pcp4+
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal brain ependyma motile cilium physiology
|
J:241597
|
Dp(16Lipi-Zbtb21)1Yey/0
(B6.129S7-Dp(16Lipi-Zbtb21)1Yey)
|
reduced long-term potentiation
|
J:224899
|
Dp(16Lipi-Zbtb21)1Yey/0
(B6.129S7-Dp(16Lipi-Zbtb21)1Yey/J)
|
abnormal CNS synaptic transmission
|
J:351206
|
| abnormal excitatory postsynaptic potential
|
J:351206
|
| abnormal inhibitory postsynaptic currents
|
J:351206
|
| decreased excitatory postsynaptic current frequency
|
J:351206
|
| reduced long-term potentiation
|
J:351206
|
Dp(16Lipi-Zbtb21)1Yey/Zbtb21em1Jhan
(B6.Cg-Dp(16Lipi-Zbtb21)1Yey Zbtb21em1Jhan)
|
abnormal inhibitory postsynaptic currents
|
J:351206
|
Dp(17Abcg1-Cbs)1Yah/0
(B6.129P2-Dp(17Abcg1-Cbs1)1Yah)
|
enhanced long-term potentiation
|
J:154298
|
Dp(XTceal3-Plp1)1Gmh/Y
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal myelination
|
J:199809
|
| demyelination
|
J:199809
|
Dpf3em1(IMPC)J/Dpf3em1(IMPC)J
(C57BL/6NJ-Dpf3em1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Dph3tm1Lepp/Dph3tm1Lepp
(involves: 129S1/Sv * C57BL/6)
|
increased neural tube apoptosis
|
J:109066
|
Dpmy/Dpmy+
(B6NJ;CBA-Dpmy/GrsrJ)
|
demyelination
|
J:226382
|
Dpp6tm1.1Dahn/Dpp6tm1.1Dahn
(involves: C57BL/6)
|
abnormal afterhyperpolarization
|
J:178547
|
| abnormal channel response
|
J:178547
|
| abnormal long-term potentiation
|
J:178547
|
| abnormal synaptic transmission
|
J:178547
|
Dpysl3Gt(IST14728H3)Tigm/Dpysl3Gt(IST14728H3)Tigm
(C57BL/6-Dpysl3Gt(IST14728H3)Tigm)
|
abnormal axonal transport
|
J:223415
|
Dpysl4tm1Ttq/Dpysl4tm1Ttq
(involves: 129)
|
impaired synaptic plasticity
|
J:134800
|
| reduced long-term potentiation
|
J:134800
|
Dpysl5tm1Gosh/Dpysl5tm1Gosh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neuron physiology
|
J:168982
|
| absent long-term depression
|
J:168982
|
Drd1tm1Jcd/Drd1tm1Jcd
(involves: 129S4/SvJae)
|
abnormal neuronal migration
|
J:121219
|
Drd1tm1Jcd/Drd1tm1Jcd
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
abnormal hypothalamus physiology
|
J:91781
|
Drd1tm1Tono/Drd1tm1Tono
(B6.129S-Drd1tm1Tono)
|
abnormal synaptic plasticity
|
J:143054
|
Drd1tm2.1Stl/Drd1tm2.1Stl
Drd5tm1.1Stl/Drd5tm1.1Stl
Tg(Camk2a-cre)T29-1Stl/0
(involves: BALB/c * C57BL * C57BL/6)
|
abnormal long-term potentiation
|
J:211355
|
Drd1tm2Jcd/Drd1+
Tg(Camk2a-cre)2Gsc/0
(involves: 129S4/SvJae * FVB/N)
|
abnormal brain wave pattern
|
J:120070
|
| abnormal microglial cell physiology
|
J:120070
|
| abnormal nervous system physiology
|
J:120070
|
| seizures
|
J:120070
|
Drd1tm2Jcd/Drd1+
Tg(EIIa-cre)C5379Lmgd/0
(involves: 129S4/SvJae * BALB/c * CD-1 * FVB/N)
|
abnormal nervous system physiology
|
J:120582
|
| myoclonus
|
J:120582
|
Drd2tm1.1Mrub/Drd2tm1.1Mrub
Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(B6.Cg-Drd2tm1.1Mrub Slc6a3tm1.1(cre)Bkmn)
|
abnormal inhibitory postsynaptic currents
|
J:176167
|
| abnormal single cell response
|
J:176167
|
| abnormal synaptic dopamine release
|
J:176167
|
Drd2tm1Ebo/Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6)
|
abnormal neuron physiology
|
J:65767
|
| abnormal pituitary gland physiology
|
J:110599
|
| increased susceptibility to neuronal excitotoxicity
|
J:65767
|
| increased susceptibility to pharmacologically induced seizures
|
J:65767
|
Drd2tm1Ebo/Drd2tm1Ebo
(B6.129S2-Drd2tm1Ebo)
|
increased susceptibility to neuronal excitotoxicity
|
J:65767
|
Drd2tm1Low/Drd2tm1Low
(B6.129S2-Drd2tm1Low)
|
abnormal CNS synaptic transmission
|
J:127071
|
| abnormal excitatory postsynaptic currents
|
J:127071
|
| abnormal prepulse inhibition
|
J:55027
|
| absent long-term depression
|
J:127071
|
Drd2tm1Low/Drd2tm1Low
(B6.129S2-Drd2tm1Low/J)
|
abnormal astrocyte physiology
|
J:194407
|
| abnormal neuronal migration
|
J:121219
|
| increased susceptibility to dopaminergic neuron neurotoxicity
|
J:194407
|
Drd2tm1Mok/Drd2tm1Mok
(involves: 129S/SvEv * C57BL/6J * DBA/2J)
|
abnormal single cell response
|
J:97838
|
Drd2tm1Mok/Drd2tm1Mok
(involves: 129S/SvEv)
|
abnormal single cell response
|
J:97412
|
Drd2tm1Smoc/Drd2tm1Smoc
Tg(GFAP-cre)25Mes/0
(involves: C57BL/6 * FVB/N)
|
abnormal astrocyte physiology
|
J:194407
|
Drd2tm3.1Ebo/Drd2tm3.1Ebo
En1tm2(cre)Wrst/En1+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:185643
|
Drd2tm3.1Ebo/Drd2tm3.1Ebo
Tg(Drd1a-cre)AGsc/0
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
abnormal nervous system electrophysiology
|
J:185643
|
Drd4tm1(IL2RA)Tao/Drd4tm1(IL2RA)Tao
(involves: C57BL/6J)
|
abnormal single cell response
|
J:97412
|
Drd5tm1Sib/Drd5tm1Sib
(involves: 129S4/SvJae * C57BL/6)
|
abnormal sympathetic nervous system physiology
|
J:95908
|
Drg2tm1Jgwp/Drg2tm1Jgwp
(B6.129-Drg2tm1Jgwp)
|
abnormal synaptic dopamine release
|
J:291077
|
Drp2tm1.1Brp/Y
Cnptm1(cre)Kan/Cnp+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
hypermyelination
|
J:185953
|
Dscamdel17/Dscamdel17
(involves: BALB/cByJ * C57BL/6J)
|
seizures
|
J:129238
|
Dscamtm1.1Kzy/Dscam+
(B6.129P2-Dscamtm1.1Kzy)
|
abnormal central pattern generator function
|
J:146754
|
| abnormal somatic nervous system physiology
|
J:146754
|
Dscamtm1.1Kzy/Dscamtm1.1Kzy
(B6.129P2-Dscamtm1.1Kzy)
|
abnormal central pattern generator function
|
J:146754
|
| abnormal somatic nervous system physiology
|
J:146754
|
Dscamtm1.1Kzy/Dscamtm1.1Kzy
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal somatic nervous system physiology
|
J:146754
|
Dscaml1Gt(CC0772)Wtsi/Dscaml1Gt(CC0772)Wtsi
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal excitatory postsynaptic currents
|
J:155397
|
Dsptm1Efu/Dsptm1Efu
Mnx1tm4(cre)Tmj/Mnx1+
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
decreased nerve conduction velocity
|
J:219630
|
| delayed peripheral nervous system regeneration
|
J:219630
|
| impaired ability to fire action potentials
|
J:219630
|
Dstdt-27J/Dst+
(B10.PL/(73NS)Sn-Dstdt-27J/J)
|
abnormal myelination
|
J:48174
|
Dstdt-27J/Dstdt-27J
(B10.PL/(73NS)Sn-Dstdt-27J/J)
|
abnormal axonal transport
|
J:91505
|
| abnormal myelination
|
J:48174
|
| abnormal nervous system physiology
|
J:91505
|
| demyelination
|
J:91505,
J:48174,
J:91495
|
Dstdt-33J/Dstdt-33J
(129S1/Sv)
|
seizures
|
J:61053
|
Dstdt-37J/Dstdt-37J
(C57BL/6J-Dstdt-37J/J)
|
demyelination
|
J:82238
|
Dstdt/Dstdt
(involves: C57BL/6 * Q)
|
demyelination
|
J:6491
|
DstGt(E182H05)Wrst/DstGt(E182H05)Wrst
(B6NCrj.129P2-DstGt(E182H05)Wrst)
|
abnormal neuron physiology
|
J:228781
|
| demyelination
|
J:228781
|
DstTg4/Dst+
(involves: CD-1)
|
abnormal myelination
|
J:48174
|
DstTg4/DstTg4
(involves: CD-1)
|
abnormal myelination
|
J:17844,
J:48174
|
| abnormal nervous system physiology
|
J:48174
|
Dtnbp1sdy/Dtnbp1sdy
(B6J.D2-Dtnbp1sdy)
|
decreased prepulse inhibition
|
J:223954
|
Dtx1em1(IMPC)H/Dtx1em1(IMPC)H
(C57BL/6N-Dtx1em1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Duox2em1(IMPC)Mbp/Duox2em1(IMPC)Mbp
(C57BL/6N-Duox2em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Dusp1tm1Brv/Dusp1tm1Brv
(B6.129S2-Dusp1tm1Brv)
|
increased neuron apoptosis
|
J:163234
|
Dusp16em1(IMPC)Tcp/Dusp16em1(IMPC)Tcp
(C57BL/6NCrl-Dusp16em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Dvl1tm1Awb/Dvl1tm1Awb
(involves: 129S6/SvEvTac)
|
decreased prepulse inhibition
|
J:42758
|
| reduced sensorimotor gating
|
J:42758
|
Dymem1(IMPC)Tcp/Dymem1(IMPC)Tcp
(C57BL/6N-Dymem1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Dync1h1Loa/Dync1h1Loa
(C3H/HeH-Dync1h1Loa)
|
abnormal axonal transport
|
J:83128
|
Dync1h1tm1.1Ics/Dync1h1+
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal neuronal migration
|
J:334549
|
| increased neuron apoptosis
|
J:334549
|
Dync1li1m1Emcf/Dync1li1m1Emcf
(involves: BALB/cAnNCrl * C3H/HeH * C57BL/6)
|
abnormal action potential
|
J:171267
|
| abnormal neuronal migration
|
J:171267
|
Dynlrb1tm1c(EUCOMM)Wtsi/Dynlrb1tm1c(EUCOMM)Wtsi
(involves: 129S4/SvJaeSor * C57BL/6N)
|
abnormal axonal transport
|
J:292124
|
Dyrk1aem1Kzy/Dyrk1a+
(C57BL/6J-Dyrk1aem1Kzy)
|
environmentally induced seizures
|
J:259596
|
Dyrk1btm1b(EUCOMM)Wtsi/Dyrk1b+
(C57BL/6N-Dyrk1btm1b(EUCOMM)Wtsi/Ics)
|
increased prepulse inhibition
|
J:211773
|
E2f5tm1Dli/E2f5tm1Dli
(either: (involves: 129S1/Sv * BALB/c) or (involves: 129S1/Sv * C57BL/6))
|
intracerebral hemorrhage
|
J:47283
|
| intraventricular hemorrhage
|
J:47283
|
Eae2bC57BL/10SnSg/Eae2bC57BL/10SnSg
(involves: B10.RIII * RIIIS/J)
|
CNS inflammation
|
J:96204
|
Eae7B10.S/DvTe/Eae7B10.S/DvTe
(involves: B10.S/DvTe * SJL/J)
|
brain inflammation
|
J:49054
|
Eae7B10.S/DvTe/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J)
|
brain inflammation
|
J:49054
|
Eae7SJL/J/Eae7SJL/J
(involves: B10.S/DvTe * SJL/J)
|
brain inflammation
|
J:49054
|
Eae14C57BL/10/?
(involves: B10.S/DvTe * SJL/J)
|
demyelination
|
J:69083
|
Eae19SJL/J/?
(involves: B10.S/DvTe * SJL/J)
|
demyelination
|
J:67840
|
Eae20SJL/J/?
(involves: B10.S/DvTe * SJL/J)
|
demyelination
|
J:67840
|
Eae27C57BL/10SnSg/Eae27RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
CNS inflammation
|
J:96204
|
Eae27RIIIS/J/Eae27RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
CNS inflammation
|
J:96204
|
Eae30SJL/J/?
(involves: B10.S * SJL/J)
|
abnormal nerve conduction
|
J:99793
|
Eae31C57BL/10SnSg/Eae31SJL/J
(involves: B10.S * SJL/J)
|
abnormal nerve conduction
|
J:99793
|
Eae31SJL/J/Eae31SJL/J
(involves: B10.S * SJL/J)
|
abnormal nerve conduction
|
J:99793
|
Eae32C57BL/10SnSg/Eae32C57BL/10SnSg
(involves: B10.S * SJL/J)
|
abnormal nerve conduction
|
J:99793
|
Eae32C57BL/10SnSg/Eae32SJL/J
(involves: B10.S * SJL/J)
|
abnormal nerve conduction
|
J:99793
|
Eae39C57BL/10SnSg/Eae39RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
CNS inflammation
|
J:96204
|
Eae39RIIIS/J/Eae39RIIIS/J
(involves: B10.RIII * RIIIS/J)
|
CNS inflammation
|
J:96204
|
Eae41C57BL/10SnSg/Eae41C57BL/10SnSg
(involves: B10.RIII * RIIIS/J)
|
CNS inflammation
|
J:96204
|
Eae44aB10.S/DvTe/Eae44aSJL/J
(involves: B10.S/DvTe * SJL/J)
|
brain inflammation
|
J:49054
|
Eae44aSJL/J/Eae44aSJL/J
(involves: B10.S/DvTe * SJL/J)
|
brain inflammation
|
J:49054
|
Ebf1em1(IMPC)Mbp/Ebf1+
(C57BL/6N-Ebf1em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Ebf2tm1Ggc/Ebf2tm1Ggc
(either: (involves: 129S2/SvPas * 129X1/SvJ) or (involves: 129S2/SvPas * C57BL/6J))
|
abnormal hypothalamus secretion
|
J:80220
|
| decreased nerve conduction velocity
|
J:80220
|
Ebi3Gt716Lex/Ebi3Gt716Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
brain inflammation
|
J:286951
|
Ecpasem1Plch/Ecpasem1Plch
(C57BL/6-Ecpasem1Plch)
|
abnormal GABA-mediated receptor currents
|
J:282974
|
| abnormal GABAergic neuron physiology
|
J:282974
|
| increased susceptibility to pharmacologically induced seizures
|
J:282974
|
Ecrg4tm1.1Toko/Ecrg4tm1.1Toko
(involves: C57BL/6)
|
increased neuronal stem cell self-renewal
|
J:272555
|
Edartm1b(KOMP)Wtsi/Edar+
(C57BL/6N-Edartm1b(KOMP)Wtsi/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Edaraddcr/Edaraddcr
(involves: C57BL/6 * C3H)
|
abnormal myelination
|
J:5680
|
| demyelination
|
J:5680
|
Edaraddcr/Edaraddcr
(B6C3Fe a/a-Edaraddcr/J)
|
demyelination
|
J:5870
|
Edil3Tg(Sox2-cre)1Amc/Edil3+
Tgif1tm1Caw/Tgif1tm1Caw
Tgif2tm1Dwot/Tgif2tm1Dwot
(involves: 129S/SvEv * C57BL/6 * C57BL/6J * CBA)
|
decreased embryonic neuroepithelial cell proliferation
|
J:183402
|
Edil3Tg(Sox2-cre)1Amc/Edil3+
Wnt7atm1Amc/Wnt7atm1Amc
Wnt7btm1Parr/Wnt7btm2Amc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal blood-brain barrier function
|
J:142352
|
| intracranial hemorrhage
|
J:142352
|
| spinal hemorrhage
|
J:142352
|
Edn1tm1Utj/Edn1+
(involves: 129X1/SvJ * ICR)
|
abnormal sympathetic nervous system physiology
|
J:60070
|
Ednram1Mhda/Ednra+
(C3HeB/FeJ-Ednram1Mhda)
|
decreased prepulse inhibition
|
J:237903
|
Ednram1Mhda/Ednram1Mhda
(C3HeB/FeJ-Ednram1Mhda)
|
decreased prepulse inhibition
|
J:237903
|
Eef1a2em1Abb/Eef1a2em1Abb
(C57BL/6JCrl-Eef1a2em1Abb)
|
sporadic seizures
|
J:296080
|
Eef1a2wst/Eef1a2wst
(B6C3Fe a/a-Eef1a2wst/J)
|
demyelination
|
J:6766
|
Eef1a2wst/Eef1a2wst
(involves: HRS/J)
|
abnormal endplate potential
|
J:104855
|
| abnormal neurotransmitter uptake
|
J:104855
|
| decreased neurotransmitter release
|
J:104855
|
Eef1dtm1.2Mkma/Eef1dtm1.2Mkma
(B6J.B6N(Cg)-Eef1dtm1.2Mkma)
|
audiogenic seizures
|
J:288930
|
| tonic-clonic seizures
|
J:288930
|
Eef2ktm1.1Cgpd/Eef2ktm1.1Cgpd
(involves: C57BL/6)
|
abnormal neuron physiology
|
J:224411
|
Efhc1tm1Kzy/Efhc1+
(B6.129P2-Efhc1tm1Kzy)
|
increased susceptibility to pharmacologically induced seizures
|
J:145858
|
| myoclonus
|
J:145858
|
Efhc1tm1Kzy/Efhc1tm1Kzy
(B6.129P2-Efhc1tm1Kzy)
|
abnormal brain ependyma motile cilium physiology
|
J:145858
|
| increased susceptibility to pharmacologically induced seizures
|
J:145858
|
| myoclonus
|
J:145858
|
Efhd1em1Wei/Efhd1em1Wei
(Not Specified)
|
abnormal sensory neuron physiology
|
J:305107
|
| increased neuron apoptosis
|
J:305107
|
Efhd2tm1(KOMP)Vlcg/Efhd2tm1(KOMP)Vlcg
(C57BL/6-Efhd2tm1(KOMP)Vlcg)
|
abnormal axonal transport
|
J:223142
|
Efna2tm1Jgf/Efna2tm1Jgf
Efna3tm1Rax/Efna3tm1Rax
(involves: 129S6/SvEvTac * C57BL/6 * Swiss Webster)
|
abnormal sensorimotor gating
|
J:216970
|
| increased prepulse inhibition
|
J:216970
|
Efna3tm1.1Ebp/Efna3tm1.1Ebp
(involves: C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:154648
|
| abnormal glutamate-mediated receptor currents
|
J:154648
|
| reduced long-term potentiation
|
J:154648
|
Efna5tm1Wrst/Efna5tm1Wrst
(Not Specified)
|
abnormal neuronal migration
|
J:79997
|
Efnb2tm4Kln/Efnb2tm4Kln
Tg(Camk2a-cre)159Kln/0
(involves: 129P2/OlaHsd * C57BL/6)
|
reduced long-term potentiation
|
J:87398
|
Efnb2tm4Kln/Efnb2tm4Kln
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal long-term depression
|
J:87398
|
Efnb3tm1Nwg/Efnb3tm1Nwg
(involves: 129 * C57BL/6)
|
abnormal long-term depression
|
J:87398
|
| reduced long-term potentiation
|
J:87398
|
Efnb3tm1Nwg/Efnb3tm1Nwg
(involves: C57BL/6)
|
abnormal central pattern generator function
|
J:82479
|
Efr3atm1Bgsn/Efr3atm1Bgsn
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6J * SJL)
|
decreased neuron apoptosis
|
J:273433
|
Efr3bem1(IMPC)Mbp/Efr3bem1(IMPC)Mbp
(C57BL/6N-Efr3bem1(IMPC)Mbp/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Efr3btm1Gpt/Efr3btm1Gpt
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
abnormal nervous system electrophysiology
|
J:344437
|
| impaired ability to fire action potentials
|
J:344437
|
Egln3tm1Pjr/Egln3tm1Pjr
(involves: 129S/SvEv * Swiss)
|
abnormal neuron physiology
|
J:136034
|
| decreased neuron apoptosis
|
J:136034
|
Egln3tm1Pjr/Egln3tm1Pjr
Epas1tm1Pec/Epas1+
(involves: 129S/SvEv * Swiss)
|
abnormal neuron physiology
|
J:136034
|
Egln3tm1Pjr/Egln3tm1Pjr
Hif1atm1Pec/Hif1a+
(involves: 129S/SvEv * Swiss)
|
abnormal neuron physiology
|
J:136034
|
Egr1tm1Jmi/Egr1tm1Jmi
(involves: 129 * C57BL/6)
|
abnormal microglial cell physiology
|
J:135238
|
| decreased cerebral infarct size
|
J:135238
|
Egr1tm1Pch/Egr1tm1Pch
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal pituitary secretion
|
J:45064
|
Egr2tm1.1Jchn/Egr2tm1Pch
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal neuronal migration
|
J:82071
|
Egr2tm1Jmi/Egr2tm1Jmi
(Not Specified)
|
abnormal myelination
|
J:96641,
J:99824
|
| increased Schwann cell proliferation
|
J:96641
|
Egr2tm2(cre)Pch/?
Mnat1tm2Tpm/Mnat1tm2.1Tpm
(involves: 129S2/SvPas)
|
demyelination
|
J:120170
|
Egr2tm2(cre)Pch/Egr2+
Erbb2tm1Cbm/Erbb2tm2Cbm
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal myelination
|
J:75421
|
Egr2tm2(cre)Pch/Egr2+
Erbb2tm2Cbm/Erbb2tm2Cbm
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
demyelination
|
J:199150
|
Egr2tm2(cre)Pch/Egr2+
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/?
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myelination
|
J:207470
|
Egr2tm2(cre)Pch/Egr2+
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/?
Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal myelination
|
J:207470
|
Egr2tm2(cre)Pch/Egr2+
Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky/?
(involves: 129S2/SvPas * C57BL/6)
|
abnormal nerve conduction
|
J:207470
|
| hypermyelination
|
J:207470
|
| increased nerve conduction velocity
|
J:207470
|
Egr2tm2(cre)Pch/Egr2+
Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky/?
Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
hypermyelination
|
J:207470
|
Egr2tm2(cre)Pch/Egr2+
Phox2btm4Jbr/Phox2b+
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal autonomic nervous system physiology
|
J:176573
|
Egr2tm2(cre)Pch/Egr2+
Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL)
|
abnormal myelination
|
J:207470,
J:153219
|
| decreased nerve conduction velocity
|
J:153219
|
Egr2tm2Jmi/Egr2tm2Jmi
(B6.Cg-Egr2tm2Jmi)
|
abnormal myelination
|
J:145949
|
| decreased nerve conduction velocity
|
J:145949
|
Egr2tm4Pch/Egr2tm4Pch
(involves: BALB/c * C57BL/6)
|
abnormal myelination
|
J:137156
|
| increased Schwann cell proliferation
|
J:137156
|
Egr3tm1(cre)Mod/Egr3tm1(cre)Mod
Ntf3tm2Jae/Ntf3tm2Jae
(involves: 129S1/Sv * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:147957
|
Egr3tm1Jmi/Egr3tm1Jmi
(Not Specified)
|
abnormal excitatory postsynaptic potential
|
J:76256
|
| abnormal nervous system physiology
|
J:76256
|
| abnormal somatic nervous system physiology
|
J:76256
|
Ehmt1tm1Yshk/Ehmt1+
(involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal miniature excitatory postsynaptic currents
|
J:192316
|
| enhanced paired-pulse facilitation
|
J:192316
|
| impaired synaptic plasticity
|
J:192316
|
Ehmt2tm1.1Tara/Ehmt2tm1.1Tara
Tg(Drd2-cre)ER44Gsat/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal neuron physiology
|
J:155739
|
Ei24tm1Hzha/Ei24tm1Hzha
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
increased neuron apoptosis
|
J:193420
|
Eid1em1Gpt/Eid1em1Gpt
(C57BL/6JGpt-Eid1em1Gpt/Gpt)
|
decreased neuronal stem cell self-renewal
|
J:291224
|
Eif2aem1(IMPC)Mbp/Eif2aem1(IMPC)Mbp
(C57BL/6N-Eif2aem1(IMPC)Mbp/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Eif2ak3tm1Dron/Eif2ak3+
Tg(GFAP-tTA)110Pop/0
Tg(tetO-Ifng)184Pop/0
(involves: 129S6/SvEvTac * C57BL/6 * DBA/2 * Swiss Webster)
|
abnormal myelination
|
J:99655
|
| abnormal oligodendrocyte apoptosis
|
J:99655
|
| increased spinal cord apoptosis
|
J:99655
|
| tonic seizures
|
J:99655
|
Eif2ak4tm1.2Dron/Eif2ak4tm1.2Dron
(129S6/SvEvTac-Eif2ak4tm1.2Dron)
|
abnormal long-term potentiation
|
J:100646
|
Eif2b4tm1.1Vdk/Eif2b4+
Eif2b5tm1.1Vdk/Eif2b5tm1.1Vdk
(involves: C57BL/6 * C57BL/6J)
|
abnormal myelination
|
J:234659
|
| sporadic seizures
|
J:234659
|
Eif2b4tm1.1Vdk/Eif2b4tm1.1Vdk
(involves: C57BL/6 * C57BL/6J)
|
sporadic seizures
|
J:234659
|
Eif2b4tm1.1Vdk/Eif2b4tm1.1Vdk
Eif2b5tm1.1Vdk/Eif2b5+
(involves: C57BL/6 * C57BL/6J)
|
abnormal myelination
|
J:234659
|
| sporadic seizures
|
J:234659
|
Eif2b4tm1.1Vdk/Eif2b4tm1.1Vdk
Eif2b5tm1.1Vdk/Eif2b5tm1.1Vdk
(involves: C57BL/6 * C57BL/6J)
|
abnormal myelination
|
J:234659
|
| sporadic seizures
|
J:234659
|
Eif2b5tm1.1Sidr/Eif2b5tm1.1Sidr
(B6(Cg)-Eif2b5tm1.1Sidr)
|
abnormal nervous system physiology
|
J:278928
|
| demyelination
|
J:278928
|
Eif2b5tm1.1Vdk/Eif2b5tm1.1Vdk
(involves: C57BL/6 * C57BL/6J)
|
abnormal myelination
|
J:234659
|
| sporadic seizures
|
J:234659
|
Eif2b5tm1Itl/Eif2b5tm1Itl
(involves: 129S/SvEv * C57BL * Swiss Webster)
|
demyelination
|
J:179801
|
Eif2b5tm1Itl/Eif2b5tm1Itl
(involves: 129S/SvEv)
|
abnormal astrocyte physiology
|
J:192103
|
| abnormal microglial cell physiology
|
J:192103
|
Eif2b5tm2.1Sidr/Eif2b5tm2.1Sidr
(B6(Cg)-Eif2b5tm2.1Sidr)
|
abnormal nervous system physiology
|
J:278928
|
Eif2s1em1(IMPC)Mbp/Eif2s1+
(C57BL/6NCrl-Eif2s1em1(IMPC)Mbp/Mmucd)
|
decreased prepulse inhibition
|
J:211773
|
Eif4ebp2tm1Klan/Eif4ebp2tm1Klan
(B6.129S4(C)-Eif4ebp2tm1Klan)
|
abnormal CNS synaptic transmission
|
J:194221
|
| abnormal inhibitory postsynaptic currents
|
J:194221
|
| abnormal long-term potentiation
|
J:102163
|
| abnormal miniature excitatory postsynaptic currents
|
J:194221
|
| increased excitatory postsynaptic current amplitude
|
J:194221
|
| increased miniature excitatory postsynaptic current amplitude
|
J:194221
|
| increased miniature excitatory postsynaptic current frequency
|
J:194221
|
| increased miniature inhibitory postsynaptic current amplitude
|
J:194221
|
Eif4g1em1Bjbl/Eif4g1em1Bjbl
(C57BL/6J-Eif4g1em1Bjbl)
|
enhanced long-term potentiation
|
J:287743
|
| increased miniature inhibitory postsynaptic current amplitude
|
J:287743
|
El1EL/?
(involves: DBA/2J * EL)
|
seizures
|
J:11381
|
El1EL/?
(involves: ABP/LeJ * EL)
|
seizures
|
J:11381
|
El2EL/?
(involves: ABP/LeJ * EL)
|
seizures
|
J:11381
|
El2EL/El2EL
(involves: ABP/LeJ * EL/Suz)
|
seizures
|
J:114157
|
El3EL/SuzSeyFrkJ/El3ABP/LeJ
(involves: ABP/LeJ * EL/Suz)
|
seizures
|
J:30433
|
El3EL/SuzSeyFrkJ/El3EL/SuzSeyFrkJ
(involves: ABP/LeJ * EL/Suz)
|
seizures
|
J:30433
|
El4EL/SuzSeyFrkJ/El4EL/SuzSeyFrkJ
(involves: DDY/Jcl * EL/Suz)
|
seizures
|
J:30433
|
El4EL/SuzSeyFrkJ/El4EL/SuzSeyFrkJ
(involves: ABP/LeJ * EL/Suz)
|
seizures
|
J:114157,
J:30433
|
El5DDY/Jcl/El5EL/SuzSeyFrkJ
(involves: DDY/Jcl * EL/Suz)
|
seizures
|
J:30433
|
El5EL/SuzSeyFrkJ/El5EL/SuzSeyFrkJ
(involves: DDY/Jcl * EL/Suz)
|
seizures
|
J:30433
|
El6DDY/Jcl/El6DDY/Jcl
(involves: DDY/Jcl * EL/Suz)
|
seizures
|
J:30433
|
Elavl3tm1.1Rbd/Elavl3+
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1))
|
abnormal brain wave pattern
|
J:188326
|
| abnormal spike wave discharge
|
J:188326
|
Elavl3tm1.1Rbd/Elavl3tm1.1Rbd
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1))
|
abnormal brain wave pattern
|
J:188326
|
| abnormal spike wave discharge
|
J:188326
|
| nonconvulsive seizures
|
J:188326
|
Elavl4tm1Okn/Elavl4tm1Okn
(Not Specified)
|
increased neuron apoptosis
|
J:97282
|
Elfn1tm1(KOMP)Vlcg/Elfn1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
seizures
|
J:209758
|
Elfn1tm1.1Jaru/Elfn1tm1.1Jaru
(involves: C57BL/6)
|
abnormal brain wave pattern
|
J:226212
|
| abnormal excitatory postsynaptic currents
|
J:226212
|
| environmentally induced seizures
|
J:226212
|
| impaired synaptic plasticity
|
J:226212
|
| increased susceptibility to pharmacologically induced seizures
|
J:226212
|
| increased synaptic depression
|
J:226212
|
| reduced long-term potentiation
|
J:226212
|
Elfn2tm1(KOMP)Vlcg/Elfn2tm1(KOMP)Vlcg
(C57BL/6NTac-Elfn2tm1(KOMP)Vlcg)
|
abnormal CNS synaptic transmission
|
J:286127
|
| abnormal excitatory postsynaptic potential
|
J:286127
|
| audiogenic seizures
|
J:286127
|
| increased susceptibility to pharmacologically induced seizures
|
J:286127
|
Elmod1tm1a(EUCOMM)Hmgu/Elmod1tm1a(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1a(EUCOMM)Hmgu/H)
|
decreased prepulse inhibition
|
J:165965
|
Elmod1tm1b(EUCOMM)Hmgu/Elmod1tm1b(EUCOMM)Hmgu
(C57BL/6N-Elmod1tm1b(EUCOMM)Hmgu/H)
|
decreased prepulse inhibition
|
J:211773
|
ElnvEL/SuzSeyFrkJ/ElnvEL/SuzSeyFrkJ
(involves: ABP/LeJ * EL/Suz)
|
seizures
|
J:114157
|
Elovl4tm1Wked/Elovl4tm1Wked
(involves: 129S/SvEv * 129S1/Sv)
|
abnormal synaptic vesicle exocytosis
|
J:277065
|
Elovl4tm1Wked/Elovl4tm1Wked
Tg(IVL-Elovl4)#Wked/0
Tg(KRT14-Elovl4)#Mpag/0
(involves: 129 * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:277065
|
| abnormal excitatory postsynaptic potential
|
J:277065
|
| abnormal nervous system electrophysiology
|
J:277065
|
| seizures
|
J:277065
|
Elp1tm1.1Id/Elp1tm1.2Id
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)
|
audiogenic seizures
|
J:188923
|
| environmentally induced seizures
|
J:188923
|
Elp1tm1.2Id/Elp1tm1.2Id
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * CBA)
|
abnormal autonomic nervous system physiology
|
J:188923
|
| audiogenic seizures
|
J:188923
|
| environmentally induced seizures
|
J:188923
|
Elp1tm1c(KOMP)Wtsi/Elp1tm1c(KOMP)Wtsi
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: C57BL/6J * C57BL/6N * CBA/J)
|
abnormal nervous system physiology
|
J:202989
|
| increased neuron apoptosis
|
J:202989
|
Emilin3tm1.1(KOMP)Vlcg/Emilin3tm1.1(KOMP)Vlcg
(C57BL/6N-Emilin3tm1.1(KOMP)Vlcg/J)
|
decreased prepulse inhibition
|
J:211773
|
Eml1heco/?
(involves: CD-1)
|
abnormal neuronal precursor proliferation
|
J:211342
|
| increased neuron apoptosis
|
J:211342
|
Eml1heco/Eml1heco
(involves: NOR)
|
increased susceptibility to pharmacologically induced seizures
|
J:208031
|
| myoclonus
|
J:208031
|
| seizures
|
J:208031
|
Eml1tm1.2Ics/Eml1tm1.2Ics
(C57BL/6N-Eml1tm1.2Ics)
|
abnormal neuronal precursor proliferation
|
J:294769
|
Emx1tm1(cre)Ito/Emx1+
Grin1tm1Stl/Grin1tm2Stl
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJae * C57BL/6)
|
reduced NMDA receptor mediated synaptic activity in barrel cortex
|
J:64064
|
Emx1tm1(cre)Ito/Emx1+
Olig2tm1Qrlu/Olig2tm1Qrlu
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal myelination
|
J:105071
|
Emx1tm1(cre)Ito/Emx1+
Tg(CAG-Mtor*)#Atai/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2 * ICR)
|
increased neuron apoptosis
|
J:211789
|
Emx1tm1(cre)Krj/?
Kcnq2tm1.1Avtz/Kcnq2tm1.1Avtz
(involves: 129S2/SvPas * C57BL/6)
|
abnormal action potential
|
J:208109
|
| abnormal afterhyperpolarization
|
J:208109
|
| abnormal brain wave pattern
|
J:208109
|
| abnormal nervous system electrophysiology
|
J:208109
|
| tonic-clonic seizures
|
J:208109
|
Emx1tm1(cre)Krj/?
Kcnq3tm1.1Avtz/Kcnq3tm1.1Avtz
(involves: 129S2/SvPas * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:208109
|
Emx1tm1(cre)Krj/Emx1+
Esco2tm1.1Ge/Esco2tm1.1Ge
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:180371
|
| increased neuron apoptosis
|
J:180371
|
Emx1tm1(cre)Krj/Emx1+
Numbtm1Ynj/Numbtm1Ynj
Numbltm1Wmz/Numbltm1Wmz
(involves: 129S2/SvPas * 129X1/SvJ * CD-1)
|
increased neuron apoptosis
|
J:87149
|
| sporadic seizures
|
J:87149
|
Emx1tm1(cre)Krj/Emx1+
Rbm8atm1Dlsi/Rbm8a+
(involves: C57BL/6J)
|
abnormal radial glial cell apoptosis
|
J:221648
|
| increased forebrain apoptosis
|
J:221648
|
| increased neuron apoptosis
|
J:221648
|
| increased neuronal precursor proliferation
|
J:221648
|
Emx1tm1.1(cre)Ito/Emx1+
Scn1atm2.1Kzy/Scn1atm2.1Kzy
Tg(Slc32a1-cre)65Kzy/0
(involves: 129P2/OlaHsd * C57BL/6)
|
convulsive seizures
|
J:202863
|
Emx1tm1.1(cre)Ito/Emx1+
Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:139349
|
Emx2Pdo/Emx2+
(involves: BALB/c * C3H/HeN)
|
decreased cochlear nerve compound action potential
|
J:89093
|
Emx2Pdo/Emx2+
(involves: BALB/c)
|
increased cochlear nerve compound action potential
|
J:250208
|
En1tm1Alj/En1tm8.1Alj
En2tm1Alj/En2tm6Alj
Gt(ROSA)26Sortm1(cre/ERT2)Alj/Gt(ROSA)26Sor+
(involves: 129S2/SvPas * 129S6/SvEvTac * Swiss Webster)
|
abnormal cerebellar granule cell precursor proliferation
|
J:156169
|
En1tm1Gld/En1+
En2tm1Alj/En2tm1Alj
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6 * Swiss Webster)
|
decreased neurotransmitter release
|
J:115270
|
En1tm1Gld/En1tm1Gld
(involves: 129S/SvEv)
|
abnormal CNS synaptic transmission
|
J:106437
|
En1tm2(cre)Gld/En1+
Gt(ROSA)26Sortm1(DTA)Riet/Gt(ROSA)26Sor+
(involves: 129P2/OlaHsd * 129S1/Sv)
|
abnormal CNS synaptic transmission
|
J:106437
|
En1tm2(cre)Gld/En1+
Tg(CAG-Bgeo,-AlstR,-EGFP)192Gld/0
(involves: 129S1/Sv)
|
abnormal CNS synaptic transmission
|
J:106437
|
En1tm2(cre)Wrst/En1+
Gbx2tm1.1Mrt/Gbx2tm1.1Alj
(involves: 129/Sv * C57BL/6 * SJL * Swiss Webster)
|
decreased embryonic neuroepithelial cell proliferation
|
J:79431
|
En1tm2(cre)Wrst/En1+
Mfn2tm1Dcc/Mfn2tm3Dcc
(involves: 129 * 129S4/SvJaeSor * Black Swiss)
|
increased neuron apoptosis
|
J:132329
|
En1tm2Alj/En1+
Tg(Th-EGFP)6-7Okn/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2J * OF1)
|
abnormal synaptic dopamine release
|
J:214073
|
Eno2tm1(DTA)Hsak/Eno2+
Gng7tm2(cre/PGR)Mmsh/Gng7+
(involves: C57BL/6)
|
increased neuron apoptosis
|
J:145152
|
Eno2tm1(DTA)Hsak/Eno2+
Tg(Gpr151-cre)#Ito/0
(involves: C57BL/6)
|
decreased prepulse inhibition
|
J:214076
|
Enoph1em1Zhgy/Enoph1em1Zhgy
(C57BL/6J-Enoph1em1Zhgy)
|
decreased cerebral infarct size
|
J:336756
|
| decreased susceptibility to ischemic brain injury
|
J:336756
|
Enpp2tm1.1Vart/Enpp2tm1.1Vart
(B6.Cg-Enpp2tm1.1Vart/Flmg)
|
increased neural tube apoptosis
|
J:159118
|
Entpd1tm1Djp/Entpd1tm1Djp
(involves: 129 * C57BL/6)
|
increased cerebral infarct size
|
J:76092
|
| increased susceptibility to ischemic brain injury
|
J:76092
|
Entpd1tm1Djp/Entpd1tm1Djp
(B6.129-Entpd1tm1Djp)
|
abnormal neurotransmitter secretion
|
J:143010
|
| abnormal synaptic norepinephrine release
|
J:143010
|
| increased neurotransmitter release
|
J:143010
|
Entpd2tm1Srob/Entpd2tm1Srob
(B6.129-Entpd2tm1Srob)
|
abnormal nerve fiber response
|
J:200972
|
Eomestm1Rob/Eomestm1Rob
Sox1tm1(cre)Take/0
(involves: 129S/SvEv * C57BL/6 * CBA)
|
abnormal neuron apoptosis
|
J:138764
|
| abnormal neuronal precursor proliferation
|
J:138764
|
Epas1tm1.1Mcs/Epas1+
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal type I cell of carotid body physiology
|
J:302384
|
Epas1tm1Mcs/Epas1tm1.1Mcs
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129X1/SvJ * C57BL/6 * CBA)
|
abnormal type I cell of carotid body physiology
|
J:302384
|
Epb41l3tm1.1Jglt/Epb41l3tm1.1Jglt
(involves: FVB/N)
|
abnormal nervous system electrophysiology
|
J:177866
|
| hypermyelination
|
J:177866
|
epf/epf
(Not Specified)
|
seizures
|
J:6309
|
Epg5em1(IMPC)H/Epg5em1(IMPC)H
(C57BL/6NTac-Epg5em1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Epha4tm1.1Bzh/Epha4tm1.2Bzh
Tg(Slc17a6-icre)1Oki/0
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal nerve fiber response
|
J:209606
|
Epha4tm1Byd/Epha4tm1Byd
(involves: 129S1/Sv * C57BL/6)
|
reduced long-term potentiation
|
J:87398
|
Epha4tm1Kldr/Epha4tm1Kldr
(Not Specified)
|
abnormal central pattern generator function
|
J:82479
|
Epha4tm1Kldr/Epha4tm1Kldr
(involves: 129S/SvEv * C57BL/6)
|
abnormal central pattern generator function
|
J:101019
|
Epha4tm2.1Kldr/Epha4tm2.1Kldr
(involves: BALB/c * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:154648
|
Epha4tm6Kln/Epha4tm6Kln
(involves: 129S/SvEv * C57BL/6)
|
abnormal central pattern generator function
|
J:101019
|
Epha5tm1b(NCOM)Mfgc/Epha5tm1b(NCOM)Mfgc
(C57BL/6N-Epha5tm1b(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Epm2atm1Kzy/Epm2atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal brain wave pattern
|
J:76688
|
| increased neuron apoptosis
|
J:76688
|
| myoclonus
|
J:76688
|
Eppiq1A/J/Eppiq1C57BL/6J
(involves: A/J * C57BL/6J)
|
abnormal prepulse inhibition
|
J:104045
|
Eppiq2A/J/Eppiq2A/J
(involves: A/J * C57BL/6J)
|
abnormal prepulse inhibition
|
J:104045
|
Eprs1tm1b(EUCOMM)Hmgu/Eprs1+
(C57BL/6N-Eprs1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Eps8tm1Ppdf/Eps8tm1Ppdf
(B6.129P2-Eps8tm1Ppdf)
|
abnormal excitatory postsynaptic currents
|
J:116055
|
| enhanced NMDA-mediated synaptic currents
|
J:116055
|
Eps8l2tm1b(EUCOMM)Wtsi/Eps8l2tm1b(EUCOMM)Wtsi
(C57BL/6N-Eps8l2tm1b(EUCOMM)Wtsi/H)
|
decreased prepulse inhibition
|
J:211773
|
Eps8l2tm1Wma/Eps8l2tm1Wma
(B6.129P2-Eps8l2tm1Wma)
|
decreased cochlear nerve compound action potential
|
J:200669
|
Eps15l1tm1.1Noff/Eps15l1tm1.1Noff
(B6(Cg)-Eps15l1tm1.1Noff)
|
abnormal synaptic vesicle clustering
|
J:272122
|
Erbb2tm1Cbm/Erbb2+
Erbb3tm2Cbm/Erbb3+
Nrg1tm1Cbm/Nrg1+
(involves: 129P2/OlaHsd)
|
abnormal myelination
|
J:90038
|
| abnormal nerve conduction
|
J:90038
|
Erbb2tm1Cbm/Erbb2+
Nrg1tm1Cbm/Nrg1+
(involves: 129P2/OlaHsd)
|
abnormal myelination
|
J:90038
|
| abnormal nerve conduction
|
J:90038
|
Erbb2tm1Haus/Erbb2tm1Klee
Myf5tm3(cre)Sor/Myf5+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:147957
|
Erbb2tm3(Erbb2)Mul/Erbb2tm1Mll
Tg(ACTA1-cre)1Mll/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:82801
|
Erbb3tm1Cbm/Erbb3tm1Cbm
(either: 129P2/OlaHsd or (involves: 129P2/OlaHsd * C57BL/6))
|
increased neuron apoptosis
|
J:43515
|
Erbb3tm1Gne/Erbb3tm1Gne
(involves: 129S2/SvPas * C57BL/6)
|
abnormal neuronal migration
|
J:45302
|
Erbb3tm2Cbm/Erbb3tm2Cbm
(either: 129P2/OlaHsd or (involves: 129P2/OlaHsd * C57BL/6))
|
increased neuron apoptosis
|
J:43515
|
Erbb3tm2Cbm/Erbb3tm3Cbm
Erbb4tm1Fej/Erbb4tm1Fej
Cnptm1(cre)Kan/?
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal myelination
|
J:145464
|
Erbb3tm3Cbm/Erbb3tm3Cbm
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/?
Tg(Dhh-cre)1Mejr/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal myelination
|
J:207470
|
Erbb3tm3Cbm/Erbb3tm3Cbm
Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky/?
Tg(Dhh-cre)1Mejr/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal myelination
|
J:207470
|
| hypermyelination
|
J:207470
|
Erbb4tm1Fej/Erbb4tm1Fej
Pvalbtm1(cre)Arbr/Pvalb+
(involves: 129 * C57BL/6)
|
decreased prepulse inhibition
|
J:182690
|
| enhanced long-term potentiation
|
J:182690
|
Erbb4tm1Grl/Erbb4+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal prepulse inhibition
|
J:81106
|
Erbb4tm1Grl/Erbb4tm1Grl
Tg(Myh6-ERBB4)HT2Gass/0
(B6.Cg-Erbb4tm1Grl Tg(Myh6-ERBB4)HT2Gass)
|
abnormal long-term potentiation
|
J:182690
|
| decreased prepulse inhibition
|
J:182690
|
| enhanced long-term potentiation
|
J:182690
|
ErbinGt(BGA258)Byg/ErbinGt(BGA258)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myelination
|
J:149996
|
| decreased nerve conduction velocity
|
J:149996
|
Erbintm1Line/Erbintm1Line
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myelination
|
J:149996
|
| decreased nerve conduction velocity
|
J:149996
|
Erc2tm1.1Sud/Erc2tm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:133656
|
| abnormal inhibitory postsynaptic currents
|
J:133656
|
| abnormal synaptic neurotransmitter level
|
J:133656
|
Erc2tm1.1Sud/Erc2tm1.1Sud
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal CNS synaptic transmission
|
J:155764
|
| abnormal inhibitory postsynaptic currents
|
J:155764
|
| abnormal synaptic neurotransmitter level
|
J:155764
|
Erc2tm1.2Sud/Erc2tm1.2Sud
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal inhibitory postsynaptic currents
|
J:155764
|
Ercc3tm1b(NCOM)Mfgc/Ercc3+
(C57BL/6N-Ercc3tm1b(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Gvh/Xpatm1Hvs
Tg(Camk2a-cre)1Szi/0
(involves: 129P2/OlaHsd * C57BL/6J * CBA)
|
seizures
|
J:179808
|
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpatm1Tnka/Xpatm1Tnka
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
decreased cerebellar granule cell precursor proliferation
|
J:72574
|
Ercc6tm1Gvh/Ercc6tm1Gvh
Xpctm1Brd/Xpctm1Brd
(involves: 129P2/OlaHsd * 129S7/SvEvBrd)
|
abnormal myelination
|
J:182229
|
| abnormal oligodendrocyte physiology
|
J:182229
|
Ercc6ltm1.2Ajlc/Y
(involves: 129S2/SvPas * C57BL/6J * C57BL/6N * SJL/J)
|
increased brain apoptosis
|
J:271028
|
Ergtm2Poet/Ergtm2Poet
(involves: 129S6/SvEvTac * C57BL/6)
|
intracranial hemorrhage
|
J:188920
|
Erlec1em1(IMPC)Mbp/Erlec1em1(IMPC)Mbp
(C57BL/6N-Erlec1em1(IMPC)Mbp/Ucd)
|
increased prepulse inhibition
|
J:211773
|
Ermntm1Bcgen/Ermntm1Bcgen
(involves: C57BL/6)
|
decreased nerve conduction velocity
|
J:297572
|
| demyelination
|
J:297572
|
Esm1tm1.1Rha/Esm1tm1.1Rha
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * C57BL/6NTac)
|
decreased susceptibility to ischemic brain injury
|
J:246778
|
Espnje/Espnje
(involves: fancier's dancing mouse)
|
absent cochlear microphonics
|
J:7124
|
| absent cochlear nerve compound action potential
|
J:7124
|
Esr1tm1Ksk/Esr1tm1Ksk
(involves: 129P2/OlaHsd)
|
abnormal pituitary gland physiology
|
J:40607
|
Esr2tm1Mma/Esr2tm1Mma
(involves: 129S2/SvPas * C57BL/6)
|
abnormal synaptic plasticity
|
J:72240
|
Esr2tm1Unc/Esr2tm1Unc
(involves: 129P2/OlaHsd)
|
abnormal excitatory postsynaptic potential
|
J:115451
|
| reduced long-term potentiation
|
J:115451
|
Etv1tm1Tmj/Etv1tm1Tmj
(involves: 129S1/Sv * C57BL/6J)
|
abnormal nerve conduction
|
J:78232
|
| impaired ability to fire action potentials
|
J:78232
|
Eva1atm1Nju/Eva1atm1Nju
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal neuronal stem cell physiology
|
J:301660
|
| decreased neuronal stem cell self-renewal
|
J:301660
|
Evc2em1(IMPC)Mbp/Evc2em1(IMPC)Mbp
(C57BL/6N-Evc2em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Exq1A/J/?
(involves: A/J * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:54925
|
Exq1C57BL/6J/?
(involves: A/J * C57BL/6J)
|
abnormal seizure response to pharmacological agent
|
J:54925
|
Ext1tm1Yama/Ext1tm1Yama
Tg(Camk2a-cre)2834Lusc/0
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:182220
|
| abnormal miniature excitatory postsynaptic currents
|
J:182220
|
| abnormal synaptic transmission
|
J:182220
|
| reduced AMPA-mediated synaptic currents
|
J:182220
|
Eya1tm1b(EUCOMM)Hmgu/Eya1+
(C57BL/6N-Eya1tm1b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Ezh1tm1b(EUCOMM)Wtsi/Ezh1tm1b(EUCOMM)Wtsi
(C57BL/6N-Ezh1tm1b(EUCOMM)Wtsi/Nju)
|
decreased prepulse inhibition
|
J:211773
|
Ezh2tm2Sho/Ezh2tm2Sho
Olig1tm1(cre)Rth/0
(involves: 129S1/Sv * 129S4/SvJae)
|
dysmyelination
|
J:256017
|
F2tm1Jes/F2tm1Jes
(involves: 129P2/OlaHsd * C57BL/6J)
|
intracranial hemorrhage
|
J:48274
|
F2tm1Jld/F2tm1Sjd
Tg(Mx1-cre)1Cgn/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * CBA)
|
cerebellum hemorrhage
|
J:144572
|
| intracranial hemorrhage
|
J:144572
|
| spinal hemorrhage
|
J:144572
|
F2rtm1Ajc/F2rtm1Ajc
(B6.129S4-F2rtm1Ajc)
|
abnormal neuron apoptosis
|
J:89774
|
F2rl1tm1Wrf/F2rl1tm1Wrf
(involves: 129P2/OlaHsd * C57BL/6)
|
increased cerebral infarct size
|
J:112482
|
F3tm1Gjb/F3tm1Gjb
(involves: 129X1/SvJ * C57BL/6)
|
intracerebral hemorrhage
|
J:41500
|
F5tm2Dgi/F5tm2Dgi
Serpina10tm1Gjb/Serpina10tm1Gjb
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
intracranial hemorrhage
|
J:136102
|
F11tm1Gjb/F11tm1Gjb
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to ischemic brain injury
|
J:123758
|
F11tm1Gjb/F11tm1Gjb
(B6.129X1-F11tm1Gjb)
|
decreased cerebral infarct size
|
J:123758
|
| decreased susceptibility to ischemic brain injury
|
J:123758
|
F11tm1Gjb/F11tm1Gjb
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intracranial hemorrhage
|
J:67398
|
F12tm1Pbfd/F12tm1Pbfd
(B6.Cg-F12tm1Pbfd)
|
abnormal response to CNS ischemic injury
|
J:123758
|
| decreased cerebral infarct size
|
J:123758
|
Fa2htm1.1Hama/Fa2htm1.1Hama
(involves: 129 * C57BL/6)
|
demyelination
|
J:171655
|
Fabp7tm1Owad/Fabp7tm1Owad
(B6.Cg-Fabp7tm1Owad)
|
decreased prepulse inhibition
|
J:128536
|
| reduced NMDA-mediated synaptic currents
|
J:111540
|
Faddtm1Mpa/Faddtm1Mpa
Mogtm1(cre)Gkl/Mog+
(involves: C57BL/6 * SJL)
|
abnormal oligodendrocyte apoptosis
|
J:167475
|
Faf1Gt(XK588)Byg/Faf1Gt(XK588)Byg
(B6.129P2-Faf1Gt(XK588)Byg)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:194987
|
Faim2tm1.1Jbsc/Faim2tm1.1Jbsc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
increased cerebral infarct size
|
J:167848
|
Faim2tm1Dgen/Faim2tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Fam20ctm1Lex/Fam20ctm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal prepulse inhibition
|
J:186384
|
Fam53aem1(IMPC)Ccpcz/Fam53aem1(IMPC)Ccpcz
(C57BL/6N-Fam53aem1(IMPC)Ccpcz/Ccpcz)
|
increased prepulse inhibition
|
J:211773
|
Fam53btm1b(EUCOMM)Hmgu/Fam53btm1b(EUCOMM)Hmgu
(C57BL/6N-Fam53btm1b(EUCOMM)Hmgu/Cnrm)
|
decreased prepulse inhibition
|
J:211773
|
Fam83dem1(IMPC)Ccpcz/Fam83dem1(IMPC)Ccpcz
(C57BL/6N-Fam83dem1(IMPC)Ccpcz/Ccpcz)
|
decreased prepulse inhibition
|
J:211773
|
Fam117aem1(IMPC)Bay/Fam117aem1(IMPC)Bay
(C57BL/6N-Fam117aem1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Fam135bem1(IMPC)Rbrc/Fam135bem1(IMPC)Rbrc
(C57BL/6NJcl-Fam135bem1(IMPC)Rbrc/Rbrc)
|
decreased prepulse inhibition
|
J:211773
|
Fam162atm1b(EUCOMM)Hmgu/Fam162atm1b(EUCOMM)Hmgu
(C57BL/6N-Fam162atm1b(EUCOMM)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Faslpr/Faslpr
(MRL/MpJ-Faslpr/J)
|
CNS inflammation
|
J:14151
|
Faslpr/Faslpr
(B6.MRL-Faslpr/J)
|
brain inflammation
|
J:120427
|
| CNS inflammation
|
J:120427
|
| demyelination
|
J:120427
|
Faslpr/Faslpr
(C3.MRL-Faslpr)
|
decreased neuron apoptosis
|
J:124252
|
Faslgld/Faslgld
(B6Smn.C3-Faslgld/J)
|
brain inflammation
|
J:120427
|
| CNS inflammation
|
J:120427
|
| demyelination
|
J:120427
|
Faslgld/Faslgld
(C3H/HeJ-Faslgld)
|
decreased neuron apoptosis
|
J:124252
|
Fasntm1Sem/Fasntm1Sem
Tg(Ins2-cre)25Mgn/?
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
abnormal hypothalamus physiology
|
J:127482
|
Fbln1Gt(XST011)Byg/Fbln1Gt(XST011)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased hindbrain apoptosis
|
J:137690
|
| intracerebral hemorrhage
|
J:137690
|
| spinal hemorrhage
|
J:137690
|
Fbln1tm1Tmpl/Fbln1tm1Tmpl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intracranial hemorrhage
|
J:71581
|
Fbn1em1Chop/Fbn1+
(C57BL/6-Fbn1em1Chop)
|
abnormal neuron physiology
|
J:251851
|
Fbxl3Afh/Fbxl3+
(involves: BALB/c * C3H/HeH)
|
abnormal hypothalamus physiology
|
J:121578
|
Fbxl3Afh/Fbxl3Afh
(involves: BALB/c * C3H/HeH)
|
abnormal hypothalamus physiology
|
J:121578
|
Fbxl20tm1Seto/Fbxl20tm1Seto
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:127941
|
| decreased paired-pulse facilitation
|
J:127941
|
Fbxl21Psttm/Fbxl21Psttm
Tg(Per2-luc)1Jt/0
(involves: C57BL/6J)
|
abnormal hypothalamus physiology
|
J:194037
|
Fbxo9tm1b(EUCOMM)Hmgu/Fbxo9tm1b(EUCOMM)Hmgu
(C57BL/6N-Fbxo9tm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Fbxo22tm1b(EUCOMM)Wtsi/Fbxo22tm1b(EUCOMM)Wtsi
(C57BL/6N-Fbxo22tm1b(EUCOMM)Wtsi/Nju)
|
decreased prepulse inhibition
|
J:211773
|
Fbxo30tm1b(KOMP)Wtsi/Fbxo30+
(C57BL/6N-Fbxo30tm1b(KOMP)Wtsi/J)
|
increased prepulse inhibition
|
J:211773
|
Fbxo41tm1(KOMP)Vlcg/Fbxo41tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal neuronal migration
|
J:222558
|
Fbxo45tm1Kei/Fbxo45tm1Kei
(B6.129P2-Fbxo45tm1Kei)
|
abnormal neuronal migration
|
J:149890
|
Fbxw7tm1.1Axbe/Fbxw7tm1.1Axbe
Juntm4Wag/Jun+
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal neuron apoptosis
|
J:166928
|
Fbxw7tm1Kin/Fbxw7tm1Kin
(involves: C57BL/6)
|
intracranial hemorrhage
|
J:88517
|
Fbxw18em1(IMPC)Ccpcz/Fbxw18+
(C57BL/6N-Fbxw18em1(IMPC)Ccpcz/Ccpcz)
|
increased prepulse inhibition
|
J:211773
|
Fcgr2btm1Ttk/Fcgr2btm1Ttk
(B6.129S4-Fcgr2btm1Ttk)
|
abnormal seizure response to electrical stimulation
|
J:169028
|
| maximal tonic hindlimb extension seizures
|
J:169028
|
| tonic-clonic seizures
|
J:169028
|
Fcmrtm1b(KOMP)Wtsi/Fcmrtm1b(KOMP)Wtsi
(C57BL/6N-Fcmrtm1b(KOMP)Wtsi/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Fdft1tm1Kan/Fdft1tm1Kan
Cnptm1(cre)Kan/Cnp+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
demyelination
|
J:98525
|
Ferd3ltm1Yono/Ferd3ltm1Yono
(involves: C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:160534
|
Fermt3tm1Ref/Fermt3tm1Ref
(involves: 129S1/Sv * 129X1/SvJ)
|
intracranial hemorrhage
|
J:133659
|
Fevtm1Esd/Fevtm2Esd
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Tg(Fev-cre)1Esd/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal action potential
|
J:165266
|
| abnormal nervous system electrophysiology
|
J:165266
|
Fezf1tm1Hibi/Fezf1tm1Hibi
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal neuronal migration
|
J:107405
|
Ffar1tm1Dgen/Ffar1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal sensory neuron physiology
|
J:161517
|
Ffar3tm1Gzt/Ffar3tm1Gzt
(involves: C57BL/6)
|
abnormal sympathetic neuron physiology
|
J:172798
|
Ffar4tm1Sdmk/Ffar4tm1Sdmk
(C57BL/6J-Ffar4tm1Sdmk)
|
abnormal sensory neuron physiology
|
J:161517
|
Fgatm1Jld/Fgatm1Jld
(involves: 129P2/OlaHsd * CF-1)
|
abnormal myelination
|
J:75437
|
Fgatm1Jld/Fgatm1Jld
(B6.129P2-Fgatm1Jld)
|
abnormal myelination
|
J:75437
|
Fgatm1Jld/Fgatm1Jld
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd)
|
abnormal nervous system physiology
|
J:42819
|
Fgd4tm1.1Ics/Fgd4tm1.1Ics
(Not Specified)
|
abnormal action potential
|
J:190437
|
| abnormal myelination
|
J:190437
|
| abnormal nervous system electrophysiology
|
J:190437
|
| decreased nerve conduction velocity
|
J:190437
|
| demyelination
|
J:190437
|
Fgd4tm1Ics/Fgd4tm1Ics
Tg(Dhh-cre)1Mejr/0
(involves: FVB/N)
|
abnormal myelination
|
J:190437
|
Fgd5em1(IMPC)Mbp/Fgd5+
(C57BL/6NCrl-Fgd5em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Fgf2tm1Zllr/Fgf2tm1Zllr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal baroreceptor physiology
|
J:49141
|
| abnormal neuronal migration
|
J:49141
|
Fgf7tm1Efu/Fgf7tm1Efu
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal synaptic vesicle clustering
|
J:161954
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:161954
|
Fgf7tm1Efu/Fgf7tm1Efu
(B6.129-Fgf7tm1Efu)
|
increased susceptibility to pharmacologically induced seizures
|
J:161954
|
Fgf8tm1.1Mrt/Fgf8tm1.4Mrt
(involves: 129P2/OlaHsd)
|
decreased neuron apoptosis
|
J:111586
|
Fgf8tm1.1Mrt/Fgf8tm1.4Mrt
Foxg1tm1(cre)Skm/Foxg1+
(involves: 129P2/OlaHsd)
|
increased neuron apoptosis
|
J:111586
|
Fgf8tm1.1Mrt/Fgf8tm1.4Mrt
Foxg1tm1M/Foxg1+
(involves: 129P2/OlaHsd)
|
abnormal neuron apoptosis
|
J:111586
|
Fgf8tm1.3Mrt/Fgf8tm1.4Mrt
Foxg1tm1(cre)Skm/Foxg1+
(involves: 129P2/OlaHsd)
|
increased neuron apoptosis
|
J:111586
|
Fgf12tm1Gol/Fgf12tm1Gol
Fgf14tm1Dor/Fgf14tm1Dor
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
abnormal channel response
|
J:128732
|
| abnormal CNS synaptic transmission
|
J:128732
|
Fgf13em1Xuzh/Y
(involves: C57BL/6J)
|
abnormal neuronal migration
|
J:307501
|
Fgf13tm1Jom/Fgf13+
(C57BL/6-Fgf13tm1Jom)
|
abnormal CNS synaptic transmission
|
J:222555
|
| abnormal inhibitory postsynaptic currents
|
J:222555
|
| abnormal kindling response
|
J:222555
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:222555
|
| environmentally induced seizures
|
J:222555
|
| increased excitatory postsynaptic current frequency
|
J:222555
|
| seizures
|
J:222555
|
Fgf13tm1Xuzh/Fgf13tm1Xuzh
(involves: 129)
|
abnormal neuronal migration
|
J:186253
|
Fgf14tm1Dor/Fgf14tm1Dor
(129S6/SvEvTac-Fgf14tm1Dor)
|
abnormal nervous system physiology
|
J:77806
|
| increased susceptibility to pharmacologically induced seizures
|
J:77806
|
Fgf14tm1Dor/Fgf14tm1Dor
(B6.129S6-Fgf14tm1Dor)
|
abnormal nervous system physiology
|
J:77806
|
| increased susceptibility to pharmacologically induced seizures
|
J:77806
|
| reduced long-term potentiation
|
J:134733
|
Fgf14tm1Dor/Fgf14tm1Dor
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:128732
|
| abnormal nervous system electrophysiology
|
J:144561
|
Fgf20em1(IMPC)Ccpcz/Fgf20em1(IMPC)Ccpcz
(C57BL/6NCrl-Fgf20em1(IMPC)Ccpcz/Ccpcz)
|
decreased prepulse inhibition
|
J:211773
|
Fgf21tm1Emf/Fgf21tm1Emf
(B6.Cg-Fgf21tm1Emf)
|
abnormal hypothalamus secretion
|
J:157309
|
Fgf22tm1Dgen/Fgf22tm1Dgen
(Not Specified)
|
abnormal synaptic vesicle clustering
|
J:161954
|
| decreased miniature excitatory postsynaptic current frequency
|
J:161954
|
| enhanced paired-pulse facilitation
|
J:161954
|
| increased synaptic depression
|
J:161954
|
Fgf22tm1Dgen/Fgf22tm1Dgen
(B6.Cg-Fgf22tm1Dgen)
|
decreased susceptibility to pharmacologically induced seizures
|
J:161954
|
Fgfr1Hspy/Fgfr1+
(C3HeB/FeJ-Hspy)
|
abnormal cochlear nerve compound action potential
|
J:95895
|
Fgfr1tm1Upir/Fgfr1tm1Upir
Tg(GFAP-cre)25Mes/0
(involves: FVB/N)
|
abnormal neuronal migration
|
J:110263
|
Fgfr2tm1Dor/Fgfr2tm1Dor
Lamb2tm1Jrs/Lamb2tm1Jrs
Tg(Mnx1-cre)1Jrs/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal synaptic vesicle clustering
|
J:126496
|
Fgfr2tm1Dor/Fgfr2tm1Dor
Tg(Mnx1-cre)1Jrs/?
(involves: 129X1/SvJ * C57BL/6)
|
abnormal synaptic vesicle clustering
|
J:126496
|
Fgfr2tm2.1Lni/Fgfr2tm2.1Lni
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal synaptic vesicle clustering
|
J:126496
|
Fig4plt1/Fig4plt1
(involves: 129P2/OlaHsd * C3H * C57BL/6 * CAST/Ei * SJL)
|
abnormal action potential
|
J:122737
|
| abnormal nerve conduction
|
J:185989,
J:122737
|
| demyelination
|
J:185989
|
Fig4plt1/Fig4plt1
(involves: 129 * C3H * C57BL/6J * CAST/Ei * SJL)
|
decreased nerve conduction velocity
|
J:173446
|
Fig4plt1/Fig4plt1
Tg(ACTB-Fig4*I41T)705Mm/0
(involves: 129 * C3H * C57BL/6J * CAST/Ei * SJL)
|
decreased nerve conduction velocity
|
J:173446
|
Fig4plt1/Fig4plt1
Tg(ACTB-Fig4*I41T)721Mm/0
(involves: 129 * C3H * C57BL/6J * CAST/Ei * SJL)
|
decreased nerve conduction velocity
|
J:173446
|
Fig4plt1/Fig4plt1
Tg(GFAP-Fig4)#Mm/?
(involves: 129P2/OlaHsd * C3H * C57BL/6 * CAST/Ei * SJL)
|
demyelination
|
J:185989
|
Fignl2tm1.1Geno/Fignl2tm1.1Geno
(involves: C57BL/6)
|
abnormal neuron physiology
|
J:309596
|
Filip1tm1Msat/Filip1tm1Msat
(involves: C57BL/6)
|
abnormal nervous system physiology
|
J:260692
|
| abnormal neuron physiology
|
J:260692
|
Fitm2tm1.1(KOMP)Vlcg/Fitm2+
(C57BL/6N-Fitm2tm1.1(KOMP)Vlcg/J)
|
decreased prepulse inhibition
|
J:211773
|
Fkbp8Gt(OST287985)Lex/Fkbp8Gt(OST287985)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased neural tube apoptosis
|
J:132031
|
Fkbp10tm2a(EUCOMM)Wtsi/Fkbp10+
(C57BL/6N-Fkbp10tm2a(EUCOMM)Wtsi/Ics)
|
decreased prepulse inhibition
|
J:165965
|
Fkrptm1Itl/Fkrptm1Itl
(involves: 129S6/SvEvTac * C57BL/6N)
|
abnormal neuronal migration
|
J:164448
|
Fktntm1Ttd/Fktntm2(FCMD)Ttd
(involves: 129S7/SvEvBrd)
|
abnormal neuronal migration
|
J:144746
|
Fli1tm1Adh/Fli1tm1Adh
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))
|
intracranial hemorrhage
|
J:64178
|
Fli1tm1Dkw/Fli1tm1Dkw
(either: B6.Cg-Fli1tm1Dkw or (involves: CD-1) or (involves: 129S6/SvEvTac * C57BL/6))
|
intraventricular hemorrhage
|
J:63242
|
| spinal hemorrhage
|
J:63242
|
Fli1tm2Adh/Fli1tm2Adh
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))
|
intracranial hemorrhage
|
J:64178
|
Flrt2tm1.1Kln/Flrt2tm1.1Kln
(involves: BALB/c * C57BL/6 * CD-1)
|
abnormal neuronal migration
|
J:196042
|
Flvcr2tm1.2Tda/Flvcr2tm1.2Tda
(involves: C57BL/6J)
|
brain inflammation
|
J:287134
|
| brain ischemia
|
J:287134
|
Fmc1em1Aitn/Fmc1+
(C57BL/6JJmsSlc-Fmc1em1Aitn)
|
decreased susceptibility to neuronal excitotoxicity
|
J:257586
|
Fmnl2em2(IMPC)Tcp/Fmnl2em2(IMPC)Tcp
(C57BL/6NCrl-Fmnl2em2(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Fmo1em1Anz/Fmo1em1Anz
(involves: C57BL/6N)
|
abnormal neuron physiology
|
J:312983
|
Fmr1tm1.1Cidz/Fmr1tm1.1Cidz
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal long-term depression
|
J:101021
|
Fmr1tm1.1Ics/Fmr1tm1.1Ics
(C57BL/6-Fmr1tm1.1Ics)
|
impaired synaptic plasticity
|
J:304982
|
| increased miniature excitatory postsynaptic current amplitude
|
J:304982
|
| reduced long-term potentiation
|
J:304982
|
Fmr1tm1.2Cidz/Y
(involves: 129P2/OlaHsd * 129/Sv * C57BL/6 * FVB/N)
|
abnormal CNS synaptic transmission
|
J:176553
|
| abnormal miniature excitatory postsynaptic currents
|
J:176553
|
| enhanced long-term potentiation
|
J:176553
|
Fmr1tm1Cgr/Y
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal nerve fiber response
|
J:127792
|
| audiogenic seizures
|
J:127792
|
Fmr1tm1Cgr/Y
(B6.129P2-Fmr1tm1Cgr/J)
|
increased prepulse inhibition
|
J:102061
|
Fmr1tm1Cgr/Y
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased prepulse inhibition
|
J:219363
|
Fmr1tm1Cgr/Y
(involves: 129P2/OlaHsd)
|
abnormal long-term depression
|
J:101021
|
Fmr1tm1Cgr/Y
(involves: 129P2/OlaHsd * FVB)
|
convulsive seizures
|
J:113177
|
| tonic-clonic seizures
|
J:113177
|
Fmr1tm1Cgr/Y
(FVB.129P2(B6)-Pde6b+ Fmr1tm1Cgr)
|
reduced long-term potentiation
|
J:100197
|
Fmr1tm1Cgr/Y
(either: FVB.129P2(B6)-Fmr1tm1Cgr/J or FVB;129P2(B6)-Fmr1tm1Cgr/J)
|
audiogenic seizures
|
J:85912
|
| increased prepulse inhibition
|
J:85912
|
Fmr1tm1Cgr/Y
(FVB.129P2-Pde6b+ Tyrc-ch Fmr1tm1Cgr/J)
|
increased prepulse inhibition
|
J:171069
|
Fmr1tm1Cgr/Y
(B6.129P2-Fmr1tm1Cgr/Nwu)
|
increased prepulse inhibition
|
J:171069
|
Fmr1tm1Cgr/Y
Grm5tm1Rod/Grm5+
(involves: 129P2/OlaHsd * C57BL/6 * FVB)
|
audiogenic seizures
|
J:127792
|
Fmr1tm1Cgr/Fmr1tm1Cgr
(involves: 129P2/OlaHsd)
|
abnormal long-term depression
|
J:101021
|
| abnormal neuronal precursor proliferation
|
J:159211
|
Fmr1tm1Rbd/Y
(B6.129-Fmr1tm1Rbd)
|
abnormal long-term depression
|
J:155593
|
| audiogenic seizures
|
J:155593
|
Fn1tm1Ref/Fn1tm1Ref
Tg(Mx1-cre)1Cgn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
increased cerebral infarct size
|
J:67961
|
| increased neuron apoptosis
|
J:67961
|
| increased susceptibility to ischemic brain injury
|
J:67961
|
Fndc9tm1.1(KOMP)Vlcg/Fndc9tm1.1(KOMP)Vlcg
(C57BL/6N-Fndc9tm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Folh1tm1Nle/Folh1tm1Nle
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal peripheral nervous system regeneration
|
J:103536
|
| decreased cerebral infarct size
|
J:103536
|
| decreased susceptibility to ischemic brain injury
|
J:103536
|
Fostm1Mxu/Fostm1Mxu
Tg(Camk2a-cre)T50Stl/0
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:108041
|
Fostm7Wag/Fostm7Wag
Tg(Nes-cre)1Kln/?
(involves: 129P2/OlaHsd)
|
reduced long-term potentiation
|
J:85928
|
Fosbtm1Brv/Fosbtm1Brv
(involves: 129S2/SvPas)
|
tonic-clonic seizures
|
J:33415
|
Fosbtm1Meg/Fosbtm1Meg
(involves: 129S4/SvJae * 129X1/SvJ)
|
abnormal seizure response to electrical stimulation
|
J:110995
|
| reduced NMDA-mediated synaptic currents
|
J:110995
|
Foxa2tm1Khk/Foxa2tm1Khk
(involves: 129P2/OlaHsd * C57BL/6 * CD-1 * DBA)
|
seizures
|
J:70409
|
Foxc1ch/Foxc1ch
(involves: CBA * STOCK Tyrc f)
|
intracranial hemorrhage
|
J:5191,
J:75733
|
Foxc1hith/Foxc1hith
(involves: C57BL/6J)
|
abnormal neuron proliferation
|
J:157301
|
Foxc1hith/Foxc1tm1Blh
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal neuron proliferation
|
J:157301
|
Foxc1tm1Blh/Foxc1tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
intracranial hemorrhage
|
J:48079
|
Foxc1tm1Blh/Foxc1tm1Blh
(involves: 129S6/SvEvTac)
|
abnormal neuron proliferation
|
J:157301
|
Foxc2tm1Blh/Foxc2tm1Blh
(involves: 129S6/SvEvTac * Black Swiss)
|
intracranial hemorrhage
|
J:39636
|
| spinal hemorrhage
|
J:39636
|
Foxd3tm2Lby/Foxd3tm3Lby
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
increased hindbrain apoptosis
|
J:134482
|
Foxg1tm1Chzh/Foxg1tm1Chzh
Tg(Fzd9-cre/ERT)1Chzh/0
(involves: C57BL/6 * FVB)
|
abnormal neuronal precursor proliferation
|
J:182692
|
Foxg1tm1M/Foxg1tm1M
(involves: 129S1/Sv)
|
abnormal neuronal precursor proliferation
|
J:78115
|
Foxn3em1(IMPC)Bay/Foxn3+
(C57BL/6N-Foxn3em1(IMPC)Bay/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Foxo3tm1.1(KOMP)Vlcg/Foxo3tm1.1(KOMP)Vlcg
(C57BL/6N-Foxo3tm1.1(KOMP)Vlcg/J)
|
decreased prepulse inhibition
|
J:211773
|
Foxo6tm1Abru/Foxo6tm1Abru
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal brain wave pattern
|
J:191193
|
Foxp2R552H/Foxp2+
(involves: BALB/c * C3H/HeH)
|
enhanced paired-pulse facilitation
|
J:135404
|
| reduced long-term depression
|
J:135404
|
Foxp2tm2.1Woen/Foxp2tm2.1Woen
(involves: C57BL/6 * C57BL/6J * SJL)
|
abnormal long-term depression
|
J:150425
|
| abnormal synaptic plasticity
|
J:150425
|
Foxq1sa/Foxq1+
M876b/+
(involves: 101 * BALB/cOlaHsd * C3H * C57BL/6J * C57BR)
|
decreased prepulse inhibition
|
J:101156
|
Fpr3del/Fpr3del
(129S2/SvPasCrl)
|
abnormal vomeronasal sensory neuron physiology
|
J:279957
|
Fpr3tm1b(EUCOMM)Hmgu/Fpr3tm1b(EUCOMM)Hmgu
(involves: C57BL/6N)
|
abnormal vomeronasal sensory neuron physiology
|
J:279957
|
Frmd5em#Yuw/Frmd5em#Yuw
(C57BL/6J-Frmd5em#Yuw)
|
abnormal nervous system electrophysiology
|
J:345640
|
| decreased excitatory postsynaptic current frequency
|
J:345640
|
Frmd5tm1a(EUCOMM)Hmgu/Frmd5tm1a(EUCOMM)Hmgu
(Not Specified)
|
decreased prepulse inhibition
|
J:165965
|
Frrs1ltm1b(EUCOMM)Hmgu/Frrs1ltm1b(EUCOMM)Hmgu
(C57BL/6N-Frrs1ltm1b(EUCOMM)Hmgu/H)
|
decreased prepulse inhibition
|
J:211773
|
Fscn2em1Fhan/Fscn2em1Fhan
(C57BL/6J-Fscn2em1Fhan)
|
abnormal cochlear outer hair cell physiology
|
J:274170
|
Fstl1tm1Nju/Fstl1tm1Nju
Tg(Scn10a-cre)1Rkun/0
(involves: 129 * C57BL/6 * DBA)
|
abnormal action potential
|
J:188549
|
| increased excitatory postsynaptic current frequency
|
J:188549
|
Fth1tm1Kjt/Fth1+
(involves: 129S/SvEvBrd * C57BL/6)
|
abnormal neuron physiology
|
J:158718
|
Ftsj1tm1Tomik/Y
(Not Specified)
|
impaired synaptic plasticity
|
J:328916
|
| reduced long-term depression
|
J:328916
|
| reduced long-term potentiation
|
J:328916
|
Fustm1.1(KOMP)Vlcg/Fus+
(C57BL/6N-Fustm1.1(KOMP)Vlcg/Ucd)
|
increased prepulse inhibition
|
J:211773
|
Fut8em1(IMPC)Wtsi/Fut8em1(IMPC)Wtsi
(C57BL/6N-Fut8em1(IMPC)Wtsi/Wtsi)
|
spinal hemorrhage
|
J:239583
|
Fut9tm1Nari/Fut9tm1Nari
(involves: 129S4/SvJae * BALB/cJ * C57BL/6)
|
increased neuronal stem cell self-renewal
|
J:204554
|
Fxntm1Mkn/Fxntm1Mkn
Tg(FXN)YG8Pook/0
(involves: 129/Sv * C57BL/6 * CBA)
|
abnormal action potential
|
J:114840
|
| brain inflammation
|
J:216422
|
| decreased nerve conduction velocity
|
J:114840
|
Fxntm1Mkn/Fxntm1Pand
(involves: 129/Sv * C57BL/6)
|
brain inflammation
|
J:216422
|
Fxntm2Mkn/Fxntm2.1Mkn
Tg(Eno2-cre)39Jme/0
(involves: 129 * C57BL/6J)
|
abnormal nerve conduction
|
J:75420
|
Fxr2tm1Cgr/Fxr2tm1Cgr
(involves: 129S7/SvEvBrd * C57BL/6J * FVB)
|
decreased prepulse inhibition
|
J:75389
|
Fyntm1Fam/Fyntm1Fam
(involves: C57BL/6)
|
abnormal myelination
|
J:109485
|
Fyntm1Sor/Fyn+
Tg(Camk2a-Fyn-531)1Nko/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
tonic seizures
|
J:59490
|
Fyntm1Sor/Fyntm1Sor
(either: 129S7/SvEvBrd-Fyntm1Sor or (involves: 129S7/SvEvBrd * C57BL/6J))
|
reduced long-term potentiation
|
J:3417
|
Fyntm1Sor/Fyntm1Sor
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal myelination
|
J:109485
|
| reduced long-term potentiation
|
J:80637
|
Fyntm1Yik/Fyntm1Yik
(involves: C57BL/6 * CBA)
|
abnormal excitatory postsynaptic potential
|
J:43707
|
| abnormal myelination
|
J:16847
|
| audiogenic seizures
|
J:23384
|
Fzd2tm1.1Nat/Fzd2tm1.1Nat
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal nervous system electrophysiology
|
J:165556
|
Fzd3tm1(FZD3)Lex/Fzd3tm1(FZD3)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased prepulse inhibition
|
J:185566
|
| reduced sensorimotor gating
|
J:185566
|
Fzd4tm1Nat/Fzd4tm1Nat
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal astrocyte physiology
|
J:70078
|
Fzd9tm1Sjp/Fzd9tm1Sjp
(involves: C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:99893
|
Fzr1Gt(RRJ067)Byg/Fzr1+
(involves: 129P2/OlaHsd)
|
reduced long-term potentiation
|
J:138545
|
G3bp1tm1b(KOMP)Wtsi/G3bp1tm1b(KOMP)Wtsi
(C57BL/6N-G3bp1tm1b(KOMP)Wtsi/Bay)
|
decreased prepulse inhibition
|
J:211773
|
G3bp1tm1Tazi/G3bp1tm1Tazi
(involves: 129S2/SvPas)
|
increased neuron apoptosis
|
J:101358
|
| intracranial hemorrhage
|
J:101358
|
G6pc1tm1Jyc/G6pc1tm1Jyc
(involves: 129S4/SvJae)
|
seizures
|
J:33212
|
G6pc1tm2.2Jyc/G6pc1tm2.2Jyc
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6J * FVB/N)
|
seizures
|
J:155990
|
Gabbr1tm1Bet/Gabbr1tm1Bet
(BALB/c-Gabbr1tm1Bet)
|
abnormal excitatory postsynaptic currents
|
J:70558
|
| abnormal inhibitory postsynaptic currents
|
J:70558
|
| abnormal myelination
|
J:132683
|
| abnormal nervous system electrophysiology
|
J:70558
|
| abnormal synaptic transmission
|
J:70558
|
| absence seizures
|
J:70558
|
| audiogenic seizures
|
J:70558
|
| clonic seizures
|
J:70558
|
| reduced long-term potentiation
|
J:113340
|
| seizures
|
J:70558
|
| tonic-clonic seizures
|
J:70558
|
Gabbr1tm1Pngl/Gabbr1+
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased prepulse inhibition
|
J:70254
|
Gabbr1tm1Pngl/Gabbr1tm1Pngl
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal action potential
|
J:70254
|
| abnormal inhibitory postsynaptic potential
|
J:70254
|
| abnormal nervous system electrophysiology
|
J:70254
|
| sporadic seizures
|
J:70254
|
| tonic-clonic seizures
|
J:70254
|
Gabbr1tm2Bet/Gabbr1tm2Bet
Hdctm1.1(icre)Wwis/Hdc+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal neuron physiology
|
J:188103
|
Gabbr1tm2Bet/Gabbr1tm2Bet
Tg(HCRT-cre)1Stak/0
(involves: BALB/cA * C57BL/6 * DBA/1)
|
abnormal CNS synaptic transmission
|
J:146778
|
| abnormal inhibitory postsynaptic currents
|
J:146778
|
Gabbr1tm3Bet/Gabbr1tm3Bet
(BALB/c-Gabbr1tm3Bet)
|
abnormal excitatory postsynaptic currents
|
J:276486,
J:113340
|
| reduced long-term potentiation
|
J:113340
|
Gabbr1tm4Bet/Gabbr1tm4Bet
(BALB/c-Gabbr1tm4Bet)
|
abnormal inhibitory postsynaptic currents
|
J:113340
|
Gabbr2tm1.1Stmo/Gabbr2tm1.1Stmo
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal excitatory postsynaptic currents
|
J:205570
|
| abnormal hippocampus physiology
|
J:205570
|
| abnormal synaptic plasticity
|
J:205570
|
Gabbr2tm1Arca/Gabbr2tm1Arca
(involves: 129P2/OlaHsd)
|
abnormal inhibitory postsynaptic currents
|
J:146953
|
| abnormal inhibitory postsynaptic potential
|
J:146953
|
| seizures
|
J:146953
|
| tonic-clonic seizures
|
J:146953
|
Gabbr2tm1Bet/Gabbr2tm1Bet
(BALB/c-Gabbr2tm1Bet)
|
abnormal brain wave pattern
|
J:103989
|
| abnormal excitatory postsynaptic currents
|
J:103989
|
| abnormal inhibitory postsynaptic currents
|
J:103989
|
| abnormal nervous system electrophysiology
|
J:103989
|
| abnormal synaptic transmission
|
J:103534
|
| clonic seizures
|
J:103989
|
Gabpatm1Pjh/Gabpatm1Pjh
Tg(ACTA1-cre)79Jme/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
abnormal channel response
|
J:121356
|
| abnormal PNS synaptic transmission
|
J:121356
|
| abnormal synaptic acetylcholine release
|
J:121356
|
| decreased neurotransmitter release
|
J:121356
|
Gabra1tm1.1Geh/Gabra1+
(D2.129(Cg)-Gabra1tm1.1Geh)
|
abnormal spike wave discharge
|
J:186685
|
| absence seizures
|
J:186685
|
Gabra1tm1.1Geh/Gabra1+
(B6.129(Cg)-Gabra1tm1.1Geh)
|
abnormal miniature inhibitory postsynaptic currents
|
J:227437
|
| abnormal spike wave discharge
|
J:186685,
J:227437
|
| absence seizures
|
J:186685,
J:227437
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:227437
|
| increased susceptibility to pharmacologically induced seizures
|
J:227437
|
| myoclonus
|
J:227437
|
| seizures
|
J:227437
|
| tonic-clonic seizures
|
J:227437
|
Gabra1tm1.1Geh/Gabra1tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal inhibitory postsynaptic currents
|
J:70505,
J:103381
|
Gabra1tm1.1Mjga/Gabra1+
(B6J.Cg-Gabra1tm1.1Mjga)
|
abnormal miniature inhibitory postsynaptic currents
|
J:227437
|
| abnormal spike wave discharge
|
J:227437
|
| absence seizures
|
J:227437
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:227437
|
| increased susceptibility to pharmacologically induced seizures
|
J:227437
|
| myoclonus
|
J:227437
|
| seizures
|
J:227437
|
| tonic-clonic seizures
|
J:227437
|
Gabra1tm1.1Uru/Gabra1tm1.1Uru
(either: 129X1.129P2-Gabra1tm1.1Uru or B6.129P2-Gabra1tm1.1Uru)
|
increased susceptibility to pharmacologically induced seizures
|
J:75895
|
Gabra1tm1Twr/Gabra1tm1Twr
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal GABA-mediated receptor currents
|
J:69290
|
Gabra1tm2.1Geh/Gabra1+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal inhibitory postsynaptic currents
|
J:105293
|
Gabra2tm1.1Geh/Gabra2tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal miniature inhibitory postsynaptic currents
|
J:171967
|
Gabra2tm1.1Uru/Gabra2tm1.1Uru
(129-Gabra2tm1.1Uru)
|
abnormal GABA-mediated receptor currents
|
J:65100
|
Gabra2tm2.1Uru/Gabra2tm2.1Uru
Tg(Scn10a-cre)1Rkun/0
(involves: C57BL/6 * DBA/2 * SJL)
|
abnormal CNS synaptic transmission
|
J:173378
|
| abnormal GABA-mediated receptor currents
|
J:173378
|
Gabra3tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prepulse inhibition
|
J:101679
|
Gabra3tm2Uru/Y
(129X1(Cg)-Gabra3tm2Uru)
|
abnormal GABA-mediated receptor currents
|
J:103831
|
| decreased prepulse inhibition
|
J:103831
|
Gabra3tm2Uru/Gabra3tm2Uru
(129X1(Cg)-Gabra3tm2Uru)
|
abnormal GABA-mediated receptor currents
|
J:103831
|
| decreased prepulse inhibition
|
J:103831
|
Gabra4tm1.1Geh/Gabra4tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * FVB/N)
|
abnormal GABA-mediated receptor currents
|
J:115154
|
| abnormal inhibitory postsynaptic currents
|
J:115154
|
Gabra5tm1.1Uru/Gabra5tm1.1Uru
(129X1/SvJ-Gabra5tm1.1Uru)
|
decreased prepulse inhibition
|
J:127869
|
Gabra5tm1Twr/Gabra5tm1Twr
(involves: 129S7/SvEvBrd)
|
abnormal GABA-mediated receptor currents
|
J:107253
|
| abnormal long-term potentiation
|
J:107253
|
Gabra5tm1Twr/Gabra5tm1Twr
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:108206
|
Gabrb1m1Qnma/Gabrb1+
(involves: BALB/cAnN * C3H/HeH)
|
abnormal miniature inhibitory postsynaptic currents
|
J:223500
|
| abnormal single cell response
|
J:223500
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:223500
|
| increased miniature inhibitory postsynaptic current amplitude
|
J:223500
|
Gabrb1m2Qnma/Gabrb1+
(involves: BALB/cAnN * C3H/HeH)
|
abnormal miniature inhibitory postsynaptic currents
|
J:223500
|
| abnormal single cell response
|
J:223500
|
Gabrb2tm1Twr/Gabrb2tm1Twr
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal GABA-mediated receptor currents
|
J:69290
|
Gabrb3tm1Geh/Gabrb3tm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:39801
|
| seizures
|
J:39801
|
Gabrb3tm1Uru/Gabrb3tm1Uru
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal action potential
|
J:81497,
J:105539
|
| abnormal CNS synaptic transmission
|
J:105539
|
| abnormal GABA-mediated receptor currents
|
J:81497
|
Gabrb3tm2.1Geh/Gabrb3tm2.1Geh
Tg(Camk2a-cre)T29-1Stl/?
(involves: 129 * BALB/c * C57BL/6 * SJL)
|
absence seizures
|
J:127877
|
Gabrb3tm2.1Uru/Gabrb3tm2.1Uru
(B6J.129S6(Cg)-Gabrb3tm2.1Uru)
|
abnormal CNS synaptic transmission
|
J:228332
|
| abnormal inhibitory postsynaptic potential
|
J:228332
|
| increased excitatory postsynaptic current amplitude
|
J:228332
|
| increased susceptibility to pharmacologically induced seizures
|
J:228332
|
| prolonged excitatory postsynaptic current decay time
|
J:228332
|
Gabrdtm1.1Jmag/Gabrd+
Gad2tm2(cre)Zjh/Gad2+
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
abnormal CNS synaptic transmission
|
J:203336
|
| abnormal GABAergic neuron physiology
|
J:203336
|
| abnormal inhibitory postsynaptic currents
|
J:203336
|
| decreased susceptibility to pharmacologically induced seizures
|
J:203336
|
| impaired ability to fire action potentials
|
J:203336
|
| increased excitatory postsynaptic current amplitude
|
J:203336
|
Gabrdtm1Geh/Gabrdtm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal inhibitory postsynaptic currents
|
J:64288
|
| absence seizures
|
J:64288
|
Gabrdtm1Geh/Gabrdtm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:145475
|
Gabrg2tm1.1(Gabrg2)Wwis/Gabrg2tm1.1(Gabrg2)Wwis
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal inhibitory postsynaptic currents
|
J:199326
|
Gabrg2tm1.1Stmo/Gabrg2+
(B6.129S2-Gabrg2tm1.1Stmo)
|
abnormal miniature inhibitory postsynaptic currents
|
J:154745
|
| increased miniature inhibitory postsynaptic current amplitude
|
J:154745
|
| increased miniature inhibitory postsynaptic current frequency
|
J:154745
|
Gabrg2tm1.2Rmac/Gabrg2+
(involves: C57BL/6 * C57BL/6J * SJL)
|
abnormal nervous system electrophysiology
|
J:306976
|
| absence seizures
|
J:306976
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:306976
|
| febrile seizures
|
J:306976
|
| increased susceptibility to pharmacologically induced seizures
|
J:306976
|
| myoclonus
|
J:306976
|
| seizures
|
J:306976
|
| tonic-clonic seizures
|
J:306976
|
Gabrg2tm1Geh/Gabrg2tm1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal GABA-mediated receptor currents
|
J:53823
|
Gabrg2tm1Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:127120
|
| absence seizures
|
J:127120
|
| increased susceptibility to pharmacologically induced seizures
|
J:127120
|
Gabrg2tm1Spet/Gabrg2+
(involves: 129 * BALB/cJ * C57BL/6 * DBA/2J)
|
abnormal inhibitory postsynaptic currents
|
J:127120
|
| absence seizures
|
J:127120
|
Gabrg2tm1Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ)
|
increased susceptibility to pharmacologically induced seizures
|
J:194736
|
Gabrg2tm1Spet/Gabrg2tm1Spet
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)
|
abnormal brain wave pattern
|
J:127120
|
Gabrg2tm1Spet/Gabrg2tm1Spet
n-TRtct5m1J/n-TRtct5m1J
(B6.129(Cg)-Gabrg2tm1Spet/Frk)
|
abnormal spike wave discharge
|
J:297745
|
Gabrg2tm1Spet/Gabrg2tm1Spet
n-TRtct5m1J/n-TRtct5m1J
Tg(n-TRtct5)574Slac/0
(B6.129(Cg)-Gabrg2tm1Spet Tg(n-TRtct5)574Slac)
|
abnormal spike wave discharge
|
J:297745
|
Gabrg2tm1Wul/Gabrg2tm1Wul
Hdctm1.1(icre)Wwis/Hdc+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal GABA-mediated receptor currents
|
J:188103
|
| abnormal inhibitory postsynaptic currents
|
J:188103
|
| abnormal neuron physiology
|
J:188103
|
Gabrg2tm1Wul/Gabrg2tm1Wul
Tg(Pcp2-cre)2Mpin/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:124171
|
Gabrg2tm1Wul/Gabrg2tm1Wul
Tg(Pcp2-cre)2Mpin/?
Tg(Pcp2-EGFP/Gabrg2)1Wul/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal inhibitory postsynaptic currents
|
J:124171
|
Gabrg2tm2Lusc/Gabrg2tm2Lusc
Tg(Camk2a-cre)2834Lusc/0
(involves: 129P2/OlaHsd * 129X1/SvJ)
|
seizures
|
J:86221
|
Gabrg2tm2Spet/Gabrg2+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased susceptibility to pharmacologically induced seizures
|
J:194196
|
Gabrg2tm2Spet/Gabrg2+
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)LC1Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:194736
|
Gabrqtm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prepulse inhibition
|
J:101679
|
Gabrr1tm1Llu/Gabrr1tm1Llu
(involves: 129S4/SvJae * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:86721
|
Gad1tm1(Gria2)Mony/Gad1tm1(Gria2)Mony
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal brain wave pattern
|
J:134013
|
| abnormal excitatory postsynaptic potential
|
J:134013
|
Gad1tm1.1Tama/Gad1+
Pcntm239Asp/Pcntm239Asp
(involves: C57BL/6 * C57BL/6J * CBA * FVB/N)
|
abnormal neuronal migration
|
J:158418
|
| abnormal neuronal precursor proliferation
|
J:158418
|
Gad1tm1.1Tama/Gad1+
Pkd2l1tm1.1Yuni/Pkd2l1tm1.1Yuni
(involves: 129S/SvEv * C57BL/6 * CBA)
|
abnormal nerve fiber response
|
J:172581
|
Gad1tm1Tama/?
Lhx6tm2Vpa/Lhx6tm2Vpa
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * CBA)
|
abnormal neuronal migration
|
J:119476
|
Gad1tm1Tama/Gad1tm1Tama
(involves: C57BL/6 * CBA)
|
abnormal nervous system electrophysiology
|
J:100809
|
Gad1tm1Tama/Gad1tm1Tama
Gad2tm1Oba/Gad2tm1Oba
(involves: C57BL/6 * CBA)
|
abnormal nerve fiber response
|
J:122055
|
| abnormal nervous system electrophysiology
|
J:122055
|
Gad1tm2Oba/Gad1tm2Oba
Ptf1atm1.1(cre)Cvw/Ptf1a+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal inhibitory postsynaptic currents
|
J:134497
|
Gad2tm1b(EUCOMM)Wtsi/Gad2tm1b(EUCOMM)Wtsi
(C57BL/6N-Gad2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Gad2tm1Bae/Gad2tm1Bae
(involves: 129X1/SvJ * C57BL/6)
|
seizures
|
J:44638
|
Gad2tm1Bae/Gad2tm1Bae
(involves: 129X1/SvJ * NOD)
|
seizures
|
J:44638
|
Gad2tm1Miya/Gad2tm1Miya
(NOD.129P2-Gad2tm1Miya)
|
seizures
|
J:88785
|
Gad2tm1Oba/Gad2+
(involves: C57BL/6 * CBA)
|
seizures
|
J:37576
|
Gad2tm1Oba/Gad2tm1Oba
(involves: C57BL/6 * CBA)
|
myoclonus
|
J:62320
|
| seizures
|
J:62320,
J:37576
|
| tonic-clonic seizures
|
J:62320
|
Gaktm2Legr/Gaktm2Legr
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:180119
|
Gal3st1tm1Kho/Gal3st1tm1Kho
(involves: 129P2/OlaHsd)
|
abnormal myelination
|
J:78560
|
Galtm1Wyn/Galtm1Wyn
(129P2-Galtm1Wyn)
|
abnormal nervous system regeneration
|
J:65261
|
| abnormal pituitary secretion
|
J:78046
|
| enhanced long-term potentiation
|
J:77625
|
| increased susceptibility to neuronal excitotoxicity
|
J:89287
|
| increased susceptibility to pharmacologically induced seizures
|
J:77625
|
| seizures
|
J:77625
|
Galtm1Wyn/Galtm1Wyn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal pituitary secretion
|
J:84420
|
Galctm1Wngr/Galctm1Wngr
(involves: 129S2/SvPas)
|
demyelination
|
J:78691
|
Galctwi-5J/Galctwi-5J
(BXD32/TyJ-Galctwi-5J/J)
|
demyelination
|
J:139715,
J:199132
|
Galctwi/Galctwi
(B6.CE-Galctwi/J)
|
demyelination
|
J:108359,
J:170081,
J:126892
|
Galctwi/Galctwi
(involves: CE/J)
|
abnormal glial cell apoptosis
|
J:57215
|
| abnormal nervous system physiology
|
J:7115
|
| CNS inflammation
|
J:78223
|
| demyelination
|
J:78223,
J:13867
|
Galctwi/Galctwi
(involves: C57BL/6J * CAST/EiJ * CE/J)
|
demyelination
|
J:126892
|
Galctwi/Galctwi
Glb1tm1Adz/Glb1+
(involves: 129P2/OlaHsd * C57BL/6J * CE/J)
|
demyelination
|
J:63197
|
| seizures
|
J:63197
|
Galctwi/Galctwi
Glb1tm1Adz/Glb1tm1Adz
(involves: 129P2/OlaHsd * C57BL/6J * CE/J)
|
demyelination
|
J:63197
|
Galctwi/Galctwi
Il6+/?
(involves: 129S2/SvPas * C57BL/6J * CE/J)
|
abnormal blood-brain barrier function
|
J:56656
|
| demyelination
|
J:56656
|
Galctwi/Galctwi
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6J * CE/J)
|
abnormal blood-brain barrier function
|
J:56656
|
Galr1tm1Tpi/Galr1tm1Tpi
(B6.129S1-Galr1tm1Tpi)
|
abnormal excitatory postsynaptic potential
|
J:214920
|
Galr2Gt(OST105469)Lex/Galr2Gt(OST105469)Lex
(B6.129S5-Galr2Gt(OST105469)Lex)
|
abnormal excitatory postsynaptic potential
|
J:214920
|
GaltGt(E285B04)Wrst/GaltGt(E285B04)Wrst
(involves: 129P2/OlaHsd * C57BL/6J)
|
brain inflammation
|
J:234753
|
Gantm1Yany/Gantm1Yany
(Not Specified)
|
abnormal axonal transport
|
J:108239
|
| seizures
|
J:108239
|
Gap43tm1Kmr/Gap43tm1Kmr
(B6.129S1-Gap43tm1Kmr)
|
abnormal neuronal precursor proliferation
|
J:126908
|
Gars1C201R/Gars1+
(involves: BALB/cAnN * C3H/HeH * C57BL/6J)
|
decreased nerve conduction velocity
|
J:149830,
J:179811
|
Gars1C201R/Gars1+
Nrcamm1J/Nrcamm1J
(involves: BALB/cAnN * C3H/HeH * C57BL/6J)
|
decreased nerve conduction velocity
|
J:240096
|
Gars1C201R/Gars1+
Scn8am10J/Scn8a+
(involves: BALB/cAnN * C3H/HeJ * FVB/NJ)
|
decreased nerve conduction velocity
|
J:240096
|
Gars1C201R/Gars1+
Tg(CAG-GARS)DRwb/0
(involves: BALB/cAnN * C3H/HeH * C57BL/6J * FVB/N)
|
decreased nerve conduction velocity
|
J:179811
|
Gars1C201R/Gars1+
Tg(Thy1-YFP)16Jrs/?
(involves: BALB/cAnN * C3H/HeH * C57BL/6J * CBA)
|
abnormal PNS synaptic transmission
|
J:229590
|
| abnormal synaptic transmission
|
J:229590
|
Gars1C201R/Gars1C201R
Tg(CAG-GARS)DRwb/0
(involves: BALB/cAnN * C3H/HeH * C57BL/6J * FVB/N)
|
decreased nerve conduction velocity
|
J:179811
|
Gars1C201R/Gars1Gt(XM256)6Byg
Tg(CAG-GARS)DRwb/0
(involves: 129P2/OlaHsd * BALB/cAnN * C3H/HeH * C57BL/6J * FVB/N)
|
decreased nerve conduction velocity
|
J:179811
|
Gars1em1Rwb/Gars1em2Rwb
(involves: C57BL/6NJ * FVB/NJ)
|
decreased nerve conduction velocity
|
J:284948
|
Gars1Nmf249/Gars1+
(C57BL/6J-Gars1Nmf249/J)
|
abnormal nerve conduction
|
J:112221
|
| abnormal PNS synaptic transmission
|
J:112221
|
Gars1Nmf249/Gars1+
(involves: C57BL/6J * CAST/Ei)
|
decreased nerve conduction velocity
|
J:179811
|
| demyelination
|
J:179811
|
Gars1Nmf249/Gars1+
Scn8am10J/Scn8a+
(involves: C57BL/6J * FVB/NJ)
|
decreased nerve conduction velocity
|
J:240096
|
Gars1Nmf249/Gars1+
Tg(CAG-GARS)DRwb/0
(involves: C57BL/6J * CAST/Ei * FVB/N)
|
decreased nerve conduction velocity
|
J:179811
|
Gars1Nmf249/Gars1+
Tg(Thy1-YFP)16Jrs/?
(involves: C57BL/6J * CAST/Ei * CBA/J)
|
abnormal endplate potential
|
J:229590
|
| abnormal PNS synaptic transmission
|
J:229590
|
| abnormal synaptic transmission
|
J:229590
|
Gas7tm1Slch/Gas7tm1Slch
(B6.129-Gas7tm1Slch)
|
abnormal motor nerve collateral sprouting
|
J:227375
|
Gas8Gt(CH0760)Wtsi/Gas8Gt(CH0760)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal brain ependyma motile cilium physiology
|
J:234173
|
Gata2tm1Sac/Gata2tm1Sac
Tg(Cga-cre)3Sac/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SJL)
|
abnormal pituitary secretion
|
J:108963
|
Gatmtm1b(KOMP)Wtsi/Gatmtm1b(KOMP)Wtsi
(C57BL/6N-Gatmtm1b(KOMP)Wtsi/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Gba1tm1Karl/Gba1tm1Karl
Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
seizures
|
J:127108
|
Gba1tm2Karl/Gba1tm2Karl
Tg(KRT14-cre)8Brn/?
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
seizures
|
J:127108
|
Gbx1tm1Mrh/Gbx1tm1Mrh
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased nerve conduction velocity
|
J:201154
|
Gclmtm1Tdal/Gclmtm1Tdal
(B6.129-Gclmtm1Tdal)
|
abnormal nervous system electrophysiology
|
J:197430
|
Gclmtm1Tjka/Gclmtm1Tjka
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:129361
|
Gclmtm1Tjka/Gclmtm1Tjka
(involves: 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to neuronal excitotoxicity
|
J:129045
|
Gdap1tm1.1Ics/Gdap1tm1.1Ics
(Not Specified)
|
abnormal action potential
|
J:221297
|
| abnormal axonal transport
|
J:221297
|
| decreased nerve conduction velocity
|
J:221297
|
| dysmyelination
|
J:221297
|
Gdap1tm1.2Geno/Gdap1tm1.2Geno
(involves: 129 * C57BL/6)
|
abnormal action potential
|
J:224701
|
| abnormal axonal transport
|
J:224701
|
| decreased nerve conduction velocity
|
J:224701
|
Gdap1tm1Ics/Gdap1tm1Ics
Tg(Mpz-cre)26Mes/0
(involves: FVB/NTac)
|
decreased nerve conduction velocity
|
J:221297
|
| dysmyelination
|
J:221297
|
Gdf7tm3(cre)Tmj/Gdf7+
Otx2tm6Asim/Otx2tm6Asim
Tg(CAG-cat,-EGFP)1Rbns/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal nervous system physiology
|
J:194049
|
Gdi1tm1Toni/Y
(either: B6.129S7-Gdi1tm1Toni or (involves: 129S7/SvEvBrd * C57BL/6J) or (involves: 129S7/SvEvBrd * C57BL/6J * DBA/2))
|
abnormal excitatory postsynaptic potential
|
J:79454
|
Gdi1tm1Toni/Y
(B6N.129S7-Gdi1tm1Toni)
|
abnormal excitatory postsynaptic potential
|
J:142806
|
| abnormal synaptic glutamate release
|
J:142806
|
| decreased synaptic glutamate release
|
J:142806
|
| enhanced paired-pulse facilitation
|
J:142806
|
Gdi1tm1Ytk/Gdi1tm1Ytk
(either: (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * C57BL/6 * DBA/2))
|
abnormal excitatory postsynaptic currents
|
J:65258
|
| enhanced paired-pulse facilitation
|
J:65258
|
| increased susceptibility to pharmacologically induced seizures
|
J:65258
|
Gdnftm1Rosl/Gdnf+
(involves: 129S2/SvPas * C57BL/6)
|
abnormal neurotransmitter secretion
|
J:82456
|
Gdnftm1Rosl/Gdnf+
Nrtntm1Jmi/Nrtntm1Jmi
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal neurotransmitter secretion
|
J:82456
|
Gdpd2tm1.1Soc/Y
(involves: 129/Sv * BALB/cJ * C57BL/6J)
|
increased neuronal precursor proliferation
|
J:291492
|
Gdpd2tm1.1Soc/Gdpd2tm1.1Soc
(involves: 129/Sv * BALB/cJ * C57BL/6J)
|
increased neuronal precursor proliferation
|
J:291492
|
Gdpd5tm1.1Itl/Gdpd5tm1.1Itl
(involves: 129 * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:178550
|
Gdpd5tm1b(EUCOMM)Hmgu/Gdpd5tm1b(EUCOMM)Hmgu
(C57BL/6N-Gdpd5tm1b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Gena217/Gena217+
(involves: BALB/c * C3H/HeH)
|
decreased prepulse inhibition
|
J:169366
|
Gfaptm1Ito/Gfaptm1Ito
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal excitatory postsynaptic potential
|
J:32098
|
| reduced long-term depression
|
J:32098
|
Gfaptm1Ldtk/Gfaptm1Ldtk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal blood-brain barrier function
|
J:77630
|
| abnormal myelination
|
J:77630
|
| abnormal oligodendrocyte physiology
|
J:77630
|
Gfaptm1Mes/Gfaptm1Mes
(either: (involves: 129S7/SvEvBrd * 129X1/SvJ) or (involves: 129S7/SvEvBrd * C57BL/6))
|
enhanced long-term potentiation
|
J:64290
|
Gfaptm1Pkny/Gfaptm1Pkny
Ppt1tm1Hof/Ppt1tm1Hof
Vimtm1Cba/Vimtm1Cba
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
brain inflammation
|
J:177265
|
Gfaptm1Pkny/Gfaptm1Pkny
Vimtm1Cba/Vimtm1Cba
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6)
|
abnormal astrocyte physiology
|
J:125659
|
| decreased neuron apoptosis
|
J:123278
|
| intracranial hemorrhage
|
J:124385
|
Gfaptm2Mes/Gfap+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N)
|
increased susceptibility to pharmacologically induced seizures
|
J:114689
|
Gfaptm2Mes/Gfap+
Tg(GFAP)10Mes/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * FVB/N)
|
seizures
|
J:114689
|
Gfi1tm1(cre)Gan/Gfi1+
Rfx1tm1.1Wrth/Rfx1tm1.1Wrth
Rfx3tm2Wrth/Rfx3tm2Wrth
(involves: 129 * 129S7/SvEvBrd)
|
abnormal cochlear outer hair cell physiology
|
J:227631
|
Gfra1tm1Jmi/Gfra1+
(involves: 129X1/SvJ * C57BL/6)
|
abnormal neurotransmitter secretion
|
J:82456
|
Gfra1tm1Jmi/Gfra1tm2Jmi
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129/Sv * C57BL/6 * CBA * SJL)
|
abnormal neuronal precursor proliferation
|
J:122607
|
Gfra2tm1Msa/Gfra2tm1Msa
(either: (involves: 129S1/Sv * 129S2/SvHsd * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6NHsd))
|
decreased kindling response
|
J:53284
|
Gfra3tm1Adav/Gfra3tm1Adav
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1)
|
abnormal neuronal precursor proliferation
|
J:71959
|
Gfra3tm1Hmd/Gfra3tm1Hmd
(involves: 129P2/OlaHsd * C57BL/6Cr)
|
abnormal neuronal migration
|
J:57342
|
| increased neuron apoptosis
|
J:57342
|
Ghtm1.1(KOMP)Vlcg/Ghtm1.1(KOMP)Vlcg
(C57BL/6N-Ghtm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Gipc3tm1b(KOMP)Wtsi/Gipc3tm1b(KOMP)Wtsi
(C57BL/6N-Gipc3tm1b(KOMP)Wtsi/J)
|
decreased prepulse inhibition
|
J:211773
|
Git1Gt(FHCRC-GT-S10-12C1)Sor/Git1Gt(FHCRC-GT-S10-12C1)Sor
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal brain wave pattern
|
J:171608
|
| abnormal CNS synaptic transmission
|
J:171608
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:171608
|
Gja1tm1Kwi/Gja1tm1Kwi
Tg(S100b-cre)20Ito/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal glial cell physiology
|
J:159160
|
Gja10tm2.1(cre)Kwi/Gja10+
Gria4tm1Mony/Gria4tm1Mony
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal glutamate-mediated receptor currents
|
J:207456
|
Gjb1tm1Kwi/Y
(involves: 129S4/SvJae * C57BL/6)
|
demyelination
|
J:85828
|
Gjb1tm1Kwi/Y
(involves: 129S4/SvJae)
|
abnormal myelination
|
J:40955
|
| abnormal nerve conduction
|
J:40955
|
| demyelination
|
J:40955
|
Gjb1tm1Kwi/Y
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal oligodendrocyte apoptosis
|
J:219594
|
| demyelination
|
J:219594
|
| dysmyelination
|
J:219594
|
| optic nerve inflammation
|
J:219594
|
| spinal cord inflammation
|
J:219594
|
| tonic seizures
|
J:219594
|
Gjb1tm1Kwi/Y
Gjc2tm2.1Kwi/Gjc2tm2.1Kwi
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
abnormal myelination
|
J:174197
|
Gjb1tm1Kwi/Gjb1+
(involves: 129S4/SvJae * C57BL/6)
|
demyelination
|
J:85828
|
Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129S4/SvJae * C57BL/6)
|
demyelination
|
J:85828
|
Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129S4/SvJae)
|
abnormal myelination
|
J:40955
|
| abnormal nerve conduction
|
J:40955
|
| demyelination
|
J:40955
|
Gjb2tm1Ugds/Gjb2tm1Ugds
Tg(Sox10-cre)1Wdr/0
(involves: 129S2/SvPasCrl * C57BL/6 * CBA)
|
abnormal hair cell physiology
|
J:178055
|
Gjb6tm1Kwi/Gjb6+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal nervous system physiology
|
J:89971
|
Gjb6tm1Kwi/Gjb6tm1Kwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal hair cell physiology
|
J:178055
|
Gjb6tm1Kwi/Gjb6tm1Kwi
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal nervous system physiology
|
J:89971
|
Gjc1tm2.1Kni/Gjc1tm2.1Kni
(Not Specified)
|
increased embryonic neuroepithelium apoptosis
|
J:103078
|
Gjc1tm2Kni/Gjc1tm2Kni
Tg(ACTC1-cre)1Miwa/0
(involves: C57BL/6 * DBA)
|
increased embryonic neuroepithelium apoptosis
|
J:103078
|
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myelination
|
J:83885,
J:174197
|
| abnormal oligodendrocyte physiology
|
J:174197
|
Gjc2tm1(EGFP)Kwi/Gjc2tm1(EGFP)Kwi
Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal myelination
|
J:83885
|
| abnormal oligodendrocyte apoptosis
|
J:219594
|
| demyelination
|
J:219594
|
| dysmyelination
|
J:219594
|
| optic nerve inflammation
|
J:219594
|
| seizures
|
J:83885
|
| spinal cord inflammation
|
J:219594
|
| sporadic seizures
|
J:83885
|
| tonic seizures
|
J:83885,
J:219594
|
Gjc2tm1Paul/Gjc2tm1Paul
Gjb1tm1Kwi/Gjb1tm1Kwi
(involves: 129/Sv * C57BL/6)
|
abnormal myelination
|
J:84338
|
| demyelination
|
J:84338
|
| tonic seizures
|
J:84338
|
Gjc2tm2.1Kwi/Gjc2+
(involves: C57BL/6 * SJL)
|
abnormal oligodendrocyte physiology
|
J:174197
|
Gjc2tm2.1Kwi/Gjc2tm2.1Kwi
(involves: C57BL/6 * SJL)
|
abnormal myelination
|
J:174197
|
| abnormal oligodendrocyte physiology
|
J:174197
|
Gjc3tm1Paul/Gjc3tm1Paul
(involves: 129S4/SvJae)
|
demyelination
|
J:105700
|
Gjd2tm1Kwi/Gjd2tm1Kwi
(involves: 129P2/OlaHsd)
|
abnormal nervous system electrophysiology
|
J:99856
|
Gjd2tm1Kwi/Gjd2tm1Kwi
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal nerve fiber response
|
J:145292
|
| abnormal single cell response
|
J:145292
|
Gjd2tm1Mony/Gjd2tm1Mony
(Not Specified)
|
abnormal action potential
|
J:71116
|
| abnormal brain wave pattern
|
J:71116
|
| abnormal CNS synaptic transmission
|
J:71116
|
| abnormal excitatory postsynaptic potential
|
J:71116
|
| abnormal inhibitory postsynaptic potential
|
J:71116
|
Gjd2tm1Paul/Gjd2tm1Paul
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:71117
|
Gktm1Wjc/Y
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal pituitary secretion
|
J:43449
|
GldcGt(EUCG0001d02)Hmgu/GldcGt(EUCG0001d02)Hmgu
(B6.129P2-GldcGt(EUCG0001d02)Hmgu)
|
intracranial hemorrhage
|
J:221782
|
Gli1tm2Alj/Gli1+
Gli2tm1Alj/Gli2tm1Alj
Gli3Xt/Gli3Xt
(involves: 101/H * 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C3H/HeH * C57BL * CBA/H * Swiss Webster)
|
abnormal neuronal precursor proliferation
|
J:87948
|
Gli3Pdn/Gli3Pdn
(involves: Jcl:ICR)
|
abnormal neuronal migration
|
J:43330
|
Gli3tm1Alj/Gli3+
Tgif1tm1Caw/Tgif1tm1Caw
Tgif2tm1Dwot/Tgif2tm1Dwot
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J * CBA)
|
decreased embryonic neuroepithelial cell proliferation
|
J:183402
|
Glra1m1Cpai/Glra1m1Cpai
(involves: 129 * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:248717
|
| abnormal inhibitory postsynaptic currents
|
J:248717
|
| abnormal miniature inhibitory postsynaptic currents
|
J:248717
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:248717
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:248717
|
Glra1nmf11/Glra1nmf11
(C57BL/6J-Glra1nmf11/J)
|
seizures
|
J:78134
|
Glra1spd-ot9J/Glra1spd-ot9J
(B6.Cg-Glra1spd-ot9J/GrsrJ)
|
tonic-clonic seizures
|
J:234690
|
Glra1spd-ot/Glra1spd-ot
(involves: C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:107942
|
Glra1tm1.1Geh/Glra1tm1.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to pharmacologically induced seizures
|
J:177105
|
Glra1tm1Betz/Glra1tm1Betz
(B6.129P2-Glra1tm1Betz)
|
abnormal inhibitory postsynaptic currents
|
J:117236
|
| abnormal single cell response
|
J:117236
|
Glra1tm1Rah/Glra1+
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal channel response
|
J:85341
|
Glra1tm1Rah/Glra1tm1Rah
(involves: 129X1/SvJ * C57BL/6J)
|
seizures
|
J:85341
|
Glra1tm2.1Geh/Glra1tm2.1Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to pharmacologically induced seizures
|
J:177106
|
Glra2tm1.2Lngu/Y
Tg(mI56i-cre,EGFP)1Kc/0
(involves: 129S4/SvJae * C57BL/6J * FVB/N * MF1)
|
abnormal neuronal migration
|
J:202763
|
Glra2tm1.2Lngu/Glra2tm1.2Lngu
Tg(mI56i-cre,EGFP)1Kc/0
(involves: 129S4/SvJae * C57BL/6J * FVB/N * MF1)
|
abnormal neuronal migration
|
J:202763
|
Glra2tm1Clc/Glra2tm1Clc
(involves: 129X1/SvJ)
|
abnormal single cell response
|
J:111414
|
Glra2tm1Lex/Glra2tm1Lex
(Not Specified)
|
abnormal inhibitory postsynaptic currents
|
J:132622
|
Glra3tm1.1Umu/Glra3tm1.1Umu
(involves: 129P2/OlaHsd)
|
abnormal inhibitory postsynaptic currents
|
J:132622
|
Glra3tm1Dgen/Glra3tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Glrx3Gt(RRF094)Byg/Glrx3Gt(RRF094)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
intracranial hemorrhage
|
J:143577
|
Glt8d1tm1Lex/Glt8d1tm1Lex
(B6;129S5-Glt8d1tm1Lex/Mmucd)
|
reduced sensorimotor gating
|
J:171883
|
Glultm1.1Ncd/Glultm1.1Ncd
Emx1tm1(cre)Krj/Emx1+
(B6.Cg-Glultm1.1Ncd Emx1tm1(cre)Krj)
|
seizures
|
J:272643
|
Gm4922em1(IMPC)Tcp/Gm4922em1(IMPC)Tcp
(C57BL/6NCrl-Gm4922em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Gm30731tm1.1Dalm/Gm30731tm1.1Dalm
Emx1tm1(cre)Krj/Emx1+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6)
|
abnormal neuronal stem cell physiology
|
J:281278
|
Gm30731tm1.1Dalm/Gm30731tm1.1Dalm
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal neuronal stem cell physiology
|
J:281278
|
Gm30731tm1.1Dalm/Gm30731tm1.1Dalm
Ndor1Tg(UBC-cre/ERT2)1Ejb/Ndor1+
(involves: 129S/SvEv * C57BL/6)
|
abnormal neuronal stem cell physiology
|
J:281278
|
Gm30731tm1.2Dalm/Gm30731tm1.2Dalm
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
abnormal neuronal stem cell physiology
|
J:281278
|
Gm41261em1Geh/Gm41261em1Geh
(C57BL/6J-Gm41261em1Geh)
|
abnormal miniature inhibitory postsynaptic currents
|
J:345829
|
| increased miniature inhibitory postsynaptic current frequency
|
J:345829
|
Gmppaem1(IMPC)Tcp/Gmppaem1(IMPC)Tcp
(C57BL/6N-Gmppaem1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Gmppatm1d(EUCOMM)Wtsi/Gmppatm1d(EUCOMM)Wtsi
(involves: C57BL/6N)
|
decreased nerve conduction velocity
|
J:305791
|
Gna11tm1Soff/Gna11tm1Soff
Gnaqtm2Soff/Gnaqtm2Soff
Tg(Camk2a-cre)1Gsc/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
abnormal nervous system electrophysiology
|
J:123222
|
| clonic seizures
|
J:111559
|
| seizures
|
J:111559
|
| tonic-clonic seizures
|
J:111559
|
Gnai1tm1Drs/Gnai1+
(Not Specified)
|
abnormal long-term potentiation
|
J:87423
|
Gnai1tm1Drs/Gnai1tm1Drs
(Not Specified)
|
abnormal long-term potentiation
|
J:87423
|
Gnao1em1Rneu/Gnao1+
(involves: C57BL/6J * C57BL/6NCrl)
|
increased kindling response
|
J:271137
|
Gnao1tm1Ejne/Gnao1tm1Ejne
(involves: 129S4/SvJae * C57BL/6)
|
abnormal channel response
|
J:39013
|
| sporadic seizures
|
J:39013
|
Gnao1tm1Lbi/Gnao1tm1Lbi
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal channel response
|
J:46898
|
Gnao1tm2.1Rneu/Gnao1+
(B6.129S-Gnao1tm2.1Rneu)
|
abnormal kindling response
|
J:216850
|
| abnormal nervous system physiology
|
J:216850
|
Gnao1tm2Rneu/Gnao1+
(involves: 129S1/Sv * C57BL/6J)
|
abnormal spike wave discharge
|
J:197965
|
Gnao1tm4Lbi/Gnao1tm4Lbi
Omptm4(cre)Mom/?
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vomeronasal sensory neuron physiology
|
J:279957
|
Gnaqtm1Soff/Gnaqtm1Soff
(involves: 129S1/Sv * C57BL/6)
|
abnormal afterhyperpolarization
|
J:126972
|
| abnormal glutamate-mediated receptor currents
|
J:126972
|
| abnormal nervous system electrophysiology
|
J:126972
|
| absent long-term depression
|
J:70180
|
Gnat1tm1Clma/Gnat1tm1Clma
Gnat3tm1Rfm/Gnat3tm1Rfm
(involves: 129S1/Sv * BALB/c * C57BL/6)
|
abnormal somatic nervous system physiology
|
J:92635
|
Gnb1em1Dgold/Gnb1+
(C57BL/6NJ-Gnb1em1Dgold)
|
abnormal spike wave discharge
|
J:346983
|
| minimal clonic seizures
|
J:346983
|
Gnb1em1Dgold/Gnb1+
(involves: 129P2/OlaHsd * C57BL/6NJ * FVB)
|
abnormal spike wave discharge
|
J:346983
|
Gnb1Gt(prvSStrap)4B8Yiw/Gnb1Gt(prvSStrap)4B8Yiw
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:157907
|
Gnb1lGt(OST35527)Lex/Gnb1l+
(B6.Cg-Tyrc-Brd Gnb1lGt(OST35527)Lex)
|
decreased prepulse inhibition
|
J:110101
|
Gnb5flr/Gnb5flr
Myo5aflr/Myo5aflr
(involves: C57BL/6J * C57BL/10J * CBA/Ca)
|
convulsive seizures
|
J:61324
|
Gneem1(IMPC)Mbp/Gne+
(C57BL/6N-Gneem1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Gneem1Lx/Gneem1Lx
(C57BL/6J-Gneem1Lx)
|
intracranial hemorrhage
|
J:345585
|
| spinal hemorrhage
|
J:345585
|
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: FVB/N)
|
audiogenic seizures
|
J:92791
|
| convulsive seizures
|
J:92791
|
Gng3tm1.1Rbs/Gng3tm1.1Rbs
(involves: C57BL/6J * FVB/N)
|
audiogenic seizures
|
J:92791
|
Gng3tm1.1Rbs/Gng3tm1.1Rbs
Gng7tm1Lex/Gng7tm1Lex
(B6.Cg-Gng7tm1Lex Gng3tm1.1Rbs)
|
abnormal brain wave pattern
|
J:182775
|
| environmentally induced seizures
|
J:182775
|
| seizures
|
J:182775
|
| tonic-clonic seizures
|
J:182775
|
Gng7tm1Lex/Gng7tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal nervous system physiology
|
J:81988
|
Gng13tm1Liqh/Gng13tm1Liqh
Omptm4(cre)Mom/Omp+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
abnormal olfactory sensory neuron physiology
|
J:197147
|
Gnpattm1Just/Gnpattm1Just
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal cerebellar granule cell migration
|
J:148119
|
| abnormal myelination
|
J:148119
|
| decreased nerve conduction velocity
|
J:148119
|
Gnptabnym/Gnptabnym
(involves: BALB/cAnNHsd * C3H/HeNHsd)
|
brain inflammation
|
J:218156
|
| demyelination
|
J:218156
|
Gnrh1hpg/Gnrh1hpg
(involves: 101/H * C3H/HeH)
|
abnormal pituitary gland physiology
|
J:5877
|
Gnrhrtm2.1(GNRHR)Djb/Gnrhrtm2.1(GNRHR)Djb
(involves: 129 * C57BL/6J * FVB/N)
|
abnormal pituitary gland physiology
|
J:324870
|
Golga2tm1.1Baos/Golga2tm1.1Baos
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
increased neuron apoptosis
|
J:272184
|
Gpcpd1em1(IMPC)Tcp/Gpcpd1+
(C57BL/6N-Gpcpd1em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Gphntm1Jrs/Gphntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:98106
|
Gpm6btm1KanPlp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal myelination
|
J:193310
|
| abnormal oligodendrocyte apoptosis
|
J:193310
|
| demyelination
|
J:193310
|
Gpr4tm1Mglg/Gpr4tm1Mglg
Tg(Phox2b-EGFP)JX99Gsat/0
(either: (involves: BALB/c * FVB/NTac) or (involves: BALB/c * C57BL/6J * FVB/NTac))
|
abnormal nerve fiber response
|
J:224758
|
Gpr17tm1Qrlu/Gpr17tm1Qrlu
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal myelination
|
J:154602
|
Gpr37tm1.1Ryot/Gpr37tm1.1Ryot
(involves: C57BL/6)
|
abnormal CNS synaptic transmission
|
J:128745
|
| abnormal inhibitory postsynaptic currents
|
J:128745
|
| abnormal neuron physiology
|
J:128745
|
| decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:128745
|
Gpr37l1tm1.2Gtva/Gpr37l1tm1.2Gtva
(involves: 129S/SvEv * BALB/c * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:201190
|
Gpr37l1tm1.2Gtva/Gpr37l1tm1.2Gtva
Ptch1tm1Zim/Ptch1+
(STOCK Gpr37l1tm1.2Gtva Ptch1tm1Zim/Cnrm)
|
decreased cerebellar granule cell precursor proliferation
|
J:272049
|
Gpr61tm1Dgen/Gpr61tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal hypothalamus physiology
|
J:302257
|
Gpr88tm1.1(cre/GFP)Rpa/Gpr88tm1.1(cre/GFP)Rpa
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:193543
|
| abnormal GABA-mediated receptor currents
|
J:193543
|
| abnormal inhibitory postsynaptic currents
|
J:193543
|
| abnormal nervous system electrophysiology
|
J:193543
|
| abnormal neuron physiology
|
J:193543
|
| increased excitatory postsynaptic current amplitude
|
J:193543
|
Gpr88tm1.2Ics/Gpr88tm1.2Ics
(involves: 129 * C57BL/6J)
|
abnormal nervous system physiology
|
J:236208
|
Gpr139tm1.1(KOMP)Vlcg/Gpr139tm1.1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal nervous system electrophysiology
|
J:280704
|
Gpr158tm1(KOMP)Vlcg/Gpr158tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
enhanced AMPA-mediated synaptic currents
|
J:263624
|
| increased excitatory postsynaptic current frequency
|
J:263624
|
Gpr161tm1.2Smuk/Gpr161tm1.2Smuk
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: C57BL/6J * CBA/J)
|
increased neuronal precursor proliferation
|
J:316181
|
Gprasp2tm1.1Jpe/Y
(B6.129(FVB)-Gprasp2tm1.1Jpe)
|
abnormal excitatory postsynaptic potential
|
J:273373
|
| abnormal long-term depression
|
J:273373
|
| decreased excitatory postsynaptic current amplitude
|
J:273373
|
Gprin3em1Sns/Gprin3em1Sns
(C57BL/6-Gprin3em1Sns)
|
abnormal nervous system electrophysiology
|
J:279507
|
Gprin3em1Sns/Gprin3em1Sns
Tg(Drd2-EGFP)S118Gsat/0
(involves: C57BL/6 * C57BL/6J * CD-1 * FVB/NTac)
|
abnormal nervous system electrophysiology
|
J:279507
|
Gpsm1tm1.1Lajb/Gpsm1tm1.1Lajb
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
abnormal baroreceptor physiology
|
J:138126
|
Gpx1tm1Kola/Gpx1tm1Kola
(involves: 129S2/SvPas * BALB/c * CF-1)
|
brain ischemia
|
J:71798
|
| increased cerebral infarct size
|
J:71798
|
| increased neuron apoptosis
|
J:71798,
J:79183
|
| increased susceptibility to ischemic brain injury
|
J:71798
|
Gpx3tm1Jlos/Gpx3tm1Jlos
(B6N.Cg-Gpx3tm1Jlos)
|
decreased cerebral infarct size
|
J:183744
|
| decreased susceptibility to ischemic brain injury
|
J:183744
|
Gpx4tm2Marc/Gpx4tm2Marc
Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * FVB/N)
|
convulsive seizures
|
J:139668
|
| increased neuron apoptosis
|
J:139668
|
Gria1em1(IMPC)H/Gria1em1(IMPC)H
(C57BL/6N-Gria1em1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Gria1em1(IMPC)Hmgu/Gria1em1(IMPC)Hmgu
(C57BL/6N-Gria1em1(IMPC)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Gria1tm1Rlh/Gria1tm1Rlh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absent long-term depression
|
J:82443
|
| reduced long-term potentiation
|
J:82443
|
Gria1tm1Rsp/Gria1tm1Rsp
(B6.129-Gria1tm1Rsp)
|
impaired synaptic plasticity
|
J:96597
|
| reduced AMPA-mediated synaptic currents
|
J:96597
|
Gria1tm1Rsp/Gria1tm1Rsp
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
reduced AMPA-mediated synaptic currents
|
J:55695
|
| reduced long-term potentiation
|
J:55695
|
Gria1tm2Rsp/Gria1tm2Rsp
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal miniature excitatory postsynaptic currents
|
J:197912
|
Gria1tm2Rsp/Gria1tm2Rsp
Tg(Pvalb-cre)1Mony/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:136763
|
| abnormal nervous system electrophysiology
|
J:136763
|
| impaired ability to fire action potentials
|
J:136763
|
| reduced AMPA-mediated synaptic currents
|
J:136763
|
Gria1tm2Rsp/Gria1tm2Rsp
Tg(Slc6a3-icre)9075Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal glutamate-mediated receptor currents
|
J:139693
|
Gria1tm4Rlh/Gria1tm4Rlh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absent long-term depression
|
J:126784
|
Gria1tm7Rlh/Gria1tm7Rlh
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal long-term potentiation
|
J:172128
|
Gria2tm1.1Bvis/Gria2tm1.1Bvis
Tg(Camk2a-cre)T29-1Stl/0
(129S6.Cg-Gria2tm1.1Bvis Tg(Camk2a-cre)T29-1Stl)
|
enhanced long-term potentiation
|
J:223717
|
Gria2tm1Phs/Gria2tm1Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:50929
|
Gria2tm1Rlh/Gria2tm1Rlh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired synaptic plasticity
|
J:99813
|
Gria2tm1Rod/Gria2+
(B6.129-Gria2tm1Rod/J)
|
abnormal AMPA-mediated synaptic currents
|
J:104951
|
| increased susceptibility to neuronal excitotoxicity
|
J:104951
|
Gria2tm1Rod/Gria2tm1Rod
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
enhanced long-term potentiation
|
J:64275
|
Gria2tm1Rod/Gria2tm1Rod
(B6.129-Gria2tm1Rod/J)
|
abnormal AMPA-mediated synaptic currents
|
J:104951
|
| increased susceptibility to neuronal excitotoxicity
|
J:104951
|
Gria2tm1Rod/Gria2tm1Rod
Gria3tm1Zpj/Y
(involves: 129/Sv * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:84336
|
| abnormal long-term depression
|
J:84336
|
| abnormal synaptic plasticity
|
J:84336
|
| enhanced long-term potentiation
|
J:84336
|
Gria2tm1Rod/Gria2tm1Rod
Tg(SOD1*G93A)1Gur/0
(B6.Cg-Gria2tm1Rod Tg(SOD1*G93A)1Gur)
|
abnormal AMPA-mediated synaptic currents
|
J:104951
|
Gria2tm1Rsp/Gria2+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal AMPA-mediated synaptic currents
|
J:30145
|
| seizures
|
J:30145
|
| tonic-clonic seizures
|
J:30145
|
Gria2tm2.1Rsp/Gria2+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal AMPA-mediated synaptic currents
|
J:51845
|
| seizures
|
J:51845
|
Gria2tm2Rlh/Gria2tm2Rlh
(involves: 129S1/Sv * 129X1/SvJ)
|
absent long-term depression
|
J:107573
|
Gria2tm2Rsp/Gria2+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal AMPA-mediated synaptic currents
|
J:51845
|
Gria2tm2Rsp/Gria2+
Tg(Camk2a-cre)1Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
seizures
|
J:111689
|
Gria2tm2Rsp/Gria2+
Tg(Gria2*586N)238.2Rsp/0
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal AMPA-mediated synaptic currents
|
J:51845
|
| seizures
|
J:51845
|
Gria2tm2Rsp/Gria2tm2Rsp
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal AMPA-mediated synaptic currents
|
J:51845
|
| abnormal excitatory postsynaptic potential
|
J:51845
|
Gria2tm3.1Rsp/Gria2tm3.1Rsp
(involves: CD-1)
|
enhanced AMPA-mediated synaptic currents
|
J:96597
|
| impaired synaptic plasticity
|
J:96597
|
Gria2tm3Rsp/Gria2tm3Rsp
Tg(Camk2a-cre)1Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * FVB/N)
|
abnormal AMPA-mediated synaptic currents
|
J:111689
|
| abnormal excitatory postsynaptic currents
|
J:111689
|
| abnormal excitatory postsynaptic potential
|
J:111689
|
| abnormal paired-pulse facilitation
|
J:111689
|
Gria2tm3Rsp/Gria2tm3Rsp
Tg(Gnrh1-cre)1Rsp/0
(involves: C57BL/6)
|
abnormal AMPA-mediated synaptic currents
|
J:103818
|
Gria2tm3Rsp/Gria2tm3Rsp
Tg(Slc6a3-icre)9075Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal glutamate-mediated receptor currents
|
J:139693
|
Gria3em1Wthg/Y
(C57BL/6-Gria3em1Wthg)
|
abnormal miniature excitatory postsynaptic currents
|
J:250314
|
Gria3tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:101679
|
Gria3tm1Dgen/Gria3tm1Dgen
Gria4spkw1/Gria4spkw1
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J)
|
absence seizures
|
J:135814
|
Gria3tm1Zpj/Y
(involves: 129/Sv * C57BL/6)
|
abnormal long-term potentiation
|
J:84336
|
Gria4spkw1/Gria4+
(involves: C3H/HeJ * C3HeB/FeJ)
|
absence seizures
|
J:135814
|
Gria4spkw1/Gria4spkw1
(involves: C3H/HeJ * C57BL/6J)
|
absence seizures
|
J:98638
|
Gria4spkw1/Gria4spkw1
(C3H/HeJ)
|
absence seizures
|
J:135814
|
Gria4spkw1/Gria4spkw1
(involves: C3H/HeJ * C3HeB/FeJ)
|
absence seizures
|
J:135814
|
Gria4spkw1/Gria4spkw1
(C3Fe.C3-Gria4spkw1)
|
abnormal spike wave discharge
|
J:228536
|
Gria4spkw1/Gria4spkw1
Pcnx2em1Frk/Pcnx2em1Frk
(C3Fe.C3-Pcnx2em1Frk Gria4spkw1)
|
abnormal spike wave discharge
|
J:228536
|
Gria4spkw1/Gria4spkw1
Pcnx2em5Frk/Pcnx2em5Frk
(C3Fe.C3-Pcnx2em5Frk Gria4spkw1)
|
abnormal spike wave discharge
|
J:228536
|
Gria4spkw1/Gria4spkw1
spkw2C3H/HeJ/spkw2C57BL/6J
(involves: C3H/HeJ * C57BL/6J)
|
absence seizures
|
J:98638
|
Gria4spkw1/Gria4tm1Dgen
(involves: 129P2/OlaHsd * C3H/HeJ * C57BL/6J)
|
absence seizures
|
J:135814
|
Gria4tm1.1Mony/Gria4tm1.1Mony
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal action potential
|
J:136763
|
| abnormal AMPA-mediated synaptic currents
|
J:136763
|
| abnormal excitatory postsynaptic potential
|
J:136763
|
| abnormal inhibitory postsynaptic potential
|
J:136763
|
| abnormal nervous system electrophysiology
|
J:136763
|
| abnormal neuron physiology
|
J:136763
|
| impaired ability to fire action potentials
|
J:136763
|
Gria4tm1Dgen/Gria4+
(involves: 129P2/OlaHsd * C57BL/6J)
|
absence seizures
|
J:135814
|
Gria4tm1Dgen/Gria4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal seizure response to pharmacological agent
|
J:101679
|
Gria4tm1Dgen/Gria4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
absence seizures
|
J:135814
|
Gria4tm1Yfkk/Gria4tm1Yfkk
(B6.129S-Gria4tm1Yfkk)
|
decreased prepulse inhibition
|
J:178206
|
Grid1em1(IMPC)J/Grid1em1(IMPC)J
(C57BL/6NJ-Grid1em1(IMPC)J/Mmjax)
|
increased prepulse inhibition
|
J:211773
|
Grid2ho-cpr/Grid2ho-cpr
(involves: C57BL/10J * DBA/2J)
|
abnormal myelination
|
J:13994
|
Grid2ho/Grid2ho
(involves: C57BLKS/J)
|
abnormal synaptic neurotransmitter level
|
J:18056
|
Grid2tm1Mim/Grid2tm1Mim
(involves: C57BL/6 * CBA)
|
abnormal CNS synaptic transmission
|
J:109764,
J:24975
|
| abnormal excitatory postsynaptic currents
|
J:73385
|
| abnormal GABA-mediated receptor currents
|
J:109764
|
| absent long-term depression
|
J:24477
|
| increased miniature inhibitory postsynaptic current amplitude
|
J:109764
|
Grid2tm1Mim/Grid2tm1Mim
(B6.Cg-Grid2tm1Mim)
|
abnormal action potential
|
J:97010
|
| increased prepulse inhibition
|
J:89405
|
Grid2tm1Mmsh/Grid2tm1Mmsh
(involves: C57BL/6N)
|
abnormal CNS synaptic transmission
|
J:127449
|
| abnormal excitatory postsynaptic currents
|
J:127449
|
| prolonged excitatory postsynaptic current decay time
|
J:127449
|
| prolonged excitatory postsynaptic current rise time
|
J:127449
|
| reduced long-term depression
|
J:127449
|
Grid2iptm1.1Mmsh/Grid2iptm1.1Mmsh
(C57BL/6-Grid2iptm1.1Mmsh)
|
abnormal long-term depression
|
J:136382
|
Grik1tm1Sfh/Grik1tm1Sfh
(involves: 129S/SvEv)
|
abnormal inhibitory postsynaptic currents
|
J:96594,
J:66021
|
| abnormal nervous system electrophysiology
|
J:96594
|
Grik1tm1Sfh/Grik1tm1Sfh
(involves: 129S/SvEv * C57BL/6)
|
enhanced long-term potentiation
|
J:98109
|
Grik1tm1Sfh/Grik1tm1Sfh
Grik2tm1Sfh/Grik2tm1Sfh
(involves: 129S/SvEv * 129S1/Sv * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:66021
|
Grik1tm2Sfh/Grik1tm2Sfh
(involves: 129S/SvEv * C57BL/6J)
|
abnormal glutamate-mediated receptor currents
|
J:57983
|
Grik2tm1Bvis/Grik2tm1Bvis
(129S/Sv-Grik2tm1Bvis)
|
abnormal CNS synaptic transmission
|
J:107698
|
| abnormal excitatory postsynaptic potential
|
J:107698
|
| abnormal long-term potentiation
|
J:107698
|
| abnormal single cell response
|
J:107698
|
| increased susceptibility to pharmacologically induced seizures
|
J:107698
|
Grik2tm1Sfh/Grik2tm1Sfh
(involves: 129S1/Sv * C57BL/6)
|
abnormal glutamate-mediated receptor currents
|
J:46932
|
| abnormal long-term potentiation
|
J:91763
|
| decreased paired-pulse facilitation
|
J:91763
|
| decreased susceptibility to pharmacologically induced seizures
|
J:46932
|
| reduced long-term potentiation
|
J:98109
|
Grik2tm1Sfh/Grik2tm1Sfh
(involves: 129S1/Sv)
|
abnormal CNS synaptic transmission
|
J:148310
|
| decreased paired-pulse facilitation
|
J:148310
|
Grik3tm1Cmul/Grik3tm1Cmul
(Not Specified)
|
abnormal CNS synaptic transmission
|
J:148310
|
| decreased paired-pulse facilitation
|
J:148310
|
| decreased post-tetanic potentiation
|
J:148310
|
| reduced long-term potentiation
|
J:148310
|
Grik4em1(IMPC)Mbp/Grik4em1(IMPC)Mbp
(C57BL/6N-Grik4em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Grik4tm1(cre)Mim/Grik4+
Grin1tm1Mim/Grin1tm1Mim
(involves: C57BL/6N)
|
abnormal brain wave pattern
|
J:144994
|
| abnormal nervous system electrophysiology
|
J:144994
|
| increased susceptibility to pharmacologically induced seizures
|
J:144994
|
| tonic-clonic seizures
|
J:144994
|
Grik4tm1.1Sfh/Grik4tm1.1Sfh
(involves: 129S4/SvJae)
|
abnormal excitatory postsynaptic currents
|
J:155003
|
Grik4tm1.1Sfh/Grik4tm1.1Sfh
Grik5tm1Cont/Grik5tm1Cont
(involves: 129S/SvEv * 129S4/SvJae)
|
abnormal excitatory postsynaptic currents
|
J:155003
|
| decreased paired-pulse facilitation
|
J:155003
|
Grik5tm1Cont/Grik5tm1Cont
(129S/SvEv-Grik5tm1Cont)
|
abnormal CNS synaptic transmission
|
J:81742
|
| abnormal excitatory postsynaptic currents
|
J:81742
|
| short excitatory postsynaptic current decay time
|
J:81742
|
Grik5tm1Dgen/Grik5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Grin1Rgsc174/Grin1+
(C57BL/6J-Grin1Rgsc174)
|
abnormal neuron physiology
|
J:160947
|
Grin1Rgsc174/Grin1Rgsc174
(C57BL/6J-Grin1Rgsc174)
|
abnormal neuron physiology
|
J:160947
|
Grin1tm1.1Ese/Grin1tm1.1Ese
(involves: C57BL/6)
|
abnormal glutamate-mediated receptor currents
|
J:153043
|
| abnormal miniature excitatory postsynaptic currents
|
J:153043
|
| decreased prepulse inhibition
|
J:153043
|
| reduced AMPA-mediated synaptic currents
|
J:153043
|
| reduced long-term potentiation
|
J:153043
|
Grin1tm1.1Phs/Grin1tm1.1Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:75497
|
| abnormal NMDA-mediated synaptic currents
|
J:75497
|
Grin1tm1Bhk/Grin1tm1Bhk
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased prepulse inhibition
|
J:91878
|
Grin1tm1Bhk/Grin1tm1Bhk
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * DBA/2)
|
decreased prepulse inhibition
|
J:203256
|
Grin1tm1Blt/Grin1tm1Blt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal nervous system physiology
|
J:62289
|
| decreased susceptibility to pharmacologically induced seizures
|
J:62289
|
| reduced long-term potentiation
|
J:62289
|
Grin1tm1c(EUCOMM)Wtsi/Grin1tm1c(EUCOMM)Wtsi
Tg(Slc6a4-cre)ET127Gsat/0
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
abnormal miniature excitatory postsynaptic currents
|
J:193625
|
| abnormal NMDA-mediated synaptic currents
|
J:193625
|
| decreased excitatory postsynaptic current amplitude
|
J:193625
|
| reduced NMDA-mediated synaptic currents
|
J:193625
|
Grin1tm1c(EUCOMM)Wtsi/Grin1tm2.1Stl
Tg(Slc6a4-cre)ET127Gsat/0
(involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL)
|
abnormal miniature excitatory postsynaptic currents
|
J:193625
|
| abnormal NMDA-mediated synaptic currents
|
J:193625
|
| decreased excitatory postsynaptic current amplitude
|
J:193625
|
| reduced NMDA-mediated synaptic currents
|
J:193625
|
Grin1tm1Cur/Grin1tm1.1Phs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absence of NMDA-mediated synaptic currents
|
J:75497
|
Grin1tm1Cur/Grin1tm1Cur
(involves: 129S1/Sv * C57BL/6)
|
abnormal glutamate-mediated receptor currents
|
J:66345
|
| absence of NMDA-mediated synaptic currents
|
J:66345
|
Grin1tm1Jjwd/Grin1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal NMDA-mediated synaptic currents
|
J:209690
|
Grin1tm1Jjwd/Grin1tm1Jjwd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal NMDA-mediated synaptic currents
|
J:209690
|
Grin1tm1Nak/Grin1tm1Nak
(involves: 129S/Sv * C57BL/6 * DBA/2)
|
abnormal glutamate-mediated receptor currents
|
J:38582
|
| decreased susceptibility to neuronal excitotoxicity
|
J:38582
|
Grin1tm1Rpa/Grin1tm1.1Rpa
(Not Specified)
|
abnormal excitatory postsynaptic currents
|
J:145468
|
| abnormal miniature excitatory postsynaptic currents
|
J:145468
|
Grin1tm1Rpa/Grin1tm1.1Rpa
Slc6a3tm1(cre)Xz/Slc6a3+
(involves: 129S1/Sv)
|
abnormal excitatory postsynaptic currents
|
J:145468
|
| abnormal miniature excitatory postsynaptic currents
|
J:145468
|
| increased miniature excitatory postsynaptic current amplitude
|
J:145468
|
| increased miniature excitatory postsynaptic current frequency
|
J:145468
|
| reduced long-term potentiation
|
J:145468
|
Grin1tm1Rsp/Grin1tm1Rsp
Tg(Camk2a-tTA)1Mmay/?
Tg(tetO-cre)LC1Bjd/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
abnormal long-term potentiation
|
J:119834
|
Grin1tm1Rsp/Grin1tm1Rsp
Tg(Gnrh1-cre)1Rsp/0
(involves: C57BL/6)
|
absence of NMDA-mediated synaptic currents
|
J:103818
|
Grin1tm1Rsp/Grin1tm1Rsp
Tg(Slc6a3-icre)9075Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal AMPA-mediated synaptic currents
|
J:139693
|
| abnormal glutamate-mediated receptor currents
|
J:139693
|
| abnormal NMDA-mediated synaptic currents
|
J:139693
|
Grin1tm1Rsp/Grin1tm1Rsp
Tg(Slc6a3-icre)9075Gsc/0
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal glutamate-mediated receptor currents
|
J:139693
|
| abnormal NMDA-mediated synaptic currents
|
J:139693
|
Grin1tm1Stl/Grin1tm1Stl
(either: (involves: 129S2/SvPas * 129/Sv) or (involves: 129S2/SvPas * BALB/c) or (involves: 129S2/SvPas * C57BL/6))
|
absence of NMDA-mediated synaptic currents
|
J:17384
|
Grin1tm1Yql/Grin1tm1Yql
Rgs9tm1.1(cre)Yql/Rgs9+
(involves: 129/Sv * BALB/c * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:115299
|
| abnormal NMDA-mediated synaptic currents
|
J:115299
|
| absent long-term depression
|
J:115299
|
| reduced long-term potentiation
|
J:115299
|
Grin1tm1Yql/Grin1tm1Yql
Tg(Ppp1r2-cre)4127Nkza/0
(involves: C57BL/6N)
|
abnormal nervous system electrophysiology
|
J:156785
|
| decreased prepulse inhibition
|
J:156785
|
Grin1tm2Blt/Grin1tm2Blt
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal nervous system physiology
|
J:62289
|
Grin1tm2Slab/Grin1tm1.1Slab
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:82670
|
Grin1tm2Stl/Grin1tm2Stl
Tg(Actb-tTA)1Jzt/0
Tg(Camk2a-cre)T29-1Stl/0
Tg(tetO-Grin1/GFP)1Jzt/0
(involves: C57BL/6 * CBA)
|
absence of NMDA-mediated synaptic currents
|
J:88689,
J:77659
|
Grin1tm2Stl/Grin1tm2Stl
Tg(Camk2a-cre)T29-1Stl/0
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:37457
|
| absence of NMDA-mediated synaptic currents
|
J:37457
|
| reduced long-term potentiation
|
J:37457
|
Grin1tm2Stl/Grin1tm2Stl
Tg(Grik4-cre)G32-4Stl/0
(involves: C57BL/6)
|
abnormal NMDA-mediated synaptic currents
|
J:77718
|
| abnormal single cell response
|
J:77718
|
| reduced long-term potentiation
|
J:77718
|
Grin1tm2Stl/Grin1tm2Stl
Tg(Pomc-cre)1Lowl/0
(involves: 129S4/SvJae * C57BL/6 * FVB)
|
impaired synaptic plasticity
|
J:122763
|
Grin2atm1.1Ppao/Grin2atm1.1Ppao
(involves: 129 * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:175900
|
Grin2atm1.1Tnkw/Grin2atm1.1Tnkw
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J)
|
abnormal excitatory postsynaptic currents
|
J:155360
|
| reduced NMDA-mediated synaptic currents
|
J:155360
|
Grin2atm1Mim/Grin2atm1Mim
(involves: C57BL/6 * CBA)
|
reduced long-term potentiation
|
J:22295
|
| reduced NMDA-mediated synaptic currents
|
J:22295
|
Grin2atm1Nak/Grin2atm1Nak
(involves: 129S/SvEv)
|
abnormal excitatory postsynaptic currents
|
J:66455
|
| abnormal miniature excitatory postsynaptic currents
|
J:66455
|
Grin2atm1Nak/Grin2atm1Nak
Grin2ctm1Nak/Grin2ctm1Nak
(involves: 129S/SvEv)
|
abnormal excitatory postsynaptic currents
|
J:66455
|
| abnormal miniature excitatory postsynaptic currents
|
J:66455
|
Grin2atm1Rsp/Grin2atm1Rsp
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased kindling response
|
J:45446
|
| reduced long-term potentiation
|
J:197485,
J:45446
|
Grin2bem1Weya/Grin2bem1Weya
(Not Specified)
|
abnormal miniature excitatory postsynaptic currents
|
J:334279
|
| abnormal nervous system physiology
|
J:334279
|
Grin2btm1(GRIN2A/GRIN2B)Twr/Grin2btm1(GRIN2A/GRIN2B)Twr
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal NMDA-mediated synaptic currents
|
J:116524
|
Grin2btm1.1(Grin2a)Bjha/Grin2btm1.1(Grin2a)Bjha
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal AMPA-mediated synaptic currents
|
J:178913
|
| abnormal miniature excitatory postsynaptic currents
|
J:178913
|
| abnormal NMDA-mediated synaptic currents
|
J:178913
|
Grin2btm1.1Jlbr/Grin2btm1.1Jlbr
Tg(Camk2a-cre)T29-1Stl/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:159387
|
| abnormal excitatory postsynaptic potential
|
J:159387
|
| absent long-term depression
|
J:159387
|
| decreased excitatory postsynaptic current amplitude
|
J:159387
|
| reduced long-term depression
|
J:159387
|
| reduced long-term potentiation
|
J:159387
|
| short excitatory postsynaptic current decay time
|
J:159387
|
Grin2btm1.1Jwhe/Grin2btm1.1Jwhe
(B6JBomTac.129P2-Grin2btm1.1Jwhe)
|
reduced long-term potentiation
|
J:181943
|
Grin2btm1.1Nhk/Grin2btm1.1Nhk
(involves: 129P2/OlaHsd * C57BL/6J)
|
enhanced long-term potentiation
|
J:197485
|
| reduced long-term potentiation
|
J:197485
|
Grin2btm1Ksak/Grin2btm1Ksak
Grik4tm1(cre)Ksak/Grik4+
(C57BL/6-Grin2btm1Ksak Grik4tm1(cre)Ksak)
|
absence of NMDA-mediated synaptic currents
|
J:152455
|
| reduced long-term potentiation
|
J:152455
|
Grin2btm1Mim/Grin2b+
(B6.Cg-Grin2btm1Mim)
|
increased prepulse inhibition
|
J:89405
|
Grin2btm1Mim/Grin2btm1Mim
(involves: C57BL/6 * CBA)
|
abnormal AMPA-mediated synaptic currents
|
J:178913
|
| absence of NMDA-mediated synaptic currents
|
J:31622
|
| absent long-term depression
|
J:31622
|
Grin2btm1Mony/Grin2btm1Mony
Tg(Camk2a-cre)1Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal excitatory postsynaptic currents
|
J:186311
|
| abnormal excitatory postsynaptic potential
|
J:186311
|
| abnormal miniature excitatory postsynaptic currents
|
J:186311
|
| abnormal NMDA-mediated synaptic currents
|
J:186311
|
| reduced long-term potentiation
|
J:186311
|
Grin2btm1Mony/Grin2btm1Mony
Tg(Camk2a-Grin2c/itTA)12Rsp/0
Tg(tetO-cre)LC1Bjd/0
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:186311
|
| abnormal NMDA-mediated synaptic currents
|
J:186311
|
Grin2btm1Rsp/Grin2b+
(involves: 129S1/Sv * 129X1/SvJ)
|
reduced long-term potentiation
|
J:197485
|
Grin2btm1Rsp/Grin2btm1Rsp
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal NMDA-mediated synaptic currents
|
J:45446
|
Grin2btm1Tya/Grin2btm1Tya
(involves: C57BL/6J)
|
abnormal nervous system physiology
|
J:119025
|
| impaired synaptic plasticity
|
J:119025
|
Grin2btm2Mim/Grin2btm2Mim
(involves: C57BL/6 * CBA)
|
abnormal CNS synaptic transmission
|
J:76019
|
| abnormal excitatory postsynaptic potential
|
J:76019
|
| abnormal long-term depression
|
J:76019
|
Grin2ctm1Nak/Grin2ctm1Nak
(involves: 129S/SvEv)
|
abnormal excitatory postsynaptic currents
|
J:66455
|
| abnormal miniature excitatory postsynaptic currents
|
J:66455
|
Grin2ctm1Nts/Grin2ctm1Nts
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:34597
|
| abnormal NMDA-mediated synaptic currents
|
J:34597
|
Grin3atm1Nnk/Grin3atm1Nnk
(either: (involves: 129S/SvEv * 129X1/SvJ) or (involves: 129X1/SvJ * Black Swiss))
|
abnormal single cell response
|
J:66481
|
Grin3atm1Nnk/Grin3atm1Nnk
(involves: 129X1/SvJ * Black Swiss * C57BL/6)
|
abnormal prepulse inhibition
|
J:102120
|
Grip1tm1Paw/Grip1tm1Paw
(involves: 129X1/SvJ * ICR)
|
intracranial hemorrhage
|
J:79476
|
Grip1tm1Rlh/Grip1tm1Rlh
Grip2tm1Rha/Grip2tm1Rha
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
absent long-term depression
|
J:136388
|
Gripap1tm1Rlh/Gripap1tm1Rlh
(B6.129-Gripap1tm1Rlh)
|
abnormal miniature excitatory postsynaptic currents
|
J:256043
|
| reduced long-term potentiation
|
J:256043
|
Grk5tm1Rjl/Grk5tm1Rjl
(involves: 129S4/SvJaeSor * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:59179
|
Grm1rcw-4J/Grm1rcw-4J
(C57BL/6J-Grm1rcw-4J/GrsrJ)
|
abnormal nervous system electrophysiology
|
J:104879
|
Grm1tm1Crpl/Grm1tm1Crpl
(involves: 129P2/OlaHsd * C57BL/6)
|
reduced long-term depression
|
J:21644
|
| reduced long-term potentiation
|
J:21644
|
Grm1tm1Crpl/Grm1tm1Crpl
(Not Specified)
|
reduced long-term potentiation
|
J:97042
|
Grm1tm1Kyo/Grm1tm1Kyo
(involves: C57BL/6)
|
abnormal nervous system electrophysiology
|
J:101301
|
Grm1tm1Stl/Grm1tm1Stl
(involves: 129S2/SvPas * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:73385
|
| reduced long-term potentiation
|
J:21086
|
| short excitatory postsynaptic current decay time
|
J:73385
|
Grm2tm1Nak/Grm2tm1Nak
(involves: 129S/SvEv)
|
abnormal excitatory postsynaptic potential
|
J:34606
|
| reduced long-term depression
|
J:34606
|
Grm2tm1Nak/Grm2tm1Nak
(B6.129S-Grm2tm1Nak)
|
abnormal GABAergic neuron physiology
|
J:202321
|
| decreased susceptibility to neuronal excitotoxicity
|
J:202321
|
Grm3tm1Vbn/Grm3tm1Vbn
(B6.129P2-Grm3tm1Vbn)
|
abnormal astrocyte physiology
|
J:202321
|
| abnormal neuron physiology
|
J:202321
|
Grm4tm1Dgen/Grm4tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased prepulse inhibition
|
J:82809
|
Grm4tm1Hpn/Grm4tm1Hpn
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
decreased paired-pulse facilitation
|
J:35793
|
| decreased post-tetanic potentiation
|
J:35793
|
Grm5tm1Dgen/Grm5tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased susceptibility to pharmacologically induced seizures
|
J:82809
|
| increased susceptibility to pharmacologically induced seizures
|
J:82809
|
Grm5tm1Fcq/Grm5tm1Fcq
(Not Specified)
|
reduced long-term potentiation
|
J:97042
|
Grm5tm1Rod/Grm5+
(involves: 129 * C57BL/6 * FVB)
|
abnormal nerve fiber response
|
J:127792
|
Grm5tm1Rod/Grm5tm1Rod
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal excitatory postsynaptic potential
|
J:41096
|
| reduced long-term potentiation
|
J:41096
|
Grm6tm1Nak/Grm6tm1Nak
(involves: 129S/SvEv * C57BL/6 * DBA)
|
abnormal synaptic transmission
|
J:48532
|
Grm7m1Btlr/Grm7m1Btlr
(C57BL/6J-Grm7m1Btlr)
|
convulsive seizures
|
J:224658
|
Grm7tm1Betz/Grm7tm1Betz
(B6.129P2-Grm7tm1Betz)
|
abnormal excitatory postsynaptic currents
|
J:138831
|
| increased susceptibility to pharmacologically induced seizures
|
J:138831
|
Grm7tm1Dgen/Grm7tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Grm7tm1Nak/Grm7tm1Nak
(involves: 129P2/OlaHsd * C57BL/6)
|
seizures
|
J:52411
|
Grm8tm1Dgen/Grm8tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased prepulse inhibition
|
J:82809
|
Grntm1.1Aidi/Grntm1.1Aidi
(involves: C57BL/6 * C57BL/6J)
|
abnormal microglial cell physiology
|
J:156824
|
Grntm1.1Aidi/Grntm1.1Aidi
(involves: C57BL/6J)
|
abnormal hypothalamus secretion
|
J:268827
|
Grntm1.1Far/Grntm1.1Far
(involves: 129S4/SvJae * C57BL/6J * FVB/N)
|
abnormal neuron physiology
|
J:188324,
J:218705
|
| increased susceptibility to dopaminergic neuron neurotoxicity
|
J:188324
|
Grntm1.1Geno/Grntm1.1Geno
(involves: 129 * C57BL/6J)
|
abnormal nervous system physiology
|
J:188420
|
Grntm1Blrl/Grntm1Blrl
(involves: C57BL/6J)
|
abnormal excitatory postsynaptic potential
|
J:182051
|
| impaired synaptic plasticity
|
J:182051
|
| reduced long-term potentiation
|
J:182051
|
Grntm1Far/Grntm1Far
(involves: 129S4/SvJae * C57BL/6J * FVB/N)
|
abnormal neuron physiology
|
J:188324
|
Grntm1Far/Grntm1Far
Tg(ITGAM-cre)2781Gkl/0
(involves: 129S4/SvJae * C57BL/6 * CBA * FVB/N)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:188324
|
Grxcr1em1(IMPC)J/Grxcr1em1(IMPC)J
(C57BL/6NJ-Grxcr1em1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Grxcr1pi-tde/Grxcr1pi-tde
(Not Specified)
|
decreased cochlear nerve compound action potential
|
J:86585
|
Gsg1ltm1.2Tern/Gsg1ltm1.2Tern
(C57BL/6J-Gsg1ltm1.2Tern)
|
abnormal action potential
|
J:301313
|
| abnormal excitatory postsynaptic currents
|
J:301313
|
| abnormal miniature excitatory postsynaptic currents
|
J:301313
|
| abnormal synaptic transmission
|
J:301313
|
| increased excitatory postsynaptic current amplitude
|
J:301313
|
| increased susceptibility to pharmacologically induced seizures
|
J:301313
|
| short excitatory postsynaptic current decay time
|
J:301313
|
Gsk3atm1Dral/Gsk3atm1Dral
Gsk3btm1Dral/Gsk3btm1Dral
(involves: 129P2/OlaHsd)
|
abnormal long-term depression
|
J:200517
|
Gsk3btm1Jrw/Gsk3b+
(involves: 129 * C57BL/6J)
|
decreased prepulse inhibition
|
J:161844
|
Gsk3btm2138.1Arte/Gsk3btm2138.1Arte
(C57BL/6-Gsk3btm2138.1Arte)
|
abnormal Wallerian degeneration
|
J:188272
|
Gsntm1Djk/Gsntm1Djk
(involves: 129S4/SvJae * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:52545
|
| increased cerebral infarct size
|
J:52545
|
| increased susceptibility to ischemic brain injury
|
J:52545
|
Gstm1tm1Gcw/Gstm1tm1Gcw
(involves: 129S/SvEv * C57BL/6)
|
increased neuron apoptosis
|
J:159701
|
Gstm6tm1b(EUCOMM)Hmgu/Gstm6tm1b(EUCOMM)Hmgu
(C57BL/6N-Gstm6tm1b(EUCOMM)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Gsx1tm1Ssp/Gsx1tm1Ssp
(involves: 129P2/OlaHsd)
|
abnormal hypothalamus secretion
|
J:31764
|
| abnormal pituitary secretion
|
J:31764
|
Gt(ROSA)26Sorem1(CAG-Zbtb21,-GFP)Jhan/Gt(ROSA)26Sor+
Tg(Camk2a-cre)T29-1Stl/0
(B6.Cg-Gt(ROSA)26Sorem1(CAG-Zbtb21,-GFP)Jhan Tg(Camk2a-cre)T29-1Stl)
|
abnormal CNS synaptic transmission
|
J:351206
|
| abnormal excitatory postsynaptic potential
|
J:351206
|
| reduced long-term potentiation
|
J:351206
|
Gt(ROSA)26Sorem1(CAG-Zbtb21,-GFP)Jhan/Gt(ROSA)26Sor+
Tg(Nes-cre)1Kln/0
(B6.Cg-Gt(ROSA)26Sorem1(CAG-Zbtb21,-GFP)Jhan Tg(Nes-cre)1Kln)
|
abnormal CNS synaptic transmission
|
J:351206
|
| abnormal excitatory postsynaptic potential
|
J:351206
|
| reduced long-term potentiation
|
J:351206
|
Gt(ROSA)26Sortm1(ACTB-Map2k5*/EGFP)Zxi/Gt(ROSA)26Sortm1(ACTB-Map2k5*/EGFP)Zxi
Tg(Nes-cre/Esr1*)4Ynj/0
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
abnormal neuron physiology
|
J:206948
|
Gt(ROSA)26Sortm1(CAG-Bgeo,-Insc/GFP)Jakn/Gt(ROSA)26Sortm1(CAG-Bgeo,-Insc/GFP)Jakn
Tg(Nes-cre)1Wmz/0
(involves: C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:178712
|
| seizures
|
J:178712
|
Gt(ROSA)26Sortm1(CAG-Kcnj11*,-GFP)Nich/?
Tg(CAG-Bgeo/GFP)21Lbe/0
Tg(Pmch-cre)1Lowl/0
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB/NJ)
|
abnormal single cell response
|
J:167906
|
Gt(ROSA)26Sortm1(CAG-MFN2*T105M)Dple/Gt(ROSA)26Sor+
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA)
|
abnormal myelination
|
J:251584
|
Gt(ROSA)26Sortm1(CAG-Mir21)Jake/Gt(ROSA)26Sor+
Tg(Gfap-cre)#Mvs/0
(involves: BALB/c * C57BL/6 * C57BL/6NHsd)
|
abnormal astrocyte physiology
|
J:192021
|
Gt(ROSA)26Sortm1(CAG-Rheb*)Pfw/Gt(ROSA)26Sortm1(CAG-Rheb*)Pfw
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
hypermyelination
|
J:168571
|
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
Secisbp2tm1.1Amdu/Secisbp2tm1.2Amdu
(B6(129S4)-Gt(ROSA)26Sortm1(cre/ERT2)Tyj Secisbp2tm1.1Amdu Secisbp2tm1.2Amdu)
|
abnormal pituitary gland physiology
|
J:251875
|
Gt(ROSA)26Sortm1(Crh)Jde/Gt(ROSA)26Sortm1(Crh)Jde
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal seizure response to pharmacological agent
|
J:140968
|
| decreased susceptibility to neuronal excitotoxicity
|
J:140968
|
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+
Kittm1(cre/ERT2)Dsa/Kit+
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6)
|
abnormal synaptic transmission
|
J:204737
|
Gt(ROSA)26Sortm1(DTA)Jpmb/Gt(ROSA)26Sor+
Tg(Plp1-cre/ERT)3Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2)
|
CNS inflammation
|
J:234435
|
| demyelination
|
J:234435
|
| seizures
|
J:234435
|
Gt(ROSA)26Sortm1(DTA)Mrc/?
Tg(Rlbp1-cre/ERT2,-EGFP)1Wshn/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA)
|
abnormal blood-retina barrier function
|
J:192243
|
Gt(ROSA)26Sortm1(DTA)Riet/Gt(ROSA)26Sor+
Cnptm1(cre)Kan/Cnp+
(involves: 129P2/OlaHsd)
|
demyelination
|
J:92789
|
Gt(ROSA)26Sortm1(HA)Libl/Gt(ROSA)26Sortm1(HA)Libl
Mogtm1(cre)Gkl/?
Tg(TcraCl4,TcrbCl4)1Shrm/0
(involves: 129/Sv * BALB/c * C57BL/6)
|
brain inflammation
|
J:137838
|
| demyelination
|
J:137838
|
| optic nerve inflammation
|
J:137838
|
| spinal cord inflammation
|
J:137838
|
Gt(ROSA)26Sortm1(HBEGF)Awai/Gt(ROSA)26Sortm1(HBEGF)Awai
Mogtm1(cre)Gkl/?
(involves: C57BL/6)
|
demyelination
|
J:131076
|
| increased neuron apoptosis
|
J:131076
|
Gt(ROSA)26Sortm1(HD*103Q)Xwy/?
Tg(Nes-cre)1Kln/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal inhibitory postsynaptic currents
|
J:99759
|
Gt(ROSA)26Sortm1(Kcnj11*V59M)Fmas/Gt(ROSA)26Sor+
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
abnormal action potential
|
J:162008
|
| abnormal channel response
|
J:162008
|
| abnormal nervous system electrophysiology
|
J:162008
|
Gt(ROSA)26Sortm1(NOTCH3)Sat/Gt(ROSA)26Sor+
Notch3Gt(PST033)Byg/Notch3Gt(PST033)Byg
Tg(Tagln-cre)1Her/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * SJL)
|
decreased cerebral infarct size
|
J:133358
|
Gt(ROSA)26Sortm1(PDGFB)Cbet/Gt(ROSA)26Sor+
Pdgfbtm1Cbet/Pdgfbtm1Cbet
Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * SJL)
|
impaired blood-brain barrier function
|
J:166532
|
Gt(ROSA)26Sortm1(PDGFB)Cbet/Gt(ROSA)26Sortm1(PDGFB)Cbet
Pdgfbtm1Cbet/Pdgfbtm1Cbet
Tg(Tek-cre)1Ywa/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * SJL)
|
impaired blood-brain barrier function
|
J:166532
|
Gt(ROSA)26Sortm1(rtTA,EGFP)Nagy/Gt(ROSA)26Sor+
Tg(Nes-cre)1Kln/0
Tg(tetO-Vegfa)90Ala/0
(mixed)
|
intracranial hemorrhage
|
J:99607
|
| spinal hemorrhage
|
J:99607
|
Gt(ROSA)26Sortm1(Smo/EYFP)Amc/Gt(ROSA)26Sor+
Hk2tm1.1Uku/Hk2tm1.1Uku
Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal neuronal precursor proliferation
|
J:210113
|
Gt(ROSA)26Sortm1(Trpv1,ECFP)Mde/Gt(ROSA)26Sor+
Tg(Nes-cre)1Wme/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal single cell response
|
J:136582
|
| increased susceptibility to neuronal excitotoxicity
|
J:136582
|
Gt(ROSA)26Sortm1(tTA,CMV*1-Rheb,-EGFP)Gtm/Gt(ROSA)26Sor+
Tg(GFAP-cre)#Gtm/0
(involves: C57BL/6 * CBA)
|
abnormal astrocyte physiology
|
J:176586
|
Gt(ROSA)26Sortm1.1(CAG-COX8A/Dendra2)Dcc/Gt(ROSA)26Sor+
Mfn2tm3Dcc/Mfn2tm3Dcc
Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(involves: 129 * 129S6/SvEvTac * C57BL/6J * SJL/J)
|
abnormal axonal transport
|
J:188347
|
Gt(ROSA)26Sortm1.1(CAG-SPAST*C448Y)Baas/Gt(ROSA)26Sor+
(involves: C57BL/6N)
|
abnormal axonal transport
|
J:273408
|
Gt(ROSA)26Sortm1.1(CAG-SPAST*C448Y)Baas/Gt(ROSA)26Sortm1.1(CAG-SPAST*C448Y)Baas
(involves: C57BL/6N)
|
abnormal axonal transport
|
J:273408
|
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+
Ndor1Tg(UBC-cre/ERT2)1Ejb/0
(involves: 129S/SvEv * C57BL/6)
|
seizures
|
J:256652
|
Gt(ROSA)26Sortm1.1(Otx2)Daac/Gt(ROSA)26Sor+
Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:166896
|
Gt(ROSA)26Sortm1.1(Otx2)Daac/Gt(ROSA)26Sortm1.1(Otx2)Daac
Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:166896
|
Gt(ROSA)26Sortm1.1(Otx2)Daac/Gt(ROSA)26Sortm1.1(Otx2)Daac
Slc6a3tm1.1(cre)Bkmn/Slc6a3+
Tg(CAG-Otx2,-GFP)21Asim/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:166896
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(MMTV-cre)4Mam/0
(involves: C57BL/6J * C57BL/6N * FVB/N)
|
meningitis
|
J:202090
|
Gt(ROSA)26Sortm1Jus/Gt(ROSA)26Sor+
Tg(Mx1-cre)1Cgn/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * CBA)
|
meningitis
|
J:202090
|
Gt(ROSA)26Sortm1Lrsn/Gt(ROSA)26Sor+
Prkntm1Roo/Prkntm1Roo
Slc6a3tm1(cre)Lrsn/Slc6a3+
Tfamtm1Lrsn/Tfamtm1Lrsn
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
abnormal axonal transport
|
J:176022
|
Gt(ROSA)26Sortm1Sor/Gt(ROSA)26Sor+
Pdss2tm1.1Jdhu/Pdss2tm1.2Jdhu
Tg(Pcp2-cre)3555Jdhu/0
(involves: 129 * C3H/HeNCr MMTV- * C57BL/6N * FVB/N)
|
increased neuron apoptosis
|
J:179845
|
Gt(ROSA)26Sortm1Uga/Gt(ROSA)26Sortm1Uga
Tg(Thy1-cre)703Vaw/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
abnormal synaptic transmission
|
J:179833
|
| reduced long-term potentiation
|
J:179833
|
Gt(ROSA)26Sortm2(CAG-Lancl1)Pfw/Gt(ROSA)26Sortm2(CAG-Lancl1)Pfw
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
decreased susceptibility to neuronal excitotoxicity
|
J:214805
|
Gt(ROSA)26Sortm2(DTA)Riet/Gt(ROSA)26Sor+
Cnptm1(cre)Kan/Cnp+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
demyelination
|
J:110983
|
Gt(ROSA)26Sortm2(GFP/tetX)Gld/Gt(ROSA)26Sor+
Sim1tm1.1(cre)Gld/Sim1+
(involves: C57BL/6 * SJL)
|
abnormal CNS synaptic transmission
|
J:147245
|
Gt(ROSA)26Sortm2(GFP/tetX)Gld/Gt(ROSA)26Sor+
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal CNS synaptic transmission
|
J:147245
|
Gt(ROSA)26Sortm2(NOTCH3*C455R)Sat/Gt(ROSA)26Sor+
Notch3Gt(PST033)Byg/Notch3Gt(PST033)Byg
Tg(Tagln-cre)1Her/0
(involves: 129 * C57BL/6 * SJL)
|
increased susceptibility to ischemic brain injury
|
J:171887
|
Gt(ROSA)26Sortm2(tTA,CMV*1-KIAA1549/BRAF,-EGFP)Gtm/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal neuronal stem cell physiology
|
J:204469
|
| increased neuronal stem cell self-renewal
|
J:204469
|
Gt(ROSA)26Sortm2Jake/Gt(ROSA)26Sor+
Tg(Gfap-cre)#Mvs/0
(involves: BALB/c * C57BL/6 * C57BL/6NHsd)
|
abnormal astrocyte physiology
|
J:192021
|
Gt(ROSA)26Sortm2Sho/Gt(ROSA)26Sor+
Leprtm1.1Chua/Leprtm1.1Chua
Ntstm1(cre)Mgmj/Nts+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal nervous system electrophysiology
|
J:176657
|
Gt(ROSA)26Sortm2Sho/Gt(ROSA)26Sor+
Sp8tm1Smb/Sp8tm1Smb
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J * CBA/J)
|
increased embryonic neuroepithelium apoptosis
|
J:200761
|
Gt(ROSA)26Sortm3(NOTCH3*R1031C)Sat/Gt(ROSA)26Sor+
Notch3Gt(PST033)Byg/Notch3Gt(PST033)Byg
Tg(Tagln-cre)1Her/0
(involves: 129 * C57BL/6 * SJL)
|
increased susceptibility to ischemic brain injury
|
J:171887
|
Gt(ROSA)26Sortm5Mom/?
Or8a1tm28(cre)Mom/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal olfactory sensory neuron physiology
|
J:233447
|
Gt(ROSA)26Sortm7(CAG-mCherry,-EGFP/tetX)Dym/Gt(ROSA)26Sor+
Tg(ACTFLPe)9205Dym/0
Tg(Atoh1-cre)1Bfri/0
(involves: 129S6/SvEvTac * C57BL/6 * CBA * SJL)
|
abnormal excitatory postsynaptic currents
|
J:154944
|
| abnormal synaptic vesicle recycling
|
J:154944
|
Gt(ROSA)26Sortm7(CAG-mCherry,-EGFP/tetX)Dym/Gt(ROSA)26Sor+
Tmem163Tg(ACTB-cre)2Mrt/0
Tg(Fev-flpe)1Dym/0
(involves: 129S6/SvEvTac * FVB/N)
|
increased prepulse inhibition
|
J:154944
|
Gt(ROSA)26Sortm7(Pik3ca*,EGFP)Rsky/?
Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
Tg(Dhh-cre)1Mejr/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal myelination
|
J:207470
|
Gt(ROSA)26Sortm8(Map2k1*,EGFP)Rsky/?
Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
Tg(Dhh-cre)1Mejr/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
hypermyelination
|
J:207470
|
Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
Syngap1tm1.1Geno/Syngap1+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6 * C57BL/6NCr)
|
abnormal CNS synaptic transmission
|
J:193208
|
| abnormal glutamate-mediated receptor currents
|
J:193208
|
Gt(ROSA)26Sortm39.1(CAG-hop/EYFP)Hze/Gt(ROSA)26Sor+
Shox2tm1.1(cre)Oki/Shox2+
(involves: 129S/SvEv * 129S6/SvEvTac * C57BL/6)
|
abnormal nervous system physiology
|
J:209344
|
Gt(ROSA)26Sortm95.1(CAG-GCaMP6f)Hze/Gt(ROSA)26Sor+
Piezo2tm1c(KOMP)Wtsi/Piezo2tm1c(KOMP)Wtsi
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal CNS synaptic transmission
|
J:266637
|
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd
(B6.129-Gtf2ird1tm1Hrd)
|
abnormal nervous system physiology
|
J:159762
|
Gtf2ird1tm1Hrd/Gtf2ird1tm1Hrd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal neuron physiology
|
J:182346
|
Gtpbp2nmf205/Gtpbp2nmf205
n-TRtct5m1J/n-TRtct5m1J
(C57BL/6J-Gtpbp2nmf205/J)
|
increased neuron apoptosis
|
J:211326
|
Gtpbp2tm1Ynim/Gtpbp2tm1Ynim
n-TRtct5m1J/n-TRtct5m1J
(B6.Cg-Gtpbp2tm1Ynim)
|
increased neuron apoptosis
|
J:211326
|
Gucy1b2tm2Mom/Gucy1b2tm2Mom
Trpc2tm2Mom/Trpc2tm2Mom
(B6;129P2-Trpc2tm2Mom Gucy1b2tm2Mom/Mom)
|
abnormal olfactory sensory neuron physiology
|
J:235858
|
Gucy1b2tm3Mom/Gucy1b2tm3Mom
Trpc2tm1Mom/Trpc2tm1Mom
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal olfactory sensory neuron physiology
|
J:235858
|
Gys1tm1c(EUCOMM)Wtsi/Gys1tm1c(EUCOMM)Wtsi
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6J * C57BL/6N * SJL)
|
enhanced paired-pulse facilitation
|
J:218886
|
| impaired synaptic plasticity
|
J:218886
|
| reduced long-term potentiation
|
J:218886
|
H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi
(involves: 129S2/SvPas)
|
abnormal neuron proliferation
|
J:170591
|
H2-D1b-tm1Bpe/H2-D1b-tm1Bpe
H2-K1b-tm1Bpe/H2-K1b-tm1Bpe
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal glutamate-mediated receptor currents
|
J:148342
|
| enhanced paired-pulse facilitation
|
J:148342
|
| increased synaptic depression
|
J:148342
|
H2-D1bm14/H2-D1bm14
(C57BL/6)
|
demyelination
|
J:97717
|
| spinal cord inflammation
|
J:97717
|
H2-Oa/Brd2Tg(otx2-lacZ)F5pImat/H2-Oa/Brd2Tg(otx2-lacZ)F5pImat
(involves: CD-1)
|
increased embryonic neuroepithelium apoptosis
|
J:188139
|
H2-Oa/Brd2Tg(otx2-lacZ)F5pImat/H2-Oa/Brd2Tg(otx2-lacZ)F5pImat
(involves: CD-1)
|
increased embryonic neuroepithelium apoptosis
|
J:188139
|
H2dlAb1-Ea/H2dlAb1-Ea
Rag1tm1Mom/Rag1tm1Mom
Tg(HLA-DRA,HLA-DRB5*0101)hiKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
brain inflammation
|
J:189816
|
H2dlAb1-Ea/H2dlAb1-Ea
Rag1tm1Mom/Rag1tm1Mom
Tg(HLA-DRA,HLA-DRB5*0101)loKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * 129S7/SvEvBrd * C57BL/6)
|
brain inflammation
|
J:189816
|
H2dlAb1-Ea/H2dlAb1-Ea
Tg(HLA-DRA,HLA-DRB5*0101)hiKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6)
|
brain inflammation
|
J:189816
|
| CNS inflammation
|
J:189816
|
H2dlAb1-Ea/H2dlAb1-Ea
Tg(HLA-DRA,HLA-DRB5*0101)loKito/0
Tg(TRATL3A6,TRBTL3A6)#Kito/0
(involves: 129S2/SvPas * C57BL/6)
|
brain inflammation
|
J:189816
|
H2az2Tg(Wnt1-cre)11Rth/H2az2+
Tg(CAG-Lhx,-EGFP)1Eno/?
(involves: C3H * C57BL/6)
|
intracranial hemorrhage
|
J:150709
|
H2az2Tg(Wnt1-cre)11Rth/H2az2+
Tg(CAG-Otx2,-EGFP)1Eno/?
(involves: C3H * C57BL/6)
|
intracranial hemorrhage
|
J:150709
|
H2bc21tm1Dlc/H2bc21tm1Dlc
(involves: 129S4/SvJae * C57BL/6)
|
decreased neuron apoptosis
|
J:197878
|
H3c2tm1Mak/H3c2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal glial cell physiology
|
J:285841
|
hael/hael
(C3.Cg-H2p hael/GrsrJ)
|
tonic seizures
|
J:231653
|
Hap1tm2Xjl/Hap1tm2Xjl
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal neuron proliferation
|
J:224698
|
Hap1tm2Xjl/Hap1tm2Xjl
Tg(Camk2a-cre)159Kln/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6)
|
abnormal neuron proliferation
|
J:224698
|
Hapln2tm1Ooh/Hapln2tm1Ooh
(involves: 129/Sv * ICR)
|
abnormal nervous system physiology
|
J:157824
|
Hax1tm1Jni/Hax1tm1Jni
(involves: 129P2/OlaHsd * C57BL/6)
|
increased neuron apoptosis
|
J:132627
|
hb/hb
(involves: FVB)
|
absent cochlear microphonics
|
J:45223
|
| absent cochlear nerve compound action potential
|
J:45223
|
Hbegftm1Hhar/Hbegftm1Hhar
Tg(Six3-cre)69Frty/0
(involves: C57BL/6 * CBA * DBA/2)
|
decreased prepulse inhibition
|
J:154094
|
Hbp1tm1.1Ohts/Hbp1tm1.1Ohts
Tg(Nes-cre/ERT2)5-1Imayo/0
(involves: C57BL/6 * CBA/JNCrlj * ICR)
|
increased neuron apoptosis
|
J:278919
|
| increased neuronal stem cell self-renewal
|
J:278919
|
Hbs1ltm1c(KOMP)Wtsi/Hbs1ltm1c(KOMP)Wtsi
En1tm2(cre)Wrst/En1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6NTac)
|
increased neuronal precursor proliferation
|
J:306384
|
Hc1/Hc1
Tg(APPswe,PSEN1dE9)85Dbo/0
(D2.Cg-Tg(APPswe,PSEN1dE9)85Dbo)
|
convulsive seizures
|
J:227541
|
Hcn1tm1.1Lex/Hcn1tm1.1Lex
(129S/SvEvBrd-Hcn1tm1.1Lex)
|
abnormal nervous system electrophysiology
|
J:176560
|
Hcn1tm2Kndl/Hcn1tm2Kndl
(involves: 129S/SvEv * C57BL/6)
|
abnormal action potential
|
J:188823
|
Hcn2ap/Hcn2+
(DW/Pas-Hcn2ap)
|
abnormal spike wave discharge
|
J:146530
|
| absence seizures
|
J:146530
|
| increased susceptibility to pharmacologically induced seizures
|
J:146530
|
Hcn2ap/Hcn2ap
(DW/Pas-Hcn2ap)
|
abnormal spike wave discharge
|
J:146530
|
| absence seizures
|
J:146530
|
| tonic-clonic seizures
|
J:146530
|
Hcn2tm1.2Lex/Hcn2tm1.2Lex
(involves: BALB/cJ * C57BL/6)
|
abnormal action potential
|
J:176663
|
| abnormal neuron physiology
|
J:176663
|
Hcn2tm1Ldw/Hcn2tm1Ldw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal afterhyperpolarization
|
J:81398
|
| abnormal nervous system electrophysiology
|
J:81398
|
| abnormal summary potential
|
J:81398
|
| absence seizures
|
J:81398
|
| decreased channel response intensity
|
J:81398
|
Hcn3tm1.1Biel/Hcn3tm1.1Biel
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal action potential
|
J:188823
|
Hcn4tm1Nnka/Hcn4+
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal nervous system electrophysiology
|
J:207953
|
Hcrttm1Ywa/Hcrttm1Ywa
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:85405
|
Hcrtr1tm1Dgen/Hcrtr1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Hcrtr2tm1Tesc/Hcrtr2tm1Tesc
(B6.Cg-Hcrtr2tm1Tesc)
|
abnormal neuron physiology
|
J:170824
|
Hdac2tm1.2Rdp/Hdac2tm1.2Rdp
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
enhanced long-term potentiation
|
J:148391
|
Hdac4Gt(OST361114)Lex/Hdac4Gt(OST361114)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal spike wave discharge
|
J:152466
|
| convulsive seizures
|
J:152466
|
| environmentally induced seizures
|
J:152466
|
| tonic seizures
|
J:152466
|
Hdac4tm2.1Eno/Hdac4tm2.1Eno
Tg(Myog-cre)1Eno/0
(involves: 129S/SvEv)
|
abnormal motor nerve collateral sprouting
|
J:155806
|
Hdac6tm1.1Pmt/Y
Tg(SOD1*G93A)1Gur/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * SJL)
|
abnormal action potential
|
J:194977
|
Hdac8tm1.1Eno/Y
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129 * C57BL/6 * CBA * CD-1)
|
intracranial hemorrhage
|
J:150709
|
Hdac8tm1.2Eno/Y
(involves: 129 * C57BL/6 * CD-1)
|
intracranial hemorrhage
|
J:150709
|
Hdac8tm1.2Eno/Hdac8+
(involves: 129 * C57BL/6 * CD-1)
|
intracranial hemorrhage
|
J:150709
|
Hdac8tm1.2Eno/Hdac8tm1.2Eno
(involves: 129 * C57BL/6 * CD-1)
|
intracranial hemorrhage
|
J:150709
|
Hdctm1Nagy/Hdc+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased prepulse inhibition
|
J:220412
|
Hdctm1Nagy/Hdctm1Nagy
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased prepulse inhibition
|
J:220412
|
Hecw2tm1.1Fhe/Hecw2tm1.1Fhe
(involves: C57BL/6J)
|
decreased neuronal precursor proliferation
|
J:306367
|
Helttm1Wrst/Helttm1Wrst
(B6.Cg-Helttm1Wrst)
|
seizures
|
J:119562
|
| tonic-clonic seizures
|
J:119562
|
Hepacamtm1.1Tjj/Hepacamtm1.1Tjj
(involves: C57BL/6NTac)
|
abnormal glial cell physiology
|
J:210308
|
| abnormal oligodendrocyte physiology
|
J:210308
|
Hepacamtm1.2Tjj/Hepacamtm1.2Tjj
(involves: C57BL/6NTac)
|
abnormal glial cell physiology
|
J:210308
|
| abnormal oligodendrocyte physiology
|
J:210308
|
Herc3tm1a(EUCOMM)Wtsi/Herc3tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Herc3tm1a(EUCOMM)Wtsi/Wtsi)
|
increased prepulse inhibition
|
J:165965
|
Herpud1tm1Kame/Herpud1tm1Kame
(B6CrSlc.129-Herpud1tm1Kame)
|
decreased cerebral infarct size
|
J:210654
|
Hexatm1Grv/Hexatm1Grv
(involves: 129P2/Ola * C57BL/6J)
|
abnormal nervous system physiology
|
J:30899
|
| convulsive seizures
|
J:88460
|
Hexatm1Rlp/Hexatm1Rlp
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myelination
|
J:41920
|
| abnormal nervous system physiology
|
J:41920
|
| sporadic seizures
|
J:36305
|
Hexbtm1Grv/Hexbtm1Grv
(either: (involves: 129P2/Ola * C57BL/6J) or (involves: 129S1/Sv * 129X1/SvJ * C57L/6J))
|
abnormal nervous system physiology
|
J:30899
|
| abnormal seizure response to electrical stimulation
|
J:30899
|
Hexbtm1Rlp/Hexbtm1Rlp
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
CNS inflammation
|
J:90687
|
| increased forebrain apoptosis
|
J:87617
|
Hgstm2Tkh/Hgstm2Tkh
Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6 * CBA * SJL)
|
increased neuron apoptosis
|
J:141391
|
Hif1atm1Rsjo/Hif1a+
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased neuron apoptosis
|
J:98637
|
Hif1atm3Rsjo/Hif1atm3Rsjo
Tg(Camk2a-cre)1Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased susceptibility to ischemic brain injury
|
J:121971
|
| increased cerebral infarct size
|
J:121971
|
| increased susceptibility to ischemic brain injury
|
J:121971
|
Hif1atm3Rsjo/Hif1atm3Rsjo
Tg(Camk2a-cre)2Szi/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased susceptibility to ischemic brain injury
|
J:98637
|
| increased cerebral infarct size
|
J:121971
|
| increased susceptibility to ischemic brain injury
|
J:121971
|
Hif1anem1(IMPC)Mbp/Hif1anem1(IMPC)Mbp
(C57BL/6N-Hif1anem1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Higd1cem2Chaa/Higd1cem2Chaa
(C57BL/6J-Higd1cem2Chaa)
|
abnormal type I cell of carotid body physiology
|
J:345095
|
Hip1rtm2b(KOMP)Wtsi/Hip1rtm2b(KOMP)Wtsi
(C57BL/6N-Hip1rtm2b(KOMP)Wtsi/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Hipk2tm1Ejh/Hipk2tm1Ejh
(involves: 129X1/SvJ * C57BL/6)
|
decreased neuron apoptosis
|
J:117465
|
Hipk3tm1b(EUCOMM)Hmgu/Hipk3tm1b(EUCOMM)Hmgu
(C57BL/6N-Hipk3tm1b(EUCOMM)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Hivep1tm1(KOMP)Mbp/Hivep1+
(C57BL/6N-Hivep1tm1(KOMP)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Hivep2tm1Sis/Hivep2tm1Sis
(either: (involves: BALB/cA * C57BL/6NCrlj * CBA/JNCrlj) or (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj))
|
abnormal astrocyte physiology
|
J:263351
|
| abnormal brain wave pattern
|
J:263351
|
| abnormal synaptic transmission
|
J:263351
|
| CNS inflammation
|
J:263351
|
| decreased prepulse inhibition
|
J:263351
|
Hjvtm1b(KOMP)Wtsi/Hjvtm1b(KOMP)Wtsi
(C57BL/6N-Hjvtm1b(KOMP)Wtsi/J)
|
increased prepulse inhibition
|
J:211773
|
Hk2tm1.1Uku/Hk2tm1.1Uku
Tg(GFAP-cre)25Mes/0
(B6.Cg-Hk2tm1.1Uku Tg(GFAP-cre)25Mes)
|
abnormal cerebellar granule cell migration
|
J:210113
|
| abnormal neuronal precursor proliferation
|
J:210113
|
Hld/Hld
(either: (involves: BALB/cByJ) or (involves: BALB/cJ))
|
abnormal neuronal migration
|
J:13989
|
Hltftm1.1Arte/Hltftm1.1Arte
(Not Specified)
|
abnormal neuron physiology
|
J:193813
|
| abnormal neuronal precursor proliferation
|
J:193813
|
Hltftm1.2Geno/Hltftm1.2Geno
(B6.129S2-Hltftm1.2Geno)
|
increased brain apoptosis
|
J:203735
|
Hmbstm1.1Rjde/Hmbstm1.1Rjde
(involves: 129/Sv * C57BL/6)
|
abnormal myelination
|
J:275245
|
Hmgn1tm1Mbus/Hmgn1tm1Mbus
(involves: 129X1/SvJ)
|
decreased prepulse inhibition
|
J:199604
|
Hmgn3tm1.2Mbus/Hmgn3tm1.2Mbus
(involves: 129S4/SvJae * C57BL/6J)
|
decreased prepulse inhibition
|
J:199604
|
Hmgn5tm1.2Mbus/Y
(involves: 129S4/SvJae * C57BL/6J)
|
decreased prepulse inhibition
|
J:199604
|
Hmgn5tm1.2Mbus/Hmgn5tm1.2Mbus
(involves: 129S4/SvJae * C57BL/6J)
|
decreased prepulse inhibition
|
J:199604
|
Hmox2tm1Poss/Hmox2tm1Poss
(involves: 129S2/SvPas * C57BL/6)
|
abnormal nerve fiber response
|
J:89562
|
Hmx3/Hmx2tm3Tlu/Hmx3/Hmx2tm3Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J))
|
abnormal hypothalamus secretion
|
J:92940
|
Hmx3/Hmx2tm3Tlu/Hmx3/Hmx2tm3Tlu
(either: (involves: 129) or (involves: 129 * C57BL/6J))
|
abnormal hypothalamus secretion
|
J:92940
|
Hnf4atm1.1Gonz/Hnf4atm1.1Gonz
Tg(Ins2-cre)25Mgn/0
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
abnormal channel response
|
J:108652
|
HnrnpabGt(AV0462)Wtsi/HnrnpabGt(AV0462)Wtsi
(involves: 129P2/OlaHsd)
|
increased susceptibility to neuronal excitotoxicity
|
J:227973
|
Hnrnpabtm2b(EUCOMM)Hmgu/Hnrnpab+
(C57BL/6N-Hnrnpabtm2b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Hnrnph2em1Jpat/Y
(C57BL/6J-Hnrnph2em1Jpat)
|
abnormal brain wave pattern
|
J:338313
|
| audiogenic seizures
|
J:338313
|
Hnrnph2em1Jpat/Hnrnph2+
(C57BL/6J-Hnrnph2em1Jpat)
|
audiogenic seizures
|
J:338313
|
Hnrnph2em2Jpat/Y
(C57BL/6J-Hnrnph2em2Jpat)
|
audiogenic seizures
|
J:338313
|
Hnrnph2em2Jpat/Hnrnph2em2Jpat
(C57BL/6J-Hnrnph2em2Jpat)
|
audiogenic seizures
|
J:338313
|
Hnrnph2em3Jpat/Y
(C57BL/6J-Hnrnph2em3Jpat)
|
abnormal autonomic nervous system physiology
|
J:338313
|
Hnrnpuem1Frk/Hnrnpu+
(Not Specified)
|
abnormal brain wave pattern
|
J:342579
|
| maximal tonic hindlimb extension seizures
|
J:342579
|
Hoatzem1Seta/Hoatzem1Seta
(B6N.Cg-Hoatzem1Seta)
|
abnormal brain ependyma motile cilium physiology
|
J:287082
|
Homer1tm1Mhd/Homer1tm1Mhd
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6)
|
abnormal nervous system physiology
|
J:96554
|
Homer1tm2Mhd/Homer1tm2Mhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:174500
|
Homer2tm1Mhd/Homer2tm1Mhd
(B6.129-Homer2tm1Mhd)
|
abnormal nervous system physiology
|
J:96554
|
Hook3tm1b(NCOM)Mfgc/Hook3tm1b(NCOM)Mfgc
(C57BL/6N-Hook3tm1b(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Hoxa1tm3.1Mrc/Hoxa1tm3.1Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
increased hindbrain apoptosis
|
J:41540
|
Hoxa1tm3.1Mrc/Hoxa1tm3.1Mrc
Hoxb1tm3Mrc/Hoxb1tm3Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
increased hindbrain apoptosis
|
J:41540
|
Hoxa2tm1b(EUCOMM)Wtsi/Hoxa2+
(C57BL/6N-Hoxa2tm1b(EUCOMM)Wtsi/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Hoxa3tm3Mrc/Hoxa3tm3Mrc
Hoxd3tm2Mrc/Hoxd3tm2Mrc
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuronal migration
|
J:86041
|
hpc/hpc
(involves: STOCK Hps6ru f)
|
clonic seizures
|
J:64096
|
Hpcatm1Toho/Hpcatm1Toho
(involves: 129S/SvEv * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:97752
|
Hpdlem1(IMPC)Mbp/Hpdl+
(C57BL/6N-Hpdlem1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Hpdlem1Jgg/Hpdlem1Jgg
(C57BL/6-Hpdlem1Jgg)
|
increased neuron apoptosis
|
J:334229
|
| seizures
|
J:334229
|
Hpntm1Qwu/Hpntm1Qwu
(involves: 129X1/SvJ * NIH Swiss)
|
abnormal cochlear inner hair cell physiology
|
J:123922
|
| abnormal cochlear outer hair cell physiology
|
J:123922
|
| abnormal myelination
|
J:123922
|
Hprt1tm1(CAG-Glra3*)Jcme/Y
Pvalbtm1(cre)Arbr/Pvalb+
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:207981
|
| abnormal nervous system electrophysiology
|
J:207981
|
| absent long-term depression
|
J:207981
|
Hprt1tm1(CAG-Glra3*)Jcme/Y
Tg(Camk2a-cre)2Gsc/0
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
abnormal nervous system electrophysiology
|
J:207981
|
| abnormal synaptic glutamate release
|
J:207981
|
| increased susceptibility to pharmacologically induced seizures
|
J:207981
|
Hprt1tm1(Camk2a-APP*Swe*Lon,-MAPT*P301L*R406W)Geno/Hprt1+
Tg(PSEN1)5Dbo/0
(involves: 129P2/OlaHsd)
|
abnormal brain wave pattern
|
J:180977
|
| abnormal long-term potentiation
|
J:180977
|
| decreased paired-pulse facilitation
|
J:180977
|
Hprt1tm1(H1-RNAi:Tmsb4x)Prri/Hprt1+
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
intracranial hemorrhage
|
J:195902
|
Hprt1tm1(MAPT)Dph/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal hippocampus physiology
|
J:263643
|
Hprt1tm1Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
convulsive seizures
|
J:44728
|
| seizures
|
J:44728
|
Hprt1tm1Detl/Hprt1tm1Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
convulsive seizures
|
J:44728
|
| seizures
|
J:44728
|
Hprt1tm2Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
seizures
|
J:84451
|
Hprt1tm2Detl/Hprt1tm2Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
seizures
|
J:84451
|
Hprt1tm4Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
seizures
|
J:84451
|
Hprt1tm4Detl/Hprt1tm4Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
seizures
|
J:84451
|
Hprt1tm6Detl/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
seizures
|
J:84451
|
Hprt1tm6Detl/Hprt1tm6Detl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
seizures
|
J:84451
|
Hprt1tm86(NR2E1,bEMS223)Ems/Y
(B6.Cg-Hprt1tm86(NR2E1,bEMS223)Ems)
|
abnormal neuronal precursor proliferation
|
J:183689
|
Hprt1tm86(NR2E1,bEMS223)Ems/Y
Nr2e1frc/Nr2e1frc
(involves: 129P2/OlaHsd * 129S1/SvImJ * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:183689
|
Hrastm1Grnt/Hrastm1Grnt
Syngap1tm1Grnt/Syngap1+
(involves: 129P2/OlaHsd * MF1)
|
reduced long-term potentiation
|
J:98903
|
Hrh2tm1Yfks/Hrh2tm1Yfks
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal seizure response to electrical stimulation
|
J:102252
|
Hrh3tm1Twl/Hrh3tm1Twl
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal nervous system physiology
|
J:79168
|
Hrh3tm1Twl/Hrh3tm1Twl
(involves: 129P2/OlaHsd)
|
abnormal synaptic norepinephrine release
|
J:103897
|
Hrh3tm1Twl/Hrh3tm1Twl
(B6.129X1-Hrh3tm1Twl)
|
impaired blood-brain barrier function
|
J:122269
|
Hrktm1Ast/Hrktm1Ast
(C57BL/6-Hrktm1Ast)
|
decreased neuron apoptosis
|
J:124044
|
Hrktm1Nnz/Hrktm1Nnz
(involves: 129 * C57BL/6J)
|
decreased neuron apoptosis
|
J:96893
|
Hsd17b4tm2Baes/Hsd17b4tm2Baes
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
demyelination
|
J:201698
|
Hsd17b7tm1Mpo/Hsd17b7tm1Mpo
(involves: 129S7/SvEvBrd)
|
increased neural tube apoptosis
|
J:160004
|
Hsf2tm1Miv/Hsf2tm1Miv
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
intracerebral hemorrhage
|
J:83730
|
Hspa1btm1Bwy/Hspa1btm1Bwy
(B6.129P2-Hspa1btm1Bwy)
|
increased cerebral infarct size
|
J:103999
|
| increased susceptibility to ischemic brain injury
|
J:103999
|
Hspa5baffled/Hspa5baffled
(FVB.Cg-Hspa5baffled)
|
abnormal neuron proliferation
|
J:191772
|
Hspa12atm1.1Zdi/Hspa12atm1.1Zdi
(involves: 129 * C57BL/6)
|
increased cerebral infarct size
|
J:271786
|
| increased susceptibility to ischemic brain injury
|
J:271786
|
Hspb8tm1Vti/Hspb8tm1Vti
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl)
|
abnormal action potential
|
J:284796
|
Hspg2tm1.1Soni/Hspg2tm1.1Soni
(involves: 129S/SvEv * C57BL/6)
|
abnormal endplate potential
|
J:139975
|
| abnormal miniature endplate potential
|
J:139975
|
Hspg2tm1Ref/Hspg2tm1Ref
(involves: 129S1/Sv * 129X1/SvJ)
|
intracranial hemorrhage
|
J:58700
|
Hspg2tm1Soni/Hspg2tm1Soni
(involves: 129S/SvEv * DBA/2J)
|
abnormal action potential
|
J:183547
|
| demyelination
|
J:183547
|
Hsph1tm1Kzn/Hsph1tm1Kzn
(B6.129P2-Hsph1tm1Kzn)
|
decreased cerebral infarct size
|
J:218516
|
| decreased susceptibility to ischemic brain injury
|
J:218516
|
Htr1atm1Rhn/Htr1atm1Rhn
(involves: 129S/SvEv * 129S1/Sv)
|
abnormal nervous system physiology
|
J:167655
|
Htr1atm1Toth/Htr1atm1Toth
(involves: 129P2/OlaHsd * Black Swiss)
|
decreased paired-pulse facilitation
|
J:66581,
J:61579
|
| increased susceptibility to pharmacologically induced seizures
|
J:66581
|
Htr1atm3.1Rhn/Htr1atm3.1Rhn
Slc6a4tm1(tTA)Cogr/Slc6a4+
(involves: 129S1/Sv * BALB/cJ * C57BL/6 * CBA)
|
abnormal autonomic nervous system physiology
|
J:137439
|
| abnormal neuron physiology
|
J:137439
|
Htr1ftm1Dgen/Htr1ftm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased prepulse inhibition
|
J:101679
|
Htr2ctm1Jke/Y
(B6.129-Htr2ctm1Jke)
|
tonic-clonic seizures
|
J:147514
|
Htr2ctm1Jke/Y
Tg(Pomc1-cre)16Lowl/0
(B6.Cg-Htr2ctm1Jke Tg(Pomc1-cre)16Lowl)
|
tonic-clonic seizures
|
J:147514
|
Htr2ctm1Jul/Y
(either: (involves: 129S2/SvPas * C57BL/6J * DBA/2) or (involves: 129S4/SvJae * C57BL/6J * DBA/2))
|
increased susceptibility to pharmacologically induced seizures
|
J:24339
|
| sporadic seizures
|
J:24339
|
| tonic seizures
|
J:24339
|
| tonic-clonic seizures
|
J:24339
|
Htr2ctm1Jul/Y
(B6.129S-Htr2ctm1Jul)
|
reduced long-term potentiation
|
J:51567
|
Htr2ctm2Jke/Y
Tg(Pomc1-cre)16Lowl/0
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB/N)
|
abnormal nervous system electrophysiology
|
J:207704
|
Htr2ctm2Jke/Y
Tg(Zp3-cre)93Knw/0
(involves: 129X1/SvJ * C57BL/6J)
|
seizures
|
J:207704
|
Htr4tm1Comp/Htr4tm1Comp
(129/Sv-Htr4tm1Comp)
|
increased susceptibility to pharmacologically induced seizures
|
J:87451
|
Htr7tm1Wtkn/Htr7tm1Wtkn
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal seizure response to electrical stimulation
|
J:124549
|
| increased susceptibility to pharmacologically induced seizures
|
J:124549
|
Htra2mnd2/Htra2mnd2
(involves: C3H/HeJ * C57BL/6J * CAST/Ei)
|
abnormal action potential
|
J:12780
|
| seizures
|
J:50420
|
Htra2tm1.1Hohj/Htra2tm1.1Hohj
Tg(Nes-cre)1Kln/0
(involves: C57BL/6J)
|
increased brain apoptosis
|
J:225666
|
Htra2tm1.2Hohj/Htra2tm1.2Hohj
(involves: C57BL/6 * C57BL/6J)
|
increased brain apoptosis
|
J:225666
|
Htra2tm1Jdo/Htra2tm1Jdo
(involves: 129P/Ola * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:94227
|
Htttm1Detl/Htttm1Detl
(involves: 129P2/OlaHsd * C57BL/6J)
|
tonic-clonic seizures
|
J:67074
|
Htttm1Hay/Htttm1Hay
Tg(HTT*97Q)IXwy/0
Tg(YAC18)18Hay/Tg(YAC18)18Hay
(FVB.Cg-Htttm1Hay Tg(HTT*97Q)IXwy Tg(YAC18)18Hay)
|
abnormal action potential
|
J:215223
|
| abnormal CNS synaptic transmission
|
J:215223
|
| decreased excitatory postsynaptic current amplitude
|
J:215223
|
| decreased excitatory postsynaptic current frequency
|
J:215223
|
| decreased paired-pulse facilitation
|
J:215223
|
| impaired synaptic plasticity
|
J:215223
|
| reduced long-term potentiation
|
J:215223
|
Htttm1Mem/Htttm6Mem
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA * Swiss Webster)
|
dysmyelination
|
J:260244
|
| environmentally induced seizures
|
J:260244
|
Htttm2Detl/Htt+
(B6J.129P2-Htttm2Detl)
|
abnormal myelination
|
J:220868
|
| abnormal oligodendrocyte physiology
|
J:220868
|
| dysmyelination
|
J:220868
|
Htttm2Detl/Htttm2Detl
(involves: 129P2/OlaHsd * C57BL/6J)
|
tonic-clonic seizures
|
J:67074,
J:123681
|
Htttm2Msl/Htttm2Msl
(involves: 129S1/Sv * C57BL/6J)
|
abnormal neuron physiology
|
J:76018
|
Htttm4Mem/Htttm4Mem
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal nervous system physiology
|
J:99425
|
Htttm5Mem/Htttm5Mem
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal nervous system physiology
|
J:99425
|
Htttm6Mem/Htttm8Mem
(involves: 129S1/Sv * 129X1/SvJ * Swiss Webster)
|
seizures
|
J:72915
|
Hunktm1b(EUCOMM)Wtsi/Hunktm1b(EUCOMM)Wtsi
(C57BL/6N-Hunktm1b(EUCOMM)Wtsi/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Huwe1tm1Alas/Y
Tg(Nes-cre)1Kag/0
(involves: 129S7/SvEvBrd)
|
abnormal neuronal precursor proliferation
|
J:152966
|
Hydinhy3-Tg(Bdnf)459Ove/Hydinhy3-Tg(Bdnf)459Ove
(FVB/N-Hydinhy3-Tg(Bdnf)459Ove)
|
abnormal brain ependyma motile cilium physiology
|
J:135322
|
Hyls1em1(IMPC)Tcp/Hyls1+
(C57BL/6NCrl-Hyls1em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Hyou1tm1Oga/Hyou1+
(involves: 129S1/Sv)
|
increased susceptibility to ischemic brain injury
|
J:91007
|
Hyou1tm1Oga/Hyou1+
(involves: 129S1/Sv * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:91396
|
Iah1tm1b(EUCOMM)Hmgu/Iah1tm1b(EUCOMM)Hmgu
(C57BL/6N-Iah1tm1b(EUCOMM)Hmgu/Ics)
|
increased prepulse inhibition
|
J:211773
|
Icam5tm1(cre)Mmsh/Icam5tm1(cre)Mmsh
(involves: C57BL/6 * CBA)
|
abnormal sensorimotor gating
|
J:89407
|
| enhanced long-term potentiation
|
J:89407
|
Icmttm1Hzo/Icmttm1Hzo
(involves: 129S/SvEv)
|
increased forebrain apoptosis
|
J:77742
|
| increased neural tube apoptosis
|
J:77742
|
Id1tm1Zhu/Id1tm1Zhu
Id3tm1Zhu/Id3tm1Zhu
(involves: 129S1/Sv * 129S4/SvJaeSor)
|
abnormal neuronal precursor proliferation
|
J:86480,
J:170418
|
| intracranial hemorrhage
|
J:86480
|
Id1tm3Bene/Id1tm3Bene
Id2tm1Xdz/Id2tm1Xdz
Id3tm1Zhu/Id3tm1Zhu
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:185426
|
Id2tm1Mcha/Id2tm1Mcha
(involves: C57BL/6 * CD-1)
|
abnormal neuronal precursor proliferation
|
J:143882
|
Id3em1(IMPC)Mbp/Id3em1(IMPC)Mbp
(C57BL/6N-Id3em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Idh1tm1b(EUCOMM)Wtsi/Idh1tm1b(EUCOMM)Wtsi
(C57BL/6N-Idh1tm1b(EUCOMM)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Iduatm1Efn/Iduatm1Efn
(involves: C57BL/6)
|
abnormal microglial cell physiology
|
J:81974
|
Ifi44tm1b(KOMP)Wtsi/Ifi44tm1b(KOMP)Wtsi
(C57BL/6N-Ifi44tm1b(KOMP)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Ifi208Tg(Cspg4-cre)1Akik/Ifi208+
Tubb4aJit/Tubb4atm1c(EUCOMM)Hmgu
(involves: C57BL/6 * C57BL/6N * FVB/N * SJL)
|
dysmyelination
|
J:321692
|
Ifit1tm1(KOMP)Vlcg/Ifit1tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
brain inflammation
|
J:205203
|
Ifnar1tm1Agt/Ifnar1tm1Agt
Tg(CD46)373Zbz/Tg(CD46)373Zbz
(involves: 129S2/SvPas * C3H/He * C57BL/6)
|
abnormal neuron physiology
|
J:160878
|
| brain inflammation
|
J:160878
|
| meningitis
|
J:160878
|
Ifnb1tm1Tl/Ifnb1tm1Tl
(B10.129P2-Ifnb1tm1Tl)
|
abnormal microglial cell physiology
|
J:83021
|
| CNS inflammation
|
J:83021
|
| demyelination
|
J:83021
|
Ifngtm1.1(KOMP)Vlcg/Ifng+
(C57BL/6N-Ifngtm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Ifngtm1Ts/Ifngtm1Ts
Nlrp1aNeut1/Nlrp1aNeut1
(involves: 129S7/SvEvBrd * C57BL/6)
|
brain inflammation
|
J:191055
|
Ifngr1tm1Agt/Ifngr1tm1Agt
(B6.129S7-Ifngr1tm1Agt)
|
abnormal myelination
|
J:108669
|
Igf1tm1Arge/Igf1tm1Arge
(involves: 129S/SvEv * MF1)
|
abnormal myelination
|
J:71687
|
| increased neuron apoptosis
|
J:71687
|
Igf1tm1Ts/Igf1tm1Ts
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal nervous system physiology
|
J:24953
|
Igf1rtm1Arge/Igf1rtm2Arge
Tg(Camk2a-cre)2Szi/0
(involves: 129S/SvEv * C57BL/6J * CBA)
|
abnormal myelination
|
J:88198
|
Igf2bp1Gt(OST33739)Lex/Igf2bp1Gt(OST33739)Lex
(involves: 129S5/SvEvBrd)
|
decreased neuronal stem cell self-renewal
|
J:207231
|
Igh-Jtm1Aigl/Igh-J+
Mogtm1Dpd/Mogtm1Dpd
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6)
|
CNS inflammation
|
J:151335
|
| demyelination
|
J:151335
|
Igh-Jtm1Aigl/Igh-J+
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
CNS inflammation
|
J:151335
|
| demyelination
|
J:151335
|
Ighmbp2em5Cx/Ighmbp2+
(C57BL/6J-Ighmbp2em5Cx/Cx)
|
decreased nerve conduction velocity
|
J:337488
|
Ighmbp2em5Cx/Ighmbp2em5Cx
(C57BL/6J-Ighmbp2em5Cx/Cx)
|
decreased nerve conduction velocity
|
J:337488
|
Igsf9tm1Kln/Igsf9tm1Kln
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased miniature inhibitory postsynaptic current frequency
|
J:209586
|
| increased susceptibility to pharmacologically induced seizures
|
J:209586
|
Igsf11tm1a(KOMP)Wtsi/Igsf11tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
decreased excitatory postsynaptic current amplitude
|
J:234439
|
Igsf11tm1d(KOMP)Wtsi/Igsf11tm1d(KOMP)Wtsi
(involves: 129S4/SvJae * C57BL/6N)
|
decreased excitatory postsynaptic current amplitude
|
J:234439
|
| reduced long-term potentiation
|
J:234439
|
Igsf21tm2a(EUCOMM)Hmgu/Igsf21tm2a(EUCOMM)Hmgu
(B6J;B6N-Igsf21tm2a(EUCOMM)Hmgu)
|
decreased miniature inhibitory postsynaptic current frequency
|
J:249826
|
| decreased prepulse inhibition
|
J:249826
|
Il1btm1Dch/Il1btm1Dch
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myelination
|
J:71534
|
Il1btm1Lvp/Il1btm1Lvp
(involves: 129S7/SvEvBrd * C57BL/6 * C57BL/10 * RIIIS)
|
abnormal blood-brain barrier function
|
J:105009
|
Il1r1tm1Imx/Il1r1tm1Imx
(B6.129S7-Il1r1tm1Imx/J)
|
abnormal nervous system electrophysiology
|
J:145169
|
Il1r1tm1Quan/Il1r1tm1Quan
(involves: C57BL/6)
|
abnormal microglial cell activation
|
J:219864
|
Il1r1tm1Quan/Il1r1tm1Quan
Lyz2tm1(cre)Ifo/Lyz2tm1(cre)Ifo
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal microglial cell activation
|
J:219864
|
Il1r1tm1Quan/Il1r1tm1Quan
Tg(Tek-cre)12Flv/0
(involves: C3H * C57BL/6)
|
abnormal microglial cell activation
|
J:219864
|
Il1rapl1tm1.1Hesk/Y
(involves: C57BL/6)
|
abnormal CNS synaptic transmission
|
J:155437
|
| abnormal inhibitory postsynaptic currents
|
J:155437
|
Il1rapl1tm1.1Hesk/Il1rapl1tm1.1Hesk
(involves: C57BL/6)
|
abnormal CNS synaptic transmission
|
J:155437
|
| abnormal inhibitory postsynaptic currents
|
J:155437
|
Il4tm1Nnt/Il4tm1Nnt
(C57BL/6-Il4tm1Nnt/J)
|
CNS inflammation
|
J:125605
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6)
|
abnormal nervous system physiology
|
J:148881
|
| abnormal neuron physiology
|
J:148881
|
Il6tm1Kopf/Il6tm1Kopf
(involves: 129S2/SvPas * C57BL/6J * CE/J)
|
seizures
|
J:63197
|
Il6tm1Kopf/Il6tm1Kopf
Npc1m1N/Npc1m1N
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal glial cell physiology
|
J:118352
|
Il6tm1Mur/Il6tm1Mur
(involves: 129/Sv * C57BL/6)
|
brain inflammation
|
J:40579
|
Il6tm1Mur/Il6tm1Mur
(B6.129P2(B6)-Il6tm1Mur)
|
abnormal microglial cell physiology
|
J:85581
|
| increased susceptibility to dopaminergic neuron neurotoxicity
|
J:86039
|
Il6sttm1Thir/Il6sttm1Thir
(Not Specified)
|
abnormal action potential
|
J:130276
|
| abnormal channel response intensity
|
J:130276
|
Il6sttm1Wme/Il6sttm1Wme
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myelination
|
J:67677
|
Il10tm1Cgn/Il10tm1Cgn
(B6.129P2-Il10tm1Cgn/J)
|
abnormal neuron physiology
|
J:108086
|
| increased cerebral infarct size
|
J:108086
|
| increased susceptibility to neuronal excitotoxicity
|
J:108086
|
Il18tm1Aki/Il18tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cerebral infarct size
|
J:124249
|
Il20rbem2(IMPC)Mbp/Il20rbem2(IMPC)Mbp
(C57BL/6N-Il20rbem2(IMPC)Mbp/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Il34tm1b(EUCOMM)Wtsi/Il34tm1b(EUCOMM)Wtsi
(involves: BALB/cJ * C57BL/6N)
|
increased neuron apoptosis
|
J:187643
|
Immp2lem1(IMPC)Bay/Immp2lem1(IMPC)Bay
(C57BL/6N-Immp2lem1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
ImmtGt(AW0256)Wtsi/Immt+
(involves: 129P2/OlaHsd)
|
increased neuron apoptosis
|
J:344896
|
Impa1Rgsc01846/Impa1Rgsc01846
(B6NJcl.B6JJcl-Impa1Rgsc01846/Rbrc)
|
seizures
|
J:250420
|
Impa1tm1Lex/Impa1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:157887
|
Impa2tm1.2Tohn/Impa2tm1.2Tohn
(involves: C57BL/6 * C57BL/6JJcl * C57BL/6NCrSlc)
|
increased prepulse inhibition
|
J:193924
|
Inatm1Jpj/Inatm1Jpj
Nefmtm1Jpj/Nefmtm1Jpj
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal axonal transport
|
J:112938
|
Inpp4atm1Tsak/Inpp4atm1Tsak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:161963
|
Insctm1Jakn/Insctm1Jakn
Tg(Nes-cre)1Wmz/0
(involves: C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:178712
|
Insm1tm1.1Jga/Insm1tm1.1Jga
(either: B6.129P2-Insm1tm1.1Jga or (involves: 129P2/OlaHsd * C57BL/6 * CD-1 * FVB/N))
|
increased neuron apoptosis
|
J:168833
|
Insyn1em1Ssod/Insyn1em1Ssod
(C57BL/6J-Insyn1em1Ssod)
|
abnormal hippocampus physiology
|
J:284536
|
| abnormal nervous system electrophysiology
|
J:284536
|
| abnormal neuron physiology
|
J:284536
|
Ip6k1em1Seyk/Ip6k1em1Seyk
(C57BL/6-Ip6k1em1Seyk)
|
abnormal synaptic vesicle exocytosis
|
J:306957
|
| abnormal synaptic vesicle recycling
|
J:306957
|
| decreased excitatory postsynaptic current amplitude
|
J:306957
|
| decreased paired-pulse facilitation
|
J:306957
|
| enhanced paired-pulse facilitation
|
J:306957
|
Ip6k3tm1.1Snyd/Ip6k3tm1.1Snyd
(Not Specified)
|
abnormal nervous system physiology
|
J:225876
|
Iqsec1tm1.1Hck/Iqsec1tm1.1Hck
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
absent long-term depression
|
J:163183
|
Iqsec2em1Alev/Iqsec2em1Alev
(C57BL/6J-Iqsec2em1Alev)
|
abnormal CNS synaptic transmission
|
J:280198
|
Iqsec2em1Csbg/Y
(C57BL/6NHsd-Iqsec2em1Csbg)
|
sporadic seizures
|
J:284750
|
Iqsec2em1Csbg/Iqsec2+
(C57BL/6NHsd-Iqsec2em1Csbg)
|
sporadic seizures
|
J:284750
|
Iqsec2em1Frk/Y
(involves: C3HeB/FeJ * C57BL/6NJ)
|
abnormal GABAergic neuron physiology
|
J:284762
|
| abnormal miniature excitatory postsynaptic currents
|
J:284762
|
| convulsive seizures
|
J:284762
|
| decreased susceptibility to induction of seizure by inducing agent
|
J:284762
|
| decreased susceptibility to pharmacologically induced seizures
|
J:284762
|
Iqsec2em1Frk/Iqsec2+
(involves: C3HeB/FeJ * C57BL/6NJ)
|
decreased susceptibility to induction of seizure by inducing agent
|
J:284762
|
Iqsec3tm3b(KOMP)Wtsi/Iqsec3tm3b(KOMP)Wtsi
(C57BL/6N-Iqsec3tm3b(KOMP)Wtsi/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Irgcem1(IMPC)Tcp/Irgcem1(IMPC)Tcp
(C57BL/6N-Irgcem1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Itga3tm1Jak/Itga3+
Itga5tm1Hyn/Itga5+
Itga8tm1Lfr/Itga8+
(involves: 129S2/SvPas * 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
reduced long-term potentiation
|
J:84858
|
Itga3tm1Jak/Itga3+
Itga8tm1Lfr/Itga8+
(involves: 129S4/SvJae * 129X1/SvJ * C57BL/6J)
|
reduced long-term potentiation
|
J:84858
|
Itga3tm1Rdav/Itga3tm1Rdav
Tg(Camk2a-cre)T29-1Stl/0
(B6.Cg-Itga3tm1Rdav Tg(Camk2a-cre)T29-1Stl)
|
reduced long-term potentiation
|
J:147820
|
Itga5tm2Hyn/Itga5tm2Hyn
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuronal migration
|
J:159465
|
Itga6tm1Egl/Itga6tm1Egl
(either: (involves: 129S2/SvPas * C57BL/6) or (involves: 129S2/SvPas * C57BL/6 * CD-1))
|
abnormal neuronal precursor cell migration
|
J:79739
|
Itga6tm2Egl/Itga6tm2Egl
Itga7tm1Umr/Itga7tm1Umr
Tg(Mpz-cre)26Mes/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/NTac)
|
abnormal myelination
|
J:204174
|
| abnormal Schwann cell physiology
|
J:204174
|
| hypermyelination
|
J:204174
|
Itga6tm2Egl/Itga6tm2Egl
Tg(Mpz-cre)26Mes/0
(involves: C57BL/6 * FVB/NTac)
|
abnormal myelination
|
J:204174
|
| abnormal Schwann cell physiology
|
J:204174
|
| hypermyelination
|
J:204174
|
Itga7tm1Burk/Itga7tm1Burk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
intracranial hemorrhage
|
J:100236
|
Itga7tm1Umr/Itga7tm1Umr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal Schwann cell physiology
|
J:204174
|
Itga8tm1.1Rdav/Itga8tm1.1Rdav
Tg(Camk2a-cre)#Szi/0
(involves: 129S6/SvEvTac * C57BL/6J * CBA)
|
impaired synaptic plasticity
|
J:170959
|
| reduced long-term potentiation
|
J:170959
|
Itgamtm1Myd/Itgamtm1Myd
(involves: 129S4/SvJae * C57BL/6)
|
decreased cerebral infarct size
|
J:103873
|
Itgavtm1Hyn/Itgavtm1Hyn
(either: (involves: 129/Sv * 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6J))
|
intracerebral hemorrhage
|
J:50951
|
Itgavtm1Hyn/Itgavtm1Hyn
(involves: 129S2/SvPas * C57BL/6 * FVB/N)
|
intracerebral hemorrhage
|
J:79611
|
Itgavtm2.1Hyn/Itgavtm2.1Hyn
(involves: 129P2/OlaHsd)
|
intracerebral hemorrhage
|
J:94376
|
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(GFAP-cre)#Gtm/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
cerebellum hemorrhage
|
J:94376
|
| intracerebral hemorrhage
|
J:94376
|
| intracranial hemorrhage
|
J:94376
|
Itgavtm2Hyn/Itgavtm2.1Hyn
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6 * FVB * SJL)
|
convulsive seizures
|
J:94376
|
| demyelination
|
J:94376
|
| intracerebral hemorrhage
|
J:94376
|
| intracranial hemorrhage
|
J:94376
|
| seizures
|
J:94376
|
| spinal hemorrhage
|
J:94376
|
Itgb1tm1Lscd/Itgb1tm1Ref
Tg(PLAT-cre)116Sdu/0
(Not Specified)
|
abnormal myelination
|
J:92060
|
Itgb1tm1Lscd/Itgb1tm1Ref
Tg(PLAT-cre)116Sdu/0
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuronal migration
|
J:108439
|
Itgb1tm1Mll/Itgb1tm1Mll
Tg(Nes-cre)1Kln/0
(involves: 129X1/SvJ * C57BL/6 * SJL)
|
abnormal neuronal precursor cell migration
|
J:120076
|
Itgb3tm1Hyn/Itgb3tm1.1Wlbcr
Tg(Pf4-icre)Q3Rsko/0
(involves: 129S2/SvPas * C57BL/6)
|
intracranial hemorrhage
|
J:224675
|
Itgb8tm1Lfr/Itgb8tm1Lfr
(either: (involves: 129/Sv) or (involves: 129/Sv * C57BL/6J))
|
intracerebral hemorrhage
|
J:77682
|
Itgb8tm1Lfr/Itgb8tm2Lfr
Tg(Nes-cre)1Kln/0
(involves: 129/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
intracranial hemorrhage
|
J:102190
|
Itgb8tm1Lfr/Itgb8tm2Lfr
Tg(Nes-cre)1Wmz/0
(involves: 129/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
intracranial hemorrhage
|
J:102190
|
Itm2btm1.1Ldad/Itm2b+
(B6.129-Itm2btm1.1Ldad)
|
reduced long-term potentiation
|
J:167154
|
Itm2btm1.1Ldad/Itm2b+
Tg(APPswe,PSEN1dE9)85Dbo/0
(involves: 129 * C3H * C57BL/6)
|
abnormal nervous system physiology
|
J:138796
|
Itm2btm1.1Ldad/Itm2btm1.1Ldad
(involves: 129 * C57BL/6J)
|
abnormal nervous system physiology
|
J:138796
|
Itm2btm2.1Ldad/Itm2b+
(B6.129-Itm2btm2.1Ldad)
|
reduced long-term potentiation
|
J:167154
|
Itpkatm1Hssh/Itpkatm1Hssh
(involves: 129S4/SvJae * C57BL/6J)
|
enhanced long-term potentiation
|
J:51150
|
Itpr1opt/Itpr1opt
(involves: C57BLKS)
|
seizures
|
J:50383,
J:28829,
J:37547
|
Itpr1tm1.1Kmik/Itpr1tm1.1Kmik
Tg(Pcp2-cre)2Mpin/0
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:199800
|
| abnormal excitatory postsynaptic potential
|
J:199800
|
| absent long-term depression
|
J:199800
|
Itpr1tm1Tno/Itpr1tm1Tno
(involves: 129S4/SvJae * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:30633
|
| seizures
|
J:30633
|
| tonic-clonic seizures
|
J:30633
|
Itpriptm1.1Snyd/Itpriptm1.1Snyd
(involves: C57BL/6)
|
increased cerebral infarct size
|
J:157643
|
Itsn1em1(IMPC)H/Itsn1em1(IMPC)H
(C57BL/6NTac-Itsn1em1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Itsn1tm1.1Mapr/Itsn1tm1.1Mapr
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal synaptic vesicle recycling
|
J:140030
|
Itsn1tm2.1Mapr/Itsn1tm2.1Mapr
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal synaptic vesicle recycling
|
J:140030
|
Jade2em1(IMPC)Tcp/Jade2em1(IMPC)Tcp
(C57BL/6N-Jade2em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Jade2em1Cya/Jade2em1Cya
(involves: C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:333965
|
| abnormal synaptic transmission
|
J:333965
|
| decreased miniature excitatory postsynaptic current frequency
|
J:333965
|
| impaired synaptic plasticity
|
J:333965
|
| reduced long-term potentiation
|
J:333965
|
Jag1tm1Grid/Cm
(involves: 101/H * 129S1/Sv * C3H/He * C57BL/6 * FVB/N)
|
intracranial hemorrhage
|
J:54907
|
Jag1tm2.1Grid/Jag1tm2.1Grid
(involves: 129S1/Sv * C57BL/6)
|
intracranial hemorrhage
|
J:115783
|
Jak2tm1Kuw/Jak2tm1Kuw
Tg(Gnrh1-cre)35Awo/0
(involves: 129X1/SvJ * CD-1)
|
abnormal neuron physiology
|
J:167849
|
Jakmip1tm1(KOMP)Vlcg/Jakmip1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal nervous system electrophysiology
|
J:228732
|
Jam3tm1Rha/Jam3tm1Rha
(B6.129P2-Jam3tm1Rha)
|
abnormal nervous system physiology
|
J:191990
|
| intracranial hemorrhage
|
J:191990
|
| intraventricular hemorrhage
|
J:191990
|
| subarachnoid hemorrhage
|
J:191990
|
jb/jb
(involves: C3HeB/FeJ * C57BL/6J)
|
convulsive seizures
|
J:39707
|
Jph3tm1Hta/Jph3tm1Hta
Jph4tm1Hta/Jph4tm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal afterhyperpolarization
|
J:111805
|
| abnormal excitatory postsynaptic potential
|
J:111805
|
| reduced long-term potentiation
|
J:111805
|
jpl/jpl
(B6;D2-jpl)
|
abnormal nervous system physiology
|
J:76714
|
Junem1(IMPC)Mbp/Jun+
(C57BL/6N-Junem1(IMPC)Mbp/MbpMmucd)
|
increased prepulse inhibition
|
J:211773
|
Juntm1Bdc/Juntm1Bdc
(Not Specified)
|
decreased neuron apoptosis
|
J:78265
|
Juntm2.1Wag/Juntm2.1Wag
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
decreased susceptibility to neuronal excitotoxicity
|
J:53481
|
| decreased susceptibility to pharmacologically induced seizures
|
J:53481
|
Juntm4Wag/Juntm4Wag
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
decreased neuron apoptosis
|
J:176956
|
Kalrntm1.1Npl/Kalrntm1.1Npl
(involves: 129S1/Sv * C57BL/6)
|
abnormal action potential
|
J:142364
|
| abnormal neuron physiology
|
J:142364
|
| decreased excitatory postsynaptic current frequency
|
J:142364
|
| reduced long-term potentiation
|
J:142364
|
Kalrntm1Ppen/Kalrntm1Ppen
(Not Specified)
|
decreased miniature excitatory postsynaptic current frequency
|
J:152011
|
| decreased prepulse inhibition
|
J:152011
|
| reduced AMPA-mediated synaptic currents
|
J:152011
|
Kalrntm2.1Npl/Kalrntm2.1Npl
(B6.Cg-Kalrntm2.1Npl)
|
abnormal pituitary secretion
|
J:206512
|
| acromegaly
|
J:206512
|
Kank1em1(IMPC)Bay/Kank1em1(IMPC)Bay
(C57BL/6N-Kank1em1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Kansl1/Mapttm1.1Cole/Kansl1/Mapttm1.1Cole
(involves: C57BL/6 * C57BL/6J * C57BL/6JOlaHsd)
|
abnormal axonal transport
|
J:188213
|
Kansl1/Mapttm1.1Cole/Kansl1/Mapttm1.1Cole
(involves: C57BL/6 * C57BL/6J * C57BL/6JOlaHsd)
|
abnormal axonal transport
|
J:188213
|
Kansl2tm1c(EUCOMM)Wtsi/Kansl2tm1c(EUCOMM)Wtsi
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
intraventricular hemorrhage
|
J:291094
|
Kansl3tm1.1Max/Kansl3tm1.1Max
Tg(Nes-cre)1Kln/0
(involves: C57BL/6N * SJL)
|
intraventricular hemorrhage
|
J:291094
|
Kat6bGt(pKC199)1Pgr/Kat6bGt(pKC199)1Pgr
(involves: 129S2/SvPas)
|
abnormal neuronal migration
|
J:178264
|
Kat14Gt(OST388291)Lex/Kat14Gt(OST388291)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
increased embryonic neuroepithelium apoptosis
|
J:145720
|
Katna1tm1a(KOMP)Wtsi/Katna1+
(involves: C57BL/6J * C57BL/6N)
|
abnormal neuronal precursor proliferation
|
J:284578
|
| decreased neuronal precursor proliferation
|
J:284578
|
Katnb1tm1a(EUCOMM)Hmgu/Katnb1tm1a(EUCOMM)Hmgu
(C57BL/6-Katnb1tm1a(EUCOMM)Hmgu)
|
abnormal neuronal precursor proliferation
|
J:220901
|
| increased brain apoptosis
|
J:220901
|
KatnipGt(RRG309)Byg/KatnipGt(RRG309)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal cerebrospinal fluid flow
|
J:239987
|
Kcna1mceph/Kcna1mceph
(BALB/cByJ-Kcna1mceph/J)
|
convulsive seizures
|
J:89910,
J:119491
|
| seizures
|
J:89910
|
| tonic-clonic seizures
|
J:89910
|
Kcna1tm1Jmay/Kcna1+
(B6.129S4-Kcna1tm1Jmay)
|
abnormal inhibitory postsynaptic currents
|
J:82778
|
Kcna1tm1Tem/Kcna1+
(involves: 129S7/SvEvBrd * various)
|
increased susceptibility to pharmacologically induced seizures
|
J:47349
|
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * various)
|
abnormal action potential
|
J:47349
|
| abnormal brain wave pattern
|
J:47349
|
| abnormal CNS synaptic transmission
|
J:47349
|
| abnormal paired-pulse facilitation
|
J:47349
|
| increased susceptibility to pharmacologically induced seizures
|
J:47349
|
| seizures
|
J:47349
|
| tonic-clonic seizures
|
J:47349
|
Kcna1tm1Tem/Kcna1tm1Tem
(C3Fe.129S7-Kcna1tm1Tem)
|
abnormal action potential
|
J:105296
|
| abnormal nervous system electrophysiology
|
J:105296
|
| decreased nerve fiber response threshold
|
J:105296
|
| decreased paired-pulse ratio
|
J:206598
|
| seizures
|
J:206598
|
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal PNS synaptic transmission
|
J:77281
|
| seizures
|
J:77281
|
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd * BALB/cByJ * C3HeB/FeJ)
|
convulsive seizures
|
J:119491
|
Kcna1tm1Tem/Kcna1tm1Tem
(involves: 129S7/SvEvBrd)
|
myoclonus
|
J:164091
|
| seizures
|
J:164091
|
| tonic-clonic seizures
|
J:164091
|
Kcna2Pgu/Kcna2+
(involves: C3H/HeJ * C57BL/6J)
|
abnormal inhibitory postsynaptic currents
|
J:166795
|
| abnormal miniature inhibitory postsynaptic currents
|
J:166795
|
| abnormal single cell response
|
J:166795
|
| impaired ability to fire action potentials
|
J:166795
|
Kcna2Pgu/Kcna2Pgu
(involves: C3H/HeJ * C57BL/6J)
|
abnormal inhibitory postsynaptic currents
|
J:166795
|
| abnormal miniature inhibitory postsynaptic currents
|
J:166795
|
| abnormal single cell response
|
J:166795
|
| impaired ability to fire action potentials
|
J:166795
|
Kcna2tm1Tem/Kcna2+
(C3Fe.129S7-Kcna2tm1Tem)
|
impaired ability to fire action potentials
|
J:131735
|
| increased susceptibility to pharmacologically induced seizures
|
J:131735
|
Kcna2tm1Tem/Kcna2tm1Tem
(involves: 129S7/SvEvBrd * C57BL/6)
|
tonic seizures
|
J:131735
|
Kcna2tm1Tem/Kcna2tm1Tem
(C3Fe.129S7-Kcna2tm1Tem)
|
abnormal action potential
|
J:131735
|
| abnormal channel response
|
J:131735
|
| abnormal nervous system electrophysiology
|
J:131735
|
| impaired ability to fire action potentials
|
J:131735
|
| increased susceptibility to pharmacologically induced seizures
|
J:131735
|
| tonic seizures
|
J:131735
|
Kcna2tm1Tem/Kcna2tm1Tem
(involves: 129S7/SvEvBrd)
|
abnormal brain wave pattern
|
J:130097
|
| seizures
|
J:130097
|
Kcna4tm1Lndn/Kcna4tm1Lndn
(involves: 129S4/SvJae * C57BL/6)
|
seizures
|
J:48415
|
Kcna5tm1Hket/Kcna5tm1Hket
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
abnormal nervous system electrophysiology
|
J:116545
|
| decreased channel response intensity
|
J:116545
|
Kcnab1tm1Sva/Kcnab1tm1Sva
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal action potential
|
J:51147
|
| abnormal afterhyperpolarization
|
J:94633
|
| abnormal nervous system electrophysiology
|
J:51147
|
| enhanced long-term potentiation
|
J:94633
|
Kcnab1tm1Sva/Kcnab1tm1Sva
(B6.129-Kcnab1tm1Sva)
|
abnormal afterhyperpolarization
|
J:94633
|
Kcnab2tm1Kmc/Kcnab2tm1Kmc
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal afterhyperpolarization
|
J:167856
|
| abnormal nervous system electrophysiology
|
J:167856
|
| sporadic seizures
|
J:75891
|
Kcnc1tm1Joho/Kcnc1tm1Joho
Kcnc3tm1Echa/Kcnc3tm1Echa
(involves: 129/Sv * C57BL/6)
|
myoclonus
|
J:71179
|
Kcnc2tm1Rudy/Kcnc2tm1Rudy
(B6.129S1-Kcnc2tm1Rudy)
|
abnormal action potential
|
J:66730
|
| abnormal afterhyperpolarization
|
J:66730
|
| abnormal brain wave pattern
|
J:66730
|
| abnormal nervous system electrophysiology
|
J:66730
|
| increased susceptibility to pharmacologically induced seizures
|
J:66730
|
| myoclonus
|
J:66730
|
| seizures
|
J:66730
|
| sporadic seizures
|
J:66730
|
| tonic-clonic seizures
|
J:66730
|
Kcnd2tm1Jmn/Kcnd2tm1Jmn
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal channel response
|
J:110968
|
Kcnd2tm1Jmn/Kcnd2tm1Jmn
(FVB.129-Kcnd2tm1Jmn)
|
abnormal channel response
|
J:111318
|
Kcne1tm1b(EUCOMM)Hmgu/Kcne1tm1b(EUCOMM)Hmgu
(C57BL/6N-Kcne1tm1b(EUCOMM)Hmgu/Ics)
|
decreased prepulse inhibition
|
J:211773
|
Kcne3tm1(KOMP)Vlcg/Kcne3tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal action potential
|
J:215948
|
Kcng1em1(IMPC)Tcp/Kcng1em1(IMPC)Tcp
(C57BL/6NCrl-Kcng1em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Kcnh3tm1.1Tije/Kcnh3tm1.1Tije
(involves: C57BL/6)
|
abnormal single cell response
|
J:165296
|
| decreased single cell response threshold
|
J:165296
|
Kcnh3tm1.2Tije/Kcnh3+
(involves: C57BL/6)
|
abnormal spike wave discharge
|
J:165296
|
Kcnh3tm1.2Tije/Kcnh3tm1.2Tije
(involves: C57BL/6)
|
abnormal single cell response
|
J:165296
|
| abnormal spike wave discharge
|
J:165296
|
| decreased single cell response threshold
|
J:165296
|
| increased susceptibility to pharmacologically induced seizures
|
J:165296
|
| nonconvulsive seizures
|
J:165296
|
Kcnh3tm1Akmi/Kcnh3tm1Akmi
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:155749
|
| abnormal long-term potentiation
|
J:155749
|
Kcnh6em1Jkya/Kcnh6em1Jkya
(involves: C57BL/6N)
|
abnormal action potential
|
J:271003
|
| decreased channel response intensity
|
J:271003
|
Kcnh6em2Jkya/Kcnh6em2Jkya
(involves: C57BL/6N)
|
abnormal action potential
|
J:271003
|
| decreased channel response intensity
|
J:271003
|
Kcnip1tm1Zhzh/Kcnip1tm1Zhzh
(involves: C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:227383
|
Kcnip3tm1Bux/Kcnip3tm1Bux
(involves: 129S4/SvJae * C57BL/6)
|
abnormal channel response
|
J:85927
|
| enhanced long-term potentiation
|
J:85927
|
Kcnj6em1.1Ktaka/Kcnj6em1.1Ktaka
Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(involves: C57BL/6J * C57BL/6N)
|
abnormal nervous system electrophysiology
|
J:257982
|
Kcnj6tm1Stf/Kcnj6tm1Stf
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal synaptic transmission
|
J:77047
|
| environmentally induced seizures
|
J:38206
|
| increased susceptibility to pharmacologically induced seizures
|
J:38206
|
| tonic-clonic seizures
|
J:38206
|
Kcnj6tm1Stf/Kcnj6tm1Stf
Kcnj9tm1Kwn/Kcnj9tm1Kwn
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal synaptic transmission
|
J:77047
|
| seizures
|
J:77047
|
Kcnj6wv/Kcnj6wv
(C57BL/6J-Kcnj6wv)
|
tonic-clonic seizures
|
J:30520
|
Kcnj6wv/Kcnj6wv
(involves: C57BL/6)
|
abnormal CNS synaptic transmission
|
J:35792
|
| abnormal synaptic glutamate release
|
J:6875
|
| abnormal synaptic neurotransmitter level
|
J:6875
|
Kcnj8em1Nich/Kcnj8+
(involves: C57BL/6J * CBA/J)
|
abnormal channel response
|
J:281903
|
Kcnj9tm1Kwn/Kcnj9tm1Kwn
(involves: 129X1/SvJ)
|
abnormal synaptic transmission
|
J:77047
|
Kcnj10tm1Kdmc/Kcnj10tm1Kdmc
Tg(GFAP-cre)1Kdmc/?
(involves: 129S6/SvEvTac * C3H * C57BL/6 * C57BL/6J * SJL)
|
abnormal astrocyte physiology
|
J:126082
|
| abnormal CNS synaptic transmission
|
J:126082
|
| abnormal excitatory postsynaptic currents
|
J:126082
|
| abnormal nervous system physiology
|
J:126082
|
| enhanced long-term potentiation
|
J:126082
|
| increased post-tetanic potentiation
|
J:126082
|
| tonic-clonic seizures
|
J:126082
|
Kcnj10tm1Lst/Kcnj10tm1Lst
(involves: 129S1/Sv * C57BL/6J)
|
abnormal myelination
|
J:77663
|
| abnormal nervous system electrophysiology
|
J:77663
|
Kcnj11tm1Sse/Kcnj11tm1Sse
(B6.129P2-Kcnj11tm1Sse)
|
abnormal action potential
|
J:106396
|
| abnormal nerve fiber response
|
J:69163
|
Kcnj11tm1Sse/Kcnj11tm1Sse
(involves: 129P2/OlaHsd)
|
abnormal nerve fiber response
|
J:69832
|
| abnormal nerve fiber response intensity
|
J:69832
|
| convulsive seizures
|
J:69832
|
| myoclonus
|
J:69832
|
| tonic-clonic seizures
|
J:69832
|
Kcnj16tm1Pess/Kcnj16tm1Pess
(B6.129X1-Kcnj16tm1Pess)
|
abnormal nerve fiber response
|
J:167533
|
| abnormal neuron physiology
|
J:167533
|
Kcnk2tm1Lzd/Kcnk2tm1Lzd
(involves: 129 * C57BL/6J)
|
abnormal response to CNS ischemic injury
|
J:91531
|
| increased susceptibility to ischemic brain injury
|
J:91531
|
| increased susceptibility to pharmacologically induced seizures
|
J:91531
|
Kcnk3tm1.1Daba/Kcnk3tm1.1Daba
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal action potential
|
J:130850
|
Kcnk3tm1.1Daba/Kcnk3tm1.1Daba
Kcnk9tm1.1Daba/Kcnk9tm1.1Daba
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal channel response
|
J:131927
|
Kcnk3tm1.1Daba/Kcnk3tm1.1Daba
Kcnk9tm1.1Daba/Kcnk9tm1.1Daba
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal action potential
|
J:130850
|
Kcnk5Gt(KST024)Byg/Kcnk5Gt(KST024)Byg
(B6.129P2-Kcnk5Gt(KST024)Byg)
|
abnormal nervous system physiology
|
J:157526
|
Kcnk9tm1.1Daba/Kcnk9tm1.1Daba
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal action potential
|
J:130850
|
Kcnk13em1(IMPC)H/Kcnk13em1(IMPC)H
(involves: C57BL/6NTac)
|
abnormal microglial cell physiology
|
J:256020
|
Kcnk18m1Ewis/Kcnk18m1Ewis
(C3HeB/FeJ-Kcnk18m1Ewis)
|
abnormal action potential
|
J:175137
|
| abnormal afterhyperpolarization
|
J:175137
|
| abnormal neuron physiology
|
J:175137
|
Kcnma1tm1Ruth/Kcnma1tm1Ruth
(involves: 129/Sv * C57BL/6)
|
impaired ability to fire action potentials
|
J:91427
|
| increased synaptic depression
|
J:91427
|
Kcnma1tm1Ruth/Kcnma1tm1Ruth
(129-Kcnma1tm1Ruth)
|
abnormal cochlear inner hair cell physiology
|
J:109217
|
| abnormal cochlear nerve fiber response
|
J:109217
|
Kcnma1tm1Rwa/Kcnma1tm1Rwa
(FVB.129-Kcnma1tm1Rwa)
|
abnormal cochlear inner hair cell physiology
|
J:117811
|
Kcnma1tm1Rwa/Kcnma1tm1Rwa
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal action potential
|
J:225860
|
| abnormal channel response
|
J:225860
|
Kcnmb2tm1.2Clin/Kcnmb2tm1.2Clin
(B6(FVB)-Kcnmb2tm1.2Clin)
|
abnormal action potential
|
J:225860
|
| abnormal channel response
|
J:225860
|
| impaired ability to fire action potentials
|
J:225860
|
Kcnmb4tm1Rwa/Kcnmb4tm1Rwa
(involves: 129X1/SvJ * C57BL/6)
|
nonconvulsive seizures
|
J:103931
|
Kcnmb4tm1Rwa/Kcnmb4tm1Rwa
(B6.129X1-Kcnmb4tm1Rwa)
|
abnormal action potential
|
J:103931
|
Kcnn2fri/Kcnn2fri
(129S2.C3Pas-Kcnn2fri)
|
abnormal afterhyperpolarization
|
J:177761
|
| abnormal single cell response
|
J:177761
|
Kcnn2tm1.1Jpad/Kcnn2tm1.1Jpad
(Not Specified)
|
abnormal action potential
|
J:187145
|
| abnormal afterhyperpolarization
|
J:94941
|
Kcnn2tm2Jpad/Kcnn2+
(B6.129S4-Kcnn2tm2Jpad)
|
abnormal CNS synaptic transmission
|
J:105645
|
| abnormal excitatory postsynaptic potential
|
J:105645
|
| reduced long-term potentiation
|
J:105645
|
Kcnn3tm2.2Jpad/Kcnn3tm2.2Jpad
(involves: 129S6/SvEvTac * BALB/cJ * C57BL/6J)
|
abnormal action potential
|
J:187145
|
Kcnq2Nmf134/Kcnq2+
(C57BL/6J-Kcnq2Nmf134/J)
|
abnormal seizure response to electrical stimulation
|
J:82238
|
Kcnq2Nmf134/Kcnq2+
(C57BL/6J-Kcnq2Nmf134)
|
abnormal seizure response to electrical stimulation
|
J:136510
|
| increased susceptibility to pharmacologically induced seizures
|
J:136510
|
Kcnq2Nmf134/Kcnq2+
Scn1atm1.1Aesc/Scn1a+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J)
|
convulsive seizures
|
J:170734
|
| tonic-clonic seizures
|
J:170734
|
Kcnq2Nmf134/Kcnq2+
Tg(Eno2-Scn2a1*)Q54Mm/0
(involves: C57BL/6J * SJL/J)
|
seizures
|
J:136510
|
| tonic-clonic seizures
|
J:136510
|
Kcnq2Nmf134/Kcnq2Nmf134
(C57BL/6J-Kcnq2Nmf134/J)
|
abnormal seizure response to electrical stimulation
|
J:82238
|
Kcnq2tm1.1Lvi/Kcnq2+
(129-Kcnq2tm1.1Lvi/Lvi)
|
tonic-clonic seizures
|
J:298666
|
Kcnq2tm1.1Naas/Kcnq2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal seizure response to electrical stimulation
|
J:154582
|
Kcnq2tm1.1Naas/Kcnq2tm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neuron physiology
|
J:154582
|
| seizures
|
J:154582
|
Kcnq2tm1.1Naas/Kcnq2tm1.1Naas
(B6.129-Kcnq2tm1.1Naas)
|
tonic-clonic seizures
|
J:154582
|
Kcnq2tm1.1Naas/Kcnq2tm1.1Naas
(FVB.129-Kcnq2tm1.1Naas)
|
seizures
|
J:154582
|
Kcnq2tm1Dgen/Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Kcnq2tm1Dgen/Kcnq2+
(B6.129P2-Kcnq2tm1Dgen/J)
|
decreased prepulse inhibition
|
J:161844
|
Kcnq2tm1Dgen/Kcnq2tm1Dgen
(B6.129P2-Kcnq2tm1Dgen/J)
|
abnormal afterhyperpolarization
|
J:142688
|
Kcnq2tm1Hsa/Kcnq2+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:62797
|
Kcnq2tm2.1Snhr/Kcnq2+
(B6.Cg-Kcnq2tm2.1Snhr)
|
abnormal nervous system electrophysiology
|
J:213443
|
| clonic seizures
|
J:213443
|
Kcnq2tm2.1Snhr/Kcnq2tm2.1Snhr
(B6.Cg-Kcnq2tm2.1Snhr)
|
abnormal nervous system electrophysiology
|
J:213443
|
| clonic seizures
|
J:213443
|
Kcnq2tm3.1Snhr/Kcnq2+
(B6.Cg-Kcnq2tm3.1Snhr)
|
clonic seizures
|
J:213443
|
Kcnq3tm1.1Naas/Kcnq3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal seizure response to electrical stimulation
|
J:154582
|
Kcnq3tm1.1Naas/Kcnq3+
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal seizure response to electrical stimulation
|
J:154582
|
Kcnq3tm1.1Naas/Kcnq3tm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neuron physiology
|
J:154582
|
| seizures
|
J:154582
|
Kcnq3tm1.1Naas/Kcnq3tm1.1Naas
(B6.129-Kcnq3tm1.1Naas)
|
seizures
|
J:154582
|
Kcnq3tm1.1Naas/Kcnq3tm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal neuron physiology
|
J:154582
|
Kcnq3tm1.1Naas/Kcnq3tm1.1Naas
(FVB.129-Kcnq3tm1.1Naas)
|
seizures
|
J:154582
|
Kcnq3tm1Dgen/Kcnq3tm1Dgen
(Not Specified)
|
abnormal afterhyperpolarization
|
J:142688
|
Kcnq4tm1.2Tjj/Kcnq4tm1.2Tjj
(involves: 129/Sv * C57BL/6)
|
abnormal cochlear outer hair cell physiology
|
J:105924
|
Kcnq5tm1.1Tjj/Kcnq5tm1.1Tjj
(involves: 129S2/SvPas)
|
abnormal afterhyperpolarization
|
J:195336
|
Kcnt1em1Lekk/Kcnt1+
(C57BL/6J-Kcnt1em1Lekk)
|
increased susceptibility to pharmacologically induced seizures
|
J:287751
|
| seizures
|
J:287751
|
Kcnt1em1Nju/Kcnt1em1Nju
(involves: C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:333464
|
| impaired ability to fire action potentials
|
J:333464
|
Kcnt1em1Pqt/Kcnt1em1Pqt
(C57BL/6J-Kcnt1em1Pqt)
|
seizures
|
J:333512
|
| tonic-clonic seizures
|
J:333512
|
Kcnt1em8Frk/Kcnt1em8Frk
(C57BL/6NJ-Kcnt1em8Frk)
|
abnormal CNS synaptic transmission
|
J:300699
|
| abnormal GABAergic neuron physiology
|
J:300699
|
| seizures
|
J:300699
|
| tonic seizures
|
J:300699
|
| tonic-clonic seizures
|
J:300699
|
Kcnt1em8Frk/Kcnt1em8Frk
(involves: 129P2/OlaHsd * C57BL/6NJ * FVB)
|
seizures
|
J:300699
|
Kcnt1tm1.2Acsc/Kcnt1tm1.2Acsc
(B6N.Cg-Kcnt1tm1.2Acsc)
|
abnormal sensory neuron physiology
|
J:218978
|
| impaired ability to fire action potentials
|
J:218978
|
Kcnt1tm1.2Acsc/Kcnt1tm1.2Acsc
(involves: 129 * C57BL/6N)
|
abnormal seizure response to electrical stimulation
|
J:287751
|
Kcnt1tm1.2Clin/Kcnt1tm1.2Clin
(B6.Cg-Kcnt1tm1.2Clin)
|
decreased channel response intensity
|
J:228059
|
Kcnt1tm1.2Clin/Kcnt1tm1.2Clin
Kcnt2tm1.2Clin/Kcnt2tm1.2Clin
(B6.Cg-Kcnt2tm1.2Clin Kcnt1tm1.2Clin)
|
abnormal action potential
|
J:228059
|
| decreased channel response intensity
|
J:228059
|
Kcnt1tm1Dgen/Kcnt1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal action potential
|
J:333464
|
| abnormal nervous system electrophysiology
|
J:333464
|
Kctd12tm1.1Bet/Kctd12tm1.1Bet
(B6.Cg-Kctd12tm1.1Bet)
|
abnormal action potential
|
J:227160
|
| abnormal nervous system electrophysiology
|
J:227160
|
Kctd13tm1.1(KOMP)Vlcg/Kctd13+
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal CNS synaptic transmission
|
J:250125
|
| abnormal excitatory postsynaptic potential
|
J:250125
|
| decreased miniature excitatory postsynaptic current frequency
|
J:250125
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:250125
|
Kctd13tm1.1(KOMP)Vlcg/Kctd13tm1.1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal CNS synaptic transmission
|
J:250125
|
| abnormal excitatory postsynaptic potential
|
J:250125
|
| abnormal miniature excitatory postsynaptic currents
|
J:250125
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:250125
|
Kdm1atm1Ebg/Kdm1atm1Ebg
(B6.129-Kdm1atm1Ebg)
|
abnormal brain wave pattern
|
J:235553
|
| absence seizures
|
J:235553
|
| decreased susceptibility to pharmacologically induced seizures
|
J:235553
|
| tonic-clonic seizures
|
J:235553
|
Kdm2atm1d(KOMP)Mtok/Kdm2atm1d(KOMP)Mtok
(involves: C57BL/6 * C57BL/6JJcl * C57BL/6N)
|
abnormal neuron proliferation
|
J:217589
|
| increased neuron apoptosis
|
J:217589
|
Kdm2btm1Nobu/Kdm2btm1Nobu
(either: (involves: 129S/SvEv * 129P2/OlaHsd) or (involves: 129P2/OlaHsd * C57BL/6J))
|
abnormal neuronal precursor proliferation
|
J:171291
|
| increased embryonic neuroepithelium apoptosis
|
J:171291
|
| intracranial hemorrhage
|
J:171291
|
Kdm3aem1(IMPC)Mbp/Kdm3aem1(IMPC)Mbp
(C57BL/6N-Kdm3aem1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Kdm3bem1(IMPC)Tcp/Kdm3b+
(C57BL/6NCrl-Kdm3bem1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Kdm6bGt(XB814)Byg/Kdm6bGt(XB814)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal nervous system physiology
|
J:196346
|
| abnormal pre-Botzinger complex physiology
|
J:196346
|
Kidins220tm1.2Fces/Kidins220tm1.2Fces
(involves: 129 * BALB/c * C57BL/6 * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:203073
|
| increased neuron apoptosis
|
J:203073
|
Kif1atm1Noh/Kif1atm1Noh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal nervous system physiology
|
J:47170
|
| abnormal synaptic vesicle clustering
|
J:47170
|
Kif1btm1Noh/Kif1b+
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal axonal transport
|
J:69772
|
Kif2atm1Noh/Kif2atm1Noh
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal neuronal migration
|
J:107737
|
Kif2cem1Nju/Kif2cem1Nju
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal excitatory postsynaptic currents
|
J:322820
|
| abnormal miniature excitatory postsynaptic currents
|
J:322820
|
| increased excitatory postsynaptic current amplitude
|
J:322820
|
| reduced long-term depression
|
J:322820
|
Kif3btm1Noh/Kif3b+
(involves: 129S4/SvJae * C57BL/6J)
|
decreased prepulse inhibition
|
J:286227
|
| enhanced long-term potentiation
|
J:286227
|
| impaired synaptic plasticity
|
J:286227
|
| reduced long-term depression
|
J:286227
|
| reduced NMDA-mediated synaptic currents
|
J:286227
|
Kif4em1Noh/Y
(C57BL/6J-Kif4em1Noh)
|
abnormal neuron physiology
|
J:336792
|
| increased susceptibility to pharmacologically induced seizures
|
J:336792
|
Kif5atm1.2Noh/Kif5atm1.2Noh
Tg(Syn1-cre)671Jxm/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J * CBA)
|
abnormal GABA-mediated receptor currents
|
J:197666
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:197666
|
| seizures
|
J:197666
|
Kif5atm1Gsn/Kif5atm2Gsn
Tg(Syn1-cre)671Jxm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal axonal transport
|
J:82911
|
| sporadic seizures
|
J:82911
|
Kif6em1Rgray/Kif6em1Rgray
(involves: C57BL/6J)
|
intracranial hemorrhage
|
J:269442
|
Kif13aem1(IMPC)Mbp/Kif13aem1(IMPC)Mbp
(C57BL/6N-Kif13aem1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Kif14lag/Kif14lag
(B6.D2(129X1)-Kif14lag)
|
abnormal cerebellar granule cell migration
|
J:195809
|
| abnormal oligodendrocyte physiology
|
J:195809
|
| demyelination
|
J:195809
|
Kif14tm1Tskk/Kif14tm1Tskk
(C57BL/6N-Kif14tm1Tskk)
|
demyelination
|
J:195809
|
Kif17tm1Noh/Kif17tm1Noh
(Not Specified)
|
abnormal axonal transport
|
J:174822
|
| impaired synaptic plasticity
|
J:174822
|
| reduced long-term depression
|
J:174822
|
| reduced long-term potentiation
|
J:174822
|
| reduced NMDA-mediated synaptic currents
|
J:174822
|
Kif20bmagoo/Kif20bmagoo
(involves: BALB/c * C57BL/6 * C57BL/6J * FVB/N)
|
abnormal neuronal precursor proliferation
|
J:205043
|
| increased neuron apoptosis
|
J:205043
|
Kif20bmagoo/Kif20bmagoo
(involves: BALB/c * C57BL/6)
|
abnormal neuron physiology
|
J:242310
|
Kif21atm1.1Ece/Kif21atm1.1Ece
Tg(Isl1-EGFP*)1Slp/0
(involves: 129S1/Sv * 129S4/SvJae * BALB/c * C57BL/6)
|
increased neuron apoptosis
|
J:213171
|
Kif26atm1.1Noh/Kif26atm1.1Noh
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:154859
|
Kif27Gt(OST441915)Lex/Kif27Gt(OST441915)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
intraventricular hemorrhage
|
J:185566
|
KitW-bd/KitW-bd
(involves: STOCK Rw Fgf5go Vps33abf)
|
abnormal action potential
|
J:45208
|
Klkl/Klkl
(involves: C3H/HeJ * C57BL/6J)
|
abnormal nervous system physiology
|
J:81240
|
Klc1tm1Gsn/Klc1tm1Gsn
(B6.129-Klc1tm1Gsn)
|
abnormal axonal transport
|
J:148380
|
Klhdc7bem1(IMPC)H/Klhdc7bem1(IMPC)H
(C57BL/6N-Klhdc7bem1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Klhl17em1Yph/Klhl17+
(C57BL/6-Klhl17em1Yph)
|
increased miniature excitatory postsynaptic current amplitude
|
J:308069
|
Klhl18lowf/Klhl18lowf
(C57BL/6N-Klhl18lowf)
|
abnormal cochlear nerve compound action potential
|
J:311444
|
Klk8tm1Lth/Klk8tm1Lth
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:71533
|
| increased susceptibility to pharmacologically induced seizures
|
J:71533
|
Klk15em1(IMPC)Ccpcz/Klk15em1(IMPC)Ccpcz
(C57BL/6N-Klk15em1(IMPC)Ccpcz/Ccpcz)
|
decreased prepulse inhibition
|
J:211773
|
Kmt2atm1.1Erns/Kmt2atm1.1Erns
Tg(GFAP-cre)25Mes/0
(involves: 129S2/SvPas * FVB/N)
|
abnormal neuronal precursor cell migration
|
J:147104
|
Kptntm1a(EUCOMM)Wtsi/Kptntm1a(EUCOMM)Wtsi
(C57BL/6N-Kptntm1a(EUCOMM)Wtsi)
|
abnormal nervous system physiology
|
J:343200
|
Krastm1Mok/Krastm1Mok
(involves: 129S/SvEv * C57BL/6J)
|
increased neuron apoptosis
|
J:42943
|
Krastm4.1Tyj/Kras+
(Not Specified)
|
increased embryonic neuroepithelium apoptosis
|
J:89333
|
Krastm4Tyj/Kras+
Tg(Cdh5-cre/ERT2)1Rha/0
(involves: 129S4/SvJae * FVB)
|
intracranial hemorrhage
|
J:312482
|
Krastm4Tyj/Kras+
Tg(Slco1c1-icre/ERT2)1Mrks/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB)
|
intracranial hemorrhage
|
J:312482
|
Krt8tm1b(EUCOMM)Hmgu/Krt8+
(C57BL/6N-Krt8tm1b(EUCOMM)Hmgu/Ics)
|
increased prepulse inhibition
|
J:211773
|
Ksr1tm1Shaw/Ksr1tm1Shaw
(Not Specified)
|
impaired synaptic plasticity
|
J:122941
|
| reduced long-term potentiation
|
J:122941
|
Kyky/Kyky
(Not Specified)
|
abnormal motor nerve collateral sprouting
|
J:116344
|
L1camtm1Fmo/Y
Tg(Camk2a-cre)1Gsc/0
(involves: 129/Sv * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:86626
|
L1camtm1Sor/Y
(involves: 129S7/SvEvBrd)
|
abnormal somatic nervous system physiology
|
J:137627
|
L2hgdhGt(DC0625)Wtsi/L2hgdhGt(DC0625)Wtsi
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:228407
|
Lama2dy-2J/Lama2dy-2J
(B6.WK-Lama2dy-2J/J)
|
abnormal myelination
|
J:134367,
J:98086
|
Lama2dy-2J/Lama2dy-2J
(B6.WK-Lama2dy-2J)
|
enhanced long-term potentiation
|
J:97464
|
| reduced long-term depression
|
J:97464
|
Lama2dy-2J/Lama2dy-2J
Lama4tm1Ktry/Lama4tm1Ktry
(involves: 129X1/SvJ * C57BL/6 * WK/ReJ)
|
abnormal myelination
|
J:98086
|
Lama2dy-7J/Lama2dy-7J
(C57BL/6J-Lama2dy-7J/J)
|
abnormal myelination
|
J:134367
|
| demyelination
|
J:82238
|
Lama2dy/Lama2dy
(involves: 129P1/Re * C57BL/6)
|
abnormal myelination
|
J:134367
|
Lama2dy/Lama2dy
(B6.129P1-Lama2dy/J)
|
decreased nerve conduction velocity
|
J:5948
|
Lama2dy/Lama2dy
(129P1/ReJ-Lama2dy/J)
|
abnormal axonal transport
|
J:5709
|
| demyelination
|
J:12730,
J:5331
|
Lama4tm1Ktry/Lama4tm1Ktry
(B6.129X1-Lama4tm1Ktry)
|
abnormal myelination
|
J:98348,
J:98086
|
Lamb1Lt/Lamb1+
(B6N.Cg-Lamb1Lt)
|
abnormal single cell response
|
J:247484
|
Lamb2tm1Jrs/Lamb2tm1Jrs
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal miniature endplate potential
|
J:23783
|
Lamc1tm1Strl/Lamc1tm1.2Strl
(either: (involves: 129P2/OlaHsd * C57BL/6 * CBA) or (involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * CBA))
|
demyelination
|
J:199683
|
Lamc1tm1Strl/Lamc1tm1Strl
Tg(Camk2a-cre)2Szi/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal myelination
|
J:86714
|
| abnormal peripheral nervous system regeneration
|
J:86714
|
Lamc1tm1Strl/Lamc1tm1Strl
Tg(Mpz-cre)26Mes/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal myelination
|
J:86714
|
Lamc1tm1Umr/Lamc1tm1Umr
(involves: 129S1/Sv * 129X1/SvJ)
|
intracranial hemorrhage
|
J:124247
|
Lamp5em1Lmit/Lamp5+
(C57BL/6-Lamp5em1Lmit)
|
increased susceptibility to pharmacologically induced seizures
|
J:345459
|
Lamp5em1Lmit/Lamp5+
Tg(Thy1-APP)3Somm/0
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
abnormal brain wave pattern
|
J:345459
|
Lamp5em1Lmit/Lamp5em1Lmit
(C57BL/6-Lamp5em1Lmit)
|
abnormal brain wave pattern
|
J:345459
|
| increased susceptibility to pharmacologically induced seizures
|
J:345459
|
Lamp5em1Lmit/Lamp5em1Lmit
Tg(Thy1-APP)3Somm/0
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
abnormal brain wave pattern
|
J:345459
|
Lamp5em1Lmit/Lamp5em1Lmit
Tg(Thy1-MAPT*P301S)58.2Npa/0
(involves: C57BL/6 * BALB/c)
|
abnormal brain wave pattern
|
J:345459
|
Lancl1tm1.1Pfw/Lancl1tm1.1Pfw
(involves: 129 * C57BL/6)
|
brain inflammation
|
J:214805
|
| increased neuron apoptosis
|
J:214805
|
| increased susceptibility to neuronal excitotoxicity
|
J:214805
|
Laptm4atm1b(EUCOMM)Hmgu/Laptm4atm1b(EUCOMM)Hmgu
(C57BL/6N-Laptm4atm1b(EUCOMM)Hmgu/Ics)
|
increased prepulse inhibition
|
J:211773
|
Laptm4btm1e.1(KOMP)Wtsi/Laptm4b+
(C57BL/6N-Laptm4btm1e.1(KOMP)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Large1enr-Tg(MbpReg)36Pop/Large1+
(involves: C57BL/6J * DBA/2J * SJL/J)
|
abnormal peripheral nervous system regeneration
|
J:29784
|
Large1enr-Tg(MbpReg)36Pop/Large1enr-Tg(MbpReg)36Pop
(involves: C57BL/6J * DBA/2J)
|
abnormal myelination
|
J:16281
|
Large1enr-Tg(MbpReg)36Pop/Large1enr-Tg(MbpReg)36Pop
(involves: C57BL/6J * DBA/2J * SJL/J)
|
abnormal myelination
|
J:29784
|
| abnormal peripheral nervous system regeneration
|
J:29784
|
Large1myd/Large1myd
(MYD/Le-Os +/+ Largemyd/J)
|
abnormal myelination
|
J:5974
|
Lats1em1(IMPC)H/Lats1em1(IMPC)H
(C57BL/6NTac-Lats1em1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Lats2tm1Noj/Lats2tm1Noj
(involves: 129S2/SvPas * C57BL/6)
|
increased spinal cord apoptosis
|
J:123480
|
Lbrem1(IMPC)Tcp/Lbrem1(IMPC)Tcp
(C57BL/6N-Lbrem1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
LbrGt(XE569)Byg/LbrGt(XE569)Byg
(involves: 129P2/OlaHsd * C57BL/6Cr)
|
increased neuron apoptosis
|
J:138854
|
Lbric-J/Lbr+
Tm7sf2tm1Fdp/Tm7sf2tm1Fdp
(involves: 129S4/SvJae * C57BL/6)
|
demyelination
|
J:143838
|
Ldlrtm1Her/Ldlrtm1Her
Lrp1tm2Her/Lrp1tm2Her
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J)
|
abnormal microglial cell physiology
|
J:144185
|
| abnormal response to CNS ischemic injury
|
J:144185
|
| decreased cerebral infarct size
|
J:144185
|
| decreased susceptibility to ischemic brain injury
|
J:144185
|
Lef1tm1.1(KOMP)Vlcg/Lef1+
(C57BL/6N-Lef1tm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Lemd2Gt(DD0639)Wtsi/Lemd2Gt(DD0639)Wtsi
(B6.129P2-Lemd2Gt(DD0639)Wtsi)
|
decreased embryonic neuroepithelial cell proliferation
|
J:221495
|
| increased embryonic neuroepithelium apoptosis
|
J:221495
|
| intracranial hemorrhage
|
J:221495
|
Lepob/Lepob
(involves: C57BL/6J)
|
decreased nerve conduction velocity
|
J:121015
|
Lepob/Lepob
(B6.Cg-Lepob/J)
|
abnormal sympathetic nervous system physiology
|
J:145998
|
Lepob/Lepob
(involves: STOCK Mlphln a Tgfawa1 Cdh23v Ednrbs)
|
abnormal microglial cell physiology
|
J:115569
|
| decreased embryonic neuroepithelial cell proliferation
|
J:105139
|
Lepob/Lepob
Tg(Npy-MAPT/Sapphire)1Rck/0
(involves: C57BL/6 * CBA)
|
abnormal excitatory postsynaptic currents
|
J:90242
|
Lepob/Lepob
Tg(Pomc-MAPT/Topaz)1Rck/0
(involves: C57BL/6 * CBA)
|
abnormal inhibitory postsynaptic currents
|
J:90242
|
Leprdb/Leprdb
(involves: C57BLKS/J)
|
abnormal hypothalamus physiology
|
J:1325
|
Leprdb/Leprdb
(B6.Cg-Dock7m +/+ Leprdb/J)
|
abnormal hypothalamus physiology
|
J:6157
|
Leprdb/Leprdb
(BKS.Cg-Dock7m +/+ Leprdb/J)
|
abnormal CNS synaptic transmission
|
J:109401
|
| abnormal nerve conduction
|
J:6323
|
| absent long-term depression
|
J:109401
|
| reduced long-term potentiation
|
J:109401
|
Leprtm1.1Chua/Leprtm1.1Chua
Ntstm1(cre)Mgmj/Nts+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB)
|
abnormal neuron physiology
|
J:176657
|
| abnormal synaptic dopamine release
|
J:176657
|
Leprtm1.1Chua/Leprtm1.1Chua
Slc32a1tm2(cre)Lowl/Slc32a1+
(involves: 129S6/SvEvTac)
|
abnormal inhibitory postsynaptic currents
|
J:174691
|
| abnormal nervous system electrophysiology
|
J:174691
|
Leprtm1.1Chua/Leprtm1.1Chua
Slc32a1tm2(cre)Lowl/Slc32a1+
Tg(Pomc1-hrGFP)1Lowl/0
(involves: 129S6/SvEvTac * FVB/N)
|
abnormal inhibitory postsynaptic currents
|
J:174691
|
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Nr5a1-cre)2Lowl/0
(involves: 129 * C57BL/6J * FVB)
|
abnormal nervous system electrophysiology
|
J:105327
|
Leprtm1.1Chua/Leprtm1.1Chua
Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6 * CBA)
|
abnormal sympathetic nervous system physiology
|
J:145998
|
Leprtm1.2Chua/Leprtm1.2Chua
(involves: 129 * C57BL/6 * CBA)
|
abnormal inhibitory postsynaptic currents
|
J:174691
|
Letm1Gt(CC0204)Wtsi/Letm1+
(129S.129P2-Letm1Gt(CC0204)Wtsi)
|
increased susceptibility to pharmacologically induced seizures
|
J:222017
|
Letm1Gt(DD0926)Wtsi/Letm1+
(129S.129P2-Letm1Gt(DD0926)Wtsi)
|
increased susceptibility to pharmacologically induced seizures
|
J:222017
|
Letmd1em1(IMPC)Kmpc/Letmd1em1(IMPC)Kmpc
(C57BL/6NTac-Letmd1em1(IMPC)Kmpc/Kmpc)
|
decreased prepulse inhibition
|
J:211773
|
Lgals3tm1Ftl/Lgals3tm1Ftl
(B6.129S2-Lgals3tm1Ftl)
|
brain inflammation
|
J:109126
|
Lgi1tm1.1Ics/Lgi1+
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
audiogenic seizures
|
J:182795
|
Lgi1tm1.1Ics/Lgi1tm1.1Ics
(involves: 129S2/SvPas * BALB/c * C57BL/6)
|
abnormal brain wave pattern
|
J:182795
|
| abnormal spike wave discharge
|
J:182795
|
| environmentally induced seizures
|
J:182795
|
| seizures
|
J:182795
|
| tonic-clonic seizures
|
J:182795
|
Lgi1tm1.1Jkc/Lgi1tm1.1Jkc
Tyrc-Brd/Tyrc-Brd
(B6.Cg-Tyrc-Brd Lgi1tm1.1Jkc)
|
clonic seizures
|
J:158715
|
| enhanced AMPA-mediated synaptic currents
|
J:158715
|
| enhanced NMDA-mediated synaptic currents
|
J:158715
|
| increased miniature excitatory postsynaptic current frequency
|
J:158715
|
| seizures
|
J:158715
|
Lgi1tm1Mafu/Lgi1+
(involves: 129S6/SvEvTac * C57BL/6)
|
clonic seizures
|
J:157578
|
| increased susceptibility to pharmacologically induced seizures
|
J:157578
|
| tonic seizures
|
J:157578
|
Lgi1tm1Mafu/Lgi1tm1Mafu
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal glutamate-mediated receptor currents
|
J:157578
|
| decreased miniature excitatory postsynaptic current amplitude
|
J:157578
|
| seizures
|
J:157578
|
| tonic-clonic seizures
|
J:157578
|
Lgi1tm2.1Jkc/Lgi1tm2.1Jkc
Tg(CMV-cre)1Cgn/0
(involves: 129/Sv * BALB/cJ * C57BL/6)
|
seizures
|
J:269784
|
Lgi1tm2.1Jkc/Lgi1tm2.1Jkc
Tg(Nes-cre)1Kln/0
(involves: 129/Sv * C57BL/6 * SJL)
|
seizures
|
J:269784
|
Lgi4clp/Lgi4clp
(C57BL/6J-Lgi4clp/J)
|
abnormal myelination
|
J:11392,
J:24743
|
Lgi4clp/Lgi4clp
(involves: C57BL/6J)
|
demyelination
|
J:158973
|
Lgi4clp/Lgi4clp
(involves: C57BL/6J * FVB/N)
|
abnormal myelination
|
J:208847
|
Lgi4tm1.1Jrb/Lgi4tm1.1Jrb
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S4/SvJaeSor * C57BL/6J * CBA/J)
|
demyelination
|
J:158973
|
Lgi4tm1.1Jrb/Lgi4tm1.1Jrb
Tg(Dhh-cre)1Mejr/0
(involves: 129S4/SvJaeSor * FVB/N)
|
demyelination
|
J:158973
|
Lgi4tm1Sjm/Lgi4tm1Sjm
(involves: C57BL/6 * SJL)
|
abnormal glial cell physiology
|
J:166449
|
| demyelination
|
J:166449
|
Lgmntm1b(NCOM)Mfgc/Lgmntm1b(NCOM)Mfgc
(C57BL/6N-Lgmntm1b(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Lhfpl4tm1Lex/Lhfpl4tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal miniature inhibitory postsynaptic currents
|
J:254795
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:254795
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:254795
|
| increased miniature inhibitory postsynaptic current frequency
|
J:254795
|
Lhx5tm1Lmgd/Lhx5tm1Lmgd
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal neuronal migration
|
J:55103
|
| abnormal neuronal precursor proliferation
|
J:55103
|
Lhx5as1em1Jzx/Lhx5as1em1Jzx
(C57BL/6J-Lhx5as1em1Jzx)
|
decreased excitatory postsynaptic current amplitude
|
J:328356
|
| decreased miniature excitatory postsynaptic current amplitude
|
J:328356
|
| reduced long-term potentiation
|
J:328356
|
Lhx6tm1Vpa/Lhx6tm2Vpa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal spike wave discharge
|
J:198547
|
| environmentally induced seizures
|
J:198547
|
| increased miniature inhibitory postsynaptic current frequency
|
J:198547
|
| increased susceptibility to pharmacologically induced seizures
|
J:198547
|
| tonic-clonic seizures
|
J:198547
|
Lhx6tm2Vpa/Lhx6tm2Vpa
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal neuronal migration
|
J:119476
|
Lhx6tm2Vpa/Lhx6tm2Vpa
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:198547
|
Lig3tm1.1Pmc/Lig3tm1.1Pmc
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal astrocyte physiology
|
J:170077
|
| abnormal neuronal precursor proliferation
|
J:170077
|
Lig4tm1Fwa/Lig4tm1Fwa
(involves: 129S6/SvEvTac)
|
increased forebrain apoptosis
|
J:110848
|
| increased spinal cord apoptosis
|
J:110848
|
Lig4tm1Fwa/Lig4tm1Fwa
Trp53tm1Brd/Trp53+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
decreased neuron apoptosis
|
J:63078
|
Lig4tm1Fwa/Lig4tm1Fwa
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S6/SvEvTac * 129S7/SvEvBrd)
|
decreased neuron apoptosis
|
J:63078
|
Lig4tm1Icrf/Lig4tm1Icrf
(either: (involves: 129P2/OlaHsd) or (involves: 129S1/Sv * 129X1/SvJ))
|
increased neuron apoptosis
|
J:111068,
J:51608,
J:65540
|
Limd1em1(IMPC)H/Limd1em1(IMPC)H
(C57BL/6NTac-Limd1em1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Limk1tm1Zpj/Limk1tm1Zpj
(involves: 129)
|
abnormal long-term potentiation
|
J:86283
|
Lin7atm1Dsb/Lin7atm1Dsb
Lin7btm1Dsb/Lin7btm1Dsb
Lin7ctm1Dsb/Lin7ctm1Dsb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:102649
|
Lingo1tm1Shmi/Lingo1tm1Shmi
(involves: 129S2/SvPas * C57BL/6)
|
abnormal myelination
|
J:99078
|
Litaftm1.1Ics/Litaftm1.1Ics
(Not Specified)
|
demyelination
|
J:186411
|
Llgl1tm1.1Vv/Llgl1tm1.1Vv
(Not Specified)
|
abnormal neuronal precursor proliferation
|
J:89028
|
| intraventricular hemorrhage
|
J:89028
|
Llgl1tm1Vv/Llgl1tm1Vv
Meox2tm1(cre)Sor/Meox2+
(involves: 129 * 129S4/SvJaeSor * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:89028
|
| intraventricular hemorrhage
|
J:89028
|
Lmcd1em1(IMPC)J/Lmcd1em1(IMPC)J
(C57BL/6NJ-Lmcd1em1(IMPC)J/J)
|
decreased prepulse inhibition
|
J:211773
|
Lmnatm1Stw/Lmnatm1Stw
(involves: 129S1/Sv)
|
abnormal myelination
|
J:75378
|
Lmnb1tm1Yxz/Lmnb1tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal neuronal migration
|
J:178993
|
| abnormal neuronal precursor proliferation
|
J:178993
|
Lmnb1tm1Yxz/Lmnb1tm1Yxz
Lmnb2tm1Yxz/Lmnb2tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal neuronal migration
|
J:178993
|
| abnormal neuronal precursor proliferation
|
J:178993
|
Lmnb2tm1Ccof/Lmnb2tm1Ccof
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neuronal migration
|
J:158610
|
| abnormal neuronal precursor proliferation
|
J:158610
|
Lmnb2tm1Yxz/Lmnb2tm1Yxz
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
abnormal neuronal migration
|
J:178993
|
| abnormal neuronal precursor proliferation
|
J:178993
|
Lmo1tm1b(KOMP)Mbp/Lmo1tm1b(KOMP)Mbp
(C57BL/6N-Lmo1tm1b(KOMP)Mbp/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Lmo4tm1.1Gng/Lmo4tm1.1Gng
(involves: 129X1/SvJ)
|
abnormal embryonic neuroepithelial cell proliferation
|
J:96957
|
| increased embryonic neuroepithelium apoptosis
|
J:96957
|
Lmod3em1(IMPC)Mbp/Lmod3em1(IMPC)Mbp
(C57BL/6N-Lmod3em1(IMPC)Mbp/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Lmtk3tm1Tya/Lmtk3tm1Tya
(B6JJcl.Cg-Lmtk3tm1Tya)
|
abnormal neuron physiology
|
J:210612
|
Lmx1adr-J/Lmx1adr-J
(involves: C3H * C57BL/6)
|
abnormal neuronal migration
|
J:1460
|
Lmx1atm1Tpe/Lmx1atm1Tpe
Lmx1btm1Zfc/Lmx1btm1Zfc
Slc6a3tm1(cre)Lrsn/Slc6a3+
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6)
|
enhanced long-term potentiation
|
J:222854
|
Lmx1btm1Zfc/Lmx1btm1Zfc
Tg(Fev-cre)1Esd/0
(involves: 129S7/SvEvBrd * C57BL/6 * SJL)
|
abnormal long-term depression
|
J:139720
|
| abnormal long-term potentiation
|
J:139720
|
| decreased neurotransmitter release
|
J:139720
|
Lncbarem1Bcgen/Lncbarem1Bcgen
(involves: C57BL/6)
|
increased neuron apoptosis
|
J:316179
|
Lonp1tm1b(EUCOMM)Hmgu/Lonp1+
(C57BL/6N-Lonp1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Lore1SS/Lore1SS
(LS.SS-Lore1)
|
abnormal nervous system physiology
|
J:93175
|
Lore4SS/Lore4SS
(LS.SS-Lore4)
|
abnormal nervous system physiology
|
J:93175
|
Loxl1tm1.1(KOMP)Vlcg/Loxl1tm1.1(KOMP)Vlcg
(B6N(Cg)-Loxl1tm1.1(KOMP)Vlcg/J)
|
convulsive seizures
|
J:211773
|
Lpar1tm1Mcox/Lpar1tm1Mcox
(B6.129P2-Lpar1tm1Mcox)
|
decreased prepulse inhibition
|
J:87198
|
Lpin120884/Lpin120884
(involves: C57BL/6J)
|
abnormal action potential
|
J:153042
|
| decreased nerve conduction velocity
|
J:153042
|
| demyelination
|
J:153042
|
Lpin120884/Lpin120884
Nrcam20884/Nrcam20884
(involves: C57BL/6J)
|
abnormal action potential
|
J:153042
|
| decreased nerve conduction velocity
|
J:153042
|
| demyelination
|
J:153042
|
Lpin1fld/Lpin1fld
(BALB/cByJ-Lpin1fld/J)
|
abnormal action potential
|
J:137213
|
| abnormal myelination
|
J:137213
|
| decreased nerve conduction velocity
|
J:137213
|
Lpin1tm1Rchr/Lpin1tm1Rchr
Tg(Mpz-cre)26Mes/0
(involves: 129S6/SvEvTac * FVB/N)
|
abnormal action potential
|
J:137213
|
| abnormal nervous system electrophysiology
|
J:137213
|
| decreased nerve conduction velocity
|
J:137213
|
| demyelination
|
J:137213
|
Lpin2tm1b(KOMP)Wtsi/Lpin2tm1b(KOMP)Wtsi
(C57BL/6N-Lpin2tm1b(KOMP)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Lpoem1Zlu/Lpoem1Zlu
(involves: C57BL/6 * SJL)
|
seizures
|
J:307289
|
Lrfn2tm1.1Jaru/Lrfn2tm1.1Jaru
(B6J.129P2-Lrfn2tm1.1Jaru)
|
abnormal CNS synaptic transmission
|
J:241916
|
| abnormal excitatory postsynaptic currents
|
J:241916
|
| abnormal synaptic plasticity
|
J:241916
|
| decreased miniature excitatory postsynaptic current frequency
|
J:241916
|
| decreased prepulse inhibition
|
J:241916
|
| enhanced long-term potentiation
|
J:241916
|
Lrfn3tm1(KOMP)Vlcg/Lrfn3tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
increased miniature excitatory postsynaptic current frequency
|
J:241274
|
| increased miniature inhibitory postsynaptic current frequency
|
J:241274
|
Lrfn3tm1(KOMP)Vlcg/Lrfn3tm1(KOMP)Vlcg
Lrfn4tm1(KOMP)Vlcg/Lrfn4tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal inhibitory postsynaptic currents
|
J:241274
|
Lrfn4tm1(KOMP)Vlcg/Lrfn4tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal miniature excitatory postsynaptic currents
|
J:233980
|
Lrp1tm2Her/Lrp1tm2Her
Tg(Camk2a-cre)T29-1Stl/0
(involves: 129S7/SvEvBrd * BALB/c * C57BL)
|
abnormal nervous system physiology
|
J:167724
|
| brain inflammation
|
J:167724
|
| reduced long-term potentiation
|
J:167724
|
Lrp4tm1.1Line/Lrp4tm1.1Line
Tg(ACTA1-cre)79Jme/0
(involves: 129S/SvEv * C57BL/6 * C57BL/6J * SJL)
|
abnormal endplate potential
|
J:188352
|
| abnormal miniature endplate potential
|
J:188352
|
Lrp5tvrm111B/Lrp5tvrm111B
(C57BL/6J-Lrp5tvrm111b/Pjn)
|
abnormal blood-retina barrier function
|
J:241491
|
Lrp8tm1Her/Lrp8tm1Her
(involves: 129S6/SvEvTac)
|
abnormal neuronal migration
|
J:117956
|
Lrp8tm1Her/Lrp8tm1Her
Vldlrtm1Her/Vldlrtm1Her
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6J)
|
abnormal neuronal precursor cell migration
|
J:121846
|
Lrp8tm3Her/Lrp8tm3Her
(involves: 129S6/SvEvTac * C57BL/6J)
|
reduced long-term potentiation
|
J:100988
|
Lrp8tm4Her/Lrp8tm4Her
(Not Specified)
|
abnormal neuronal migration
|
J:117956
|
Lrp8tm5Her/Lrp8tm5Her
(Not Specified)
|
abnormal neuronal migration
|
J:117956
|
Lrrc2tm1b(EUCOMM)Wtsi/Lrrc2tm1b(EUCOMM)Wtsi
(C57BL/6N-Lrrc2tm1b(EUCOMM)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Lrrc4btm1Lex/Lrrc4btm1Lex
(B6.129S-Lrrc4btm1Lex)
|
reduced long-term potentiation
|
J:276446
|
Lrrc4btm1Lex/Lrrc4btm1Lex
(involves: 129S/SvEv * C57BL/6J)
|
abnormal brain wave pattern
|
J:276446
|
| abnormal excitatory postsynaptic currents
|
J:276446
|
| decreased excitatory postsynaptic current amplitude
|
J:276446
|
| decreased excitatory postsynaptic current frequency
|
J:276446
|
| increased excitatory postsynaptic current amplitude
|
J:276446
|
| increased susceptibility to pharmacologically induced seizures
|
J:276446
|
| reduced long-term potentiation
|
J:276446
|
Lrrc7tm1.1Mabk/Lrrc7tm1.1Mabk
(involves: 129S1/Sv * FVB/N)
|
reduced long-term depression
|
J:177836
|
Lrrc7tm1.1Mabk/Lrrc7tm1.1Mabk
(B6.129S1-Lrrc7tm1.1Mabk)
|
decreased prepulse inhibition
|
J:177836
|
Lrrk2tm1.1Dlbe/Lrrk2+
(C57BL/6NTac-Lrrk2tm1.1Dlbe)
|
increased excitatory postsynaptic current frequency
|
J:234639
|
Lrrk2tm1.1Dlbe/Lrrk2tm1.1Dlbe
(C57BL/6NTac-Lrrk2tm1.1Dlbe)
|
abnormal excitatory postsynaptic current amplitude
|
J:234639
|
| abnormal excitatory postsynaptic currents
|
J:234639
|
| increased excitatory postsynaptic current frequency
|
J:234639
|
Lrrk2tm1.1Hlme/Lrrk2+
(involves: C57BL/6 * C57BL/6J)
|
abnormal synaptic dopamine release
|
J:223350
|
Lrrk2tm1.1Hlme/Lrrk2tm1.1Hlme
(involves: C57BL/6 * C57BL/6J)
|
abnormal synaptic dopamine release
|
J:223350
|
Lrrk2tm1.1Shn/Lrrk2tm1.1Shn
(involves: 129 * C57BL/6)
|
abnormal action potential
|
J:151944
|
Lrrtm1tm1.1Rmlk/Lrrtm1tm1.1Rmlk
Lrrtm2tm1.1Rmlk/Lrrtm2tm1.1Rmlk
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N * SJL)
|
abnormal miniature excitatory postsynaptic currents
|
J:263004
|
| decreased excitatory postsynaptic current amplitude
|
J:263004
|
| reduced AMPA-mediated synaptic currents
|
J:263004
|
| reduced long-term potentiation
|
J:263004
|
Lrrtm3tm1Msa/Lrrtm3tm1Msa
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal action potential
|
J:263400
|
| abnormal CNS synaptic transmission
|
J:263400
|
| abnormal miniature excitatory postsynaptic currents
|
J:263400
|
| abnormal synaptic depression
|
J:263400
|
| decreased excitatory postsynaptic current amplitude
|
J:263400
|
| decreased paired-pulse facilitation
|
J:263400
|
Lrrtm4tm1Amcr/Lrrtm4tm1Amcr
(B6.129P2-Lrrtm4tm1Amcr)
|
abnormal excitatory postsynaptic potential
|
J:201655
|
| abnormal miniature excitatory postsynaptic currents
|
J:201655
|
Lrsam1em1(IMPC)Bay/Lrsam1em1(IMPC)Bay
(C57BL/6N-Lrsam1em1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Lrsam1Gt(RRK461)Byg/Lrsam1Gt(RRK461)Byg
(involves: 129P2/OlaHsd)
|
decreased nerve conduction velocity
|
J:196447
|
Ltn1lister/Ltn1lister
(C57BL/6-Ltn1lister)
|
abnormal neuron physiology
|
J:146493
|
Luzp1tm1Acch/Luzp1tm1Acch
(B6.129P2-Luzp1tm1Acch)
|
increased hindbrain apoptosis
|
J:141306
|
Lyntm1Sor/Lyntm1Sor
(involves: 129S4/SvJaeSor)
|
abnormal microglial cell physiology
|
J:80658
|
Lynx1tm1Htz/Lynx1tm1Htz
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal nervous system physiology
|
J:122965
|
| decreased paired-pulse facilitation
|
J:122965
|
| increased susceptibility to neuronal excitotoxicity
|
J:122965
|
Lypd1tm1.1Tmj/Lypd1tm1.1Tmj
(involves: C57BL/6 * FVB/N)
|
abnormal excitatory postsynaptic currents
|
J:146775
|
Lysttm1b(EUCOMM)Wtsi/Lysttm1b(EUCOMM)Wtsi
(C57BL/6N-Lysttm1b(EUCOMM)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Lzts1tm1Kso/Lzts1tm1Kso
(B6J.B6NTac-Lzts1tm1Kso)
|
abnormal CNS synaptic transmission
|
J:226686
|
| abnormal glutamate-mediated receptor currents
|
J:226686
|
| abnormal miniature excitatory postsynaptic currents
|
J:226686
|
| prolonged excitatory postsynaptic current decay time
|
J:226686
|
m154Asp/m154Asp+
Tg(Rr291-lacZ)#Mekk/0
(involves: C57BL/6J * FVB/N)
|
sporadic seizures
|
J:136795
|
Macf1tm2.1Liem/Macf1tm2.2Liem
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N * SJL)
|
abnormal neuronal migration
|
J:164146
|
Mad2l2tm1Ymu/Mad2l2tm1Ymu
(involves: 129 * C57BL/6J)
|
increased forebrain apoptosis
|
J:198275
|
Maddtm1Ytk/Maddtm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
impaired ability to fire action potentials
|
J:126869
|
Maddtm1Ytk/Maddtm1Ytk
(involves: 129X1/SvJ)
|
abnormal excitatory postsynaptic currents
|
J:126302
|
| abnormal miniature excitatory postsynaptic currents
|
J:126302
|
| biphasic excitatory postsynaptic current amplitude
|
J:126302
|
Mafem1(IMPC)Mbp/Maf+
(C57BL/6N-Mafem1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Maftm1.1Cbm/Maftm2.1Cbm
Isl1tm1(cre)Tmj/Isl1+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal nervous system electrophysiology
|
J:181639
|
| decreased nerve conduction velocity
|
J:181639
|
Mafbtm1Mhs/Mafbtm1Mhs
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal nervous system physiology
|
J:85746
|
Mafgtm1Jeng/Mafgtm1Jeng
Mafktm1Jeng/Mafk+
(involves: 129S1/Sv * 129X1/SvJ)
|
myoclonus
|
J:81813
|
Magtm1.1(KOMP)Vlcg/Magtm1.1(KOMP)Vlcg
(C57BL/6N-Magtm1.1(KOMP)Vlcg/J)
|
convulsive seizures
|
J:211773
|
Magtm1Mtg/Magtm1Mtg
(either: (involves: 129S2/SvPas) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal myelination
|
J:19475
|
Magtm1Mtg/Magtm1Mtg
(involves: 129S2/SvPas)
|
demyelination
|
J:106609
|
Magtm1Mtg/Magtm1Mtg
(B6N.129S2-Magtm1Mtg)
|
dysmyelination
|
J:236408
|
Magtm1Pop/Magtm1Pop
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myelination
|
J:46770
|
Magtm1Rod/Magtm1Rod
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased prepulse inhibition
|
J:217719
|
Maged1tm1.1Urfm/Maged1tm1.1Urfm
(B6.129P2-Maged1tm1.1Urfm)
|
abnormal sympathetic neuron physiology
|
J:157604
|
| decreased neuron apoptosis
|
J:157604
|
Magel2tm1.1Mus/Magel2+
(B6.129S2-Magel2tm1.1Mus)
|
abnormal hypothalamus secretion
|
J:166548
|
MagohMos2/Magoh+
(involves: BALB/cJ * C57BL/6J)
|
abnormal neuron apoptosis
|
J:159625
|
| abnormal neuron proliferation
|
J:159625
|
| increased brain apoptosis
|
J:240595
|
Maltm1Nsw/Maltm1Nsw
(involves: 129P2/Ola)
|
abnormal myelination
|
J:92517
|
Malat1tm1.2Dlsp/Malat1tm1.2Dlsp
(B6J.Cg-Malat1tm1.2Dlsp)
|
abnormal nervous system physiology
|
J:239375
|
| brain inflammation
|
J:239375
|
| increased brain apoptosis
|
J:239375
|
| increased cerebral infarct size
|
J:239375
|
| increased susceptibility to ischemic brain injury
|
J:239375
|
Maml1tm1Mkit/Maml1tm1Mkit
Maml3tm1Mkit/Maml3tm1Mkit
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neuron proliferation
|
J:178680
|
Mamld1tm1.1(NCOM)Mfgc/Y
(C57BL/6N-Mamld1tm1.1(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Mamld1tm1.1(NCOM)Mfgc/Mamld1tm1.1(NCOM)Mfgc
(C57BL/6N-Mamld1tm1.1(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Man2b1tm1Psa/Man2b1tm1Psa
(involves: 129 * C57BL/6J)
|
enhanced long-term potentiation
|
J:99812
|
Man2c1tm1.1Tbec/Man2c1tm1.1Tbec
(B6N.129P2-Man2c1tm1.1Tbec)
|
abnormal microglial cell activation
|
J:205550
|
| abnormal oligodendrocyte physiology
|
J:205550
|
Manftm1a(KOMP)Wtsi/Manftm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal neuronal migration
|
J:255942
|
MaoaTg(H2-K1-Ifnb1)8Seif/?
(involves: C3H/HeJ)
|
abnormal nervous system electrophysiology
|
J:78281
|
Maobtm1Shih/Maobtm1Shih
(either: (involves: 129S/SvEv) or (involves: 129S4/SvJae))
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:43648
|
Map1btm1Prop/Map1btm1Prop
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myelination
|
J:97423
|
| abnormal nerve conduction
|
J:97423
|
Map2k4tm1Ctr/Map2k4tm1Ctr
Map2k7tm1Rjd/Map2k7tm1Rjd
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA)
|
decreased neuron apoptosis
|
J:178060
|
Map3k12Gt(RRN366)Byg/Map3k12Gt(RRN366)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
slow Wallerian degeneration
|
J:188476
|
Map3k12tm1.1Adia/Map3k12tm1.1Adia
(involves: C57BL/6 * C57BL/6J * SJL)
|
slow Wallerian degeneration
|
J:188476
|
Map3k12tm1.1Lewc/Map3k12tm1.1Lewc
(Not Specified)
|
decreased neuron apoptosis
|
J:176956
|
Map3k12tm1.2Adia/Map3k12tm1.2Adia
(involves: C57BL/6 * C57BL/6J * SJL)
|
slow Wallerian degeneration
|
J:188476
|
Map3k12tm1Shir/Map3k12tm1Shir
(B6.Cg-Mapk12tm1Shir)
|
abnormal neuronal migration
|
J:115575
|
Map6tm1Job/Map6+
(involves: 129S2/SvPas * C57BL/6)
|
decreased prepulse inhibition
|
J:225083
|
Map6tm1Job/Map6tm1Job
(either: 129S2/SvPas or (involves: 129S2/SvPas * BALB/c))
|
impaired synaptic plasticity
|
J:79099
|
Map6tm1Job/Map6tm1Job
(involves: 129S2/SvPas * C57BL/6)
|
decreased prepulse inhibition
|
J:225083
|
Mapk3tm1Gpg/Mapk3tm1Gpg
(involves: 129/Sv * C57BL/6)
|
reduced long-term potentiation
|
J:89788
|
Mapk7tm1Jsca/Mapk7tm1Jsca
(either: (involves: BALB/c) or (involves: C57BL/6))
|
intracerebral hemorrhage
|
J:107620
|
Mapk8tm1Flv/Mapk8tm1Flv
Mapk9tm1Flv/Mapk9tm1Flv
(involves: 129S1/Sv * 129S2/SvPas)
|
decreased hindbrain apoptosis
|
J:54653
|
| increased embryonic neuroepithelium apoptosis
|
J:54653
|
| increased forebrain apoptosis
|
J:54653
|
Mapk8tm1Wag/Mapk8tm1Wag
Mapk9tm1Mka/Mapk9tm1Mka
(involves: 129 * C57BL/6)
|
decreased hindbrain apoptosis
|
J:58622
|
| increased forebrain apoptosis
|
J:58622
|
| increased hindbrain apoptosis
|
J:58622
|
Mapk8ip1tm1Plhn/Mapk8ip1tm1Plhn
(either: B6.129S4-Mapk8ip1tm1Plhn or (involves: 129S4/SvJae * C57BL/6J))
|
decreased susceptibility to ischemic brain injury
|
J:104842
|
Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal NMDA-mediated synaptic currents
|
J:125318
|
| decreased susceptibility to neuronal excitotoxicity
|
J:77616
|
Mapk8ip1tm1Rjd/Mapk8ip1tm1Rjd
Mapk8ip2tm1Rjd/Mapk8ip2tm1Rjd
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
abnormal NMDA-mediated synaptic currents
|
J:125318
|
Mapk8ip2tm1.1Gol/Mapk8ip2tm1.1Gol
(129S/SvEv-Mapk8ip2tm1.1Gol)
|
abnormal excitatory postsynaptic currents
|
J:166700
|
| abnormal miniature excitatory postsynaptic currents
|
J:166700
|
| decreased synaptic glutamate release
|
J:166700
|
| enhanced NMDA-mediated synaptic currents
|
J:166700
|
| reduced AMPA-mediated synaptic currents
|
J:166700
|
Mapk8ip2tm1Rjd/Mapk8ip2tm1Rjd
(involves: 129X1/SvJ * C57BL/6)
|
abnormal NMDA-mediated synaptic currents
|
J:125318
|
Mapk8ip3tm1Plhn/Mapk8ip3tm1Plhn
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal neuronal migration
|
J:95744
|
Mapk8ip3tm1Rjd/Mapk8ip3tm1Rjd
(B6.129S6-Mapk8ip3tm1Rjd)
|
abnormal CNS synaptic transmission
|
J:85160
|
Mapk9tm1Mka/Mapk9tm1Mka
(either: (involves: 129S2/SvPas * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal excitatory postsynaptic potential
|
J:105153
|
| abnormal neurotransmitter secretion
|
J:105153
|
| decreased paired-pulse facilitation
|
J:105153
|
| decreased post-tetanic potentiation
|
J:105153
|
| reduced long-term potentiation
|
J:105153
|
Mapk10tm1Flv/Mapk10tm1Flv
(involves: 129S1/Sv)
|
decreased neuron apoptosis
|
J:124252
|
| decreased susceptibility to neuronal excitotoxicity
|
J:43658
|
| decreased susceptibility to pharmacologically induced seizures
|
J:43658
|
Mapk10tm1Flv/Mapk10tm1Flv
(B6.129S1-Mapk10tm1Flv)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:87428
|
Mapk10tm1Flv/Mapk10tm1Flv
Mapk9tm1Flv/Mapk9tm1Flv
(B6.129S-Mapk9tm1Flv Mapk10tm1Flv)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:87428
|
Mapk11tm1Jsca/Mapk11tm1Jsca
Mapk14tm2Nbr/Mapk14tm2Nbr
Edil3Tg(Sox2-cre)1Amc/Edil3+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal neuron proliferation
|
J:176023
|
Mapttm1(EGFP)Klt/Mapttm1(EGFP)Klt
(B6.129S4-Mapttm1(EGFP)Klt)
|
reduced long-term potentiation
|
J:213115
|
Mapttm1(Mecp2)Jae/Mapttm1(Mecp2)Jae
(B6.Cg-Mapttm1(Mecp2)Jae)
|
abnormal miniature excitatory postsynaptic currents
|
J:182685
|
| enhanced paired-pulse facilitation
|
J:182685
|
| reduced long-term potentiation
|
J:182685
|
Mapttm1(Sema3e)Yuyo/Mapt+
Olig2tm1(cre)Tmj/Olig2+
(Not Specified)
|
abnormal excitatory postsynaptic potential
|
J:205528
|
Mapttm1Hnd/Mapt+
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:121330
|
Mapttm1Hnd/Mapt+
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased susceptibility to pharmacologically induced seizures
|
J:121330
|
Mapttm1Hnd/Mapttm1Hnd
(involves: 129X1/SvJ * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:121330
|
Mapttm1Hnd/Mapttm1Hnd
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: 129X1/SvJ * C57BL/6 * DBA/2)
|
decreased susceptibility to pharmacologically induced seizures
|
J:121330
|
Mapttm2.1(RHOA*)Klt/Mapt+
(involves: 129S4/SvJae * C57BL/6 * FVB/N)
|
decreased neuron apoptosis
|
J:159220
|
Mapttm2Arbr/Mapt+
Shox2tm1.1(cre)Oki/Shox2+
Slc17a6tm1.1Thna/Slc17a6tm1.2Edw
(involves: 129P2/OlaHsd * 129S/SvEv * C57BL/6J)
|
abnormal nervous system physiology
|
J:209344
|
Mapttm3(Hdac2)Jae/Mapttm3(Hdac2)Jae
(involves: 129S4/SvJae * C57BL/6)
|
reduced long-term potentiation
|
J:148391
|
Mapttm3.1(FUS)Neas/Mapt+
(B6J.129P2(129S)-Mapttm3.1(FUS)Neas)
|
abnormal synaptic depression
|
J:232167
|
| abnormal synaptic transmission
|
J:232167
|
Marchf5tm1.1Ygi/Marchf5tm1.1Ygi
Tg(Emx1-cre)#Ito/0
(involves: C57BL/6)
|
increased microglial cell activation
|
J:284572
|
Marchf6tm1b(EUCOMM)Hmgu/Marchf6tm1b(EUCOMM)Hmgu
(C57BL/6N-Marchf6tm1b(EUCOMM)Hmgu/Ccpcz)
|
decreased prepulse inhibition
|
J:211773
|
Marveld1tm1.1Liy/Marveld1tm1.1Liy
Tg(GFAP-cre)25Mes/0
(involves: C57BL/6J * FVB/N)
|
abnormal cerebellar granule cell migration
|
J:279065
|
Marveld1tm1.1Liy/Marveld1tm1.1Liy
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
abnormal cerebellar granule cell migration
|
J:279065
|
Marveld1tm1.2Liy/Marveld1tm1.2Liy
(involves: C57BL/6J)
|
abnormal cerebellar granule cell migration
|
J:279065
|
| abnormal neuronal migration
|
J:279065
|
| increased neuron apoptosis
|
J:279065
|
Marveld2tm1b(EUCOMM)Wtsi/Marveld2tm1b(EUCOMM)Wtsi
(C57BL/6N-Marveld2tm1b(EUCOMM)Wtsi/H)
|
decreased prepulse inhibition
|
J:211773
|
Mas1tm1Bdr/Mas1tm1Bdr
(involves: 129P2/OlaHsd)
|
enhanced long-term potentiation
|
J:47445
|
Mast1em1Dak/Mast1+
(B6.Cg-Mast1em1Dak)
|
increased neuron apoptosis
|
J:268904
|
Mast1em1Dak/Mast1em1Dak
(B6.Cg-Mast1em1Dak)
|
increased neuron apoptosis
|
J:268904
|
Mat2atm1a(EUCOMM)Hmgu/Mat2a+
(C57BL/6N-Mat2atm1a(EUCOMM)Hmgu/Ics)
|
decreased prepulse inhibition
|
J:165965
|
Matcap1em1Nki/Matcap1em1Nki
Svbpem1Mjom/Svbpem1Mjom
(involves: C57BL/6)
|
decreased neuronal precursor proliferation
|
J:325393
|
Matr3em1Tcp/Matr3em1Tcp
(C57BL/6J-Matr3em1Tcp)
|
increased microglial cell activation
|
J:298091
|
Mavstm1Aki/Mavstm1Aki
(involves: 129S/SvEv * C57BL/6)
|
abnormal neuron physiology
|
J:162888
|
| brain inflammation
|
J:162888
|
| CNS inflammation
|
J:162888
|
Mbd1tm1Fhg/Mbd1tm1Fhg
(129S4/SvJae-Mbd1tm1Fhg)
|
abnormal long-term potentiation
|
J:83613
|
Mbnl2tm1.1Sws/Mbnl2+
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:218010
|
Mbnl2tm1.1Sws/Mbnl2tm1.1Sws
(involves: 129S1/SvImJ * BALB/cJ * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:218010
|
| abnormal excitatory postsynaptic potential
|
J:218010
|
| impaired synaptic plasticity
|
J:218010
|
| increased susceptibility to pharmacologically induced seizures
|
J:218010
|
| reduced long-term potentiation
|
J:218010
|
| tonic-clonic seizures
|
J:218010
|
Mboat1em1(IMPC)Bay/Mboat1em1(IMPC)Bay
(C57BL/6N-Mboat1em1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Mboat2em1(IMPC)Mbp/Mboat2em1(IMPC)Mbp
(C57BL/6N-Mboat2em1(IMPC)Mbp/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Mboat7tm1Arai/Mboat7tm1Arai
(B6.129P2-Mboat7tm1Arai)
|
abnormal neuronal migration
|
J:200247
|
| increased neuron apoptosis
|
J:200247
|
Mbpjve/Mbpjve
(involves: C57BL/6J)
|
abnormal action potential
|
J:221049
|
| absence seizures
|
J:221049
|
| environmentally induced seizures
|
J:221049
|
| tonic seizures
|
J:221049
|
Mbpshi-J/Mbpshi-J
(BALB/cJ-Mbpshi-J/GrsrJ)
|
abnormal myelination
|
J:117543
|
Mbpshi-mld+/Mbpshi-mld+
(involves: C3H/HeJ * C57BL/6J * MDB/Dt)
|
convulsive seizures
|
J:1873
|
| demyelination
|
J:1873
|
Mbpshi-mld/Mbpshi-mld
(involves: MDB/Dt)
|
sporadic seizures
|
J:5917
|
Mbpshi/Mbpshi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SWV)
|
abnormal myelination
|
J:38856
|
Mbpshi/Mbpshi
(C3Fe.SWV-Mbpshi/J)
|
decreased nerve conduction velocity
|
J:211344
|
Mbpshi/Mbpshi
(involves: C3H * ICR * SWV)
|
audiogenic seizures
|
J:6578
|
| environmentally induced seizures
|
J:6578
|
| tonic seizures
|
J:6578
|
Mbpshi/Mbpshi
(involves: SWV)
|
abnormal axonal transport
|
J:57128
|
| abnormal myelination
|
J:57128
|
Mbpshi/Mbpshi
Plp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * SWV)
|
abnormal myelination
|
J:38856
|
Mbpshi/Mbpshi
Plp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ * SWV)
|
demyelination
|
J:48031
|
Mbpshi/Mbpshi
Pmp2tm1.1(KOMP)Vlcg/Pmp2tm1.1(KOMP)Vlcg
(involves: C3HeB/FeJ * C57BL/6 * C57BL/6NTac)
|
decreased nerve conduction velocity
|
J:211344
|
Mbpshi/Mbpshi
Tg(Thy1-YFP)HJrs/0
(involves: C3HeB/Fe * C57BL/6 * CBA * SWV)
|
abnormal myelination
|
J:158545
|
| demyelination
|
J:158545
|
| increased susceptibility to neuronal excitotoxicity
|
J:158545
|
| increased susceptibility to pharmacologically induced seizures
|
J:158545
|
Mbptm1Atc/Mbptm1Atc
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:100022
|
| abnormal myelination
|
J:100022
|
Mc2rtm1Dgen/Mc2rtm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:82809
|
Mc4rtm2Lowl/Mc4rtm2Lowl
Chattm1(cre)Lowl/Chat+
Gt(ROSA)26Sortm14(CAG-tdTomato)Hze/Gt(ROSA)26Sor+
(involves: 129S6/SvEvTac * C57BL/6NCr)
|
abnormal nervous system electrophysiology
|
J:193452
|
Mccc2em1(IMPC)J/Mccc2+
(C57BL/6NJ-Mccc2em1(IMPC)J/Mmjax)
|
increased prepulse inhibition
|
J:211773
|
Mchr1tm1Blak/Mchr1tm1Blak
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:101206
|
Mcidasem2(IMPC)Tcp/Mcidasem2(IMPC)Tcp
(C57BL/6NCrl-Mcidasem2(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Mcoln3Va/Mcoln3+
(involves: C57BL * C57BR)
|
tonic seizures
|
J:13133
|
Mcoln3Va/Mcoln3Va
(involves: C57BL * C57BR)
|
tonic seizures
|
J:13133
|
Mcph1tm1.1Zqw/Mcph1tm1.1Zqw
(Not Specified)
|
abnormal neuronal precursor proliferation
|
J:180706
|
| increased neuron apoptosis
|
J:180706
|
Mdga1tm1.1Tymo/Mdga1tm1.1Tymo
(B6.Cg-Mdga1tm1.1Tymo)
|
abnormal neuronal migration
|
J:166980
|
Mdga2Tg(Prnp-PFN1*G118V)838Kiaei/Mdga2+
(involves: C57BL/6N)
|
abnormal action potential
|
J:241428
|
| abnormal Wallerian degeneration
|
J:241428
|
Mdktm1Tmu/Mdktm1Tmu
(B6.129S2-Mdktm1Tmu)
|
decreased prepulse inhibition
|
J:151029
|
Me1em1(IMPC)Tcp/Me1em1(IMPC)Tcp
(C57BL/6NCrl-Me1em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Mecp2em1Jlzn/Y
(C57BL/6-Mecp2em1Jlzn)
|
environmentally induced seizures
|
J:296009
|
| seizures
|
J:296009
|
Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal synaptic neurotransmitter level
|
J:165306
|
Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd)
|
abnormal hippocampus physiology
|
J:235553
|
| abnormal nervous system physiology
|
J:235553
|
| decreased excitatory postsynaptic current amplitude
|
J:126964
|
| decreased miniature excitatory postsynaptic current frequency
|
J:126964
|
Mecp2tm1.1Bird/Y
(involves: 129P2/OlaHsd * C57BL/6J * FVB/N)
|
abnormal miniature inhibitory postsynaptic currents
|
J:166851
|
| abnormal nervous system electrophysiology
|
J:166851
|
| seizures
|
J:166851
|
Mecp2tm1.1Bird/Y
(B6.129P2(C)-Mecp2tm1.1Bird/J)
|
abnormal parasympathetic nervous system physiology
|
J:241788
|
| abnormal sympathetic nervous system physiology
|
J:241788
|
Mecp2tm1.1Dhy/Y
(C57BL/6N-Mecp2tm1.1Dhy)
|
seizures
|
J:209069
|
Mecp2tm1.1Irsf/Y
(involves: 129S2/SvPas * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:220859
|
| reduced long-term potentiation
|
J:220859
|
Mecp2tm1.1Irsf/Mecp2+
(involves: 129S2/SvPas * C57BL/6)
|
tonic-clonic seizures
|
J:220859
|
Mecp2tm1.1Jae/Y
(involves: 129S4/SvJae * C57BL/6)
|
abnormal action potential
|
J:106973
|
| abnormal brain wave pattern
|
J:181311
|
Mecp2tm1.1Joez/Y
(B6.129-Mecp2tm1.1Joez)
|
abnormal brain wave pattern
|
J:181311
|
| seizures
|
J:181311
|
Mecp2tm1.1Jtc/Mecp2+
(involves: 129S6/SvEvTac * C57BL/6)
|
tonic-clonic seizures
|
J:209637
|
Mecp2tm1.1Meg/Y
(B6.129-Mecp2tm1.1Meg)
|
increased miniature inhibitory postsynaptic current amplitude
|
J:178533
|
Mecp2tm1Bird/Y
((129S6.129P2-Mecp2tm1Bird x C57BL/6)F1)
|
decreased prepulse inhibition
|
J:135825
|
Mecp2tm1Bird/Y
((129S6.129P2-Mecp2tm1Bird x FVB/N)F1)
|
decreased prepulse inhibition
|
J:135825
|
Mecp2tm1Bird/Y
Ssttm2.1(cre)Zjh/Sst+
(involves: 129P2/OlaHsd * 129S4/SvJae * 129S6/SvEvTac * C57BL/6)
|
seizures
|
J:228740
|
| tonic-clonic seizures
|
J:228740
|
Mecp2tm1Bird/Y
Tg(dlx5a-cre)1Mekk/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * CD-1 * FVB/N)
|
increased prepulse inhibition
|
J:166851
|
Mecp2tm1Bird/Y
Tg(Slc32a1-cre)2.1Hzo/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * FVB/N)
|
abnormal miniature inhibitory postsynaptic currents
|
J:166851
|
| abnormal nervous system electrophysiology
|
J:166851
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:166851
|
| increased prepulse inhibition
|
J:166851
|
| reduced long-term potentiation
|
J:166851
|
Mecp2tm1Hzo/Y
(involves: 129S7/SvEvBrd * C57BL/6J)
|
seizures
|
J:78009
|
Mecp2tm1Nlnd/Y
(involves: 129 * CD-1)
|
abnormal neuron physiology
|
J:268051
|
Mecp2tm1Pplt/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
sporadic seizures
|
J:137513
|
Mecp2tm2Bird/Mecp2+
(involves: 129P2/OlaHsd * C57BL/6)
|
reduced long-term potentiation
|
J:118365
|
Mecp2tm2Bird/Mecp2+
Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
reduced long-term potentiation
|
J:118365
|
Mecp2tm3Meg/Y
(B6.129-Mecp2tm3Meg)
|
increased susceptibility to pharmacologically induced seizures
|
J:204723
|
Med1tm1Rgr/Med1tm1Rgr
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * 129X1/SvJ))
|
abnormal neuron apoptosis
|
J:61840
|
Mef2atm1.1Limm/Mef2atm1.1Limm
Mef2ctm2Eno/Mef2ctm2Eno
Mef2dtm3Eno/Mef2dtm3Eno
Tg(GFAP-cre)25Mes/0
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
abnormal long-term potentiation
|
J:207812
|
| enhanced paired-pulse facilitation
|
J:207812
|
| increased neuron apoptosis
|
J:207812
|
Mef2atm1.1Limm/Mef2atm1.1Limm
Mef2dtm3Eno/Mef2dtm3Eno
Tg(GFAP-cre)25Mes/0
(involves: 129S/SvEv * C57BL/6 * FVB/N)
|
enhanced paired-pulse facilitation
|
J:207812
|
Megf10tm1(KOMP)Vlcg/Megf10+
(C57BL/6N-Megf10tm1(KOMP)Vlcg)
|
abnormal astrocyte physiology
|
J:231811
|
| increased hindbrain apoptosis
|
J:231811
|
Megf10tm1(KOMP)Vlcg/Megf10tm1(KOMP)Vlcg
(C57BL/6N-Megf10tm1(KOMP)Vlcg)
|
abnormal astrocyte physiology
|
J:231811
|
| increased hindbrain apoptosis
|
J:231811
|
Meis1tm1b(EUCOMM)Hmgu/Meis1+
(C57BL/6N-Meis1tm1b(EUCOMM)Hmgu/J)
|
decreased prepulse inhibition
|
J:211773
|
Mettm1Cpo/Mettm1Cpo
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuron physiology
|
J:174591
|
Mettl14tm1.1Czhao/Mettl14tm1.1Czhao
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6NCrl * SJL)
|
abnormal glial cell physiology
|
J:258043
|
Mettl14tm1.2Czhao/Mettl14tm1.2Czhao
(involves: 129S6/SvEvTac * C57BL/6NCrl * FVB/N * SJL)
|
abnormal neuronal stem cell physiology
|
J:258043
|
Mfn2tm1.1Arte/Mfn2tm1.1Arte
Slc6a3tm1(cre)Lrsn/Slc6a3+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuron physiology
|
J:188337
|
Mfn2tm1.1Balo/Mfn2tm1.1Balo
(Not Specified)
|
abnormal axonal transport
|
J:159219
|
Mfn2tm2Dcc/Mfn2tm2Dcc
(involves: 129S/SvEv)
|
abnormal axonal transport
|
J:159219
|
Mfsd2atm1Dls/Mfsd2atm1Dls
(B6.Cg-Mfsd2atm1Dls)
|
abnormal microglial cell activation
|
J:234197
|
| abnormal nervous system physiology
|
J:234197
|
Mfsd2atm1Lex/Mfsd2atm1Lex
(B6;129S5-Mfsd2atm1Lex/Mmucd)
|
impaired blood-brain barrier function
|
J:210589
|
Mfsd8tm1a(EUCOMM)Hmgu/Mfsd8tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
CNS inflammation
|
J:211608
|
Mgat2tm1.1Jxm/Mgat2tm1.1Jxm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal PNS synaptic transmission
|
J:80661
|
Mgat5btm1Nta/Mgat5btm1Nta
(Not Specified)
|
brain inflammation
|
J:199165
|
| demyelination
|
J:199165
|
Mgmttm1b(EUCOMM)Wtsi/Mgmttm1b(EUCOMM)Wtsi
(C57BL/6N-Mgmttm1b(EUCOMM)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Mib1tm2Kong/Mib1tm2Kong
Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal neuronal migration
|
J:130369
|
Mib2tm1a(EUCOMM)Wtsi/Mib2tm1a(EUCOMM)Wtsi
(C57BL/6N-Mib2tm1a(EUCOMM)Wtsi/Ics)
|
decreased prepulse inhibition
|
J:165965
|
Mical2em1(IMPC)Tcp/Mical2em1(IMPC)Tcp
(C57BL/6NCrl-Mical2em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Mid1em1(IMPC)Mbp/Mid1+
(C57BL/6NCrl-Mid1em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Minpp1em1Vca/Minpp1em1Vca
(C57BL/6J-Minpp1em1Vca)
|
abnormal neuron physiology
|
J:299426
|
Miostm1Pfw/Miostm1Pfw
Olig2tm2(TVA,cre)Rth/Olig2+
(involves: 129 * C57BL/6)
|
abnormal oligodendrocyte physiology
|
J:320720
|
| dysmyelination
|
J:320720
|
Miostm1Pfw/Miostm1Pfw
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
dysmyelination
|
J:320720
|
Mipol1tm1b(EUCOMM)Hmgu/Mipol1tm1b(EUCOMM)Hmgu
(C57BL/6N-Mipol1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Mir34atm1.1Aven/Mir34atm1.1Aven
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:180144
|
Mir34atm1.2Arte/Mir34atm1.2Arte
(involves: C57BL/6N)
|
decreased prepulse inhibition
|
J:221990
|
Mir96Dmdo/Mir96+
(C3HeB/FeJ-Mir96Dmdo)
|
decreased cochlear nerve compound action potential
|
J:151354
|
Mir96Dmdo/Mir96Dmdo
(C3HeB/FeJ-Mir96Dmdo)
|
absent cochlear nerve compound action potential
|
J:151354
|
Mir124a-1hgtm1Tfur/Mir124a-1hgtm1Tfur
(involves: 129S6/SvEvTac)
|
increased neuron apoptosis
|
J:179784
|
Mir128-2tm1.1Ans/Mir128-2tm1.1Ans
Tg(Camk2a-cre)2Gsc/0
(involves: BALB/cJ * C57BL/6J * FVB/N)
|
seizures
|
J:205260
|
Mir128-2tm1.1Ans/Mir128-2tm1.1Ans
Tg(Drd1-cre)EY262Gsat/0
(involves: BALB/cJ * C57BL/6J * FVB/N)
|
abnormal action potential
|
J:205260
|
| seizures
|
J:205260
|
Mir128-2tm1.2Ans/Mir128-2tm1.2Ans
(involves: BALB/cJ * C57BL/6J)
|
seizures
|
J:205260
|
Mir145atm1Eno/Mir145atm1Eno
(involves: 129S/SvEv * C57BL/6)
|
seizures
|
J:152458
|
Mir195atm1Narl/Mir195atm1Narl
Tg(Ctsk-RFP,-cre)7Narl/0
(involves: C57BL/6)
|
impaired blood-brain barrier function
|
J:297580
|
Mir206tm1Eno/Mir206tm1Eno
(involves: 129S/SvEv * C57BL/6)
|
abnormal motor nerve collateral sprouting
|
J:155806
|
Mir218-1em1Slp/Mir218-1em1Slp
Mir218-2em1Slp/Mir218-2em1Slp
(Not Specified)
|
abnormal action potential
|
J:227113
|
Mir324em1Dayn/Mir324em1Dayn
(involves: C57BL/6J * CBA/Ca)
|
abnormal CNS synaptic transmission
|
J:318050
|
Mir425em1Nju/Mir425+
(involves: C57BL/6)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:280159
|
Mir501tm1Rchen/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal hippocampus physiology
|
J:343467
|
| abnormal synaptic physiology
|
J:343467
|
| decreased paired-pulse inhibition
|
J:343467
|
| increased excitatory postsynaptic current frequency
|
J:343467
|
Mir582em1Minz/Mir582em1Minz
(involves: C57BL/6)
|
decreased neuronal stem cell self-renewal
|
J:325358
|
Mir592em1Jzhan/Mir592em1Jzhan
(Not Specified)
|
increased neuron apoptosis
|
J:323615
|
Mirc19tm1.2Arte/Mirc19tm1.2Arte
(involves: C57BL/6N)
|
abnormal excitatory postsynaptic potential
|
J:200865
|
| abnormal miniature excitatory postsynaptic currents
|
J:200865
|
| enhanced long-term potentiation
|
J:200865
|
Mirc20tm1.1Blel/Mirc20tm1.1Blel
(involves: 129S4/SvJae * C57BL/6)
|
increased brain apoptosis
|
J:232516
|
| increased embryonic neuroepithelial cell proliferation
|
J:232516
|
Mirc32tm1.2Eno/Mirc32tm1.2Eno
(involves: 129S/SvEv * C57BL/6)
|
seizures
|
J:152458
|
Mirc33em1Smoc/Mirc33em1Smoc
(Not Specified)
|
abnormal pituitary gland physiology
|
J:324059
|
| hypopituitarism
|
J:324059
|
Mirc40tm1Jzb/Mirc40tm1Jzb
(Not Specified)
|
increased microglial cell activation
|
J:244554
|
Mkln1Gt(OST448976)Lex/Mkln1Gt(OST448976)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal nervous system physiology
|
J:174709
|
Mks1tm1a(EUCOMM)Wtsi/Mks1tm1a(EUCOMM)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
increased neuron apoptosis
|
J:196290
|
ml/ml
(involves: CBA/FaCam)
|
abnormal myelination
|
J:13530
|
Mlc1tm1.1Vdk/Mlc1tm1.1Vdk
(involves: C57BL/6)
|
abnormal astrocyte physiology
|
J:250520
|
Mlc1tm1.2Nune/Mlc1tm1.2Nune
(involves: 129 * C57BL/6)
|
abnormal glial cell physiology
|
J:210308
|
| abnormal oligodendrocyte physiology
|
J:210308
|
Mldhrtm1Zhgn/Mldhrtm1Zhgn
Tg(GFAP-cre)25Mes/0
(involves: FVB/N)
|
seizures
|
J:303725
|
Mllt6em1(IMPC)Tcp/Mllt6em1(IMPC)Tcp
(C57BL/6NCrl-Mllt6em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Mllt11tm1c(KOMP)Mbp/Mllt11tm1c(KOMP)Mbp
Cux2tm1.1(cre)Mull/Cux2+
(involves: C57BL/6 * C57BL/6J * C57BL/6N)
|
abnormal neuronal migration
|
J:324710
|
Mmp2em1(IMPC)Mbp/Mmp2em1(IMPC)Mbp
(C57BL/6N-Mmp2em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Mmp2tm1Ito/Mmp2tm1Ito
(involves: 129P2/OlaHsd * C57BL/6J)
|
brain inflammation
|
J:94099
|
Mmp3tm1Mrl/Mmp3tm1Mrl
(either: 129S7/SvEvBrd or (involves: 129S7/SvEvBrd * C57BL/6))
|
abnormal miniature endplate potential
|
J:89840
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac)
|
abnormal myelination
|
J:105765
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * CD-1)
|
decreased susceptibility to ischemic brain injury
|
J:79535
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * FVB/N)
|
decreased neuron apoptosis
|
J:96548
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
reduced long-term potentiation
|
J:105763
|
Mmp9tm1Tvu/Mmp9tm1Tvu
(FVB.Cg-Mmp9tm1Tvu/J)
|
enhanced blood-brain barrier function
|
J:153406
|
Mmp12tm1Sds/Mmp12tm1Sds
(involves: 129X1/SvJ)
|
abnormal myelination
|
J:105765
|
Mmp12tm1Sds/Mmp12tm1Sds
Mmp9tm1Tvu/Mmp9tm1Tvu
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal myelination
|
J:105765
|
Mmp20em1(IMPC)Ccpcz/Mmp20em1(IMPC)Ccpcz
(C57BL/6NCrl-Mmp20em1(IMPC)Ccpcz/Ccpcz)
|
increased prepulse inhibition
|
J:211773
|
mneu/mneu
(involves: Jcl:ICR)
|
abnormal nerve conduction
|
J:30958
|
| abnormal nervous system physiology
|
J:30958
|
Mnx1tm4(cre)Tmj/Mnx1+
Tardbptm1.1Ckjs/Tardbptm1.2Cjks
(involves: 129S1/Sv * C57BL/6J)
|
increased microglial cell activation
|
J:190254
|
Mobptm1Sak/Mobptm1Sak
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal myelination
|
J:89416
|
Mocs2tm1(KOMP)Vlcg/Mocs2+
(involves: C57BL/6NTac)
|
increased neuron apoptosis
|
J:242197
|
Mocs2tm1(KOMP)Vlcg/Mocs2tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
increased neuron apoptosis
|
J:242197
|
Mogtm1Dpd/Mogtm1Dpd
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: 129S2/SvPas * C57BL/6)
|
CNS inflammation
|
J:151335
|
| demyelination
|
J:151335
|
Mogat2em1(IMPC)Mbp/Mogat2em1(IMPC)Mbp
(C57BL/6N-Mogat2em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Morc2aem1(IMPC)Wtsi/Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu)
|
intracerebral hemorrhage
|
J:239583
|
Morc2aem1Snupy/Morc2a+
(involves: C57BL/6)
|
abnormal action potential
|
J:341847
|
| abnormal myelination
|
J:341847
|
| decreased nerve conduction velocity
|
J:341847
|
| increased neuron apoptosis
|
J:341847
|
Morc2atm1.1Pngr/Morc2atm1.1Pngr
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal neuron physiology
|
J:332344
|
Mov10em1(IMPC)Tcp/Mov10em1(IMPC)Tcp
(C57BL/6NCrl-Mov10em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Mphosph9tm1e.1(EUCOMM)Hmgu/Mphosph9tm1e.1(EUCOMM)Hmgu
(C57BL/6N-Mphosph9tm1e.1(EUCOMM)Hmgu/Ieg)
|
increased prepulse inhibition
|
J:211773
|
Mpitm1a(EUCOMM)Wtsi/Mpi+
(C57BL/6N-Mpitm1a(EUCOMM)Wtsi/H)
|
increased prepulse inhibition
|
J:165965
|
Mpp3tm1.1Wij/Mpp3tm1.1Wij
Emx1tm1(cre)Ito/Emx1+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6J)
|
abnormal neuronal migration
|
J:198427
|
Mpzem1(IMPC)Tcp/Mpzem1(IMPC)Tcp
(C57BL/6NCrl-Mpzem1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Mpztm1.1Wra/Mpz+
(FVB.129S2-Mpztm1.1Wra)
|
dysmyelination
|
J:267903
|
Mpztm1.1Wra/Mpztm1.1Wra
(FVB.129S2-Mpztm1.1Wra)
|
dysmyelination
|
J:267903
|
Mpztm1Msch/Mpz+
(involves: 129S7/SvEvBrd)
|
abnormal myelination
|
J:42838
|
| abnormal nerve conduction
|
J:42838
|
| demyelination
|
J:133028
|
| dysmyelination
|
J:267903
|
Mpztm1Msch/Mpz+
(B6.129S7-Mpztm1Msch)
|
abnormal myelination
|
J:59319
|
| abnormal nerve conduction
|
J:59319
|
| abnormal nervous system physiology
|
J:59319
|
Mpztm1Msch/Mpz+
Rag1tm1Mom/Rag1tm1Mom
(B6.129S7-Mpztm1Msch Rag1tm1Mom)
|
abnormal myelination
|
J:59319
|
| abnormal nerve conduction
|
J:59319
|
Mpztm1Msch/Mpz+
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * BALB/c * C57BL/6)
|
abnormal nerve conduction
|
J:59319
|
| abnormal nervous system physiology
|
J:59319
|
| decreased nerve conduction velocity
|
J:59319
|
Mpztm1Msch/Mpz+
Tg(Mpz)88.1Mfel/0
(FVB.Cg-Mpztm1Msch Tg(Mpz)88.1Mfel)
|
decreased nerve conduction velocity
|
J:77658
|
Mpztm1Msch/Mpz+
Tg(Mpz*S63C)33Mes/0
(involves: 129S7/SvEvBrd * FVB/N)
|
demyelination
|
J:105751
|
| dysmyelination
|
J:105751
|
Mpztm1Msch/Mpz+
Tg(Mpz*S63X)31Mes/0
(involves: 129S7/SvEvBrd * FVB/N)
|
abnormal action potential
|
J:105751
|
| decreased nerve conduction velocity
|
J:105751
|
| demyelination
|
J:105751
|
Mpztm1Msch/Mpztm1Msch
(involves: 129S7/SvEvBrd)
|
abnormal myelination
|
J:42838
|
| abnormal nerve conduction
|
J:42838
|
Mpztm1Msch/Mpztm1Msch
Tg(Mpz)88.4Mfel/0
(FVB.Cg-Mpztm1Msch Tg(Mpz)88.4Mfel)
|
dysmyelination
|
J:77658
|
Mpztm1Msch/Mpztm1Msch
Tg(Mpz*S63C)33Mes/0
(involves: 129S7/SvEvBrd * FVB/N)
|
abnormal myelination
|
J:105751
|
Mpztm1Msch/Mpztm1Msch
Tg(Mpz*S63X)31Mes/0
(involves: 129S7/SvEvBrd * FVB/N)
|
abnormal myelination
|
J:105751
|
Mpztm3.1Wra/Mpz+
(FVB.129S2(Cg)-Mpztm3.1Wra)
|
abnormal action potential
|
J:241742
|
| decreased nerve conduction velocity
|
J:241742
|
| increased Schwann cell proliferation
|
J:241742
|
Mpztm3.1Wra/Mpztm3.1Wra
(FVB.129S2(Cg)-Mpztm1.1Wra)
|
abnormal action potential
|
J:241742
|
| decreased nerve conduction velocity
|
J:241742
|
| dysmyelination
|
J:241742
|
| increased Schwann cell proliferation
|
J:241742
|
Mpzttrr/Mpzttrr
(B6.Cg-Mpzttrr/GrsrJ)
|
demyelination
|
J:149880
|
Mpzl1tm1.1(KOMP)Vlcg/Mpzl1tm1.1(KOMP)Vlcg
(C57BL/6N-Mpzl1tm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Mregtm1b(EUCOMM)Hmgu/Mregtm1b(EUCOMM)Hmgu
(C57BL/6N-Mregtm1b(EUCOMM)Hmgu/Kmpc)
|
decreased prepulse inhibition
|
J:211773
|
Mrgprdtm1.1(cre)And/Mrgprdtm1.1(cre)And
(B6.129S1-Mrgprdtm1.1(cre)And)
|
abnormal single cell response
|
J:150802
|
Mrgprdtm1Mjz/Mrgprdtm1Mjz
(B6.129S1-Mrgprdtm1Mjz)
|
abnormal single cell response
|
J:150802
|
Mrgprx1em1Cao/Mrgprx1em1Cao
(involves: C57BL/6)
|
abnormal neuron physiology
|
J:329699
|
Mrm3tm1.1(KOMP)Vlcg/Mrm3+
(C57BL/6N-Mrm3tm1.1(KOMP)Vlcg/J)
|
decreased prepulse inhibition
|
J:211773
|
Mrpl3dcr/Mrpl3dcr
(B6(Cg)-Mrpl3dcr/Dcr)
|
increased susceptibility to ischemic brain injury
|
J:167846
|
Mrtfatm1Eno/Mrtfatm1Eno
Mrtfbtm2.1Eno/Mrtfbtm2.1Eno
Tg(GFAP-cre)25Mes/0
(involves: 129 * 129S/SvEv * C57BL/6 * FVB/N)
|
abnormal neuronal migration
|
J:161853
|
| increased neuron apoptosis
|
J:161853
|
Msi1tm1Okn/Msi1tm1Okn
(involves: C57BL/6)
|
intracerebral hemorrhage
|
J:81794
|
Msx1tm1Bero/Msx1tm1Bero
Msx2tm1Bero/Msx2tm1Yvla
Taglntm2(cre)Yec/Tagln+
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * NMRI)
|
intracranial hemorrhage
|
J:173525
|
Msx2tm1Rilm/Msx2tm1Rilm
(either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * BALB/c) or (involves: 129S4/SvJae * C57BL/6J))
|
tonic seizures
|
J:61509
|
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(involves: 129S7/SvEvBrd)
|
abnormal microglial cell physiology
|
J:53929
|
| increased brain apoptosis
|
J:53929
|
| increased neuron apoptosis
|
J:103102
|
Mt1tm1Bri/Mt1tm1Bri
Mt2tm1Bri/Mt2tm1Bri
(129S7/SvEvBrd-Mt1tm1Bri Mt2tm1Bri/J)
|
clonic seizures
|
J:89429
|
| increased neuron apoptosis
|
J:89429
|
| increased susceptibility to pharmacologically induced seizures
|
J:89429
|
| tonic-clonic seizures
|
J:89429
|
Mt3tm1Rpa/Mt3tm1Rpa
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:38222
|
Mta3tm3a(KOMP)Wtsi/Mta3tm3a(KOMP)Wtsi
(Not Specified)
|
decreased prepulse inhibition
|
J:165965
|
Mtmr2tm1.1Abol/Mtmr2tm1.1Abol
(involves: 129S2/SvPas)
|
abnormal myelination
|
J:94373
|
| abnormal nerve conduction
|
J:94373
|
Mtmr2tm1Abol/Mtmr2tm1Abol
Tg(Mpz-cre)26Mes/0
(involves: 129S2/SvPas * FVB/N)
|
abnormal myelination
|
J:94373
|
Mtmr2tm1Ueli/Mtmr2tm1Ueli
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal myelination
|
J:104120
|
Mtmr3tm1b(EUCOMM)Hmgu/Mtmr3tm1b(EUCOMM)Hmgu
(C57BL/6N-Mtmr3tm1b(EUCOMM)Hmgu/J)
|
decreased prepulse inhibition
|
J:211773
|
Mtmr9tm1Wum/Mtmr9+
(Not Specified)
|
seizures
|
J:336167
|
Mtmr10em1(IMPC)Mbp/Mtmr10em1(IMPC)Mbp
(C57BL/6NCrl-Mtmr10em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Mtnr1atm1Rep/Mtnr1atm1Rep
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neuron physiology
|
J:41859
|
Mtnr1btm1Drw/Mtnr1btm1Drw
(C3.129S4-Mtnr1btm1Drw)
|
impaired synaptic plasticity
|
J:105804
|
| reduced long-term potentiation
|
J:105804
|
Mtortm1Koz/Mtortm1Koz
Cnptm1(cre)Kan/Cnp+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myelination
|
J:181341
|
| decreased nerve conduction velocity
|
J:181341
|
Muc5bem1(IMPC)Mbp/Muc5bem1(IMPC)Mbp
(C57BL/6N-Muc5bem1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Musktm1.1Vwi/Musktm2Vwi
(Not Specified)
|
abnormal endplate potential
|
J:141024
|
| abnormal miniature endplate potential
|
J:141024
|
Mutyhtm1Yun/Mutyhtm1Yun
(involves: 129 * C57BL/6JJcl)
|
decreased susceptibility to neuronal excitotoxicity
|
J:193978
|
Mutyhtm1Yun/Mutyhtm1Yun
Ogg1tm1Yun/Ogg1tm1Yun
(involves: 129S/SvEv * C57BL/6JJcl)
|
decreased susceptibility to neuronal excitotoxicity
|
J:193978
|
Mycem1(IMPC)Kmpc/Myc+
(C57BL/6NTac-Mycem1(IMPC)Kmpc/Kmpc)
|
decreased prepulse inhibition
|
J:211773
|
Mycntm1Psk/Mycntm1Psk
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
abnormal neuronal precursor proliferation
|
J:79489
|
Myd88tm1.1Defr/Myd88tm1.1Defr
(B6.129P2(SJL)-Myd88tm1.1Defr)
|
abnormal microglial cell physiology
|
J:224849
|
| demyelination
|
J:224849
|
Myd88tm1Aki/Myd88tm1Aki
(B6.129P2-Myd88tm1Aki)
|
abnormal nervous system physiology
|
J:122826
|
Myf5tm3(cre)Sor/Myf5+
Ntf3tm2Jae/Ntf3tm2Jae
(involves: 129S1/Sv * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:147957
|
Myh1tm1b(KOMP)Wtsi/Myh1tm1b(KOMP)Wtsi
(C57BL/6N-Myh1tm1b(KOMP)Wtsi/J)
|
decreased prepulse inhibition
|
J:211773
|
Myh10tm3Rsad/Myh10tm3Rsad
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal neuronal migration
|
J:92081
|
Myh10tm4Rsad/Myh10tm4Rsad
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal neuronal migration
|
J:112536
|
Myh10tm6(Myh9/GFP)Rsad/Myh10tm6(Myh9/GFP)Rsad
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal neuronal migration
|
J:124610
|
Myo1ctm1Pgg/Myo1ctm1Pgg
(B6.129S4-Myo1ctm1Pgg)
|
abnormal vestibular hair cell physiology
|
J:100987
|
Myo3btm1b(EUCOMM)Hmgu/Myo3btm1b(EUCOMM)Hmgu
(C57BL/6N-Myo3btm1b(EUCOMM)Hmgu/J)
|
convulsive seizures
|
J:211773
|
Myo5ad-15H/Myo5ad-15H
(Not Specified)
|
seizures
|
J:13409
|
Myo5ad-l32J/Myo5ad-l32J
(B6.Cg-Myo5ad-l32J/GrsrJ)
|
clonic seizures
|
J:169210
|
Myo5ad-l/Myo5ad-l
(involves: C57BL)
|
clonic seizures
|
J:12978
|
Myo5ad-n2Btlr/Myo5ad-n2Btlr
(C57BL/6J-Myo5ad-n2Btlr)
|
myoclonus
|
J:133120
|
Myo5ad-n/Myo5ad-n
(B10.D2-H2d/nSnJ)
|
clonic seizures
|
J:171603
|
| reduced long-term depression
|
J:171603
|
Myo5ad-nBtlr/Myo5ad-nBtlr
(C57BL/6J-Myo5ad-nBtlr)
|
myoclonus
|
J:133119
|
Myo6em1(IMPC)Tcp/Myo6em1(IMPC)Tcp
(C57BL/6N-Myo6em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Myo6sv/Myo6sv
(involves: B10.HA/(33NX)Sn * C57BL/6J)
|
absent cochlear nerve compound action potential
|
J:29898
|
Myo7a816SB/Myo7a816SB
(involves: BALB/cRl * 47BS/Rl)
|
absent cochlear microphonics
|
J:46373
|
Myo7a4626SB/Myo7a+
(involves: BALB/cRl * 47BS/Rl * CBA/Ca)
|
abnormal cochlear nerve compound action potential
|
J:134369
|
Myo7aHdb/Myo7a+
(C3HeB/FeJ-Myo7aHdb/Ieg)
|
increased cochlear nerve compound action potential
|
J:93998
|
Myo7aHdb/Myo7aHdb
(C3HeB/FeJ-Myo7aHdb/Ieg)
|
increased cochlear nerve compound action potential
|
J:93998
|
Myo9aem1Atuf/Myo9aem1Atuf
(C57BL/6J-Myo9aem1Atuf)
|
seizures
|
J:302901
|
Myo15atm1.1(cre)Ugds/Myo15a+
Ush1gtm1.1Ugds/Ush1gtm1.1Ugds
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal hair cell mechanoelectric transduction
|
J:171218
|
| abnormal hair cell physiology
|
J:171218
|
| absent cochlear microphonics
|
J:171218
|
Myo15atm1.1Jebd/Myo15atm1.1Jebd
(involves: C57BL/6 * FVB/N)
|
abnormal cochlear inner hair cell physiology
|
J:226820
|
Myrftm1Barr/Myrftm1Barr
Cnptm1(cre)Kan/Cnp+
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6)
|
abnormal myelination
|
J:150563
|
| seizures
|
J:150563
|
Myrftm1Barr/Myrftm1Barr
Olig2tm2(TVA,cre)Rth/Olig2+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6)
|
abnormal myelination
|
J:150563
|
| seizures
|
J:150563
|
Myt1lem1Jdd/Myt1l+
(C57BL/6-Myt1lem1Jdd/J)
|
abnormal neuron physiology
|
J:321206
|
| decreased neuronal precursor proliferation
|
J:321206
|
Myzaptm1Norf/Myzaptm1Norf
(involves: C57BL/6J)
|
abnormal action potential
|
J:231032
|
n-TRtct5m1J/n-TRtct5m1J
(C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:297745
|
| abnormal paired-pulse inhibition
|
J:297745
|
| abnormal seizure response to electrical stimulation
|
J:297745
|
| abnormal seizure response to pharmacological agent
|
J:297745
|
| abnormal synaptic transmission
|
J:297745
|
n-TRtct5tm1.1Slac/n-TRtct5tm1.1Slac
(C57BL/6J-n-TRtct5tm1.1Slac)
|
abnormal CNS synaptic transmission
|
J:297745
|
| abnormal miniature excitatory postsynaptic currents
|
J:297745
|
| abnormal paired-pulse inhibition
|
J:297745
|
| abnormal seizure response to electrical stimulation
|
J:297745
|
| abnormal seizure response to pharmacological agent
|
J:297745
|
| increased miniature inhibitory postsynaptic current frequency
|
J:297745
|
n-TRtct5tm2.1Slac/n-TRtct5tm2.1Slac
(C57BL/6NJ-n-TRtct5tm2.1Slac)
|
abnormal action potential
|
J:297745
|
| abnormal CNS synaptic transmission
|
J:297745
|
| abnormal miniature inhibitory postsynaptic currents
|
J:297745
|
| abnormal paired-pulse inhibition
|
J:297745
|
| abnormal seizure response to pharmacological agent
|
J:297745
|
| increased miniature inhibitory postsynaptic current amplitude
|
J:297745
|
| increased miniature inhibitory postsynaptic current frequency
|
J:297745
|
Nab1tm1Jmi/Nab1tm1Jmi
Nab2tm1Jmi/Nab2tm1Jmi
(involves: 129X1/SvJ)
|
abnormal myelination
|
J:99824
|
| increased Schwann cell proliferation
|
J:99824
|
Nae1tm1c(EUCOMM)Wtsi/Nae1tm1c(EUCOMM)Wtsi
Tg(Camk2a-cre/ERT2)2Gsc/0
Tg(Thy1-EGFP)MJrs/0
(involves: C57BL/6J * C57BL/6N * CBA * FVB/N * SJL)
|
abnormal CNS synaptic transmission
|
J:262411
|
Naip1tm1Aem/Naip1tm1Aem
(129X1/SvJ-Naip1tm1Aem)
|
increased susceptibility to neuronal excitotoxicity
|
J:60925
|
NalcnDrl/Nalcn+
(involves: C57BL/6J * C57BL/6N)
|
abnormal brain wave pattern
|
J:236598
|
| abnormal nervous system electrophysiology
|
J:236598
|
Nalcntm1.1Dren/Nalcntm1.1Dren
(involves: C57BL/6)
|
abnormal channel response
|
J:141581
|
| abnormal nerve conduction
|
J:141581
|
| abnormal nervous system electrophysiology
|
J:141581
|
Nalcntm1c(KOMP)Wtsi/Nalcntm1c(KOMP)Wtsi
Tg(Camk2a-cre)2Gsc/0
(involves: C57BL/6N * FVB/N)
|
abnormal nervous system electrophysiology
|
J:238767
|
| impaired ability to fire action potentials
|
J:238767
|
Nap1l1em1Jwji/Nap1l1em1Jwji
(Not Specified)
|
abnormal glial cell physiology
|
J:263406
|
| decreased neuronal precursor proliferation
|
J:263406
|
Napahyh/Napahyh
Napbtm1Bros/Napbtm1Bros
(involves: C57BL/10J)
|
abnormal excitatory postsynaptic currents
|
J:167753
|
| abnormal neuron physiology
|
J:167753
|
Napbtm1Bros/Napbtm1Bros
(Not Specified)
|
abnormal neuron physiology
|
J:167753
|
| seizures
|
J:167753
|
Napepldtm1Crv/Napepldtm1Crv
(involves: 129X1/SvJ * C57BL/6)
|
abnormal nervous system physiology
|
J:108301
|
NbeaGt(RRK418)Byg/NbeaGt(RRK418)Byg
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal CNS synaptic transmission
|
J:159572
|
| abnormal inhibitory postsynaptic currents
|
J:159572
|
| abnormal miniature excitatory postsynaptic currents
|
J:159572
|
| abnormal miniature inhibitory postsynaptic currents
|
J:159572
|
| decreased excitatory postsynaptic current frequency
|
J:159572
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:159572
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:159572
|
NbeaTg(GH1)240BNec/Nbea+
(B6JRj.Cg-NbeaTg(GH1)240BNec)
|
enhanced long-term potentiation
|
J:197577
|
NbeaTg(GH1)240BNec/NbeaTg(GH1)240BNec
(involves: C57BL/6 * SJL)
|
abnormal miniature endplate potential
|
J:128767
|
Nbeal2tm1Lex/Nbeal2tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
decreased cerebral infarct size
|
J:201413
|
Ncaldtm1.1(KOMP)Vlcg/Ncaldtm1.1(KOMP)Vlcg
(C57BL/6N-Ncaldtm1.1(KOMP)Vlcg/J)
|
decreased prepulse inhibition
|
J:211773
|
Ncaldtm1.1(KOMP)Vlcg/Ncaldtm1.1(KOMP)Vlcg
(B6N(Cg)-Ncaldtm1.1(KOMP)Vlcg/J)
|
abnormal myelination
|
J:273172
|
| abnormal nervous system physiology
|
J:273172
|
| abnormal neuronal migration
|
J:273172
|
Ncam1tm1Msch/Ncam1tm1Msch
Tg(Camk2a-cre)1Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
absent long-term depression
|
J:96990
|
| reduced long-term potentiation
|
J:96990
|
Ncam2tm1.1Bdrt/Ncam2tm1.1Bdrt
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neuron proliferation
|
J:233502
|
Ncam2tm1b(EUCOMM)Hmgu/Ncam2tm1b(EUCOMM)Hmgu
(C57BL/6N-Ncam2tm1b(EUCOMM)Hmgu/Orl)
|
decreased prepulse inhibition
|
J:211773
|
Ncantm1Ref/Ncantm1Ref
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal long-term potentiation
|
J:70858
|
Ncantm2Ref/Ncantm2Ref
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal long-term potentiation
|
J:70858
|
Ncantm3Ref/Ncantm3Ref
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal long-term potentiation
|
J:70858
|
Ncaph2tm1.1Hiran/Ncaph2tm1.2Hiran
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
abnormal neuronal stem cell physiology
|
J:222181
|
Ncaphtm1.1Hiran/Ncaphtm1.2Hiran
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
abnormal neuronal stem cell physiology
|
J:222181
|
Ncdntm1.1Mfla/Ncdntm1.1Mfla
Tg(Camk2a-cre)2Gsc/0
(involves: C57BL/6 * FVB/N)
|
decreased prepulse inhibition
|
J:155805
|
| reduced long-term depression
|
J:155805
|
| reduced long-term potentiation
|
J:155805
|
Ncdntm2Afu/Ncdntm2Afu
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
seizures
|
J:99914
|
Ncf1tm1Shl/Ncf1tm1Shl
(B6.129S2-Ncf1tm1Shl)
|
enhanced long-term potentiation
|
J:111410
|
| reduced long-term potentiation
|
J:111410
|
Nck1tm1Paw/Nck1tm1Paw
Nck2tm1Paw/Nck2tm3Paw
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal central pattern generator function
|
J:129166
|
Ncor2tm1Rsd/Ncor2tm1Rsd
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuronal precursor proliferation
|
J:127720
|
Ncstntm1.1Sud/Ncstntm1.1Sud
Olig1tm1(cre)Rth/Olig1+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
decreased prepulse inhibition
|
J:234705
|
| dysmyelination
|
J:234705
|
Ncstntm1.1Sud/Ncstntm1.1Sud
Tg(Camk2a-cre)1Shn/0
(B6.Cg-Ncstntm1.1Sud Tg(Camk2a-cre)1Shn)
|
increased neuron apoptosis
|
J:149506
|
Ncstntm1Rroz/Ncstntm1Rroz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased embryonic neuroepithelium apoptosis
|
J:108976
|
nd/nd
(129/Sv-nd)
|
abnormal nerve conduction
|
J:10974
|
| abnormal nervous system electrophysiology
|
J:10974
|
Nde1tm1Caw/Nde1tm1Caw
(involves: 129S4/SvJae * Black Swiss)
|
abnormal neuronal migration
|
J:94756
|
Ndfip1tm1.1Sest/Ndfip1tm1.1Sest
(involves: C57BL/6)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:212711
|
Ndfip1tm1Sest/Ndfip1tm1Sest
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
increased cerebral infarct size
|
J:180657
|
Ndntm1.1Mus/Ndn+
(B6.129S2-Ndntm1.1Mus)
|
abnormal nervous system electrophysiology
|
J:119656
|
Ndntm2Stw/Ndn+
(involves: 129S1/Sv * C57BL/6J)
|
abnormal central pattern generator function
|
J:82266
|
| abnormal pre-Botzinger complex physiology
|
J:82266
|
Ndrg1em1Lxli/Ndrg1em1Lxli
(C57BL/6N-Ndrg1em1Lxli)
|
abnormal action potential
|
J:330126
|
| decreased nerve conduction velocity
|
J:330126
|
| demyelination
|
J:330126
|
Ndrg1str/Ndrg1str
(involves: BALB/c * C57BL/6 * NOD/ShiLtWtsi)
|
decreased nerve conduction velocity
|
J:172770
|
| demyelination
|
J:172770
|
Ndrg1tm1Myta/Ndrg1tm1Myta
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased nerve conduction velocity
|
J:172770
|
| demyelination
|
J:89888,
J:172770
|
Ndrg1tm2b(KOMP)Wtsi/Ndrg1tm2b(KOMP)Wtsi
(C57BL/6N-Ndrg1tm2b(KOMP)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Ndrg2tm1.1Hori/Ndrg2tm1.1Hori
(B6.129-Ndrg2tm1.1Hori)
|
abnormal astrocyte physiology
|
J:214686
|
| abnormal glial cell physiology
|
J:214686
|
| abnormal microglial cell chemotaxis
|
J:214686
|
| decreased neuron apoptosis
|
J:214686
|
Ndrg4tm1Myta/Ndrg4tm1Myta
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal nervous system physiology
|
J:175573
|
| increased cerebral infarct size
|
J:175573
|
| increased susceptibility to ischemic brain injury
|
J:175573
|
Ndst1tm1.1Grob/Ndst1tm1.1Grob
Ndst3tm1.1Grob/Ndst3tm1.1Grob
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased hindbrain apoptosis
|
J:138557
|
Ndufb9tm1b(EUCOMM)Hmgu/Ndufb9+
(C57BL/6N-Ndufb9tm1b(EUCOMM)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Ndufs4tm1.1Rpa/Ndufs4tm1.1Rpa
(involves: 129S4/SvJaeSor)
|
abnormal neuron physiology
|
J:161393
|
| brainstem hemorrhage
|
J:161393
|
| environmentally induced seizures
|
J:161393
|
| intracranial hemorrhage
|
J:161393
|
| seizures
|
J:161393
|
Ndufs4tm1.1Rpa/Ndufs4tm1.1Rpa
(B6.129S4-Ndufs4tm1.1Rpa)
|
abnormal pre-Botzinger complex physiology
|
J:190475
|
Ndufs4tm1Rpa/Ndufs4tm1Rpa
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * C57BL/6 * SJL)
|
brainstem hemorrhage
|
J:161393
|
| environmentally induced seizures
|
J:161393
|
| intracranial hemorrhage
|
J:161393
|
| seizures
|
J:161393
|
| tonic-clonic seizures
|
J:161393
|
Ndufs4tm1Rpa/Ndufs4tm1Rpa
Tg(Nes-cre)1Kln/0
(B6.Cg-Tg(Nes-cre)1Kln Ndufs4tm1Rpa)
|
abnormal pre-Botzinger complex physiology
|
J:190475
|
Nedd4Gt(XA209)Byg/Nedd4Gt(XA209)Byg
(involves: 129P2/OlaHsd)
|
increased embryonic neuroepithelium apoptosis
|
J:203994
|
Nedd4tm2Bros/Nedd4tm2Bros
(involves: C57BL/6N)
|
abnormal miniature excitatory postsynaptic currents
|
J:164745
|
| decreased excitatory postsynaptic current amplitude
|
J:164745
|
Nedd4ltm1b(KOMP)Wtsi/Nedd4ltm1b(KOMP)Wtsi
(C57BL/6N-Nedd4ltm1b(KOMP)Wtsi/H)
|
decreased prepulse inhibition
|
J:211773
|
Nefhtm1Dwc/Nefhtm1Dwc
Nefmtm1Jpj/Nefmtm1Jpj
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal axonal transport
|
J:112938
|
Nefhtm2Dwc/Nefhtm2Dwc
Nefmtm1Mvr/Nefmtm1Mvr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal action potential
|
J:87156
|
Nefmtm1Jpj/Nefmtm1Jpj
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal axonal transport
|
J:112938
|
Nefmtm1Milg/Nefmtm1Milg
(involves: 129S/SvEv * C57BL/6)
|
abnormal myelination
|
J:184861
|
Nefmtm1Mvr/Nefmtm1Mvr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal action potential
|
J:87156
|
Neil3tm1Bjor/Neil3tm1Bjor
(involves: 129 * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:180177
|
| decreased microglial cell activation
|
J:180177
|
| increased cerebral infarct size
|
J:180177
|
Nek1em1(IMPC)Bay/Nek1em1(IMPC)Bay
(C57BL/6N-Nek1em1(IMPC)Bay/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Nell2tm1Mho/Nell2tm1Mho
(involves: 129S7/SvEvBrd * C57BL/6)
|
enhanced long-term potentiation
|
J:89818
|
Nemp2em1(IMPC)Tcp/Nemp2em1(IMPC)Tcp
(C57BL/6N-Nemp2em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
nerv/nerv
(BALB/c-nerv)
|
seizures
|
J:227974
|
Neto1tm1(KOMP)Vlcg/Neto1tm1(KOMP)Vlcg
(B6.B6NTac-Neto1tm1(KOMP)Vlcg)
|
abnormal acid-activated cation-mediated receptor currents
|
J:174015
|
| abnormal excitatory postsynaptic currents
|
J:174015
|
| abnormal synaptic transmission
|
J:174015
|
Neto1tm1Mci/Neto1tm1Mci
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal excitatory postsynaptic currents
|
J:174557,
J:145953
|
| reduced long-term potentiation
|
J:145953
|
| seizures
|
J:145953
|
| short excitatory postsynaptic current decay time
|
J:174557
|
Neto1tm1Mci/Neto1tm1Mci
Neto2tm1Mci/Neto2tm1Mci
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal excitatory postsynaptic currents
|
J:174557
|
Neu1tm1Adz/Neu1tm1Adz
(either: (involves: 129S1/Sv * C57BL/6) or (involves: 129S1/Sv * NMRI))
|
myoclonus
|
J:76937
|
Neurl4em1(IMPC)Mbp/Neurl4em1(IMPC)Mbp
(C57BL/6NCrl-Neurl4em1(IMPC)Mbp/Mmucd)
|
decreased prepulse inhibition
|
J:211773
|
Neurod1tm1Mjts/Neurod1tm1Mjts
(involves: 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J)
|
abnormal brain wave pattern
|
J:59932
|
| seizures
|
J:59932
|
| sporadic seizures
|
J:59932
|
| tonic-clonic seizures
|
J:59932
|
Neurod1tm1Mjts/Neurod1tm1Mjts
Neurod6tm1Kan/Neurod6tm1Kan
(involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6J)
|
abnormal nervous system physiology
|
J:62118
|
| abnormal neuron physiology
|
J:62118
|
| impaired ability to fire action potentials
|
J:62118
|
Neurod2em1(IMPC)Hmgu/Neurod2em1(IMPC)Hmgu
(C57BL/6N-Neurod2em1(IMPC)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Neurod2tm1Tap/Neurod2+
(involves: 129/Sv * C57BL/6)
|
sporadic seizures
|
J:69606
|
| tonic-clonic seizures
|
J:69606
|
Neurod2tm1Tap/Neurod2tm1Tap
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:69606
|
Neurod6tm1(cre)Kan/Neurod6+
Prkg1tm2Naw/Prkg1tm2.1Naw
(involves: 129S1/Sv * 129X1/SvJ)
|
reduced long-term potentiation
|
J:84444
|
Neurog2tm4Fgu/Neurog2tm4Fgu
(involves: MF1)
|
abnormal neuronal migration
|
J:134976
|
| abnormal neuronal precursor proliferation
|
J:134976
|
Neurog2tm5(Neurog2)Fgu/Neurog2tm5(Neurog2)Fgu
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuronal migration
|
J:109091
|
Nexmiftm1(KOMP)Wtsi/Y
(B6J.B6N-Nexmiftm1(KOMP)Wtsi)
|
abnormal CNS synaptic transmission
|
J:283395
|
| enhanced paired-pulse facilitation
|
J:283395
|
| seizures
|
J:283395
|
Nf1tm1Fcr/Nf1+
Tg(GFAP-cre)#Gtm/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA)
|
abnormal neuron proliferation
|
J:176586
|
Nf1tm1Par/Nf1+
Ptentm1Hwu/Pten+
Trp53tm1Elee/Trp53+
Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N)
|
seizures
|
J:134611
|
Nf1tm1Par/Nf1+
Ptentm1Hwu/Pten+
Trp53tm1Tyj/Trp53+
Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S2/SvPas * 129S4/SvJae * 129X1/SvJ * FVB/N)
|
seizures
|
J:134611
|
Nf1tm1Par/Nf1+
Trp53tm1Elee/Trp53+
Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N)
|
seizures
|
J:134611
|
Nf1tm1Par/Nf1tm1Fcr
Tg(GFAP-cre)#Gtm/0
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal astrocyte physiology
|
J:165209
|
| abnormal myelination
|
J:165209
|
| hypermyelination
|
J:165209
|
Nf1tm1Par/Nf1tm1Par
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal astrocyte physiology
|
J:176586
|
Nf1tm1Par/Nf1tm1Par
Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
abnormal hypothalamus physiology
|
J:138868
|
| abnormal nervous system physiology
|
J:139866
|
| abnormal neuronal precursor proliferation
|
J:139866
|
| abnormal pituitary gland physiology
|
J:138868
|
Nf1tm1Tyj/Nf1tm1Tyj
Rasa1tm1Paw/Rasa1tm1Paw
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))
|
increased hindbrain apoptosis
|
J:29825
|
Nf2tm2Gvn/Nf2tm2Gvn
(Not Specified)
|
abnormal action potential
|
J:197562
|
Nfasctm1.1Brp/Nfasctm1.1Brp
(B6.129P2-Nfasctm1.1Brp)
|
decreased nerve conduction velocity
|
J:107591
|
Nfasctm1.1Brp/Nfasctm1.1Brp
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal oligodendrocyte physiology
|
J:139185
|
Nfasctm1.1Brp/Nfasctm1.1Brp
Tg(Nefl-Nfasc)1Brp/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal oligodendrocyte physiology
|
J:139185
|
Nfasctm1.1Brp/Nfasctm1.2Brp
Tg(Thy1-cre/ERT2)#Brp/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal action potential
|
J:174740
|
| impaired ability to fire action potentials
|
J:174740
|
Nfasctm1Bhat/Nfasctm1Bhat
Cnptm1(cre)Kan/?
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased nerve conduction velocity
|
J:145846
|
Nfasctm1Bhat/Nfasctm1Bhat
Tg(Mpz-cre)26Mes/?
(involves: FVB/N)
|
decreased nerve conduction velocity
|
J:145846
|
Nfasctm1Bhat/Nfasctm1Bhat
Tg(Plp1-cre/ERT)3Pop/?
(involves: C57BL/6 * DBA/2)
|
decreased nerve conduction velocity
|
J:145846
|
Nfe2l2tm1Mym/Nfe2l2tm1Mym
(involves: 129P2/OlaHsd * CD-1)
|
increased cerebral infarct size
|
J:122813
|
| increased susceptibility to ischemic brain injury
|
J:122813
|
Nfkb1tm1Bal/Nfkb1tm1Bal
(B6;129P-Nfkb1tm1Bal/J)
|
decreased cochlear nerve compound action potential
|
J:107245
|
Ngfrtm1Jae/Ngfrtm1Jae
(C;129S-Ngfrtm1Jae/J)
|
abnormal neuron apoptosis
|
J:46125
|
Ngfrtm1Jae/Ngfrtm1Jae
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal peripheral nervous system regeneration
|
J:116954
|
Ngfrtm1Jae/Ngfrtm1Jae
(involves: 129S4/SvJae)
|
decreased neuron apoptosis
|
J:123022
|
Ngfrtm1Jae/Ngfrtm1Jae
Ntf5tm1Jae/Ntf5tm1Jae
(involves: 129S4/SvJae)
|
decreased neuron apoptosis
|
J:123022
|
Nhlh1tm1b(KOMP)Wtsi/Nhlh1+
(C57BL/6N-Nhlh1tm1b(KOMP)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Nhlh1tm1Irk/Nhlh1tm1Irk
(involves: 129S4/SvJae)
|
abnormal parasympathetic nervous system physiology
|
J:78031
|
Nhlh1tm1Irk/Nhlh1tm1Irk
Nhlh2tm1Irk/Nhlh2+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal parasympathetic nervous system physiology
|
J:78031
|
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal excitatory postsynaptic potential
|
J:218959
|
| enhanced long-term potentiation
|
J:218959
|
| increased susceptibility to pharmacologically induced seizures
|
J:218959
|
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal seizure response to electrical stimulation
|
J:210491
|
| abnormal seizure response to pharmacological agent
|
J:210491
|
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
Gys1tm1c(EUCOMM)Wtsi/Gys1+
Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac)
|
abnormal seizure response to electrical stimulation
|
J:210491
|
| abnormal seizure response to pharmacological agent
|
J:210491
|
Nhlrc1tm1(KOMP)Vlcg/Nhlrc1tm1(KOMP)Vlcg
Gys1tm1c(EUCOMM)Wtsi/Gys1tm1c(EUCOMM)Wtsi
Tg(Nes-cre)1Kag/?
(involves: C57BL/6NTac)
|
abnormal seizure response to electrical stimulation
|
J:210491
|
| abnormal seizure response to pharmacological agent
|
J:210491
|
Nhlrc1tm1.2Geno/Nhlrc1tm1.2Geno
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal spike wave discharge
|
J:181559
|
| myoclonus
|
J:181559
|
Nid1tm1Dong/Nid1tm1Dong
(involves: 129P2/OlaHsd)
|
sporadic seizures
|
J:80843
|
Nintm1b(EUCOMM)Hmgu/Nintm1b(EUCOMM)Hmgu
(C57BL/6N-Nintm1b(EUCOMM)Hmgu/Rbrc)
|
decreased prepulse inhibition
|
J:211773
|
Nkapd1em1(IMPC)Mbp/Nkapd1+
(C57BL/6N-Nkapd1em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Nkx6-2tm1Gow/Nkx6-2tm1Gow
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
abnormal myelination
|
J:94807
|
| abnormal nerve conduction
|
J:94807
|
Nlgn1tm1.1Sud/Nlgn1tm1.1Sud
Nlgn2tm1.1Sud/Nlgn2tm1.1Sud
Nlgn3tm4.1Sud/Y
Tg(Pcp2-cre)2Mpin/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
abnormal CNS synaptic transmission
|
J:227671
|
| abnormal inhibitory postsynaptic currents
|
J:227671
|
| abnormal miniature inhibitory postsynaptic currents
|
J:227671
|
| decreased excitatory postsynaptic current amplitude
|
J:227671
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:227671
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:227671
|
Nlgn1tm1.1Sud/Nlgn1tm1.1Sud
Nlgn3tm4.1Sud/Y
Tg(Pcp2-cre)2Mpin/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
decreased excitatory postsynaptic current amplitude
|
J:227671
|
Nlgn1tm1.1Sud/Nlgn1tm1.1Sud
Tg(Pcp2-cre)2Mpin/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
decreased excitatory postsynaptic current amplitude
|
J:227671
|
Nlgn1tm1Bros/Nlgn1tm1Bros
(Not Specified)
|
abnormal CNS synaptic transmission
|
J:113647
|
Nlgn1tm1Bros/Nlgn1tm1Bros
Nlgn2tm1Bros/Nlgn2tm1Bros
(Not Specified)
|
abnormal CNS synaptic transmission
|
J:113647
|
Nlgn1tm1Bros/Nlgn1tm1Bros
Nlgn2tm1Bros/Nlgn2tm1Bros
Nlgn3tm1Bros/Nlgn3tm1Bros
(Not Specified)
|
abnormal pre-Botzinger complex physiology
|
J:113647
|
Nlgn1tm1Bros/Nlgn1tm1Bros
Nlgn3tm1Bros/Nlgn3tm1Bros
(Not Specified)
|
abnormal CNS synaptic transmission
|
J:113647
|
Nlgn2tm1.1Gchn/Nlgn2tm1.1Gchn
(involves: 129S/SvEv * C57BL/6J)
|
abnormal hippocampus physiology
|
J:272181
|
| abnormal miniature inhibitory postsynaptic currents
|
J:272181
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:272181
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:272181
|
| decreased prepulse inhibition
|
J:272181
|
Nlgn2tm1.1Sud/Nlgn2tm1.1Sud
(involves: C57BL/6NTac)
|
abnormal CNS synaptic transmission
|
J:229887
|
| abnormal inhibitory postsynaptic currents
|
J:229887
|
| abnormal miniature inhibitory postsynaptic currents
|
J:229887
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:229887
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:229887
|
Nlgn2tm1.1Sud/Nlgn2tm1.1Sud
Nlgn3tm4.1Sud/Y
Tg(Pcp2-cre)2Mpin/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
abnormal miniature inhibitory postsynaptic currents
|
J:227671
|
| decreased excitatory postsynaptic current amplitude
|
J:227671
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:227671
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:227671
|
Nlgn2tm1.1Sud/Nlgn2tm1.1Sud
Tg(Pcp2-cre)2Mpin/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
abnormal inhibitory postsynaptic currents
|
J:227671
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:227671
|
| increased excitatory postsynaptic current amplitude
|
J:227671
|
Nlgn2tm1Bros/Nlgn2tm1Bros
Nlgn3tm1Bros/Nlgn3tm1Bros
(Not Specified)
|
abnormal CNS synaptic transmission
|
J:113647
|
Nlgn3tm1Rhn/Y
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:187744
|
| absent long-term depression
|
J:187744
|
| impaired synaptic plasticity
|
J:187744
|
| increased excitatory postsynaptic current amplitude
|
J:187744
|
Nlgn3tm1Sud/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:125344
|
Nlgn3tm1Sud/Y
Tg(Drd1-tdTomato)5Calak/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased miniature inhibitory postsynaptic current frequency
|
J:214636
|
Nlgn3tm2.1Sud/Y
Tg(Drd1-tdTomato)5Calak/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
decreased miniature inhibitory postsynaptic current frequency
|
J:214636
|
Nlgn3tm3.1Sud/Nlgn3tm3.1Sud
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal excitatory postsynaptic potential
|
J:184114
|
| abnormal glutamate-mediated receptor currents
|
J:184114
|
| abnormal miniature excitatory postsynaptic currents
|
J:184114
|
| reduced AMPA-mediated synaptic currents
|
J:184114
|
Nlgn3tm4.1Sud/Y
Tg(Pcp2-cre)2Mpin/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac)
|
decreased excitatory postsynaptic current amplitude
|
J:227671
|
Nlrp1aNeut1/Nlrp1a+
(C.B6-Nlrp1aNeut1)
|
meningitis
|
J:191055
|
Nlrp1aNeut1/Nlrp1aNeut1
(C.B6-Nlrp1aNeut1)
|
meningitis
|
J:191055
|
Nlrp3tm3.1Hhf/Nlrp3+
(involves: 129)
|
meningitis
|
J:202147
|
Nme5tm1Lex/Nme5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
intraventricular hemorrhage
|
J:185566
|
Nme6tm1.1(KOMP)Vlcg/Nme6+
(C57BL/6N-Nme6tm1.1(KOMP)Vlcg/J)
|
decreased prepulse inhibition
|
J:211773
|
Nmf31/Nmf31
(BALB/cByJ-Nmf31/J)
|
myoclonus
|
J:87349
|
Nmf31/Nmf31+
(BALB/cByJ-Nmf31/J)
|
minimal clonic seizures
|
J:78134
|
nmf63/nmf63
(C57BL/6J-nmf63/J)
|
abnormal brain wave pattern
|
J:82238
|
| abnormal nervous system electrophysiology
|
J:82238
|
nmf88/nmf88
(C57BL/6J-nmf88/J)
|
abnormal seizure response to electrical stimulation
|
J:82238
|
nmf161/nmf161
(C57BL/6J-nmf161/J)
|
demyelination
|
J:82238
|
nmf391/nmf391
(C57BL/6J-nmf391/J)
|
myoclonus
|
J:87349
|
NodalTgR(MPSVNeo)413.dRob/Nodaltm4Rob
(involves: 129S/SvEv * C57BL/6)
|
decreased embryonic neuroepithelial cell proliferation
|
J:84300
|
Nogtm1Amc/Nogtm1Amc
(either: (involves: 129S1/Sv * CD-1) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal pituitary gland physiology
|
J:121318
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal peripheral nervous system regeneration
|
J:104916
|
| delayed peripheral nervous system regeneration
|
J:104916
|
| slow Wallerian degeneration
|
J:104916
|
Nos1tm1Plh/Nos1tm1Plh
(involves: 129S4/SvJae)
|
abnormal long-term potentiation
|
J:19282
|
| abnormal nervous system physiology
|
J:93439
|
| absent long-term depression
|
J:42548
|
| decreased cerebral infarct size
|
J:127062
|
| decreased susceptibility to neuronal excitotoxicity
|
J:111644
|
| decreased synaptic glutamate release
|
J:119052
|
Nos1tm1Plh/Nos1tm1Plh
(B6.129S4-Nos1tm1Plh)
|
abnormal blood-brain barrier function
|
J:150557
|
| abnormal nervous system physiology
|
J:107964
|
| abnormal seizure response to inducing agent
|
J:107964
|
| decreased cerebral infarct size
|
J:128835
|
| decreased susceptibility to ischemic brain injury
|
J:128835
|
| decreased susceptibility to neuronal excitotoxicity
|
J:150557
|
Nos1tm1Plh/Nos1tm1Plh
(B6;129S4-Nos1tm1Plh/J)
|
abnormal brain wave pattern
|
J:83571
|
Nos1tm1Plh/Nos1tm1Plh
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae)
|
reduced long-term potentiation
|
J:37956
|
Nos1tm1Plh/Nos1tm1Plh
Tg(SOD1)76Dpr/0
(involves: 129S4/SvJae * C3H/HeJ * C57BL/6 * C57BL/6J)
|
decreased cerebral infarct size
|
J:128835
|
| decreased susceptibility to ischemic brain injury
|
J:128835
|
Nos1tm2Plh/Nos1tm2Plh
(Not Specified)
|
abnormal hypothalamus secretion
|
J:106816
|
Nos1aptm1Tsso/Nos1aptm1Tsso
(involves: C57BL/6JJcl)
|
abnormal action potential
|
J:268528
|
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau)
|
enhanced central nervous system regeneration
|
J:110081
|
| increased susceptibility to pharmacologically induced seizures
|
J:107300
|
Nos2tm1Lau/Nos2tm1Lau
(B6.129P2-Nos2tm1Lau/J)
|
abnormal brain wave pattern
|
J:83571
|
Nos2tm1Lau/Nos2tm1Lau
Tg(Thy1-APPSwDutIowa)BWevn/?
(involves: C57BL/6)
|
increased neuron apoptosis
|
J:132221
|
Nos2tm1Mrl/Nos2tm1Mrl
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal peripheral nervous system regeneration
|
J:104959
|
| decreased cerebral infarct size
|
J:44287
|
| delayed peripheral nervous system regeneration
|
J:104959
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae)
|
decreased neurotransmitter release
|
J:119052
|
| increased susceptibility to neuronal excitotoxicity
|
J:111644
|
Nos3tm1Plh/Nos3tm1Plh
(B6.129S4-Nos3tm1Plh)
|
abnormal nervous system physiology
|
J:107964
|
| abnormal seizure response to inducing agent
|
J:107964
|
Nos3tm1Plh/Nos3tm1Plh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:101302
|
Nos3tm1Unc/Nos3tm1Unc
(B6.129P2-Nos3tm1Unc)
|
abnormal blood-brain barrier function
|
J:150557
|
Notch2tm3Grid/Notch2tm3Grid
Foxg1tm1(cre)Skm/Foxg1+
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6)
|
abnormal nervous system physiology
|
J:130929
|
| increased neuron apoptosis
|
J:130929
|
Notch3Gt(PST033)Byg/Notch3Gt(PST033)Byg
(involves: 129P2/OlaHsd)
|
increased cerebral infarct size
|
J:133358
|
| increased susceptibility to ischemic brain injury
|
J:133358
|
Notch3tm1.1(KOMP)Vlcg/Notch3tm1.1(KOMP)Vlcg
(C57BL/6N-Notch3tm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Nova1tm1Rbd/Nova1tm1Rbd
(Not Specified)
|
increased neuron apoptosis
|
J:60771
|
Nova2tm1Rbd/Nova2tm1Rbd
(involves: 129)
|
abnormal inhibitory postsynaptic currents
|
J:115195
|
| abnormal long-term potentiation
|
J:115195
|
Nox4tm1.1Hwsc/Nox4tm1.1Hwsc
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased cerebral infarct size
|
J:166948
|
| decreased neuron apoptosis
|
J:166948
|
| decreased susceptibility to ischemic brain injury
|
J:166948
|
| enhanced blood-brain barrier function
|
J:166948
|
Npas1tm1Slm/Npas1tm1Slm
Npas3tm1Slm/Npas3tm1Slm
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal prepulse inhibition
|
J:92610
|
Npas2tm1Slm/Npas2tm1Slm
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal brain wave pattern
|
J:109589
|
Npas4tm1Meg/Npas4tm1Meg
(involves: C57BL/6)
|
seizures
|
J:143367
|
Npas4tm1Ooe/Npas4tm1Ooe
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:145569
|
| myoclonus
|
J:145569
|
Npas4tm2Meg/Npas4tm2Meg
(Not Specified)
|
abnormal inhibitory postsynaptic currents
|
J:143367
|
| abnormal miniature excitatory postsynaptic currents
|
J:143367
|
Npc1m1N/Npc1m1N
(involves: BALB/c)
|
abnormal myelination
|
J:104996
|
Npc1m1N/Npc1m1N
(BALB/cNctr-Npc1m1N/J)
|
decreased prepulse inhibition
|
J:179744
|
| demyelination
|
J:179744
|
Npc1m1N/Npc1m1N
(involves: BALB/c * C57BL/6 * CBA)
|
increased microglial cell activation
|
J:144240
|
Npc1m1N/Npc1m1N
(BALB/c-Npc1m1N)
|
abnormal microglial cell activation
|
J:221855
|
| demyelination
|
J:172769
|
| increased microglial cell activation
|
J:221855
|
Npc1m1N/Npc1m1N
(involves: BALB/c * C3H/HeJ * C57BL/6J)
|
demyelination
|
J:188345
|
Npc1m1N/Npc1m1N
Tg(PRNP-APPSweInd)8Dwst/0
(involves: BALB/c * C3H/HeJ * C57BL/6J)
|
demyelination
|
J:188345
|
Npc1m1N/Npc1tm1.1Apl
Tg(CAG-cre/Esr1*)5Amc/0
(B6J.Cg-Npc1m1N/Npc1tm1.1Apl Tg(CAG-cre/Esr1*)5Amc)
|
demyelination
|
J:176888
|
Npc1m1N/Npc1tm1.1Apl
Tg(Syn1-cre)671Jxm/0
(B6J.Cg-Npc1m1N/Npc1tm1.1Apl Tg(Syn1-cre)671Jxm)
|
demyelination
|
J:176888
|
Npc1nmf164/Npc1nmf164
(C57BL/6J-Npc1nmf164/J)
|
abnormal astrocyte physiology
|
J:179744
|
| decreased prepulse inhibition
|
J:179744
|
| increased microglial cell activation
|
J:179744
|
Npc1tm1.1Dso/Npc1tm1.1Dso
(B6.129-Npc1tm1.1Dso)
|
abnormal microglial cell activation
|
J:221855
|
| increased microglial cell activation
|
J:221855
|
Npffr1tm1Lex/Npffr1tm1Lex
(involves: 129 * C57BL/6)
|
abnormal pituitary secretion
|
J:214329
|
Nppctm1.1Fgr/Nppctm1.1Fgr
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:153212
|
| abnormal neuron physiology
|
J:153212
|
Nptnpitch/Nptnpitch
(involves: C3H * C57BL/6J)
|
abnormal cochlear inner hair cell physiology
|
J:228717
|
Nptntm1.2Mtg/Nptntm1.2Mtg
(involves: 129)
|
abnormal CNS synaptic transmission
|
J:212431
|
| abnormal miniature excitatory postsynaptic currents
|
J:212431
|
| abnormal miniature inhibitory postsynaptic currents
|
J:212431
|
| increased miniature inhibitory postsynaptic current amplitude
|
J:212431
|
Nptntm1b(EUCOMM)Hmgu/Nptntm1b(EUCOMM)Hmgu
(C57BL/6N-Nptntm1b(EUCOMM)Hmgu/H)
|
decreased prepulse inhibition
|
J:211773
|
Npy2rtm1.1Hhz/Npy2rtm1.1Hhz
(involves: 129X1/SvJ * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:124729
|
Npytm1Rpa/Npytm1Rpa
(involves: 129S7/SvEvBrd)
|
increased susceptibility to pharmacologically induced seizures
|
J:33261
|
| sporadic seizures
|
J:33261
|
Npytm2Rpa/Npytm2Rpa
(involves: 129S4/SvJaeSor * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:104699
|
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased microglial cell activation
|
J:278794
|
Nr1h2tm1.1Gstr/Nr1h2tm1.1Gstr
Nr1h3tm1.1Gstr/Nr1h3tm1.1Gstr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal myelination
|
J:81790
|
| intracranial hemorrhage
|
J:81790
|
Nr2c2tm1Bbm/Nr2c2tm1Bbm
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal neuron physiology
|
J:197895
|
Nr2e1frc/Nr2e1frc
(involves: 129P2/OlaHsd * 129S1/SvImJ)
|
abnormal neuronal precursor proliferation
|
J:183689
|
Nr2f1tm1Mjts/Nr2f1+
(involves: 129S7/SvEvBrd)
|
abnormal long-term depression
|
J:286647
|
| impaired synaptic plasticity
|
J:286647
|
| reduced long-term potentiation
|
J:286647
|
Nr2f6tm1Ge/Nr2f6tm1Ge
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal synaptic norepinephrine release
|
J:96328
|
Nr3c1tm1.1Mvc/Nr3c1+
Tg(Sim1-cre)1Lowl/0
(involves: 129 * C57BL/6 * FVB)
|
abnormal hypothalamus physiology
|
J:179918
|
Nr3c1tm2.1Gsc/Nr3c1+
(B6.129P2-Nr3c1tm2.1Gsc)
|
abnormal blood-brain barrier function
|
J:137157
|
Nr3c1tm2.1Ljm/Nr3c1tm2.1Ljm
Lyz2tm1(cre)Ifo/Lyz2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac)
|
abnormal response to CNS ischemic injury
|
J:197150
|
| decreased susceptibility to neuronal excitotoxicity
|
J:197150
|
Nr3c1tm2.1Ljm/Nr3c1tm2.1Ljm
Tg(Camk2a-cre)T29-1Stl/0
(involves: 129S6/SvEvTac * BALB/c * C57BL)
|
abnormal response to CNS ischemic injury
|
J:197150
|
Nr3c1tm2Gsc/Nr3c1tm2Gsc
Tg(Drd1a-cre)AGsc/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
abnormal nervous system electrophysiology
|
J:150544
|
Nr3c1tm2Gsc/Nr3c1tm2Gsc
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6J * SJL)
|
hypersecretion of corticotropin-releasing hormone
|
J:57315
|
Nr3c1tm2Gsc/Nr3c1tm2Gsc
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal nervous system electrophysiology
|
J:150544
|
Nr3c1tm2Ljm/Nr3c1tm2Ljm
Tg(Camk2a-cre)T50Stl/?
(involves: 129 * BALB/c * C57BL/6 * CBA)
|
absent long-term depression
|
J:96260
|
Nr3c2tm1Krst/Nr3c2tm1Krst
Tg(Camk2a-cre)2Gsc/?
(involves: FVB/N)
|
abnormal miniature excitatory postsynaptic currents
|
J:104691
|
Nr4a2tm1Omc/Nr4a2tm1Omc
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased midbrain apoptosis
|
J:46856
|
Nr4a2tm1Tpe/Nr4a2+
Nr4a3tm1Dgen/Nr4a3tm1Dgen
(involves: 129P2/OlaHsd)
|
increased susceptibility to neuronal excitotoxicity
|
J:162076
|
Nr4a3tm1Omc/Nr4a3tm1Omc
(involves: 129S/SvEv * C57BL/6)
|
increased neuron apoptosis
|
J:93320
|
| increased susceptibility to pharmacologically induced seizures
|
J:93320
|
| tonic-clonic seizures
|
J:93320
|
Nrcam20884/Nrcam20884
(involves: C57BL/6J)
|
decreased nerve conduction velocity
|
J:153042
|
Nrcamm1J/Nrcamm1J
(B6.Cg-Nrcamm1J/GrsrRwb)
|
abnormal myelination
|
J:240096
|
| decreased nerve conduction velocity
|
J:240096
|
Nrcamm1J/Nrcamm1J
Sh3tc2m1J/Sh3tc2m1J
(B6.Cg-Nrcamm1J Sh3tc2m1J/GrsrRwb)
|
abnormal nerve conduction
|
J:240096
|
| decreased nerve conduction velocity
|
J:240096
|
Nrcamtm1Gmt/Nrcamtm1Gmt
(involves: 129S6/SvEvTac * Swiss Webster)
|
decreased prepulse inhibition
|
J:153165
|
Nrcamtm2e.1(KOMP)Wtsi/Nrcamtm2e.1(KOMP)Wtsi
(C57BL/6N-Nrcamtm2e.1(KOMP)Wtsi/J)
|
convulsive seizures
|
J:211773
|
Nrdctm1Eiin/Nrdctm1Eiin
(B6.Cg-Nrdctm1Eiin)
|
abnormal myelination
|
J:155532
|
Nrg1tm1Cbm/Nrg1+
(involves: 129P2/OlaHsd)
|
abnormal myelination
|
J:90038
|
| abnormal nerve conduction
|
J:90038
|
Nrg1tm1Gne/Nrg1+
(B6.129S2-Nrg1tm1Gne)
|
abnormal excitatory postsynaptic currents
|
J:182690
|
| enhanced long-term potentiation
|
J:182690
|
Nrg1tm1Leth/Nrg1+
(involves: 129S1/Sv * C57BL/6)
|
abnormal endplate potential
|
J:39800
|
| abnormal miniature endplate potential
|
J:39800
|
| abnormal PNS synaptic transmission
|
J:39800
|
Nrg1tm1Lwr/Nrg1+
(involves: 129)
|
abnormal myelination
|
J:90038
|
Nrg1tm2Zhou/Nrg1+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal prepulse inhibition
|
J:81106
|
Nrg3tm1.1Plet/Nrg3tm1.1Plet
(involves: C57BL/6)
|
decreased prepulse inhibition
|
J:270199
|
| reduced sensorimotor gating
|
J:270199
|
Nrgntm1Kph/Nrgntm1Kph
(involves: 129/Sv * C57BL/6)
|
abnormal long-term potentiation
|
J:65166
|
| impaired synaptic plasticity
|
J:65166
|
Nrgntm1Sut/Nrgntm1Sut
(involves: 129S4/SvJae * Black Swiss)
|
abnormal excitatory postsynaptic potential
|
J:109224
|
| abnormal long-term depression
|
J:109224
|
| enhanced long-term potentiation
|
J:109224
|
| increased post-tetanic potentiation
|
J:109224
|
Nrn1tm1.2Ndiv/Nrn1tm1.2Ndiv
(C57BL/6-Nrn1tm1.2Ndiv)
|
abnormal miniature excitatory postsynaptic currents
|
J:178970
|
Nrp1tm1b(EUCOMM)Hmgu/Nrp1+
(C57BL/6N-Nrp1tm1b(EUCOMM)Hmgu/Orl)
|
decreased prepulse inhibition
|
J:211773
|
Nrp1tm1Hfu/Nrp1tm1Hfu
(involves: CD-1 * JF1)
|
abnormal neuronal migration
|
J:94050
|
Nrp2tm1.2Mom/Nrp2+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)
|
abnormal nervous system physiology
|
J:166116
|
| abnormal synaptic plasticity
|
J:166116
|
| environmentally induced seizures
|
J:166116
|
| increased susceptibility to pharmacologically induced seizures
|
J:166116
|
| myoclonus
|
J:166116
|
| seizures
|
J:166116
|
Nrp2tm1.2Mom/Nrp2tm1.2Mom
(involves: 129P2/OlaHsd * C57BL/6 * SJL/J)
|
abnormal vomeronasal sensory neuron physiology
|
J:76686
|
Nrp2tm1.2Mom/Nrp2tm1.2Mom
(involves: 129P2/OlaHsd * C57BL/6 * FVB/NJ)
|
environmentally induced seizures
|
J:166116
|
| increased susceptibility to pharmacologically induced seizures
|
J:166116
|
| myoclonus
|
J:166116
|
| seizures
|
J:166116
|
Nrp2tm1Mkl/Nrp2tm1Mkl
(involves: ICR)
|
abnormal neuronal migration
|
J:134616
|
Nrsn1tm1.1(KOMP)Vlcg/Nrsn1tm1.1(KOMP)Vlcg
(C57BL/6N-Nrsn1tm1.1(KOMP)Vlcg/J)
|
decreased prepulse inhibition
|
J:211773
|
Nrtntm1Jmi/Nrtntm1Jmi
(involves: 129X1/SvJ * C57BL/6)
|
abnormal neurotransmitter secretion
|
J:82456
|
Nrxn1tm1Sud/Nrxn1tm1Sud
(involves: 129)
|
abnormal nervous system physiology
|
J:115214
|
| decreased synaptic glutamate release
|
J:115214
|
Nrxn1tm1Sud/Nrxn1tm1Sud
(involves: 129 * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:153748
|
| abnormal miniature excitatory postsynaptic currents
|
J:153748
|
| decreased prepulse inhibition
|
J:153748
|
Nrxn1tm1Sud/Nrxn1tm1Sud
Nrxn2tm1Sud/Nrxn2tm1Sud
(involves: 129 * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:89452
|
| abnormal excitatory postsynaptic currents
|
J:89452
|
Nrxn1tm1Sud/Nrxn1tm1Sud
Nrxn2tm1Sud/Nrxn2tm1Sud
Nrxn3tm1Sud/Nrxn3tm1Sud
(involves: 129 * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:88641,
J:89452
|
| abnormal GABA-mediated receptor currents
|
J:89452
|
| abnormal paired-pulse inhibition
|
J:89452
|
| abnormal synaptic depression
|
J:89452
|
| decreased excitatory postsynaptic current amplitude
|
J:89452
|
| decreased neurotransmitter release
|
J:89452
|
| reduced AMPA-mediated synaptic currents
|
J:89452
|
| reduced NMDA-mediated synaptic currents
|
J:88641
|
Nrxn2tm1Sud/Nrxn2tm1Sud
Nrxn3tm1Sud/Nrxn3tm1Sud
(involves: 129 * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:89452
|
Nrxn2tm3Sud/Nrxn2tm3Sud
(involves: 129 * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:142107
|
Nrxn3tm4.1Sud/Nrxn3tm4.1Sud
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal miniature excitatory postsynaptic currents
|
J:199997
|
| reduced long-term potentiation
|
J:199997
|
Nsdhltm1.1Hrm/Y
Tg(GFAP-cre)25Mes/0
(involves: 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal neuronal stem cell physiology
|
J:220990
|
Nsftm1Himat/Nsf+
(C57BL/6N-Nsftm1Himat)
|
reduced long-term depression
|
J:313900
|
Nsmftm1.2Mrkr/Nsmftm1.2Mrkr
(involves: C57BL/6 * C57BL/6J)
|
abnormal excitatory postsynaptic potential
|
J:232404
|
| impaired synaptic plasticity
|
J:232404
|
| reduced long-term potentiation
|
J:232404
|
Nsun5em1Lgch/Nsun5em1Lgch
(involves: C57BL/6J)
|
abnormal excitatory postsynaptic potential
|
J:271670
|
| reduced long-term potentiation
|
J:271670
|
Ntf3tm1Par/Ntf3tm2Jae
Tg(Tagln-cre)1Her/0
(involves: 129S1/Sv * C57BL/6 * SJL)
|
abnormal nervous system physiology
|
J:201812
|
Ntf5tm1Jae/Ntf5tm1Jae
(involves: 129S4/SvJae)
|
decreased neuron apoptosis
|
J:123022
|
Ntrk1em1Krvl/Ntrk1em1Krvl
(C57BL/6J-Ntrk1em1Krvl)
|
increased neuron apoptosis
|
J:338830
|
Ntrk1tm1.1Jcar/Ntrk1tm1.1Jcar
(involves: 129S1/Sv * C57BL/6)
|
abnormal sensory neuron physiology
|
J:219326
|
Ntrk1tm1Bbd/Ntrk1tm1Bbd
(involves: 129S2/SvPas)
|
abnormal sympathetic nervous system physiology
|
J:17194
|
Ntrk1tm2.1Tes/Ntrk1tm2.1Tes
(B6.129S1(Cg)-Ntrk1tm2.1Tes)
|
abnormal neuron physiology
|
J:209600
|
Ntrk2tm1.1Lfr/Ntrk2+
(involves: 129X1/SvJ)
|
abnormal peripheral nervous system regeneration
|
J:116954
|
Ntrk2tm1b(EUCOMM)Wtsi/Ntrk2+
(C57BL/6N-Ntrk2tm1b(EUCOMM)Wtsi/H)
|
decreased prepulse inhibition
|
J:211773
|
Ntrk2tm1Bbd/Ntrk2tm2Kln
Tg(Camk2a-cre)159Kln/0
(involves: 129S2/SvPas * CBA/J)
|
abnormal myelination
|
J:58229
|
| reduced long-term potentiation
|
J:58229
|
Ntrk2tm1Bxu/Ntrk2tm1Bxu
(involves: 129 * C57BL/6)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:170724
|
Ntrk2tm1Jom/Ntrk2+
Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR)
|
decreased kindling response
|
J:91467
|
Ntrk2tm1Jom/Ntrk2tm1Jom
Tg(Syn1-cre)671Jxm/0
(involves: 129/Sv * C57BL/6 * ICR)
|
decreased kindling response
|
J:91467
|
Ntrk2tm1Mini/Ntrk2tm1Mini
(involves: 129P2/OlaHsd)
|
abnormal excitatory postsynaptic potential
|
J:130626
|
| abnormal long-term potentiation
|
J:130626
|
| impaired synaptic plasticity
|
J:130626
|
Ntrk2tm2.1Mini/Ntrk2tm2.1Mini
(involves: 129P2/OlaHsd)
|
abnormal neuronal migration
|
J:132562
|
Ntrk2tm2.1Tes/Ntrk2tm2.1Tes
(involves: 129S4/SvJae * C57BL/6J)
|
reduced long-term potentiation
|
J:193542
|
Ntrk2tm2Kln/Ntrk2tm2Kln
Slc1a3tm1(cre/ERT2)Mgoe/?
Gt(ROSA)26Sortm1Sor/?
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * SJL)
|
reduced long-term potentiation
|
J:143452
|
Ntrk2tm2Kln/Ntrk2tm2Kln
Tg(Camk2a-cre)159Kln/?
(involves: 129S2/SvPas * CBA/J)
|
abnormal long-term potentiation
|
J:130626
|
| impaired synaptic plasticity
|
J:130626
|
Ntrk2tm2Kln/Ntrk2tm2Kln
Tg(Cck-cre,-lacZ)1Mini/0
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
abnormal GABAergic neuron physiology
|
J:210229
|
Ntrk2tm2Kln/Ntrk2tm2Kln
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
abnormal neuronal migration
|
J:132562
|
| demyelination
|
J:132562
|
Ntsr1tm1Pang/Ntsr1tm1Pang
(C57BL/6-Ntsr1tm1Pang)
|
abnormal prepulse inhibition
|
J:155775
|
Ntsr2tm1Dafe/Ntsr2tm1Dafe
(B6.129P2-Ntsr2tm1Dafe)
|
increased prepulse inhibition
|
J:160157
|
Nudctm1c(KOMP)Mbp/Nudctm1c(KOMP)Mbp
Tg(Rho-icre)1Ck/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
increased microglial cell activation
|
J:346299
|
Nudt1tm1Tts/Nudt1tm1Tts
Ogg1tm1Yun/Ogg1tm1Yun
(involves: 129S/SvEv * C57BL/6JJcl)
|
increased susceptibility to neuronal excitotoxicity
|
J:193978
|
Nufip2em1(IMPC)J/Nufip2+
(C57BL/6NJ-Nufip2em1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Numbtm1Ynj/Numbtm1Ynj
Numbltm1Wmz/Numbltm1Wmz
Tg(Nes-cre/Esr1*)4Ynj/0
(involves: 129X1/SvJ * C57BL/6)
|
increased neuron apoptosis
|
J:127227
|
Nup155Gt(RRD107)Byg/Nup155+
(involves: 129P2/OlaHsd)
|
abnormal action potential
|
J:147210
|
nur8/nur8
(Not Specified)
|
seizures
|
J:85113
|
nur33/nur33
(Not Specified)
|
myoclonus
|
J:89098
|
Nur37/Nur37+
(Not Specified)
|
seizures
|
J:89098
|
Odad3tm1b(EUCOMM)Hmgu/Odad3tm1b(EUCOMM)Hmgu
(C57BL/6N-Odad3tm1b(EUCOMM)Hmgu/Cnrm)
|
intracranial hemorrhage
|
J:278798
|
Ogfod3tm1b(KOMP)Wtsi/Ogfod3tm1b(KOMP)Wtsi
(C57BL/6N-Ogfod3tm1b(KOMP)Wtsi/Wtsi)
|
decreased prepulse inhibition
|
J:211773
|
Ogg1tm1Yun/Ogg1tm1Yun
(involves: 129S/SvEv * C57BL/6JJcl)
|
increased susceptibility to neuronal excitotoxicity
|
J:193978
|
Olfm1tm1.1Lex/Olfm1tm1.1Lex
(involves: 129S/SvEvBrd * 129S4/SvJae)
|
decreased cerebral infarct size
|
J:118333
|
Olig2tm1(cre)Tmj/Olig2+
Smn1tm1Jme/Smn1tm1Msd
Grm7Tg(SMN2)89Ahmb/Grm7Tg(SMN2)89Ahmb
(involves: 129 * 129P2/OlaHsd * FVB/N)
|
abnormal CNS synaptic transmission
|
J:164292
|
| abnormal miniature endplate potential
|
J:164292
|
| abnormal PNS synaptic transmission
|
J:164292
|
| abnormal synaptic transmission
|
J:164292
|
Olig2tm1(cre/Esr1*)Htak/Olig2tm1(cre/Esr1*)Htak
(involves: BALB/c * C57BL/6 * C57BL/6NCrj * CBA)
|
abnormal neuronal migration
|
J:77821
|
Olig2tm1Qrlu/Olig2tm1Qrlu
Foxg1tm1(cre)Skm/Foxg1+
(involves: 129P2/OlaHsd * 129S4/SvJae * C57BL/6)
|
abnormal myelination
|
J:105071
|
Olig3tm1Tre/Olig3tm1Tre
(involves: 129P2/OlaHsd)
|
abnormal neuronal migration
|
J:96749
|
Omptm1(tTA)Gogo/Omp+
Tg(tetO-APPSwInd)Dbo/0
(involves: 129 * C3H/HeJ * C57BL/6J)
|
abnormal olfactory sensory neuron physiology
|
J:176127
|
Omptm4(cre)Mom/Omp+
Ric8btm1c(EUCOMM)Hmgu/Ric8btm1c(EUCOMM)Hmgu
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6N * SJL)
|
abnormal olfactory sensory neuron physiology
|
J:247954
|
| increased neuron apoptosis
|
J:247954
|
Opa1em1(IMPC)Bay/Opa1+
(C57BL/6N-Opa1em1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Opa1tm1.1Geno/Opa1+
(involves: 129S2/SvPas)
|
demyelination
|
J:237963
|
Ophn1tm1Bill/Y
(involves: 129S2/SvPas)
|
abnormal excitatory postsynaptic potential
|
J:124943
|
Oprd1tm1Dgen/Oprd1tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Oprk1tm1Jep/Oprk1tm1Jep
(involves: 129S/SvEv * C57BL/6)
|
abnormal synaptic dopamine release
|
J:226396
|
Oprk1tm2.1Kff/Oprk1tm2.1Kff
Slc6a3tm1(cre)Xz/0
(involves: 129 * 129S1/Sv * C57BL/6)
|
abnormal synaptic dopamine release
|
J:226396
|
Oprl1tm1Hta/Oprl1tm1Hta
(involves: 129S4/SvJae * C57BL/6J)
|
enhanced long-term potentiation
|
J:49161
|
Oprm1tm1Jep/Oprm1tm1Jep
(B6.129S-Oprm1tm1Jep)
|
impaired ability to fire action potentials
|
J:101066
|
Oprm1tm1Loh/Oprm1tm1Loh
(involves: 129P2/OlaHsd * BALB/c * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:61244
|
| reduced long-term potentiation
|
J:61244
|
Oprm1tm1Loh/Oprm1tm1Loh
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6J)
|
abnormal nervous system physiology
|
J:106367
|
Optnem1Hyua/Optnem1Hyua
(C57BL/6J-Optnem1Hyua)
|
abnormal axonal transport
|
J:324291
|
Or2b4tm2Mom/Or2b4+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal olfactory sensory neuron physiology
|
J:214042
|
Or2b4tm2Mom/Or2b4tm2Mom
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal olfactory sensory neuron physiology
|
J:214042
|
Or51e2tm3.1Mom/Or51e2tm3.1Mom
Thtm1(cre)Te/?
(involves: 129X1/SvJ * C57BL/6)
|
abnormal type I cell of carotid body physiology
|
J:350385
|
Orai1Gt(XL922)Byg/Orai1Gt(XL922)Byg
(involves: 129P2/OlaHsd)
|
abnormal neuron physiology
|
J:159604
|
Orc3tm1.1Zhua/Orc3tm1.1Zhua
Emx1tm1(cre)Krj/Emx1+
(involves: 129S2/SvPas)
|
decreased neuronal precursor proliferation
|
J:170581
|
Osbpl8em1(IMPC)Tcp/Osbpl8em1(IMPC)Tcp
(C57BL/6NCrl-Osbpl8em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Oser1em1(IMPC)Bay/Oser1+
(C57BL/6N-Oser1em1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Otcspf/Y
(involves: C3H/HeJ * C57BL/6J)
|
tonic-clonic seizures
|
J:31237
|
Otoatm1.1(KOMP)Vlcg/Otoatm1.1(KOMP)Vlcg
(C57BL/6N-Otoatm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Otoatm1Gpr/Otoatm1Gpr
(involves: 129S/SvEv)
|
abnormal cochlear nerve compound action potential
|
J:192263
|
Otofdeaf5Jcs/Otofdeaf5Jcs
(STOCK Otofdeaf5Jcs/Kjn)
|
abnormal paired-pulse facilitation
|
J:269136
|
| abnormal synaptic transmission
|
J:269136
|
Otoftm1.1Erei/Otoftm1.1Erei
(involves: 129P2/OlaHsd)
|
abnormal cochlear inner hair cell physiology
|
J:171203
|
| abnormal miniature excitatory postsynaptic currents
|
J:171203
|
Otoftm1Ugds/Otoftm1Ugds
(involves: 129S2/SvPas * C57BL/6)
|
abnormal cochlear inner hair cell physiology
|
J:116097
|
Otostm1Cham/Otostm1Cham
(involves: 129P2/OlaHsd * C57BL/6N)
|
decreased cochlear microphonics
|
J:96000
|
| decreased cochlear nerve compound action potential
|
J:96000
|
Otptm1Tlu/Otptm1Tlu
(either: 129/Sv-Otptm1Tlu or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal hypothalamus physiology
|
J:65759
|
Otud7aem1Cpsc/Otud7aem1Cpsc
(C57BL/6J-Otud7aem1Cpsc)
|
abnormal miniature excitatory postsynaptic currents
|
J:259730
|
| abnormal spike wave discharge
|
J:259730
|
| decreased prepulse inhibition
|
J:259730
|
Otx1tm1Asim/Otx1tm1Asim
(involves: 129P2/OlaHsd * C57BL/6 * DBA/2)
|
abnormal pituitary secretion
|
J:47322
|
| convulsive seizures
|
J:35640
|
| nonconvulsive seizures
|
J:35640
|
Otx1tm1Asim/Otx1tm1Asim
(involves: 129P2/OlaHsd)
|
seizures
|
J:52989
|
Otx1tm4(cre)Asim/Otx1+
Otx2tm6Asim/Otx2tm6.1Asim
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal neuronal precursor proliferation
|
J:83110
|
Otx2tm6Asim/Otx2tm11Asim
Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:166896
|
Ovol2tm1Xdai/Ovol2tm1Xdai
(either: (involves: 129P2/OlaHsd * C57BL/6J) or (involves: 129P2/OlaHsd * CD-1))
|
decreased embryonic neuroepithelial cell proliferation
|
J:106405
|
Oxct1tm1a(KOMP)Wtsi/Oxct1tm1a(KOMP)Wtsi
(C57BL/6-Oxct1tm1a(KOMP)Wtsi)
|
abnormal nervous system physiology
|
J:170537
|
Oxr1tm1a(EUCOMM)Wtsi/Oxr1tm1a(EUCOMM)Wtsi
(C57BL/6N-Oxr1tm1a(EUCOMM)Wtsi)
|
increased neuron apoptosis
|
J:230923
|
Oxttm1Wsy/Oxttm1Wsy
(involves: 129S/SvEv * C57BL/6)
|
abnormal baroreceptor physiology
|
J:83910
|
P2rx3tm1Jwo/P2rx3tm1Jwo
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * MF1))
|
abnormal single cell response
|
J:65558
|
P2rx4tm1Rass/P2rx4tm1Rass
(B6.Cg-P2rx4tm1Rass)
|
reduced long-term potentiation
|
J:112177
|
P2rx6tm1Dgen/P2rx6tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased susceptibility to pharmacologically induced seizures
|
J:82809
|
Pacc1em1.1Zzq/Pacc1em1.1Zzq
(involves: C57BL/6 * FVB/N)
|
abnormal neuron physiology
|
J:273611
|
| decreased cerebral infarct size
|
J:273611
|
| decreased susceptibility to ischemic brain injury
|
J:273611
|
Pacsin1tm1.1Bqu/Pacsin1tm1.1Bqu
(Not Specified)
|
abnormal inhibitory postsynaptic currents
|
J:180017
|
| abnormal miniature excitatory postsynaptic currents
|
J:180017
|
| abnormal nervous system electrophysiology
|
J:180017
|
| abnormal synaptic vesicle recycling
|
J:180017
|
| decreased excitatory postsynaptic current amplitude
|
J:180017
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:180017
|
| decreased synaptic depression
|
J:180017
|
| tonic-clonic seizures
|
J:180017
|
Pacsin2tm1.1Cgn/Pacsin2tm1.1Cgn
(involves: BALB/cJ * C57BL/6)
|
abnormal action potential
|
J:276621
|
Pafah1b1tm1Awb/Pafah1b1+
(involves: 129S6/SvEvTac)
|
abnormal neuronal migration
|
J:100552
|
| increased neuron apoptosis
|
J:100552
|
Pafah1b1tm1Awb/Pafah1b1+
Ndel1tm1.1Shr/Ndel1+
(involves: 129S6/SvEvTac)
|
abnormal neuronal migration
|
J:100552
|
| increased neuron apoptosis
|
J:100552
|
Pafah1b1tm1Awb/Pafah1b1+
Ywhaetm1Awb/Ywhae+
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
abnormal neuronal migration
|
J:84075
|
Pagr1atm1Kaig/Pagr1atm1Kaig
(involves: 129S6/SvEvTac * C57BL/6)
|
increased embryonic neuroepithelium apoptosis
|
J:210984
|
Pahem1Skym/Pahem1Skym
(C57BL/6J-Pahem1Skym)
|
abnormal synaptic neurotransmitter level
|
J:305392
|
| dysmyelination
|
J:305392
|
Pahm1Btlr/Pahm1Btlr
(C57BL/6J-Pahm1Btlr)
|
audiogenic seizures
|
J:152890
|
| environmentally induced seizures
|
J:152890
|
Pak1tm1b(EUCOMM)Hmgu/Pak1tm1b(EUCOMM)Hmgu
(C57BL/6N-Pak1tm1b(EUCOMM)Hmgu/H)
|
decreased prepulse inhibition
|
J:211773
|
Pak1tm1Zpj/Pak1tm1Zpj
(involves: 129S1/Sv * 129X1/SvJ)
|
reduced long-term potentiation
|
J:225714
|
Pak2Gt(OST104058)Lex/Pak2+
(B6;129S5-Pak2Gt(OST104058)Lex/J)
|
abnormal excitatory postsynaptic potential
|
J:271067
|
| abnormal neuronal migration
|
J:271067
|
| reduced long-term potentiation
|
J:271067
|
Pak3tm1.1Rpo/Y
(B6.129S2(Cg)-Pak3tm1.1Rpo)
|
abnormal neuron physiology
|
J:292116
|
Pak3tm1Zpj/Pak3tm1Zpj
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6) or (involves: 129S1/Sv * 129X1/SvJ * CD-1))
|
reduced long-term potentiation
|
J:99811
|
Pak4tm1Amin/Pak4tm1Amin
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129S2/SvPas * C57BL/6))
|
abnormal neuronal migration
|
J:85954
|
Pald1em1(IMPC)Kmpc/Pald1em1(IMPC)Kmpc
(C57BL/6NTac-Pald1em1(IMPC)Kmpc/Kmpc)
|
increased prepulse inhibition
|
J:211773
|
Palm3tm1b(EUCOMM)Wtsi/Palm3tm1b(EUCOMM)Wtsi
(C57BL/6N-Palm3tm1b(EUCOMM)Wtsi/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Pals1tm1Caw/Pals1+
Emx1tm1(cre)Krj/Emx1+
(involves: 129S2/SvPas)
|
abnormal neuronal precursor proliferation
|
J:160624
|
Pals1tm1Caw/Pals1tm1Caw
Emx1tm1(cre)Krj/Emx1+
(involves: 129S2/SvPas)
|
abnormal neuronal precursor proliferation
|
J:160624
|
| increased neuron apoptosis
|
J:160624
|
Panx1tm1.1Fama/Panx1+
Panx2tm1.1Mony/Panx2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal channel response
|
J:180516
|
Panx1tm1.1Fama/Panx1tm1.1Fama
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neuron physiology
|
J:177671
|
| decreased susceptibility to pharmacologically induced seizures
|
J:177671
|
Panx1tm1.1Fama/Panx1tm1.1Fama
Panx2tm1.1Mony/Panx2tm1.1Mony
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal channel response
|
J:180516
|
| decreased cerebral infarct size
|
J:180516
|
| decreased susceptibility to ischemic brain injury
|
J:180516
|
Panx1tm1.1Vshe/Panx1tm1.1Vshe
(B6.129-Panx1tm1.1Vshe)
|
decreased neuron apoptosis
|
J:196355
|
Panx1tm1a(KOMP)Wtsi/Panx1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
abnormal neuron physiology
|
J:177671
|
| decreased susceptibility to pharmacologically induced seizures
|
J:177671
|
Panx1tm1Vshe/Panx1tm1Vshe
Tg(Thy1-cre)1Vln/0
(B6.Cg-Panx1tm1Vshe Tg(Thy1-cre)1Vln)
|
decreased neuron apoptosis
|
J:196355
|
Panx2tm1.1Mony/Panx2tm1.1Mony
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased susceptibility to ischemic brain injury
|
J:180516
|
Panx2tm1b(KOMP)Wtsi/Panx2tm1b(KOMP)Wtsi
(C57BL/6N-Panx2tm1b(KOMP)Wtsi/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Park7Gt(XE726)Byg/Park7Gt(XE726)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:134826
|
Park7tm1Shn/Park7tm1Shn
(involves: 129 * C57BL/6)
|
abnormal action potential
|
J:98436
|
| abnormal neurotransmitter uptake
|
J:98436
|
| absent long-term depression
|
J:98436
|
Parltm1.1Bdes/Parltm1.1Bdes
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal nerve conduction
|
J:116017
|
| abnormal nervous system physiology
|
J:116017
|
| increased neuron apoptosis
|
J:116017
|
Parltm1.1Bdes/Parltm1.1Bdes
(involves: 129P2/OlaHsd)
|
brainstem hemorrhage
|
J:269785
|
| encephalopathy
|
J:269785
|
| spinal hemorrhage
|
J:269785
|
Parp1tm1b(EUCOMM)Hmgu/Parp1tm1b(EUCOMM)Hmgu
(C57BL/6N-Parp1tm1b(EUCOMM)Hmgu/Ics)
|
increased prepulse inhibition
|
J:211773
|
Parp1tm1Zqw/Parp1tm1Zqw
(involves: 129S2/SvPas * C57BL/6)
|
decreased neuron apoptosis
|
J:65747
|
| decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:23942
|
Parp1tm1Zqw/Parp1tm1Zqw
(129S-Parp1tm1Zqw/J)
|
abnormal microglial cell physiology
|
J:96548
|
| decreased neuron apoptosis
|
J:96548
|
Pasktm1Weng/Pasktm1Weng
(B6.129S6-Pasktm1Weng)
|
abnormal nervous system physiology
|
J:139216
|
Patl1tm1b(EUCOMM)Wtsi/Patl1+
(C57BL/6N-Patl1tm1b(EUCOMM)Wtsi/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Pax3Sp/Pax3Sp
(involves: 129S2/SvPas * C57BL * C57BL/6J * FVB)
|
increased embryonic neuroepithelium apoptosis
|
J:75569
|
Pax6Sey/Pax6Sey
(Not Specified)
|
abnormal synaptic transmission
|
J:87771
|
Pax6tm1Pgr/Pax6tm1Pgr
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal CNS synaptic transmission
|
J:106437
|
| abnormal neuron physiology
|
J:106437
|
Pax6tm2(Pax6_i5a,Pax2)Xzh/Pax6tm2(Pax6_i5a,Pax2)Xzh
(involves: 129S6/SvEvTac)
|
abnormal neuronal precursor proliferation
|
J:198381
|
Pax6tm2.1(Pax6_i5a,Pax2)Xzh/Pax6tm2.1(Pax6_i5a,Pax2)Xzh
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal neuronal precursor proliferation
|
J:198381
|
Pax8tm1Pgr/Pax8tm1Pgr
(either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal action potential
|
J:119449,
J:119450
|
| abnormal cochlear inner hair cell physiology
|
J:119449,
J:119450
|
Paxxem1Spj/Paxxem1Spj
Nhej1tm1Fwa/Nhej1tm1Fwa
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
increased neural tube apoptosis
|
J:236776
|
Pbrm1tm1b(EUCOMM)Wtsi/Pbrm1+
(C57BL/6N-Pbrm1tm1b(EUCOMM)Wtsi/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Pbx3tm1Mlc/Pbx3tm1Mlc
(involves: C57BL/6)
|
abnormal somatic nervous system physiology
|
J:93761
|
Pcaretm1Kpal/Pcaretm1Kpal
(involves: C57BL/6J * C57BL/6NTac)
|
increased microglial cell activation
|
J:220866
|
Pcdh9tm1Mjhk/Pcdh9tm1Mjhk
(B6.Cg-Pcdh9tm1Mjhk)
|
decreased prepulse inhibition
|
J:237757
|
Pcdh15em1Zma/Pcdh15em1Zma
(involves: C57BL/6J)
|
abnormal hair cell mechanoelectric transduction
|
J:342718
|
Pcdh15tm1.1Ugds/Pcdh15tm1.1Ugds
Myo15atm1.1(cre)Ugds/Myo15a+
(involves: 129S1/SvImJ * C57BL/6J)
|
abnormal cochlear nerve compound action potential
|
J:209275
|
| abnormal hair cell mechanoelectric transduction
|
J:209275
|
Pcdh17tm1.1Sia/Pcdh17tm1.1Sia
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal paired-pulse inhibition
|
J:201552
|
| decreased synaptic depression
|
J:201552
|
Pcdh19tm1Tac/Y
(involves: 129S/SvEv * C57BL/6)
|
abnormal neuronal migration
|
J:256961
|
Pcdh19tm1Tac/Pcdh19+
(involves: 129S/SvEv * C57BL/6)
|
abnormal brain wave pattern
|
J:255320
|
Pcdh19tm1Tac/Pcdh19tm1Tac
(involves: 129S/SvEv * C57BL/6)
|
abnormal neuronal migration
|
J:256961
|
Pcdhgem5Rwb/Pcdhgem5Rwb
(C57BL/6J-Pcdhgem5Rwb/Rwb)
|
increased spinal cord apoptosis
|
J:285314
|
Pcdhgem41Rwb/Pcdhgem41Rwb
(C57BL/6J-Pcdhgem41Rwb/Rwb)
|
increased spinal cord apoptosis
|
J:285314
|
Pcdhgtm1.1Tman/Pcdhgtm1.1Tman
(involves: 129S4/SvJae * C57BL/6)
|
increased neuron apoptosis
|
J:188341
|
Pcgf2tm1Hko/Pcgf2tm1Hko
Bmi1tm1Brn/Bmi1tm1Brn
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased neural tube apoptosis
|
J:68216
|
Pcgf3em1(IMPC)Bay/Pcgf3+
(C57BL/6N-Pcgf3em1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Pclotm1.1Mver/Pclotm1.1Mver
(involves: C57BL/6 * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:225358
|
| increased excitatory postsynaptic current amplitude
|
J:225358
|
| increased neurotransmitter release
|
J:225358
|
| increased synaptic depression
|
J:225358
|
Pclotm3.2Sud/Pclotm3.2Sud
(involves: 129S1/Sv * 129X1/SvJ)
|
increased synaptic depression
|
J:159311
|
Pcm1em1(IMPC)Tcp/Pcm1em1(IMPC)Tcp
(C57BL/6NCrl-Pcm1em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Pcmt1tm1Scl/Pcmt1tm1Scl
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:40967
|
| tonic-clonic seizures
|
J:40967
|
Pcmt1tm1Shs/Pcmt1tm1Shs
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal brain wave pattern
|
J:46228
|
| abnormal nervous system electrophysiology
|
J:46228
|
| clonic seizures
|
J:46228
|
| convulsive seizures
|
J:46228
|
| myoclonus
|
J:46228
|
| tonic-clonic seizures
|
J:46228
|
PcntGt(RRU388)Byg/PcntGt(RRU388)Byg
(B6.129P2-PcntGt(RRU388)Byg)
|
intracranial hemorrhage
|
J:226309
|
Pcntm239Asp/Pcnt+
Tg(Rr291-lacZ)#Mekk/0
(involves: C57BL/6J * FVB/N)
|
sporadic seizures
|
J:136795
|
Pcntm275Asp/Pcnt+
Tg(Rr291-lacZ)#Mekk/0
(involves: C57BL/6J * FVB/N)
|
sporadic seizures
|
J:136795
|
Pcp4tm1.1Jim/Pcp4tm1.1Jim
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal synaptic plasticity
|
J:174091
|
Pcsk1em2Irli/Pcsk1em2Irli
(C57BL/6J-Pcsk1em2Irli)
|
abnormal pituitary gland physiology
|
J:324309
|
Pdctm1Luhe/Pdctm1Luhe
(B6.129P2-Pdctm1Luhe)
|
abnormal action potential
|
J:155373
|
Pdcd6iptm1.2Adz/Pdcd6iptm1.2Adz
(either: (involves: 129S1/Sv) or (involves: 129S1/Sv * C57BL/6))
|
abnormal brain ependyma motile cilium physiology
|
J:238436
|
| abnormal cerebrospinal fluid flow
|
J:238436
|
Pdcd10tm1Kwhi/Pdcd10tm1.1Kwhi
Tg(Pdgfb-icre/ERT2,-EGFP)1Frut/?
(involves: C57BL/6 * CBA)
|
CNS inflammation
|
J:173947
|
Pde4benu1H/Pde4benu1H
(B6.C(C3H)-Pde4benu1H)
|
abnormal CNS synaptic transmission
|
J:223217
|
| decreased synaptic depression
|
J:223217
|
| enhanced long-term potentiation
|
J:223217
|
| increased post-tetanic potentiation
|
J:223217
|
Pde8atm1Dgen/Pde8atm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:82809
|
Pde10atm1Dgen/Pde10atm1Dgen
(involves: C57BL/6J)
|
abnormal action potential
|
J:216851
|
Pdgfbtm1Cbet/Pdgfbtm2Cbet
Tg(Tie1-cre)9Ref/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA)
|
intracerebral hemorrhage
|
J:89186
|
Pdgfbtm3.1Cbet/Pdgfbtm3.1Cbet
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired blood-brain barrier function
|
J:166532
|
Pdgfratm5Sor/Pdgfratm5Sor
(either: 129S4/SvJaeSor-Pdgfratm5Sor or (involves: 129S4/SvJaeSor * C57BL/6J))
|
abnormal myelination
|
J:73817
|
Pdgfratm6Sor/Pdgfratm6Sor
(either: 129S4/SvJaeSor-Pdgfratm6Sor or (involves: 129S4/SvJaeSor * C57BL/6J))
|
abnormal myelination
|
J:73817
|
| seizures
|
J:73817
|
Pdgfrbredeye/Pdgfrbredeye
(C3N.C-Pdgfrbredeye)
|
abnormal blood-retina barrier function
|
J:199483
|
Pdgfrbtm1Msas/Pdgfrbtm1Msas
Tg(Nes-cre)1Nogu/?
(involves: 129 * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:110616
|
Pdgfrbtm1Msas/Pdgfrbtm1Msas
Tg(Nes-cre)1Nogu/0
(B6J.Cg-Pdgfrbtm1Msas Tg(Nes-cre)1Nogu)
|
abnormal nervous system electrophysiology
|
J:229179
|
| decreased prepulse inhibition
|
J:229179
|
| reduced sensorimotor gating
|
J:229179
|
Pdgfrbtm10Sor/Pdgfrbtm10Sor
(involves: 129S4/SvJae * C57BL/6)
|
intracranial hemorrhage
|
J:86542
|
Pdlim5Gt(XH199)Byg/Pdlim5+
(B6.129P2-Pdlim5Gt(XH199)Byg)
|
abnormal prepulse inhibition
|
J:200039
|
Pdpk1tm1Maka/Pdpk1tm1Maka
Tg(CAG-cat,-lacZ)11Miya/0
Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * FVB/N)
|
abnormal neuron physiology
|
J:162892
|
| increased corticotroph apoptosis
|
J:162892
|
| increased melanotroph apoptosis
|
J:162892
|
| increased pituitary gland apoptosis
|
J:162892
|
Pdss2tm1.1Jdhu/Pdss2tm1.2Jdhu
Tg(Pax2-cre)1Akg/0
(involves: 129 * C57BL/6N * FVB/N)
|
abnormal Purkinje cell migration
|
J:179845
|
| increased neuron apoptosis
|
J:179845
|
Pdyntm1(cre)Czer/Pdyn+
(B6.Cg-Pdyntm1(cre)Czer)
|
increased susceptibility to pharmacologically induced seizures
|
J:122651
|
Pdyntm1(cre)Czer/Pdyntm1(cre)Czer
(B6.Cg-Pdyntm1(cre)Czer)
|
increased susceptibility to pharmacologically induced seizures
|
J:122651
|
Pdzd7tm1a(EUCOMM)Wtsi/Pdzd7tm1a(EUCOMM)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal cochlear outer hair cell physiology
|
J:209073
|
| abnormal hair cell mechanoelectric transduction
|
J:209073
|
| decreased cochlear microphonics
|
J:209073
|
Pdzd8tm1b(EUCOMM)Wtsi/Pdzd8tm1b(EUCOMM)Wtsi
(C57BL/6N-Pdzd8tm1b(EUCOMM)Wtsi)
|
decreased paired-pulse facilitation
|
J:317428
|
| reduced long-term potentiation
|
J:317428
|
Pebp1tm1.1Norm/Pebp1tm1.1Norm
Tg(Camk2a-cre/ERT2)1Aibs/0
(involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl)
|
decreased summary potential intensity
|
J:292694
|
Pelotm1Slac/Pelotm1Slac
En1tm2(cre)Wrst/En1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased neuron apoptosis
|
J:306384
|
| increased neuronal precursor proliferation
|
J:306384
|
Pelotm1Slac/Pelotm1Slac
Tg(Atoh1-cre)1Bfri/0
(involves: C57BL/6J * CBA)
|
increased neuronal precursor proliferation
|
J:306384
|
Per1tm1Drw/Per1tm1Drw
(involves: 129S4/SvJae)
|
abnormal brain wave pattern
|
J:95746
|
Per1tm1Drw/Per1tm1Drw
Per2tm1Drw/Per2tm1Drw
(involves: 129S4/SvJae)
|
abnormal brain wave pattern
|
J:95746
|
Per2M1Btlr/Per2M1Btlr
(C57BL/6J-Per2M1Btlr)
|
abnormal brain wave pattern
|
J:101977
|
Per2tm1Jt/Per2+
Zfhx3Sci/Zfhx3+
(involves: 129S6/SvEvTac * BALB/cOlaHsd * C3H/HeH * C57BL/6J)
|
abnormal hypothalamus physiology
|
J:223990
|
Per3tm1Drw/Per3tm1Drw
(involves: 129S4/SvJae)
|
abnormal brain wave pattern
|
J:95746
|
Perptm1Att/Perptm1Att
(involves: 129S4/SvJae)
|
decreased neuron apoptosis
|
J:86549
|
Pex5tm1Pec/Pex5tm1Pec
Cnptm1(cre)Kan/Cnp+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal myelination
|
J:123503
|
Pex5ltm1.1Chet/Pex5ltm1.1Chet
(involves: BALB/cJ * C57BL/6 * C57BL/6J * C57BL/6NTac)
|
abnormal neuron physiology
|
J:173355
|
Pex7tm1Nbra/Pex7tm1Nbra
(involves: 129S/SvEv * C57BL/6)
|
demyelination
|
J:158845
|
Pex7tm1Rjaw/Pex7tm1Rjaw
(Swiss)
|
abnormal neuronal migration
|
J:92346
|
Pex10m1Nisw/Pex10m1Nisw
(129S1.B6-Pex10m1Nisw)
|
abnormal endplate potential
|
J:216140
|
Pex11btm1Sjg/Pex11b+
(B6.129-Pex11btm1Sjg)
|
increased neuron apoptosis
|
J:180632
|
Pex11btm1Sjg/Pex11btm1Sjg
(B6.129-Pex11btm1Sjg)
|
increased neuron apoptosis
|
J:180632
|
Pex13tm1Crne/Pex13tm1.1Crne
Tg(Nes-cre)1Kln/0
(involves: 129T2/SvEms * C57BL/6 * C57BL/6J * SJL)
|
abnormal cerebellar granule cell migration
|
J:167578
|
Pfdn5nmf5a/Pfdn5nmf5a
(C57BL/6-Pfdn5nmf5a)
|
abnormal nervous system physiology
|
J:167349
|
Pfn2tm1Wit/Pfn2tm1Wit
(Not Specified)
|
abnormal excitatory postsynaptic currents
|
J:122603
|
| abnormal miniature excitatory postsynaptic currents
|
J:122603
|
| decreased paired-pulse facilitation
|
J:122603
|
Pgcem1(IMPC)Ccpcz/Pgcem1(IMPC)Ccpcz
(C57BL/6NCrl-Pgcem1(IMPC)Ccpcz/Ccpcz)
|
decreased prepulse inhibition
|
J:211773
|
Pgpep1em1(IMPC)J/Pgpep1em1(IMPC)J
(C57BL/6NJ-Pgpep1em1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Phf6em1Azbi/Y
(B6.Cg-Phf6em1Azbi)
|
abnormal action potential
|
J:271089
|
| abnormal neuron physiology
|
J:271089
|
| decreased single cell response threshold
|
J:271089
|
| increased single cell response intensity
|
J:271089
|
| increased susceptibility to pharmacologically induced seizures
|
J:271089
|
Phf8tm1.1Cdcn/Y
(B6.129S6(Cg)-Phf8tm1.1Cdcn)
|
abnormal synaptic transmission
|
J:258245
|
| reduced long-term potentiation
|
J:258245
|
Phf21bem1Mlwg/Phf21bem1Mlwg
(C57BL/6J-Phf21bem1Mlwg)
|
reduced long-term potentiation
|
J:328040
|
Phl1101/H/?
Phl2101/H/?
(involves: 101/H * MAI/Pas * MBT/Pas)
|
decreased cochlear nerve compound action potential
|
J:111682
|
Phl1101/H/Phl1101/H
(involves: 101/H * MAI/Pas)
|
increased cochlear nerve compound action potential
|
J:111682
|
Phl1101/H/Phl1101/H
(involves: 101/H * MBT/Pas)
|
increased cochlear nerve compound action potential
|
J:111682
|
Phl1101/H/Phl1101/H
Phl2101/H/?
(involves: 101/H * MAI/Pas * MBT/Pas)
|
decreased cochlear nerve compound action potential
|
J:111682
|
Phl1101/H/Phl1MAI/Pas
(involves: 101/H * MAI/Pas)
|
increased cochlear nerve compound action potential
|
J:111682
|
Phl1101/H/Phl1MBT/Pas
(involves: 101/H * MBT/Pas)
|
increased cochlear nerve compound action potential
|
J:111682
|
Phl2101/H/Phl2101/H
(involves: 101/H * MAI/Pas)
|
increased cochlear nerve compound action potential
|
J:111682
|
Phl2101/H/Phl2101/H
(involves: 101/H * MBT/Pas)
|
increased cochlear nerve compound action potential
|
J:111682
|
Phl2101/H/Phl2MAI/Pas
(involves: 101/H * MAI/Pas)
|
increased cochlear nerve compound action potential
|
J:111682
|
Phl2101/H/Phl2MBT/Pas
(involves: 101/H * MBT/Pas)
|
increased cochlear nerve compound action potential
|
J:111682
|
Phox2btm1.1Heno/Phox2b+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))
|
abnormal neuron physiology
|
J:190742
|
| abnormal neuronal precursor proliferation
|
J:190742
|
Phox2btm1Rth/Phox2b+
Hprt1tm1(CAG-cre)Mnn/?
(involves: 129 * 129S1/Sv * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:331513
|
Phox2btm2.1Heno/Phox2b+
(either: (involves: 129P2/OlaHsd * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * DBA/2))
|
abnormal neuron physiology
|
J:190742
|
| abnormal neuronal precursor proliferation
|
J:190742
|
Phox2btm2Jbr/Phox2b+
(involves: 129S2/SvPas)
|
abnormal neuron physiology
|
J:155885
|
Phox2btm3.1Jbr/Phox2btm3.1Jbr
Egr2tm2(cre)Pch/Egr2+
(involves: 129S2/SvPas * C57BL/6 * DBA/2)
|
abnormal neuron physiology
|
J:155885
|
Phox2btm3.1Jbr/Phox2btm3.1Jbr
Isl1tm1(cre)Tmj/Isl1+
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal neuron physiology
|
J:155885
|
Phrf1em1Mscha/Phrf1em1Mscha
Tg(Camk2a-cre)T29-1Stl/0
(involves: BALB/c * C57BL)
|
impaired synaptic plasticity
|
J:294183
|
Phyhtm1b(EUCOMM)Wtsi/Phyhtm1b(EUCOMM)Wtsi
(C57BL/6N-Phyhtm1b(EUCOMM)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Phyhtm1Safe/Phyhtm1Safe
(involves: 129P2/OlaHsd * 129X1/SvJ * Black Swiss * FVB/N)
|
abnormal action potential
|
J:142512
|
| abnormal astrocyte physiology
|
J:142512
|
| abnormal nervous system physiology
|
J:142512
|
| decreased nerve conduction velocity
|
J:142512
|
Pi4kbtm1.1Tbal/Pi4kbtm1.1Tbal
Tg(Mpz-cre)26Mes/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB)
|
decreased nerve conduction velocity
|
J:297534
|
Pianpem1Bet/Pianpem1Bet
(Not Specified)
|
abnormal excitatory postsynaptic currents
|
J:279537
|
| abnormal paired-pulse facilitation
|
J:279537
|
| decreased prepulse inhibition
|
J:279537
|
Pianptm1d(KOMP)Wtsi/Pianptm1d(KOMP)Wtsi
(involves: BALB/cJ * C57BL/6N * SJL)
|
increased neuron apoptosis
|
J:279537
|
Pick1tm1Rlh/Pick1tm1Rlh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
impaired synaptic plasticity
|
J:99813
|
Pick1tm1Rlh/Pick1tm1Rlh
(involves: 129S1/Sv * 129X1/SvJ)
|
absent long-term depression
|
J:107573
|
Pid2CAST/Ei/?
(involves: CAST/Ei * SJL/J)
|
abnormal nervous system physiology
|
J:65122
|
Pik3r4mbe/Pik3r4mbe
(involves: C3H/HeH * C57BL/6)
|
abnormal neuronal migration
|
J:258027
|
Pik3r4tm1.1Mpnd/Pik3r4tm1.1Mpnd
(involves: 129S2/SvPas * C57BL/6)
|
abnormal neuronal migration
|
J:258027
|
Pink1tm1Hlw/Pink1tm1Hlw
(involves: 129 * C57BL/6J)
|
abnormal neuron physiology
|
J:175006
|
Pink1tm1Lex/Pink1tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:148988
|
| abnormal neuron physiology
|
J:148988
|
| increased neuron apoptosis
|
J:148903
|
Pink1tm1Shn/Pink1tm1Shn
(involves: 129S4/SvJae * C57BL/6)
|
abnormal nervous system physiology
|
J:122728
|
| reduced long-term depression
|
J:122728
|
| reduced long-term potentiation
|
J:122728
|
Pip5k1cGt(XD096)Byg/Pip5k1cGt(XD096)Byg
(involves: 129P2/OlaHsd)
|
abnormal neuronal migration
|
J:131432
|
Pip5k1ctm1.2Ref/Pip5k1ctm1.2Ref
(involves: 129)
|
abnormal synaptic vesicle recycling
|
J:200273
|
Pip5k1ctm1Pdc/Pip5k1c+
(involves: C57BL/6)
|
abnormal glutamate-mediated receptor currents
|
J:92666
|
Pip5k1ctm1Pdc/Pip5k1ctm1Pdc
(involves: C57BL/6)
|
abnormal CNS synaptic transmission
|
J:92666
|
| abnormal inhibitory postsynaptic currents
|
J:92666
|
| abnormal miniature excitatory postsynaptic currents
|
J:92666
|
| impaired synaptic plasticity
|
J:92666
|
| increased synaptic depression
|
J:92666
|
Pip5k1ctm2.1Ref/Pip5k1ctm2.1Ref
(B6.129-Pip5k1ctm2.1Ref)
|
abnormal synaptic vesicle recycling
|
J:200273
|
Pirttm1Xzd/Pirttm1Xzd
(B6.129-Pirt1tm1Xzd)
|
abnormal sympathetic neuron physiology
|
J:145300
|
Pis1A/J/Pis1A/J
(C57BL/6J-Chr 10A/J/NaJ)
|
increased susceptibility to pharmacologically induced seizures
|
J:118211
|
Pis2A/J/Pis2A/J
(C57BL/6J-Chr 18A/J/NaJ)
|
increased susceptibility to pharmacologically induced seizures
|
J:118211
|
PitpnaGt(OST1152)Lex/PitpnaGt(OST1152)Lex
(involves: 129S5/SvEvBrd)
|
demyelination
|
J:85204
|
| seizures
|
J:85204
|
Pitpnatm1Vab/Pitpnatm1Vab
(involves: 129S7/SvEvBrd)
|
demyelination
|
J:85204
|
| increased hindbrain apoptosis
|
J:85204
|
| seizures
|
J:85204
|
Pitx2tm1.1Dmm/Pitx2tm2Sac
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal neuronal migration
|
J:181058
|
Pitx3tm1.1Cai/Pitx3+
Tg(tetO-SNCA*A53T)E2Cai/0
(involves: 129 * C57BL/6J * FVB/N)
|
abnormal neuron physiology
|
J:185958
|
| abnormal synaptic dopamine release
|
J:185958
|
Pitx3tm1Mli/Pitx3tm1Mli
(involves: 129P2/OlaHsd)
|
increased neuron apoptosis
|
J:99395
|
Pjvkem1(IMPC)J/Pjvkem1(IMPC)J
(C57BL/6NJ-Pjvkem1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Pkd1l3tm1.1Abek/Pkd1l3tm1.1Abek
Pkd2l1tm1.1Yuni/Pkd2l1tm1.1Yuni
(involves: 129S/SvEv * C57BL/6 * CBA)
|
abnormal nerve fiber response
|
J:172581
|
Pkd2l1tm1.1Yuni/Pkd2l1tm1.1Yuni
(involves: 129S/SvEv * C57BL/6)
|
abnormal nerve fiber response
|
J:172581
|
Pla2g4atm1Jvb/Pla2g4atm1Jvb
(involves: 129S4/SvJae)
|
decreased cerebral infarct size
|
J:39681
|
| decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:120035
|
| decreased susceptibility to ischemic brain injury
|
J:39681
|
Pla2g6m1J/Pla2g6m1J
(C3H/HeJ-Pla2g6m1J)
|
abnormal astrocyte physiology
|
J:183152
|
Pla2g6m1Sein/Pla2g6m1Sein
(C57BL/6JJcl-Pla2g6m1Sein)
|
abnormal astrocyte physiology
|
J:183152
|
Plaaem1Pmi/Plaaem1Pmi
(C57BL/6J-Plaaem1Pmi)
|
abnormal miniature endplate potential
|
J:240526
|
| abnormal PNS synaptic transmission
|
J:240526
|
| abnormal Purkinje cell migration
|
J:240526
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:240526
|
Plattm1Mlg/Plattm1Mlg
(involves: 129S2/SvPas * C57BL/6)
|
decreased cerebral infarct size
|
J:55243
|
| intracerebral hemorrhage
|
J:89052
|
Plattm1Mlg/Plattm1Mlg
(B6.Cg-Plattm1Mlg)
|
absent long-term depression
|
J:89431
|
| impaired synaptic plasticity
|
J:81694,
J:94733
|
| reduced long-term potentiation
|
J:89431
|
Plattm1Mlg/Plattm1Mlg
(involves: 129S2/SvPas)
|
abnormal microglial cell physiology
|
J:144185
|
| abnormal response to CNS ischemic injury
|
J:144185
|
Plaurem1(IMPC)H/Plaurem1(IMPC)H
(C57BL/6NTac-Plaurem1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Plaurtm1Mlg/Plaurtm1Mlg
(B6.Cg-Plaurtm1Mlg)
|
abnormal neuronal migration
|
J:69135
|
| increased susceptibility to pharmacologically induced seizures
|
J:81735
|
| myoclonus
|
J:81735
|
Plcb1tm1Hssh/Plcb1tm1Hssh
(Not Specified)
|
convulsive seizures
|
J:43077
|
| increased susceptibility to pharmacologically induced seizures
|
J:43077
|
Plcb1tm1Hssh/Plcb1tm1Hssh
(involves: 129/Sv * C57BL/6)
|
decreased prepulse inhibition
|
J:151070
|
Plcb1tm1Hssh/Plcb1tm1Hssh
(involves: 129 * C57BL/6J)
|
abnormal excitatory postsynaptic currents
|
J:159855
|
Plcb2tm1Dwu/Plcb2tm1Dwu
(B6.129S1-Plcb2tm1Dwu/J)
|
abnormal vomeronasal sensory neuron physiology
|
J:223366
|
Plcb4tm1Hssh/Plcb4tm1Hssh
(Not Specified)
|
abnormal synaptic transmission
|
J:43077
|
Plcb4tm1Tyo/Plcb4tm1Tyo
(involves: C57BL/6J)
|
abnormal nervous system physiology
|
J:72939
|
| reduced long-term depression
|
J:72939
|
Plcl1tm1Mh/Plcl1tm1Mh
(involves: C57BL/6)
|
abnormal nervous system electrophysiology
|
J:92489
|
Plcl1tm1Mh/Plcl1tm1Mh
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:92956
|
| seizures
|
J:92956
|
Pld1tm3Mafr/Pld1tm3Mafr
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
decreased cerebral infarct size
|
J:211547
|
| decreased susceptibility to ischemic brain injury
|
J:211547
|
Pld1tm3Mafr/Pld1tm3Mafr
Pld2tm1(KOMP)Vlcg/Pld2tm1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
decreased cerebral infarct size
|
J:216114
|
| decreased susceptibility to ischemic brain injury
|
J:216114
|
Plec/Parp10tm1.1Gwi/Plec/Parp10tm1.1Gwi
(involves: BALB/cJ * C57BL/6)
|
decreased nerve conduction velocity
|
J:155511
|
Plec/Parp10tm1.1Gwi/Plec/Parp10tm1.1Gwi
(involves: BALB/cJ * C57BL/6)
|
decreased nerve conduction velocity
|
J:155511
|
Plectm4Gwi/Plectm4.1Gwi
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 * SJL)
|
decreased nerve conduction velocity
|
J:155511
|
Plekhm1tm1b(EUCOMM)Hmgu/Plekhm1tm1b(EUCOMM)Hmgu
(C57BL/6N-Plekhm1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Plgtm1Jld/Plgtm1Jld
(involves: 129P2/OlaHsd)
|
abnormal nervous system physiology
|
J:42819
|
Plgtm1Jld/Plgtm1Jld
(B6.129P2-Plgtm1Jld/J)
|
abnormal microglial cell physiology
|
J:141739
|
| decreased susceptibility to neuronal excitotoxicity
|
J:141739
|
Plod1tm1b(EUCOMM)Hmgu/Plod1tm1b(EUCOMM)Hmgu
(C57BL/6N-Plod1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Plod3tm2Rmyl/Plod3tm2Rmyl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intracranial hemorrhage
|
J:106510
|
Plp1jp-4J/Y
(involves: C3H/HeJ * C57BL/6J)
|
demyelination
|
J:41569,
J:36181
|
| seizures
|
J:41569
|
Plp1jp-msd/Y
(involves: BALB/c * C57BL/6J * C57BL/10)
|
abnormal myelination
|
J:159450
|
Plp1jp-msd/Y
(involves: C57BL/10Sn * BALB/cJ)
|
abnormal myelination
|
J:5170
|
| demyelination
|
J:5170
|
| seizures
|
J:5170
|
Plp1jp-msd/Y
(B6C3-EdaTa Plp1jp-msd)
|
demyelination
|
J:7157
|
Plp1jp-msd/Plp1jp-msd
(involves: BALB/c * C57BL/6J * C57BL/10)
|
abnormal myelination
|
J:159450
|
Plp1jp-rsh/Y
(involves: 101 * C3H)
|
abnormal axonal transport
|
J:229229
|
| demyelination
|
J:88023,
J:10575,
J:14143
|
| dysmyelination
|
J:229229
|
Plp1jp-rsh/Y
(involves: C57BL/6NCrl)
|
demyelination
|
J:88023
|
| seizures
|
J:88023
|
Plp1jp-rsh/Y
(C3H * C57BL/6 * STOCK Rb(1.3)1Bnr)
|
demyelination
|
J:31089
|
Plp1jp-rsh/Plp1+
(either: STOCK Rb(1.3)1Bnr or (involves: BALB/c * DBA/2 * STOCK Rb(1.3)1Bnr))
|
abnormal myelination
|
J:604
|
| demyelination
|
J:604
|
Plp1jp-rsh/Plp1jp-rsh
(involves: 101 * C3H)
|
demyelination
|
J:10575,
J:14143
|
Plp1jp/Y
(B6CB-Aw-J/A EdaTa Plp1jp)
|
abnormal astrocyte physiology
|
J:116364
|
| abnormal myelination
|
J:5611,
J:160743
|
Plp1jp/Y
(Not Specified)
|
abnormal myelination
|
J:13141
|
| environmentally induced seizures
|
J:288
|
| tonic-clonic seizures
|
J:13141
|
Plp1jp/Y
(B6C3-EdaTa Plp1jp)
|
abnormal myelination
|
J:7157
|
| demyelination
|
J:7157
|
Plp1tm1.1Gow/Y
(Not Specified)
|
abnormal myelination
|
J:62287
|
| demyelination
|
J:62287
|
Plp1tm1Frca/Y
(B6.129-Plp1tm1Frca)
|
demyelination
|
J:143305
|
Plp1tm1Gow/Y
(Not Specified)
|
abnormal myelination
|
J:62287
|
| demyelination
|
J:62287
|
Plp1tm1Kan/Y
(involves: 129S1/Sv * 129X1/SvJ)
|
demyelination
|
J:48031
|
Plp1tm1Kan/Y
(B6.129-Plp1tm1Kan)
|
demyelination
|
J:201143
|
Plp1tm1Kan/Y
(B6N.129-Plp1tm1Kan)
|
dysmyelination
|
J:236408
|
Plp1tm1Kan/Y
Tspan2tm1Hbw/Tspan2tm1Hbw
(B6.Cg-Tspan2tm1Hbw Plp1tm1Kan)
|
brain inflammation
|
J:201143
|
| demyelination
|
J:201143
|
Plp1tm1Wst/Plp1tm1Wst
(involves: 129P2/OlaHsd)
|
abnormal myelination
|
J:105188,
J:21976
|
| abnormal nerve conduction
|
J:21976
|
Plp1tm2Wst/Plp1tm2Wst
(involves: 129P2/OlaHsd)
|
abnormal myelination
|
J:21976
|
| abnormal nerve conduction
|
J:21976
|
Plp1tm3Wst/Plp1tm3Wst
(B6.129S1-Plp1tm3Wst)
|
abnormal myelination
|
J:105188
|
Plp2tm1Dva/Y
(involves: 129 * C57BL/6J)
|
increased neuron apoptosis
|
J:227053
|
| increased susceptibility to ischemic brain injury
|
J:227053
|
Plppr4tm1Roni/Plppr4+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:157318
|
Plppr4tm1Roni/Plppr4tm1Roni
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:157318
|
| abnormal miniature excitatory postsynaptic currents
|
J:157318
|
| abnormal nervous system physiology
|
J:157318
|
| seizures
|
J:157318
|
| tonic-clonic seizures
|
J:157318
|
Plppr4tm1Roni/Plppr4tm1Roni
Lpar2tm1Jch/Lpar2tm1Jch
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:157318
|
Plppr4tm2.1Roni/Plppr4tm2.1Roni
(involves: 129P2/OlaHsd * C57BL/6)
|
increased excitatory postsynaptic current amplitude
|
J:157318
|
| increased miniature excitatory postsynaptic current frequency
|
J:157318
|
Plppr5em2Gpt/Plppr5em2Gpt
(C57BL/6-Plppr5em2Gpt)
|
increased cerebral infarct size
|
J:324004
|
| increased susceptibility to pharmacologically induced seizures
|
J:324004
|
Plrg1tm2Jcbr/Plrg1tm2Jcbr
Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6 * CBA)
|
increased neuron apoptosis
|
J:149153
|
Pls1tm1Fri/Pls1tm1Fri
(B6.129-Pls1tm1Fri)
|
abnormal hair cell mechanoelectric transduction
|
J:216416
|
Plxna2nmf454/Plxna2nmf454
(involves: C57BL/6J)
|
abnormal neuronal migration
|
J:135408
|
Plxna2tm1Hfu/Plxna2tm1Hfu
(involves: C57BL/6 * CBA)
|
abnormal neuronal migration
|
J:135408
|
Plxna2tm1Hfu/Plxna2tm1Hfu
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal neuron physiology
|
J:202884
|
Plxnb1tm1Matl/Plxnb1tm1Matl
Plxnb2tm1c(EUCOMM)Wtsi/Plxnb2tm1Matl
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * C57BL/6N * SJL)
|
decreased neuronal precursor proliferation
|
J:228347
|
Plxnb2tm1c(EUCOMM)Wtsi/Plxnb2tm1Matl
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * C57BL/6J * C57BL/6N * SJL)
|
abnormal neuronal precursor cell migration
|
J:228347
|
Plxnb2tm1Matl/Plxnb2tm1Matl
(involves: 129P2/OlaHsd * CD-1)
|
abnormal neuronal precursor cell migration
|
J:190014
|
| decreased neuronal precursor proliferation
|
J:190014
|
Plxnb2tm1Matl/Plxnb2tm1Matl
(B6.129P2-Plxnb2tm1Matl)
|
abnormal cerebellar granule cell migration
|
J:167973
|
Plxnb2tm1Matl/Plxnb2tm1Matl
Sema4ctm1Matl/Sema4ctm1Matl
(B6.129P2-Sema4ctm1Matl Plxnb2tm1Matl)
|
abnormal cerebellar granule cell migration
|
J:167973
|
Plxnb2tm1Matl/Plxnb2tm1Matl
Sema4gtm1Kik/Sema4gtm1Kik
(B6.Cg-Plxnb2tm1Matl Sema4gtm1Kik)
|
abnormal cerebellar granule cell migration
|
J:167973
|
Plxnc1tm1Alk/Plxnc1tm1Alk
(involves: 129/Sv * C57BL/6)
|
abnormal neuronal migration
|
J:120909
|
Plxnd1tm1.1Tmj/Plxnd1tm1.1Tmj
Tg(Tek-cre)1Ywa/0
(involves: 129S/SvEv * 129S4/SvJaeSor * C57BL/6 * SJL)
|
intracranial hemorrhage
|
J:143763
|
Plxnd1tm1Ddg/Plxnd1tm1.1Tmj
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S/SvEv * C57BL/6J * CBA/J)
|
abnormal excitatory postsynaptic potential
|
J:205528
|
Pmp2tm1.1(KOMP)Vlcg/Pmp2tm1.1(KOMP)Vlcg
(involves: C57BL/6 * C57BL/6NTac)
|
decreased nerve conduction velocity
|
J:211344
|
Pmp22tm1Lnot/Pmp22tm1Lnot
(Not Specified)
|
demyelination
|
J:104989
|
Pmp22tm1Ueli/Pmp22+
(involves: 129S/SvEv)
|
abnormal myelination
|
J:29517
|
Pmp22tm1Ueli/Pmp22tm1Ueli
(involves: 129S/SvEv)
|
abnormal action potential
|
J:29517
|
| abnormal myelination
|
J:29517
|
| convulsive seizures
|
J:29517
|
| decreased nerve conduction velocity
|
J:29517
|
Pmp22tm1Ueli/Pmp22tm1Ueli
(involves: 129S/SvEv * C57BL/6)
|
abnormal myelination
|
J:98118
|
| abnormal Schwann cell physiology
|
J:98118
|
| increased Schwann cell proliferation
|
J:98118
|
Pmp22Tr-1H/Pmp22+
(involves: BALB/cAnNCrl * C3H/HeN)
|
demyelination
|
J:63816,
J:79382
|
Pmp22Tr-2H/Pmp22+
(involves: BALB/cAnNCrl * C3H/HeN)
|
demyelination
|
J:63816,
J:79382
|
Pmp22Tr-2J/Pmp22+
(C57BL/6J-Pmp22Tr-2J/GrsrJ)
|
demyelination
|
J:201866
|
Pmp22Tr-3H/Pmp22+
(involves: BALB/c * C3H/HeH)
|
demyelination
|
J:79382
|
Pmp22Tr-J/?
(involves: C57BL/6J)
|
abnormal myelination
|
J:7222
|
| dysmyelination
|
J:76795
|
Pmp22Tr-J/Pmp22+
(involves: C57BL/6)
|
abnormal myelination
|
J:98231,
J:39953
|
Pmp22Tr-J/Pmp22+
(B6.Cg-Pmp22Tr-J Krt25Re/+ +/J)
|
abnormal action potential
|
J:101812
|
| demyelination
|
J:101812
|
Pmp22Tr-Ncnp/Pmp22+
(GAD/Ncnp-Pmp22Tr-Ncnp)
|
demyelination
|
J:43874
|
Pmp22Tr-Ncnp/Pmp22Tr-Ncnp
(GAD/Ncnp-Pmp22Tr-Ncnp)
|
abnormal myelination
|
J:43874
|
Pmp22Tr/?
(Not Specified)
|
abnormal myelination
|
J:7222
|
| seizures
|
J:7222
|
Pmp22Tr/Pmp22+
(Not Specified)
|
convulsive seizures
|
J:13038
|
| demyelination
|
J:27475
|
Pmp22Tr/Pmp22Tr
(Not Specified)
|
demyelination
|
J:27475
|
Pnkptm1.1Pmc/Pnkptm1.1Pmc
Emx1tm1(cre)Krj/Emx1+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
increased brain apoptosis
|
J:226703
|
Pnkptm1.1Pmc/Pnkptm1.1Pmc
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal myelination
|
J:226703
|
| increased brain apoptosis
|
J:226703
|
Pnkptm1.1Pmc/Pnkptm1.1Pmc
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * C57BL/6 * SJL)
|
increased brain apoptosis
|
J:226703
|
| intracranial hemorrhage
|
J:226703
|
Pnkptm1Pmc/Pnkptm1Pmc
(involves: 129S1/Sv * C57BL/6)
|
increased brain apoptosis
|
J:226703
|
Pnpla6tm1Mos/Pnpla6tm1Mos
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intracranial hemorrhage
|
J:87675
|
Poc5em1(IMPC)Tcp/Poc5em1(IMPC)Tcp
(C57BL/6NCrl-Poc5em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Pogzem1Tnkw/Pogz+
(involves: C57BL/6NJcl)
|
increased excitatory postsynaptic current frequency
|
J:286398
|
Polbtm1.1Jbsw/Polbtm1.1Jbsw
(involves: 129/Sv * C57BL/6)
|
increased neuron apoptosis
|
J:183837
|
Polbtm1Koy/Polbtm1Koy
(involves: 129P2/OlaHsd * C57BL/6)
|
increased neuron apoptosis
|
J:61143
|
Pole2em1(IMPC)Mbp/Pole2+
(C57BL/6NCrl-Pole2em1(IMPC)Mbp/Mmucd)
|
increased prepulse inhibition
|
J:211773
|
Pole4tm1(KOMP)Vlcg/Pole4tm1(KOMP)Vlcg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NTac * FVB/N)
|
increased forebrain apoptosis
|
J:261973
|
Pomctm1Low/Pomctm1Low
(B6.129S2-Pomctm1Low)
|
abnormal neuron physiology
|
J:113139
|
Pomgnt2tm1Kkat/Pomgnt2tm1Kkat
(either: B6J.Cg-Pomgnt2tm1Kkat or (involves: C57BL/6J * C57BL/6NJcl) or (involves: C57BL/6J * C57BL/6NCrlj * CBA/JNCrlj))
|
abnormal neuronal migration
|
J:215959
|
PomkGt(OST243203)Lex/PomkGt(OST243203)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal cerebellar granule cell migration
|
J:185566
|
| abnormal neuronal migration
|
J:185566
|
| abnormal Purkinje cell migration
|
J:185566
|
| decreased prepulse inhibition
|
J:185566
|
| reduced sensorimotor gating
|
J:185566
|
Pomt2tm1.1Hhu/Pomt2tm1.1Hhu
Tg(GFAP-cre)25Mes/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6J * FVB/N)
|
abnormal cerebellar granule cell migration
|
J:179356
|
Portm1Cbk/Portm1Cbk
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intracranial hemorrhage
|
J:74666
|
Pou1f1dw/Pou1f1dw
(Not Specified)
|
abnormal hair cell physiology
|
J:144823
|
| absent cochlear microphonics
|
J:144823
|
Pou1f1dw/Pou1f1dw
(DW/J Pou1f1dw)
|
increased pituitary gland apoptosis
|
J:108961
|
Pou2af3tm1b(NCOM)Mfgc/Pou2af3tm1b(NCOM)Mfgc
(C57BL/6N-Pou2af3tm1b(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Pou3f1tm1Mejr/Pou3f1tm1Mejr
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myelination
|
J:34465
|
Pou3f1tm1Mejr/Pou3f1tm2.1Mejr
(involves: 129P2/OlaHsd)
|
abnormal myelination
|
J:83739
|
Pou3f1tm1Mejr/Pou3f1tm2.1Mejr
Pou3f2tm1Mejr/Pou3f2tm1Mejr
Tg(Dhh-cre)1Mejr/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal myelination
|
J:83739
|
Pou3f1tm1Rsd/Pou3f1tm1Rsd
(either: (involves: 129S4/SvJae * 129/Sv * C57BL/6J) or (involves: 129S4/SvJae * C57BL/6 * C57BL/6J))
|
abnormal myelination
|
J:34460
|
Pou3f1tm2.1Mejr/Pou3f1tm2.1Mejr
(involves: 129P2/OlaHsd * FVB)
|
abnormal myelination
|
J:78939
|
Pou3f2tm1Tno/Pou3f2tm1Tno
Pou3f3tm1Tno/Pou3f3tm1Tno
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal neuronal migration
|
J:77999
|
Pou4f2tm1Nat/Pou4f2tm1Nat
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal neuron physiology
|
J:109300
|
Pou4f3tm1Rsd/Pou4f3tm1Rsd
(involves: 129S4/SvJae * C57BL/6)
|
abnormal autonomic nervous system physiology
|
J:81013
|
Pparaem1Tyrb/Pparaem1Tyrb
(C57BL/6J-Pparaem1Tyrb)
|
decreased prepulse inhibition
|
J:313946
|
Ppardtm1Jps/Ppardtm1Jps
(involves: 129/Sv * C57BL/6N)
|
abnormal myelination
|
J:63040
|
Ppargtm2Rev/Ppargtm2Rev
Tg(Camk2a-cre)62Jzt/?
(B6.Cg-Ppargtm2Rev Tg(Camk2a-cre)62Jzt)
|
abnormal neuron physiology
|
J:148757
|
| brain ischemia
|
J:148757
|
Ppargc1atm1Brsp/Ppargc1atm1Brsp
(involves: 129/Sv * C57BL/6 * FVB/N)
|
myoclonus
|
J:93896
|
Ppfia3em1Pska/Ppfia3em1Pska
(129S2.FVB-Ppfia3em1Pska)
|
abnormal CNS synaptic transmission
|
J:265782
|
| abnormal synaptic vesicle exocytosis
|
J:265782
|
Ppiftm1.1Mmos/Ppif+
(involves: 129X1/SvJ * FVB/NJ)
|
decreased cerebral infarct size
|
J:101149
|
Ppiftm1.1Mmos/Ppiftm1.1Mmos
(involves: 129X1/SvJ * FVB/NJ)
|
decreased cerebral infarct size
|
J:101149
|
Ppil1em3Jgg/Ppil1em3Jgg
(C57BL/6-Ppil1em3Jgg)
|
increased neuron apoptosis
|
J:300487
|
Ppil1em4Jgg/Ppil1em4Jgg
(C57BL/6-Ppil1em4Jgg)
|
increased neuron apoptosis
|
J:300487
|
Ppm1gtm1Dgen/Ppm1g+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prepulse inhibition
|
J:101679
|
Ppm1ltm1Tkoba/Ppm1ltm1Tkoba
(CBA.Cg-Ppm1ltm1Tkoba)
|
dysmyelination
|
J:238086
|
Ppp1r1atm1Pba/Ppp1r1atm1Pba
(involves: 129P2/OlaHsd * C57BL/6J)
|
reduced long-term potentiation
|
J:76892
|
Ppp1r1btm5.1Pggd/Ppp1r1btm5.1Pggd
Tg(Drd1-cre)EY262Gsat/0
Tg(Drd1-EGFP)X60Gsat/0
(involves: C57BL/6 * FVB/N * FVB/NTac)
|
reduced long-term potentiation
|
J:163700
|
Ppp1r1btm5.1Pggd/Ppp1r1btm5.1Pggd
Tg(Drd2-cre)ER44Gsat/0
Tg(Drd2-EGFP)S118Gsat/0
(involves: C57BL/6 * FVB/N * FVB/NTac)
|
reduced long-term potentiation
|
J:163700
|
Ppp1r9atm1Pggd/Ppp1r9atm1Pggd
(involves: 129/SvEv * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:110264
|
| abnormal neuron physiology
|
J:110264
|
| increased excitatory postsynaptic current frequency
|
J:110264
|
| reduced long-term potentiation
|
J:110264
|
Ppp1r9btm1Jfe/Ppp1r9btm1Jfe
(involves: 129X1/SvJ * C57BL/6)
|
abnormal AMPA-mediated synaptic currents
|
J:77284
|
| abnormal neuron physiology
|
J:110264
|
| absent long-term depression
|
J:110264
|
| decreased susceptibility to neuronal excitotoxicity
|
J:77284
|
| decreased susceptibility to pharmacologically induced seizures
|
J:77284
|
| reduced long-term depression
|
J:77284
|
Ppp1r35tm1.1(KOMP)Vlcg/Ppp1r35tm1.1(KOMP)Vlcg
(B6N(Cg)-Ppp1r35tm1.1(KOMP)Vlcg/J)
|
increased neural tube apoptosis
|
J:279207,
J:290235
|
Ppp2r5dGt(RRG285)Byg/Ppp2r5d+
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased prepulse inhibition
|
J:161844
|
Ppp3r1tm1Stl/Ppp3r1tm1Stl
Tg(Camk2a-cre)CW2Stl/0
(C57BL/6-Ppp3r1tm1Stl Tg(Camk2a-cre)CW2Stl)
|
reduced long-term depression
|
J:73203
|
| reduced sensorimotor gating
|
J:84640
|
Ppp4r3aem1Qili/Ppp4r3aem1Qili
Emx1tm1(cre)Krj/Emx1+
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:326388
|
| decreased neurotransmitter release
|
J:326388
|
Ppt1tm1.1Dprc/Ppt1tm1.1Dprc
(involves: 129S6/SvEvTac * BALB/cJ * C57BL/6)
|
abnormal microglial cell activation
|
J:213552
|
Ppt1tm1Aj/Ppt1tm1Aj
(involves: 129S4/SvJae * C57BL/6)
|
brain inflammation
|
J:95522
|
| myoclonus
|
J:95522
|
| seizures
|
J:95522
|
Ppt1tm1Hof/Ppt1tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J)
|
myoclonus
|
J:72931
|
Ppt1tm1Hof/Ppt1tm1Hof
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S6/SvEvTac * C57BL/6)
|
brain inflammation
|
J:177265
|
Ppt2tm1Hof/Ppt2tm1Hof
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased neuron apoptosis
|
J:86202
|
Prag1em2(IMPC)Tcp/Prag1em2(IMPC)Tcp
(C57BL/6NCrl-Prag1em2(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Prcdtm1Vya/Prcdtm1Vya
(B6.Cg-Prcdtm1Vya)
|
increased microglial cell activation
|
J:276708
|
Prdm8em1(IMPC)Wtsi/Prdm8+
(C57BL/6N-Prdm8em1(IMPC)Wtsi/Wtsi)
|
increased prepulse inhibition
|
J:211773
|
Prdm12tm1Ejbd/Prdm12tm1Ejbd
(involves: C57BL/6J * C57BL/6N)
|
increased neuron apoptosis
|
J:283226
|
Prdt2CAST/EiJH/Prdt2CAST/EiJH
(involves: CAST/Ei * NZW/OlaHsd)
|
abnormal nervous system physiology
|
J:69579
|
Prdt2NZW/OlaHsd/Prdt2NZW/OlaHsd
(involves: CAST/Ei * NZW/OlaHsd)
|
abnormal nervous system physiology
|
J:69579
|
Prdt4CAST/EiJH/Prdt4CAST/EiJH
(involves: CAST/Ei * NZW/OlaHsd)
|
abnormal nervous system physiology
|
J:69579
|
Prdt4CAST/EiJH/Prdt4NZW/OlaHsd
(involves: CAST/Ei * NZW/OlaHsd)
|
abnormal nervous system physiology
|
J:69579
|
Prdt4NZW/OlaHsd/Prdt4NZW/OlaHsd
(involves: CAST/Ei * NZW/OlaHsd)
|
abnormal nervous system physiology
|
J:69579
|
Preptm1Dgen/Preptm1Dgen
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased prepulse inhibition
|
J:82809
|
Prex1tm1Hcew/Prex1tm1Hcew
(involves: 129P2/OlaHsd * C57BL/6)
|
reduced long-term depression
|
J:228203
|
Prf1tm1Sdz/Prf1tm1Sdz
(C57BL/6-Prf1tm1Sdz/J)
|
brain inflammation
|
J:92260,
J:120427
|
| CNS inflammation
|
J:120427
|
| demyelination
|
J:120427
|
Prickle1em1Yzou/Prickle1+
(C57BL/6-Prickle1em1Yzou)
|
increased susceptibility to pharmacologically induced seizures
|
J:321396
|
Prickle1m1Ingm/Prickle1+
(involves: C57BL/6)
|
abnormal seizure response to electrical stimulation
|
J:169136
|
Prickle1m2Ingm/Prickle1+
(C57BL/6-Prickle1m2Ingm)
|
abnormal seizure response to electrical stimulation
|
J:169136
|
Prickle1tm1Nue/Prickle1+
(B6.Cg-Prickle1tm1Nue)
|
abnormal seizure response to electrical stimulation
|
J:169136
|
Prickle2tm1Nue/Prickle2+
(B6.Cg-Prickle2tm1Nue)
|
abnormal seizure response to electrical stimulation
|
J:169136
|
Prickle2tm1Nue/Prickle2tm1Nue
(B6.Cg-Prickle2tm1Nue)
|
abnormal seizure response to electrical stimulation
|
J:169136
|
| increased susceptibility to pharmacologically induced seizures
|
J:169136
|
Prkaa2tm1.1Vio/Prkaa2tm1.1Vio
(involves: 129S2/SvPas * C57BL/6)
|
abnormal sympathetic nervous system physiology
|
J:81120
|
Prkaa2tm1Vio/Prkaa2tm1Vio
Tg(Agrp-cre)1Gsb/0
(involves: 129S2/SvPas * FVB/N)
|
abnormal neuron physiology
|
J:123951
|
Prkaa2tm1Vio/Prkaa2tm1Vio
Tg(Pomc1-cre)1Gsb/0
(involves: 129S2/SvPas * FVB/N)
|
abnormal neuron physiology
|
J:123951
|
Prkab1Gt(RRR454)Byg/Prkab1Gt(RRR454)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myelination
|
J:146618
|
| abnormal neuronal precursor proliferation
|
J:146618
|
| seizures
|
J:146618
|
Prkacatm1Gsm/Prkaca+
Prkacbtm1Gsm/Prkacbtm1Gsm
(involves: 129X1/SvJ * C57BL/6)
|
increased neural tube apoptosis
|
J:76765
|
Prkacbtm1Gsm/Prkacbtm1Gsm
(involves: 129X1/SvJ * C57BL/6)
|
absent long-term depression
|
J:31731
|
| decreased synaptic depression
|
J:31731
|
| reduced long-term potentiation
|
J:31731
|
Prkacbtm2Gsm/Prkacbtm2Gsm
(involves: 129X1/SvJ * C57BL/6)
|
abnormal nervous system physiology
|
J:78451
|
Prkar1btm1Gsm/Prkar1btm1Gsm
(involves: 129X1/SvJ * C57BL/6)
|
reduced long-term depression
|
J:28735
|
| reduced long-term potentiation
|
J:30405
|
Prkcdtm1Msg/Prkcdtm1Msg
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal response to CNS ischemic injury
|
J:91377
|
Prkcgtm1Stl/Prkcgtm1Stl
(involves: 129P2/OlaHsd * C57BL/6)
|
reduced long-term potentiation
|
J:16392
|
Prkcgtm1Stl/Prkcgtm1Stl
(B6;129P2-Prkcgtm1Stl/J)
|
abnormal excitatory postsynaptic currents
|
J:159855
|
Prkcqtm1Litt/Prkcqtm1Litt
(B6.129P2-Prkcqtm1Litt)
|
abnormal endplate potential
|
J:96919
|
Prkd2em1(IMPC)Hmgu/Prkd2em1(IMPC)Hmgu
(C57BL/6N-Prkd2em1(IMPC)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Prkg1tm2Naw/Prkg1tm2Naw
Tg(Pcp2-cre)2Mpin/?
(involves: 129/Sv * C57BL/6)
|
abnormal long-term depression
|
J:86329
|
Prkntm1Roo/Prkntm1Roo
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6))
|
abnormal synaptic transmission
|
J:85561
|
Prkntm1Roo/Prkntm1Roo
(involves: 129S2/SvPas)
|
increased neuron apoptosis
|
J:125148
|
Prkntm1Shn/Prkntm1Shn
(involves: 129S4/SvJae)
|
abnormal nervous system electrophysiology
|
J:86377
|
Prkraem1(IMPC)H/Prkraem1(IMPC)H
(C57BL/6N-Prkraem1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Prl3c1tm1(KOMP)Vlcg/Prl3c1tm1(KOMP)Vlcg
(involves: C57BL/6NTac * CD-1)
|
abnormal pituitary gland physiology
|
J:256588
|
Prltm1Hmn/Prltm1Hmn
(involves: 129S2/SvPas)
|
abnormal pituitary secretion
|
J:83246
|
Prlhtm1Taon/Prlhtm1Taon
(B6N.129X1-Prlhtm1Taon)
|
abnormal autonomic nervous system physiology
|
J:144729
|
Prlrtm1Cnp/Prlr+
(B6.129P2-Prlrtm1Cnp/J)
|
abnormal neuron proliferation
|
J:83248
|
Prmt5tm2c(EUCOMM)Wtsi/Prmt5tm2c(EUCOMM)Wtsi
Tg(Nes-cre)1Kln/0
(B6.Cg-Prmt5tm2c(EUCOMM)Wtsi Tg(Nes-cre)1Kln)
|
abnormal neuronal precursor proliferation
|
J:201152
|
| increased neuron apoptosis
|
J:201152
|
Prmt8tm1d(EUCOMM)Wtsi/Prmt8+
(involves: C57BL/6N)
|
abnormal nervous system physiology
|
J:234033
|
Prmt8tm1d(EUCOMM)Wtsi/Prmt8tm1d(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal nervous system physiology
|
J:234033
|
| decreased neurotransmitter release
|
J:234033
|
Prnptm1Cwe/Prnptm1Cwe
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:19448
|
| abnormal inhibitory postsynaptic currents
|
J:19448
|
| abnormal inhibitory postsynaptic potential
|
J:19448
|
| reduced long-term potentiation
|
J:19448
|
Prnptm1Cwe/Prnptm1Cwe
Tg(Nefh-cre)22Jcol/?
Tg(Prnp)37Jcol/?
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * FVB)
|
abnormal excitatory postsynaptic potential
|
J:126424
|
Prnptm1Cwe/Prnptm1Cwe
Tg(Nefh-cre)22Jcol/?
Tg(Prnp)46Jcol/?
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * FVB)
|
abnormal afterhyperpolarization
|
J:74652
|
Prnptm1Cwe/Prnptm1Cwe
Tg(Prnp)37Jcol/?
(involves: 129/Sv * 129S7/SvEvBrd * C57BL/6 * FVB)
|
abnormal excitatory postsynaptic potential
|
J:126424
|
Prnptm1Cwe/Prnptm1Cwe
Tg(Prnp*)#Rgab/0
(involves: 129S7/SvEvBrd * C57BL/6 * FVB/N)
|
myoclonus
|
J:183170
|
Prnptm1Cwe/Prnptm1Cwe
Tg(Prnp*P101L)2866Sbp/0
(involves: 129S7/SvEvBrd * FVB/N)
|
abnormal nervous system physiology
|
J:136434
|
Prnptm1Cwe/Prnptm1Cwe
Tg(Prnp*P101L)2866Sbp/Tg(Prnp*P101L)2866Sbp
(involves: 129S7/SvEvBrd * FVB/N)
|
abnormal nervous system physiology
|
J:136434
|
Prnptm2Edin/Prnptm2Edin
(B6.129P2-Prnptm2Edin)
|
abnormal neuronal precursor proliferation
|
J:107170
|
Prnptm2Edin/Prnptm2Edin
Tg(Prnp)a20Cwe/0
(B6.Cg-Prnptm2Edin Tg(Prnp)a20Cwe)
|
abnormal neuronal precursor proliferation
|
J:107170
|
Prnptm2Lnq/Prnptm2Lnq
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal neuron proliferation
|
J:200974
|
| increased neuron apoptosis
|
J:200974
|
Prnptm3Lnq/Prnptm3Lnq
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal neuron proliferation
|
J:200974
|
| increased neuron apoptosis
|
J:200974
|
Proctm1Fjc/Proctm1Fjc
(involves: 129S1/Sv * 129X1/SvJ * Swiss)
|
intracranial hemorrhage
|
J:50527
|
Prokr2tm1Api/Prokr2tm1Api
(involves: C57BL/6 * CBA)
|
abnormal hypothalamus physiology
|
J:107587
|
Prom1tm1.1(DTA)Toko/Prom1tm1.1(DTA)Toko
Tg(CAG-cre/Esr1*)5Amc/0
(involves: C57BL/6 * CBA * SJL)
|
increased brain apoptosis
|
J:152390
|
Prop1tm1Sac/Prop1tm1Sac
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J)
|
hypopituitarism
|
J:94409
|
Pros1tm1.1Ansc/Pros1tm1.1Ansc
(involves: 129/Sv * C57BL/6J * FVB/N)
|
intracranial hemorrhage
|
J:152423
|
Pros1tm1.2Grl/Pros1tm1.2Grl
(involves: 129S1/SvImJ * FVB/N)
|
intracranial hemorrhage
|
J:198769
|
Prph2em1Sal/Prph2em1Sal
(C57BL/6J-Prph2em1Sal)
|
increased microglial cell activation
|
J:342243
|
Prrc2atm1Fcw/Prrc2atm1Fcw
Olig2tm2(TVA,cre)Rth/Olig2+
(involves: 129 * C57BL/6)
|
dysmyelination
|
J:301796
|
Prrc2atm1Fcw/Prrc2atm1Fcw
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal astrocyte physiology
|
J:301796
|
| decreased nerve conduction velocity
|
J:301796
|
| dysmyelination
|
J:301796
|
Prrt1tm1(KOMP)Vlcg/Prrt1tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal miniature excitatory postsynaptic currents
|
J:260353
|
| reduced long-term potentiation
|
J:260353
|
Prrt2tm1a(KOMP)Wtsi/Prrt2tm1a(KOMP)Wtsi
(C57BL/6N-Atm1Brd Prrt2tm1a(KOMP)Wtsi/Wtsi)
|
abnormal inhibitory postsynaptic currents
|
J:237823
|
| abnormal miniature excitatory postsynaptic currents
|
J:237823
|
| abnormal synaptic plasticity
|
J:237823
|
| audiogenic seizures
|
J:237823
|
| increased susceptibility to pharmacologically induced seizures
|
J:237823
|
Prrt2tm1d(KOMP)Wtsi/Prrt2+
(B6(Cg)-Prrt2tm1d(KOMP)Wtsi)
|
decreased excitatory postsynaptic current amplitude
|
J:299667
|
Prrt2tm1d(KOMP)Wtsi/Prrt2tm1d(KOMP)Wtsi
(B6(Cg)-Prrt2tm1d(KOMP)Wtsi)
|
abnormal excitatory postsynaptic currents
|
J:299667
|
| decreased excitatory postsynaptic current amplitude
|
J:299667
|
Prss3btm1b(KOMP)Wtsi/Prss3btm1b(KOMP)Wtsi
(C57BL/6N-Prss3btm1b(KOMP)Wtsi/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Prss12tm1Mits/Prss12tm1Mits
(B6.Cg-Prss12tm1Mits)
|
abnormal neuron physiology
|
J:157626
|
Prss33em1(IMPC)Ccpcz/Prss33em1(IMPC)Ccpcz
(C57BL/6N-Prss33em1(IMPC)Ccpcz/Ccpcz)
|
increased prepulse inhibition
|
J:211773
|
Prss57em1(IMPC)Ccpcz/Prss57em1(IMPC)Ccpcz
(C57BL/6N-Prss57em1(IMPC)Ccpcz/Ccpcz)
|
increased prepulse inhibition
|
J:211773
|
Prxtm1Brp/Prxtm1Brp
(involves: 129P2/Ola * C57BL/6)
|
abnormal action potential
|
J:62566
|
| abnormal myelination
|
J:62566
|
| abnormal nerve conduction
|
J:62566
|
| abnormal nervous system electrophysiology
|
J:62566
|
Prxtm1Brp/Prxtm1Brp
(involves: 129P2/OlaHsd)
|
abnormal myelination
|
J:199744
|
| decreased nerve conduction velocity
|
J:199744
|
Prxtm2.1Brp/Prxtm2.1Brp
(B6.129P2-Prxtm2.1Brp)
|
abnormal myelination
|
J:199744
|
| abnormal nerve conduction
|
J:199744
|
| decreased nerve conduction velocity
|
J:199744
|
Psaptm1Ggb/Psaptm1Ggb
(involves: 129S/SvEv * C57BL/6J)
|
abnormal microglial cell physiology
|
J:121761
|
| abnormal myelination
|
J:121761
|
Psaptm1Juma/Psaptm1Juma
(FVB.129S-Psaptm1Juma)
|
abnormal microglial cell physiology
|
J:121761
|
| abnormal myelination
|
J:121761
|
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd)
|
demyelination
|
J:33477
|
| seizures
|
J:113052
|
| tonic seizures
|
J:33477
|
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal myelination
|
J:121761
|
Psaptm1Suz/Psaptm1Suz
(involves: 129P2/OlaHsd * FVB)
|
abnormal cochlear outer hair cell physiology
|
J:116349
|
Psaptm2Ggb/Psaptm2Ggb
(involves: 129S/SvEv * C57BL/6J)
|
abnormal nervous system physiology
|
J:137650
|
| abnormal neuron physiology
|
J:137650
|
| CNS inflammation
|
J:137650
|
Psaptm2Suz/Psaptm2Suz
(involves: 129S/SvEv * C57BL/6J)
|
CNS inflammation
|
J:78223
|
| demyelination
|
J:73188,
J:78223
|
| seizures
|
J:78223
|
Psaptm3.1Ggb/Psaptm3.1Ggb
(involves: 129S/SvEv * C57BL/6J)
|
demyelination
|
J:155864
|
| reduced long-term potentiation
|
J:155864
|
Psen1tm1Bdes/Psen1tm1Bdes
(involves: 129P2/OlaHsd)
|
abnormal neuronal migration
|
J:95663
|
| intracerebral hemorrhage
|
J:95663
|
Psen1tm1Hko/Psen1tm1Hko
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
intracerebral hemorrhage
|
J:84418
|
Psen1tm1Mpm/Psen1tm1Mpm
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to neuronal excitotoxicity
|
J:51950
|
Psen1tm1Pcw/Psen1tm1Pcw
(involves: 129S7/SvEvBrd)
|
intracranial hemorrhage
|
J:40308
|
| intraventricular hemorrhage
|
J:40308
|
| spinal hemorrhage
|
J:40308
|
Psen1tm1Shn/Psen1tm1Shn
(involves: 129S7/SvEvBrd * C57BL/6)
|
intracranial hemorrhage
|
J:40365
|
Psen1tm1Shs/Psen1tm1Shs
(involves: C57BL/6)
|
abnormal neuronal migration
|
J:91975
|
| abnormal neuronal precursor proliferation
|
J:91975
|
| intracranial hemorrhage
|
J:91975
|
Psen1tm1Vln/Psen1tm1Vln
Tg(Thy1-APPLon)2Vln/0
Tg(Thy1-cre)1Vln/0
(involves: FVB/N)
|
abnormal long-term potentiation
|
J:87229
|
Psen1tm1Vln/Psen1tm1Vln
Tg(Thy1-cre)1Vln/0
(involves: FVB/N)
|
abnormal long-term potentiation
|
J:87229
|
Psen1tm2Psgh/Psen1tm2Psgh
(involves: 129S1/Sv * 129X1/SvJ)
|
intracranial hemorrhage
|
J:80624
|
| spinal hemorrhage
|
J:80624
|
Psen1tm4.1Shn/Psen1+
Psen2tm1Haa/Psen2tm1Haa
(involves: 129 * C57BL/6 * C57BL/6J)
|
decreased paired-pulse facilitation
|
J:219929
|
| impaired synaptic plasticity
|
J:219929
|
| increased synaptic depression
|
J:219929
|
| reduced long-term potentiation
|
J:219929
|
Psmc1tm1Maye/Psmc1tm1Maye
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-cre)1Lin/0
(involves: 129 * C57BL/6 * CD-1)
|
increased neuron apoptosis
|
J:138991
|
Psmg1tm1.1Smta/Psmg1tm1.1Smta
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * CBA * SJL)
|
decreased cerebellar granule cell precursor proliferation
|
J:162790
|
Pspntm1Bjh/Pspntm1Bjh
(involves: 129S1/Sv * 129X1/SvJ)
|
increased cerebral infarct size
|
J:77733
|
| increased susceptibility to ischemic brain injury
|
J:77733
|
psrt1R/psrt1R
(involves: BJR)
|
seizures
|
J:73982
|
psrt2R/psrt2R
(involves: BJR)
|
seizures
|
J:73982
|
Ptafrtm1Eit/Ptafrtm1Eit
(involves: C57BL/6)
|
abnormal blood-brain barrier function
|
J:104293
|
Ptch1tm1Bjw/Ptch1tm1Bjw
Tg(Atoh1-cre)1Bfri/0
(involves: 129T2/SvEms * C57BL/6 * CBA)
|
abnormal neuronal precursor proliferation
|
J:139573
|
Ptch1tm1Bjw/Ptch1tm1Bjw
Tg(Atoh1-cre/Esr1*)14Fsh/0
(involves: 129T2/SvEms * FVB/N)
|
abnormal neuronal precursor proliferation
|
J:139573
|
Ptchd1tm2.2Gfng/Y
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal single cell response
|
J:232709
|
Ptdss1tm1b(EUCOMM)Hmgu/Ptdss1tm1b(EUCOMM)Hmgu
(C57BL/6N-Ptdss1tm1b(EUCOMM)Hmgu/Ics)
|
increased prepulse inhibition
|
J:211773
|
Ptentm1.1Jaes/Ptentm1.1Jaes
(B6.129S6(FVB)-Ptentm1.1Jaes)
|
abnormal CNS synaptic transmission
|
J:234430
|
| abnormal synaptic depression
|
J:234430
|
Ptentm1.1Yxy/Ptentm1.1Yxy
(involves: C57BL/6)
|
abnormal glutamate-mediated receptor currents
|
J:256248
|
| reduced long-term potentiation
|
J:256248
|
Ptentm1Engc/Ptentm1Engc
(involves: CD-1)
|
abnormal microglial cell physiology
|
J:210487
|
Ptentm1Hwu/Ptentm1Hwu
Cnptm1(cre)Kan/Cnp+
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
hypermyelination
|
J:161841
|
Ptentm1Hwu/Ptentm1Hwu
Slc6a3tm1.1(cre)Bkmn/Slc6a3+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal nervous system physiology
|
J:153622
|
Ptentm1Hwu/Ptentm1Hwu
Tg(Gfap-cre)77.6Mvs/0
(involves: 129S4/SvJae * BALB/c * C57BL/6NHsd)
|
abnormal neuronal precursor proliferation
|
J:146630
|
| abnormal response to CNS ischemic injury
|
J:146630
|
Ptentm1Hwu/Ptentm1Hwu
Tg(Plp1-cre/ERT2)1Ueli/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2)
|
hypermyelination
|
J:161841
|
Ptentm1Mro/Ptentm1Mro
Tg(En2-cre)22Alj/0
(Not Specified)
|
abnormal neuronal migration
|
J:77123
|
Ptentm1Rdp/Pten+
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N)
|
seizures
|
J:140704
|
Ptentm1Rps/Pten+
(B6.129S1-Ptentm1Rps)
|
decreased prepulse inhibition
|
J:144937
|
Ptentm1Rps/Pten+
Slc6a4tm1Kpl/Slc6a4+
(B6.129-Slc6a4tm1Kpl Ptentm1Rps)
|
decreased prepulse inhibition
|
J:144937
|
| reduced sensorimotor gating
|
J:144937
|
Ptentm2.1Ppp/Ptentm2.1Ppp
(involves: 129S1/Sv)
|
abnormal excitatory postsynaptic currents
|
J:181347
|
| abnormal miniature excitatory postsynaptic currents
|
J:181347
|
| abnormal synaptic transmission
|
J:181347
|
| increased miniature excitatory postsynaptic current amplitude
|
J:181347
|
| increased miniature excitatory postsynaptic current frequency
|
J:181347
|
Ptentm2.1Ppp/Ptentm2.1Ppp
Tg(GFAP-TAg121)1Tvd/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2 * FVB/N)
|
abnormal astrocyte apoptosis
|
J:99385
|
Ptentm2Mak/Ptentm2Mak
(involves: 129P2/OlaHsd)
|
abnormal astrocyte physiology
|
J:176586
|
Ptentm2Mak/Ptentm2Mak
Tg(Eno2-cre)39Jme/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
reduced sensorimotor gating
|
J:109635
|
| sporadic seizures
|
J:109635
|
Ptentm2Mak/Ptentm2Mak
Tg(Gfap-cre)1Sbk/0
(involves: 129P2/OlaHsd)
|
abnormal spike wave discharge
|
J:149829
|
| seizures
|
J:75500
|
| tonic-clonic seizures
|
J:149829
|
Ptentm2Mak/Ptentm2Mak
Tg(Nes-cre/ERT2,-ALPP)1Sbk/0
(involves: 129P2/OlaHsd)
|
abnormal nervous system physiology
|
J:237990
|
| seizures
|
J:237990
|
Ptgdrtm1Sna/Ptgdrtm1Sna
(involves: 129P2/OlaHsd * C57BL/6)
|
brain inflammation
|
J:243958
|
| decreased microglial cell activation
|
J:243958
|
Ptger2tm1.1Kand/Ptger2tm1.1Kand
Tg(ITGAM-cre)2781Gkl/0
(involves: C57BL/6 * CBA)
|
abnormal microglial cell physiology
|
J:202677
|
Ptger2tm1Brey/Ptger2tm1Brey
(B6.129S6-Ptger2tm1Brey)
|
increased cerebral infarct size
|
J:87388
|
Ptger2tm1Brey/Ptger2tm1Brey
(C.129S6-Ptger2tm1Brey)
|
abnormal excitatory postsynaptic potential
|
J:143076
|
| abnormal microglial cell physiology
|
J:97062
|
| reduced long-term potentiation
|
J:143076
|
Ptger2tm1Brey/Ptger2tm1Brey
(involves: 129S6/SvEvTac * BALB/c)
|
abnormal nervous system physiology
|
J:164638
|
Ptger2tm1Brey/Ptger2tm1Brey
Tg(APPswe,PSEN1dE9)85Dbo/0
(involves: 129S6/SvEvTac * C3H * C57BL/6)
|
abnormal nervous system physiology
|
J:102728
|
Ptgs2tm1Unc/Ptgs2+
(B6.129P2-Ptgs2tm1Unc)
|
decreased cerebral infarct size
|
J:67211
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6.129P2-Ptgs2tm1Unc)
|
abnormal response to CNS ischemic injury
|
J:67211
|
| decreased cerebral infarct size
|
J:67211
|
| decreased susceptibility to neuronal excitotoxicity
|
J:67211
|
Ptgs2tm1Unc/Ptgs2tm1Unc
(B6;129P2-Ptgs2tm1Unc/Tac)
|
abnormal inhibitory postsynaptic currents
|
J:141610
|
| increased susceptibility to neuronal excitotoxicity
|
J:141610
|
| increased susceptibility to pharmacologically induced seizures
|
J:141610
|
| tonic-clonic seizures
|
J:141610
|
Ptmatm1.1Got/Ptma+
(involves: C57BL/6J * C57BL/6NTac)
|
abnormal excitatory postsynaptic potential
|
J:240549
|
| abnormal neuron proliferation
|
J:240549
|
| reduced long-term potentiation
|
J:240549
|
Ptntm1Rau/Ptn+
(either: (involves: 129P2/OlaHsd * 129X1/SvJ) or (involves: 129P2/OlaHsd * C57BL/6J))
|
enhanced long-term potentiation
|
J:70253
|
Ptntm1Rau/Ptntm1Rau
(either: (involves: 129P2/OlaHsd * 129X1/SvJ) or (involves: 129P2/OlaHsd * C57BL/6J))
|
enhanced long-term potentiation
|
J:70253
|
| enhanced paired-pulse facilitation
|
J:70253
|
Ptp4a2em1(IMPC)Tcp/Ptp4a2em1(IMPC)Tcp
(C57BL/6N-Ptp4a2em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Ptpn4tm1Tya/Ptpn4tm1Tya
(involves: 129P2/OlaHsd * C57BL/6J)
|
reduced long-term depression
|
J:127245
|
Ptpn6me/Ptpn6me
(involves: C3HeB/FeJ * C57BL/6)
|
abnormal myelination
|
J:72655
|
Ptpn6me/Ptpn6me
(C3FeLe.B6 a/a-Ptpn6me/J)
|
increased microglial cell activation
|
J:88807
|
Ptpn9tm1Dny/Ptpn9tm1Dny
(B6.129-Ptpn9tm1Dny)
|
intracranial hemorrhage
|
J:118880
|
Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal Schwann cell physiology
|
J:153219
|
Ptpn11tm1.1Wbm/Ptpn11tm1.1Wbm
Tg(Dhh-cre)1Mejr/0
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal Schwann cell physiology
|
J:207470
|
Ptpn20em1Mmsk/Ptpn20em1Mmsk
(C57BL/6J-Ptpn20em1Mmsk)
|
abnormal cerebrospinal fluid physiology
|
J:326016
|
Ptpratm1b(EUCOMM)Hmgu/Ptpratm1b(EUCOMM)Hmgu
(C57BL/6N-Ptpratm1b(EUCOMM)Hmgu/Orl)
|
decreased prepulse inhibition
|
J:211773
|
Ptprcm1Smv/Ptprcm1Smv
(involves: C57BL/6J * C57BL/10J)
|
CNS inflammation
|
J:214487
|
Ptprctm1Mak/Ptprctm1Mak
(involves: 129)
|
abnormal myelination
|
J:104929
|
Ptprdtm1Yiw/Ptprdtm1Yiw
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
enhanced long-term potentiation
|
J:63046
|
| enhanced paired-pulse facilitation
|
J:63046
|
Ptpretm1Ael/Ptpretm1Ael
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal channel response
|
J:63866
|
| demyelination
|
J:63866
|
Ptprftm1Wjh/Ptprftm1Wjh
(B6.129P2-Ptprftm1Wjh)
|
abnormal peripheral nervous system regeneration
|
J:128187
|
| delayed peripheral nervous system regeneration
|
J:128187
|
| impaired central nervous system regeneration
|
J:128187
|
Ptprotm1Dgen/Ptprotm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Ptprqtm1Bow/Ptprqtm1Bow
(involves: 129/Sv * C57BL/6)
|
abnormal hair cell mechanoelectric transduction
|
J:85926
|
Ptprqtm2Bow/Ptprqtm2Bow
(involves: 129 * C57BL/6)
|
abnormal hair cell mechanoelectric transduction
|
J:85926
|
Ptprstm1Mtr/Ptprstm1Mtr
(involves: BALB/c)
|
enhanced central nervous system regeneration
|
J:85382
|
Ptprstm1Mtr/Ptprstm1Mtr
(Not Specified)
|
abnormal neuron physiology
|
J:191258
|
Ptprstm1Mtr/Ptprstm1Mtr
Rtn4rtm1.1Pado/Rtn4rtm1.1Pado
Rtn4rl1tm1.1Rojg/Rtn4rl1tm1.1Rojg
(involves: 129S/SvEvBrd * 129S4/SvJae)
|
enhanced central nervous system regeneration
|
J:191258
|
Ptprtm1Rgsc/Ptprtm1Rgsc
(C57BL/6J-Ptprtm1Rgsc)
|
abnormal miniature inhibitory postsynaptic currents
|
J:298303
|
| enhanced long-term potentiation
|
J:298303
|
Ptprttm1Sata/Ptprttm1Sata
(involves: 129P2/OlaHsd)
|
decreased miniature inhibitory postsynaptic current frequency
|
J:298303
|
| decreased neuronal stem cell self-renewal
|
J:298303
|
| enhanced long-term potentiation
|
J:298303
|
Ptprvtm1b(NCOM)Mfgc/Ptprvtm1b(NCOM)Mfgc
(C57BL/6N-Ptprvtm1b(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Ptprz1tm1Mno/Ptprz1tm1Mno
(B6.129-Ptprz1tm1Mno)
|
enhanced long-term potentiation
|
J:98253
|
Ptprz1tm1Schl/Ptprz1tm1Schl
(involves: 129 * Swiss Webster)
|
abnormal myelination
|
J:79860
|
Ptstm1Ich/Ptstm1Ich
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal nervous system physiology
|
J:84764
|
Ptstm1Ich/Ptstm1Ich
Tg(DBH-PTS)6Csic/0
(B6.Cg-Ptstm1Ich Tg(DBH-PTS)6Csic)
|
abnormal nervous system physiology
|
J:102278
|
Ptstm1Ich/Ptstm1Ich
Tg(DBH-PTS)6Csic/0
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal nervous system physiology
|
J:138968
|
| abnormal neuron physiology
|
J:138968
|
Pum1em1(IMPC)Mbp/Pum1em1(IMPC)Mbp
(C57BL/6NCrl-Pum1em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Puratm1Herm/Pura+
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal neuron proliferation
|
J:179606
|
Puratm1Herm/Puratm1Herm
(involves: 129P2/OlaHsd * BALB/c)
|
abnormal neuron proliferation
|
J:179606
|
Puratm1Kkh/Pura+
(involves: 129)
|
seizures
|
J:85759
|
Puratm1Kkh/Puratm1Kkh
(involves: 129)
|
decreased neuronal precursor proliferation
|
J:85759
|
| seizures
|
J:85759
|
Pycr2tm1.1Brre/Pycr2tm1.1Brre
(involves: C57BL/6)
|
abnormal oligodendrocyte apoptosis
|
J:296329
|
| increased neuron apoptosis
|
J:296329
|
Pyytm1(cre)Hhzg/Pyytm1(cre)Hhzg
(involves: 129)
|
abnormal hypothalamus physiology
|
J:111480
|
Qkie5/Qkie5
(B6.101Rl-Qkie5)
|
abnormal myelination
|
J:102038
|
| seizures
|
J:102038
|
Qkie5/Qkiqk-k2
(involves: 101/Rl * C57BL/6J * CBA/Ca)
|
seizures
|
J:102038
|
Qkie5/Qkiqk-kt1
(involves: 101/Rl * C57BL/6J)
|
seizures
|
J:102038
|
Qkiqk-shk/Qkiqk-shk
(involves: 129 * C57BL/6)
|
demyelination
|
J:220956
|
| tonic seizures
|
J:220956
|
Qkiqk-v/Qkiqk-v
(B6C3Fe a/a-Qkiqk-v/J)
|
abnormal myelination
|
J:160743,
J:102038
|
| seizures
|
J:102038
|
Qkiqk-v/Qkiqk-v
(involves: C3H/Di * DBA/2J)
|
abnormal myelination
|
J:13141
|
| tonic seizures
|
J:13141
|
Qsox1em1(IMPC)Kmpc/Qsox1em1(IMPC)Kmpc
(C57BL/6NTac-Qsox1em1(IMPC)Kmpc/Kmpc)
|
decreased prepulse inhibition
|
J:211773
|
Rab3atm1Sud/Rab3atm1Sud
(involves: 129)
|
increased synaptic depression
|
J:64297
|
Rab3atm1Sud/Rab3atm1Sud
Rab3btm1Sud/Rab3btm1Sud
Rab3ctm1Sud/Rab3ctm1Sud
Rab3dtm1Rja/Rab3dtm1Rja
(involves: 129 * 129P2/OlaHsd)
|
abnormal CNS synaptic transmission
|
J:104983
|
| abnormal excitatory postsynaptic currents
|
J:105478,
J:104983
|
| decreased neurotransmitter release
|
J:105478
|
| enhanced paired-pulse facilitation
|
J:104983
|
Rab3gap1tm1Tkss/Rab3gap1tm1Tkss
(involves: 129X1/SvJ * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:111069
|
| abnormal neurotransmitter secretion
|
J:111069
|
| enhanced paired-pulse facilitation
|
J:111069
|
Rab6bem1(IMPC)J/Rab6bem1(IMPC)J
(C57BL/6NJ-Rab6bem1(IMPC)J/J)
|
decreased prepulse inhibition
|
J:211773
|
Rabep2em1Dmar/Rabep2+
(C57BL/6J-Rabep2em1Dmar)
|
increased cerebral infarct size
|
J:330882
|
Rabep2em1Dmar/Rabep2em1Dmar
(C57BL/6J-Rabep2em1Dmar)
|
increased cerebral infarct size
|
J:330882
|
Rabgap1tm1b(EUCOMM)Hmgu/Rabgap1tm1b(EUCOMM)Hmgu
(C57BL/6N-Rabgap1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Rad54l2Gt(A016E03)Oaj/Rad54l2Gt(A016E03)Oaj
(involves: ICR)
|
decreased embryonic neuroepithelial cell proliferation
|
J:121844
|
| increased neural tube apoptosis
|
J:121844
|
Rag1tm1Mom/Rag1tm1Mom
(involves: 129S7/SvEvBrd)
|
abnormal neuron proliferation
|
J:170591
|
Rag2tm1.1Cgn/Rag2tm1.1Cgn
Tg(HLA-DR2)#Lfug/0
Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2)
|
CNS inflammation
|
J:134764
|
| demyelination
|
J:134764
|
Rai1tm1Jrl/Rai1+
(involves: 129S/SvEvBrd * C57BL/6)
|
abnormal brain wave pattern
|
J:125089
|
| seizures
|
J:125089
|
Rai1tm1Jrl/Rai1tm1Jrl
(involves: 129S/SvEvBrd * C57BL/6)
|
abnormal brain wave pattern
|
J:125089
|
| seizures
|
J:125089
|
| tonic-clonic seizures
|
J:125089
|
Ralatm1a(EUCOMM)Wtsi/Ralatm1a(EUCOMM)Wtsi
(C57BL/6N-Ralatm1a(EUCOMM)Wtsi/Wtsi)
|
intraventricular hemorrhage
|
J:239583
|
| spinal hemorrhage
|
J:239583
|
Ralbp1Gt(RRC077)Byg/Ralbp1Gt(RRC077)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
reduced long-term depression
|
J:201267
|
Ramp2tm1.1Tash/Ramp2+
(involves: C57BL/6)
|
impaired blood-brain barrier function
|
J:130931
|
Ranbp1Gt(S17-6E1)1.1Sor/Ranbp1Gt(S17-6E1)1.1Sor
(B6.129S4(129S6)-Ranbp1Gt(S17-6E1)1.1Sor)
|
abnormal neuronal precursor proliferation
|
J:235630
|
Ranbp2Gt(pGT0pfs)630Wcs/Ranbp2+
(129P2/OlaHsd-Ranbp2Gt(pGT0pfs)630Wcs)
|
abnormal nervous system physiology
|
J:116134
|
Rap1atm1Morz/Rap1atm1Morz
Rap1btm1Morz/Rap1btm1Morz
Tg(Camk2a-cre)1Szi/?
(involves: 129S/SvEv * C57BL/6J * CBA)
|
abnormal excitatory postsynaptic potential
|
J:132855
|
| abnormal nervous system physiology
|
J:132855
|
| abnormal synaptic glutamate release
|
J:132855
|
| decreased paired-pulse facilitation
|
J:132855
|
| reduced long-term potentiation
|
J:132855
|
Rap1gds1tm1Ytk/Rap1gds1tm1Ytk
(involves: 129X1/SvJ * C57BL/6 * DBA)
|
increased spinal cord apoptosis
|
J:62244
|
Rapgef3tm1Utak/Rapgef3tm1Utak
(involves: C57BL/6 * CBA)
|
decreased neuron apoptosis
|
J:170436
|
Rapsnem1Gan/Rapsnem1Gan
(C57BL/6J-Rapsnem1Gan)
|
abnormal miniature endplate potential
|
J:282816
|
Rapsnem1Gan/Rapsntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal miniature endplate potential
|
J:282816
|
Raratm1Ipc/Raratm2Ipc
Rargtm1Ipc/Rarg+
(involves: 129S2/SvPas)
|
intracerebral hemorrhage
|
J:21009
|
Rarbtm1Vgi/Rarbtm1Vgi
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:51892
|
| absent long-term depression
|
J:51892
|
| reduced long-term potentiation
|
J:51892
|
Rarbtm1Vgi/Rarbtm1Vgi
Rxrbtm1Rev/Rxrbtm1Rev
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:51892
|
| absent long-term depression
|
J:51892
|
| reduced long-term potentiation
|
J:51892
|
ras/ras
(involves: DBA/1Bg)
|
abnormal brain wave pattern
|
J:16802
|
Rasd1tm1.1Snyd/Rasd1tm1.1Snyd
(involves: C57BL/6)
|
decreased susceptibility to neuronal excitotoxicity
|
J:195135
|
Rasgef1bem1(IMPC)J/Rasgef1bem1(IMPC)J
(C57BL/6NJ-Rasgef1bem1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Rasgrf1tm1Kln/Rasgrf1tm1Kln
(involves: 129/Sv * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:73879
|
| impaired synaptic plasticity
|
J:73879
|
| reduced long-term potentiation
|
J:73879
|
Rasgrf1tm1Sva/Rasgrf1tm1Sva
Rasgrf2tm1Feig/Rasgrf2tm1Feig
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased susceptibility to ischemic brain injury
|
J:90111
|
Rasgrf1tm1Toc/Rasgrf1+
(involves: 129)
|
abnormal pituitary secretion
|
J:47681
|
Raver1tm1Hha/Raver1tm1Hha
(B6.129S2-Raver1tm1Hha)
|
reduced long-term depression
|
J:137591
|
| reduced long-term potentiation
|
J:137591
|
Raxtm1.1(cre/ERT2)Sbls/Rax+
Yap1tm1Hmc/Yap1tm1Hmc
(involves: 129S6/SvEvTac * C57BL/6NCrl)
|
abnormal glial cell physiology
|
J:304126
|
Rb1tm1Brd/Rb1tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
increased neuron apoptosis
|
J:2516
|
Rb1tm1Tyj/Rb1tm1Tyj
(involves: 129S2/SvPas)
|
increased neuron apoptosis
|
J:81643
|
Rb1tm1Tyj/Rb1tm1Tyj
(involves: 129S2/SvPas * C57BL/6)
|
increased neuron apoptosis
|
J:2511
|
Rb1tm2Brn/Rb1tm2Brn
Rbl1tm1Htr/Rbl1+
Tg(En2-cre)22Alj/0
(involves: 129P2/OlaHsd * CD-1)
|
abnormal neuronal precursor proliferation
|
J:83783
|
| increased neuron apoptosis
|
J:83783
|
Rb1tm2Brn/Rb1tm2Brn
Rbl1tm1Htr/Rbl1tm1Htr
Tg(En2-cre)22Alj/0
(involves: 129P2/OlaHsd * CD-1)
|
abnormal neuronal precursor proliferation
|
J:83783
|
Rb1tm2Brn/Rb1tm2Brn
Tg(En2-cre)22Alj/0
(involves: 129P2/OlaHsd * CD-1)
|
abnormal neuronal precursor proliferation
|
J:83783
|
| increased neuron apoptosis
|
J:83783
|
Rb1tm3Tyj/Rb1tm3.1Tyj
Tg(Nes-cre)1Atp/0
(involves: 129S4/SvJae * FVB/N)
|
increased neuron apoptosis
|
J:81643
|
Rb(12.Ts171665Dn)2Cje/0
(involves: C3H/HeSnJ * C57BL/6JEiJ)
|
increased neuron apoptosis
|
J:110478
|
Rb(12.Ts171665Dn)2Cje/0
(Not Specified)
|
abnormal nervous system electrophysiology
|
J:294908
|
Rbfox1tm1.1Dblk/Rbfox1+
Rbfox2tm1.1Dblk/Rbfox2tm1.1Dblk
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
abnormal neuron physiology
|
J:181631
|
Rbfox1tm1.1Dblk/Rbfox1+
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)
|
increased susceptibility to pharmacologically induced seizures
|
J:176189
|
Rbfox1tm1.1Dblk/Rbfox1tm1.1Dblk
Rbfox2tm1.1Dblk/Rbfox2tm1.1Dblk
Tg(Pcp2-cre)2Mpin/0
(involves: 129 * C57BL/6J)
|
abnormal neuron physiology
|
J:181631
|
Rbfox1tm1.1Dblk/Rbfox1tm1.1Dblk
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * 129S4/SvJaeSor * C57BL/6 * C57BL/6J * SJL)
|
abnormal excitatory postsynaptic potential
|
J:176189
|
| increased susceptibility to pharmacologically induced seizures
|
J:176189
|
| seizures
|
J:176189
|
| tonic-clonic seizures
|
J:176189
|
Rbfox2tm1.1Dblk/Rbfox2tm1.1Dblk
Tg(Nes-cre)1Kln/0
(involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL)
|
abnormal neuron physiology
|
J:181631
|
| abnormal Purkinje cell migration
|
J:181631
|
| decreased cerebellar granule cell precursor proliferation
|
J:181631
|
| increased neuron apoptosis
|
J:181631
|
Rbfox3tm1a(EUCOMM)Hmgu/Rbfox3tm1a(EUCOMM)Hmgu
(B6Dnk;B6N-Rbfox3tm1a(EUCOMM)Hmgu/H)
|
abnormal CNS synaptic transmission
|
J:234043
|
| abnormal excitatory postsynaptic potential
|
J:234043,
J:240501
|
| abnormal hippocampus physiology
|
J:234043
|
| abnormal miniature inhibitory postsynaptic currents
|
J:234043
|
| decreased neuronal precursor proliferation
|
J:240501
|
| decreased paired-pulse facilitation
|
J:234043
|
| impaired synaptic plasticity
|
J:234043,
J:240501
|
| increased miniature inhibitory postsynaptic current frequency
|
J:234043
|
| increased neurotransmitter release
|
J:234043
|
| increased susceptibility to pharmacologically induced seizures
|
J:234043
|
| reduced long-term depression
|
J:234043,
J:240501
|
Rbl1tm1Mru/Rbl1tm1Mru
(involves: 129S4/SvJae * BALB/c * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:92520
|
Rbl2tm1Mru/Rbl2tm1Mru
(involves: 129S4/SvJae * BALB/cJ)
|
increased neuron apoptosis
|
J:50516
|
Rbm25em1(IMPC)J/Rbm25+
(C57BL/6NJ-Rbm25em1(IMPC)J/J)
|
decreased prepulse inhibition
|
J:211773
|
Rcor2tm1c(EUCOMM)Wtsi/Rcor2tm1c(EUCOMM)Wtsi
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal neuron physiology
|
J:235702
|
| decreased neuronal precursor proliferation
|
J:235702
|
Reep1Gt(OST398247)Tigm/Reep1Gt(OST398247)Tigm
(B6J.Cg-Reep1Gt(OST398247)Tigm)
|
abnormal nervous system electrophysiology
|
J:239250
|
| demyelination
|
J:239250
|
Reltm1Hcl/Reltm1Hcl
(involves: 129S4/SvJae * C57BL/6)
|
increased neuron apoptosis
|
J:111862
|
Relatm1Bal/Relatm1Bal
(involves: 129S4/SvJae)
|
abnormal neuron physiology
|
J:119844
|
| increased neuron apoptosis
|
J:119844
|
Relatm1Bal/Relatm1Bal
Tnftm1Ljo/Tnftm1Ljo
(involves: 129S1/Sv * 129S4/SvJae * C57BL/6)
|
abnormal nervous system physiology
|
J:124444
|
Rell1em1(IMPC)J/Rell1em1(IMPC)J
(C57BL/6NJ-Rell1em1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Relnrl/Reln+
(B6.Cg-Relnrl)
|
abnormal prepulse inhibition
|
J:223944
|
Relnrl/Relnrl
(C3.Cg-Relnrl)
|
abnormal neuronal migration
|
J:12728
|
Rem2tm1a(EUCOMM)Hmgu/Rem2tm1a(EUCOMM)Hmgu
(129S2.B6N-Rem2tm1a(EUCOMM)Hmgu)
|
abnormal action potential
|
J:263600
|
| abnormal CNS synaptic transmission
|
J:263600
|
| abnormal miniature excitatory postsynaptic currents
|
J:263600
|
| increased miniature inhibitory postsynaptic current frequency
|
J:263600
|
Rem2tm1c(EUCOMM)Hmgu/Rem2tm1c(EUCOMM)Hmgu
(involves: 129S4/SvJaeSor * C57BL/6N)
|
abnormal action potential
|
J:263600
|
| abnormal CNS synaptic transmission
|
J:263600
|
| abnormal miniature excitatory postsynaptic currents
|
J:263600
|
Ren1tm1.2Sig/Ren1tm1.2Sig
(involves: C57BL/6J)
|
abnormal baroreceptor physiology
|
J:169129
|
Resttm1Mlit/Resttm1Mlit
Tg(Eno2-cre)#Mlit/0
(involves: 129S1/Sv * C57BL/6 * DBA)
|
increased neuron apoptosis
|
J:173834
|
Rettm1Cos/Ret+
(involves: 129S/SvEv * C57BL/6)
|
abnormal neurotransmitter secretion
|
J:82456
|
Rettm1Jmi/Rettm1Jmi
(involves: 129X1/SvJ)
|
increased neuron apoptosis
|
J:71881
|
Rettm1Kln/Rettm1Kln
Slc6a3tm1(cre)Xz/Slc6a3+
(involves: 129S1/Sv)
|
abnormal synaptic dopamine release
|
J:188348
|
Rettm2.1Heno/Rettm2.1Heno
(involves: 129S/Sv * C57BL/6 * FVB/N)
|
increased neuron apoptosis
|
J:135153
|
Rettm3.1(Bcl2l1)Heno/Ret+
(involves: 129/Sv * C57BL/6)
|
decreased neuron apoptosis
|
J:159854
|
Retreg3tm2b(EUCOMM)Wtsi/Retreg3tm2b(EUCOMM)Wtsi
(C57BL/6N-Fam134ctm2b(EUCOMM)Wtsi/Wtsi)
|
decreased prepulse inhibition
|
J:211773
|
Rgl1em1(IMPC)Mbp/Rgl1+
(C57BL/6N-Rgl1em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Rgs2tm1Pngr/Rgs2tm1Pngr
(involves: C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:77273
|
Rgs11tm1Lex/Rgs11tm1Lex
Rgs7tm1.1Kama/Rgs7tm1.1Kama
(involves: 129S5/SvEvBrd * C57BL/6 * FVB/N * SJL)
|
abnormal single cell response
|
J:184794
|
Rgs14tm1Lex/Rgs14tm1Lex
(involves: 129S/SvEvBrd * C57BL/6)
|
abnormal action potential
|
J:164681
|
| abnormal neuron physiology
|
J:164681
|
| abnormal synaptic plasticity
|
J:164681
|
| enhanced long-term potentiation
|
J:164681
|
Rgsc73/Rgsc73+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
convulsive seizures
|
J:133634
|
Rhbdf1tm1.1Mfm/Rhbdf1tm1.1Mfm
(involves: 129S/SvEv * 129S6/SvEvTac)
|
intracerebral hemorrhage
|
J:203951
|
Rhbdf2tm1Mak/Rhbdf2tm1Mak
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal microglial cell physiology
|
J:221411
|
Rhebtm1Pfw/Rhebtm1Pfw
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
demyelination
|
J:168571
|
Rhoatm1Jrel/Rhoatm1Jrel
Tg(Pou3f4-cre)32Cren/0
(involves: CD-1)
|
abnormal neuronal precursor proliferation
|
J:171199
|
| increased spinal cord apoptosis
|
J:171199
|
Rhoatm1Yuyo/Rhoatm1Yuyo
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: C57BL/6J * CBA/J)
|
abnormal neuron proliferation
|
J:172044
|
Rhoqtm1b(EUCOMM)Hmgu/Rhoqtm1b(EUCOMM)Hmgu
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N)
|
abnormal peripheral nervous system regeneration
|
J:308705
|
| impaired central nervous system regeneration
|
J:308705
|
Rhoqtm1c(EUCOMM)Hmgu/Rhoqtm1c(EUCOMM)Hmgu
Tg(Atf3-GFP*,-cre)#Hiki/0
(involves: C57BL/6 * C57BL/6N * DBA/2)
|
abnormal peripheral nervous system regeneration
|
J:308705
|
Rhot1tm1c(EUCOMM)Wtsi/Rhot1tm1c(EUCOMM)Wtsi
Tg(Camk2a-cre)1Gsc/0
(involves: C57BL/6Dnk * C57BL/6N * FVB/N)
|
abnormal axonal transport
|
J:240500
|
Rhot1tm1d(EUCOMM)Wtsi/Rhot1tm1d(EUCOMM)Wtsi
(involves: C57BL/6Dnk * C57BL/6N)
|
abnormal axonal transport
|
J:240500
|
Ric8atm1.1Zhua/Ric8atm1.1Zhua
Tg(GFAP-cre)25Mes/0
(involves: FVB/N)
|
abnormal cerebellar granule cell migration
|
J:191222
|
Rimbp2tm1.2Geno/Rimbp2tm1.2Geno
(involves: C57BL/6)
|
abnormal CNS synaptic transmission
|
J:238503
|
| abnormal excitatory postsynaptic currents
|
J:238503
|
| abnormal paired-pulse inhibition
|
J:238503
|
| abnormal synaptic plasticity
|
J:238503
|
| decreased excitatory postsynaptic current amplitude
|
J:238503
|
| enhanced paired-pulse facilitation
|
J:238503
|
| increased paired-pulse ratio
|
J:238503
|
Rimbp2tm1.2Geno/Rimbp2tm1.2Geno
Tspoap1tm1.2Geno/Tspoap1tm1.2Geno
(involves: C57BL/6)
|
abnormal CNS synaptic transmission
|
J:238503
|
| abnormal paired-pulse inhibition
|
J:238503
|
| abnormal synaptic plasticity
|
J:238503
|
| enhanced paired-pulse facilitation
|
J:238503
|
Rims1tm1Sud/Rims1tm1Sud
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:73900
|
| abnormal excitatory postsynaptic potential
|
J:73900
|
| abnormal long-term depression
|
J:73899
|
| abnormal paired-pulse facilitation
|
J:73900
|
| abnormal post-tetanic potentiation
|
J:73900
|
| decreased paired-pulse facilitation
|
J:73900
|
| enhanced paired-pulse facilitation
|
J:73900
|
| reduced long-term potentiation
|
J:73899
|
Rims1tm1Sud/Rims1tm1Sud
(involves: 129P2/OlaHsd)
|
abnormal excitatory postsynaptic currents
|
J:106269
|
| abnormal inhibitory postsynaptic currents
|
J:143053
|
| abnormal paired-pulse inhibition
|
J:143053
|
| impaired synaptic plasticity
|
J:106269
|
Rims1tm1Sud/Rims1tm1Sud
Rims2tm1.1Schc/Rims2tm1.1Schc
(involves: 129P2/OlaHsd * 129S1/Sv * 129S4/SvJae * 129X1/SvJ)
|
abnormal endplate potential
|
J:119934
|
| abnormal miniature endplate potential
|
J:119934
|
Rims1tm3.1Sud/Rims1tm3.1Sud
(involves: 129S/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal inhibitory postsynaptic currents
|
J:143053
|
| abnormal paired-pulse inhibition
|
J:143053
|
| enhanced paired-pulse facilitation
|
J:143053
|
| impaired synaptic plasticity
|
J:143053
|
Rims1tm3Sud/Rims1tm3Sud
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal inhibitory postsynaptic currents
|
J:143053
|
Rims1tm3Sud/Rims1tm3Sud
Rims2tm1.1Sud/Rims2tm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal neuron physiology
|
J:168840
|
Rin1tm1Colc/Rin1tm1Colc
(involves: 129X1/SvJ * C57BL/6)
|
enhanced long-term potentiation
|
J:81922
|
Rln3tm1Mast/Rln3tm1Mast
(B6N.129-Rln3tm1Mast)
|
abnormal paired-pulse inhibition
|
J:176206
|
Rnase1em5(IMPC)Tcp/Rnase1em5(IMPC)Tcp
(C57BL/6NCrl-Rnase1em5(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Rnd2tm1.1Fgu/Rnd2tm1.1Fgu
(Not Specified)
|
abnormal action potential
|
J:344858
|
| abnormal cerebellar granule cell migration
|
J:344858
|
| increased neuron apoptosis
|
J:344858
|
Rnd2tm1.1Jya/Rnd2tm1.1Jya
Tg(Mbp-cre)9Gvn/0
(involves: C57BL/6 * FVB/N)
|
abnormal myelination
|
J:309719
|
Rnd2tm1.1Jya/Rnd2tm1.1Jya
Tg(Plp1-cre/ERT)3Pop/0
(B6.Cg-Rnd2tm1.1Jya Tg(Plp1-cre/ERT)3Pop)
|
abnormal myelination
|
J:309719
|
Rnd3Gt(OST364657)Lex/Rnd3Gt(OST364657)Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
convulsive seizures
|
J:172361
|
Rnf7Gt(XE423)Byg/Rnf7Gt(XE423)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
increased spinal cord apoptosis
|
J:178926
|
Rnf7tm1c(EUCOMM)Wtsi/Rnf7tm1c(EUCOMM)Wtsi
(involves: C57BL/6N)
|
abnormal neuronal migration
|
J:205551
|
Rnf7tm1c(EUCOMM)Wtsi/Rnf7tm1c(EUCOMM)Wtsi
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
decreased cerebellar granule cell precursor proliferation
|
J:205551
|
Rnf10em1(IMPC)Bay/Rnf10em1(IMPC)Bay
(C57BL/6N-Rnf10em1(IMPC)Bay/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Ics)
|
decreased prepulse inhibition
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/H)
|
decreased prepulse inhibition
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/J)
|
convulsive seizures
|
J:211773
|
| decreased prepulse inhibition
|
J:211773
|
Rnf10tm1b(KOMP)Wtsi/Rnf10tm1b(KOMP)Wtsi
(C57BL/6N-Rnf10tm1b(KOMP)Wtsi/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Rnf19aGt(OST244733)Lex/Rnf19aGt(OST244733)Lex
(B6.129S5-Rnf19aGt(OST244733)Lex)
|
abnormal miniature excitatory postsynaptic currents
|
J:250032
|
| abnormal neuron proliferation
|
J:250032
|
| enhanced long-term potentiation
|
J:250032
|
Rnf43em1(IMPC)Tcp/Rnf43em1(IMPC)Tcp
(C57BL/6NCrl-Rnf43em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Rnf103tm1.1Thg/Rnf103tm1.1Thg
(B6N.129-Rnf103tm1.1Thg)
|
increased prepulse inhibition
|
J:154853
|
Rnf112tm1(KOMP)Vlcg/Rnf112tm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
abnormal miniature excitatory postsynaptic currents
|
J:232515
|
| decreased paired-pulse facilitation
|
J:232515
|
Rnf128tm1Cdon/Rnf128tm1Cdon
(involves: 129 * C57BL/6)
|
CNS inflammation
|
J:160681
|
Robo1tm1.1Ljr/Robo1tm1.1Ljr
(B6.129-Robo1tm1.1Ljr)
|
abnormal neuronal migration
|
J:109478
|
Robo3tm1Matl/Robo3tm1Matl
(involves: C57BL/6)
|
abnormal pre-Botzinger complex physiology
|
J:165285
|
Rock1tm1.1Itl/Rock1tm1.1Itl
Tg(Npy-hrGFP)1Lowl/0
Tg(Pomc1-cre)16Lowl/0
(involves: 129S4/SvJaeSor * C57BL/6 * FVB/N)
|
abnormal nervous system electrophysiology
|
J:204885
|
Rock2tm1Zpj/Rock2tm1Zpj
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal excitatory postsynaptic potential
|
J:225274
|
| decreased paired-pulse facilitation
|
J:225274
|
| reduced long-term potentiation
|
J:225274
|
Rogditm1.2Ics/Rogditm1.2Ics
(involves: C57BL/6N)
|
increased susceptibility to pharmacologically induced seizures
|
J:344072
|
Ror1em1(IMPC)Ccpcz/Ror1+
(C57BL/6NCrl-Ror1em1(IMPC)Ccpcz/Ccpcz)
|
increased prepulse inhibition
|
J:211773
|
Rorasg/Rorasg
(involves: obese stock)
|
abnormal nervous system physiology
|
J:28478
|
Rorasg/Rorasg
(involves: C57BL)
|
abnormal synaptic glutamate release
|
J:6875
|
Roratm1Mba/Roratm1Mba
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:46854
|
Roratmgc26/Roratmgc26
(involves: D7R75M)
|
abnormal neuron proliferation
|
J:171777
|
| decreased cerebellar granule cell precursor proliferation
|
J:171777
|
Rp9tm1b(EUCOMM)Wtsi/Rp9tm1b(EUCOMM)Wtsi
(C57BL/6N-Rp9tm1b(EUCOMM)Wtsi/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Rps6ka3tm1.1Kry/Rps6ka3tm1.1Kry
(B6.129X1(Cg)-Rps6ka3tm1.1Kry)
|
abnormal CNS synaptic transmission
|
J:201540
|
| abnormal excitatory postsynaptic potential
|
J:201540
|
| reduced AMPA-mediated synaptic currents
|
J:201540
|
| short excitatory postsynaptic current decay time
|
J:201540
|
Rps6ka5tm1.1Arte/Rps6ka5tm1.1Arte
(involves: C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:188104
|
Rps6ka5tm1Jsca/Rps6ka5tm1Jsca
(Not Specified)
|
increased susceptibility to neuronal excitotoxicity
|
J:172062
|
Rps7Zma/Rps7+
(involves: BALB/c * C3H/HeH * C57BL/6J)
|
increased neuron apoptosis
|
J:195156
|
Rps23rg1em1Ywuz/Rps23rg1em1Ywuz
(C57BL/6-Rps23rg1em1Ywuz)
|
abnormal excitatory postsynaptic potential
|
J:272361
|
| abnormal miniature excitatory postsynaptic currents
|
J:272361
|
| decreased excitatory postsynaptic current amplitude
|
J:272361
|
| reduced long-term potentiation
|
J:272361
|
Rr305em1Drf/Rr305em1Drf
(Not Specified)
|
reduced long-term depression
|
J:308813
|
Rrn3tm1.2Igt/Rrn3tm1.2Igt
(involves: 129/Sv * C57BL/6 * SJL)
|
increased neural tube apoptosis
|
J:99711
|
Rs1tm1.1Rom/Y
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal neuron physiology
|
J:285517
|
Rs1tm2.1Rom/Y
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal neuron physiology
|
J:285517
|
Rs1tm3.1Rom/Y
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal neuron physiology
|
J:285517
|
Rsf1tm1b(EUCOMM)Wtsi/Rsf1+
(C57BL/6N-Rsf1tm1b(EUCOMM)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Rsf1tm1c(EUCOMM)Wtsi/Rsf1tm1c(EUCOMM)Wtsi
Tg(Nes-cre)1Kln/0
(involves: C57BL/6N * SJL)
|
decreased neuron apoptosis
|
J:267928
|
Rsph9em1Jwji/Rsph9em1Jwji
(B6.Cg-Rsph9em1Jwji)
|
abnormal brain ependyma motile cilium physiology
|
J:294184
|
| abnormal cerebrospinal fluid flow
|
J:294184
|
| abnormal myelination
|
J:294184
|
| increased microglial cell activation
|
J:294184
|
Rtcatm1a(EUCOMM)Hmgu/Rtcatm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
enhanced central nervous system regeneration
|
J:233466
|
Rtn4em1(IMPC)Hmgu/Rtn4em1(IMPC)Hmgu
(C57BL/6NCrl-Rtn4em1(IMPC)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Rtn4Gt(OST45048)Lex/Rtn4Gt(OST45048)Lex
(involves: 129S5/SvEvBrd)
|
enhanced central nervous system regeneration
|
J:83193
|
Rtn4tm1Matl/Rtn4tm1Matl
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal nervous system physiology
|
J:83192
|
Rtn4tm1Schw/Rtn4tm1Schw
(involves: 129S6/SvEvTac * C57BL/6)
|
enhanced central nervous system regeneration
|
J:107700
|
Rtn4tm3.1Matl/Rtn4tm3.1Matl
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal central nervous system regeneration
|
J:151085
|
Rtn4rtm1.1Pado/Rtn4rtm1.1Pado
Rtn4rl1tm1.1Rojg/Rtn4rl1tm1.1Rojg
(involves: 129S/SvEvBrd * 129S4/SvJae)
|
enhanced central nervous system regeneration
|
J:191258
|
Rtn4rtm1.1Pado/Rtn4rtm1.1Pado
Rtn4rl1tm1.1Rojg/Rtn4rl1tm1.1Rojg
Rtn4rl2tm1.1Pado/Rtn4rl2tm1.1Pado
(involves: 129S/SvEvBrd * 129S4/SvJae)
|
abnormal neuron physiology
|
J:191258
|
| enhanced central nervous system regeneration
|
J:191258
|
Rtn4rtm1Matl/Rtn4rtm1Matl
(involves: 129S7/SvEvBrd)
|
abnormal response to CNS ischemic injury
|
J:166895
|
Rtn4rtm1Stmr/Rtn4rtm1Stmr
(involves: 129X1/SvJ * C57BL/6J)
|
enhanced central nervous system regeneration
|
J:94754
|
Rtn4rtm2.1Stmr/Rtn4rtm2.2Stmr
Tg(CAG-cre/Esr1*)5Amc/0
(B6.Cg-Rtn4rtm2.1Stmr/Rtn4rtm2.2Stmr Tg(CAG-cre/Esr1*)5Amc0)
|
abnormal nervous system regeneration
|
J:201118
|
Rtn4rtm2.2Stmr/Rtn4rtm2.2Stmr
(B6.Cg-Rtn4rtm2.2Stmr)
|
abnormal nervous system regeneration
|
J:201118
|
Runx1tm1(RUNX1/EVI1)Kmit/Runx1+
(involves: C57BL/6 * CBA)
|
intraventricular hemorrhage
|
J:118892
|
Runx1tm1Dow/Runx1tm1Dow
(involves: 129P2/OlaHsd * C57BL/6)
|
intraventricular hemorrhage
|
J:31130
|
Runx1tm1Sata/Runx1tm1Sata
(involves: 129S4/SvJae * C57BL/6J)
|
intraventricular hemorrhage
|
J:63424
|
Runx1tm1Yg/Runx1tm2Spe
(either: (involves: 129/Sv) or (involves: 129/Sv * ICR) or (involves: 129/Sv * MF1))
|
intracranial hemorrhage
|
J:125830
|
| spinal hemorrhage
|
J:125830
|
Runx1tm2Dow/Runx1+
(involves: 129P2/OlaHsd * C57BL/6)
|
intraventricular hemorrhage
|
J:79160
|
Runx1tm5Spe/Runx1tm5Spe
(involves: 129/Sv * C57BL/6)
|
intraventricular hemorrhage
|
J:120100
|
Runx1tm6Spe/Runx1tm6Spe
(involves: 129/Sv * C57BL/6)
|
intraventricular hemorrhage
|
J:120100
|
Runx1tm7Spe/Runx1tm7Spe
(involves: 129/Sv * C57BL/6)
|
intraventricular hemorrhage
|
J:120100
|
Runx2em1(IMPC)Rbrc/Runx2+
(C57BL/6NJcl-Runx2em1(IMPC)Rbrc/Rbrc)
|
decreased prepulse inhibition
|
J:211773
|
Runx3tm1Yg/Runx3tm1Yg
(either: (involves: 129S1/Sv * 129X1/SvJ * ICR) or (involves: 129S1/Sv * 129X1/SvJ * MF1))
|
abnormal excitatory postsynaptic potential
|
J:77764
|
| abnormal nervous system electrophysiology
|
J:77764
|
Ryr2em1Swch/Ryr2+
(involves: 129 * C57BL/6)
|
abnormal action potential
|
J:302151
|
Ryr2tm1Slh/Ryr2+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal afterhyperpolarization
|
J:235432
|
| abnormal brain wave pattern
|
J:235432
|
| abnormal miniature excitatory postsynaptic currents
|
J:235432
|
| abnormal nervous system electrophysiology
|
J:235432
|
| decreased paired-pulse ratio
|
J:235432
|
| increased susceptibility to pharmacologically induced seizures
|
J:235432
|
Ryr2tm2Amks/Ryr2+
(B6.129-Ryr2tm2Amks)
|
abnormal brain wave pattern
|
J:137696
|
| increased susceptibility to pharmacologically induced seizures
|
J:137696
|
| tonic-clonic seizures
|
J:137696
|
Ryr2tm2Amks/Ryr2tm2Amks
(B6.129-Ryr2tm2Amks)
|
increased susceptibility to pharmacologically induced seizures
|
J:137696
|
| tonic-clonic seizures
|
J:137696
|
Ryr3tm1Jms/Ryr3tm1Jms
(involves: 129P2/OlaHsd * C57BL/6J)
|
absent long-term depression
|
J:58558
|
| enhanced long-term potentiation
|
J:58558
|
S1pr1tm1Jch/S1pr1tm1Jch
Tg(GFAP-cre)25Mes/?
(involves: C57BL/6J * FVB/N)
|
demyelination
|
J:168824
|
S1pr1tm1Jch/S1pr1tm1Jch
Tg(Nes-cre)1Kln/0
(involves: C57BL/6J * SJL)
|
demyelination
|
J:168824
|
S1pr1tm1Rlp/S1pr1tm1Rlp
(involves: 129S6/SvEvTac)
|
increased neuron apoptosis
|
J:189010
|
S1pr2tm1Ajml/S1pr2tm1Ajml
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal action potential
|
J:73957
|
| abnormal brain wave pattern
|
J:73957
|
| abnormal CNS synaptic transmission
|
J:73957
|
| abnormal excitatory postsynaptic currents
|
J:73957
|
| abnormal nervous system electrophysiology
|
J:73957
|
| increased excitatory postsynaptic current amplitude
|
J:73957
|
| increased excitatory postsynaptic current frequency
|
J:73957
|
| seizures
|
J:73957
|
| tonic-clonic seizures
|
J:73957
|
S1pr2tm1Ajml/S1pr2tm1Ajml
(either: (involves: 129S5/SvEvBrd) or (involves: 129S5/SvEvBrd * C57BL/6))
|
seizures
|
J:112371
|
S1pr2tm1Ytak/S1pr2tm1Ytak
(involves: 129P2/OlaHsd * C57BL/6)
|
seizures
|
J:168060
|
S1pr4tm1Dgen/S1pr4+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased prepulse inhibition
|
J:101679
|
S1pr5tm1Club/S1pr5tm1Club
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal oligodendrocyte physiology
|
J:98099
|
S100a10tm1Jwo/S100a10tm1Jwo
Scn10atm2(cre)Jwo/Scn10a+
(involves: 129 * C57BL/6)
|
decreased single cell response intensity
|
J:113256
|
Sall2tm1Jkoh/Sall2tm1Jkoh
Sall4Gt(W097E01)Flo/Sall4+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6J)
|
increased embryonic neuroepithelium apoptosis
|
J:143350
|
Saraftm1c(KOMP)Wtsi/Saraftm1c(KOMP)Wtsi
Tg(Pgk1-cre)1Lni/0
(involves: 129S4/SvJaeSor * BALB/c * C57BL/6J * C57BL/6N)
|
abnormal hippocampus physiology
|
J:337869
|
| decreased neuronal precursor proliferation
|
J:337869
|
Sardhem1Tzq/Sardhem1Tzq
(Not Specified)
|
reduced NMDA-mediated synaptic currents
|
J:285251
|
Sarm1tm1.1Diam/Sarm1tm1.1Diam
(involves: 129X1/SvJ * C57BL/6)
|
abnormal nervous system physiology
|
J:196200
|
| decreased microglial cell activation
|
J:200140
|
| decreased neuron apoptosis
|
J:196200
|
| increased neuron apoptosis
|
J:200140
|
Sbf1em1(IMPC)Mbp/Sbf1em1(IMPC)Mbp
(C57BL/6N-Sbf1em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Sbf2Gt(RRF511)Byg/Sbf2Gt(RRF511)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal nerve conduction
|
J:133391
|
Sbf2Gt(XH212)Byg/Sbf2Gt(XH212)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal action potential
|
J:132044
|
Scamp5tm1Smoc/Scamp5tm1Smoc
(involves: C57BL/6J)
|
abnormal brain wave pattern
|
J:288324
|
| abnormal miniature excitatory postsynaptic currents
|
J:288324
|
| audiogenic seizures
|
J:288324
|
| increased excitatory postsynaptic current amplitude
|
J:288324
|
| seizures
|
J:288324
|
Scarb2tm1Psa/Scarb2tm1Psa
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vestibular hair cell physiology
|
J:121998
|
| demyelination
|
J:82474
|
Scg2em1Meg/Scg2em1Meg
(C57BL/6J-Scg2em1Meg)
|
abnormal neuron physiology
|
J:316855
|
Scg3Gt(VICTR20)13Lex/Scg3Gt(VICTR20)13Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal pituitary gland physiology
|
J:256077
|
Scg5tm1Led/Scg5tm1Led
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * FVB) or (involves: 129S6/SvEvTac * C57BL/6))
|
convulsive seizures
|
J:77510
|
Scn1aem1Anord/Scn1a+
(C57BL/6N-Scn1aem1Anord)
|
abnormal spike wave discharge
|
J:333350
|
| environmentally induced seizures
|
J:333350
|
| increased susceptibility to pharmacologically induced seizures
|
J:333350
|
Scn1aem1Anord/Scn1aem1Anord
(C57BL/6N-Scn1aem1Anord)
|
environmentally induced seizures
|
J:333350
|
Scn1atm1.1Aesc/Scn1a+
(involves: 129X1/SvJ * C57BL/6J * SJL)
|
abnormal GABA-mediated receptor currents
|
J:161191
|
| abnormal spike wave discharge
|
J:161191
|
| environmentally induced seizures
|
J:161191
|
| increased susceptibility to pharmacologically induced seizures
|
J:161191
|
| seizures
|
J:161191
|
| tonic seizures
|
J:161191
|
| tonic-clonic seizures
|
J:161191
|
Scn1atm1.1Aesc/Scn1a+
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:170734
|
Scn1atm1.1Aesc/Scn1a+
Tg(Eno2-Scn2a1*)Q54Mm/0
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6J * SJL/J)
|
convulsive seizures
|
J:170734
|
| tonic-clonic seizures
|
J:170734
|
Scn1atm1.1Aesc/Scn1atm1.1Aesc
(involves: 129X1/SvJ * C57BL/6J * SJL)
|
abnormal GABA-mediated receptor currents
|
J:161191
|
| clonic seizures
|
J:161191
|
| environmentally induced seizures
|
J:161191
|
| impaired ability to fire action potentials
|
J:161191
|
| maximal tonic hindlimb extension seizures
|
J:161191
|
| seizures
|
J:161191
|
| tonic seizures
|
J:161191
|
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C57BL/6)
|
seizures
|
J:121969
|
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C3HeB/FeJ * C57BL/6J)
|
convulsive seizures
|
J:209093
|
| increased susceptibility to pharmacologically induced seizures
|
J:209093
|
Scn1atm1.1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C3HeB/FeJ)
|
environmentally induced seizures
|
J:260796
|
| seizures
|
J:260796
|
Scn1atm1.1Swl/Scn1a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl)
|
abnormal miniature excitatory postsynaptic currents
|
J:221045
|
| abnormal miniature inhibitory postsynaptic currents
|
J:221045
|
| abnormal synaptic transmission
|
J:221045
|
| decreased paired-pulse ratio
|
J:221045
|
| environmentally induced seizures
|
J:221045
|
| tonic-clonic seizures
|
J:221045
|
Scn1atm1.1Swl/Scn1atm1.1Swl
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6JNarl)
|
tonic-clonic seizures
|
J:221045
|
Scn1atm1Kea/Scn1a+
((C57BL/6J x 129S6/SvEvTac-Scn1atm1Kea)F1)
|
seizures
|
J:203040
|
Scn1atm1Kzy/Scn1a+
(involves: 129P2/OlaHsd * C57BL/6)
|
seizures
|
J:121969
|
Scn1atm1Kzy/Scn1atm1Kzy
(involves: 129P2/OlaHsd * C57BL/6)
|
seizures
|
J:121969
|
| tonic seizures
|
J:121969
|
| tonic-clonic seizures
|
J:121969
|
Scn1atm1Wac/Scn1a+
(B6.129-Scn1atm1Wac)
|
abnormal action potential
|
J:113149
|
| abnormal brain wave pattern
|
J:113149
|
| abnormal nervous system electrophysiology
|
J:113149
|
| seizures
|
J:113149
|
Scn1atm1Wac/Scn1a+
(involves: 129S1/Sv * 129X1/SvJ * FVB/NJ)
|
abnormal spike wave discharge
|
J:129998
|
| increased susceptibility to pharmacologically induced seizures
|
J:129998
|
| tonic-clonic seizures
|
J:129998
|
Scn1atm1Wac/Scn1a+
Scn8amed-jo/Scn8a+
(involves: 129 * C57BL/6J * DBA/2WyDi * FVB/NJ)
|
abnormal spike wave discharge
|
J:129998
|
Scn1atm1Wac/Scn1atm1Wac
(B6.129-Scn1atm1Wac)
|
abnormal action potential
|
J:113149
|
| abnormal nervous system electrophysiology
|
J:113149
|
| clonic seizures
|
J:113149
|
| convulsive seizures
|
J:113149
|
| seizures
|
J:113149
|
Scn1atm2.1Kzy/Scn1a+
Tg(Pvalb-cre)1Tama/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
convulsive seizures
|
J:202863
|
Scn1atm2.1Kzy/Scn1a+
Tg(Slc32a1-cre)65Kzy/0
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal brain wave pattern
|
J:202863
|
| convulsive seizures
|
J:202863
|
Scn1atm2.1Kzy/Scn1atm2.1Kzy
Tg(Pvalb-cre)1Tama/0
(involves: 129P2/OlaHsd * C57BL/6 * DBA)
|
convulsive seizures
|
J:202863
|
Scn1atm2.1Kzy/Scn1atm2.1Kzy
Tg(Slc32a1-cre)65Kzy/0
(involves: 129P2/OlaHsd * C57BL/6)
|
convulsive seizures
|
J:202863
|
Scn1atm2.1Wac/Scn1a+
Tg(I12b-cre)1Jlr/0
(involves: C57BL/6J * CD-1)
|
clonic seizures
|
J:189897
|
| environmentally induced seizures
|
J:189897
|
| seizures
|
J:189897
|
| tonic-clonic seizures
|
J:189897
|
Scn1atm2.1Wac/Scn1a+
Tg(I12b-cre)1Jlr/0
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal inhibitory postsynaptic currents
|
J:188126
|
| increased excitatory postsynaptic current frequency
|
J:188126
|
Scn1atm2.2Kzy/Scn1a+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
convulsive seizures
|
J:202863
|
Scn1atm2.2Kzy/Scn1atm2.2Kzy
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
convulsive seizures
|
J:202863
|
Scn1btm1.1Bion/Scn1b+
(Not Specified)
|
abnormal action potential
|
J:163771
|
| abnormal nervous system electrophysiology
|
J:163771
|
| environmentally induced seizures
|
J:163771
|
Scn1btm1.1Bion/Scn1btm1.1Bion
(Not Specified)
|
abnormal brain wave pattern
|
J:163771
|
| environmentally induced seizures
|
J:163771
|
| seizures
|
J:163771
|
| tonic-clonic seizures
|
J:163771
|
Scn1btm1Isom/Scn1btm1Isom
(involves: 129X1/SvJ * C57BL/6)
|
abnormal action potential
|
J:90136
|
| seizures
|
J:90136
|
Scn1btm2.1Isom/Scn1btm2.1Isom
(involves: 129X1/SvJ * C57BL/6)
|
seizures
|
J:128713
|
Scn2aem1Gsp/Scn2a+
(involves: C57BL/6J * SJL/J)
|
abnormal action potential
|
J:311772
|
| abnormal channel response
|
J:311772
|
| abnormal CNS synaptic transmission
|
J:311772
|
| decreased excitatory postsynaptic current frequency
|
J:311772
|
Scn2atm1Mml/Scn2atm1Mml
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:76457
|
Scn2btm1Isom/Scn2btm1Isom
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:82050
|
| increased susceptibility to pharmacologically induced seizures
|
J:82050
|
Scn4btm1.2Geh/Scn4btm1.2Geh
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal action potential
|
J:261348
|
| decreased single cell response threshold
|
J:261348
|
| reduced long-term depression
|
J:261348
|
Scn5atm1.1Iba/Scn5a+
(involves: 129 * C57BL/6)
|
abnormal action potential
|
J:266290
|
Scn5atm1Clhh/Scn5a+
(involves: 129 * 129S/SvEv * C57BL/6J)
|
seizures
|
J:127879
|
Scn8a7J/Scn8a7J
(involves: BALB/cByJ * C57BL/6J)
|
myoclonus
|
J:87349
|
Scn8a8J/Scn8a8J
(involves: C3HeB/FeJ * C57BL/6J)
|
abnormal spike wave discharge
|
J:147199
|
Scn8a8J/Scn8a+
(involves: C3HeB/FeJ * C57BL/6J)
|
abnormal spike wave discharge
|
J:147199
|
Scn8a9J/Scn8a9J
(B6J.C-Scn8a9J/Mm)
|
abnormal neuron physiology
|
J:230867
|
| decreased nerve conduction velocity
|
J:230867
|
Scn8aem1Mm/Scn8a+
(involves: C57BL/6J * SJL)
|
seizures
|
J:207931
|
Scn8am10J/Scn8a+
(FVB/NJ-Scn8am10J/GrsrCx)
|
decreased nerve conduction velocity
|
J:240096
|
Scn8amed-J/Scn8amed-J
Scnm1s/Scnm1+
(involves: C3HeB/FeJ * C57BL/6J)
|
abnormal action potential
|
J:108906
|
| abnormal CNS synaptic transmission
|
J:108906
|
Scn8amed-jo/Scn8a+
(B6.D2-Scn8amed-jo/J)
|
abnormal spike wave discharge
|
J:147199
|
| decreased susceptibility to pharmacologically induced seizures
|
J:170734,
J:129998
|
Scn8amed-jo/Scn8amed-jo
(DBA/2WyDi-Scn8amed-jo)
|
abnormal nervous system electrophysiology
|
J:14894
|
Scn8amed/Scn8a+
(C3Fe.Cg-Scn8amed/J)
|
abnormal spike wave discharge
|
J:147199
|
| decreased susceptibility to pharmacologically induced seizures
|
J:129998
|
Scn8amed/Scn8amed
(PCT)
|
abnormal action potential
|
J:5192
|
| abnormal endplate potential
|
J:5192
|
| abnormal miniature endplate potential
|
J:5192
|
| abnormal nerve conduction
|
J:6888
|
| demyelination
|
J:6888,
J:7297
|
Scn9aem1Wlf/Scn9a+
(C57BL/6J-Scn9aem1Wlf)
|
abnormal action potential
|
J:329231
|
| abnormal nervous system electrophysiology
|
J:329231
|
| increased single cell response intensity
|
J:329231
|
Scn9aem1Wlf/Scn9aem1Wlf
(C57BL/6J-Scn9aem1Wlf)
|
abnormal action potential
|
J:329231
|
| abnormal nervous system electrophysiology
|
J:329231
|
| increased single cell response intensity
|
J:329231
|
Scn9atm1.1Naas/Scn9atm1.1Naas
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal seizure response to electrical stimulation
|
J:154118
|
| minimal clonic seizures
|
J:154118
|
Scn9atm1.1Naas/Scn9atm1.1Naas
(B6.129-Scn9atm1.1Naas)
|
abnormal kindling response
|
J:154118
|
Scn9atm1Dgen/Scn9a+
(involves: 129P2/OlaHsd * C57BL/6)
|
increased prepulse inhibition
|
J:101679
|
Scn9atm1Dgen/Scn9atm1Dgen
(either: (involves: 129P2/OlaHsd * BALB/c * C57BL/6) or (involves: 129P2/OlaHsd * C57BL/6 * CD-1))
|
abnormal action potential
|
J:223425
|
| abnormal synaptic transmission
|
J:223425
|
Scn10aPsm/Scn10aPsm
(C57BL/6J-Scn10aPsm)
|
abnormal brain wave pattern
|
J:180381
|
| abnormal nervous system electrophysiology
|
J:180381
|
| abnormal single cell response
|
J:180381
|
Scn10atm1Lex/Scn10atm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal action potential
|
J:157066
|
| impaired ability to fire action potentials
|
J:157066
|
Scn11aem1Akoi/Scn11a+
(involves: C57BL/6)
|
abnormal action potential
|
J:268684
|
| abnormal nervous system electrophysiology
|
J:268684
|
Scn11aem2Akoi/Scn11a+
(involves: C57BL/6NCrSlc)
|
abnormal action potential
|
J:268091
|
| abnormal nervous system electrophysiology
|
J:268091
|
Scn11aem3Akoi/Scn11a+
(involves: C57BL/6NCrSlc)
|
abnormal action potential
|
J:268091
|
| abnormal nervous system electrophysiology
|
J:268091
|
Scn11atm1.1Ikth/Scn11a+
(involves: 129 * BALB/c * C57BL/6)
|
abnormal action potential
|
J:206848
|
| abnormal afterhyperpolarization
|
J:206848
|
| abnormal channel response
|
J:206848
|
| abnormal miniature excitatory postsynaptic currents
|
J:206848
|
| abnormal nervous system electrophysiology
|
J:206848
|
Scn11atm1Gsk/Scn11atm1Gsk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal single cell response
|
J:216497
|
Scn11atm1Mdba/Scn11atm1.1Ikth
(involves: 129 * BALB/c * C57BL/6)
|
abnormal channel response
|
J:206848
|
| abnormal nervous system electrophysiology
|
J:206848
|
Scn11atm1Mdba/Scn11atm1Mdba
(involves: C57BL/6)
|
abnormal nervous system electrophysiology
|
J:141209
|
Scn11atm1Mdba/Scn11atm1Mdba
(Not Specified)
|
abnormal action potential
|
J:206848
|
| abnormal nervous system electrophysiology
|
J:206848
|
Scn11atm1Wlf/Scn11atm1Wlf
(B6.Cg-Scn11atm1Wlf)
|
abnormal single cell response
|
J:116768
|
Scttm1Inis/Scttm1Inis
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased paired-pulse facilitation
|
J:140787
|
| decreased post-tetanic potentiation
|
J:140787
|
| reduced long-term potentiation
|
J:140787
|
Sctrtm1Brd/Sctrtm1Brd
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:114853
|
| abnormal excitatory postsynaptic potential
|
J:114853
|
| reduced long-term potentiation
|
J:114853
|
Scube1tm1Rbya/Scube1tm1Rbya
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased embryonic neuroepithelial cell proliferation
|
J:136534
|
Scyl1mdf/Scyl1mdf
(B6C3Fe a/a-Scyl1mdf/J)
|
abnormal motor nerve collateral sprouting
|
J:30384
|
Scyl1mdf/Scyl1mdf
(involves: CFW * C57BL/6J * C57BR)
|
abnormal nervous system physiology
|
J:4479
|
| abnormal peripheral nervous system regeneration
|
J:4479
|
Scyl1tm1.1Spel/Scyl1tm1.1Spel
(involves: 129S6/SvEvTac * C57BL/6J)
|
demyelination
|
J:192445
|
Scyl1tm1.1Spel/Scyl1tm1.1Spel
(involves: 129S6/SvEvTac)
|
abnormal myelination
|
J:262629
|
Scyl1tm1.1Spel/Scyl1tm1.1Spel
Scyl3tm1.1Spel/Scyl3tm1.1Spel
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal myelination
|
J:262629
|
Scyl2tm1.1Spel/Scyl2tm1.1Spel
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal excitatory postsynaptic potential
|
J:225808
|
| increased neuron apoptosis
|
J:225808
|
Sdccag8tm1e(EUCOMM)Wtsi/Sdccag8tm1e(EUCOMM)Wtsi
(involves: C57BL/6)
|
abnormal neuronal migration
|
J:215665
|
Sdhdtm1Jlob/Sdhd+
(involves: 129X1/SvJ)
|
abnormal type I cell of carotid body physiology
|
J:95252
|
Sec23aGt(RRE297)Byg/Sec23aGt(RRE297)Byg
(B6J.129P2-Sec23aGt(RRE297)Byg)
|
decreased embryonic neuroepithelial cell proliferation
|
J:237614
|
| intracranial hemorrhage
|
J:237614
|
Seh1ltm1Lzha/Seh1ltm1Lzha
Olig1tm1(cre)Rth/Olig1+
(involves: 129S4/SvJae * C57BL/6)
|
dysmyelination
|
J:276253
|
| seizures
|
J:276253
|
Seh1ltm1Lzha/Seh1ltm1Lzha
Tg(CAG-cre/Esr1*)5Amc/0
(involves: 129 * C57BL/6 * CBA)
|
dysmyelination
|
J:276253
|
Seh1ltm1Lzha/Seh1ltm1Lzha
Tg(Cspg4-cre/Esr1*)BAkik/0
(involves: 129 * C57BL/6)
|
abnormal myelination
|
J:276253
|
Seh1ltm1Lzha/Seh1ltm1Lzha
Tg(Sox10-icre/ERT2)388Wdr/0
(involves: 129 * C57BL/6 * CBA)
|
dysmyelination
|
J:276253
|
Selenotem1(IMPC)Mbp/Selenotem1(IMPC)Mbp
(C57BL/6NCrl-Selenotem1(IMPC)Mbp/MbpMmucd)
|
increased prepulse inhibition
|
J:211773
|
Sema3atm1.1Tyag/Sema3atm1.1Tyag
Vegfatm1Pec/Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal neuronal migration
|
J:175836
|
Sema3etm1(cre/ERT2)Arbr/Sema3etm1(cre/ERT2)Arbr
(involves: 129P2/OlaHsd)
|
abnormal excitatory postsynaptic potential
|
J:205528
|
Sema3ftm1Atai/Sema3ftm1Atai
(involves: 129P2/OlaHsd * C57BL/6J * ICR)
|
abnormal neuronal migration
|
J:134616
|
Sema4ctm1Matl/Sema4ctm1Matl
(B6.129P2-Sema4ctm1Matl)
|
abnormal cerebellar granule cell migration
|
J:167973
|
Sema6aGt(KST069)Byg/Sema6aGt(KST069)Byg
Tg(Trhr-EGFP)HU193Gsat/0
(involves: 129P2/OlaHsd * FVB/NTac)
|
abnormal single cell response
|
J:202884
|
Senp1tm1.1Eyeh/Senp1tm1.1Eyeh
Tg(Pdx1-cre)6Tuv/0
(involves: C57BL/6)
|
impaired ability to fire action potentials
|
J:226392
|
Senp2tm1Eyeh/Senp2tm1Eyeh
(Not Specified)
|
abnormal brain wave pattern
|
J:217910
|
| abnormal nervous system electrophysiology
|
J:217910
|
| abnormal neuron physiology
|
J:217910
|
| audiogenic seizures
|
J:217910
|
| convulsive seizures
|
J:217910
|
Septin2em1(IMPC)Tcp/Septin2+
(C57BL/6NCrl-Septin2em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Septin5tm1Wtr/Septin5tm1Wtr
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
increased prepulse inhibition
|
J:147200
|
Septin8tm1c(EUCOMM)Wtsi/Septin8tm1c(EUCOMM)Wtsi
Tg(Plp1-cre/ERT2)1Ueli/0
(B6N.Cg-Septin8tm1c(EUCOMM)Wtsi Tg(Plp1-cre/ERT2)1Ueli)
|
demyelination
|
J:236408
|
Septin8tm1d(EUCOMM)Wtsi/Septin8tm1d(EUCOMM)Wtsi
(B6N(Cg)-Septin8tm1d(EUCOMM)Wtsi)
|
decreased nerve conduction velocity
|
J:236408
|
Septin14em1.1Plk/Septin14em1.1Plk
(involves: C57BL/6 * CBA)
|
increased neuronal stem cell self-renewal
|
J:338866
|
Serac1em1Bcgen/Serac1em1Bcgen
(C57BL/6N-Serac1em1Bcgen)
|
encephalopathy
|
J:326672
|
Serpinc1tm1Sai/Serpinc1tm1Sai
(involves: 129S2/SvPas * C57BL/6J)
|
intracranial hemorrhage
|
J:65092
|
Serpine2tm1Dmn/Serpine2tm1Dmn
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:40953
|
| increased susceptibility to pharmacologically induced seizures
|
J:40953
|
| reduced long-term potentiation
|
J:40953
|
Serpine2tm1Dmn/Serpine2tm1Dmn
(B6.129P2-Serpine2tm1Dmn)
|
abnormal excitatory postsynaptic currents
|
J:94811
|
| delayed peripheral nervous system regeneration
|
J:121223
|
| reduced NMDA receptor mediated synaptic activity in barrel cortex
|
J:94811
|
Serpine2tm1Dmn/Serpine2tm1Dmn
Tg(Thy1-Serpine2)2Dmn/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal Schwann cell physiology
|
J:121223
|
| decreased Schwann cell proliferation
|
J:121223
|
| delayed peripheral nervous system regeneration
|
J:121223
|
Serpinf2tm1Hrl/Serpinf2tm1Hrl
(involves: 129X1/SvJ * C57BL/6J)
|
decreased cerebral infarct size
|
J:55243
|
Setd1aem1Yzhg/Setd1a+
(B6.Cg-Setd1aem1Yzhg)
|
abnormal synaptic vesicle exocytosis
|
J:328716
|
| decreased prepulse inhibition
|
J:328716
|
| reduced sensorimotor gating
|
J:328716
|
Setd2tm1b(NCOM)Mfgc/Setd2tm1b(NCOM)Mfgc
(C57BL/6N-Setd2tm1b(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Setd3tm1.1(NCOM)Mfgc/Setd3tm1.1(NCOM)Mfgc
(C57BL/6N-Setd3tm1.1(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Setdb1tm1.1Yshk/Setdb1tm1.1Yshk
Emx2tm2(cre)Sia/Emx2+
(involves: C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal neuronal precursor proliferation
|
J:188109
|
| increased neuron apoptosis
|
J:188109
|
Setmartm1a(EUCOMM)Wtsi/Setmartm1a(EUCOMM)Wtsi
(C57BL/6N-Setmartm1a(EUCOMM)Wtsi/Wtsi)
|
increased prepulse inhibition
|
J:165965
|
Setxtm1.1Als/Setx+
(involves: C57BL/6J)
|
abnormal neuron physiology
|
J:320844
|
| increased susceptibility to neuronal excitotoxicity
|
J:320844
|
Sez6tm1.1Sest/Sez6tm1.1Sest
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:132725
|
| abnormal excitatory postsynaptic currents
|
J:132725
|
| abnormal excitatory postsynaptic potential
|
J:132725
|
| decreased susceptibility to pharmacologically induced seizures
|
J:132725
|
Sez6tm1Hta/Sez6tm1Hta
Sez6ltm1Hta/Sez6ltm1Hta
Sez6l2tm1Hta/Sez6l2tm1Hta
(involves: 129 * C57BL)
|
abnormal excitatory postsynaptic currents
|
J:111556
|
| biphasic excitatory postsynaptic current amplitude
|
J:111556
|
| decreased excitatory postsynaptic current amplitude
|
J:111556
|
| short excitatory postsynaptic current rise time
|
J:111556
|
Sf3b4em1Mce/Sf3b4+
(C57BL/6J-Sf3b4em1Mce)
|
decreased neuronal precursor proliferation
|
J:285287
|
Sfpqtm1.1Takea/Sfpqtm1.1Takea
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * CBA/JNCrlj * SJL)
|
increased neuron apoptosis
|
J:271630
|
Sgcetm1Ygl/Sgce+
(involves: 129S2/SvPas)
|
myoclonus
|
J:180682
|
Sgcetm1Ygl/Sgcetm1Ygl
(involves: 129S2/SvPas * 129S4/SvJaeSor * BALB/c * C57BL/6)
|
myoclonus
|
J:101332
|
Sh2d3ctm1.1Ebp/Sh2d3ctm1.1Ebp
(involves: C57BL/6)
|
abnormal nervous system physiology
|
J:164874
|
Sh3bp2tm1Bjro/Sh3bp2tm1Bjro
(involves: 129S4/SvJae * BALB/cJ * C57BL/6J)
|
spinal cord inflammation
|
J:117880
|
Sh3gl1tm1Pdc/Sh3gl1tm1Pdc
Sh3gl2tm1Pdc/Sh3gl2+
Sh3gl3tm1.2Itl/Sh3gl3tm1.2Itl
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * FVB/N * SJL)
|
seizures
|
J:178947
|
Sh3gl1tm1Pdc/Sh3gl1tm1Pdc
Sh3gl2tm1Pdc/Sh3gl2tm1Pdc
(involves: 129)
|
seizures
|
J:178947
|
Sh3gl1tm1Pdc/Sh3gl1tm1Pdc
Sh3gl2tm1Pdc/Sh3gl2tm1Pdc
Sh3gl3tm1.2Itl/Sh3gl3tm1.2Itl
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * FVB/N * SJL)
|
abnormal miniature excitatory postsynaptic currents
|
J:178947
|
| abnormal synaptic vesicle recycling
|
J:178947
|
| decreased excitatory postsynaptic current amplitude
|
J:178947
|
| increased synaptic depression
|
J:178947
|
Sh3kbp1tm1Ivdi/Sh3kbp1tm1Ivdi
(B6.129S-Sh3kbp1tm1Ivdi)
|
abnormal nervous system physiology
|
J:162088
|
Sh3rf1em1Bcgen/Sh3rf1em1Bcgen
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
decreased excitatory postsynaptic current amplitude
|
J:326378
|
| reduced long-term potentiation
|
J:326378
|
Sh3rf2tm1Zhxu/Sh3rf2+
(C57BL/6-Sh3rf2tm1Zhxu)
|
abnormal afterhyperpolarization
|
J:270945
|
| abnormal miniature excitatory postsynaptic currents
|
J:270945
|
| abnormal nervous system electrophysiology
|
J:270945
|
| seizures
|
J:270945
|
Sh3tc2m1J/Sh3tc2m1J
(B6.Cg-Sh3tc2m1J/GrsrRwb)
|
decreased nerve conduction velocity
|
J:240096,
J:229591
|
| demyelination
|
J:240096
|
Sh3tc2tm1.1Rchr/Sh3tc2tm1.1Rchr
(involves: 129/Sv * FVB/N)
|
abnormal myelination
|
J:153705
|
| decreased nerve conduction velocity
|
J:153705
|
Shank1tm1Shng/Shank1tm1Shng
(involves: 129S4/SvJae * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:132277
|
Shank2tm1.1Bcgen/Shank2tm1.1Bcgen
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:237188
|
Shank2tm1.1Tmb/Shank2+
(B6.129-Shank2tm1.1Tmb)
|
abnormal excitatory postsynaptic potential
|
J:186719
|
Shank2tm1.1Tmb/Shank2tm1.1Tmb
(B6.129-Shank2tm1.1Tmb)
|
abnormal excitatory postsynaptic potential
|
J:186719
|
| abnormal miniature excitatory postsynaptic currents
|
J:186719
|
| enhanced long-term potentiation
|
J:186719
|
Shank2tm1Mgle/Shank2tm1Mgle
(B6.129S4-Shank2tm1Mgle)
|
abnormal miniature excitatory postsynaptic currents
|
J:237188
|
| abnormal nervous system physiology
|
J:186718
|
| reduced long-term depression
|
J:186718
|
| reduced long-term potentiation
|
J:186718
|
Shank3em1Hzo/Shank3em1Hzo
(involves: C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:305052
|
Shank3tm1.1Cya/Shank3tm1.1Cya
(B6.Cg-Shank3tm1.1Cya)
|
abnormal brain wave pattern
|
J:281328
|
| abnormal nervous system electrophysiology
|
J:281328
|
| abnormal neuron physiology
|
J:281328
|
| decreased susceptibility to pharmacologically induced seizures
|
J:281328
|
| increased miniature inhibitory postsynaptic current frequency
|
J:281328
|
Shank3tm1.1Pfw/Shank3+
(B6.129S6-Shank3tm1.1Pfw)
|
abnormal glutamate-mediated receptor currents
|
J:198768
|
| abnormal long-term depression
|
J:198768
|
| decreased synaptic depression
|
J:198768
|
| reduced long-term potentiation
|
J:198768
|
| reduced NMDA-mediated synaptic currents
|
J:198768
|
Shank3tm1.1Pfw/Shank3tm1.1Pfw
(B6.129S6-Shank3tm1.1Pfw)
|
abnormal excitatory postsynaptic currents
|
J:204162
|
| abnormal glutamate-mediated receptor currents
|
J:204162
|
| abnormal miniature excitatory postsynaptic currents
|
J:204162
|
| reduced long-term potentiation
|
J:204162
|
Shank3tm1.2Bux/Shank3+
(C57BL/6-Shank3tm1.2Bux)
|
abnormal excitatory postsynaptic potential
|
J:175320
|
| abnormal miniature excitatory postsynaptic currents
|
J:175320
|
| abnormal neuron physiology
|
J:175320
|
| decreased paired-pulse ratio
|
J:175320
|
| reduced long-term potentiation
|
J:175320
|
Shank3tm1Cmpl/Shank3tm1Cmpl
(B6J.129S6-Shank3tm1Cmpl)
|
abnormal CNS synaptic transmission
|
J:224381
|
| abnormal excitatory postsynaptic potential
|
J:224381
|
| abnormal long-term depression
|
J:224381
|
| abnormal miniature excitatory postsynaptic currents
|
J:224381
|
| decreased post-tetanic potentiation
|
J:224381
|
| impaired synaptic plasticity
|
J:224381
|
Shank3tm1d(KOMP)Mbp/Shank3tm1d(KOMP)Mbp
(involves: C57BL/6N)
|
abnormal CNS synaptic transmission
|
J:233405
|
| abnormal excitatory postsynaptic potential
|
J:233405
|
| abnormal miniature inhibitory postsynaptic current frequency
|
J:233405
|
Shank3tm1Yhj/Shank3tm1Yhj
(B6.129S7-Shank3tm1Yhj)
|
decreased post-tetanic potentiation
|
J:173402
|
| impaired synaptic plasticity
|
J:173402
|
| reduced long-term potentiation
|
J:173402
|
Shank3tm2.1Bux/Shank3tm2.1Bux
(B6(Cg)-Shank3tm2.1Bux)
|
decreased prepulse inhibition
|
J:270363
|
Shank3tm2.2Yhj/Shank3tm2.2Yhj
(B6.129S7(C)-Shank3tm2.2Yhj)
|
abnormal nervous system electrophysiology
|
J:235641
|
| abnormal single cell response
|
J:235641
|
| decreased excitatory postsynaptic current frequency
|
J:235641
|
| reduced long-term depression
|
J:235641
|
Shank3tm2Cmpl/Shank3+
(B6.129S6-Shank3tm2Cmpl)
|
reduced long-term potentiation
|
J:289874
|
Shank3tm2Cmpl/Shank3tm2Cmpl
(B6.129S6-Shank3tm2Cmpl)
|
abnormal synaptic transmission
|
J:289874
|
| impaired synaptic plasticity
|
J:289874
|
| reduced long-term potentiation
|
J:289874
|
Shank3tm2Gfng/Shank3tm2Gfng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:171113
|
| environmentally induced seizures
|
J:171113
|
Shank3tm2Gfng/Shank3tm2Gfng
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal miniature excitatory postsynaptic currents
|
J:305052
|
Shank3tm3.1Gfng/Shank3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:230887
|
Shank3tm3.1Gfng/Shank3tm3.1Gfng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:230887
|
| abnormal paired-pulse inhibition
|
J:230887
|
| decreased excitatory postsynaptic current amplitude
|
J:230887
|
| reduced NMDA-mediated synaptic currents
|
J:230887
|
Shank3tm3.2Cmpl/Shank3+
(B6.129S6(Cg)-Shank3tm3.2Cmpl)
|
abnormal synaptic transmission
|
J:289884
|
Shank3tm3.2Cmpl/Shank3tm3.2Cmpl
(B6.129S6(Cg)-Shank3tm3.2Cmpl)
|
abnormal synaptic transmission
|
J:289884
|
| impaired synaptic plasticity
|
J:289884
|
| reduced long-term potentiation
|
J:289884
|
Shank3tm4.1Gfng/Shank3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:230887
|
Shank3tm4.1Gfng/Shank3tm4.1Gfng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:230887
|
| abnormal paired-pulse inhibition
|
J:230887
|
| decreased excitatory postsynaptic current amplitude
|
J:230887
|
| reduced NMDA-mediated synaptic currents
|
J:230887
|
Shank3tm5.1Gfng/Shank3tm5.1Gfng
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J)
|
decreased excitatory postsynaptic current amplitude
|
J:229668
|
Shank3tm5.1Gfng/Shank3tm5.1Gfng
Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129S1/Sv * 129S1/SvImJ * 129X1/SvJ * C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:229668
|
| decreased excitatory postsynaptic current amplitude
|
J:229668
|
Shc1tm4Paw/Shc1tm4Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal excitatory postsynaptic potential
|
J:122927
|
| abnormal nerve conduction
|
J:122927
|
Shc1tm7Paw/Shc1tm7Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal excitatory postsynaptic potential
|
J:122927
|
| abnormal nerve conduction
|
J:122927
|
Shhtm1Ahk/Shhtm1Ahk
Slc6a3tm1(cre)Xz/Slc6a3+
(involves: 129S1/Sv * C57BL/6)
|
abnormal synaptic dopamine release
|
J:188348
|
Shhtm2Amc/Shhtm2Amc
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
seizures
|
J:102950
|
Shisa7tm1.2Sasp/Shisa7tm1.2Sasp
(involves: C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:255015
|
| reduced AMPA-mediated synaptic currents
|
J:255015
|
| reduced long-term potentiation
|
J:255015
|
| short excitatory postsynaptic current decay time
|
J:255015
|
| short excitatory postsynaptic current rise time
|
J:255015
|
Shisa9em1(IMPC)H/Shisa9em1(IMPC)H
(C57BL/6N-Shisa9em1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Shisa9tm1Mony/Shisa9tm1Mony
(involves: 129 * C57BL/6)
|
abnormal synaptic plasticity
|
J:158757
|
Shisa9tm1Mony/Shisa9tm1Mony
(involves: 129)
|
abnormal action potential
|
J:257714
|
| abnormal excitatory postsynaptic current amplitude
|
J:257714
|
| decreased synaptic depression
|
J:257714
|
| enhanced paired-pulse facilitation
|
J:257714
|
| reduced AMPA-mediated synaptic currents
|
J:257714
|
Shox2tm1.1(cre)Oki/Shox2+
Tg(CAG-Bgeo/GFP)21Lbe/0
Vsx2tm1(DTA)Kash/Vsx2+
(involves: 129S/SvEv * 129X1/SvJ * C57BL/6J)
|
abnormal nervous system physiology
|
J:209344
|
Sicd1C57BL/6J/Sicd1C57BL/6J
(FVB.B6-(D18Mit141-D18Mit25))
|
increased susceptibility to pharmacologically induced seizures
|
J:122922
|
Sik3Slp/Sik3+
(involves: C57BL/6J * C57BL/6N)
|
abnormal brain wave pattern
|
J:236598
|
Sik3Slp/Sik3Slp
(involves: C57BL/6J * C57BL/6N)
|
abnormal brain wave pattern
|
J:236598
|
Sim1tm1.1(cre)Gld/Sim1+
Tg(CAG-Bgeo,-AlstR,-EGFP)192Gld/0
(involves: 129S1/Sv * C57BL/6 * SJL)
|
abnormal CNS synaptic transmission
|
J:147245
|
Sim1tm1Jlmd/Sim1tm1Jlmd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neuronal migration
|
J:120909
|
sims/sims
(B6.Cg-sims/GrsrJ)
|
audiogenic seizures
|
J:161505
|
sims/sims+
(B6.Cg-sims/GrsrJ)
|
environmentally induced seizures
|
J:161505
|
Sipa1l1tm1Taki/Sipa1l1tm1Taki
(B6.Cg-Sipa1l1tm1Taki/Taki)
|
increased susceptibility to pharmacologically induced seizures
|
J:345320
|
Sipa1l2tm1Mrkr/Sipa1l2tm1Mrkr
(B6.129S-Sipa1l2tm1Mrkr)
|
reduced long-term potentiation
|
J:286683
|
Sirpatm1b(EUCOMM)Hmgu/Sirpatm1b(EUCOMM)Hmgu
(C57BL/6N-Sirpatm1b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Sirpatm1Umri/Sirpatm1Umri
Tg(CAG-cre/Esr1*)1Lbe/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:204011
|
| enhanced paired-pulse facilitation
|
J:204011
|
| reduced long-term potentiation
|
J:204011
|
Sirt1tm3Fwa/Sirt1tm3Fwa
Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal pituitary gland physiology
|
J:155802
|
Sirt2tm1.1Auw/Sirt2tm1.1Auw
Tg(Mpz-cre)26Mes/0
(involves: 129 * C57BL/6J * FVB/N)
|
abnormal myelination
|
J:177468
|
| decreased nerve conduction velocity
|
J:177468
|
Sirt2tm1.2Auw/Sirt2tm1.2Auw
Tg(SOD1*G93A)1Gur/0
(involves: 129 * C57BL/6 * C57BL/6J * SJL)
|
abnormal action potential
|
J:194977
|
Six1em1(IMPC)Mbp/Six1+
(C57BL/6N-Six1em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Six1tm2Kwk/Six1tm2Kwk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal nervous system physiology
|
J:114468
|
| increased neuron apoptosis
|
J:114468
|
Skor2tm1Yono/Skor2tm1Yono
(involves: 129 * C57BL/6)
|
abnormal Purkinje cell migration
|
J:208769
|
Skor2Tn(sb-Tyr)1799B.CA7BOve/Skor2Tn(sb-Tyr)1799B.CA7BOve
(involves: FVB/N)
|
decreased cerebellar granule cell precursor proliferation
|
J:178891
|
Skor2Tn(sb-Tyr)1799B.CA7Ove/Skor2Tn(sb-Tyr)1799B.CA7Ove
(involves: FVB/N)
|
decreased cerebellar granule cell precursor proliferation
|
J:178818
|
Slc1a1tm1Wst/Slc1a1tm1Wst
Slc1a3tm1Wst/Slc1a3tm1Wst
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal nerve conduction
|
J:93201
|
Slc1a2tm1.1Ncd/Slc1a2tm1.1Ncd
Tg(Nes-cre)1Kln/0
(B6.Cg-Slc1a2tm1.1Ncd Tg(Nes-cre)1Kln)
|
seizures
|
J:207177
|
Slc1a2tm1.1Pros/Slc1a2tm1.1Pros
Tg(GFAP-cre/ERT2)13Kdmc/0
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6)
|
abnormal brain wave pattern
|
J:221590
|
| seizures
|
J:221590
|
Slc1a2tm1.1Pros/Slc1a2tm1.1Pros
Tg(Syn1-cre)671Jxm/0
(involves: 129S4/SvJae * 129S4/SvJaeSor * C57BL/6)
|
abnormal synaptic physiology
|
J:221590
|
Slc1a2tm1Kta/Slc1a2tm1Kta
(involves: 129P2/OlaHsd * C57BL/6)
|
convulsive seizures
|
J:40984
|
| increased susceptibility to pharmacologically induced seizures
|
J:40984
|
Slc1a3tm1Kta/Slc1a3tm1Kta
(involves: 129P2/OlaHsd)
|
abnormal kindling response
|
J:58180
|
| abnormal nervous system physiology
|
J:46746
|
| abnormal synaptic glutamate release
|
J:66146
|
| increased susceptibility to pharmacologically induced seizures
|
J:58180
|
| seizures
|
J:58180
|
Slc1a3tm1Wst/Slc1a3tm1Wst
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal excitatory postsynaptic currents
|
J:93201
|
| prolonged excitatory postsynaptic current decay time
|
J:93201
|
| short excitatory postsynaptic current rise time
|
J:93201
|
Slc1a6tm1Dbe/Slc1a6tm1Dbe
(Not Specified)
|
abnormal nerve conduction
|
J:87447
|
Slc2a1Rgsc200/Slc2a1+
(involves: C57BL/6JJcl * DBA/2JJcl)
|
convulsive seizures
|
J:281292
|
| environmentally induced seizures
|
J:281292
|
Slc2a1Rgsc200/Slc2a1+
(B6(D2)-Slc2a1Rgsc200)
|
abnormal brain wave pattern
|
J:281292
|
| sporadic seizures
|
J:281292
|
Slc2a1tm1Dcdv/Slc2a1+
(involves: 129S6/SvEvTac * C57BL/6J)
|
sporadic seizures
|
J:108250
|
Slc2a3Gt(XG611)Byg/Slc2a3+
(B6.129P2-Slc2a3Gt(XG611)Byg)
|
abnormal brain wave pattern
|
J:142763
|
| decreased prepulse inhibition
|
J:142763
|
Slc2a4tm1Abel/Slc2a4tm1Abel
Tg(Myhca-cre)1Abel/?
(involves: 129S4/SvJae * FVB)
|
abnormal nervous system physiology
|
J:59054
|
Slc4a3tm1Cahb/Slc4a3tm1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:104157
|
Slc4a10tm1.1Cahb/Slc4a10tm1.1Cahb
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neuron physiology
|
J:131058
|
| decreased susceptibility to pharmacologically induced seizures
|
J:131058
|
Slc5a3tm1Gtb/Slc5a3tm1Gtb
(involves: 129X1/SvJ)
|
abnormal nervous system electrophysiology
|
J:83591
|
Slc5a3tm1Skc/Slc5a3tm1Skc
(involves: 129S7/SvEvBrd)
|
abnormal nerve conduction
|
J:102665
|
Slc5a5tm1b(KOMP)Wtsi/Slc5a5tm1b(KOMP)Wtsi
(C57BL/6N-Slc5a5tm1b(KOMP)Wtsi/J)
|
decreased prepulse inhibition
|
J:211773
|
Slc5a7tm1Rbl/Slc5a7tm1Rbl
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal synaptic acetylcholine release
|
J:90846
|
Slc6a1tm1Lst/Slc6a1tm1Lst
(involves: 129S1/Sv * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:95639
|
| abnormal neurotransmitter secretion
|
J:95639
|
| abnormal neurotransmitter uptake
|
J:95639
|
Slc6a1tm1Mlit/Slc6a1tm1Mlit
(B6.129S1-Slc6a1tm1Mlit)
|
abnormal GABA-mediated receptor currents
|
J:204368
|
| decreased prepulse inhibition
|
J:204368
|
| reduced sensorimotor gating
|
J:204368
|
Slc6a2tm1Mca/Slc6a2tm1Mca
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal nervous system physiology
|
J:61825
|
Slc6a2tm1Mca/Slc6a2tm1Mca
(B6.129S4-Slc6a2tm1Mca)
|
enhanced long-term potentiation
|
J:89778
|
Slc6a3tm1.1Jaja/Slc6a3tm1.1Jaja
(B6.129-Slc6a3tm1.1Jaja)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:180517
|
Slc6a3tm1Hhg/Slc6a3tm1Hhg
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal neurotransmitter uptake
|
J:111041
|
| abnormal synaptic dopamine release
|
J:111041
|
Slc6a3tm1Hhg/Slc6a3tm1Hhg
(B6.129X1-Slc6a3tm1Hhg)
|
abnormal CNS synaptic transmission
|
J:183177
|
| abnormal inhibitory postsynaptic currents
|
J:183177
|
| abnormal miniature inhibitory postsynaptic current frequency
|
J:183177
|
Slc6a3tm1Mca/Slc6a3tm1Mca
(involves: 129P2/OlaHsd)
|
abnormal pituitary gland physiology
|
J:41856
|
| abnormal pituitary secretion
|
J:41856
|
| hypopituitarism
|
J:41856
|
Slc6a3tm1Mca/Slc6a3tm1Mca
(B6.129P2-Slc6a3tm1Mca)
|
enhanced long-term potentiation
|
J:89778
|
Slc6a3tm1Rbl/Slc6a3tm1Rbl
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal inhibitory postsynaptic currents
|
J:216661
|
| abnormal neuron physiology
|
J:216661
|
| abnormal synaptic dopamine release
|
J:216661
|
Slc6a3tm2(tTA)Xz/Slc6a3tm3(tetO)Xz
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal action potential
|
J:144671
|
Slc6a3tm2Mca/Slc6a3tm2Mca
(involves: 129S1/Sv * 129X1/SvJ)
|
decreased neurotransmitter release
|
J:67549
|
Slc6a4tm1.1Rbl/Slc6a4tm1.1Rbl
(129S6/SvEvTac-Slc6a4tm1.1Rbl)
|
abnormal neuron physiology
|
J:170356
|
Slc6a4tm1Grch/Slc6a4tm1Grch
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal action potential
|
J:109542
|
Slc6a4tm2.1Rbl/Slc6a4tm2.1Rbl
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
abnormal nervous system electrophysiology
|
J:202876
|
| abnormal neurotransmitter uptake
|
J:202876
|
Slc6a5m1J/Slc6a5m1J
(involves: 129S2/SvPas * NOD)
|
abnormal neuron physiology
|
J:184306
|
Slc6a5tm1Betz/Slc6a5tm1Betz
(involves: 129P2/OlaHsd)
|
abnormal CNS synaptic transmission
|
J:86625
|
| abnormal inhibitory postsynaptic currents
|
J:86625
|
| abnormal miniature inhibitory postsynaptic currents
|
J:86625
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:86625
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:86625
|
Slc6a5trsl/Slc6a5trsl
(C57BL/6J-Slc6a5trsl/GrsrJ)
|
tonic seizures
|
J:235637
|
Slc6a7tm1Veul/Slc6a7tm1Veul
(B6.129P2-Slc6a7tm1Veul)
|
abnormal nervous system physiology
|
J:288931
|
Slc6a8tm1.1Lbar/Y
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * C57BL/6J * C57BL/6N * SJL)
|
abnormal neuron proliferation
|
J:238578
|
Slc6a8tm1.2Lbar/Y
(involves: 129 * 129S1/Sv * C57BL/6J * C57BL/6N)
|
abnormal neuron proliferation
|
J:238578
|
Slc6a9tm1.1Blt/Slc6a9+
(C57BL/6J-Slc6a9tm1.1Blt)
|
enhanced NMDA-mediated synaptic currents
|
J:93288
|
Slc6a9tm1.1Bois/Slc6a9tm1.1Bois
Tg(Camk2a-cre)2834Lusc/0
(involves: C57BL/6J)
|
enhanced NMDA-mediated synaptic currents
|
J:106967
|
Slc6a9tm1Betz/Slc6a9tm1Betz
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:86624
|
| abnormal nervous system electrophysiology
|
J:86624
|
| abnormal nervous system physiology
|
J:86624
|
Slc6a9tm1Jtc/Slc6a9+
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal nervous system physiology
|
J:90689
|
| abnormal NMDA-mediated synaptic currents
|
J:90689
|
| abnormal sensorimotor gating
|
J:90689
|
Slc6a9tm1Jtc/Slc6a9tm1Jtc
(involves: 129S6/SvEvTac * 129X1/SvJ)
|
abnormal nervous system physiology
|
J:90689
|
Slc6a9tm1Veul/Slc6a9tm1Veul
Tg(Syn1-cre)671Jxm/?
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal neuron physiology
|
J:161993
|
Slc6a11tm1Dgen/Slc6a11+
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:101679
|
Slc7a5tm1.1Daca/Slc7a5tm1.1Daca
Tg(Tek-cre)12Flv/0
(B6J.Cg-Slc7a5tm1.1Daca Tg(Tek-cre)12Flv)
|
abnormal CNS synaptic transmission
|
J:238065
|
| abnormal miniature excitatory postsynaptic currents
|
J:238065
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:238065
|
Slc7a8tm1Dgen/Slc7a8tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to pharmacologically induced seizures
|
J:101679
|
Slc7a8tm1Geno/Slc7a8tm1Geno
(involves: 129 * C57BL/6J)
|
decreased prepulse inhibition
|
J:256844
|
Slc7a10tm1Dgen/Slc7a10tm1Dgen
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:100127
|
| abnormal excitatory postsynaptic potential
|
J:100127
|
| abnormal nervous system physiology
|
J:122880
|
| abnormal synaptic physiology
|
J:122880
|
| myoclonus
|
J:100127
|
| seizures
|
J:100127
|
| tonic-clonic seizures
|
J:100127
|
Slc8a2tm1(cre)Hssh/Slc8a2tm1(cre)Hssh
(involves: 129 * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:84050
|
| abnormal long-term depression
|
J:84050
|
| abnormal neuron physiology
|
J:84050
|
| abnormal post-tetanic potentiation
|
J:84050
|
| abnormal synaptic plasticity
|
J:84050
|
| enhanced long-term potentiation
|
J:84050
|
| enhanced paired-pulse facilitation
|
J:84050
|
Slc8a3tm1Sso/Slc8a3tm1Sso
(Not Specified)
|
abnormal channel response
|
J:87615
|
| abnormal synaptic transmission
|
J:87615
|
| increased cerebral infarct size
|
J:131833
|
Slc9a1swe/Slc9a1swe
(SJL/J-Slc9a1swe/J)
|
seizures
|
J:43429
|
| tonic-clonic seizures
|
J:43429
|
Slc9a1swe/Slc9a1swe
(B6.SJL-Slc9a1swe)
|
seizures
|
J:43429
|
| tonic-clonic seizures
|
J:43429
|
Slc9a1swe/Slc9a1swe
(involves: C57BL/6J * SJL/J)
|
absence seizures
|
J:43429
|
| seizures
|
J:43429
|
| tonic-clonic seizures
|
J:43429
|
Slc9a1tm1Smb/Slc9a1tm1Smb
(involves: 129X1/SvJ * Black Swiss)
|
convulsive seizures
|
J:54705
|
Slc9a3tm1b(NCOM)Mfgc/Slc9a3+
(C57BL/6N-Slc9a3tm1b(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Slc9a4tm1b(EUCOMM)Wtsi/Slc9a4tm1b(EUCOMM)Wtsi
(C57BL/6N-Slc9a4tm1b(EUCOMM)Wtsi/H)
|
decreased prepulse inhibition
|
J:211773
|
Slc9a5tm1Smoc/Slc9a5tm1Smoc
(involves: C57BL/6)
|
abnormal nervous system physiology
|
J:302075
|
Slc9a6tm1Dgen/Y
(involves: 129P2/OlaHsd * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:101679
|
Slc9a9tm2d(KOMP)Wtsi/Slc9a9tm2d(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N * SJL)
|
abnormal brain wave pattern
|
J:258593
|
| abnormal CNS synaptic transmission
|
J:258593
|
| abnormal excitatory postsynaptic potential
|
J:258593
|
| abnormal miniature excitatory postsynaptic currents
|
J:258593
|
| abnormal neuron physiology
|
J:258593
|
| abnormal synaptic vesicle exocytosis
|
J:258593
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:258593
|
Slc10a4tm1Tigm/Slc10a4tm1Tigm
(involves: 129S/SvEvBrd)
|
abnormal spike wave discharge
|
J:196996
|
| increased susceptibility to pharmacologically induced seizures
|
J:196996
|
| seizures
|
J:196996
|
Slc12a5tm1Dlp/Slc12a5+
(involves: C57BL/6J)
|
abnormal summary potential
|
J:113307
|
| increased susceptibility to pharmacologically induced seizures
|
J:113307
|
Slc12a5tm1Dlp/Slc12a5tm1Dlp
(involves: 129 * C57BL/6J)
|
abnormal summary potential
|
J:113307
|
| tonic-clonic seizures
|
J:113307
|
Slc12a5tm1Hsav/Slc12a5tm1Hsav
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:127091
|
Slc12a5tm1Hsav/Slc12a5tm2Hsav
(involves: 129S1/Sv * 129S2/SvPasHsd * 129X1/SvJ * C57BL/6J * C57BL/6JOlaHsd)
|
increased susceptibility to pharmacologically induced seizures
|
J:101079
|
Slc12a5tm1Tjj/Slc12a5tm1Tjj
(either: 129X1/SvJ or (involves: 129X1/SvJ * C57BL/6) or (involves: 129X1/SvJ * NMRI))
|
abnormal action potential
|
J:69625
|
| abnormal central pattern generator function
|
J:69625
|
| abnormal nervous system electrophysiology
|
J:69625
|
| abnormal somatic nervous system physiology
|
J:69625
|
Slc12a5tm2.1Tjj/Slc12a5tm2.1Tjj
Gabra6tm2(cre)Wwis/Gabra6+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal action potential
|
J:181930
|
Slc12a5tm2.1Tjj/Slc12a5tm2.1Tjj
Gabra6tm2(cre)Wwis/Gabra6+
Tg(Pcp2-cre)2Mpin/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal GABA-mediated receptor currents
|
J:181930
|
Slc12a5tm2.1Tjj/Slc12a5tm2.1Tjj
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal GABA-mediated receptor currents
|
J:181930
|
| impaired ability to fire action potentials
|
J:181930
|
Slc12a5tm2Hsav/Slc12a5tm2Hsav
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:136887
|
Slc12a6em1Dlp/Slc12a6em1Dlp
(involves: C57BL/6J)
|
abnormal nerve conduction
|
J:259728
|
| demyelination
|
J:259728
|
Slc12a6gaxp/Slc12a6gaxp
(C3H/HeSnJ-Slc12a6gaxp/GrsrJ)
|
abnormal myelination
|
J:82451
|
Slc12a6tm1.1Garo/Slc12a6tm1.1Garo
(involves: 129 * C57BL/6)
|
demyelination
|
J:183239
|
Slc12a6tm1Dlp/Slc12a6+
(involves: 129 * C57BL/6J)
|
decreased prepulse inhibition
|
J:79870
|
Slc12a6tm1Dlp/Slc12a6tm1Dlp
(involves: 129 * C57BL/6J)
|
abnormal myelination
|
J:79870
|
| decreased prepulse inhibition
|
J:79870
|
| demyelination
|
J:79870
|
Slc12a6tm1Garo/Slc12a6tm1Garo
Tg(Syn1-cre)671Jxm/0
(involves: 129 * C57BL/6 * CBA)
|
demyelination
|
J:183239
|
Slc12a6tm1Tjj/Slc12a6tm1Tjj
(involves: 129/Sv * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:86183
|
Slc13a1tm1Mark/Slc13a1+
(involves: 129T2/SvEms * C57BL/6J)
|
clonic seizures
|
J:86561
|
Slc13a1tm1Mark/Slc13a1tm1Mark
(involves: 129T2/SvEms * C57BL/6J)
|
clonic seizures
|
J:86561
|
Slc16a3tm1Tac/Slc16a3tm1Tac
(B6NTac.Cg-Slc16a3tm1Tac/Tac)
|
abnormal action potential
|
J:288233
|
Slc17a5tm1Lex/Slc17a5tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal myelination
|
J:158444
|
| abnormal nervous system physiology
|
J:158444
|
| demyelination
|
J:158444
|
| environmentally induced seizures
|
J:158444
|
| tonic-clonic seizures
|
J:158444
|
Slc17a6tm1.1Jder/Slc17a6tm1.1Jder
Emx1tm1(cre)Krj/Emx1+
(B6.Cg-Emx1tm1(cre)Krj Slc17a6tm1.1Jder)
|
abnormal glutamate-mediated receptor currents
|
J:192240
|
| decreased synaptic glutamate release
|
J:192240
|
| increased paired-pulse ratio
|
J:192240
|
| reduced long-term depression
|
J:192240
|
Slc17a6tm1.1Kldr/Slc17a6tm1.1Kldr
(involves: 129S1/Sv * 129X1/SvJ * BALB/c * C57BL/6)
|
abnormal nervous system physiology
|
J:116180
|
| abnormal pre-Botzinger complex physiology
|
J:116180
|
| absence of AMPA-mediated synaptic currents
|
J:116180
|
Slc17a6tm1.1Thna/Slc17a6tm1.1Thna
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Slc6a3tm1(cre)Xz/Slc6a3+
(involves: 129/Sv * 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6J)
|
abnormal excitatory postsynaptic currents
|
J:167767
|
Slc17a6tm1Lex/Slc17a6+
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:116159
|
Slc17a6tm1Lex/Slc17a6tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:116159
|
| abnormal excitatory postsynaptic currents
|
J:116159
|
| decreased miniature excitatory postsynaptic current amplitude
|
J:116159
|
| decreased miniature excitatory postsynaptic current frequency
|
J:116159
|
| increased excitatory postsynaptic current amplitude
|
J:116159
|
Slc17a6tm1Lowl/Slc17a6tm1Lowl
Tg(CAG-Bgeo/GFP)21Lbe/0
Tg(Nr5a1-cre)2Lowl/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * FVB)
|
abnormal excitatory postsynaptic currents
|
J:129860
|
Slc17a7tm1Bros/Slc17a7+
(involves: 129 * C57BL/6N)
|
abnormal nervous system physiology
|
J:118618
|
Slc17a7tm1Bros/Slc17a7tm1Bros
(involves: 129P2/OlaHsd)
|
abnormal excitatory postsynaptic currents
|
J:89958
|
| abnormal miniature excitatory postsynaptic currents
|
J:89958
|
Slc17a7tm1Edw/Slc17a7tm1Edw
(involves: 129X1/SvJ)
|
abnormal CNS synaptic transmission
|
J:105647
|
| abnormal excitatory postsynaptic potential
|
J:105647
|
| abnormal neurotransmitter uptake
|
J:105647
|
| abnormal single cell response
|
J:105647
|
| decreased miniature excitatory postsynaptic current frequency
|
J:105647
|
Slc17a7tm1Lex/Slc17a7+
(involves: 129S5/SvEvBrd * C57BL/6J)
|
abnormal excitatory postsynaptic potential
|
J:174414
|
| reduced long-term potentiation
|
J:174414
|
Slc17a8em1(IMPC)Mbp/Slc17a8em1(IMPC)Mbp
(C57BL/6N-Slc17a8em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Slc17a8tm1(cre)Lowl/Slc17a8+
Runx1tm3Spe/Runx1tm3Spe
(involves: 129S4/SvJae * 129S6/SvEvTac * C57BL/6NCr)
|
abnormal sympathetic neuron physiology
|
J:193903
|
Slc17a8tm1Edw/Slc17a8+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal brain wave pattern
|
J:132704
|
Slc17a8tm1Edw/Slc17a8tm1Edw
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal brain wave pattern
|
J:132704
|
| decreased synaptic glutamate release
|
J:132704
|
| nonconvulsive seizures
|
J:132704
|
Slc17a8tm1Selm/Slc17a8tm1Selm
(involves: 129/Sv * C57BL/6)
|
abnormal cochlear inner hair cell physiology
|
J:139493
|
| abnormal neurotransmitter uptake
|
J:135586
|
| abnormal synaptic acetylcholine release
|
J:135586
|
| absent cochlear nerve compound action potential
|
J:139493
|
Slc17a9tm1Nomu/Slc17a9tm1Nomu
(involves: 129 * C57BL/6J)
|
abnormal neuroendocrine gland physiology
|
J:256580
|
Slc18a1tm1Dgen/Slc18a1tm1Dgen
(B6.129P2-Slc18a1tm1Dgen/J)
|
abnormal neuron proliferation
|
J:194189
|
| increased neuron apoptosis
|
J:194189
|
Slc18a2tm1Edw/Slc18a2tm1Edw
(involves: 129X1/SvJ)
|
abnormal neurotransmitter secretion
|
J:96932
|
Slc18a2tm1Edw/Slc18a2tm1Edw
(involves: 129X1/SvJ * C57BL/6)
|
abnormal neurotransmitter secretion
|
J:45183
|
Slc18a2tm1Mca/Slc18a2+
(involves: 129X1/SvJ)
|
abnormal neurotransmitter secretion
|
J:45184
|
| abnormal neurotransmitter uptake
|
J:45184
|
Slc18a2tm1Mca/Slc18a2+
(B6.129X1-Slc18a2tm1Mca)
|
enhanced long-term potentiation
|
J:89778
|
Slc18a2tm1Mca/Slc18a2tm1Mca
(involves: 129X1/SvJ)
|
abnormal synaptic neurotransmitter level
|
J:45184
|
Slc18a2tm1Uhl/Slc18a2+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:42811
|
Slc18a2tm2Kmo/Slc18a2tm2Kmo
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal nervous system physiology
|
J:150414
|
| increased susceptibility to dopaminergic neuron neurotoxicity
|
J:70606
|
Slc18a3tm1Mca/Slc18a3+
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal miniature endplate potential
|
J:137284
|
| abnormal synaptic acetylcholine release
|
J:137284
|
Slc18a3tm1Mca/Slc18a3tm1Mca
(involves: 129S4/SvJae * C57BL/6J)
|
abnormal endplate potential
|
J:137284
|
| abnormal miniature endplate potential
|
J:137284
|
| abnormal synaptic acetylcholine release
|
J:137284
|
| increased susceptibility to pharmacologically induced seizures
|
J:136620
|
Slc22a3tm1Dpb/Slc22a3tm1Dpb
(involves: 129P2/OlaHsd)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:180517
|
Slc23a2tm1Nbm/Slc23a2tm1Nbm
(129S6/SvEvTac-Slc23a2tm1Nbm)
|
intracranial hemorrhage
|
J:76194
|
Slc24a2tm1Jlyt/Slc24a2tm1Jlyt
(either: B6.129-Slc24a2tm1Jlyt or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6))
|
abnormal long-term depression
|
J:110313
|
| reduced long-term potentiation
|
J:110313
|
Slc24a3em1(IMPC)Kmpc/Slc24a3em1(IMPC)Kmpc
(C57BL/6NTac-Slc24a3em1(IMPC)Kmpc/Kmpc)
|
increased prepulse inhibition
|
J:211773
|
Slc24a4tm1.1Hazh/Slc24a4tm1.1Hazh
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal sensory neuron physiology
|
J:180325
|
Slc24a4tm1.2Hazh/Slc24a4tm1.2Hazh
Omptm4(cre)Mom/Omp+
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6)
|
abnormal sensory neuron physiology
|
J:180325
|
Slc24a4tm1b(KOMP)Wtsi/Slc24a4tm1b(KOMP)Wtsi
(C57BL/6N-Slc24a4tm1b(KOMP)Wtsi/H)
|
decreased prepulse inhibition
|
J:211773
|
Slc24a5tm1b(KOMP)Mbp/Slc24a5tm1b(KOMP)Mbp
(C57BL/6N-Slc24a5tm1b(KOMP)Mbp/J)
|
decreased prepulse inhibition
|
J:211773
|
Slc25a3tm1.1Jmol/Slc25a3tm1.1Jmol
A1cfTg(Myh6-cre/Esr1*)1Jmk/?
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal channel response
|
J:229795
|
Slc25a12Gt(OST123999)Lex/Slc25a12+
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal nervous system physiology
|
J:193095
|
Slc25a12Gt(OST123999)Lex/Slc25a12Gt(OST123999)Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal myelination
|
J:101164
|
| abnormal nervous system physiology
|
J:193095
|
| abnormal synaptic dopamine release
|
J:193095
|
| convulsive seizures
|
J:101164
|
Slc25a46atc/Slc25a46atc
(B6.Cg-Slc25a46atc)
|
tonic-clonic seizures
|
J:242350
|
Slc26a5tm1Jnz/Slc26a5+
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased cochlear outer hair cell electromotility
|
J:79029
|
Slc26a5tm1Jnz/Slc26a5tm1Jnz
(involves: 129S7/SvEvBrd * C57BL/6J)
|
absent cochlear microphonics
|
J:79029
|
| absent cochlear outer hair cell electromotility
|
J:79029
|
| decreased cochlear microphonics
|
J:124148,
J:105502
|
| decreased cochlear nerve compound action potential
|
J:124148,
J:105502
|
Slc26a5tm1Jnz/Slc26a5tm1Jnz
(involves: 129S7/SvEvBrd)
|
increased cochlear nerve compound action potential
|
J:145297
|
Slc26a5tm2Jnz/Slc26a5tm2Jnz
(involves: 129S6/SvEvTac * FVB/N)
|
abnormal cochlear outer hair cell electromotility
|
J:123299
|
Slc26a5tm3Jnz/Slc26a5tm3Jnz
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N)
|
abnormal cochlear outer hair cell physiology
|
J:145297
|
| decreased cochlear outer hair cell electromotility
|
J:145297
|
| increased cochlear nerve compound action potential
|
J:145297
|
Slc26a11tm1.1Cidz/Slc26a11tm1.1Cidz
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal action potential
|
J:240359
|
| abnormal afterhyperpolarization
|
J:240359
|
| abnormal GABA-mediated receptor currents
|
J:240359
|
| increased miniature inhibitory postsynaptic current frequency
|
J:240359
|
Slc27a3em1(IMPC)Tcp/Slc27a3em1(IMPC)Tcp
(C57BL/6NCrl-Slc27a3em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Slc29a1tm1Msg/Slc29a1tm1Msg
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal excitatory postsynaptic currents
|
J:92100
|
| abnormal miniature excitatory postsynaptic currents
|
J:92100
|
Slc29a1tm2b(NCOM)Mfgc/Slc29a1tm2b(NCOM)Mfgc
(C57BL/6N-Slc29a1tm2b(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Slc32a1tm1Bros/Slc32a1tm1Bros
(involves: 129P2/OlaHsd)
|
abnormal inhibitory postsynaptic currents
|
J:122318
|
| decreased neurotransmitter release
|
J:122318
|
Slc32a1tm1Yyan/Slc32a1tm1Yyan
(Not Specified)
|
abnormal inhibitory postsynaptic potential
|
J:122055
|
| abnormal nerve fiber response
|
J:122055
|
| abnormal nervous system electrophysiology
|
J:122055
|
Slc32a1tm2(cre)Lowl/Slc32a1tm2(cre)Lowl
(either: B6J.129S6(FVB)-Slc32a1tm2(cre)Lowl or (involves: 129S6/SvEvTac * C57BL/6J * FVB/N))
|
abnormal inhibitory postsynaptic currents
|
J:308516
|
| increased kindling response
|
J:308516
|
| tonic-clonic seizures
|
J:308516
|
Slc33a1tm1.1Lpu/Slc33a1+
(involves: 129S7/SvEvBrd * C57BL/6)
|
brain inflammation
|
J:211266
|
| demyelination
|
J:211266
|
Slc37a4tm1Jyc/Slc37a4tm1Jyc
(involves: 129S4/SvJae * C57BL/6)
|
seizures
|
J:86005
|
Slc38a1tm1.1Ttaka/Slc38a1tm1.1Ttaka
Tg(Syn1-cre)671Jxm/0
(involves: C57BL/6 * C57BL/6NCrlj * CBA * CBA/JNCrlj)
|
decreased cerebral infarct size
|
J:288818
|
| decreased susceptibility to ischemic brain injury
|
J:288818
|
Slc44a1tm1b(EUCOMM)Hmgu/Slc44a1tm1b(EUCOMM)Hmgu
(C57BL/6N-Slc44a1tm1b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Slc44a4tm1b(EUCOMM)Hmgu/Slc44a4tm1b(EUCOMM)Hmgu
(C57BL/6N-Slc44a4tm1b(EUCOMM)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Slitrk1tm1Jaru/Slitrk1tm1Jaru
(B6.129P2-Slitrk1tm1Jaru)
|
abnormal nervous system physiology
|
J:145441
|
Slitrk2tm1.1Jaru/Slitrk2tm1.1Jaru
(B6.129P2-Slitrk2tm1.1Jaru)
|
abnormal excitatory postsynaptic potential
|
J:326787
|
Slitrk2tm1.1Jwum/Y
(involves: C57BL/6J)
|
abnormal miniature excitatory postsynaptic currents
|
J:342291
|
Slitrk2tm1.1Jwum/Y
Tg(Nes-cre)1Atp/0
(involves: C57BL/6J * FVB/N)
|
abnormal miniature excitatory postsynaptic currents
|
J:342291
|
Slitrk3tm1Jaru/Slitrk3tm1Jaru
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased miniature inhibitory postsynaptic current frequency
|
J:232385
|
| increased susceptibility to pharmacologically induced seizures
|
J:232385
|
| seizures
|
J:232385
|
Slitrk4tm1.1Jaru/Y
(B6.129P2-Slitrk4tm1.1Jaru)
|
abnormal neuron physiology
|
J:348363
|
| abnormal synaptic plasticity
|
J:348363
|
| decreased prepulse inhibition
|
J:348363
|
| enhanced long-term potentiation
|
J:348363
|
Slitrk5tm2Vlcg/Slitrk5tm2Vlcg
(involves: 129S/Sv * C57BL/6)
|
abnormal synaptic transmission
|
J:160616
|
Slitrk6tm1.1Jaru/Slitrk6tm1.1Jaru
(B6.129P2-Slitrk6tm1.1Jaru)
|
abnormal neuron physiology
|
J:155405
|
Smad2tm1.1Nomu/Smad2tm1.1Nomu
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal cerebellar granule cell migration
|
J:173787
|
| increased neuron apoptosis
|
J:173787
|
Smarca1tm1.1Pick/Y
(involves: 129S4/SvJae * CD-1)
|
abnormal neuronal precursor proliferation
|
J:183998
|
Smarca1tm1.1Pick/Smarca1tm1.1Pick
(involves: 129S4/SvJae * CD-1)
|
abnormal neuronal precursor proliferation
|
J:183998
|
Smarcb1tm1b(EUCOMM)Hmgu/Smarcb1+
(C57BL/6N-Smarcb1tm1b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Smarcb1tm2Sho/Smarcb1tm2Sho
Tg(GFAP-cre)#Gtm/0
(involves: 129S1/Sv * C57BL/6 * CBA)
|
abnormal cerebellar granule cell migration
|
J:226786
|
| demyelination
|
J:226786
|
Smarcb1tm2Sho/Smarcb1tm2Sho
Trp53tm1Brn/Trp53tm1Brn
Tg(GFAP-cre)#Gtm/0
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA)
|
abnormal cerebellar granule cell migration
|
J:226786
|
| seizures
|
J:226786
|
Smarcc2tm1.1Stoy/Smarcc2tm1.1Stoy
(involves: 129S1/Sv * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:197141
|
Smarcc2tm1.1Stoy/Smarcc2tm1.1Stoy
Emx1tm1(cre)Krj/Emx1+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:197141
|
Smarcd2tm1.1(KOMP)Vlcg/Smarcd2+
(C57BL/6N-Smarcd2tm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Smc2tm1.1Hiran/Smc2tm1.2Hiran
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
abnormal neuronal stem cell physiology
|
J:222181
|
Smchd1em1(IMPC)Tcp/Smchd1+
(C57BL/6NCrl-Smchd1em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Smim8tm1.1(KOMP)Vlcg/Smim8tm1.1(KOMP)Vlcg
(C57BL/6N-Smim8tm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Smn1tm1Cdid/Smn1tm1Cdid
Grm7Tg(SMN2)89Ahmb/Grm7+
(involves: 129 * C57BL/6 * FVB)
|
decreased single cell response threshold
|
J:183080
|
Smn1tm1Hung/Smn1tm1Hung
Tg(SMN2)2Hung/0
(involves: 129P2/OlaHsd * C57BL/6N * FVB/N)
|
abnormal endplate potential
|
J:193844
|
| abnormal synaptic vesicle clustering
|
J:193844
|
Smn1tm1Msd/Smn1tm1Msd
Tg(SMN1*A2G)2023Ahmb/0
Grm7Tg(SMN2)89Ahmb/Grm7+
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal action potential
|
J:81238
|
| abnormal motor nerve collateral sprouting
|
J:81238
|
Smn1tm1Msd/Smn1tm1Msd
Tg(SMN1*A2G)2023Ahmb/Tg(SMN1*A2G)2023Ahmb
Grm7Tg(SMN2)89Ahmb/?
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal motor nerve collateral sprouting
|
J:81238
|
Smn1tm5(Smn1/SMN2)Mrph/Smn1tm5(Smn1/SMN2)Mrph
(involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NTac)
|
abnormal endplate potential
|
J:186987
|
| abnormal miniature endplate potential
|
J:186987
|
| abnormal synaptic transmission
|
J:186987
|
Snap25Bdr/Snap25+
(involves: BALB/cAnNCrl)
|
abnormal miniature excitatory postsynaptic currents
|
J:119733
|
| decreased prepulse inhibition
|
J:119733
|
| decreased synaptic glutamate release
|
J:119733
|
Snap25tm1.1Bark/Snap25tm1.1Bark
(B6.Cg-Snap25tm1.1Bark)
|
decreased paired-pulse facilitation
|
J:142096
|
| seizures
|
J:142096
|
Snap25tm1Bark/Snap25tm1Bark
(B6.Cg-Snap25tm1Bark)
|
decreased paired-pulse facilitation
|
J:142096
|
| seizures
|
J:142096
|
Snap25tm1Mcw/Snap25tm1Mcw
(involves: C57BL/6)
|
abnormal CNS synaptic transmission
|
J:73755
|
| abnormal endplate potential
|
J:73755
|
| abnormal miniature excitatory postsynaptic currents
|
J:73755
|
| abnormal PNS synaptic transmission
|
J:73755
|
Snap25tm1Mtaka/Snap25tm1Mtaka
(B6N.129P2-Snap25tm1Mtaka)
|
convulsive seizures
|
J:177870
|
Snap25tm2Mcw/Snap25tm2Mcw
(involves: C57BL/6J)
|
enhanced paired-pulse facilitation
|
J:94005
|
| myoclonus
|
J:94005
|
Snap91tm1.1Tmar/Snap91+
Vamp2tm1Sud/Vamp2+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * C57BL/6NTac)
|
abnormal CNS synaptic transmission
|
J:228428
|
| enhanced paired-pulse facilitation
|
J:228428
|
Snap91tm1.1Tmar/Snap91tm1.1Tmar
(involves: 129S6/SvEvTac * C57BL/6NTac)
|
abnormal brain wave pattern
|
J:228428
|
| abnormal CNS synaptic transmission
|
J:228428
|
| abnormal excitatory postsynaptic potential
|
J:228428
|
| abnormal inhibitory postsynaptic currents
|
J:228428
|
| abnormal miniature excitatory postsynaptic currents
|
J:228428
|
| abnormal synaptic plasticity
|
J:228428
|
| abnormal synaptic vesicle recycling
|
J:228428
|
| decreased excitatory postsynaptic current amplitude
|
J:228428
|
| enhanced paired-pulse facilitation
|
J:228428
|
| tonic-clonic seizures
|
J:228428
|
Snapintm2Zhs/Snapintm2Zhs
Tg(Thy1-cre)703Vaw/0
(involves: C3H * C57BL/6)
|
abnormal axonal transport
|
J:207508
|
Sncatm1Rosl/Sncatm1Rosl
(B6.129X1-Sncatm1Rosl)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:92213
|
Sncatm1Rosl/Sncatm1Rosl
Sncgtm1Vlb/Sncgtm1Vlb
(B6.129-Sncatm1Rosl Sncgtm1Vlb)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:92213
|
Sncatm1Rosl/Sncatm1Rosl
Tg(SNCA)OVX37Rwm/0
(B6.Cg-Tg(SNCA)OVX37Rwm Sncatm1Rosl)
|
abnormal neuron physiology
|
J:201991
|
| abnormal synaptic dopamine release
|
J:201991
|
Sncatm1Rosl/Sncatm1Rosl
Tg(SNCA*A30P)192Rwm/0
(B6.Cg-Sncatm1Rosl Tg(SNCA*A30P)#Rwm)
|
abnormal nervous system physiology
|
J:201961
|
Sncatm1Wtd/Sncatm1Wtd
(involves: 129)
|
abnormal miniature excitatory postsynaptic currents
|
J:126092,
J:94390
|
| abnormal synaptic transmission
|
J:94390
|
| decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:79993
|
| reduced long-term potentiation
|
J:126092,
J:94390
|
Sncgtm1Vlb/Sncgtm1Vlb
(B6.129P2-Sncgtm1Vlb)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:92213
|
Snphtm1Zhs/Snphtm1Zhs
(involves: 129S6/SvEvTac)
|
abnormal neuron physiology
|
J:145318
|
| enhanced paired-pulse facilitation
|
J:145318
|
Snta1tm1Scf/Snta1tm1Scf
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased susceptibility to ischemic brain injury
|
J:81976
|
Snta1tm1Scf/Snta1tm1Scf
Sntb2tm1Scf/Sntb2tm1Scf
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal miniature endplate potential
|
J:96569
|
Snx6tm1.1Nju/Snx6tm1.1Nju
Tg(Nes-cre)1Kln/0
(involves: C57BL/6NTac * SJL)
|
reduced AMPA-mediated synaptic currents
|
J:240866
|
Snx14em1(IMPC)H/Snx14+
(C57BL/6NTac-Snx14em1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Socs7tm1Wsa/Socs7tm1Wsa
(involves: C57BL/6)
|
intracranial hemorrhage
|
J:93449
|
Sod1m1H/Sod1+
(involves: C3H/HeH * C57BL/6J)
|
abnormal neuron physiology
|
J:219360
|
Sod2tm1Cje/Sod2tm1Cje
(involves: C57BL/6J * DBA/2J)
|
seizures
|
J:73998,
J:98007
|
Sorbs2tm1.2Gfng/Sorbs2tm1.2Gfng
(B6.129(FVB)-Sorbs2tm1.2Gfng)
|
abnormal miniature excitatory postsynaptic currents
|
J:231609
|
| decreased prepulse inhibition
|
J:231609
|
Sorcs2tm1Anyk/Sorcs2tm1Anyk
(B6.129-Sorcs2tm1Anyk)
|
abnormal neuron physiology
|
J:214739
|
Sorcs3tm1.1Tew/Sorcs3tm1.1Tew
(B6N.Cg-Sorcs3tm1.1Tew)
|
absent long-term depression
|
J:207532
|
Sox1tm1Vep/Sox1tm1Vep
(either: (involves: 129/Sv * 129S/SvEv) or (involves: 129S/SvEv * MF1))
|
seizures
|
J:46636
|
Sox1tm1Vep/Sox1tm2Vep
(involves: 129S/SvEv)
|
abnormal neuronal migration
|
J:99610
|
Sox1tm1Vep/Sox1tm2Vep
Sox2tm1Vep/Sox2+
(involves: 129S/SvEv)
|
seizures
|
J:99610
|
Sox1tm2Vep/Sox1tm2Vep
(Not Specified)
|
seizures
|
J:99610
|
Sox2lcc/Sox2lcc
(involves: 101/H * C3H/HeH)
|
absent cochlear nerve compound action potential
|
J:77358
|
Sox2lcc/Sox2ysb
(involves: 101/H * C3H/HeH * C57BL/6 * CBA)
|
absent cochlear nerve compound action potential
|
J:77358
|
Sox2tm1Okud/Sox2tm1Okud
Tg(Nes-cre)1Sasa/?
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:138323
|
Sox2tm2Skn/Sox2tm3Skn
(involves: 129S/SvEv * 129S1/Sv * C57BL/6J)
|
abnormal nervous system physiology
|
J:92063
|
| nonconvulsive seizures
|
J:92063
|
Sox2tm4.1Skn/Sox2tm4.1Skn
Tg(Sox2-cre/ERT2)1Skn/0
(involves: 129S1/Sv * 129S4/SvJae)
|
abnormal neuronal precursor proliferation
|
J:154650
|
Sox2ysb/Sox2ysb
(involves: C57BL/6 * CBA)
|
decreased cochlear nerve compound action potential
|
J:77358
|
Sox10gt/Sox10gt
(involves: HYIII/LeJ)
|
demyelination
|
J:7723
|
| sporadic seizures
|
J:7723
|
Sox10gt/Sox10gt
(GT/Le)
|
dysmyelination
|
J:216967
|
Sox10gt/Sox10gt
(involves: C57BL/6 * GT/Le)
|
abnormal myelination
|
J:216967
|
| seizures
|
J:216967
|
Sox10tm1Weg/Sox10+
(involves: 129S1/Sv * 129X1/SvJ * C3H)
|
abnormal oligodendrocyte physiology
|
J:260791
|
Sox10tm1Weg/Sox10tm1Weg
(involves: 129S1/Sv * 129X1/SvJ * C3H)
|
abnormal oligodendrocyte physiology
|
J:260791
|
Sox10tm7.1(Sox10)Weg/Sox10tm7.1(Sox10)Weg
Tg(Dhh-cre)1Mejr/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N * SJL)
|
abnormal action potential
|
J:162692
|
| abnormal myelination
|
J:162692
|
| abnormal neuron proliferation
|
J:162692
|
| decreased nerve conduction velocity
|
J:162692
|
| increased neuron apoptosis
|
J:162692
|
Sox10tm8.1Weg/Sox10+
(involves: 129P2/OlaHsd * C3H)
|
abnormal oligodendrocyte physiology
|
J:260791
|
Sox10tm8.1Weg/Sox10tm8.1Weg
(involves: 129P2/OlaHsd * C3H)
|
abnormal oligodendrocyte physiology
|
J:260791
|
| abnormal Schwann cell physiology
|
J:260791
|
Sox11tm1.1Llei/Sox11tm1.1Llei
Tg(Nes-cre/ERT2)73Lfp/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2)
|
abnormal neuronal precursor proliferation
|
J:198233
|
Sox11tm1.2Llei/Sox11tm1.2Llei
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:198233
|
| increased neuron apoptosis
|
J:198233
|
Sox14em1(IMPC)Ccpcz/Sox14+
(C57BL/6N-Sox14em1(IMPC)Ccpcz/Ccpcz)
|
increased prepulse inhibition
|
J:211773
|
Sp2tm1.1Htg/Sp2+
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
decreased neuronal precursor proliferation
|
J:194076
|
Sp2tm1.1Htg/Sp2tm1.1Htg
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
decreased neuronal precursor proliferation
|
J:194076
|
Sp4tm3(Sp4)Krc/Sp4tm3(Sp4)Krc
(involves: 129S1/Sv * 129X1/SvJ * Black Swiss)
|
reduced long-term potentiation
|
J:163637
|
| reduced sensorimotor gating
|
J:110135
|
Sp8tm2.1Aman/Sp8tm2.1Aman
Foxg1tm1(cre)Skm/Foxg1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:160653
|
| increased neuron apoptosis
|
J:160653
|
Sp9tm1.1Zyan/Sp9tm1.1Zyan
(involves: 129S6/SvEvTac * C57BL/6J)
|
decreased neuronal precursor proliferation
|
J:238868
|
| increased neuron apoptosis
|
J:238868
|
Sp9tm1.2Zyan/Sp9tm1.2Zyan
Tg(Drd2-cre)ER43Gsat/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
increased neuron apoptosis
|
J:238868
|
SpastM1Gri/Spast+
(B6.C-SpastM1Gri)
|
abnormal axonal transport
|
J:148877
|
SpastM1Gri/SpastM1Gri
(B6.C-SpastM1Gri)
|
abnormal axonal transport
|
J:148877
|
Spg7tm1Eir/Spg7tm1Eir
(either: 129/Sv-Spg7tm1Eir or (involves: 129/Sv * C57BL/6))
|
abnormal axonal transport
|
J:87616
|
Sphk1tm1Rlp/Sphk1tm1Rlp
Sphk2tm1Rlp/Sphk2tm1Rlp
(involves: 129S6/SvEvTac * C57BL/6)
|
increased embryonic neuroepithelium apoptosis
|
J:103755
|
| increased hindbrain apoptosis
|
J:103755
|
| increased midbrain apoptosis
|
J:103755
|
| intracranial hemorrhage
|
J:103755
|
| intraventricular hemorrhage
|
J:103755
|
| spinal hemorrhage
|
J:103755
|
Spns1tm1a(EUCOMM)Wtsi/Spns1+
(C57BL/6N-Spns1tm1a(EUCOMM)Wtsi/Ics)
|
increased prepulse inhibition
|
J:165965
|
Spock1em1(IMPC)H/Spock1em1(IMPC)H
(C57BL/6N-Spock1em1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Spoptm1b(KOMP)Wtsi/Spop+
(C57BL/6N-Spoptm1b(KOMP)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Spp1tm1Blh/Spp1tm1Blh
(B6.129S6-Spp1tm1Blh)
|
decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:118432
|
Sprtm1Spo/Sprtm1Spo
(involves: 129 * C57BL/6)
|
abnormal synaptic neurotransmitter level
|
J:124817
|
Spred1tm1Hiin/Spred1tm1Hiin
(B6.Cg-Spred1tm1Hiin)
|
abnormal excitatory postsynaptic potential
|
J:144031
|
| absent long-term depression
|
J:144031
|
| enhanced paired-pulse facilitation
|
J:144031
|
| reduced long-term potentiation
|
J:144031
|
Spred3em1(IMPC)Tcp/Spred3+
(C57BL/6NCrl-Spred3em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
sps/sps
(involves: C57BL/10Bg)
|
abnormal brain wave pattern
|
J:6937
|
| convulsive seizures
|
J:12239,
J:32781
|
Sptbn2Gt(XK442)Byg/Sptbn2Gt(XK442)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
clonic seizures
|
J:158494
|
Sptbn2tm1Mjac/Sptbn2tm1Mjac
(B6.129P2-Sptbn2tm1Mjac)
|
abnormal nervous system electrophysiology
|
J:159622
|
| increased excitatory postsynaptic current amplitude
|
J:159622
|
Sptbn4Gt(ROSABetageo)62Sor/Sptbn4Gt(ROSABetageo)62Sor
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal myelination
|
J:120916
|
Sptbn4tm1Mkom/Sptbn4tm1Mkom
(involves: 129S4/SvJaeSor * C57BL/6J)
|
abnormal myelination
|
J:120916
|
Sra1tm1b(EUCOMM)Hmgu/Sra1tm1b(EUCOMM)Hmgu
(C57BL/6N-Sra1tm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Srcin1tm1Fdc/Srcin1tm1Fdc
(Not Specified)
|
abnormal CNS synaptic transmission
|
J:206962
|
| abnormal excitatory postsynaptic potential
|
J:206962
|
| impaired synaptic plasticity
|
J:206962
|
| reduced long-term depression
|
J:206962
|
| reduced long-term potentiation
|
J:206962
|
Srgap3tm1.1Zi/Srgap3tm1.1Zi
(B6.129(SJL)-Srgap3tm1.1Zi)
|
decreased prepulse inhibition
|
J:192388
|
Srrrgsc1872/Srrrgsc1872
(C57BL/6JJcl-Srrrgsc1872)
|
decreased prepulse inhibition
|
J:151337
|
Srrtm1(cre/PGR)Himo/Srrtm1(cre/PGR)Himo
(C57BL/6N-Srrtm1(cre/PGR)Himo)
|
decreased susceptibility to neuronal excitotoxicity
|
J:144030
|
Srrtm1.2Jtc/Srr+
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
abnormal nervous system physiology
|
J:158266
|
| increased excitatory postsynaptic current amplitude
|
J:158266
|
Srrtm1.2Jtc/Srrtm1.2Jtc
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
abnormal excitatory postsynaptic currents
|
J:158266
|
| abnormal nervous system physiology
|
J:158266
|
| reduced long-term potentiation
|
J:158266
|
Srrm3Gt(IST12726F8)Tigm/Srrm3Gt(IST12726F8)Tigm
Srrm4bv/Srrm4bv
(involves: C57BL/6N)
|
abnormal GABA-mediated receptor currents
|
J:281311
|
| abnormal neuron physiology
|
J:281311
|
Srsf11tm1b(EUCOMM)Wtsi/Srsf11+
(C57BL/6N-Srsf11tm1b(EUCOMM)Wtsi/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Ss18l1em1Zqi/Ss18l1+
(involves: C57BL/6)
|
increased microglial cell activation
|
J:278840
|
Ss18l1em1Zqi/Ss18l1em1Zqi
(involves: C57BL/6)
|
increased microglial cell activation
|
J:278840
|
Ss18l1em2Zqi/Ss18l1em2Zqi
(involves: C57BL/6)
|
increased microglial cell activation
|
J:278840
|
Ssc4dem1(IMPC)J/Ssc4dem1(IMPC)J
(C57BL/6NJ-Ssc4dem1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Ssr2tm1b(EUCOMM)Wtsi/Ssr2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ssr2tm1b(EUCOMM)Wtsi/Wtsi)
|
intracerebral hemorrhage
|
J:239583
|
Ssttm1Low/Ssttm1Low
(B6.129P2-Ssttm1Low)
|
abnormal excitatory postsynaptic potential
|
J:108920
|
| abnormal inhibitory postsynaptic potential
|
J:108920
|
| abnormal nervous system electrophysiology
|
J:108920
|
Sstr1tm1Dric/Sstr1tm1Dric
(involves: 129S4/SvJae * C57BL/6)
|
abnormal brain wave pattern
|
J:101285
|
Sstr1tm1Dric/Sstr1tm1Dric
(involves: 129S4/SvJae)
|
decreased synaptic glutamate release
|
J:122896
|
Sstr2tm1Pce/Sstr2tm1Pce
(B6.129P2-Sstr2tm1Pce)
|
abnormal synaptic glutamate release
|
J:89708
|
Sstr2tm1Pce/Sstr2tm1Pce
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal brain wave pattern
|
J:101285
|
St3gal4tm1.1Bsi/St3gal4tm1.1Bsi
(B6J.B6N-St3gal4tm1.1Bsi)
|
decreased kindling response
|
J:217104
|
St3gal5tm1Skoz/St3gal5tm1Skoz
(Not Specified)
|
abnormal synaptic glutamate release
|
J:229230
|
St8sia1tm1Kfk/St8sia1tm1Kfk
(Not Specified)
|
abnormal nervous system regeneration
|
J:73818
|
St8sia2tm1Jxm/St8sia2tm1Jxm
St8sia4tm1.1Mifu/St8sia4tm1.1Mifu
(involves: C57BL/6)
|
abnormal neuronal migration
|
J:126687
|
| increased neuron apoptosis
|
J:126687
|
St8sia4tm1Crem/St8sia4tm1Crem
(involves: 129P2/OlaHsd * C57BL/6J)
|
reduced long-term depression
|
J:63481
|
| reduced long-term potentiation
|
J:63481
|
Stac3tm1a(KOMP)Wtsi/Stac3tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal miniature endplate potential
|
J:222015
|
Stamtm1Sug/Stamtm1Sug
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to pharmacologically induced seizures
|
J:69504
|
Stard10tm1b(KOMP)Wtsi/Stard10tm1b(KOMP)Wtsi
(C57BL/6N-Stard10tm1b(KOMP)Wtsi/H)
|
decreased prepulse inhibition
|
J:211773
|
Stat1tm1Rds/Stat1tm1Rds
(129S6/SvEv-Stat1tm1Rds/Tac)
|
decreased susceptibility to neuronal excitotoxicity
|
J:116659
|
Stat3tm1Aki/Stat3tm2Aki
Tg(NEFL-cre)50Msd/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * CD-1)
|
abnormal neuron physiology
|
J:77229
|
Stau2Gt(RRG396)Byg/Stau2Gt(RRG396)Byg
(B6.129P2-Stau2Gt(RRG396)Byg)
|
abnormal CNS synaptic transmission
|
J:284920
|
Stbd1tm1b(KOMP)Wtsi/Stbd1tm1b(KOMP)Wtsi
(C57BL/6N-Stbd1tm1b(KOMP)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Stim1Gt(RRS558)Byg/Stim1Gt(RRS558)Byg
(involves: 129P2/OlaHsd)
|
abnormal neuron physiology
|
J:159604
|
Stim1tm1Kuro/Stim1tm1Kuro
Stim2tm1.1Kuro/Stim2tm1.1Kuro
Cd79atm1(cre)Reth/Cd79a+
(involves: BALB/c * C57BL/6)
|
demyelination
|
J:172608
|
Stim2tm1.1(KOMP)Vlcg/Stim2+
(C57BL/6N-Stim2tm1.1(KOMP)Vlcg/J)
|
decreased prepulse inhibition
|
J:211773
|
Stim2tm1Beni/Stim2tm1Beni
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal neuron physiology
|
J:159604
|
| decreased cerebral infarct size
|
J:159604
|
| decreased neuron apoptosis
|
J:159604
|
| decreased susceptibility to ischemic brain injury
|
J:159604
|
Stip1tm1.2Mamp/Stip1+
(involves: C57BL/6)
|
abnormal astrocyte physiology
|
J:201097
|
| increased cerebral infarct size
|
J:201097
|
| increased susceptibility to ischemic brain injury
|
J:201097
|
Stk11tm1.1Rdp/Stk11tm1.1Rdp
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S6/SvEvTac * C57BL/6J * CBA/J)
|
abnormal neuron physiology
|
J:305107
|
Stk25tm1.1Bwh/Stk25tm1.1Bwh
(involves: 129 * C57BL/6)
|
abnormal neuronal migration
|
J:203414
|
Stk36em1(IMPC)J/Stk36+
(C57BL/6NJ-Stk36em1(IMPC)J/J)
|
increased prepulse inhibition
|
J:211773
|
Stk39tm1Dlp/Stk39tm1Dlp
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal neuron physiology
|
J:150513
|
Stmn1tm1Wed/Stmn1tm1Wed
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal nerve conduction
|
J:74496
|
| demyelination
|
J:74496
|
Stmn2em1Jmi/Stmn2em1Jmi
(C57BL/6N-Stmn2em1Jmi)
|
abnormal action potential
|
J:337175
|
Stoml1Gt(M038E05)Wrst/Stoml1Gt(M038E05)Wrst
(B6.129S2-Stoml1Gt(M038E05)Wrst)
|
abnormal nervous system electrophysiology
|
J:219161
|
Stoml2tm1(KOMP)Vlcg/Stoml2tm1(KOMP)Vlcg
(C57BL/6N-Stoml2tm1(KOMP)Vlcg/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Stoml3tm1Glwn/Stoml3tm1Glwn
(involves: 129P2/OlaHsd * C57BL/6N)
|
abnormal nerve fiber response
|
J:118239
|
Ston2tm1Vha/Ston2tm1Vha
(B6.129-Ston2tm1Vha)
|
abnormal synaptic transmission
|
J:194336
|
| abnormal synaptic vesicle recycling
|
J:194336
|
| enhanced paired-pulse facilitation
|
J:194336
|
Stradaem1Pbcr/Stradaem1Pbcr
(C57BL/6N-Stradaem1Pbcr)
|
abnormal neuronal migration
|
J:308972
|
Strbpem1(IMPC)Hmgu/Strbpem1(IMPC)Hmgu
(C57BL/6N-Strbpem1(IMPC)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Strctm1Ugds/Strctm1Ugds
(involves: 129S2/SvPas * BALB/c * C57BL/6 * C57BL/6J)
|
abnormal cochlear microphonics
|
J:141421
|
Stx1atm1Migar/Stx1a+
(involves: C57BL/6N)
|
abnormal neuron physiology
|
J:204968
|
| abnormal synaptic vesicle recycling
|
J:204968
|
| decreased synaptic depression
|
J:204968
|
| enhanced paired-pulse facilitation
|
J:204968
|
| impaired synaptic plasticity
|
J:204968
|
| increased post-tetanic potentiation
|
J:204968
|
Stx1atm1Tfuj/Stx1atm1Tfuj
(involves: C57BL/6J)
|
abnormal excitatory postsynaptic potential
|
J:109042
|
| reduced long-term potentiation
|
J:109042
|
Stx1atm1Tfuj/Stx1atm1Tfuj
(B6.Cg-Stx1atm1Tfuj)
|
abnormal hypothalamus secretion
|
J:171786
|
| abnormal nervous system physiology
|
J:171786
|
Stx1atm1Tfuj/Stx1atm1Tfuj
Stx1btm1Tmis/Stx1btm1Tmis
(involves: C57BL/6J)
|
abnormal inhibitory postsynaptic currents
|
J:214474
|
| abnormal miniature excitatory postsynaptic currents
|
J:214474
|
| abnormal miniature inhibitory postsynaptic currents
|
J:214474
|
| decreased excitatory postsynaptic current amplitude
|
J:214474
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:214474
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:214474
|
Stx1atm2.1Sud/Stx1atm2.1Sud
Stx1btm1.1Sud/Stx1btm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal synaptic vesicle recycling
|
J:138035
|
Stx1btm1.1Sud/Stx1btm1.1Sud
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:138035
|
| abnormal excitatory postsynaptic currents
|
J:138035
|
| abnormal miniature excitatory postsynaptic currents
|
J:138035
|
| abnormal neuron physiology
|
J:138035
|
| abnormal synaptic vesicle recycling
|
J:138035
|
| seizures
|
J:138035
|
Stx1btm1Tmis/Stx1btm1Tmis
(B6.Cg-Stx1btm1Tmis)
|
abnormal AMPA-mediated synaptic currents
|
J:214474
|
| abnormal CNS synaptic transmission
|
J:214474
|
| abnormal GABA-mediated receptor currents
|
J:214474
|
| abnormal miniature excitatory postsynaptic currents
|
J:214474
|
| abnormal paired-pulse inhibition
|
J:214474
|
| abnormal synaptic vesicle recycling
|
J:214474
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:214474
|
Stxbp1tm1Sud/Stxbp1tm1Sud
(Not Specified)
|
abnormal neurotransmitter secretion
|
J:77237,
J:100337
|
| abnormal synaptic transmission
|
J:77237
|
Stxbp5tm1Ytk/Stxbp5tm1Ytk
(involves: 129X1/SvJ * C57BL * C57BL/6 * DBA)
|
abnormal excitatory postsynaptic potential
|
J:140649
|
| abnormal long-term potentiation
|
J:140649
|
| enhanced paired-pulse facilitation
|
J:140649
|
Stxbp5ltm1.1Aljg/Stxbp5ltm1.1Aljg
(involves: C57BL/6J)
|
abnormal endplate potential
|
J:263474
|
| abnormal synaptic acetylcholine release
|
J:263474
|
| decreased paired-pulse facilitation
|
J:263474
|
| decreased prepulse inhibition
|
J:263474
|
SucoGt(KST050)Byg/SucoGt(KST050)Byg
(involves: 129P2/OlaHsd * C57BL/6 * CD-1)
|
spinal hemorrhage
|
J:159823
|
Sufutm1Aeb/Sufutm1Aeb
(either: 129S1/Sv-Sufutm1Aeb or (involves: 129S1/Sv * C57BL/6))
|
intracranial hemorrhage
|
J:101731
|
Sult4a1em1Uab/Sult4a1em1Uab
(C57BL/6J-Sult4a1em1Uab)
|
absence seizures
|
J:280143
|
Sult4a1em2Uab/Sult4a1em2Uab
(C57BL/6J-Sult4a1em2Uab)
|
absence seizures
|
J:280143
|
Sumf1Gt(RST760)Byg/Sumf1Gt(RST760)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
CNS inflammation
|
J:120146
|
| increased neuron apoptosis
|
J:120146
|
| seizures
|
J:120146
|
Sun1tm1.1Ktj/Sun1tm1.1Ktj
(involves: 129/Sv * C57BL/6 * C57BL/6N)
|
abnormal Purkinje cell migration
|
J:224769
|
Sun1tm1.1Ktj/Sun1tm1.1Ktj
Sun2tm1.1Cyh/Sun2+
(involves: 129/Sv * C57BL/6 * C57BL/6N)
|
abnormal Purkinje cell migration
|
J:224769
|
Sun1tm1b(EUCOMM)Wtsi/Sun1tm1b(EUCOMM)Wtsi
(C57BL/6N-Sun1tm1b(EUCOMM)Wtsi/Orl)
|
decreased prepulse inhibition
|
J:211773
|
Supt16em1Hguo/Supt16+
(Not Specified)
|
abnormal nervous system electrophysiology
|
J:344671
|
| abnormal neuronal stem cell physiology
|
J:344671
|
| decreased neuronal stem cell self-renewal
|
J:344671
|
Surf1tm2.1Zev/Surf1tm2.1Zev
(involves: 129S7/SvEvBrd * C57BL/6 * DBA/2)
|
decreased susceptibility to neuronal excitotoxicity
|
J:117871
|
Susd4tm1Lex/Susd4tm1Lex
(B6.129S5-Susd4tm1Lex)
|
hypermyelination
|
J:306852
|
| increased microglial cell activation
|
J:306852
|
Sv2atm1Baj/Sv2a+
(Not Specified)
|
seizures
|
J:59073
|
Sv2atm1Baj/Sv2atm1Baj
(Not Specified)
|
abnormal inhibitory postsynaptic currents
|
J:59073
|
| seizures
|
J:59073
|
Sv2atm1Baj/Sv2atm1Baj
(involves: 129X1/SvJ * C57BL/6)
|
seizures
|
J:70828
|
Sv2atm1Baj/Sv2atm1Baj
Sv2btm1Baj/Sv2btm1Baj
(involves: 129 * C57BL/6)
|
seizures
|
J:70828
|
Sv2atm1Sud/Sv2atm1Sud
(involves: 129P2/OlaHsd * C57BL/6)
|
seizures
|
J:59180
|
Sv2atm1Sud/Sv2atm1Sud
Sv2btm1Sud/Sv2btm1Sud
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased synaptic depression
|
J:59180
|
| seizures
|
J:59180
|
Sv2btm1Baj/Sv2btm1Baj
(involves: 129 * C57BL/6)
|
seizures
|
J:70828
|
Syde1tm1a(EUCOMM)Hmgu/Syde1tm1a(EUCOMM)Hmgu
(involves: C57BL/6N)
|
abnormal miniature excitatory postsynaptic currents
|
J:201692
|
Syktm1.1Nns/Syktm1.1Nns
Tg(Pf4-icre)Q3Rsko/0
(involves: C57BL/6)
|
intracranial hemorrhage
|
J:181715
|
Syktm1Paw/Syktm1Paw
(involves: 129S1/Sv * 129X1/SvJ)
|
intracerebral hemorrhage
|
J:159112
|
Syktm1Tyb/Syktm1Tyb
(involves: 129S2/SvPas * C57BL/6J)
|
intracranial hemorrhage
|
J:181715
|
| spinal hemorrhage
|
J:181715
|
Syn1tm1Noh/Syn1tm1Noh
(involves: 129S4/SvJae * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:55506
|
| abnormal synaptic vesicle clustering
|
J:55506
|
| abnormal synaptic vesicle recycling
|
J:55506
|
Syn1tm1Noh/Syn1tm1Noh
(involves: 129S4/SvJae)
|
abnormal synaptic vesicle clustering
|
J:30400
|
Syn1tm1Pggd/Syn1tm1Pggd
(involves: 129)
|
abnormal excitatory postsynaptic potential
|
J:29086
|
| abnormal neurotransmitter secretion
|
J:29086
|
| abnormal seizure response to electrical stimulation
|
J:29086
|
| abnormal synaptic vesicle clustering
|
J:29086
|
| increased synaptic depression
|
J:29086
|
Syn1tm1Pggd/Syn1tm1Pggd
Syn2tm1Pggd/Syn2tm1Pggd
Syn3tm1Pggd/Syn3tm1Pggd
(involves: 129 * 129P2/OlaHsd * 129X1/SvJ * C57BL/6)
|
abnormal brain wave pattern
|
J:175256
|
| environmentally induced seizures
|
J:175256
|
| tonic-clonic seizures
|
J:175256
|
Syn1tm1Sud/Syn1tm1Sud
(involves: 129S7/SvEvBrd)
|
convulsive seizures
|
J:15701
|
| enhanced paired-pulse facilitation
|
J:15701
|
Syn1tm1Sud/Syn1tm1Sud
Syn2tm1Sud/Syn2tm1Sud
(involves: 129S7/SvEvBrd)
|
convulsive seizures
|
J:26920
|
| decreased post-tetanic potentiation
|
J:26920
|
| increased synaptic depression
|
J:26920
|
Syn1tm2Noh/Syn1tm2Noh
(involves: 129S4/SvJae)
|
abnormal synaptic vesicle clustering
|
J:30400
|
Syn2tm1Pggd/Syn2tm1Pggd
(Not Specified)
|
abnormal CNS synaptic transmission
|
J:202031
|
| abnormal excitatory postsynaptic potential
|
J:202031
|
| abnormal hippocampus physiology
|
J:202031
|
| abnormal miniature excitatory postsynaptic currents
|
J:202031
|
| decreased synaptic depression
|
J:202031
|
| seizures
|
J:202031
|
Syn2tm1Sud/Syn2tm1Sud
(involves: 129S7/SvEvBrd)
|
abnormal CNS synaptic transmission
|
J:26920
|
| convulsive seizures
|
J:26920
|
| decreased post-tetanic potentiation
|
J:26920
|
| increased synaptic depression
|
J:26920
|
Syn3tm1Pggd/Syn3tm1Pggd
(involves: 129X1/SvJ)
|
abnormal inhibitory postsynaptic currents
|
J:77048
|
| increased excitatory postsynaptic current amplitude
|
J:77048
|
| increased synaptic depression
|
J:77048
|
Syngap1tm1.1Mabk/Syngap1tm1.1Mabk
(involves: 129S1/Sv * C57BL/6)
|
increased miniature excitatory postsynaptic current amplitude
|
J:93969
|
| increased miniature excitatory postsynaptic current frequency
|
J:93969
|
| increased neuron apoptosis
|
J:101084
|
Syngap1tm1.1Mabk/Syngap1tm1.2Mabk
Tg(Camk2a-cre)2834Lusc/0
(involves: 129S1/Sv * C57BL/6)
|
increased neuron apoptosis
|
J:101084
|
Syngap1tm1Grnt/Syngap1+
(involves: 129P2/OlaHsd * MF1)
|
impaired synaptic plasticity
|
J:98903
|
| reduced long-term potentiation
|
J:98903
|
Syngap1tm1Rlh/Syngap1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
reduced long-term potentiation
|
J:97391
|
Syngap1tm1Rlh/Syngap1+
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal CNS synaptic transmission
|
J:193208
|
| abnormal excitatory postsynaptic potential
|
J:193208
|
| abnormal glutamate-mediated receptor currents
|
J:193208
|
| abnormal miniature excitatory postsynaptic currents
|
J:193208
|
| abnormal miniature inhibitory postsynaptic currents
|
J:193208
|
| audiogenic seizures
|
J:193208
|
| enhanced AMPA-mediated synaptic currents
|
J:193208
|
| increased miniature inhibitory postsynaptic current amplitude
|
J:193208
|
| increased miniature inhibitory postsynaptic current frequency
|
J:193208
|
| increased susceptibility to pharmacologically induced seizures
|
J:193208
|
Syngap1tm1Rlh/Syngap1+
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
decreased prepulse inhibition
|
J:194146
|
Syngr1tm1Sud/Syngr1tm1Sud
(involves: 129S6/SvEvTac * C57BL/6)
|
decreased post-tetanic potentiation
|
J:58559
|
| impaired synaptic plasticity
|
J:58559
|
Syngr1tm1Sud/Syngr1tm1Sud
Syngr3tm1Sud/Syngr3tm1Sud
Synprtm1Sud/Synprtm1Sud
Syptm1Sud/Syptm1Sud
(Not Specified)
|
seizures
|
J:156812
|
Syngr1tm1Sud/Syngr1tm1Sud
Syptm1Sud/Syptm1Sud
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6)
|
decreased paired-pulse facilitation
|
J:58559
|
| decreased post-tetanic potentiation
|
J:58559
|
| impaired synaptic plasticity
|
J:58559
|
| reduced long-term potentiation
|
J:58559
|
Synj1tm1Pdc/Synj1tm1Pdc
(involves: 129S1/Sv * C57BL/6)
|
convulsive seizures
|
J:58087
|
| increased synaptic depression
|
J:58087
|
Synpotm1Mndl/Synpotm1Mndl
(involves: 129P2/OlaHsd * C57BL/6)
|
reduced long-term potentiation
|
J:85310
|
Syt1tm1Sud/Syt1tm1Sud
(involves: 129S4/SvJae)
|
abnormal CNS synaptic transmission
|
J:21602
|
| abnormal excitatory postsynaptic currents
|
J:171203
|
| abnormal inhibitory postsynaptic currents
|
J:122459
|
| abnormal miniature excitatory postsynaptic currents
|
J:171203
|
| abnormal neuron physiology
|
J:167753
|
| abnormal neurotransmitter secretion
|
J:21602
|
| abnormal synaptic transmission
|
J:171203
|
| decreased excitatory postsynaptic current amplitude
|
J:167753
|
Syt1tm1Sud/Syt1tm1Sud
Tg(Thy1-Syt1/ECFP)1Sud/0
(involves: 129S4/SvJae * C57BL/6 * SJL)
|
abnormal synaptic transmission
|
J:105052
|
Syt1tm3Sud/Syt1tm3Sud
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neurotransmitter secretion
|
J:76452
|
| decreased excitatory postsynaptic current amplitude
|
J:76452
|
Syt1tm5Sud/Syt1tm5Sud
(Not Specified)
|
increased synaptic depression
|
J:79208
|
Syt2m1Ingm/Syt2m1Ingm
(Not Specified)
|
abnormal excitatory postsynaptic currents
|
J:108786
|
| abnormal miniature endplate potential
|
J:108786
|
| abnormal miniature excitatory postsynaptic currents
|
J:108786
|
| prolonged excitatory postsynaptic current rise time
|
J:108786
|
Syt2tm1Sud/Syt2tm1Sud
(B6.129-Syt2tm1Sud)
|
abnormal CNS synaptic transmission
|
J:117050
|
| abnormal inhibitory postsynaptic currents
|
J:117050
|
| abnormal miniature endplate potential
|
J:117050
|
| abnormal neurotransmitter secretion
|
J:117050
|
| decreased neurotransmitter release
|
J:117050
|
| enhanced paired-pulse facilitation
|
J:117050
|
Syt5tm2Sud/Syt5tm2Sud
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal inhibitory postsynaptic currents
|
J:122459
|
Sytl1tm1a(KOMP)Wtsi/Sytl1tm1a(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N)
|
meningitis
|
J:213427
|
Sytl4tm1Tiz/Y
(involves: 129P2/OlaHsd)
|
hypersecretion of adrenocorticotropin
|
J:145238
|
Szs1C57BL/6J/Szs1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:56630
|
| seizures
|
J:38888
|
Szs1DBA/2J/Szs1DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:56630
|
| seizures
|
J:38888
|
Szs1DBA/2J/Szs1DBA/2J
(involves: B6.D2-Mtv7a/Ty)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs1DBA/2J/Szs1DBA/2J
(involves: B6.D2-Mtv7a/Ty * C57BL/6J)
|
abnormal seizure response to electrical stimulation
|
J:89732
|
Szs2C57BL/6J/Szs2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to electrical stimulation
|
J:38888
|
Szs2C57BL/6J/Szs2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to electrical stimulation
|
J:38888
|
Szs5DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:56630
|
Szs6C57BL/6J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:56630
|
Szs7DBA/2J/?
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs8DBA/2J/Szs8C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs8DBA/2J/Szs8DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs9C57BL/6J/Szs9DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs9DBA/2J/Szs9DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs10C57BL/6J/Szs10C57BL/6J
(involves: B6.D2-Mtv7a/Ty)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs10C57BL/6J/Szs10DBA/2J
(involves: B6.D2-Mtv7a/Ty)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs11C57BL/6J/Szs11C57BL/6J
(D2.B6-(D5Mit345-D5Mit403))
|
abnormal seizure response to electrical stimulation
|
J:129499
|
Szs11DBA/2J/Szs11C57BL/6J
(involves: B6.D2-Mtv7a/Ty)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs11DBA/2J/Szs11DBA/2J
(involves: B6.D2-Mtv7a/Ty)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs11DBA/2J/Szs11DBA/2J
(B6.D2-(D5Mit75-D5Mit403))
|
abnormal seizure response to electrical stimulation
|
J:129499
|
Szs12DBA/2J/Szs12C57BL/6J
(involves: B6.D2-Mtv7a/Ty)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs12DBA/2J/Szs12DBA/2J
(involves: B6.D2-Mtv7a/Ty)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs13DBA/2J/Szs13C57BL/6J
(involves: B6.D2-Mtv7a/Ty)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szs13DBA/2J/Szs13DBA/2J
(involves: B6.D2-Mtv7a/Ty)
|
abnormal seizure response to electrical stimulation
|
J:70295
|
Szt1/Szt1+
(involves: BALB/cByJ * BALB/cJ * C57BL/6J)
|
abnormal seizure response to electrical stimulation
|
J:82964
|
| abnormal seizure response to pharmacological agent
|
J:82964
|
Szt1/Szt1+
(C57BL/6J-Szt1)
|
abnormal seizure response to electrical stimulation
|
J:136510
|
Szt1/Szt1+
Tg(Eno2-Scn2a1*)Q54Mm/0
(involves: C57BL/6J * SJL/J)
|
seizures
|
J:136510
|
| tonic-clonic seizures
|
J:136510
|
Szt2Gt(XH662)Byg/Szt2+
(involves: 129P2/OlaHsd * C57BL/6J)
|
minimal clonic seizures
|
J:150942
|
Szt2Gt(XH662)Byg/Szt2Gt(XH662)Byg
(129S1.129P2(B6)-Szt2Gt(XH662)Byg/FrkJ)
|
maximal tonic hindlimb extension seizures
|
J:150942
|
| minimal clonic seizures
|
J:150942
|
Szt2Gt(XH662)Byg/Szt2m1Frk
(involves: 129P2/OlaHsd * C57BL/6J)
|
minimal clonic seizures
|
J:150942
|
Szt2m1Frk/Szt2m1Frk
(C57BL/6J-Szt2m1Frk)
|
abnormal kindling response
|
J:150942
|
| minimal clonic seizures
|
J:150942
|
Szt2m1Frk/Szt2m1Frk
(involves: BALB/cByJ * C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:150942
|
| minimal clonic seizures
|
J:150942
|
| tonic-clonic seizures
|
J:150942
|
Szv1C57BL/6J/Szv1C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:38888
|
Szv2C57BL/6J/Szv2C57BL/6J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:38888
|
Szv2C57BL/6J/Szv2DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:38888
|
Szv3C57BL/6J/Szv3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:70295
|
Szv3DBA/2J/Szv3DBA/2J
(involves: C57BL/6J * DBA/2J)
|
abnormal seizure response to pharmacological agent
|
J:70295
|
Taar1tm1Tdw/Taar1tm1Tdw
(involves: 129S1/Sv * C57BL/6J)
|
abnormal prepulse inhibition
|
J:141501
|
Tac2em1Ysfk/Tac2em1Ysfk
(C57BL/6-Tac2em1Ysfk)
|
decreased neurotransmitter release
|
J:305132
|
Tacr1tm1Nge/Tacr1tm1Nge
(involves: 129S4/SvJae)
|
abnormal nervous system electrophysiology
|
J:106546
|
Tacr1tm1Rhn/Tacr1tm1Rhn
(129S/SvEv-Tacr1tm1Rhn)
|
abnormal neuron physiology
|
J:77640
|
Tacr1tm1Sph/Tacr1tm1Sph
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased nerve fiber response intensity
|
J:46629
|
Tacr1tm1Sph/Tacr1tm1Sph
(involves: 129 * C57BL/6)
|
abnormal nervous system physiology
|
J:106301
|
Tafa2tm1Zgwg/Tafa2tm1Zgwg
(involves: C57BL/6)
|
increased brain apoptosis
|
J:271697
|
Tafa4tm1.1Azmo/Tafa4tm1.1Azmo
(involves: 129S2/SvPas * C57BL/6J)
|
abnormal action potential
|
J:203770
|
| abnormal nervous system electrophysiology
|
J:203770
|
Tal1tm2Wehi/Tal1tm2Wehi
(involves: 129S1/Sv * C57BL/6)
|
increased neuron apoptosis
|
J:58825
|
Tal2tm1Thr/Tal2tm1Thr
(involves: 129 * C57BL/6)
|
convulsive seizures
|
J:65762
|
Tamalintm1.1Tes/Tamalintm1.1Tes
(B6.129S1-Tamalintm1.1Tes)
|
abnormal excitatory postsynaptic potential
|
J:181614
|
| abnormal neuron proliferation
|
J:181614
|
| reduced long-term potentiation
|
J:181614
|
Tanc2em1(IMPC)Hmgu/Tanc2em1(IMPC)Hmgu
(C57BL/6NCrl-Tanc2em1(IMPC)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Taok1em1Bcgen/Taok1+
(C57BL/6N-Taok1em1Bcgen)
|
abnormal neuron physiology
|
J:341142
|
Tas1r1tm1Csz/Tas1r1tm1Csz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal somatic nervous system physiology
|
J:86474
|
Tas1r2tm1Csz/Tas1r2tm1Csz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal somatic nervous system physiology
|
J:86474
|
Tas1r2tm1Csz/Tas1r2tm1Csz
Tas1r3tm1Csz/Tas1r3tm1Csz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal somatic nervous system physiology
|
J:86474
|
Tas1r3tm1Csz/Tas1r3tm1Csz
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal somatic nervous system physiology
|
J:86474
|
Tas1r3tm1Rfm/Tas1r3tm1Rfm
(involves: C57BL/6)
|
abnormal somatic nervous system physiology
|
J:85822
|
Tasor2em1(IMPC)J/Tasor2em1(IMPC)J
(C57BL/6NJ-Tasor2em1(IMPC)J/Mmjax)
|
increased prepulse inhibition
|
J:211773
|
Tax1bp3tm1b(EUCOMM)Hmgu/Tax1bp3+
(C57BL/6N-Tax1bp3tm1b(EUCOMM)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Tbc1d24em2Tbf/Tbc1d24em2Tbf
(C57BL/6J-Tbc1d24em2Tbf)
|
tonic-clonic seizures
|
J:273646
|
Tbc1d24em2Tbf/Tbc1d24em5Tbf
(C57BL/6J-Tbc1d24em2Tbf Tbc1d24em5Tbf)
|
seizures
|
J:299025
|
Tbc1d24tm1b(EUCOMM)Hmgu/Tbc1d24+
(B6J.B6N-Tbc1d24tm1b(EUCOMM)Hmgu)
|
abnormal miniature excitatory postsynaptic currents
|
J:271632
|
| abnormal synaptic transmission
|
J:271632
|
| abnormal synaptic vesicle recycling
|
J:271632
|
Tbcktm1b(EUCOMM)Hmgu/Tbck+
(B6J.B6N-Tbcktm1b(EUCOMM)Hmgu)
|
decreased prepulse inhibition
|
J:344893
|
Tbr1tm1.1Csbd/Tbr1+
(involves: C57BL/6J)
|
increased excitatory postsynaptic current frequency
|
J:281878
|
| increased miniature inhibitory postsynaptic current frequency
|
J:281878
|
Tbr1tm1Jlr/Tbr1+
(B6.129X1-Tbr1tm1Jlr)
|
abnormal neuron physiology
|
J:208050
|
Tbx1tm1Bld/Tbx1+
(B6.Cg-Tyrc-Brd Tbx1tm1Bld)
|
decreased prepulse inhibition
|
J:110101
|
Tbx21tm1Glm/Tbx21tm1Glm
(C.129S6-Tbx21tm1Glm/J)
|
CNS inflammation
|
J:111932
|
tbyl/tbyl
(BALB/cByJ-tbyl/GrsrJ)
|
abnormal myelination
|
J:232317
|
| demyelination
|
J:232317
|
Tc(HSA21)1TybEmcf/0
(involves: 129S2/SvPas * 129S8/SvEv * C57BL/6J)
|
reduced long-term potentiation
|
J:101383
|
Tcf4em1Bdph/?
(involves: C57BL/6 * C57BL/6J)
|
abnormal action potential
|
J:254983
|
| enhanced long-term potentiation
|
J:254983
|
| enhanced NMDA-mediated synaptic currents
|
J:254983
|
| increased prepulse inhibition
|
J:254983
|
Tcf4em2Bdph/?
(involves: C57BL/6 * C57BL/6J)
|
enhanced long-term potentiation
|
J:254983
|
Tcf4tm1Hmb/Tcf4+
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
enhanced long-term potentiation
|
J:254983
|
Tcf4tm1Hmb/Tcf4+
Tmem163Tg(ACTB-cre)2Mrt/Tmem163+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
decreased prepulse inhibition
|
J:254983
|
| enhanced long-term potentiation
|
J:254983
|
| enhanced NMDA-mediated synaptic currents
|
J:254983
|
Tcf4tm1Zhu/Tcf4+
(involves: 129P2/OlaHsd * 129S1/SvImJ * C57BL/6J)
|
decreased prepulse inhibition
|
J:239016
|
| enhanced long-term potentiation
|
J:239016
|
Tcf12tm2Zhu/Tcf12+
(Not Specified)
|
seizures
|
J:120411
|
Tcof1tm1Mjd/Tcof1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
increased neural tube apoptosis
|
J:62928
|
Tcof1tm1Mjd/Tcof1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/1)
|
decreased embryonic neuroepithelial cell proliferation
|
J:112900
|
| increased embryonic neuroepithelium apoptosis
|
J:112900
|
Tcratm1Mjo/Tcratm1Mjo
(involves: 129P2/OlaHsd)
|
abnormal neuron proliferation
|
J:170591
|
Tcrbtm1Mom/Tcrb+
Tg(SOD1*G93A)1Gur/0
(B6.Cg-Tcrbtm1Mom Tg(SOD1*G93A)1Gur/J)
|
abnormal microglial cell physiology
|
J:143173
|
Tdo2tm1b(KOMP)Mbp/Tdo2+
(C57BL/6N-Tdo2tm1b(KOMP)Mbp/Tcp)
|
increased prepulse inhibition
|
J:211773
|
Tdo2tm1Tnak/Tdo2tm1Tnak
(B6.129-Tdo2tm1Tnak)
|
abnormal neuronal precursor proliferation
|
J:177903
|
Tdp1Gt(XD105)Byg/Tdp1Gt(XD105)Byg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal neuron physiology
|
J:127605
|
Tead1tm1b(KOMP)Wtsi/Tead1+
(C57BL/6N-Tead1tm1b(KOMP)Wtsi/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Tectatm1.1Ogha/Tecta+
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * CBA)
|
abnormal cochlear microphonics
|
J:160851
|
| abnormal cochlear outer hair cell physiology
|
J:160851
|
Tectatm1.1Ogha/Tectatm1.1Ogha
(involves: 129S4/SvJaeSor * 129S7/SvEvBrd * CBA)
|
abnormal cochlear outer hair cell physiology
|
J:160851
|
| decreased cochlear microphonics
|
J:160851
|
Tectatm1Gpr/Tectatm1Gpr
(involves: 129S/SvEv * C57BL/6J)
|
abnormal cochlear microphonics
|
J:77634
|
| abnormal cochlear outer hair cell physiology
|
J:77634
|
| abnormal hair cell mechanoelectric transduction
|
J:77634
|
| decreased cochlear nerve compound action potential
|
J:77634
|
Tectatm3.1Gpr/Tecta+
(involves: 129S/SvEv)
|
audiogenic seizures
|
J:203482
|
Tectatm4.1Gpr/Tecta+
(involves: 129S/SvEv)
|
audiogenic seizures
|
J:203482
|
Tectatm5.1Gpr/Tecta+
(involves: 129S/SvEv)
|
audiogenic seizures
|
J:203482
|
Tectbtm1Gpr/Tectbtm1Gpr
(either: 129S/SvEv-Tectbtm1Gpr or (involves: 129S/SvEv * C57BL/6) or (involves: 129S/SvEv * CBA) or (involves: C57BL/6 * CBA))
|
decreased cochlear nerve compound action potential
|
J:120765
|
Teftm1Schb/Teftm1Schb
(involves: 129S2/SvPas)
|
absence seizures
|
J:90854
|
| seizures
|
J:90854
|
Tektm1Dmt/Tektm1Dmt
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
intracranial hemorrhage
|
J:99096
|
Tenm4Tg(Col2a1-Hspg2)2Yoya/Tenm4Tg(Col2a1-Hspg2)2Yoya
(C57BL/6-Tenm4Tg(Col2a1-Hspg2)2Yoya)
|
abnormal oligodendrocyte apoptosis
|
J:187705
|
| demyelination
|
J:187705
|
Terttm2.1Rdp/Terttm2.1Rdp
(involves: C57BL/6)
|
abnormal neuronal precursor proliferation
|
J:167227
|
| demyelination
|
J:167227
|
Tet1tm1.1Gxu/Tet1tm1.1Gxu
Tg(Nes-EGFP)33Enik/0
(involves: 129 * BALB/cBy * C57BL/6 * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:201001
|
Tet1tm1Gxu/Tet1tm1.1Gxu
Tg(Nes-cre/ERT2)KEisc/0
(involves: 129 * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:201001
|
Tet1tm1Gxu/Tet1tm1Gxu
(involves: 129 * C57BL/6J)
|
abnormal neuronal precursor proliferation
|
J:201001
|
Tfamtm1.1Lrsn/Tfamtm1.1Lrsn
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal nervous system physiology
|
J:46387
|
Tfap2aMhdador/Tfap2a+
(involves: C3HeB/FeJ)
|
decreased cochlear nerve compound action potential
|
J:90701
|
Tfpitm1Gjb/Tfpitm1Gjb
(involves: 129)
|
intracranial hemorrhage
|
J:51137
|
| spinal hemorrhage
|
J:51137
|
Tg(Ace2-ACE2)1Cqin/0
(involves: ICR)
|
intracranial hemorrhage
|
J:141460
|
Tg(ACTB-Eif4e)#Ppp/?
(B6.Cg-Tg(ACTB-Eif4e)#Ppp)
|
abnormal long-term depression
|
J:194400
|
| abnormal miniature excitatory postsynaptic currents
|
J:194400
|
| increased miniature inhibitory postsynaptic current amplitude
|
J:194400
|
Tg(ACTB-MAP2K1*K97M)1Stl/0
Tg(Camk2a-cre)T29-1Stl/0
(involves: BALB/c * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:88546
|
| abnormal long-term potentiation
|
J:88546
|
Tg(ACTB-NOTCH1)1Shn/?
Tg(Nes-cre/Esr1*)4Ynj/?
(involves: C57BL/6 * C57BL/6J)
|
increased neuron apoptosis
|
J:127227
|
Tg(Adora2a-Chrm3*,-mCherry)AD6Blr/?
(involves: C57BL/6J * SJL/J)
|
abnormal glutamate-mediated receptor currents
|
J:191042
|
Tg(AGT)2-5Afu/0
(involves: C57BL/6)
|
convulsive seizures
|
J:130455
|
Tg(APP695)3Dbo/0
Tg(PSEN1)5Dbo/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal neuron physiology
|
J:100961
|
Tg(APP)8.9Btla/Tg(APP)8.9Btla
Tg(SOD1)51Yg/Tg(SOD1)51Yg
(involves: 129S2/SvPas * BALB/c * C57BL/6J * DBA/2)
|
reduced long-term potentiation
|
J:96742
|
Tg(APP)8.9Btla/Tg(APP)8.9Btla
Tg(SOD1)69Yg/Tg(SOD1)69Yg
(involves: 129S2/SvPas * BALB/c * C57BL/6J * DBA/2)
|
abnormal excitatory postsynaptic potential
|
J:96742
|
| reduced long-term potentiation
|
J:96742
|
Tg(APP-App*R609D*K612E)7Vln/0
(involves: FVB)
|
increased neuron apoptosis
|
J:32213
|
Tg(APPSWE)2576Kha/0
Tg(PSEN1)5Dbo/0
(involves: C57BL/6 * SJL)
|
abnormal neuron physiology
|
J:191088
|
Tg(APPswe,PSEN1dE9)85Dbo/0
(involves: C3H/HeJ * C57BL/6J)
|
reduced long-term potentiation
|
J:139071
|
Tg(APPswe,PSEN1dE9)85Dbo/0
(B6.Cg-Tg(APPswe,PSEN1dE9)85Dbo/Mmjax)
|
abnormal CNS synaptic transmission
|
J:234430
|
| convulsive seizures
|
J:227541
|
| reduced long-term potentiation
|
J:234430
|
Tg(APPswe,PSEN1dE9)85Dbo/0
(D2.Cg-Tg(APPswe,PSEN1dE9)85Dbo)
|
convulsive seizures
|
J:227541
|
Tg(APPswe,PSEN1dE9)85Dbo/0
(involves: C3H/HeH * C57BL/6JNju)
|
abnormal action potential
|
J:275175
|
| abnormal synaptic transmission
|
J:275175
|
Tg(APPswe,PSEN1dE9)85Dbo/0
(WSB.Cg-Tg(APPswe,PSEN1dE9)85Dbo/How)
|
impaired blood-brain barrier function
|
J:276728
|
Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas/0
(involves: C57BL/6 * SJL)
|
brain inflammation
|
J:112949
|
Tg(APPSwFlLon,PSEN1*M146L*L286V)6799Vas/?
(involves: C57BL/6 * SJL)
|
abnormal astrocyte physiology
|
J:208030
|
| abnormal long-term depression
|
J:208030
|
| increased microglial cell activation
|
J:208030
|
Tg(ATN1*)Q129Stsu/0
(involves: 129S/SvEv * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:144379
|
| abnormal excitatory postsynaptic potential
|
J:144379
|
| abnormal GABA-mediated receptor currents
|
J:144379
|
| abnormal nervous system electrophysiology
|
J:144379
|
| abnormal paired-pulse facilitation
|
J:144379
|
| absence seizures
|
J:144379
|
| enhanced paired-pulse facilitation
|
J:144379
|
| reduced long-term potentiation
|
J:144379
|
Tg(ATXN3*)67.2Cce/0
Tg(ATXN3*)84.2Cce/0
(involves: C57BL/6 * CBA)
|
demyelination
|
J:76495
|
Tg(ATXN3*)84.2Cce/0
(involves: C57BL/6 * CBA)
|
demyelination
|
J:76495
|
Tg(BAC144D14)5D3Masu/0
(B6.Cg-Tg(BAC144D14)5D3Masu)
|
decreased prepulse inhibition
|
J:239325
|
| reduced sensorimotor gating
|
J:239325
|
Tg(C9orf72)500Lpwr/0
(FVB/NJ-Tg(C9orf72)500Lpwr)
|
seizures
|
J:239579
|
Tg(CAG-cre/Esr1*)5Amc/0
Ube3atm1Yelg/Ube3a+
(involves: 129P2/OlaHsd * 129S2/SvPasCrl * C57BL/6J)
|
abnormal long-term potentiation
|
J:222400
|
| audiogenic seizures
|
J:222400
|
Tg(CAG-DPP4)4Yuzh/0
(C57BL/6-Tg(CAG-DPP4)4Yuzh)
|
brain inflammation
|
J:286175
|
Tg(CAG-DPP4)52Ctkt/0
(involves: C3H/HeJ * C57BL/6J)
|
brain inflammation
|
J:227925
|
| increased microglial cell activation
|
J:227925
|
Tg(CAG-Ngb,-EGFP)1Dgrn/Tg(CAG-Ngb,-EGFP)1Dgrn
(involves: C57BL/6 * CD-1 * DBA/2)
|
decreased cerebral infarct size
|
J:117158
|
Tg(CAG-RND2)1Jya/0
Tg(Mbp-cre)9Gvn/0
(involves: C57BL/6 * C57BL/6J * DBA/2 * FVB/N)
|
abnormal myelination
|
J:309719
|
Tg(CAG-SNCA*)1.1Ccs/?
(involves: C57BL/6)
|
abnormal astrocyte physiology
|
J:168847
|
Tg(CAG-Tfb1m)AGsha/0
(B6J.Cg-Tg(CAG-Tfb1m)AGsha)
|
abnormal cochlear outer hair cell electromotility
|
J:228068
|
Tg(CAG-Ubqln1)2Hmw/0
(involves: C57BL/6 * SJL)
|
abnormal response to CNS ischemic injury
|
J:206930
|
| decreased cerebral infarct size
|
J:206930
|
Tg(Camk2a-AIDPak)21Stl/0
(C57BL/6-Tg(Camk2a-AIDPak)21Stl)
|
abnormal miniature excitatory postsynaptic currents
|
J:90763
|
| enhanced long-term potentiation
|
J:90763
|
| reduced long-term depression
|
J:90763
|
Tg(Camk2a-App*,-Apbb1)25Spim/0
(C57BL/6-Tg(Camk2a-App*,-Apbb1)25Spim)
|
increased susceptibility to neuronal excitotoxicity
|
J:153738
|
Tg(Camk2a-Bdnf)A9Stl/0
(involves: C57BL/6 * DBA/2)
|
abnormal inhibitory postsynaptic currents
|
J:57645
|
| reduced long-term potentiation
|
J:57645
|
Tg(Camk2a-Bdnf)A9Stl/0
(C57BL/6-Tg(Camk2a-Bdnf)A9Stl/J)
|
psychomotor seizures
|
J:216846
|
| seizures
|
J:216846
|
Tg(CAMK2A-CAST)7Tcs/0
(involves: C57BL/6Cr)
|
decreased susceptibility to neuronal excitotoxicity
|
J:109976,
J:98730
|
Tg(Camk2a-cre)3487Cnl/0
Tg(Thy1-Ntrk2/EGFP)817Cnl/0
(involves: C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:105706
|
Tg(Camk2a-Crebbp*)1364Tabe/0
(involves: C57BL/6 * SJL)
|
reduced long-term potentiation
|
J:121812
|
Tg(Camk2a-Crem)I15Endo/0
(involves: C3H * C57BL/6)
|
abnormal kindling response
|
J:137666
|
Tg(Camk2a-Crem)IIEndo/0
(C57BL/6-Tg(Camk2a-Crem)IIEndo/EndoRbrc)
|
abnormal kindling response
|
J:137666
|
Tg(Camk2a-DISC1)10Asaw/0
(C57BL/6-Tg(Camk2a-DISC1)10Asaw)
|
decreased prepulse inhibition
|
J:124683
|
Tg(Camk2a-DISC1)37Asaw/0
(C57BL/6-Tg(Camk2a-DISC1)37Asaw)
|
decreased prepulse inhibition
|
J:124683
|
Tg(Camk2a-ESR1/Disc1*)2698.1Sva/0
(involves: C57BL/6 * C57BL/6NTac)
|
abnormal CNS synaptic transmission
|
J:127235
|
Tg(Camk2a-Fyn-531)1Nko/0
(involves: 129S7/SvEvBrd * C57BL/6 * CBA)
|
abnormal kindling response
|
J:59490
|
| abnormal seizure response to electrical stimulation
|
J:59490
|
| increased susceptibility to pharmacologically induced seizures
|
J:59490
|
| tonic seizures
|
J:59490
|
Tg(Camk2a-Gpr85)1Mima/?
(involves: C57BL/6 * DBA)
|
abnormal paired-pulse inhibition
|
J:134303
|
| increased neuron apoptosis
|
J:134303
|
Tg(Camk2a-Grin2a/Grin2b)1Jzt/?
(C57BL/6J-Tg(Camk2a-Grin2a/Grin2b)1Jzt)
|
enhanced long-term potentiation
|
J:223086
|
Tg(Camk2a-Grin2b/Grin2a)1Jzt/?
(C57BL/6J-Tg(Camk2a-Grin2b/Grin2a)1Jzt)
|
enhanced long-term potentiation
|
J:223086
|
| reduced long-term depression
|
J:223086
|
Tg(Camk2a-Grin2d/Grin2b)1Jzt/?
(C57BL/6J-Tg(Camk2a-Grin2d/Grin2b)1Jzt)
|
enhanced long-term potentiation
|
J:223086
|
Tg(Camk2a-HRAS*G12V)1Sva/0
(involves: 129T2/SvEmsJ * C57BL/6 * C57BL/6N)
|
abnormal CNS synaptic transmission
|
J:102160
|
| abnormal excitatory postsynaptic potential
|
J:102160
|
| abnormal miniature excitatory postsynaptic currents
|
J:102160
|
| abnormal synaptic vesicle clustering
|
J:102160
|
| enhanced long-term potentiation
|
J:102160
|
| enhanced paired-pulse facilitation
|
J:102160
|
Tg(Camk2a-KCNH3)1Akmi/?
(involves: C57BL/6 * DBA/2)
|
reduced long-term potentiation
|
J:155749
|
Tg(Camk2a-Magi2)1Shlee/?
(C57BL/6J-Tg(Camk2a-Magi2)1Shlee)
|
abnormal excitatory postsynaptic potential
|
J:218971
|
| decreased prepulse inhibition
|
J:218971
|
| reduced long-term potentiation
|
J:218971
|
Tg(Camk2a-MAPT)#Atak/0
(involves: C57BL/6J)
|
abnormal neuron physiology
|
J:130237
|
Tg(Camk2a-MAPT*R406W)748Atak/0
(involves: C57BL/6 * SJL)
|
decreased prepulse inhibition
|
J:100958
|
Tg(Camk2a-Prkaca)426Tabe/0
(involves: C57BL/6J * CBA/J)
|
reduced long-term potentiation
|
J:38837
|
Tg(Camk2a-Setdb1)1Akba/0
(involves: C57BL/6 * SJL)
|
abnormal excitatory postsynaptic potential
|
J:160826
|
| abnormal NMDA-mediated synaptic currents
|
J:160826
|
Tg(Camk2a-Tardbp)#Ckjs/Tg(Camk2a-Tardbp)#Ckjs
(FVB/N-Tg(Camk2a-Tardbp)#Ckjs)
|
abnormal miniature excitatory postsynaptic currents
|
J:163612
|
| increased neuron apoptosis
|
J:163612
|
| reduced long-term potentiation
|
J:163612
|
Tg(Camk2a-tTA)1Mmay/0
Tg(PDGFB-APPSwInd)J9Lms/0
Tg(tetO-MAPT*A152T)L1Lms/0
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
abnormal brain wave pattern
|
J:233816
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-APPSwInd)18Dbo/0
(involves: C3H/HeJ * C57BL/6 * CBA)
|
abnormal nervous system physiology
|
J:109829
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-APPSwInd)102Dbo/0
(involves: C3H/HeJ * C57BL/6 * CBA)
|
abnormal nervous system physiology
|
J:109829
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-APPSwInd)107Dbo/0
(involves: C3H/HeJ * C57BL/6 * CBA)
|
abnormal nervous system physiology
|
J:109829
|
| CNS inflammation
|
J:109829
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-APPSwInd)885Dbo/0
(involves: C3H/HeJ * C57BL/6 * CBA)
|
abnormal nervous system physiology
|
J:109829
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-CDK5R1/GFP)337Lht/0
(involves: C57BL/6J)
|
impaired synaptic plasticity
|
J:177847
|
| reduced long-term potentiation
|
J:177847
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-CHMP2B*)3Fbga/0
(involves: C57BL/6)
|
abnormal CNS synaptic transmission
|
J:227797
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-Comt)1Kndl/0
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal synaptic dopamine release
|
J:225566
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-Gnas)1593Mpke/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-Gnas)1593Mpke)
|
decreased prepulse inhibition
|
J:166114
|
| enhanced long-term potentiation
|
J:166114
|
| enhanced paired-pulse facilitation
|
J:166114
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-LRRK2)C77Cai/0
Tg(tetO-SNCA*A53T)E2Cai/0
(involves: C57BL/6)
|
abnormal nervous system physiology
|
J:156512
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-LRRK2)C7874Cai/0
Tg(tetO-SNCA*A53T)E2Cai/0
(involves: C57BL/6)
|
abnormal nervous system physiology
|
J:156512
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-LRRK2*)D10Cai/0
Tg(tetO-SNCA*A53T)E2Cai/0
(involves: C57BL/6)
|
abnormal nervous system physiology
|
J:156512
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-LRRK2*G2019S)E3Cai/0
(involves: C57BL/6)
|
abnormal nervous system physiology
|
J:156512
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-MAPT)32Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT)32Lms)
|
abnormal brain wave pattern
|
J:233816
|
| abnormal CNS synaptic transmission
|
J:233816
|
| decreased paired-pulse facilitation
|
J:233816
|
| increased susceptibility to pharmacologically induced seizures
|
J:233816
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-MAPT*A152T)L1Lms/0
(B6.Cg-Tg(Camk2a-tTA)1Mmay Tg(tetO-MAPT*A152T)L1Lms)
|
abnormal brain wave pattern
|
J:233816
|
| abnormal CNS synaptic transmission
|
J:233816
|
| decreased paired-pulse facilitation
|
J:233816
|
| increased susceptibility to pharmacologically induced seizures
|
J:233816
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-MAPT*K280*I277P*I308P,-luc)#Eman/0
(involves: C57BL/6)
|
abnormal paired-pulse facilitation
|
J:169532
|
| decreased post-tetanic potentiation
|
J:169532
|
| impaired synaptic plasticity
|
J:169532
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-MAPT*K280,-luc)#Eman/0
(involves: C57BL/6)
|
decreased post-tetanic potentiation
|
J:169532
|
| impaired synaptic plasticity
|
J:169532
|
| reduced long-term potentiation
|
J:169532
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-Mtor*)#Atai/0
(involves: C57BL/6 * DBA/2 * ICR)
|
seizures
|
J:211789
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-SNCA*A53T)33Vle/0
(involves: C3H/HeH * C57BL/6)
|
increased neuron apoptosis
|
J:156801
|
Tg(Camk2a-tTA)1Mmay/0
Tg(tetO-SNCA*A53T)E2Cai/0
(involves: C57BL/6)
|
abnormal nervous system physiology
|
J:156512
|
Tg(CASP3)18Fine/?
(involves: C57BL/6J)
|
increased cerebral infarct size
|
J:101696
|
| increased susceptibility to ischemic brain injury
|
J:101696
|
Tg(CD2-Rorc)#Staka/0
(involves: C57BL/6)
|
demyelination
|
J:236222
|
Tg(Cd4-CD4)2362Litt/0
Tg(HLA-DR2)#Lfug/0
Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2 * SJL)
|
CNS inflammation
|
J:134764
|
Tg(CD46)2Gsv/0
(involves: C57BL/6 * FVB/N)
|
increased neuron apoptosis
|
J:109895
|
Tg(Ckm-Chrnd*S262T)40Cgz/0
(involves: C57BL/6 * DBA/2)
|
abnormal action potential
|
J:31221
|
| abnormal endplate potential
|
J:31221
|
| abnormal miniature endplate potential
|
J:31221
|
| abnormal PNS synaptic transmission
|
J:31221
|
Tg(Ckm-Chrne*L269F)5Cgz/?
(involves: FVB/NJ)
|
abnormal action potential
|
J:193524
|
| abnormal endplate potential
|
J:193524
|
| abnormal miniature endplate potential
|
J:193524
|
| abnormal PNS synaptic transmission
|
J:193524
|
Tg(CMV-IghvaD11)CCat/0
Tg(CMV-IgkvaD11)BCat/0
(involves: C57BL/6 * SJL)
|
increased neuron apoptosis
|
J:79946
|
Tg(CMV-IghvaD11)DCat/0
Tg(CMV-IgkvaD11)ACat/0
(involves: C57BL/6 * SJL)
|
increased neuron apoptosis
|
J:79946
|
Tg(CMV-IgkvaD11)BCat/Tg(CMV-IgkvaD11)BCat
(involves: C57BL/6 * SJL)
|
impaired blood-brain barrier function
|
J:212312
|
Tg(CMV-LITAF*W116G)#Lli/0
(FVB-Tg(CMV-LITAF*W116G)#Lli)
|
decreased nerve conduction velocity
|
J:194981
|
Tg(CMV-LITAF*W116G)#Lli/Tg(CMV-LITAF*W116G)#Lli
(FVB-Tg(CMV-LITAF*W116G)#Lli)
|
abnormal action potential
|
J:194981
|
| abnormal myelination
|
J:194981
|
| decreased nerve conduction velocity
|
J:194981
|
| demyelination
|
J:194981
|
Tg(CMV-Tsc2*)1Arbi/0
(involves: C57BL/6)
|
reduced long-term depression
|
J:182345
|
Tg(Cnp-Gpr17)1Qrlu/0
(Not Specified)
|
abnormal myelination
|
J:154602
|
| seizures
|
J:154602
|
Tg(Cnp-SNCA)M2Vle/Tg(Cnp-SNCA)M2Vle
(involves: C3H * C57BL/6)
|
demyelination
|
J:99814
|
Tg(Crh)227.1Pbl/0
(involves: C57BL/6 * SJL)
|
hypersecretion of adrenocorticotropin
|
J:92996
|
Tg(Cyp17a1-NGF)2456Oje/Tg(Cyp17a1-NGF)2456Oje
(involves: C57BL/6J * DBA/2J)
|
abnormal sympathetic nervous system physiology
|
J:218686
|
Tg(DBH-Gal)1923Stei/0
(B6.Cg-Tg(DBH-Gal)1923Stei)
|
decreased susceptibility to pharmacologically induced seizures
|
J:77625
|
| reduced long-term potentiation
|
J:77625
|
| seizures
|
J:77625
|
Tg(Disc1/EGFP)M19Sshe/0
(involves: C57BL/6JCrl * CBA/CaCrl)
|
abnormal neuron proliferation
|
J:143557
|
Tg(DYRK1A)36Wjs/0
(involves: C57BL/6NCrjBgi)
|
abnormal long-term depression
|
J:111293
|
| abnormal neuron proliferation
|
J:166796
|
| abnormal neuronal precursor proliferation
|
J:166796
|
| enhanced long-term potentiation
|
J:111293
|
| impaired synaptic plasticity
|
J:111293
|
| reduced long-term depression
|
J:111293
|
Tg(EEF1A1-SHC1*)1Ravi/0
Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL)
|
increased neuron apoptosis
|
J:111058
|
Tg(Eno2-APPSwe)1223-3Ykk/0
(involves: C57BL/6 * DBA/2)
|
increased neuron apoptosis
|
J:100955
|
Tg(Eno2-MFN2*R94Q)L51Ugfm/0
(involves: C57BL/6 * DBA/2)
|
abnormal nervous system electrophysiology
|
J:173431
|
Tg(Eno2-PTGS2)32Pasi/0
(involves: C3H/HeNTac * C57BL/6NTac)
|
abnormal neuron physiology
|
J:100961
|
| increased susceptibility to neuronal excitotoxicity
|
J:100973
|
| seizures
|
J:100973
|
| tonic-clonic seizures
|
J:100973
|
Tg(Eno2-Scn2a1*)Q54Mm/0
(B6.Cg-Tg(Eno2-Scn2a1*)Q54Mm)
|
convulsive seizures
|
J:170734
|
| seizures
|
J:136510
|
Tg(Eno2tTA)5030Nes/0
Tg(tetO-NRG1_i4)6Ajla/0
(involves: C57BL/6 * C57BL/6J * SJL)
|
abnormal CNS synaptic transmission
|
J:231737
|
| abnormal miniature excitatory postsynaptic currents
|
J:231737
|
| decreased prepulse inhibition
|
J:231737
|
| increased excitatory postsynaptic current frequency
|
J:231737
|
| reduced sensorimotor gating
|
J:231737
|
Tg(GFAP-ATXN7*92Q)2521Als/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal glial cell physiology
|
J:113150
|
Tg(GFAP-cre)8Gtm/0
Tsc2tm1.1Mjg/Tsc2tm1.1Mjg
(involves: 129X1/SvJ * 129S1/Sv * C57BL/6 * CBA)
|
seizures
|
J:167241
|
Tg(Gfap-Cyth1*Y382F)1Jya/0
(C57BL/6JJms-Tg(Gfap-Cyth1*Y382F)1Jya)
|
dysmyelination
|
J:259473
|
Tg(Gfap-Cyth1*Y382F)5Jya/0
(C57BL/6JJms-Tg(Gfap-Cyth1*Y382F)5Jya)
|
dysmyelination
|
J:259473
|
Tg(GFAP-EFNA3)181Kln/0
(involves: C57BL/6 * FVB)
|
increased susceptibility to pharmacologically induced seizures
|
J:154648
|
Tg(Gfap-GFAP*R239H)60TMIke/0
(involves: C57BL/6J)
|
increased susceptibility to pharmacologically induced seizures
|
J:139349
|
Tg(Gfap-gp120)#Lms/0
(involves: C57BL/6 * SJL)
|
decreased neuronal precursor proliferation
|
J:170738
|
Tg(Gfap-Ifna1)12Ilc/0
(involves: BALB/c * C57BL/6J)
|
CNS inflammation
|
J:68811
|
| meningoencephalitis
|
J:68811
|
| seizures
|
J:68811
|
Tg(Gfap-Ifna1)39Ilc/0
(involves: BALB/c * C57BL/6J)
|
CNS inflammation
|
J:68811
|
| meningoencephalitis
|
J:68811
|
| seizures
|
J:68811
|
Tg(Gfap-Il6)G16Lms/0
Tg(Gfap-lacZ)1Lms/0
(involves: C57BL/6J * SJL)
|
seizures
|
J:125549
|
Tg(Gfap-Il6)G167Lms/0
(involves: C57BL/6J * SJL)
|
seizures
|
J:125549
|
Tg(Gfap-Il6)G167Lms/Tg(Gfap-Il6)G167Lms
(involves: C57BL/6J * SJL)
|
seizures
|
J:125549
|
Tg(Gfap-Il6)G369Lms/0
(involves: C57BL/6J * SJL)
|
seizures
|
J:125549
|
Tg(Gfap-rtTA,tetO-MAOB,-lacZ)1Jkan/0
(involves: C57BL/6)
|
abnormal microglial cell activation
|
J:132679
|
| abnormal neuron physiology
|
J:132679
|
Tg(Gfap-TGFB1)64Lms/0
(involves: BALB/c * SJL)
|
abnormal astrocyte physiology
|
J:27781
|
Tg(Gfap-TGFB1)64Lms/0
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: BALB/c * C57BL/6 * DBA/2 * SJL)
|
abnormal somatosensory cortex physiology
|
J:167619
|
Tg(Gfap-TGFB1)64Lms/Tg(Gfap-TGFB1)64Lms
(involves: BALB/c * SJL)
|
seizures
|
J:27781
|
Tg(Gfap-TK)7.1Mvs/0
(involves: C57BL/10 * CBA * CFLP)
|
abnormal astrocyte physiology
|
J:104241
|
| abnormal blood-brain barrier function
|
J:113202
|
| brain inflammation
|
J:113202
|
| increased susceptibility to neuronal excitotoxicity
|
J:113202
|
Tg(Gfap-TNF*)K21Gkl/0
(involves: C57BL/6 * CBA)
|
abnormal oligodendrocyte apoptosis
|
J:106592
|
| CNS inflammation
|
J:106592
|
| demyelination
|
J:106592
|
Tg(Gfap-TNF*)K21Gkl/0
Tnfrsf1atm1Blt/Tnfrsf1a+
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
abnormal nervous system physiology
|
J:106592
|
| demyelination
|
J:106592
|
Tg(GFAP-tTA)6Hyms/0
Tg(tetO-HMOX1)6Hyms/0
(involves: FVB/N)
|
abnormal nervous system physiology
|
J:186620
|
| decreased prepulse inhibition
|
J:186620
|
Tg(GFAP-tTA)78Pop/0
Tg(tetO-Ifng)184Pop/0
(B6.Cg-Tg(GFAP-tTA)78Pop Tg(tetO-Ifng)184Pop)
|
CNS inflammation
|
J:109838
|
Tg(GFAP-tTA)110Pop/0
Tg(tetO-DISC1*)1302BPlet/0
(B6.Cg-Tg(GFAP-tTA)110Pop Tg(tetO-DISC1*)1302BPlet)
|
decreased prepulse inhibition
|
J:244437
|
Tg(GFAP-TVA)5Hev/0
(involves: BALB/c * C57BL/6 * FVB/N)
|
abnormal glial cell physiology
|
J:69971
|
Tg(Gng8-tTA)#Ryba/0
Tg(tetO-APPSwInd)Dbo/0
(involves: 129 * C3H/HeJ * C57BL/6J * FVB/N)
|
abnormal olfactory sensory neuron physiology
|
J:176127
|
Tg(Gnrh1-Fgfr1)1Tsai/Tg(Gnrh1-Fgfr1)1Tsai
(involves: C57BL/6J * DBA/2J)
|
abnormal hypothalamus secretion
|
J:95057
|
Tg(Gria2*586N)238.2Rsp/0
(Not Specified)
|
abnormal AMPA-mediated synaptic currents
|
J:51845
|
Tg(H2-Kb-Tcra,-Tcrb)1640Kurs/0
(SJL.FVB-Tg(H2-Kb-Tcra,-Tcrb)1640Kurs)
|
brain inflammation
|
J:149511
|
| CNS inflammation
|
J:149511
|
| demyelination
|
J:149511
|
Tg(hAGT)2041Sig/0
Tg(hREN)9Sig/0
(involves: C3H/HeRos * C57BL/6J * C57BL/10Ros * SJL/J)
|
brainstem hemorrhage
|
J:130409
|
| cerebellum hemorrhage
|
J:130409
|
| increased susceptibility to ischemic brain injury
|
J:130409
|
| intracranial hemorrhage
|
J:130409
|
Tg(hAGT)2041Sig/0
Tg(hREN)9Sig/0
(involves: C3H/HeRos * C57BL/6 * C57BL/10Ros * SJL/J)
|
abnormal baroreceptor physiology
|
J:79859
|
Tg(HCRT-MJD)1Stak/?
(B6.Cg-Tg(HCRT-MJD)1Stak)
|
abnormal brain wave pattern
|
J:141058
|
Tg(HCRT-tTA)1Ahky/0
Tg(tetO-DTA)1Gfi/0
(B6.Cg-Tg(HCRT-tTA)1Ahky Tg(tetO-DTA)1Gfi)
|
increased microglial cell activation
|
J:211045
|
Tg(HD)63Aron/?
(involves: C57BL/6 * SJL)
|
abnormal excitatory postsynaptic potential
|
J:72772
|
| enhanced NMDA-mediated synaptic currents
|
J:72772
|
Tg(HDexon1)62Gpb/0
(involves: C57BL/6J * CBA/J)
|
seizures
|
J:36689
|
Tg(HDexon1)62Gpb/0
(B6CBA-Tg(HDexon1)62Gpb/1J)
|
abnormal nervous system physiology
|
J:99425
|
| abnormal neuron physiology
|
J:76018
|
Tg(HDexon1)62Gpb/0
(B6CBA-Tg(HDexon1)62Gpb/3J)
|
decreased prepulse inhibition
|
J:185262
|
Tg(HDexon1)62Gpb/0
(B6.Cg-Tg(HDexon1)62Gpb/240)
|
decreased prepulse inhibition
|
J:185262
|
Tg(HLA-DR2)#Lfug/0
Tg(TCROb.1A12)#Lfug/0
(involves: C57BL/6 * DBA/2)
|
CNS inflammation
|
J:134764
|
Tg(Hmgcr-PSEN1*M146L)#Lpr/0
Tg(Thy1-APPSL)28Lpr/0
(involves: C57BL/6 * CBA)
|
abnormal nervous system physiology
|
J:108853
|
Tg(HTT*97Q)IXwy/0
(FVB-Tg(HTT*97Q)IXwy)
|
abnormal inhibitory postsynaptic currents
|
J:208675
|
| abnormal nervous system electrophysiology
|
J:137345
|
| decreased excitatory postsynaptic current frequency
|
J:208675
|
| decreased prepulse inhibition
|
J:185262
|
| reduced NMDA-mediated synaptic currents
|
J:208675
|
Tg(HTT*)NXwy/0
(involves: FVB/NJ)
|
abnormal nervous system electrophysiology
|
J:219890
|
| CNS inflammation
|
J:219890
|
Tg(K18-ACE2)2Prlmn/0
(B6.Cg-Tg(K18-ACE2)2Prlmn/J)
|
brain inflammation
|
J:294084
|
| cerebellum hemorrhage
|
J:300960
|
| meningitis
|
J:294084,
J:302313
|
| meningoencephalitis
|
J:300960,
J:296067
|
Tg(KRT18-DPP4)3Pbmj/0
(involves: C57BL/6J * SJL/J)
|
brain inflammation
|
J:285467
|
Tg(Lgi1)#Mpan/0
(Not Specified)
|
abnormal miniature excitatory postsynaptic currents
|
J:154129
|
| abnormal paired-pulse facilitation
|
J:154129
|
| abnormal synaptic transmission
|
J:154129
|
| decreased excitatory postsynaptic current amplitude
|
J:154129
|
Tg(Lgi1*)#Mpan/0
(Not Specified)
|
abnormal CNS synaptic transmission
|
J:154129
|
| abnormal miniature excitatory postsynaptic currents
|
J:154129
|
| abnormal paired-pulse inhibition
|
J:154129
|
| abnormal synaptic transmission
|
J:154129
|
| increased excitatory postsynaptic current amplitude
|
J:154129
|
| increased susceptibility to pharmacologically induced seizures
|
J:154129
|
Tg(Lmnb1)1Yfu/0
(involves: C57BL/6J)
|
abnormal oligodendrocyte physiology
|
J:197168
|
| abnormal spike wave discharge
|
J:197168
|
| clonic seizures
|
J:197168
|
| demyelination
|
J:197168
|
| hypermyelination
|
J:197168
|
| increased susceptibility to pharmacologically induced seizures
|
J:197168
|
| seizures
|
J:197168
|
Tg(LONP1-mt-ND4*,-mCherry*)#Jguy
(B6(D2)-Tg(LONP1-mt-ND4*,-mCherry*)#Jguy)
|
abnormal Wallerian degeneration
|
J:224897
|
Tg(Lrrk2)6Yue/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
increased neurotransmitter release
|
J:157931
|
Tg(Lrrk2*G2019S)2Yue/0
(involves: C3H * C57BL/6 * C57BL/6J)
|
abnormal neurotransmitter uptake
|
J:157931
|
| decreased neurotransmitter release
|
J:157931
|
Tg(MAPT*V337M)1Gds/0
(B6J.Cg-Tg(MAPT*V337M)1Gds)
|
abnormal CNS synaptic transmission
|
J:218742
|
| abnormal excitatory postsynaptic potential
|
J:218742
|
| decreased excitatory postsynaptic current amplitude
|
J:218742
|
| decreased miniature excitatory postsynaptic current amplitude
|
J:218742
|
Tg(Mapt-MAPT*)#Hanr/0
(involves: BALB/c * C57BL/6)
|
abnormal long-term potentiation
|
J:137947
|
| decreased paired-pulse facilitation
|
J:137947
|
Tg(Mbp-Cadm4*)#Pele/?
(Not Specified)
|
abnormal myelination
|
J:199632
|
| decreased nerve conduction velocity
|
J:199632
|
| hypermyelination
|
J:199632
|
Tg(Mbp-Pad2)28Fgm/0
(involves: CD-1)
|
convulsive seizures
|
J:142650
|
| demyelination
|
J:142650
|
Tg(Mbp-Pad2)28Fgm/Tg(Mbp-Pad2)28Fgm
(involves: CD-1)
|
convulsive seizures
|
J:142650
|
| demyelination
|
J:142650
|
Tg(Mbp-SNCA)1Ema/0
(involves: C57BL/6 * DBA/2)
|
brain inflammation
|
J:207162
|
| demyelination
|
J:102867
|
Tg(Mbp-SNCA)29Ema/0
(involves: C57BL/6 * DBA/2)
|
demyelination
|
J:102867
|
| seizures
|
J:102867
|
Tg(MECP2)1Hzo/0
(involves: FVB)
|
abnormal miniature excitatory postsynaptic currents
|
J:126964
|
| clonic seizures
|
J:94407
|
| enhanced long-term potentiation
|
J:94407
|
| enhanced paired-pulse facilitation
|
J:94407
|
| increased excitatory postsynaptic current amplitude
|
J:126964
|
Tg(Mov1/Tyr)OVE876BPay/Y
(FVB/N-Tg(Mov1/Tyr)OVE876BPay)
|
audiogenic seizures
|
J:167614
|
| decreased prepulse inhibition
|
J:167614
|
| reduced sensorimotor gating
|
J:167614
|
Tg(Mov1/Tyr)OVE876BPay/Tg(Mov1/Tyr)OVE876BPay
(FVB/N-Tg(Mov1/Tyr)OVE876BPay)
|
audiogenic seizures
|
J:167614
|
| decreased prepulse inhibition
|
J:167614
|
| reduced sensorimotor gating
|
J:167614
|
Tg(Mpz)80.2Wra/0
(involves: FVB/N)
|
decreased nerve conduction velocity
|
J:78758
|
| dysmyelination
|
J:78758
|
Tg(Mpz)80.3Wra/0
(involves: FVB/N)
|
dysmyelination
|
J:78758
|
Tg(Mpz)80.3Wra/Tg(Mpz)80.3Wra
(involves: FVB/N)
|
dysmyelination
|
J:78758
|
Tg(Mpz)80.4Wra/0
(involves: FVB/N)
|
decreased nerve conduction velocity
|
J:78758
|
| dysmyelination
|
J:78758
|
Tg(Mpz)88.1Mfel/0
(FVB/N-Tg(Mpz)88.1Mfel)
|
decreased nerve conduction velocity
|
J:77658
|
| demyelination
|
J:77658
|
| dysmyelination
|
J:77658
|
Tg(Mpz)88.2Mfel/0
(FVB/N-Tg(Mpz)88.2Mfel)
|
demyelination
|
J:77658
|
| dysmyelination
|
J:77658
|
Tg(Mpz)88.4Mfel/0
(FVB/N-Tg(Mpz)88.4Mfel)
|
decreased nerve conduction velocity
|
J:77658
|
| dysmyelination
|
J:77658
|
Tg(Mpz*S63C)32Mes/0
(involves: FVB/N)
|
abnormal nervous system physiology
|
J:105751
|
| demyelination
|
J:105751
|
| dysmyelination
|
J:105751
|
Tg(Mpz*S63C)33Mes/0
(involves: FVB/N)
|
abnormal nervous system physiology
|
J:105751
|
| demyelination
|
J:105751
|
| dysmyelination
|
J:105751
|
Tg(Mpz*S63X)30Mes/0
(involves: FVB/N)
|
abnormal nervous system physiology
|
J:105751
|
| demyelination
|
J:105751
|
| dysmyelination
|
J:105751
|
Tg(Mpz*S63X)31Mes/0
(involves: FVB/N)
|
abnormal nervous system physiology
|
J:105751
|
| demyelination
|
J:105751
|
| dysmyelination
|
J:105751
|
Tg(Mpz-RAF1/ESR1)A668Ayld/0
(involves: C57BL/6J * CBA/J)
|
abnormal Schwann cell physiology
|
J:182703
|
| demyelination
|
J:182703
|
| increased Schwann cell proliferation
|
J:182703
|
Tg(MT1A-Dyrk1a)#Xest/0
(involves: C57BL/6 * SJL)
|
abnormal paired-pulse inhibition
|
J:140647
|
Tg(Myh6*/tetO-FXYD1*S68E)39Jych/0
Tg(Myh6-tTA)55Rbns/0
(involves: FVB/N)
|
abnormal action potential
|
J:182365
|
Tg(Myh6*/tetO-Slc8a1)BJych/0
Tg(Myh6-tTA)55Rbns/0
(involves: FVB/N)
|
abnormal action potential
|
J:151091
|
Tg(Myh6-Camk2d_ic)#Jhb/0
(Not Specified)
|
abnormal action potential
|
J:117345
|
Tg(Myl1-SOD1*G93A)#Amu/0
(FVB/NJ-Tg(Myl1-SOD1*G93A)#Amu)
|
increased microglial cell activation
|
J:143747
|
Tg(NEFL*E397K)#Milg/0
(Not Specified)
|
decreased nerve conduction velocity
|
J:173771
|
Tg(NEFL-APP)#Nalb/0
(involves: C57BL/6 * C3H)
|
reduced long-term potentiation
|
J:80639
|
Tg(Nes-cre)1Kln/0
Tg(ACTB-NOTCH1)1Shn/0
(B6.Cg-Tg(Nes-cre)1Kln Tg(ACTB-NOTCH1)1Shn)
|
abnormal neuron apoptosis
|
J:90392
|
Tg(Nes-cre)1Kln/0
Triotm1Mzhu/Triotm1Mzhu
(involves: 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal cerebellar granule cell migration
|
J:165902
|
| increased neuron apoptosis
|
J:165902
|
Tg(Nes-cre)1Kln/0
Ube4bem1Bcgen/Ube4bem1Bcgen
(involves: C57BL/6N * SJL)
|
decreased neuronal precursor proliferation
|
J:332423
|
| tonic-clonic seizures
|
J:332423
|
Tg(Nes-cre)1Kln/0
Wnt7atm1Amc/Wnt7atm1Amc
Wnt7btm1Parr/Wnt7btm2Amc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL)
|
abnormal blood-brain barrier function
|
J:142352
|
| intracranial hemorrhage
|
J:142352
|
| spinal hemorrhage
|
J:142352
|
Tg(Nes-cre)1Kln/0
Zfp568tm1Ckjs/Zfp568tm1Ckjs
(involves: C57BL/6J * SJL)
|
abnormal neuronal precursor proliferation
|
J:192224
|
Tg(Nes-cre)1Wme/Tg(Nes-cre)1Wme
(involves: C57BL/6 * CBA)
|
abnormal neuronal precursor cell migration
|
J:112466
|
| decreased neuronal precursor proliferation
|
J:112466
|
| increased neuron apoptosis
|
J:112466
|
Tg(Nes-cre/ERT2)1Imayo/0
(involves: C57BL/6)
|
decreased neuronal precursor proliferation
|
J:112466
|
Tg(Nes-cre/ERT2)4Imayo/0
(involves: C57BL/6)
|
decreased neuronal precursor proliferation
|
J:112466
|
Tg(NES/TK-PDGFB,-lacZ)310Kfn/0
(B6.Cg-Tg(NES/TK-PDGFB,-lacZ)310Kfn)
|
abnormal glial cell physiology
|
J:189829
|
Tg(Neurod2-Smo*A2)#Jols/0
(C57BL/6-Tg(Neurod2-Smo*A2)#Jols)
|
abnormal neuron proliferation
|
J:189258
|
| abnormal neuronal migration
|
J:189258
|
Tg(Nfh/lacZ)44AApt/0
(involves: C3H * C57BL/6)
|
hypermyelination
|
J:76723
|
Tg(Notch3*R169C)88Bbb/0
(involves: FVB/N)
|
abnormal myelination
|
J:156682
|
Tg(Npy-MAPT/Sapphire)1Rck/?
Ucp2Gt(S20-3G1)Sor/Ucp2Gt(S20-3G1)Sor
(involves: C57BL/6 * CBA)
|
abnormal hypothalamus physiology
|
J:139938
|
Tg(Omp-Hist2h2be)14Dlc/0
(involves: C57BL/6)
|
increased neuron apoptosis
|
J:197878
|
Tg(Pcp2-ATXN2*127Q)#Plt/0
(involves: C57BL/6 * DBA/2)
|
abnormal nervous system electrophysiology
|
J:191127
|
Tg(Pcp2-cre)2Mpin/0
Tsc2tm1.1Mjg/Tsc2tm1.2Mjg
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
seizures
|
J:174327
|
Tg(Pcp2-TBP*)69Hmhl/0
(involves: FVB/N)
|
brain inflammation
|
J:174239
|
Tg(Pcp2-tTA)3Horr/0
Tg(tetO-SPTBN2*)#Lpwr/0
(involves: FVB/N)
|
abnormal nervous system physiology
|
J:215593
|
| reduced long-term potentiation
|
J:215593
|
Tg(PDGFB-Hyou1)#Tam/0
(Not Specified)
|
abnormal response to CNS ischemic injury
|
J:91007
|
Tg(PDGFB-Hyou1)#Tam/0
(involves: BALB/c * C57BL/6)
|
abnormal response to CNS ischemic injury
|
J:67962
|
| decreased susceptibility to neuronal excitotoxicity
|
J:91396
|
Tg(PDGFB-LRRK2*R1441C)31Hlw/0
(FVB/N-Tg(PDGFB-LRRK2*R1441C)31Hlw)
|
abnormal synaptic dopamine release
|
J:229559
|
Tg(PDGFB-MAPT*V337M)1Atak/0
(involves: C57BL/6 * SJL)
|
abnormal nervous system electrophysiology
|
J:100964
|
Tg(PDGFB-UCHL1*I93M)LWada/0
(involves: C57BL/6J)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:128045
|
Tg(Pkd1)26Mtru/0
(involves: C57BL/6J * CBA/J)
|
subarachnoid hemorrhage
|
J:157952
|
Tg(PLP1*)4Rsj/0
(involves: CD-1)
|
abnormal myelination
|
J:161344,
J:24069
|
| CNS inflammation
|
J:161344
|
| demyelination
|
J:171534,
J:161344,
J:24069
|
| environmentally induced seizures
|
J:24069
|
Tg(Plp1-Eif2ak3*)18Pop/Tg(Plp1-Eif2ak3*)18Pop
(C57BL/6J-Tg(Plp1-Eif2ak3*)18Pop)
|
dysmyelination
|
J:216298
|
Tg(Plp1-HTT*150Q)4aXjl/0
(Not Specified)
|
demyelination
|
J:221608
|
| increased susceptibility to pharmacologically induced seizures
|
J:221608
|
Tg(Plp1-LMNB1)1108Qsp/0
(involves: FVB/N)
|
demyelination
|
J:226169
|
Tg(Plp1-Lmnb1)#Yfu/0
(involves: FVB)
|
demyelination
|
J:197168
|
| seizures
|
J:197168
|
Tg(Plp)66Kan/0
(B6NCrl.Cg-Tg(Plp)66Kan)
|
demyelination
|
J:156106
|
Tg(Plp)66Kan/0
Tg(Plp)72Kan/0
(involves: C57BL/6 * DBA)
|
convulsive seizures
|
J:17373
|
| dysmyelination
|
J:17373
|
Tg(Plp)66Kan/Tg(Plp)66Kan
(involves: C57BL * DBA)
|
demyelination
|
J:17373
|
| seizures
|
J:17373
|
Tg(Plp)66Kan/Tg(Plp)66Kan
(B6NCrl.Cg-Tg(Plp)66Kan)
|
abnormal oligodendrocyte apoptosis
|
J:156106
|
| demyelination
|
J:156106
|
| seizures
|
J:156106
|
Tg(Plp)72Kan/Tg(Plp)72Kan
(involves: C57BL/6 * DBA)
|
dysmyelination
|
J:17373
|
Tg(Plp)72Kan/Tg(Plp)72Kan
(B6N.Cg-Tg(Plp)72Kan)
|
abnormal axonal transport
|
J:229229
|
| decreased nerve conduction velocity
|
J:229229
|
| demyelination
|
J:229229
|
| dysmyelination
|
J:229229
|
Tg(Pmp22)247Ueli/0
(involves: C3H * C57BL/6)
|
abnormal myelination
|
J:98118
|
Tg(PMP22)C3Fbas/?
(B6.Cg-Tg(PMP22)C3Fbas)
|
abnormal action potential
|
J:237901
|
| abnormal myelination
|
J:237901
|
| decreased nerve conduction velocity
|
J:237901
|
| dysmyelination
|
J:237901
|
| hypermyelination
|
J:237901
|
Tg(PMP22)C22Clh/0
(involves: C57BL/6J * CBA/Ca)
|
abnormal myelination
|
J:76795
|
| dysmyelination
|
J:76795
|
Tg(PMP22)C22Fbas/?
(B6.Cg-Tg(PMP22)C22Fbas)
|
abnormal action potential
|
J:237901
|
| abnormal myelination
|
J:237901
|
| decreased nerve conduction velocity
|
J:237901
|
| demyelination
|
J:237901
|
| dysmyelination
|
J:237901
|
| hypermyelination
|
J:237901
|
Tg(PMP22)C61Clh/0
(B6.Cg-Tg(PMP22)C61Clh)
|
abnormal action potential
|
J:158350
|
| decreased nerve conduction velocity
|
J:158350
|
| demyelination
|
J:158350
|
Tg(Pmp22)My41Clh/0
(involves: C57BL/6J * CBA/Ca)
|
abnormal myelination
|
J:76795
|
| demyelination
|
J:76795
|
| dysmyelination
|
J:76795
|
Tg(PMP22-tTA)JY13Clh/0
Tg(tetO/CMV-Pmp22)JP18Clh/0
(involves: C57BL/6J * CBA/Ca)
|
abnormal myelination
|
J:69545
|
| decreased nerve conduction velocity
|
J:69545
|
| demyelination
|
J:69545
|
Tg(Pnkd*A7V*A9V,-DsRed)671Ljp/0
(B6.Cg-Tg(Pnkd*A7V*A9V,-DsRed)671Ljp)
|
abnormal synaptic dopamine release
|
J:192798
|
| abnormal synaptic transmission
|
J:192798
|
Tg(Pnkd*A7V*A9V,-DsRed)704Ljp/0
(B6.Cg-Tg(Pnkd*A7V*A9V,-DsRed)704Ljp)
|
abnormal synaptic dopamine release
|
J:192798
|
| abnormal synaptic transmission
|
J:192798
|
Tg(Pomc-MAPT/Topaz)1Rck/0
Ucp2Gt(S20-3G1)Sor/Ucp2Gt(S20-3G1)Sor
(involves: C57BL/6 * CBA)
|
abnormal hypothalamus physiology
|
J:139938
|
| abnormal synaptic plasticity
|
J:139938
|
Tg(Prnp)4053Sbp/0
(involves: FVB/N)
|
abnormal nervous system physiology
|
J:136434
|
Tg(Prnp*)#Rgab/0
(involves: C57BL/6 * FVB/N)
|
myoclonus
|
J:183170
|
Tg(Prnp*D177N*M128V)A21Rchi/0
(involves: C57BL/6 * CBA)
|
abnormal brain wave pattern
|
J:142098
|
Tg(Prnp*P101L)2247Sbp/0
(involves: FVB/N)
|
abnormal nervous system physiology
|
J:136434
|
Tg(Prnp*P101L)2862Sbp/0
(involves: FVB/N)
|
abnormal nervous system physiology
|
J:136434
|
Tg(Prnp*P101L)2866Sbp/0
(involves: FVB/N)
|
abnormal nervous system physiology
|
J:136434
|
| abnormal Wallerian degeneration
|
J:136434
|
Tg(Prnp-Abca1)EHol/0
(involves: C57BL/6 * CBA)
|
abnormal glial cell physiology
|
J:131400
|
Tg(Prnp-APP)#Hmor/0
(B6.Cg-Tg(Prnp-APP)#Hmor)
|
decreased paired-pulse facilitation
|
J:159623
|
| reduced long-term potentiation
|
J:159623
|
Tg(Prnp-APP*)1Hmor/0
(B6.Cg-Tg(Prnp-APP*)1Hmor)
|
decreased paired-pulse facilitation
|
J:123688
|
| reduced long-term potentiation
|
J:123688
|
Tg(Prnp-APP*)3Hmor/0
(B6.Cg-Tg(Prnp-APP*)3Hmor)
|
decreased paired-pulse facilitation
|
J:159623,
J:123688
|
| reduced long-term potentiation
|
J:159623,
J:123688
|
Tg(Prnp-ATN1)150Dbo/?
(involves: C3H * C57BL/6)
|
seizures
|
J:70362
|
Tg(Prnp-ATXN3)BVcg/Tg(Prnp-ATXN3)BVcg
(involves: C3H/HeJ * C57BL/6)
|
seizures
|
J:96574
|
Tg(Prnp-ATXN3)CVcg/Tg(Prnp-ATXN3)CVcg
(involves: C3H/HeJ * C57BL/6)
|
seizures
|
J:96574
|
Tg(Prnp-ATXN3*70Q)70.61Olri/0
(involves: C57BL/6N)
|
abnormal nervous system physiology
|
J:122993
|
Tg(Prnp-ATXN7*92Q)1963Als/0
(B6J.Cg-Tg(Prnp-ATXN7*92Q)1963Als)
|
abnormal synaptic physiology
|
J:222402
|
Tg(Prnp-ATXN7*92Q)6076Als/0
(involves: C3H/HeJ * C57BL/6)
|
abnormal glial cell physiology
|
J:113150
|
Tg(Prnp-HSPB1*R136W)1Kolb/0
(involves: FVB/NJ)
|
abnormal nervous system electrophysiology
|
J:188399
|
Tg(Prnp-ITM2B*)7Jckr/0
(C57BL/6-Tg(Prnp-ITM2B*)7Jckr)
|
intracerebral hemorrhage
|
J:159279
|
Tg(Prnp-lacZ/ATXN10*)#Teas/0
(involves: FVB/N)
|
increased susceptibility to pharmacologically induced seizures
|
J:222081
|
Tg(Prnp-MAPT)7Vle/0
(involves: C57BL/6 * SJL)
|
abnormal axonal transport
|
J:61052
|
Tg(Prnp-MAPT)43Vle/0
(involves: C57BL/6 * DBA/2)
|
abnormal axonal transport
|
J:61052
|
Tg(Prnp-MAPT*)2652Gds/Tg(Prnp-MAPT*)2652Gds
(B6.Cg-Tg(Prnp-MAPT*)2652Gds)
|
seizures
|
J:244052
|
Tg(Prnp-MAPT*K274Q*K281Q)1Lgn/0
(involves: C57BL/6 * FVB/N)
|
impaired synaptic plasticity
|
J:230252
|
| reduced long-term potentiation
|
J:230252
|
Tg(Prnp-MAPT*K274Q*K281Q)286Lgn/0
(involves: C57BL/6 * FVB/N)
|
abnormal excitatory postsynaptic potential
|
J:230252
|
| impaired synaptic plasticity
|
J:230252
|
| reduced long-term potentiation
|
J:230252
|
Tg(Prnp-MAPT*P301S)50Hiw/0
(B6.Cg-Tg(Prnp-MAPT*P301S)50Hiw)
|
abnormal axonal transport
|
J:213361
|
Tg(Prnp-MAPT*P301S)PS19Vle/0
(involves: C3H * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:119741
|
| abnormal excitatory postsynaptic potential
|
J:119741
|
| decreased paired-pulse facilitation
|
J:119741
|
| reduced long-term potentiation
|
J:119741
|
Tg(Prnp-MAPT*P301S)PS19Vle/0
(B6.Cg-Tg(Prnp-MAPT*P301S)PS19Vle)
|
increased prepulse inhibition
|
J:174441
|
Tg(Prnp-RTN3)2Yanr/0
(involves: C57BL/6 * FVB/N)
|
abnormal excitatory postsynaptic potential
|
J:122560
|
| reduced long-term potentiation
|
J:122560
|
Tg(Prnp-SETX*R2136H)1920Als/0
(involves: C57BL/6J)
|
abnormal neuron physiology
|
J:320844
|
| increased susceptibility to neuronal excitotoxicity
|
J:320844
|
Tg(Prnp-SNAP25/HTT*150Q)8Xjl/0
(involves: FVB)
|
decreased paired-pulse facilitation
|
J:201806
|
| decreased synaptic glutamate release
|
J:201806
|
| reduced long-term potentiation
|
J:201806
|
Tg(Prnp-SNCA*A53T)83Vle/Tg(Prnp-SNCA*A53T)83Vle
(involves: C3H * C57BL/6)
|
abnormal myelination
|
J:76657
|
Tg(Prnp-SNCA*A53T)AAub/?
(involves: FVB/N)
|
abnormal channel response
|
J:216589
|
| abnormal nervous system electrophysiology
|
J:216589
|
| abnormal neuron physiology
|
J:216589
|
Tg(Prnp-SNCA*A53T)AAub/Tg(Prnp-SNCA*A53T)AAub
(involves: FVB/N)
|
absent long-term depression
|
J:181820
|
Tg(Prnp-TARDBP)3cPtrc/Tg(Prnp-TARDBP)3cPtrc
(C57BL/6-Tg(Prnp-TARDBP)3cPtrc)
|
demyelination
|
J:163231
|
Tg(Prnp-TARDBP*Q331K)103Dwc/?
(involves: C57BL/6 * C3H)
|
abnormal nervous system electrophysiology
|
J:191785
|
Tg(Prnp-TBP*)71-16Xjl/0
(FVB/N-Tg(Prnp-TBP*)71-16Xjl)
|
sporadic seizures
|
J:130775
|
Tg(Prnp-TBP*)71-27Xjl/0
(FVB/N-Tg(Prnp-TBP*)71-27Xjl)
|
sporadic seizures
|
J:130775
|
Tg(Prnp-TBP*)105Xjl/0
(FVB/N-Tg(Prnp-TBP*)105Xjl)
|
sporadic seizures
|
J:130775
|
Tg(Prnp-tTA)F959Sbp/0
Tg(tetO-Chrnb2*V287L)H3Gica/0
(involves: 129S7/SvEvBrd * FVB)
|
abnormal brain wave pattern
|
J:145855
|
| seizures
|
J:145855
|
Tg(Prnp-tTA)F959Sbp/?
Tg(TetO-Nfkbia*S32A*S36A)1Wcg/?
(involves: 129S7/SvEvBrd * DBA * FVB/N)
|
abnormal excitatory postsynaptic potential
|
J:112973
|
| enhanced long-term potentiation
|
J:112973
|
| environmentally induced seizures
|
J:112973
|
Tg(Prp-GPR37)1Ryot/0
(involves: C3H * C57BL/6)
|
abnormal neuron physiology
|
J:128745
|
| increased susceptibility to dopaminergic neuron neurotoxicity
|
J:128745
|
Tg(PSEN1)1098Citr/0
(B6.FVB-Tg(PSEN1)1098Citr)
|
enhanced NMDA-mediated synaptic currents
|
J:151932
|
| reduced long-term potentiation
|
J:151932
|
| reduced NMDA-mediated synaptic currents
|
J:151932
|
Tg(PSEN1*L286V)1274Citr/0
(B6.FVB-Tg(PSEN1*L286V)1274Citr)
|
enhanced long-term potentiation
|
J:151932
|
| enhanced NMDA-mediated synaptic currents
|
J:151932
|
| reduced long-term potentiation
|
J:151932
|
| reduced NMDA-mediated synaptic currents
|
J:151932
|
Tg(Pten)1Srn/0
(involves: C57BL/6 * CBA)
|
abnormal excitatory postsynaptic potential
|
J:234430
|
Tg(Pvalb-tdTomato/RNAi:Gad1)3Mirn/?
(C57BL/6-Tg(Pvalb-tdTomato/RNAi:Gad1)3Mirn)
|
abnormal GABA-mediated receptor currents
|
J:227902
|
| decreased prepulse inhibition
|
J:227902
|
Tg(RCAN1)M9Mapr/?
(involves: C57BL/6 * CBA)
|
abnormal nervous system electrophysiology
|
J:184606
|
| reduced long-term potentiation
|
J:184606
|
Tg(RNU6-RNAi:Mpp5)13Wij/0
Tg(rx3-icre)1Mjam/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N)
|
increased neuron apoptosis
|
J:178056
|
Tg(RP11-111A8)1Zim/0
(involves: CD-1)
|
decreased prepulse inhibition
|
J:150615
|
Tg(RP23-65I14)1Jno/?
(involves: FVB)
|
abnormal CNS synaptic transmission
|
J:146431
|
| absence seizures
|
J:146431
|
Tg(RP23-65I14)2Jno/?
(involves: FVB/N)
|
abnormal CNS synaptic transmission
|
J:146431
|
| absence seizures
|
J:146431
|
Tg(Scn1a*)RH9Aesc/0
(involves: FVB/NJ)
|
abnormal neuron physiology
|
J:150454
|
| increased susceptibility to pharmacologically induced seizures
|
J:150454
|
Tg(Shank3-EGFP)1Hzo/0
(involves: FVB/N)
|
decreased miniature inhibitory postsynaptic current frequency
|
J:201867
|
| decreased prepulse inhibition
|
J:201867
|
| increased excitatory postsynaptic current amplitude
|
J:201867
|
| seizures
|
J:201867
|
Tg(Snca-SNCA/GFP)#Jyl/Tg(Snca-SNCA/GFP)#Jyl
(involves: C57BL/6)
|
abnormal synaptic dopamine release
|
J:197984
|
Tg(SOD1)2Gur/0
Tg(SOD1*A4V)A1073Gur/0
(involves: C57BL/6 * SJL)
|
abnormal nervous system physiology
|
J:109458
|
Tg(SOD1)2Gur/0
Tg(SOD1*G93A)1Gur/0
(involves: C57BL/6 * SJL)
|
abnormal nervous system physiology
|
J:109458
|
Tg(SOD1)2Gur/0
Tg(SOD1*L126Z)#Deng/0
(involves: C57BL/6 * SJL)
|
abnormal nervous system physiology
|
J:109458
|
Tg(SOD1)51Yg/Tg(SOD1)51Yg
(involves: BALB/c * C57BL/6J * DBA/2)
|
reduced long-term potentiation
|
J:96742
|
Tg(SOD1)76Dpr/0
(B6.Cg-Tg(SOD1)76Dpr)
|
decreased cerebral infarct size
|
J:128835
|
| decreased susceptibility to ischemic brain injury
|
J:128835
|
Tg(SOD1*G85R/EYFP)641Alho/Tg(SOD1*G85R/EYFP)641Alho
(involves: C57BL/6J * SJL/J)
|
abnormal nervous system physiology
|
J:144475
|
Tg(SOD1*G85R/EYFP)737Alho/Tg(SOD1*G85R/EYFP)737Alho
(involves: C57BL/6J * SJL/J)
|
abnormal nervous system physiology
|
J:144475
|
Tg(SOD1*G93A)1Gur/0
(involves: C57BL/6 * SJL)
|
abnormal CNS synaptic transmission
|
J:109423
|
| abnormal excitatory postsynaptic potential
|
J:109423
|
| abnormal long-term potentiation
|
J:109423
|
| abnormal nervous system physiology
|
J:109458
|
| abnormal neuron physiology
|
J:130581
|
| abnormal paired-pulse inhibition
|
J:109423
|
| impaired synaptic plasticity
|
J:109423
|
| increased cerebral infarct size
|
J:61249
|
| reduced long-term depression
|
J:109423
|
Tg(SOD1*G93A)1Gur/0
(B6SJL-Tg(SOD1*G93A)1Gur/J)
|
abnormal axonal transport
|
J:129976
|
| abnormal nervous system physiology
|
J:111280
|
| CNS inflammation
|
J:110437
|
Tg(SOD1*G93A)1Gur/0
Wlds/+
(involves: C57BL/6J * C57BL/6Ola * SJL/J)
|
slow Wallerian degeneration
|
J:105092
|
Tg(SOD1*G93A)2Gur/0
(involves: C57BL/6 * FVB/N * SJL)
|
abnormal parasympathetic nervous system physiology
|
J:137769
|
Tg(SOD1*G93A)dl1Gur/0
(involves: C57BL/6 * SJL)
|
abnormal axonal transport
|
J:106420
|
Tg(SOD1*H46R)#Maw/0
(involves: C57BL/6 * DBA/2)
|
abnormal astrocyte physiology
|
J:99701
|
Tg(SOD1*L126Z)45Dbo/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal nervous system physiology
|
J:219482
|
Tg(SOD1*L126Z)#Deng/0
(involves: C57BL/6 * SJL)
|
abnormal nervous system physiology
|
J:109458
|
Tg(SV)427Bri/0
(C57BL/6J-Tg(SV)427Bri)
|
intracranial hemorrhage
|
J:79096
|
Tg(Syn1-cre)671Jxm/0
Ubqln1tm1.1Hmw/Ubqln1tm1.1Hmw
(involves: C57BL/6 * CBA)
|
abnormal response to CNS ischemic injury
|
J:206930
|
| increased cerebral infarct size
|
J:206930
|
Tg(Tcra2D2,Tcrb2D2)1Kuch/0
(involves: C57BL/6)
|
CNS inflammation
|
J:83278
|
| demyelination
|
J:83278
|
Tg(Tek-cre)1Ywa/0
Thbdtm2Rdr/Thbdtm2Wlr
(involves: 129S2/SvPas * C57BL/6 * SJL)
|
intracerebral hemorrhage
|
J:71269
|
Tg(Tek-tTA)1Rwng/0
Tg(tetO-Notch4*)1Rwng/0
(involves: FVB/N)
|
abnormal nervous system physiology
|
J:139943
|
| cerebellum hemorrhage
|
J:139943
|
| increased neuron apoptosis
|
J:139943
|
| intraventricular hemorrhage
|
J:139943
|
| seizures
|
J:139943
|
Tg(tetO-APPSwInd)Dbo/0
(involves: C3H/HeJ * C57BL/6J)
|
abnormal axonal transport
|
J:207508
|
Tg(tetO-NEFL)173.2Jpj/0
Tg(THY1-tTA)177Jpj/0
(involves: C3H * C57BL/6)
|
abnormal axonal transport
|
J:160704
|
Tg(Th-SNCA)5Eric/Tg(Th-SNCA)5Eric
(involves: C57BL/6)
|
abnormal microglial cell physiology
|
J:140907
|
Tg(Th-SNCA*)1.2Ccs/?
(involves: C57BL/6)
|
abnormal astrocyte physiology
|
J:168847
|
Tg(THY1-APP)2Somm/0
(involves: C57BL/6J * DBA/2)
|
brain inflammation
|
J:44603
|
Tg(Thy1-APP)3Somm/0
(involves: C57BL/6J * DBA/2)
|
brain inflammation
|
J:44603
|
| impaired blood-brain barrier function
|
J:67583
|
| intracerebral hemorrhage
|
J:67583
|
Tg(Thy1-APP)3Somm/0
(involves: C57BL/6 * C57BL/6J * DBA/2)
|
abnormal brain wave pattern
|
J:345459
|
Tg(Thy1-APP)4Vln/0
(involves: FVB/N)
|
reduced long-term potentiation
|
J:53800
|
| seizures
|
J:53800
|
Tg(Thy1-App*R609D*K612E)2Vln/0
(involves: C57BL * CBA/J)
|
increased neuron apoptosis
|
J:32213
|
| seizures
|
J:32213
|
Tg(Thy1-App*R609D*K612E)4Vln/0
(involves: FVB)
|
clonic seizures
|
J:32213
|
| increased neuron apoptosis
|
J:32213
|
| myoclonus
|
J:32213
|
| seizures
|
J:32213
|
| tonic-clonic seizures
|
J:32213
|
Tg(Thy1-App*R609D*K612E)4Vln/Tg(Thy1-App*R609D*K612E)4Vln
(involves: FVB)
|
clonic seizures
|
J:32213
|
| decreased susceptibility to pharmacologically induced seizures
|
J:32213
|
| increased susceptibility to pharmacologically induced seizures
|
J:32213
|
| myoclonus
|
J:32213
|
| seizures
|
J:32213
|
| tonic-clonic seizures
|
J:32213
|
Tg(Thy1-App*R609D*K612E)6Vln/0
(involves: FVB)
|
clonic seizures
|
J:32213
|
| myoclonus
|
J:32213
|
| seizures
|
J:32213
|
| tonic-clonic seizures
|
J:32213
|
Tg(Thy1-App*R609D*K612E)6Vln/Tg(Thy1-App*R609D*K612E)6Vln
(involves: FVB)
|
clonic seizures
|
J:32213
|
| decreased susceptibility to pharmacologically induced seizures
|
J:32213
|
| increased susceptibility to pharmacologically induced seizures
|
J:32213
|
| myoclonus
|
J:32213
|
| seizures
|
J:32213
|
| tonic-clonic seizures
|
J:32213
|
Tg(Thy1-APPSL)28Lpr/0
(involves: C57BL/6 * CBA)
|
abnormal nervous system physiology
|
J:95529
|
| abnormal neuron physiology
|
J:152956
|
Tg(Thy1-APPDutch)#Jckr/0
(involves: C57BL/6J)
|
brain ischemia
|
J:92796
|
Tg(Thy1-APPLon)2Vln/0
(involves: FVB/N)
|
reduced long-term potentiation
|
J:53800,
J:87229
|
| seizures
|
J:53800
|
Tg(Thy1-APPSw)1Vln/0
(involves: FVB/N)
|
seizures
|
J:53800
|
Tg(Thy1-APPSwDutIowa)BWevn/0
(involves: C57BL/6)
|
abnormal microglial cell physiology
|
J:124911
|
Tg(Thy1-APPSwe,Prnp-PSEN2*N141I)152HLaoz/0
(C57BL/6-Tg(Thy1-APPSwe,Prnp-PSEN2*N141I)152HLaoz)
|
enhanced long-term potentiation
|
J:165986
|
| increased post-tetanic potentiation
|
J:165986
|
Tg(Thy1-BSCL2*N88S)1Dit/0
(involves: C57BL/6 * DBA/2)
|
abnormal axonal transport
|
J:175537
|
Tg(Thy1-FUS*)1Dit/0
(B6.Cg-Tg(Thy1-FUS*)1Dit)
|
abnormal miniature excitatory postsynaptic currents
|
J:277077
|
Tg(Thy1-GLRA1*R271Q)300Wha/0
(involves: C57BL/6 * DBA/2)
|
abnormal brain wave pattern
|
J:173399
|
| abnormal inhibitory postsynaptic currents
|
J:76009
|
Tg(Thy1-HSPB1*P182L)#Lvdb/0
(involves: FVB/N)
|
abnormal action potential
|
J:174508
|
Tg(Thy1-HSPB1*S135F)#Lvdb/0
(involves: FVB/N)
|
abnormal action potential
|
J:174508
|
| abnormal axonal transport
|
J:174508
|
Tg(Thy1-MAPT)22Schd/0
(B6.Cg-Tg(Thy1-MAPT)22Schd)
|
abnormal CNS synaptic transmission
|
J:111982
|
| decreased excitatory postsynaptic current amplitude
|
J:111982
|
Tg(Thy1-MAPT*)1Avil/Tg(Thy1-MAPT*)1Avil
(involves: C57BL/6 * CBA)
|
increased susceptibility to pharmacologically induced seizures
|
J:201700
|
| myoclonus
|
J:201700
|
| nonconvulsive seizures
|
J:201700
|
| seizures
|
J:201700
|
| tonic-clonic seizures
|
J:201700
|
Tg(Thy1-MAPT*K369I)K3Gotz/0
(B6.Cg-Tg(Thy1-MAPT*K369I)K3Gotz)
|
abnormal axonal transport
|
J:143439
|
Tg(Thy1-Nlgn2)6Hnes/0
(involves: C57BL/6 * CBA)
|
abnormal brain wave pattern
|
J:137376
|
| increased miniature inhibitory postsynaptic current frequency
|
J:137376
|
Tg(Thy1-Nrg1*I)1Kan/0
(Not Specified)
|
hypermyelination
|
J:90038,
J:145464
|
Tg(Thy1-Nrg1*III)1Kan/0
(Not Specified)
|
abnormal myelination
|
J:145464
|
Tg(Thy1-SERPINI1*G392E)333Icka/0
(involves: C57BL * CD-1 * DBA)
|
increased susceptibility to pharmacologically induced seizures
|
J:144649
|
Tg(Thy1-SERPINI1*G392E)333Icka/Tg(Thy1-SERPINI1*G392E)333Icka
(involves: C57BL * CD-1 * DBA)
|
increased susceptibility to pharmacologically induced seizures
|
J:144649
|
Tg(Thy1-Snca)1S13Putt/?
(involves: C57BL/6)
|
demyelination
|
J:177661
|
Tg(Thy1-SNCA)61Ema/0
(involves: C57BL/6 * DBA/2)
|
abnormal microglial cell activation
|
J:238066
|
Tg(THY1-SNCA*A30P)M30Sud/0
(Not Specified)
|
increased neuron apoptosis
|
J:139867
|
Tg(THY1-SNCA*A53T)F53Sud/0
(involves: C57BL/6)
|
increased neuron apoptosis
|
J:140019
|
Tg(THY1-SNCA*A53T)M53Sud/0
(B6.Cg-Tg(THY1-SNCA*A53T)M53Sud/J)
|
increased neuron apoptosis
|
J:212732
|
Tg(Thy1-TARDBP)6Singh/Tg(Thy1-TARDBP)6Singh
(involves: C57BL/6 * C57BL/6J * SJL)
|
increased neuron apoptosis
|
J:157550
|
Tg(Thy1-Tcf4)1Mjro/0
(involves: C57BL/6N * FVB/N)
|
abnormal prepulse inhibition
|
J:202664
|
| reduced sensorimotor gating
|
J:202664
|
Tg(Thy1-UBQLN2*P497S)3Mont/?
(involves: C3H * C57BL/6 * C57BL/6J)
|
increased microglial cell activation
|
J:239510
|
Tg(Thy1-UBQLN2*P506T)6Mont/?
(involves: C3H * C57BL/6 * C57BL/6J)
|
decreased microglial cell activation
|
J:239510
|
Tg(Thy1-VAPB*P56S,-EGFP)D3Cai/0
(C57BL/6-Tg(Thy1-VAPB*P56S,-EGFP)D3Cai)
|
abnormal nervous system physiology
|
J:202148
|
Tg(Tk1-DPP4)27Ysj/0
(involves: C57BL/6 * FVB/N)
|
convulsive seizures
|
J:290259
|
Tg(Tnf)6074Gkl/0
(involves: C57BL/6 * CBA)
|
abnormal nervous system physiology
|
J:106592
|
| abnormal oligodendrocyte apoptosis
|
J:106592
|
| brain inflammation
|
J:106592
|
| demyelination
|
J:106592
|
| impaired blood-brain barrier function
|
J:106592
|
Tg(Tnf)6074Gkl/0
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(involves: 129S2/SvPas * C57BL/6 * CBA)
|
abnormal oligodendrocyte apoptosis
|
J:106592
|
| CNS inflammation
|
J:106592
|
| demyelination
|
J:106592
|
Tg(UBC-Adk)1Bois/0
(B6;129P3-Adktm1Bois Tg(UBC-Adk)1Bois)
|
abnormal brain wave pattern
|
J:105483
|
| abnormal seizure response to pharmacological agent
|
J:105483
|
| nonconvulsive seizures
|
J:105483
|
Tg(Ubc-Fto)#Pzg/0
(involves: C57BL/6J)
|
dysmyelination
|
J:301796
|
Tg(YAC18)18Hay/0
(involves: FVB/N)
|
decreased susceptibility to neuronal excitotoxicity
|
J:144917
|
Tg(YAC46)668Hay/?
(involves: FVB/N)
|
abnormal long-term potentiation
|
J:55405
|
| decreased post-tetanic potentiation
|
J:55405
|
Tg(YAC72)2511Hay/?
(involves: FVB/N)
|
abnormal excitatory postsynaptic potential
|
J:55405
|
| abnormal long-term potentiation
|
J:55405
|
| enhanced NMDA-mediated synaptic currents
|
J:55405
|
| reduced long-term potentiation
|
J:55405
|
Tg(YAC72)2511Hay/0
(involves: FVB/N)
|
increased susceptibility to neuronal excitotoxicity
|
J:144917
|
Tg(YAC72)2511Hay/Tg(YAC72)2511Hay
(FVB/N-Tg(YAC72)2511Hay)
|
increased neuron apoptosis
|
J:105728
|
| increased susceptibility to neuronal excitotoxicity
|
J:105728
|
Tg(YAC128)53Hay/0
(FVB/N-Tg(YAC128)53Hay)
|
increased susceptibility to neuronal excitotoxicity
|
J:105723
|
Tg(YAC128)53Hay/0
(B6.FVB-Tg(YAC128)53Hay)
|
decreased prepulse inhibition
|
J:185262
|
Tg(YAC128)55Hay/0
(FVB/N-Tg(YAC128)55Hay)
|
increased susceptibility to neuronal excitotoxicity
|
J:105723
|
Tg(YAC128)55Hay/Tg(YAC128)55Hay
(FVB/N-Tg(YAC128)55Hay)
|
increased neuron apoptosis
|
J:105728
|
| increased susceptibility to neuronal excitotoxicity
|
J:105723,
J:105728
|
Tg(YAC128)#Hay/0
(FVB/N-Tg(YAC128)#Hay)
|
decreased prepulse inhibition
|
J:98736
|
| reduced sensorimotor gating
|
J:98736
|
Tg(YAC353G6)W7Hay/Tg(YAC353G6)W7Hay
(FVB/NJ-Tg(YAC353G6)W7Hay)
|
decreased susceptibility to neuronal excitotoxicity
|
J:120991
|
Tg(Zfhx2*R1907K)#Jcox/0
(involves: C57BL/6)
|
abnormal neuron physiology
|
J:266472
|
Tgcog/Tgcog
(involves: AKR/J * C57BL/6By)
|
abnormal myelination
|
J:3079
|
Tgfb1tm1Doe/Tgfb1tm1Doe
(involves: 129S2/SvPas * CF-1)
|
brain inflammation
|
J:2892
|
Tgfb1tm1Jmu/Tgfb1tm1Jmu
(involves: 129 * C57BL/6J * ICR * Swiss Webster)
|
intracranial hemorrhage
|
J:136106
|
Tgfb1tm1Jmu/Tgfb1tm1Jmu
Tgfb3tm1Doe/Tgfb3+
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * Swiss Webster)
|
intracranial hemorrhage
|
J:136106
|
Tgfb1tm1Jmu/Tgfb1tm1Jmu
Tgfb3tm1Doe/Tgfb3+
(involves: 129 * BALB/c * C57BL/6J * Swiss Webster)
|
intracranial hemorrhage
|
J:136106
|
Tgfb1tm1Jmu/Tgfb1tm1Jmu
Tgfb3tm1Doe/Tgfb3+
(involves: 129 * C57BL/6J * ICR * Swiss Webster)
|
intracranial hemorrhage
|
J:136106
|
Tgfb1tm1Jmu/Tgfb1tm1Jmu
Tgfb3tm1Doe/Tgfb3tm1Doe
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6J * Swiss Webster)
|
intracranial hemorrhage
|
J:136106
|
Tgfb1tm1Jmu/Tgfb1tm1Jmu
Tgfb3tm1Doe/Tgfb3tm1Doe
(involves: 129 * BALB/c * C57BL/6J * Swiss Webster)
|
intracranial hemorrhage
|
J:136106
|
Tgfb1tm1Jmu/Tgfb1tm1Jmu
Tgfb3tm1Doe/Tgfb3tm1Doe
(involves: 129 * C57BL/6J * ICR * Swiss Webster)
|
intracranial hemorrhage
|
J:136106
|
Tgfb3tm1Doe/Tgfb3tm1Doe
(involves: 129P2/OlaHsd * C57BL/6)
|
decreased neuron apoptosis
|
J:117465
|
Thoc2em1Gecz/Y
(C57BL/6JArc-Thoc2em1Gecz)
|
abnormal nervous system electrophysiology
|
J:345229
|
| abnormal nervous system physiology
|
J:345229
|
| abnormal neuronal migration
|
J:345229
|
| abnormal neuronal stem cell self-renewal
|
J:345229
|
Thoc6em1Schaf/Thoc6em1Schaf
(C57BL/6JN-Thoc6em1Schaf)
|
increased embryonic neuroepithelial cell proliferation
|
J:345604
|
Thop1Gt(CSG163)Byg/Thop1Gt(CSG163)Byg
(B6.129P2-Thop1Gt(CSG163)Byg)
|
abnormal nervous system physiology
|
J:290567
|
| decreased prepulse inhibition
|
J:290567
|
Thratm1Ven/Thratm1Ven
Thrbtm1Df/Thrbtm1Df
(involves: 129P2/OlaHsd * 129S1/Sv * BALB/c * C57BL/6J)
|
abnormal cochlear inner hair cell physiology
|
J:73382
|
| abnormal cochlear outer hair cell physiology
|
J:73382
|
| decreased cochlear outer hair cell electromotility
|
J:73382
|
Thrbtm1.1Syc/Thrb+
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
abnormal pituitary gland physiology
|
J:65885
|
Thrbtm1.1Syc/Thrbtm1.1Syc
(involves: 129S6/SvEvTac * FVB/N * NIH Black Swiss)
|
abnormal pituitary gland physiology
|
J:65885
|
Thrbtm1Df/Thrbtm1Df
(involves: 129S1/Sv * C57BL/6J)
|
abnormal cochlear inner hair cell physiology
|
J:118178,
J:73382,
J:48666
|
| abnormal cochlear outer hair cell physiology
|
J:73382
|
| decreased cochlear outer hair cell electromotility
|
J:118178,
J:73382
|
Thrbtm1Df/Thrbtm1Df
(either: B6.129S1-Thrbtm1Df or (involves: 129S1/Sv * C57BL/6J))
|
audiogenic seizures
|
J:103702
|
Thrbtm1Df/Thrbtm1Df
(B6J.129S1-Thrbtm1Df)
|
abnormal cochlear inner hair cell physiology
|
J:118402
|
Thrbtm1Df/Thrbtm1Df
(involves: 129S1/Sv * C57BL/6J * FVB/NJ)
|
abnormal cochlear nerve compound action potential
|
J:145941
|
| decreased cochlear microphonics
|
J:145941
|
Thrbtm1Df/Thrbtm1Mkni
Tg(Pres-cre)1Jnz/0
(involves: 129S1/Sv * C57BL/6J * FVB/NJ)
|
abnormal cochlear inner hair cell physiology
|
J:145941
|
Thrbtm1Ehs/Thrbtm1Ehs
(C57BL/6-Thrbtm1Ehs)
|
decreased excitatory postsynaptic current amplitude
|
J:217014
|
| impaired synaptic plasticity
|
J:217014
|
| reduced long-term potentiation
|
J:217014
|
Thrbtm3Few/Thrbtm3Few
(involves: 129 * C57BL/6)
|
abnormal pituitary gland physiology
|
J:85158
|
Thrbtm4Few/Thrbtm4Few
(involves: 129 * C57BL/6)
|
abnormal pituitary gland physiology
|
J:85158
|
Thtpaem1(IMPC)Tcp/Thtpaem1(IMPC)Tcp
(C57BL/6NCrl-Thtpaem1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Thy1tm1Rjmo/Thy1tm1Rjmo
(involves: 129/Sv * C57BL/6)
|
reduced long-term potentiation
|
J:31610
|
Ticam1tm1Aki/Ticam1tm1Aki
(involves: 129P2/OlaHsd)
|
abnormal microglial cell physiology
|
J:185198
|
Timp2tm1Jjc/Timp2tm1Jjc
(B6.129P2-Timp2tm1Jjc)
|
abnormal prepulse inhibition
|
J:99752
|
Timp2tm1Pds/Timp2tm1Pds
(B6.129S4-Timp2tm1Pds)
|
decreased prepulse inhibition
|
J:99752
|
Tinf2tm2.2Tdl/Tinf2+
(involves: BALB/cJ * C57BL/6)
|
seizures
|
J:207367
|
tip/tip
(B6C3Fe a/a-tip/J)
|
abnormal miniature excitatory postsynaptic currents
|
J:236593
|
Tjp1tm1Sats/Tjp1tm1Sats
(B6.Cg-Tjp1tm1Sats)
|
increased neural tube apoptosis
|
J:222380
|
Tlcd3bem1(IMPC)Bay/Tlcd3bem1(IMPC)Bay
(C57BL/6N-Tlcd3bem1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Tle4em1(IMPC)Mbp/Tle4em1(IMPC)Mbp
(C57BL/6NCrl-Tle4em1(IMPC)Mbp/Mmucd)
|
decreased prepulse inhibition
|
J:211773
|
Tlr2tm1Aki/Tlr2tm1Aki
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal astrocyte physiology
|
J:122551
|
| abnormal glial cell physiology
|
J:122551
|
| decreased microglial cell activation
|
J:122551
|
Tlr2tm1Aki/Tlr2tm1Aki
(B6.129P2-Tlr2tm1Aki)
|
decreased cerebral infarct size
|
J:122281
|
Tlr2tm1Aki/Tlr2tm1Aki
(involves: 129P2/OlaHsd)
|
decreased cerebral infarct size
|
J:128966
|
Tlr2tm1Kir/Tlr2tm1Kir
(B6.129-Tlr2tm1Kir)
|
brain ischemia
|
J:148091
|
| decreased cerebral infarct size
|
J:124100
|
| decreased neuron apoptosis
|
J:124100
|
Tlr2tm1Kir/Tlr2tm1Kir
(involves: 129 * C57BL/6)
|
abnormal myelination
|
J:161285
|
Tlr3tm1Flv/Tlr3tm1Flv
(B6.129S1-Tlr3tm1Flv/Apb)
|
abnormal neuron physiology
|
J:127638
|
Tlr4Lps-d/Tlr4Lps-d
(involves: C3H/HeJ)
|
abnormal glial cell apoptosis
|
J:99051
|
Tlr4Lps-d/Tlr4Lps-d
(C3H/HeJ-Tlr4Lps-d)
|
abnormal microglial cell physiology
|
J:99051
|
| decreased cerebral infarct size
|
J:117223,
J:124100
|
| decreased neuron apoptosis
|
J:124100
|
| decreased susceptibility to ischemic brain injury
|
J:117223
|
Tlr4lps-del/Tlr4lps-del
(C57BL/10ScCr)
|
abnormal glial cell physiology
|
J:97819
|
Tlr4lps-del/Tlr4lps-del
(involves: C57BL/10ScN)
|
brain ischemia
|
J:148091
|
Tlx3tm1Sjk/Tlx3tm1Sjk
(involves: 129X1/SvJ)
|
abnormal nervous system physiology
|
J:60751
|
Tlx3tm2.1Qima/Tlx3tm2.1Qima
Tg(Scn10a-cre)1Rkun/0
(involves: 129S4/SvJae * C57BL/6 * DBA/2 * SJL)
|
abnormal neuron physiology
|
J:186470
|
tm/tm
(Not Specified)
|
abnormal nervous system physiology
|
J:13085
|
Tmbim6Gt1Jcre/Tmbim6Gt1Jcre
(Not Specified)
|
increased susceptibility to ischemic brain injury
|
J:91831
|
Tmc1tm1.1Ajg/Tmc1tm1.1Ajg
(B6.129-Tmc1tm1.1Ajg)
|
abnormal hair cell mechanoelectric transduction
|
J:184419
|
Tmc1tm1.1Ajg/Tmc1tm1.1Ajg
Tmc2tm1.1Ajg/Tmc2+
(B6.129-Tmc2tm1.1Ajg Tmc1tm1.1Ajg)
|
abnormal hair cell mechanoelectric transduction
|
J:184419
|
Tmc1tm1.1Ajg/Tmc1tm1.1Ajg
Tmc2tm1.1Ajg/Tmc2tm1.1Ajg
(B6.129-Tmc2tm1.1Ajg Tmc1tm1.1Ajg)
|
abnormal cochlear hair cell physiology
|
J:184419
|
| abnormal hair cell mechanoelectric transduction
|
J:184419
|
| abnormal hair cell physiology
|
J:184419
|
Tmc2tm1.1Ajg/Tmc2tm1.1Ajg
(B6.129-Tmc2tm1.1Ajg)
|
abnormal cochlear hair cell physiology
|
J:184419
|
Tmem8bem1(IMPC)Tcp/Tmem8b+
(C57BL/6N-Tmem8bem1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Tmem35atm1.1(KOMP)Vlcg/Y
(B6(FVB)-Tmem35atm1.1(KOMP)Vlcg)
|
reduced long-term potentiation
|
J:244268
|
Tmem51tm1b(EUCOMM)Hmgu/Tmem51tm1b(EUCOMM)Hmgu
(C57BL/6N-Tmem51tm1b(EUCOMM)Hmgu/H)
|
decreased prepulse inhibition
|
J:211773
|
Tmem59tm1.1Tqw/Tmem59tm1.1Tqw
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:261729
|
| abnormal neuron physiology
|
J:261729
|
Tmem63bem1Yss/Tmem63bem1Yss
(involves: C57BL/6N * FVB/N)
|
abnormal cochlear outer hair cell physiology
|
J:303483
|
Tmem74em1Fehan/Tmem74em1Fehan
(C57BL/6-Tmem74em1Fehan)
|
abnormal nervous system electrophysiology
|
J:302698
|
Tmem87aem1Glwn/Tmem87a+
(involves: C57BL/6N)
|
abnormal sensory neuron physiology
|
J:345910
|
Tmem87aem1Glwn/Tmem87aem1Glwn
(involves: C57BL/6N)
|
abnormal nerve fiber response
|
J:345910
|
| abnormal sensory neuron physiology
|
J:345910
|
| abnormal single cell response
|
J:345910
|
Tmem94em1Mcvm/Tmem94em1Mcvm
(C57BL/6-Tmem94em1Mcvm)
|
abnormal neuronal migration
|
J:269160
|
Tmem108tm1Lex/Tmem108tm1Lex
(involves: 129S5/SvEvBrd)
|
abnormal CNS synaptic transmission
|
J:239156
|
| abnormal excitatory postsynaptic currents
|
J:239156
|
| abnormal miniature excitatory postsynaptic currents
|
J:239156
|
| decreased excitatory postsynaptic current amplitude
|
J:239156
|
| decreased prepulse inhibition
|
J:239156
|
| reduced sensorimotor gating
|
J:239156
|
Tmem138tm1b(EUCOMM)Wtsi/Tmem138tm1b(EUCOMM)Wtsi
(C57BL/6N-Tmem138tm1b(EUCOMM)Wtsi/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Tmem145em1(IMPC)Mbp/Tmem145em1(IMPC)Mbp
(C57BL/6N-Tmem145em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Tmem160em1.1Bros/Tmem160em1.1Bros
(involves: C57BL/6JRj * FVB/N)
|
abnormal neuron physiology
|
J:328221
|
Tmem175em1Dren/Tmem175em1Dren
(B6.Cg-Tmem175em1Dren)
|
abnormal neuron physiology
|
J:304120
|
| increased susceptibility to neuronal excitotoxicity
|
J:304120
|
Tmem175em2Dren/Tmem175em2Dren
(C57BL/6J-Tmem175em2Dren)
|
decreased susceptibility to neuronal excitotoxicity
|
J:304120
|
Tmem175em3Dren/Tmem175+
(C57BL/6J-Tmem175em3Dren)
|
increased susceptibility to neuronal excitotoxicity
|
J:304120
|
Tmem175em3Dren/Tmem175em3Dren
(C57BL/6J-Tmem175em3Dren)
|
increased susceptibility to neuronal excitotoxicity
|
J:304120
|
Tmem175tm1b(KOMP)Wtsi/Tmem175tm1b(KOMP)Wtsi
(C57BL/6N-Tmem175tm1b(KOMP)Wtsi/Kmpc)
|
increased prepulse inhibition
|
J:211773
|
Tmem184bGt(IST10294F4)Tigm/Tmem184bGt(IST10294F4)Tigm
(involves: C57BL/6N)
|
abnormal nervous system physiology
|
J:231818
|
Tmem198btm1Lex/Tmem198btm1Lex
(B6;129S5-Tmem198btm1Lex/Mmucd)
|
reduced sensorimotor gating
|
J:171883
|
Tmem203em1(IMPC)H/Tmem203em1(IMPC)H
(C57BL/6N-Tmem203em1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Tmem222tm1b(KOMP)Mbp/Tmem222+
(C57BL/6N-Tmem222tm1b(KOMP)Mbp/J)
|
decreased prepulse inhibition
|
J:211773
|
Tmem225em1(IMPC)Mbp/Tmem225em1(IMPC)Mbp
(C57BL/6N-Tmem225em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Tmevd5C57BL/6J/Tmevd5C57BL/6J
(involves: 129 * C57BL/6J)
|
demyelination
|
J:69154
|
Tmevd6BALB/cByJ/?
(involves: BALB/cByJ * DBA/2J)
|
demyelination
|
J:82689
|
Tmevd6DBA/2J/?
(involves: BALB/cByJ * DBA/2J)
|
demyelination
|
J:82689
|
Tmevd7DBA/2J/?
(involves: BALB/cByJ * DBA/2J)
|
demyelination
|
J:82689
|
Tmevd8DBA/2J/?
(involves: BALB/cByJ * DBA/2J)
|
demyelination
|
J:82689
|
Tmevd9DBA/2J/?
(involves: BALB/cByJ * DBA/2J)
|
demyelination
|
J:82689
|
tmgc11/tmgc11
(involves: C3H/Rl * C57BL/6)
|
abnormal prepulse inhibition
|
J:81149,
J:125716
|
tmgc40/tmgc40
(involves: D7R75M)
|
abnormal prepulse inhibition
|
J:92490,
J:125716
|
tmgc42/tmgc42
(Mixed stock)
|
abnormal neuronal migration
|
J:92490
|
tmgc61/tmgc61
(Mixed stock)
|
decreased susceptibility to pharmacologically induced seizures
|
J:92490
|
tmgc62/tmgc62
(involves: C3H/Rl * C57BL/6JRn * C57BL/LiA)
|
abnormal prepulse inhibition
|
J:92490,
J:125716
|
Tmod2tm1Hzo/Tmod2tm1Hzo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
enhanced long-term potentiation
|
J:83752
|
Tmod2tm2Hzo/Tmod2tm2Hzo
(involves: 129S7/SvEvBrd * C57BL/6J)
|
decreased prepulse inhibition
|
J:83752
|
| enhanced long-term potentiation
|
J:83752
|
Tmprss6tm1b(EUCOMM)Wtsi/Tmprss6tm1b(EUCOMM)Wtsi
(C57BL/6N-Tmprss6tm1b(EUCOMM)Wtsi/Ics)
|
decreased prepulse inhibition
|
J:211773
|
Tmsb4xtm1Prri/Tmsb4xtm1Prri
(B6.129-Tmsb4xtm1Prri)
|
intracranial hemorrhage
|
J:195902
|
Tmtc4tm1.1(KOMP)Vlcg/Tmtc4tm1.1(KOMP)Vlcg
(C57BL/6N-Tmtc4tm1.1(KOMP)Vlcg/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Tnctm1Msch/Tnctm1Msch
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
impaired synaptic plasticity
|
J:78340
|
| reduced long-term potentiation
|
J:78340
|
Tnctm1Sia/Tnctm1Sia
(involves: C57BL/6N * C57BL/6NCrlj * CBA/JNCrlj)
|
abnormal CNS synaptic transmission
|
J:32517
|
Tnfaip3m1Apb/Tnfaip3m1Apb
(C57BL/6-Tnfaip3m1Apb)
|
CNS inflammation
|
J:324062
|
| increased microglial cell activation
|
J:324062
|
Tnfrsf1atm1Blt/Tnfrsf1atm1Blt
(B6.129P2-Tnfrsf1atm1Blt)
|
impaired central nervous system regeneration
|
J:71178
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
(C57BL/6-Tnfrsf1atm1Imx)
|
abnormal glutamate-mediated receptor currents
|
J:152590
|
| abnormal nervous system physiology
|
J:112713
|
| abnormal neuron proliferation
|
J:112713
|
| decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:78637
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Il1r1tm1Imx/Il1r1tm1Imx
(B6;129S-Tnfrsf1atm1Imx Il1r1tm1Imx/J)
|
abnormal brain wave pattern
|
J:137505
|
Tnfrsf1atm1Imx/Tnfrsf1atm1Imx
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal glial cell physiology
|
J:78637
|
| abnormal neuron physiology
|
J:33864
|
| decreased microglial cell activation
|
J:33864
|
| decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:78637
|
| increased cerebral infarct size
|
J:33864
|
| increased susceptibility to neuronal excitotoxicity
|
J:33864
|
| seizures
|
J:112713
|
Tnfrsf1btm1Imx/Tnfrsf1btm1Imx
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal glutamate-mediated receptor currents
|
J:152590
|
| decreased susceptibility to dopaminergic neuron neurotoxicity
|
J:78637
|
Tnfrsf1btm1Mwm/Tnfrsf1btm1Mwm
(B6.129S2-Tnfrsf1btm1Mwm)
|
impaired central nervous system regeneration
|
J:71178
|
Tnfrsf11bem1(IMPC)Mbp/Tnfrsf11bem1(IMPC)Mbp
(C57BL/6N-Tnfrsf11bem1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Tnfrsf19Gt(OST294987)Lex/Tnfrsf19Gt(OST294987)Lex
(involves: 129S5/SvEvBrd)
|
impaired blood-brain barrier function
|
J:181470
|
Tnfrsf19tm1Shmi/Tnfrsf19tm1Shmi
(involves: 129/Sv * C57BL/6)
|
abnormal neuron physiology
|
J:98433
|
Tnfrsf21tm1Arte/Tnfrsf21tm1Arte
(involves: C57BL/6NTac)
|
abnormal myelination
|
J:205651
|
| abnormal oligodendrocyte apoptosis
|
J:205651
|
Tnfrsf21tm1Vmd/Tnfrsf21tm1Vmd
(Not Specified)
|
impaired blood-brain barrier function
|
J:181470
|
| intracranial hemorrhage
|
J:181470
|
Tnfrsf21tm2Gne/Tnfrsf21tm2Gne
Tg(Tek-cre)1Ywa/0
(involves: C57BL/6 * SJL)
|
intracranial hemorrhage
|
J:181470
|
Tniktm1Grnt/Tniktm1Grnt
(involves: 129P2/OlaHsd * 129S5/SvEvBrd)
|
abnormal excitatory postsynaptic potential
|
J:190924
|
| abnormal miniature excitatory postsynaptic currents
|
J:190924
|
| enhanced paired-pulse facilitation
|
J:190924
|
Tnnc1tm1.1Jrpi/Tnnc1tm1.1Jrpi
(involves: 129S6/SvEvTac * C57BL/6)
|
abnormal sympathetic nervous system physiology
|
J:249978
|
Tnnt2tm2.1Feah/Tnnt2+
(involves: 129S6/SvEvTac * FVB/N)
|
abnormal action potential
|
J:243725
|
Tnrtm1Msch/Tnrtm1Msch
(involves: 129P2/OlaHsd * C57BL/6J)
|
decreased nerve conduction velocity
|
J:55338
|
Top2btm2.1Jcw/Top2btm2.1Jcw
(involves: 129S4/SvJae * 129S6/SvEvTac)
|
abnormal neuronal migration
|
J:94879
|
Tor1atm1Calak/Tor1atm1Calak
(involves: 129 * C57BL/6)
|
reduced long-term depression
|
J:247570
|
Tor1atm2Wtd/Tor1a+
(involves: 129S1/Sv)
|
abnormal neuron physiology
|
J:201535
|
Tor1atm2Wtd/Tor1atm2Wtd
(involves: 129S1/Sv)
|
abnormal neuron physiology
|
J:201535
|
Toxtm1b(KOMP)Wtsi/Toxtm1b(KOMP)Wtsi
(C57BL/6N-Toxtm1b(KOMP)Wtsi/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Tph2em1(IMPC)Mbp/Tph2+
(C57BL/6N-Tph2em1(IMPC)Mbp/MbpMmucd)
|
increased prepulse inhibition
|
J:211773
|
Tph2tm1Bdr/Tph2tm1Bdr
(involves: 129P2/OlaHsd * FVB/N)
|
abnormal autonomic nervous system physiology
|
J:150042
|
Tph2tm1Mca/Tph2tm1Mca
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:196373
|
Tpp1tm1Dgen/Tpp1tm1Dgen
(involves: 129S1/Sv * C57BL/6)
|
seizures
|
J:101679
|
Tpp1tm1Plob/Tpp1tm1Plob
(involves: 129S1/Sv * C57BL/6)
|
audiogenic seizures
|
J:94884
|
| demyelination
|
J:94884
|
Tppptm1.1(KOMP)Vlcg/Tppptm1.1(KOMP)Vlcg
(C57BL/6N-Tppptm1.1(KOMP)Vlcg/J)
|
convulsive seizures
|
J:211773
|
Tprntm1.1(KOMP)Vlcg/Tprntm1.1(KOMP)Vlcg
(C57BL/6N-Tprntm1.1(KOMP)Vlcg/J)
|
decreased prepulse inhibition
|
J:211773
|
Trappc2btm1b(EUCOMM)Hmgu/Trappc2btm1b(EUCOMM)Hmgu
(C57BL/6N-Trappc2btm1b(EUCOMM)Hmgu/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Trappc2lem1(IMPC)Mbp/Trappc2lem1(IMPC)Mbp
(C57BL/6N-Trappc2lem1(IMPC)Mbp/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Trdmt1tm1b(EUCOMM)Hmgu/Trdmt1+
(C57BL/6N-Trdmt1tm1b(EUCOMM)Hmgu/H)
|
decreased prepulse inhibition
|
J:211773
|
Trem2em2Bwef/Trem2em2Bwef
(involves: C57BL/6J * DBA/2J * FVB/N)
|
decreased microglial cell activation
|
J:242126
|
Trem2tm1(KOMP)Vlcg/Trem2tm1(KOMP)Vlcg
(C57BL/6N-Trem2tm1(KOMP)Vlcg)
|
abnormal glial cell apoptosis
|
J:239381
|
| abnormal microglial cell physiology
|
J:239381
|
| decreased microglial cell activation
|
J:239381
|
Trib2Tg(Thy1-Trh/APP*)2.1Ingm/Trib2Tg(Thy1-Trh/APP*)2.1Ingm
(involves: C57BL/6 * DBA/1)
|
abnormal CNS synaptic transmission
|
J:176575
|
| abnormal excitatory postsynaptic potential
|
J:176575
|
| decreased prepulse inhibition
|
J:176575
|
| reduced long-term potentiation
|
J:176575
|
Trim2Gt(IRESBetageo)11Pgr/Trim2Gt(IRESBetageo)11Pgr
(involves: 129/Sv * C57BL/6)
|
seizures
|
J:140337
|
Trim3tm1Mak/Trim3tm1Mak
(B6.129P2-Trim3tm1Mak)
|
decreased miniature inhibitory postsynaptic current amplitude
|
J:161372
|
| decreased susceptibility to pharmacologically induced seizures
|
J:161372
|
Trim9tm1.1Slgu/Trim9tm1.1Slgu
(involves: 129S4/SvJae * BALB/cJ * C57BL/6)
|
abnormal neuron physiology
|
J:215804
|
Trim67tm1.2Slgu/Trim67tm1.2Slgu
(involves: C57BL/6)
|
decreased prepulse inhibition
|
J:266702
|
Triotm1Mst/Triotm1Mst
(involves: 129S4/SvJae * BALB/c)
|
abnormal neuronal migration
|
J:65380
|
Triobpem1(IMPC)J/Triobpem1(IMPC)J
(C57BL/6NJ-Triobpem1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Triobptm1Tbf/Triobptm1Tbf
(C57BL/6-Triobptm1Tbf)
|
abnormal cochlear hair cell physiology
|
J:167947
|
Trp53tm1Brd/Trp53+
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased neuron apoptosis
|
J:66953
|
Trp53tm1Brd/Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6)
|
decreased neuron apoptosis
|
J:66953
|
Trp53tm1Elee/Trp53tm1Elee
Tg(GFAP-cre)25Mes/0
(involves: 129S4/SvJae * FVB/N)
|
seizures
|
J:149662
|
Trp53tm1Elee/Trp53tm1Tyj
Tg(GFAP-cre)25Mes/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N)
|
seizures
|
J:149662
|
Trp53tm1Tyj/Trp53tm1Tyj
Xrcc2tm1Pmc/Xrcc2tm1Pmc
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6)
|
decreased neuron apoptosis
|
J:111068
|
Trp53bp2tm1Xlu/Trp53bp2tm1Xlu
(involves: 129S6/SvEvTac * C57BL/6J)
|
abnormal embryonic neuroepithelial cell proliferation
|
J:162396
|
| abnormal neuronal precursor proliferation
|
J:162396
|
| increased embryonic neuroepithelial cell proliferation
|
J:162396
|
| increased neuron apoptosis
|
J:162396
|
Trp53bp2tm1Xlu/Trp53bp2tm1Xlu
(C.129S6-Trp53bp2tm1Xlu)
|
abnormal embryonic neuroepithelial cell proliferation
|
J:162396
|
| abnormal neuronal migration
|
J:162396
|
| intracranial hemorrhage
|
J:240594
|
| intraventricular hemorrhage
|
J:240594
|
Trp53bp2tm1Xlu/Trp53bp2tm1Xlu
(B6.129S6-Trp53bp2tm1Xlu)
|
intracranial hemorrhage
|
J:240594
|
Trp53inp2em1(IMPC)Mbp/Trp53inp2em1(IMPC)Mbp
(C57BL/6N-Trp53inp2em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Trp73tm1(cre)Agof/Trp73tm1(cre)Agof
(involves: 129S1/Sv * 129X1/SvJ)
|
increased neuron apoptosis
|
J:153209
|
Trp73tm1Fmc/Trp73tm1Fmc
(involves: 129S4/SvJae)
|
abnormal cerebrospinal fluid production
|
J:60896
|
| intracranial hemorrhage
|
J:60896
|
| intraventricular hemorrhage
|
J:60896
|
Trpa1tm1.1Bju/Trpa1tm1.1Bju
(involves: C57BL/6J)
|
abnormal neuron physiology
|
J:160860,
J:161343
|
| abnormal sensory neuron physiology
|
J:161343
|
Trpa1tm1Jul/Trpa1+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal nervous system physiology
|
J:115886
|
Trpa1tm1Jul/Trpa1tm1Jul
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal nervous system physiology
|
J:115886
|
Trpc1tm1Lbi/Trpc1tm1Lbi
(involves: 129S/SvEv * C57BL/6)
|
abnormal single cell response
|
J:194590
|
Trpc1tm1Lbi/Trpc1tm1Lbi
Trpc4tm1Bni/Trpc4tm1Bni
(involves: 129 * C57BL/6)
|
abnormal single cell response
|
J:194590
|
Trpc2tm1Dlc/Trpc2tm1Dlc
(involves: 129S1/Sv * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:74988
|
Trpc2tm1Mom/Trpc2tm1Mom
(B6.129P2-Trpc2tm1Mom/Zuf)
|
abnormal vomeronasal sensory neuron physiology
|
J:279957
|
Trpc2tm1Rax/Trpc2tm1Rax
(involves: 129S/SvEv * C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:76339
|
Trpc3Mwk/Trpc3+
(involves: BALB/cAnN * C3H/HeH)
|
abnormal nervous system electrophysiology
|
J:148340
|
Trpc3tm1.1Akon/Trpc3tm1.1Akon
(involves: 129S/SvEv * 129S4/SvJaeSor)
|
abnormal excitatory postsynaptic currents
|
J:139695
|
Trpc4tm1.1Clph/Trpc4tm1.1Clph
(129S1/Sv-Trpc4tm1.1Clph)
|
abnormal single cell response
|
J:209620
|
| decreased excitatory postsynaptic current amplitude
|
J:209620
|
Trpc5tm1.1Clph/Y
(involves: 129S1/SvImJ)
|
abnormal excitatory postsynaptic currents
|
J:148915
|
Trpc5tm1.1Clph/Trpc5tm1.1Clph
(involves: 129S1/SvImJ)
|
abnormal action potential
|
J:277600
|
| abnormal excitatory postsynaptic currents
|
J:148915
|
Trpc5tm1.1Lbi/Y
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased susceptibility to neuronal excitotoxicity
|
J:194590
|
| decreased susceptibility to pharmacologically induced seizures
|
J:194590
|
| reduced long-term potentiation
|
J:194590
|
Trpc5tm1.1Lbi/Trpc5tm1.1Lbi
(involves: 129S6/SvEvTac * C57BL/6 * CBA)
|
decreased susceptibility to neuronal excitotoxicity
|
J:194590
|
| decreased susceptibility to pharmacologically induced seizures
|
J:194590
|
| reduced long-term potentiation
|
J:194590
|
Trpc5tm1.2Mfre/Trpc5tm1.2Mfre
(B6N.129-Trpc5tm1.2Mfre)
|
abnormal action potential
|
J:277600
|
Trpm1tvrm27/Trpm1+
(involves: C57BL/6J)
|
abnormal channel response
|
J:209941
|
Trpm1tvrm27/Trpm1tvrm27
(involves: C57BL/6J)
|
abnormal channel response
|
J:209941
|
Trpm2tm1Yamo/Trpm2tm1Yamo
(B6J.129S4-Trpm2tm1Yamo)
|
abnormal brain wave pattern
|
J:226171
|
Trpm3tm1Lex/Trpm3tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J)
|
abnormal sensory neuron physiology
|
J:174798
|
Trpm7tm1Agry/Trpm7+
(involves: 129)
|
abnormal channel response
|
J:205665
|
| seizures
|
J:205665
|
Trpm8tm1Apat/Trpm8tm1Apat
(involves: 129S1/Sv * C57BL/6)
|
abnormal neuron physiology
|
J:122963
|
Trpm8tm1Lex/Trpm8tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6)
|
abnormal neuron physiology
|
J:122956
|
Trpv1tm1Jbd/Trpv1tm1Jbd
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal nervous system electrophysiology
|
J:62074
|
Trpv1tm1Jbd/Trpv1tm1Jbd
(involves: 129P2/OlaHsd)
|
abnormal sensory neuron physiology
|
J:161343
|
Trpv1tm1Jul/Trpv1tm1Jul
(involves: 129X1/SvJ)
|
abnormal nervous system electrophysiology
|
J:112194
|
| abnormal neuron physiology
|
J:329699
|
| abnormal sensory neuron physiology
|
J:61534
|
| impaired ability to fire action potentials
|
J:112194
|
Trpv1tm1Jul/Trpv1tm1Jul
(B6.129X1-Trpv1tm1Jul/J)
|
abnormal action potential
|
J:109767
|
| abnormal nervous system electrophysiology
|
J:105254
|
| abnormal neuronal precursor proliferation
|
J:102006
|
| decreased synaptic depression
|
J:132936
|
| impaired ability to fire action potentials
|
J:109767
|
| reduced long-term depression
|
J:132936
|
Trpv1tm1Jul/Trpv1tm1Jul
(B6.129X1-Trpv1tm1Jul)
|
reduced long-term potentiation
|
J:117778
|
Trpv1tm1Jul/Trpv1tm1Jul
Pirttm2Xzd/Pirt+
(involves: 129X1/SvJ)
|
abnormal neuron physiology
|
J:213013
|
Trpv4tm1Rck/Trpv4tm1Rck
(involves: C57BL/6)
|
abnormal neuron physiology
|
J:107380
|
Ts(16C-tel)1Cje/0
(B6.Cg-Ts(16C-tel)1Cje)
|
abnormal GABA-mediated receptor currents
|
J:294908
|
| abnormal nervous system electrophysiology
|
J:294908
|
Tsc1tm1Djk/Tsc1+
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/cJ * C57BL/6J)
|
abnormal nervous system physiology
|
J:186699
|
Tsc1tm1Djk/Tsc1tm1.1Djk
Tg(Syn1-cre)671Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal brain wave pattern
|
J:121858
|
| abnormal myelination
|
J:136366,
J:121858
|
| seizures
|
J:121858
|
| sporadic seizures
|
J:121858
|
Tsc1tm1Djk/Tsc1tm1Djk
Tg(GFAP-cre)8Gtm/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal astrocyte physiology
|
J:134889
|
| abnormal single cell response
|
J:116872
|
| increased neuron apoptosis
|
J:134889
|
| reduced long-term potentiation
|
J:134889
|
| seizures
|
J:116872,
J:167241
|
Tsc1tm1Djk/Tsc1tm1Djk
Tg(GFAP-cre)#Gtm/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
seizures
|
J:176586
|
Tsc1tm1Djk/Tsc1tm1Djk
Tg(Pcp2-cre)2Mpin/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * BALB/cJ * C57BL/6J)
|
abnormal nervous system physiology
|
J:186699
|
Tsc1tm1Djk/Tsc1tm1Djk
Tg(Syn1-cre)671Jxm/0
(involves: 129S4/SvJae * C57BL/6 * CBA)
|
abnormal nervous system physiology
|
J:121858
|
Tsc2tm1.1Kcess/Tsc2tm1.1Kcess
Emx1tm1(cre)Krj/Emx1+
(involves: 129S/Sv * C57BL/6J)
|
environmentally induced seizures
|
J:195049
|
Tsc2tm1Djk/Tsc2+
(involves: 129S4/SvJae * C57BL/6NCrl)
|
enhanced long-term potentiation
|
J:138621
|
Tshz3tm2.1Lafa/Tshz3tm2.1Lafa
Tg(Camk2a-cre)2Gsc/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N)
|
abnormal action potential
|
J:294534
|
| abnormal excitatory postsynaptic currents
|
J:294534
|
| abnormal synaptic transmission
|
J:294534
|
| absent long-term depression
|
J:294534
|
tsl/tsl
(CByJNarl(B6NTacTcu)-tsl)
|
dysmyelination
|
J:275934
|
| seizures
|
J:275934
|
Tspan6tm2Vlcg/Tspan6tm2Vlcg
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:301767
|
| abnormal excitatory postsynaptic potential
|
J:301767
|
| reduced long-term potentiation
|
J:301767
|
Tspan7tm1Mpass/Tspan7tm1Mpass
(Not Specified)
|
abnormal action potential
|
J:247598
|
| abnormal miniature excitatory postsynaptic currents
|
J:247598
|
| reduced long-term potentiation
|
J:247598
|
Tspan13em1(IMPC)Kmpc/Tspan13em1(IMPC)Kmpc
(C57BL/6NTac-Tspan13em1(IMPC)Kmpc/Kmpc)
|
decreased prepulse inhibition
|
J:211773
|
Tspoap1em1(IMPC)H/Tspoap1em1(IMPC)H
(C57BL/6N-Tspoap1em1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Tspyl2tm1b(KOMP)Wtsi/Y
(C57BL/6N-Tspyl2tm1b(KOMP)Wtsi/Wtsi)
|
decreased prepulse inhibition
|
J:211773
|
Ttc28tm1b(EUCOMM)Hmgu/Ttc28tm1b(EUCOMM)Hmgu
(C57BL/6N-Ttc28tm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Ttpatm1Hsz/Ttpatm1Hsz
(involves: 129S7/SvEvBrd * C57BL/6J)
|
abnormal somatosensory cortex physiology
|
J:90006
|
Tuba1aem1Rstot/Tuba1aem1Rstot
(involves: C57BL/6J * C57BL/6N)
|
abnormal neuron physiology
|
J:278765
|
| increased neuronal precursor proliferation
|
J:278765
|
Tuba1aJna/Tuba1a+
(involves: BALB/cAnN * C3H/HeH)
|
abnormal neuronal migration
|
J:117881
|
Tuba1aquas/Tuba1aquas
(involves: C57BL/6J)
|
abnormal neuron physiology
|
J:278765
|
| abnormal neuronal migration
|
J:278765
|
| decreased neuronal precursor proliferation
|
J:278765
|
| increased neuron apoptosis
|
J:278765
|
| increased neuronal precursor proliferation
|
J:278765
|
Tubb2bbrdp/Tubb2bbrdp
(involves: A/J * FVB)
|
abnormal neuronal precursor proliferation
|
J:201099
|
| increased neuron apoptosis
|
J:201099
|
Tubb4aem1Avan/Tubb4a+
(involves: C57BL/6)
|
demyelination
|
J:291062
|
| dysmyelination
|
J:291062
|
Tubb4aem1Avan/Tubb4aem1Avan
(involves: C57BL/6)
|
abnormal myelination
|
J:291062
|
| demyelination
|
J:291062
|
| dysmyelination
|
J:291062
|
Tubb4aJit/Tubb4a+
(FVB.B6-Tubb4aJit)
|
dysmyelination
|
J:321692
|
Tubb4aJit/Tubb4aJit
(FVB.B6-Tubb4aJit)
|
abnormal oligodendrocyte physiology
|
J:321692
|
| dysmyelination
|
J:321692
|
| increased neuron apoptosis
|
J:321692
|
Tubb4aJit/Tubb4atm1(KOMP)Wtsi
(involves: C57BL/6 * C57BL/6N * FVB/N)
|
dysmyelination
|
J:321692
|
Tubb5tm1.1Dak/Tubb5tm1.1Dak
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased neuron apoptosis
|
J:240157
|
Tubb5tm2.1Dak/Tubb5+
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
increased neuron apoptosis
|
J:240157
|
Tubg1tm1.1Ics/Tubg1+
(involves: C57BL/6N)
|
increased susceptibility to pharmacologically induced seizures
|
J:275532
|
Tulp3tm1b(EUCOMM)Hmgu/Tulp3+
(C57BL/6N-Tulp3tm1b(EUCOMM)Hmgu/H)
|
decreased prepulse inhibition
|
J:211773
|
Tulp3tm1Jng/Tulp3+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased embryonic neuroepithelium apoptosis
|
J:70060
|
Tulp3tm1Jng/Tulp3tm1Jng
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6J)
|
increased embryonic neuroepithelium apoptosis
|
J:70060
|
| intracranial hemorrhage
|
J:70060
|
Twist1em1(IMPC)Rbrc/Twist1+
(C57BL/6NJcl-Twist1em1(IMPC)Rbrc/Rbrc)
|
decreased prepulse inhibition
|
J:211773
|
Twsg1tm1Nosa/Twsg1tm1Nosa
(involves: 129P2/OlaHsd * C57BL/6)
|
subarachnoid hemorrhage
|
J:82738
|
Ty/Y
((129P3/J x NZB/BlNJ)F1)
|
seizures
|
J:13773
|
Tyl/Y
(involves: A/J * C57BL/6J)
|
seizures
|
J:14294
|
Tymptm1Akiy/Tymptm1Akiy
Upp1tm1Akiy/Upp1tm1Akiy
(involves: 129X1/SvJ)
|
brain inflammation
|
J:78036
|
Tyro3tm1Grl/Tyro3tm1Grl
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal seizure response to inducing agent
|
J:54681
|
Tyrobptm1.1Viv/Tyrobptm1.1Viv
(B6.129P2-Tyrobptm1.1Viv)
|
abnormal excitatory postsynaptic currents
|
J:96801
|
| abnormal myelination
|
J:95232
|
| enhanced long-term potentiation
|
J:96801
|
Tyrobptm1Ttk/Tyrobptm1Ttk
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal inhibitory postsynaptic currents
|
J:81823
|
| abnormal myelination
|
J:81823
|
| decreased prepulse inhibition
|
J:81823
|
| reduced sensorimotor gating
|
J:81823
|
Uba6tm1Whpr/Uba6tm1Whpr
Tg(Nes-cre)1Kln/0
(B6.Cg-Uba6tm1Whpr Tg(Nes-cre)1Kln)
|
decreased prepulse inhibition
|
J:198126
|
Ube2atm1Agr/Y
(involves: 129P2/OlaHsd * FVB/N)
|
reduced long-term depression
|
J:227629
|
Ube2kGt(XK109)Byg/Ube2k+
(involves: 129P2/OlaHsd)
|
decreased neuron apoptosis
|
J:138978
|
Ube2kGt(XK109)Byg/Ube2kGt(XK109)Byg
(involves: 129P2/OlaHsd)
|
decreased neuron apoptosis
|
J:138978
|
Ube3atm1.1Bdph/Ube3a+
7630403G23RikTg(Th-cre)1Tmd/7630403G23Rik+
(B6.Cg-Ube3atm1.1Bdph 7630403G23RikTg(Th-cre)1Tmd)
|
abnormal GABA-mediated receptor currents
|
J:235694
|
Ube3atm1Alb/Ube3a+
(involves: 129S7/SvEvBrd * C57BL/6)
|
abnormal brain wave pattern
|
J:50811
|
| abnormal long-term potentiation
|
J:207499
|
| abnormal nervous system electrophysiology
|
J:50811
|
| absence seizures
|
J:50811
|
| audiogenic seizures
|
J:50811
|
| reduced long-term potentiation
|
J:50811
|
| tonic-clonic seizures
|
J:50811
|
Ube3atm1Alb/Ube3a+
(involves: 129S7/SvEvBrd)
|
audiogenic seizures
|
J:50811
|
| tonic-clonic seizures
|
J:50811
|
Ube3atm1Alb/Ube3atm1Alb
(involves: 129S7/SvEvBrd * C57BL/6)
|
audiogenic seizures
|
J:50811
|
Ube3atm1Alb/Ube3atm1Alb
(involves: 129S7/SvEvBrd)
|
audiogenic seizures
|
J:50811
|
Ube3atm1Jwf/Ube3a+
(B6.129S4-Ube3atm1Jwf)
|
abnormal brain wave pattern
|
J:102546
|
| abnormal nervous system electrophysiology
|
J:95305
|
| abnormal spike wave discharge
|
J:102546,
J:75622,
J:95305
|
Ube3atm1Yelg/Ube3a+
(involves: 129P2/OlaHsd * 129S2/SvPasCrl)
|
audiogenic seizures
|
J:222400
|
Ube3ctm1b(EUCOMM)Hmgu/Ube3ctm1b(EUCOMM)Hmgu
(C57BL/6NCrl-Ube3ctm1b(EUCOMM)Hmgu/Rbrc)
|
decreased prepulse inhibition
|
J:211773
|
Ube4btm1Kei/Ube4btm1Kei
(involves: C57BL/6)
|
intraventricular hemorrhage
|
J:103761
|
Ubl4bem1(IMPC)Ccpcz/Ubl4bem1(IMPC)Ccpcz
(C57BL/6N-Ubl4bem1(IMPC)Ccpcz/Ccpcz)
|
increased prepulse inhibition
|
J:211773
|
Ubox5tm1b(EUCOMM)Hmgu/Ubox5tm1b(EUCOMM)Hmgu
(C57BL/6N-Ubox5tm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Ubqln4em1(IMPC)Mbp/Ubqln4em1(IMPC)Mbp
(C57BL/6NCrl-Ubqln4em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Ubr1tm1Avar/Ubr1tm1Avar
Ubr2tm1Ytkw/Ubr2tm1Ytkw
(involves: 129S1/Sv * C57BL/6)
|
increased neural tube apoptosis
|
J:109036
|
Uchl1tm1Dgen/Uchl1tm1Dgen
(B6.129P2-Uchl1tm1Dgen/Mmnc)
|
abnormal endplate potential
|
J:156538
|
| abnormal miniature endplate potential
|
J:156538
|
| abnormal PNS synaptic transmission
|
J:156538
|
| abnormal synaptic plasticity
|
J:156538
|
| decreased neurotransmitter release
|
J:156538
|
| decreased paired-pulse facilitation
|
J:156538
|
| increased synaptic depression
|
J:156538
|
Ucp2Gt(S20-3G1)Sor/Ucp2Gt(S20-3G1)Sor
(Not Specified)
|
abnormal hypothalamus physiology
|
J:139938
|
Ucp2tm1Lowl/Ucp2tm1Lowl
(involves: 129S4/SvJae * C57BL/6)
|
increased susceptibility to dopaminergic neuron neurotoxicity
|
J:96713
|
Ucp2tm1Rcq/Ucp2tm1Rcq
(involves: 129X1/SvJ * C57BL/6)
|
decreased cerebral infarct size
|
J:107995
|
| decreased neuron apoptosis
|
J:107995
|
| decreased susceptibility to ischemic brain injury
|
J:107995
|
Ucp2tm2.1Lowl/Ucp2tm2.1Lowl
Tg(CAG-Bgeo/GFP)21Lbe/0
Tg(Pmch-cre)1Lowl/0
(involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * FVB/NJ)
|
abnormal single cell response
|
J:167906
|
Ufm1tm1.1Kmts/Ufm1tm1.1Kmts
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * C57BL/6N * SJL)
|
increased brain apoptosis
|
J:240522
|
| increased neuron apoptosis
|
J:240522
|
Ugcgtm1Hjg/Ugcgtm1.1Hjg
Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal myelination
|
J:101155
|
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(involves: 129 * C57BL/6 * SJL)
|
increased neuron apoptosis
|
J:182805
|
Ugt1tm1.1Afmu/Ugt1tm1.1Afmu
(FVB.Cg-Ugt1tm1.1Afmu)
|
encephalopathy
|
J:216224
|
| seizures
|
J:216224
|
Ugt8atm1Pop/Ugt8atm1Pop
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal myelination
|
J:78426
|
| abnormal nerve conduction
|
J:78426,
J:58935
|
Ugt8atm1Wst/Ugt8atm1Wst
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal nerve conduction
|
J:36558
|
| demyelination
|
J:48209,
J:36558
|
Ulk4tm1a(KOMP)Wtsi/Ulk4tm1a(KOMP)Wtsi
(involves: C57BL/6N)
|
abnormal brain ependyma motile cilium physiology
|
J:234631
|
| abnormal cerebrospinal fluid flow
|
J:234631
|
Ulk4tm1Lex/Ulk4tm1Lex
(involves: 129S5/SvEvBrd * C57BL/6J)
|
intraventricular hemorrhage
|
J:185566
|
Unc5atm1Lhck/Unc5atm1Lhck
(involves: 129P2/OlaHsd)
|
decreased neuron apoptosis
|
J:111725
|
Unc5crcm/Unc5crcm
(B6C3Fe a/a-Unc5crcm/J)
|
abnormal neuronal migration
|
J:45577
|
Unc5dtm1Kln/Unc5dtm1Kln
(involves: 129S/SvEv * C57BL/6)
|
abnormal neuronal migration
|
J:196042
|
Unc13atm1Bros/Unc13atm1Bros
(involves: 129)
|
abnormal CNS synaptic transmission
|
J:138035
|
| decreased neurotransmitter release
|
J:77339
|
Unc13atm1Bros/Unc13atm1Bros
Unc13btm2Bros/Unc13btm2Bros
(involves: 129)
|
abnormal excitatory postsynaptic currents
|
J:167753
|
| abnormal neuron physiology
|
J:167753
|
| abnormal synaptic transmission
|
J:77339
|
Unc13atm2Bros/Unc13a+
Unc13btm2Bros/Unc13btm2Bros
(Not Specified)
|
abnormal excitatory postsynaptic currents
|
J:117827
|
Unc13atm2Bros/Unc13atm2Bros
(involves: FVB/N)
|
abnormal excitatory postsynaptic currents
|
J:74347
|
| abnormal synaptic vesicle recycling
|
J:74347
|
Unc13atm2Bros/Unc13atm2Bros
Unc13btm2Bros/Unc13btm2Bros
(Not Specified)
|
abnormal excitatory postsynaptic currents
|
J:117827
|
| abnormal long-term depression
|
J:117827
|
| abnormal miniature excitatory postsynaptic currents
|
J:117827
|
Unc13atm4.1Bros/Unc13atm4.1Bros
(involves: FVB/N)
|
abnormal CNS synaptic transmission
|
J:201701
|
| abnormal neuron physiology
|
J:201701
|
| decreased synaptic depression
|
J:201701
|
Unc13btm2Bros/Unc13btm2Bros
(Not Specified)
|
sporadic seizures
|
J:77339
|
Unc13ctm1Bros/Unc13ctm1Bros
(B6.129P2-Unc13ctm1Bros)
|
abnormal CNS synaptic transmission
|
J:66984
|
| enhanced paired-pulse facilitation
|
J:66984
|
Unc13dtm1(KOMP)Vlcg/Unc13dtm1(KOMP)Vlcg
(involves: C57BL/6NTac)
|
decreased cerebral infarct size
|
J:231217
|
| decreased susceptibility to ischemic brain injury
|
J:231217
|
Unc80em1Dren/Unc80em1Dren
(C57BL/6J-Unc80em1Dren)
|
abnormal channel response
|
J:291847
|
| abnormal nervous system electrophysiology
|
J:291847
|
Unc80em2Dren/Unc80em2Dren
(involves: C57BL/6J * SJL/J)
|
abnormal channel response
|
J:291847
|
| abnormal nervous system electrophysiology
|
J:291847
|
Ungtm1Mend/Ungtm1Mend
(involves: 129S4/SvJae * BALB/c)
|
increased susceptibility to ischemic brain injury
|
J:90910
|
Upf2tm1Btp/Upf2tm1Btp
En1tm2(cre)Wrst/En1+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
increased neuron apoptosis
|
J:306384
|
| increased neuronal precursor proliferation
|
J:306384
|
Upf2tm1Btp/Upf2tm1Btp
Tg(Atoh1-cre)1Bfri/0
(involves: 129P2/OlaHsd * C57BL/6 * CBA)
|
increased neuronal precursor proliferation
|
J:306384
|
Upf3bGt(IST14619B5)Tigm/Y
(involves: C57BL/6J * C57BL/6N)
|
decreased prepulse inhibition
|
J:253157
|
| increased neuronal precursor proliferation
|
J:253157
|
Upf3bGt(IST14619B5)Tigm/Upf3bGt(IST14619B5)Tigm
(involves: C57BL/6J * C57BL/6N)
|
decreased prepulse inhibition
|
J:253157
|
| increased neuronal precursor proliferation
|
J:253157
|
Uqcrc1tm1Zzuo/Uqcrc1+
(involves: 129P2/OlaHsd * C57BL/6N)
|
increased susceptibility to ischemic brain injury
|
J:285933
|
Uqcrfs1tm1Ctm/Uqcrfs1tm1Ctm
Tg(Camk2a-cre)#Szi/0
(involves: 129 * C57BL/6 * C57BL/6J * CBA)
|
abnormal glial cell physiology
|
J:188773
|
Use1tm1.1Aha/Use1tm1.1Aha
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal nervous system physiology
|
J:147771
|
Usf1tm1Msw/Usf1tm1Msw
(involves: 129S7/SvEvBrd * C57BL/6)
|
environmentally induced seizures
|
J:46788
|
| sporadic seizures
|
J:46788
|
Usf2tm1Msw/Usf2tm1Msw
(involves: 129S7/SvEvBrd * C57BL/6)
|
sporadic seizures
|
J:46788
|
Ush1cdfcr/Ush1cdfcr
(involves: BALB/cBySmn * C57BL/6 * C57BL/Ka)
|
abnormal hair cell mechanoelectric transduction
|
J:157359
|
Ush1gtm1.2Ugds/Ush1gtm1.2Ugds
(involves: 129S1/SvImJ * BALB/c * C57BL/6 * C57BL/6J)
|
abnormal hair cell mechanoelectric transduction
|
J:171218
|
| absent cochlear microphonics
|
J:171218
|
Usp14ax-J/Usp14ax-J
(B6.Cg-Usp14ax-J/J)
|
abnormal miniature endplate potential
|
J:79322
|
| abnormal neurotransmitter secretion
|
J:79322
|
| abnormal synaptic transmission
|
J:79322
|
| decreased paired-pulse facilitation
|
J:79322,
J:142436
|
| decreased post-tetanic potentiation
|
J:79322
|
| impaired synaptic plasticity
|
J:79322
|
| increased neuron apoptosis
|
J:108034
|
| increased synaptic depression
|
J:142436
|
| reduced long-term potentiation
|
J:79322
|
Usp14nmf375/Usp14nmf375
(C.B6-Usp14nmf375)
|
abnormal nervous system physiology
|
J:203043
|
Usp18tm1Dez/Usp18tm1Dez
(involves: 129S1/Sv * 129X1/SvJ)
|
convulsive seizures
|
J:78821
|
| intracerebral hemorrhage
|
J:78821
|
Usp29em1(IMPC)Tcp/Usp29em1(IMPC)Tcp
(C57BL/6NCrl-Usp29em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Usp31em1(IMPC)H/Usp31em1(IMPC)H
(C57BL/6NTac-Usp31em1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Usp38tm1b(EUCOMM)Hmgu/Usp38tm1b(EUCOMM)Hmgu
(C57BL/6N-Usp38tm1b(EUCOMM)Hmgu/H)
|
decreased prepulse inhibition
|
J:211773
|
Usp50tm1(KOMP)Vlcg/Usp50+
(C57BL/6N-Usp50tm1(KOMP)Vlcg/Nju)
|
decreased prepulse inhibition
|
J:211773
|
Usp53em1(IMPC)Tcp/Usp53em1(IMPC)Tcp
(C57BL/6N-Usp53em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Utrntm1Jrs/Utrntm1Jrs
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
abnormal nervous system physiology
|
J:89397
|
Utrntm1Ked/Utrntm1Ked
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA)
|
abnormal miniature endplate potential
|
J:70949
|
Vac14Gt(RRP155)Byg/Vac14Gt(RRP155)Byg
(involves: 129P2/OlaHsd * C57BL/6J)
|
increased forebrain apoptosis
|
J:127106
|
| increased hindbrain apoptosis
|
J:127106
|
| increased midbrain apoptosis
|
J:127106
|
Vamp2tm1Sud/Vamp2+
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:228428
|
| abnormal excitatory postsynaptic potential
|
J:228428
|
| enhanced paired-pulse facilitation
|
J:228428
|
Vamp2tm1Sud/Vamp2tm1Sud
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal miniature excitatory postsynaptic currents
|
J:72714
|
| decreased neurotransmitter release
|
J:72714
|
Vamp2tm1Sud/Vamp2tm1Sud
Vamp3tm1Jpes/Vamp3tm1Jpes
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ)
|
abnormal neurotransmitter secretion
|
J:109985
|
| decreased miniature excitatory postsynaptic current frequency
|
J:109985
|
Vav3tm1Xrb/Vav3tm1Xrb
(Not Specified)
|
abnormal sympathetic nervous system physiology
|
J:111973
|
Vcltm1.1Whz/Vcltm1.1Whz
(involves: 129/Sv * C57BL/6 * SJL)
|
increased embryonic neuroepithelium apoptosis
|
J:163108
|
Vcptm1.1Hiok/Vcp+
(B6(Cg)-Vcptm1.1Hiok)
|
decreased neuronal stem cell self-renewal
|
J:308471
|
Vcptm1Itl/Vcp+
(B6.129S-Vcptm1Itl)
|
seizures
|
J:166230
|
| tonic-clonic seizures
|
J:166230
|
Vdac1tm1Wjc/Vdac1tm1Wjc
(involves: 129S7/SvEvBrd)
|
reduced long-term potentiation
|
J:76838
|
Vdac1tm1Wjc/Vdac1tm1Wjc
Vdac3tm1Wjc/Vdac3tm1Wjc
(involves: 129S7/SvEvBrd)
|
decreased paired-pulse facilitation
|
J:76838
|
| reduced long-term potentiation
|
J:76838
|
Vdac3tm1Wjc/Vdac3tm1Wjc
(Not Specified)
|
decreased paired-pulse facilitation
|
J:76838
|
Vdrem1(IMPC)Hmgu/Vdrem1(IMPC)Hmgu
(C57BL/6NCrl-Vdrem1(IMPC)Hmgu/Ieg)
|
increased prepulse inhibition
|
J:211773
|
Vdrtm1Ska/Vdrtm1Ska
(involves: 129 * C57BL/6NCrlj * CBA/JNCrlj)
|
decreased prepulse inhibition
|
J:95324
|
Vegfatm1Gne/Vegfa+
(involves: 129S2/SvPas * C57BL/6J)
|
increased embryonic neuroepithelium apoptosis
|
J:32218
|
Vegfatm1Pec/Vegfatm1Pec
(involves: 129S1/Sv * 129X1/SvJ)
|
abnormal neuronal migration
|
J:94050
|
| increased neuron apoptosis
|
J:175836
|
Vegfatm2Gne/Vegfatm2.1Nagy
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CD-1 * SJL)
|
abnormal neuron physiology
|
J:86207
|
| abnormal neuron proliferation
|
J:86207
|
Vgfem1(IMPC)H/Vgfem1(IMPC)H
(C57BL/6NTac-Vgfem1(IMPC)H/H)
|
decreased prepulse inhibition
|
J:211773
|
Vgftm1Srjs/Vgftm1Srjs
(B6.129-Vgftm1Srjs)
|
reduced long-term depression
|
J:143370
|
Vkorc1tm1.1Jobg/Vkorc1tm1.1Jobg
(involves: 129S4/SvJae * BALB/cJ * C57BL/6)
|
intracerebral hemorrhage
|
J:207884
|
| subdural hemorrhage
|
J:207884
|
Vldlrtm1Her/Vldlrtm1Her
(involves: 129S7/SvEvBrd)
|
abnormal long-term potentiation
|
J:79593
|
| impaired synaptic plasticity
|
J:79593
|
| reduced long-term potentiation
|
J:79593
|
Vmn2r26tm2Mom/Vmn2r26tm2Mom
(involves: 129P2/OlaHsd * C57BL/6J)
|
abnormal vomeronasal sensory neuron physiology
|
J:154507
|
| avnosmia
|
J:154507
|
Vmn2r116tm1.1Ktou/Vmn2r116tm1.1Ktou
(involves: C57BL/6)
|
abnormal vomeronasal organ physiology
|
J:267556
|
Vps13atm1Asan/Vps13atm1Asan
(involves: 129S/SvEv * C57BL/6J)
|
abnormal synaptic neurotransmitter level
|
J:96243
|
Vps18tm1.1Wtao/Vps18tm1.1Wtao
Tg(Nes-cre)1Kln/0
(involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6 * SJL)
|
abnormal neuron physiology
|
J:186307
|
| abnormal neuronal migration
|
J:186307
|
| increased neuron apoptosis
|
J:186307
|
Vps35Gt(RRK261)Byg/Vps35+
Tg(APPSWE)2576Kha/0
(involves: 129P2/OlaHsd * C57BL/6 * SJL)
|
abnormal excitatory postsynaptic potential
|
J:178937
|
| abnormal miniature excitatory postsynaptic currents
|
J:178937
|
| decreased post-tetanic potentiation
|
J:178937
|
| impaired synaptic plasticity
|
J:178937
|
| reduced AMPA-mediated synaptic currents
|
J:178937
|
| reduced long-term potentiation
|
J:178937
|
| reduced NMDA-mediated synaptic currents
|
J:178937
|
Vps37dtm2b(EUCOMM)Wtsi/Vps37d+
(C57BL/6N-Vps37dtm2b(EUCOMM)Wtsi/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Vps54wr/Vps54wr
(multiple strains)
|
abnormal axonal transport
|
J:8186,
J:14361
|
| abnormal CNS synaptic transmission
|
J:3719,
J:15226,
J:35070
|
| abnormal myelination
|
J:5331
|
| abnormal nervous system physiology
|
J:5525
|
| demyelination
|
J:5525
|
Vps54wr/Vps54wr
(involves: C57BL/6J * C57BL/Fa)
|
abnormal GABA-mediated receptor currents
|
J:181019
|
| abnormal GABAergic neuron physiology
|
J:181019
|
| abnormal inhibitory postsynaptic currents
|
J:181019
|
| abnormal miniature inhibitory postsynaptic currents
|
J:181019
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:181019
|
| increased microglial cell activation
|
J:181019
|
Vrk2em9Gpt/Vrk2em9Gpt
(C57BL/6J-Vrk2em9Gpt)
|
impaired synaptic physiology
|
J:344885
|
Vrk3Gt(YTA189)Byg/Vrk3Gt(YTA189)Byg
(B6.129P2-Vrk3Gt(YTA189)Byg)
|
abnormal AMPA-mediated synaptic currents
|
J:249352
|
Vsx2tm1.1(DTA)Kash/Vsx2+
(involves: 129S4/SvJae * C57BL/6)
|
abnormal nervous system physiology
|
J:145621
|
Vti1atm1Gfvm/Vti1atm1Gfvm
Vti1btm1Gfvm/Vti1btm1Gfvm
(involves: 129P2/OlaHsd * C57BL/6)
|
increased neuron apoptosis
|
J:169107
|
Vwftm1Wgr/Vwftm1Wgr
(B6.129S2-Vwftm1Wgr)
|
impaired blood-brain barrier function
|
J:140334
|
Vwftm1Wgr/Vwftm1Wgr
(involves: 129S2/SvPas)
|
decreased susceptibility to ischemic brain injury
|
J:148295
|
Wasf1tm1Jsco/Wasf1tm1Jsco
(involves: 129X1/SvJ * C57BL/6)
|
abnormal CNS synaptic transmission
|
J:117303
|
| abnormal excitatory postsynaptic potential
|
J:117303
|
| abnormal neuron physiology
|
J:117303
|
| abnormal NMDA-mediated synaptic currents
|
J:117303
|
| enhanced long-term potentiation
|
J:117303
|
| reduced long-term depression
|
J:117303
|
Wasf1tm2Jsco/Wasf1tm2Jsco
(involves: 129X1/SvJ * C57BL/6)
|
abnormal excitatory postsynaptic potential
|
J:117303
|
| enhanced long-term potentiation
|
J:117303
|
Wasf2tm1Tta/Wasf2tm1Tta
(involves: 129P2/OlaHsd * C57BL/6J)
|
intracranial hemorrhage
|
J:84651
|
Washc4em1Ssod/Washc4em1Ssod
(involves: C57BL/6J * SJL/J)
|
increased neuron apoptosis
|
J:303795
|
Wbp1ltm2b(EUCOMM)Hmgu/Wbp1ltm2b(EUCOMM)Hmgu
(C57BL/6N-Wbp1ltm2b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Wdfy3disc/Wdfy3disc
(involves: C57BL/6J * FVB/NJ)
|
abnormal neuronal migration
|
J:225200
|
| abnormal neuronal precursor proliferation
|
J:225200
|
Wdfy3tm1a(KOMP)Mbp/Wdfy3tm1a(KOMP)Mbp
(C57BL/6N-Wdfy3tm1a(KOMP)Mbp)
|
abnormal neuronal migration
|
J:225200
|
Wdr11Gt(Ayu21-KBW205)Imeg/Wdr11Gt(Ayu21-KBW205)Imeg
(B6.Cg-Wdr11Gt(Ayu21-KBW205)Imeg)
|
abnormal hypothalamus physiology
|
J:257035
|
| abnormal neuronal migration
|
J:257035
|
Wdr33em1(IMPC)Tcp/Wdr33+
(C57BL/6NCrl-Wdr33em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Wdr45tm1Beij/Y
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6N * SJL)
|
abnormal excitatory postsynaptic potential
|
J:281235
|
| demyelination
|
J:281235
|
| reduced long-term potentiation
|
J:281235
|
Wdr62em1(IMPC)Tcp/Wdr62em1(IMPC)Tcp
(C57BL/6NCrl-Wdr62em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Wdr62Gt(AF0003)Wtsi/Wdr62Gt(AF0003)Wtsi
(involves: 129P2/OlaHsd * 129S1/SvImJ)
|
abnormal nervous system physiology
|
J:224504
|
Wdr62tm1.1Jfch/Wdr62tm1.1Jfch
(involves: 129S1/SvImJ * C57BL/6N)
|
increased forebrain apoptosis
|
J:282438
|
Wdr91tm2Bcgen/Wdr91tm2Bcgen
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
increased neuron apoptosis
|
J:247712
|
Whrntm1b(EUCOMM)Wtsi/Whrntm1b(EUCOMM)Wtsi
(involves: 129S7/SvEvBrd * C57BL/6N)
|
abnormal cochlear outer hair cell physiology
|
J:235390
|
Whrnwi/Whrnwi
(involves: STOCK a Tyrp1b Myo5ad Oca2p Ednrbs)
|
absent cochlear microphonics
|
J:235390
|
| absent cochlear nerve compound action potential
|
J:235390
|
Wlds/Wlds
(C57BL/6Ola-Wlds)
|
abnormal peripheral nervous system regeneration
|
J:12834
|
| delayed peripheral nervous system regeneration
|
J:12834,
J:19951
|
| slow Wallerian degeneration
|
J:15229,
J:3359,
J:19951,
J:19950
|
Wnk1Gt(OST38262)Lex/Wnk1Gt(OST38262)Lex
(involves: 129S5/SvEvBrd)
|
intracranial hemorrhage
|
J:152906
|
Wnt5atm1Amc/Wnt5atm1.1Krvl
H2az2Tg(Wnt1-cre)11Rth/H2az2+
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * CBA/J)
|
increased neuron apoptosis
|
J:196291
|
Wwc1tm1.1Rlh/Wwc1tm1.1Rlh
(involves: 129 * C57BL/6)
|
reduced long-term depression
|
J:178552
|
| reduced long-term potentiation
|
J:178552
|
Wwoxem1Mald/Wwoxem1Mald
(FVB/N-Wwoxem1Mald)
|
convulsive seizures
|
J:339564
|
| tonic-clonic seizures
|
J:339564
|
Wwoxtm1Ria/Wwoxtm1Ria
(involves: 129X1/SvJ * C57BL/6J)
|
abnormal pituitary gland physiology
|
J:146986
|
Xkr5tm1b(KOMP)Mbp/Xkr5tm1b(KOMP)Mbp
(C57BL/6N-Xkr5tm1b(KOMP)Mbp/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Xpo4em1Gshan/Xpo4+
(involves: C57BL/6J)
|
abnormal hippocampus physiology
|
J:330082
|
Xrcc1tm1Pmc/Xrcc1tm1Pmc
Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * C57BL/6 * SJL)
|
increased neuron apoptosis
|
J:152528
|
| seizures
|
J:152528
|
Xrcc2tm1Jtk/Xrcc2tm1Jtk
(involves: 129S/SvEv * C57BL/6)
|
increased neuron apoptosis
|
J:66529
|
Xrcc4tm1Fwa/Xrcc4tm1Fwa
(involves: 129P2/OlaHsd)
|
increased neuron apoptosis
|
J:110848
|
Xrcc5tm1Dbr/Xrcc5tm1Dbr
(Not Specified)
|
increased neuron apoptosis
|
J:110848
|
Xrcc6tm1Fwa/Xrcc6tm1Fwa
(involves: 129S6/SvEvTac)
|
increased neuron apoptosis
|
J:110848
|
Xrn1em1Tya/Xrn1em1Tya
Tg(Camk2a-cre)2Gsc/0
(involves: C57BL/6N * FVB/N)
|
abnormal hypothalamus physiology
|
J:342928
|
Yae1d1tm1b(EUCOMM)Hmgu/Yae1d1+
(C57BL/6N-Yae1d1tm1b(EUCOMM)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Yap1tm1.1Hmc/Yap1+
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * C57BL/6NCrl)
|
abnormal glial cell physiology
|
J:304126
|
Ybx1tm1Ley/Ybx1tm1Ley
(either: 129X1/SvJ-Ybx1tm1Ley or (involves: 129X1/SvJ * C57BL/6))
|
intracerebral hemorrhage
|
J:99099
|
Yipf5tm1b(EUCOMM)Hmgu/Yipf5+
(C57BL/6N-Yipf5tm1b(EUCOMM)Hmgu/Ics)
|
increased prepulse inhibition
|
J:211773
|
Ypel2em1(IMPC)Tcp/Ypel2em1(IMPC)Tcp
(C57BL/6N-Ypel2em1(IMPC)Tcp/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Ythdf1em1Chhe/Ythdf1em1Chhe
(B6.Cg-Ythdf1em1Chhe)
|
abnormal excitatory postsynaptic potential
|
J:267186
|
| abnormal miniature excitatory postsynaptic currents
|
J:267186
|
| abnormal paired-pulse ratio
|
J:267186
|
| impaired synaptic plasticity
|
J:267186
|
| reduced long-term potentiation
|
J:267186
|
Ywhaetm1Awb/Ywhaetm1Awb
(either: 129S6/SvEvTac or (involves: 129S6/SvEvTac * NIH Black Swiss))
|
abnormal neuronal migration
|
J:84075
|
YwhazGt(OST432062)Lex/YwhazGt(OST432062)Lex
(either: B6.129S5-YwhazGt(OST432062)Lex or C.129S5-YwhazGt(OST432062)Lex or (involves: 129S5/SvEvBrd * 129T2/SvEmsWehi)))
|
abnormal neuronal migration
|
J:217297
|
| decreased prepulse inhibition
|
J:217297
|
Zbtb16em1(IMPC)Mbp/Zbtb16em1(IMPC)Mbp
(C57BL/6NCrl-Zbtb16em1(IMPC)Mbp/MbpMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Zbtb18tm1.1Nda/Zbtb18tm1.1Nda
Tg(Nes-cre)1Kln/0
(involves: C57BL/6 * SJL)
|
abnormal neuronal migration
|
J:184434
|
| increased neuron apoptosis
|
J:184434
|
Zbtb18tm1Haok/Zbtb18tm1Haok
(involves: 129/Sv * C57BL/6)
|
abnormal neuron physiology
|
J:150768
|
| increased neuron apoptosis
|
J:150768
|
Zbtb18tm1Haok/Zbtb18tm1Haok
(involves: 129)
|
abnormal neuronal migration
|
J:196306
|
| abnormal neuronal precursor proliferation
|
J:196306
|
| increased neuron apoptosis
|
J:196306
|
Zbtb18tm2.1Haok/Zbtb18tm2.1Haok
(involves: 129)
|
abnormal neuronal migration
|
J:196306
|
Zbtb20Tg(PDGFB-APPSwInd)20Lms/0
(involves: C57BL/6 * DBA/2)
|
increased susceptibility to pharmacologically induced seizures
|
J:121330
|
Zbtb42em1(IMPC)Mbp/Zbtb42em1(IMPC)Mbp
(C57BL/6NCrl-Zbtb42em1(IMPC)Mbp/Mmucd)
|
decreased prepulse inhibition
|
J:211773
|
Zdhhc3tm1.2Lusc/Zdhhc3tm1.2Lusc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal GABAergic neuron physiology
|
J:237763
|
Zdhhc3tm1.2Lusc/Zdhhc3tm1.2Lusc
Zdhhc7tm1.2Lusc/Zdhhc7tm1.2Lusc
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal GABAergic neuron physiology
|
J:237763
|
| abnormal miniature excitatory postsynaptic currents
|
J:237763
|
| abnormal miniature inhibitory postsynaptic currents
|
J:237763
|
| decreased miniature inhibitory postsynaptic current amplitude
|
J:237763
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:237763
|
Zdhhc5em1Eko/Zdhhc5em1Eko
(involves: C57BL/6)
|
abnormal synaptic vesicle clustering
|
J:329241
|
Zdhhc7tm1.1Wqz/Zdhhc7tm1.1Wqz
(involves: 129S/Sv * C57BL/6J)
|
abnormal CNS synaptic transmission
|
J:293082
|
| abnormal inhibitory postsynaptic currents
|
J:293082
|
| abnormal miniature excitatory postsynaptic currents
|
J:293082
|
| abnormal miniature inhibitory postsynaptic currents
|
J:293082
|
| decreased excitatory postsynaptic current amplitude
|
J:293082
|
| decreased miniature inhibitory postsynaptic current frequency
|
J:293082
|
| impaired synaptic plasticity
|
J:293082
|
| increased miniature inhibitory postsynaptic current amplitude
|
J:293082
|
| reduced long-term potentiation
|
J:293082
|
Zdhhc8tm1Kara/Zdhhc8tm1Kara
(involves: 129/Sv * C57BL/6)
|
decreased prepulse inhibition
|
J:91131
|
Zdhhc13Gt(AC0492)Wtsi/Zdhhc13Gt(AC0492)Wtsi
(FVB.129P2-Zdhhc13Gt(AC0492)Wtsi)
|
increased neuron apoptosis
|
J:191129
|
Zdhhc17Gt(RRJ233)Byg/Zdhhc17Gt(RRJ233)Byg
(FVB.129P2-Zdhhc17Gt(RRJ233)Byg)
|
decreased prepulse inhibition
|
J:175800
|
| increased neuron apoptosis
|
J:175800
|
Zdhhc24tm1b(EUCOMM)Hmgu/Zdhhc24tm1b(EUCOMM)Hmgu
(C57BL/6N-Zdhhc24tm1b(EUCOMM)Hmgu/H)
|
decreased prepulse inhibition
|
J:211773
|
Zfhx2tm3Ymri/Zfhx2tm3Ymri
(involves: 129P2/OlaHsd * C57BL/6)
|
abnormal nervous system electrophysiology
|
J:266472
|
Zfp14tm1b(KOMP)Wtsi/Zfp14tm1b(KOMP)Wtsi
(C57BL/6N-Zfp14tm1b(KOMP)Wtsi/J)
|
convulsive seizures
|
J:211773
|
Zfp24hmcns-2J/Zfp24hmcns-2J
(CByJ(Cg)-Zfp24hmcns-2J/GrsrJ)
|
abnormal myelination
|
J:202595
|
| tonic seizures
|
J:202595
|
Zfp24hmcns/Zfp24hmcns
(C3.Cg-a Zfp24hmcns/GrsrJ)
|
tonic seizures
|
J:156938
|
Zfp24tm1.1Pop/Zfp24tm1.1Pop
Cnptm1(cre)Kan/Cnp+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6)
|
tonic seizures
|
J:156938
|
Zfp24tm1.2Pop/Zfp24tm1.2Pop
(involves: 129S4/SvJae * C57BL/6)
|
abnormal myelination
|
J:156938
|
| tonic seizures
|
J:156938
|
Zfp106tm1a(KOMP)Wtsi/Zfp106tm1a(KOMP)Wtsi
(involves: C57BL/6Brd * C57BL/6Dnk * C57BL/6N)
|
increased spinal cord apoptosis
|
J:229162
|
Zfp260tm1b(NCOM)Mfgc/Zfp260+
(C57BL/6N-Zfp260tm1b(NCOM)Mfgc/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Zfp276tm1c(EUCOMM)Hmgu/Zfp276tm1c(EUCOMM)Hmgu
Tg(Sox10-cre)1Wdr/0
(involves: C57BL/6 * C57BL/6N * CBA)
|
abnormal myelination
|
J:324574
|
| abnormal oligodendrocyte differentiation
|
J:324574
|
| dysmyelination
|
J:324574
|
Zfp280dem1(IMPC)Hmgu/Zfp280dem1(IMPC)Hmgu
(C57BL/6N-Zfp280dem1(IMPC)Hmgu/Ieg)
|
decreased prepulse inhibition
|
J:211773
|
Zfp365tm1That/Zfp365tm1That
(B6.Cg-Zfp365tm1That)
|
abnormal myelination
|
J:207476
|
Zfp385atm1Ber/Zfp385atm1Ber
(involves: 129S1/Sv * 129X1/SvJ * CD-1)
|
intracranial hemorrhage
|
J:93829
|
Zfp423tm1Reed/Zfp423tm1Reed
(involves: 129 * C57BL/6)
|
abnormal cerebellar granule cell precursor proliferation
|
J:122606
|
Zfp503tm1.1Lif/Zfp503tm1.1Lif
(involves: 129 * C57BL/6)
|
abnormal neuronal migration
|
J:286635
|
Zfp521tm1Nohk/Zfp521tm1Nohk
(B6J.Cg-Zfp521tm1Nohk)
|
abnormal neuronal stem cell physiology
|
J:214267
|
| decreased prepulse inhibition
|
J:214267
|
Zfp597tm1Hnawa/Zfp597+
(B6.Cg-Zfp597tm1Hnawa)
|
seizures
|
J:278329
|
Zfp609tm1b(EUCOMM)Hmgu/Zfp609+
(C57BL/6N-Zfp609tm1b(EUCOMM)Hmgu/Bay)
|
decreased prepulse inhibition
|
J:211773
|
Zfp787em1(IMPC)J/Zfp787em1(IMPC)J
(C57BL/6NJ-Zfp787em1(IMPC)J/Mmjax)
|
decreased prepulse inhibition
|
J:211773
|
Zfp804aem1Yqd/Zfp804aem1Yqd
(involves: C57BL/6 * FVB/N)
|
decreased prepulse inhibition
|
J:312498
|
Zgpattm1b(EUCOMM)Hmgu/Zgpattm1b(EUCOMM)Hmgu
(C57BL/6N-Zgpattm1b(EUCOMM)Hmgu/Tcp)
|
decreased prepulse inhibition
|
J:211773
|
Zic2tm1Jaru/Zic2+
(B6.129S4-Zic2tm1Jaru)
|
decreased prepulse inhibition
|
J:72342
|
Zmym2em1(IMPC)Bay/Zmym2+
(C57BL/6N-Zmym2em1(IMPC)Bay/BayMmucd)
|
decreased prepulse inhibition
|
J:211773
|
Zmynd10tm1(KOMP)Wtsi/Zmynd10tm1(KOMP)Wtsi
(involves: C57BL/6J * C57BL/6N)
|
abnormal brain ependyma motile cilium physiology
|
J:261915
|
Znhit6em1(IMPC)Mbp/Znhit6+
(C57BL/6N-Znhit6em1(IMPC)Mbp/Ucd)
|
decreased prepulse inhibition
|
J:211773
|
Zscan10Gt(285B6)1.1Cmhd/Zscan10Gt(285B6)1.1Cmhd
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N)
|
increased prepulse inhibition
|
J:221010
|
Analysis Tools